Citrus Sinensis ID: 021897
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 306 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.584 | 0.458 | 0.446 | 2e-44 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.568 | 0.105 | 0.360 | 1e-30 | |
| P18160 | 2410 | Dual specificity protein | yes | no | 0.558 | 0.070 | 0.398 | 8e-29 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.598 | 0.199 | 0.342 | 4e-28 | |
| Q66L42 | 940 | Mitogen-activated protein | yes | no | 0.549 | 0.178 | 0.401 | 6e-27 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.604 | 0.143 | 0.35 | 7e-27 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.571 | 0.107 | 0.313 | 7e-27 | |
| Q02779 | 954 | Mitogen-activated protein | yes | no | 0.549 | 0.176 | 0.401 | 2e-26 | |
| Q55EC7 | 960 | RasGEF domain-containing | no | no | 0.575 | 0.183 | 0.379 | 6e-26 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.545 | 0.143 | 0.376 | 2e-25 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 179 bits (454), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 80/179 (44%), Positives = 120/179 (67%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
+EWT DL +L +G FA GA ++YRG Y VA+K++ P + E +EQQF+ EV
Sbjct: 77 EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEV 136
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+L+ L H NIV+FI AC+K V+CI+TEY G++R +L +++ ++ ++ ++ ALD+
Sbjct: 137 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDI 196
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+RGM Y+H G IHRDLKS+NLL++ + +K+ADFG + +E Q GTYRWMAP
Sbjct: 197 SRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAP 255
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 133 bits (335), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 66/183 (36%), Positives = 107/183 (58%), Gaps = 9/183 (4%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKA--QVMEQQFQQ 185
D+W ID +L +G GAFG++++GT+ G +VA+K++ +P+K + +E+ F+
Sbjct: 777 DDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMI-----SPDKTITKDIERNFKD 831
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
EV ++ TL+H N+V F+ A K CIV E+ GS+ L +P L VK A
Sbjct: 832 EVRVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAY 891
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRW 303
++GM ++H G HRDLKS NLL+ ++K++DFG+ + + + + PE GT +W
Sbjct: 892 QASKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQW 951
Query: 304 MAP 306
AP
Sbjct: 952 TAP 954
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 127 bits (320), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 80/201 (39%), Positives = 112/201 (55%), Gaps = 30/201 (14%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
E+ ID +L G +G FG++ RG + DVAIKI+ R + + + VM FQ EV
Sbjct: 2107 EYEIDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVM---FQNEVG 2163
Query: 189 MLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTR-----RQNRAVPLKLAV 241
+L+ L+H N+V+F+GAC CIVTE+ GGS+RQFLT QN + LKL
Sbjct: 2164 ILSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKL-- 2221
Query: 242 KQALDVARGMAYVHGL--GFIHRDLKSDNLLIS-------------ADKSIKIADFGVAR 286
ALD+A+GM Y+HG +HRDL S N+L+ D KI+DFG++R
Sbjct: 2222 --ALDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSR 2279
Query: 287 IEV-QTEGMTPETGTYRWMAP 306
+++ Q MT G +MAP
Sbjct: 2280 LKMEQASQMTQSVGCIPYMAP 2300
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (314), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 64/187 (34%), Positives = 113/187 (60%), Gaps = 4/187 (2%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
P++ + + + I +L + + +G FG +Y+G + G VAIK ++ E+ QV+
Sbjct: 645 PSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINED--VNNQVL 702
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
E+ F++E+ +L+ L+H NIV + AC C +TEY GGS+ L ++ + + ++L
Sbjct: 703 EE-FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQL 760
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
K A+ +A+GM Y+H G IHRD+KS NLL+ ++KI DFG+++++ ++ MT G
Sbjct: 761 YKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIG 820
Query: 300 TYRWMAP 306
+ WM+P
Sbjct: 821 SPIWMSP 827
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 121 bits (304), Expect = 6e-27, Method: Composition-based stats.
Identities = 75/187 (40%), Positives = 102/187 (54%), Gaps = 19/187 (10%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMML 190
I +L + G FGK+YR + GE+VA+K PE +P V +Q +QE +
Sbjct: 93 IPFHELQLEEIIGVGGFGKVYRAVWRGEEVAVKAARLDPERDP---AVTAEQVRQEARLF 149
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L+H NI+ GAC C+V EYA+GG++ + L R+ VP + V A+ VARG
Sbjct: 150 GALQHPNIIALRGACLSPPNLCLVMEYARGGALSRVLAGRR---VPPHVLVNWAVQVARG 206
Query: 251 MAYVHG---LGFIHRDLKSDNLLI--------SADKSIKIADFGVARIEVQTEGMTPETG 299
M Y+H + IHRDLKS N+LI AD +KI DFG+AR +T M+ G
Sbjct: 207 MNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAREWHKTTKMSA-AG 265
Query: 300 TYRWMAP 306
TY WMAP
Sbjct: 266 TYAWMAP 272
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (303), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 70/200 (35%), Positives = 110/200 (55%), Gaps = 15/200 (7%)
Query: 116 DHRYPTEGL-------ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILER 168
DH++P + E EW + L ++ +G +G +G+++RG++ G +VA+K+L
Sbjct: 823 DHQFPVPTIPAKIIEVEKPFEWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFN 882
Query: 169 PENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT 228
N + + ++EV +L L+H NIV F+GAC + CIVTEY GS+ L
Sbjct: 883 DNVNLK----LISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILL 938
Query: 229 RRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVAR 286
++ + L ++ D ARGM Y+H IHRDLK+DNLL+ +K+ADFG+A
Sbjct: 939 -DESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLAT 997
Query: 287 IEVQTEGMTPETGTYRWMAP 306
++ T T GT W+AP
Sbjct: 998 VKSHTFAKT-MCGTTGWVAP 1016
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 121 bits (303), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 57/182 (31%), Positives = 104/182 (57%), Gaps = 7/182 (3%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
++W ID +L +G G +G++Y+ + G +VA+K++ ++ ++ ME+ F +EV
Sbjct: 777 NDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLI----SSKHVSKDMERSFFEEV 832
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
++ +L+H N+V F+ A K CIV E+ GS+ L +P L +K A
Sbjct: 833 KIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIKMAYQA 892
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE---TGTYRWM 304
++GM ++H G +HRDLKS NLL+ + ++K++DFG+ +++ + + GT W+
Sbjct: 893 SKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHWI 952
Query: 305 AP 306
AP
Sbjct: 953 AP 954
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q02779|M3K10_HUMAN Mitogen-activated protein kinase kinase kinase 10 OS=Homo sapiens GN=MAP3K10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 119 bits (299), Expect = 2e-26, Method: Composition-based stats.
Identities = 75/187 (40%), Positives = 101/187 (54%), Gaps = 19/187 (10%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMML 190
I +L + G FGK+YR + GE+VA+K PE +P V +Q QE +
Sbjct: 93 IPFHELQLEEIIGVGGFGKVYRALWRGEEVAVKAARLDPEKDP---AVTAEQVCQEARLF 149
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L+H NI+ GAC C+V EYA+GG++ + L R+ VP + V A+ VARG
Sbjct: 150 GALQHPNIIALRGACLNPPHLCLVMEYARGGALSRVLAGRR---VPPHVLVNWAVQVARG 206
Query: 251 MAYVHG---LGFIHRDLKSDNLLI--------SADKSIKIADFGVARIEVQTEGMTPETG 299
M Y+H + IHRDLKS N+LI AD +KI DFG+AR +T M+ G
Sbjct: 207 MNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAREWHKTTKMSA-AG 265
Query: 300 TYRWMAP 306
TY WMAP
Sbjct: 266 TYAWMAP 272
|
Activates the JUN N-terminal pathway. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q55EC7|GEFX_DICDI RasGEF domain-containing serine/threonine-protein kinase X OS=Dictyostelium discoideum GN=gefX PE=2 SV=1 | Back alignment and function description |
|---|
Score = 118 bits (295), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 71/187 (37%), Positives = 102/187 (54%), Gaps = 11/187 (5%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQ 182
GL W I L +G+FG ++RG Y G DVAIK +E+ ++PE + +++
Sbjct: 7 GLPTQAIWDIPFESLEFNEKIGKGSFGSVFRGCYLGLDVAIKKIEK-ADDPEYLKYIDR- 64
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
EV ML +L+H IV F G C IVTE+ GG VRQ L ++ + V
Sbjct: 65 ---EVSMLQSLRHPFIVNFSGICVHSSGLYIVTEFVSGGDVRQLL--KKTPPIGWDKRVS 119
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETG 299
A+D+A+ M ++H IHRDLKS N+L+ + I++ DFG AR+ QT+ MT G
Sbjct: 120 IAVDLAKAMVFLHAKKIIHRDLKSKNILLDEFQRIRLCDFGFARMSEQTKKSRHMT-MCG 178
Query: 300 TYRWMAP 306
T W+AP
Sbjct: 179 TEGWVAP 185
|
Promotes the exchange of Ras-bound GDP by GTP. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 116 bits (291), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 70/186 (37%), Positives = 99/186 (53%), Gaps = 19/186 (10%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
I+ +L++ G F K++RG Y+GE+VAIKI + + Q M QE +
Sbjct: 137 IEYNELDIKEVIGSGGFCKVHRGYYDGEEVAIKIAH--QTGEDDMQRMRDNVLQEAKLFW 194
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
LKH NI G C + C+V EYA+GGS+ + L + +P + V A+ +ARGM
Sbjct: 195 ALKHENIAALRGVCLNTKL-CLVMEYARGGSLNRILAGK----IPPDVLVNWAIQIARGM 249
Query: 252 AYVHG---LGFIHRDLKSDNLLISA--------DKSIKIADFGVARIEVQTEGMTPETGT 300
Y+H + IHRDLKS N+LI K++KI DFG+AR T+ M+ GT
Sbjct: 250 NYLHNEAPMSIIHRDLKSSNVLIYEAIEGNHLQQKTLKITDFGLAREMYNTQRMS-AAGT 308
Query: 301 YRWMAP 306
Y WM P
Sbjct: 309 YAWMPP 314
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 306 | ||||||
| 118488096 | 419 | unknown [Populus trichocarpa] | 1.0 | 0.730 | 0.951 | 1e-172 | |
| 224121260 | 415 | predicted protein [Populus trichocarpa] | 0.986 | 0.727 | 0.950 | 1e-169 | |
| 224115648 | 415 | predicted protein [Populus trichocarpa] | 0.986 | 0.727 | 0.940 | 1e-168 | |
| 255574169 | 414 | serine/thronine protein kinase, putative | 0.983 | 0.727 | 0.930 | 1e-162 | |
| 224121256 | 415 | predicted protein [Populus trichocarpa] | 0.986 | 0.727 | 0.900 | 1e-160 | |
| 255574171 | 418 | serine/thronine protein kinase, putative | 0.996 | 0.729 | 0.928 | 1e-158 | |
| 224115644 | 415 | predicted protein [Populus trichocarpa] | 0.986 | 0.727 | 0.914 | 1e-157 | |
| 225429872 | 417 | PREDICTED: serine/threonine-protein kina | 0.980 | 0.719 | 0.892 | 1e-152 | |
| 297798854 | 412 | kinase family protein [Arabidopsis lyrat | 0.977 | 0.725 | 0.848 | 1e-148 | |
| 116643282 | 423 | flag-tagged protein kinase domain of put | 0.977 | 0.706 | 0.844 | 1e-146 |
| >gi|118488096|gb|ABK95868.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1569), Expect = e-172, Method: Compositional matrix adjust.
Identities = 292/307 (95%), Positives = 299/307 (97%), Gaps = 1/307 (0%)
Query: 1 MIGKMVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
MIGKMVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV
Sbjct: 1 MIGKMVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
Query: 61 DNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
DNSSVGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQALMD +Y
Sbjct: 61 DNSSVGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALMDPKY 120
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PTEGL+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQ+M
Sbjct: 121 PTEGLQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQLM 180
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLA LKH NIVRFIG CRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL
Sbjct: 181 EQQFQQEVMMLANLKHPNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 240
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 241 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 300
Query: 300 TYRWMAP 306
TYRWMAP
Sbjct: 301 TYRWMAP 307
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121260|ref|XP_002330783.1| predicted protein [Populus trichocarpa] gi|222872585|gb|EEF09716.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 601 bits (1549), Expect = e-169, Method: Compositional matrix adjust.
Identities = 288/303 (95%), Positives = 295/303 (97%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 VGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALMDPKYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQ+MEQQF
Sbjct: 121 LQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQLMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIG CRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 181 QQEVMMLANLKHPNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115648|ref|XP_002332108.1| predicted protein [Populus trichocarpa] gi|222874928|gb|EEF12059.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1534), Expect = e-168, Method: Compositional matrix adjust.
Identities = 285/303 (94%), Positives = 293/303 (96%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTG+IGGN NN+NNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYS + GQSVFRPGKVTHALNDDALAQALM+ +YPTEG
Sbjct: 61 VGSSDSLTHILSHPGLKPVNHHNYSGTAGQSVFRPGKVTHALNDDALAQALMNPKYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQVMEQQF
Sbjct: 121 LQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHALGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255574169|ref|XP_002528000.1| serine/thronine protein kinase, putative [Ricinus communis] gi|223532626|gb|EEF34412.1| serine/thronine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1486), Expect = e-162, Method: Compositional matrix adjust.
Identities = 282/303 (93%), Positives = 290/303 (95%), Gaps = 2/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEGPKFTGL+GG+++N NYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS
Sbjct: 1 MVEGPKFTGLVGGSDDN-VNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 59
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRP KVTHALN+DALAQALMD RY TEG
Sbjct: 60 VGSSDSLTHILSHPGLKPVSHHNYSVSVGQSVFRPRKVTHALNEDALAQALMDSRYQTEG 119
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L+NYD+WTIDLRKLNMGTAFAQGAFGKLYRG YNGEDVAIKILERPEN EKAQVMEQQF
Sbjct: 120 LDNYDDWTIDLRKLNMGTAFAQGAFGKLYRGAYNGEDVAIKILERPENCHEKAQVMEQQF 179
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLATLKH NIVRFIGACRK MVWCIVTEYAKGGSVRQ LTRRQNRAVPLKLAVKQ
Sbjct: 180 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQALTRRQNRAVPLKLAVKQ 239
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 240 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 299
Query: 304 MAP 306
MAP
Sbjct: 300 MAP 302
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121256|ref|XP_002330782.1| predicted protein [Populus trichocarpa] gi|222872584|gb|EEF09715.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 569 bits (1467), Expect = e-160, Method: Compositional matrix adjust.
Identities = 273/303 (90%), Positives = 290/303 (95%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEG KFTGL+ +NNN N+YY FTQGFYQ++G+GTNMSIDSLQTS+AGGSVSMSVDNSS
Sbjct: 1 MVEGKKFTGLMAPSNNNGNDYYGFTQGFYQEIGDGTNMSIDSLQTSHAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPVRH-NYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGSNDSLTH+LSHPGLKPV H NY+VSVG SVFRPGKVTHALNDDALAQALMD+RYPTEG
Sbjct: 61 VGSNDSLTHMLSHPGLKPVNHRNYNVSVGASVFRPGKVTHALNDDALAQALMDNRYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L++YD+WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN PEK+QVMEQQF
Sbjct: 121 LQHYDDWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENIPEKSQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGAC+K MVWCIVTEYAKGGSVRQFLTRR NRAVPLKLAV+Q
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACQKPMVWCIVTEYAKGGSVRQFLTRRHNRAVPLKLAVQQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLI+ADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLIAADKSIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255574171|ref|XP_002528001.1| serine/thronine protein kinase, putative [Ricinus communis] gi|223532627|gb|EEF34413.1| serine/thronine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 563 bits (1450), Expect = e-158, Method: Compositional matrix adjust.
Identities = 285/307 (92%), Positives = 291/307 (94%), Gaps = 2/307 (0%)
Query: 1 MIGKMVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 60
MIGKMVEGPKFTG NN+N+NNYYDFTQ FYQKLGEGTNMSIDSLQTSNAGGSVSMSV
Sbjct: 1 MIGKMVEGPKFTGANI-NNDNENNYYDFTQSFYQKLGEGTNMSIDSLQTSNAGGSVSMSV 59
Query: 61 DNSSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
DNSSVGS+DSLTHILSHPGLKPV HNYSVSVGQSVFRPGKVTH LNDDALAQALMD RY
Sbjct: 60 DNSSVGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHPLNDDALAQALMDSRY 119
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PT GL NYDEWTIDLRKL+MGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN+PEKAQVM
Sbjct: 120 PTVGLANYDEWTIDLRKLSMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQVM 179
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLATLKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFL +RQNRAVPLKL
Sbjct: 180 EQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLAKRQNRAVPLKL 239
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLG IHRDLKSDNLLI ADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 240 AVKQALDVARGMAYVHGLGCIHRDLKSDNLLIFADKSIKIADFGVARIEVQTEGMTPETG 299
Query: 300 TYRWMAP 306
TYRWMAP
Sbjct: 300 TYRWMAP 306
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115644|ref|XP_002332107.1| predicted protein [Populus trichocarpa] gi|222874927|gb|EEF12058.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 559 bits (1440), Expect = e-157, Method: Compositional matrix adjust.
Identities = 277/303 (91%), Positives = 292/303 (96%), Gaps = 1/303 (0%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSS 64
MVEG KFTGLIG +NNN NNYY FTQGFYQ+LG+GTNMSIDSLQTS+AGGSVSMSVDNSS
Sbjct: 1 MVEGQKFTGLIGASNNNGNNYYGFTQGFYQELGDGTNMSIDSLQTSHAGGSVSMSVDNSS 60
Query: 65 VGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
VGSNDSLTH+LSHPGLKPV HNYSVSVGQSVFRPGKVTHALNDDALAQAL+D+RYPTEG
Sbjct: 61 VGSNDSLTHMLSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALVDNRYPTEG 120
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L++YD+WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERP N+PEK+QVMEQQF
Sbjct: 121 LQHYDDWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPGNSPEKSQVMEQQF 180
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEVMMLA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRR NRAVPLKLAV+Q
Sbjct: 181 QQEVMMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRHNRAVPLKLAVQQ 240
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHGLGFIHRDLKSDNLLI+ADK+IKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 241 ALDVARGMAYVHGLGFIHRDLKSDNLLIAADKTIKIADFGVARIEVQTEGMTPETGTYRW 300
Query: 304 MAP 306
MAP
Sbjct: 301 MAP 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225429872|ref|XP_002283465.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|147839316|emb|CAN72362.1| hypothetical protein VITISV_000134 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1404), Expect = e-152, Method: Compositional matrix adjust.
Identities = 274/307 (89%), Positives = 287/307 (93%), Gaps = 7/307 (2%)
Query: 5 MVEGPKFTGLIGGNNNN--DNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDN 62
MVEGPKFTG+IGG N+ DNNY+DFTQGFYQKLGE +NMSIDSLQTSNAG SVSMSVDN
Sbjct: 1 MVEGPKFTGIIGGGGNHNHDNNYFDFTQGFYQKLGEDSNMSIDSLQTSNAGLSVSMSVDN 60
Query: 63 SSVGSNDSLTHILSHPGLKPV-RHNYSVSVGQSVFRPGK--VTHALNDDALAQALMDHRY 119
SSVGSNDSLTHIL+HPGLKPV HNYSV G SV RPGK VTHALN+DALA+ALMD RY
Sbjct: 61 SSVGSNDSLTHILNHPGLKPVATHNYSV--GHSVLRPGKGKVTHALNEDALARALMDTRY 118
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRG YNG+DVAIKILERPEN+PE+AQVM
Sbjct: 119 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGEYNGDDVAIKILERPENSPERAQVM 178
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
EQQFQQEVMMLATLKH NIVRFIGACRK + WCIVTEYAKGGSVRQFL RRQNR+VPLKL
Sbjct: 179 EQQFQQEVMMLATLKHPNIVRFIGACRKPLAWCIVTEYAKGGSVRQFLMRRQNRSVPLKL 238
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
AVKQALDVARGMAYVHGLGFIHRDLKSDNLLI+ADKSIKIADFGVARIEVQTEGMTPETG
Sbjct: 239 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLIAADKSIKIADFGVARIEVQTEGMTPETG 298
Query: 300 TYRWMAP 306
TYRWMAP
Sbjct: 299 TYRWMAP 305
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798854|ref|XP_002867311.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297313147|gb|EFH43570.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 528 bits (1361), Expect = e-148, Method: Compositional matrix adjust.
Identities = 257/303 (84%), Positives = 275/303 (90%), Gaps = 4/303 (1%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGE-GTNMSIDSLQTSNAGGSVSMSVDNS 63
M+E PKF GN+NNDNNYY FTQ FYQKLGE GTNMS+DS+QTSNAGGSVSMSVDNS
Sbjct: 1 MLENPKFNLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
SVGS+D+L + HPGLKP+RH YS+SVGQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSVGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKAQ +EQQF
Sbjct: 118 LANYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEV MLA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAP 306
MAP
Sbjct: 298 MAP 300
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116643282|gb|ABK06449.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1352), Expect = e-146, Method: Compositional matrix adjust.
Identities = 256/303 (84%), Positives = 274/303 (90%), Gaps = 4/303 (1%)
Query: 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGE-GTNMSIDSLQTSNAGGSVSMSVDNS 63
M+E PKF GN+NNDNNYY FTQ FYQKLGE GTNMS+DS+QTSNAGGSVSMSVDNS
Sbjct: 1 MLENPKFDLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
SVGS+D+L + HPGLKP+RH YS+S GQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSDGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQF 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKAQ +EQQF
Sbjct: 118 LVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QQEV MLA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAP 306
MAP
Sbjct: 298 MAP 300
|
Source: synthetic construct Species: synthetic construct Genus: N/A Family: N/A Order: N/A Class: N/A Phylum: N/A Superkingdom: |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 306 | ||||||
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.973 | 0.725 | 0.759 | 1.9e-115 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.977 | 0.725 | 0.729 | 1.1e-110 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.607 | 0.522 | 0.455 | 1.6e-38 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.594 | 0.526 | 0.454 | 8e-37 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.607 | 0.526 | 0.433 | 1.3e-36 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.578 | 0.307 | 0.444 | 1.6e-36 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.633 | 0.355 | 0.416 | 1.7e-36 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.310 | 0.242 | 0.479 | 1.2e-35 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.581 | 0.312 | 0.436 | 1.7e-35 | |
| TAIR|locus:2094329 | 378 | AT3G22750 [Arabidopsis thalian | 0.310 | 0.251 | 0.458 | 1.5e-34 |
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1138 (405.7 bits), Expect = 1.9e-115, P = 1.9e-115
Identities = 230/303 (75%), Positives = 241/303 (79%)
Query: 5 MVEGPKFTGL-IXXXXXXXXXXXXFTQGFYQKLGEGTNMSIDSLQTSNAXXXXXXXXXXX 63
M+EG KF L + FTQ FYQKL EG+NMS++S+QTSNA
Sbjct: 1 MLEGAKFNVLAVGNHHNNDNNYYAFTQEFYQKLNEGSNMSMESMQTSNAGGSVSMSVDNS 60
Query: 64 XXXXXXXLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
L + HPGLKPVRH YS+SVGQSVFRPG+VTHALNDDALAQALMD RYPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPVRH-YSLSVGQSVFRPGRVTHALNDDALAQALMDTRYPTEG 116
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXXX 183
L NYDEWTIDLRKLNMG AFAQGAFGKLY+GTYNGEDVAIKILERPEN+PEKA
Sbjct: 117 LTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQF 176
Query: 184 XXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
LA LKH NIVRFIGACRK MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ
Sbjct: 177 QQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 236
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVHG FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 237 ALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 296
Query: 304 MAP 306
MAP
Sbjct: 297 MAP 299
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 1.1e-110, P = 1.1e-110
Identities = 221/303 (72%), Positives = 235/303 (77%)
Query: 5 MVEGPKFTGLIXXXXXXXXXXXXFTQGFYQKLGE-GTNMSIDSLQTSNAXXXXXXXXXXX 63
M+E PKF FTQ FYQKLGE GTNMS+DS+QTSNA
Sbjct: 1 MLENPKFDLHAVGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNS 60
Query: 64 XXXXXXXLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
L + HPGLKP+RH YS+S GQSVFRPGKVTHALNDDALAQALMD +YPTEG
Sbjct: 61 SVGSSDAL---IGHPGLKPMRHPYSLSDGQSVFRPGKVTHALNDDALAQALMDSKYPTEG 117
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXXX 183
L NY+EWTIDLRKL+MG AFAQGAFGKLYRGTYNGEDVAIK+LER ++NPEKA
Sbjct: 118 LVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQF 177
Query: 184 XXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
LA LKH NIVRFIGAC K MVWCIVTEYAKGGSVRQFLT+RQNRAVPLKLAV Q
Sbjct: 178 QQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQ 237
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
ALDVARGMAYVH FIHRDLKSDNLLISAD+SIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRW 297
Query: 304 MAP 306
MAP
Sbjct: 298 MAP 300
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 412 (150.1 bits), Expect = 1.6e-38, P = 1.6e-38
Identities = 86/189 (45%), Positives = 122/189 (64%)
Query: 119 YPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXX 178
Y E E +W +D R L +G +GA K+Y G Y + VAIKI++R E+ PE+
Sbjct: 8 YSNEEFELDPKWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGES-PEEIAK 66
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
L+ ++H N+V+FIGAC++ M+ IVTE GG++R++L + + + ++
Sbjct: 67 RDNRFAREIAMLSKVQHKNLVKFIGACKEPMM-VIVTELLLGGTLRKYLVSLRPKRLDIR 125
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPE 297
LAV ALD+AR M +H G IHRDLK +NL++SAD K++K+ADFG+AR E TE MT E
Sbjct: 126 LAVGFALDIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAE 185
Query: 298 TGTYRWMAP 306
TGTYRWMAP
Sbjct: 186 TGTYRWMAP 194
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 396 (144.5 bits), Expect = 8.0e-37, P = 8.0e-37
Identities = 84/185 (45%), Positives = 116/185 (62%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXXXXXX 182
G +W ID + L +G +GA K+Y G Y + VAIKI+ R E PE+
Sbjct: 6 GFRMEPKWQIDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGET-PEEIAKRDSR 64
Query: 183 XXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
L+ ++H N+V+FIGAC K V IVTE +GG++R++L + + ++A+
Sbjct: 65 FLREVEMLSRVQHKNLVKFIGAC-KEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIG 123
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTY 301
ALD+ARGM +H G IHRDLK +NLL++AD K++K+ADFG+AR E TE MT ETGTY
Sbjct: 124 FALDIARGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTY 183
Query: 302 RWMAP 306
RWMAP
Sbjct: 184 RWMAP 188
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 394 (143.8 bits), Expect = 1.3e-36, P = 1.3e-36
Identities = 82/189 (43%), Positives = 120/189 (63%)
Query: 119 YPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAXX 178
Y E E +W +D + L +G +GA K+Y G Y + VAIKI++R E+ PE+
Sbjct: 8 YSNEVFELDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGES-PEEIAK 66
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
L+ ++H N+V+FIGAC K + IVTE GG++R++L + ++ ++
Sbjct: 67 RESRFAREVSMLSRVQHKNLVKFIGAC-KEPIMVIVTELLLGGTLRKYLVSLRPGSLDIR 125
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPE 297
+AV ALD+AR M +H G IHRDLK ++L+++AD K++K+ADFG+AR E TE MT E
Sbjct: 126 VAVGYALDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAE 185
Query: 298 TGTYRWMAP 306
TGTYRWMAP
Sbjct: 186 TGTYRWMAP 194
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 394 (143.8 bits), Expect = 1.6e-36, P = 1.6e-36
Identities = 84/189 (44%), Positives = 117/189 (61%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKIL--ERPENNPEKAX 177
P +G D W I+L+ L G A G++G LY+GTY ++VAIK+L ER +++ EK
Sbjct: 276 PNDGT---DVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEF 332
Query: 178 XXXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
+ ++H N+V+FIGAC K CIVTE+ GGSV +L +Q L
Sbjct: 333 AQEVFI------MRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYL-HKQKGVFKL 385
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
K A+D+ +GM+Y+H IHRDLK+ NLL+ ++ +K+ADFGVAR++ QT MT E
Sbjct: 386 PTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAE 445
Query: 298 TGTYRWMAP 306
TGTYRWMAP
Sbjct: 446 TGTYRWMAP 454
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 393 (143.4 bits), Expect = 1.7e-36, P = 1.7e-36
Identities = 85/204 (41%), Positives = 123/204 (60%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVA 162
H + + L A ++ PT+G DEW ID+ +L + A G++G L+RGTY ++VA
Sbjct: 257 HDKSSNELIPACIE--IPTDGT---DEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVA 311
Query: 163 IKILERPENNPEKAXXXXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGS 222
IK L+ N E + ++H N+V+F+GAC + CIVTE+ GS
Sbjct: 312 IKFLKPDRVNNEMLREFSQEVFI----MRKVRHKNVVQFLGACTRSPTLCIVTEFMARGS 367
Query: 223 VRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
+ FL +Q A L+ +K ALDVA+GM+Y+H IHRDLK+ NLL+ +K+ADF
Sbjct: 368 IYDFL-HKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADF 426
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
GVAR+++++ MT ETGTYRWMAP
Sbjct: 427 GVARVQIESGVMTAETGTYRWMAP 450
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 263 (97.6 bits), Expect = 1.2e-35, Sum P(2) = 1.2e-35
Identities = 46/96 (47%), Positives = 72/96 (75%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
C+V EY GG++++FL ++ +P+K ++ ALD+ARG++Y+H +HRD+KS+N+L+
Sbjct: 182 CVVVEYVAGGTLKKFLIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLL 241
Query: 272 SADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
+K++KIADFGVAR+E Q + MT ETGT +MAP
Sbjct: 242 QPNKTLKIADFGVARVEAQNPQDMTGETGTLGYMAP 277
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 385 (140.6 bits), Expect = 1.7e-35, P = 1.7e-35
Identities = 82/188 (43%), Positives = 119/188 (63%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPEN-NPEKAXX 178
PT+G DEW ID+++L + A G++G+L+RGTY ++VAIKIL +PE N E
Sbjct: 278 PTDGT---DEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKIL-KPERVNAEMLRE 333
Query: 179 XXXXXXXXXXXLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ ++H N+V+FIGAC + CIVTE+ GS+ FL + + ++
Sbjct: 334 FSQEVYI----MRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKG-VFKIQ 388
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET 298
+K ALDV++GM Y+H IHRDLK+ NLL+ + +K+ADFGVAR++ ++ MT ET
Sbjct: 389 SLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAET 448
Query: 299 GTYRWMAP 306
GTYRWMAP
Sbjct: 449 GTYRWMAP 456
|
|
| TAIR|locus:2094329 AT3G22750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 249 (92.7 bits), Expect = 1.5e-34, Sum P(2) = 1.5e-34
Identities = 44/96 (45%), Positives = 71/96 (73%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
C+V EY GG+++Q+L R + + + K+ V+ ALD++RG++Y+H +HRD+K++N+L+
Sbjct: 169 CVVVEYIPGGTLKQYLFRNRRKKLAFKVVVQLALDLSRGLSYLHSERIVHRDVKTENMLL 228
Query: 272 SADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
+++KIADFGVAR+E Q + MT ETGT +MAP
Sbjct: 229 DYQRNLKIADFGVARVEAQNPKDMTGETGTLGYMAP 264
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_scaffold_147000033 | SubName- Full=Putative uncharacterized protein; (415 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 306 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-27 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-25 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-21 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 9e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 5e-50
Identities = 56/169 (33%), Positives = 90/169 (53%), Gaps = 13/169 (7%)
Query: 146 GAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GAFG++Y+GT G +VA+K L + ++ ++F +E ++ L H NIV
Sbjct: 10 GAFGEVYKGTLKGKGDGKEVEVAVKTL-----KEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ +G C + IV EY GG + +L + + + + L + AL +ARGM Y+ F
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG--TYRWMAP 306
IHRDL + N L+ + +KI+DFG++R + + G RWMAP
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 5e-49
Identities = 60/171 (35%), Positives = 95/171 (55%), Gaps = 15/171 (8%)
Query: 145 QGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+GAFG++Y+GT G+ VA+K L E E+ + ++F +E ++ L H NI
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEER---EEFLEEASIMKKLSHPNI 63
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
VR +G C + IVTEY GG + FL R+ + LK ++ AL +A+GM Y+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 306
F+HRDL + N L++ + +KI+DFG++R + + G +WMAP
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-48
Identities = 55/171 (32%), Positives = 92/171 (53%), Gaps = 16/171 (9%)
Query: 145 QGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+GAFG++Y+G G +VA+K L + ++ ++F +E ++ L H N+
Sbjct: 9 EGAFGEVYKGKLKGKGGKKKVEVAVKTL-----KEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V+ +G C + IV EY +GG + +L R+ + L + AL +ARGM Y+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESKN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
FIHRDL + N L+ + +KI+DFG++R ++ + + G RWMAP
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAP 172
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-43
Identities = 50/166 (30%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG +Y G+ VAIKI+ E + + ++ +E+ +L L H NIV+
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKII-----KKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G +V EY +GGS++ L + + + ++ L + G+ Y+H G IHR
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 263 DLKSDNLLISADK-SIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK +N+L+ +D +K+ADFG+++ + + GT +MAP
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 58/165 (35%), Positives = 93/165 (56%), Gaps = 9/165 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y+ + G+ VA+KIL++ +K +Q ++E+ +L L H NIVR I
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK----DQTARREIRILRRLSHPNIVRLI 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + +V EY +GG + +L + + A K AL + RG+ Y+H G IHR
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHR 122
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK +N+L+ + +KIADFG+A+ + + +T GT +MAP
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-43
Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 28/181 (15%)
Query: 145 QGAFGKLYRGTYNGE-----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+GAFG++Y+G G+ +VA+K L+ + E+ + F +E ++ L H N+V
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER-----KDFLKEARVMKKLGHPNVV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA-------VPLKLAVKQALDVARGMA 252
R +G C + +V EY +GG + +L + + + LK + A+ +A+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
Y+ F+HRDL + N L+ D +KI+DFG++R +T G P RWMA
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP----IRWMA 175
Query: 306 P 306
P
Sbjct: 176 P 176
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-42
Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+Y G+ VAIK++ +K + ++ +E+ +L LKH NIVR
Sbjct: 9 EGSFGKVYLARDKKTGKLVAIKVI-----KKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+V EY +GG + L ++ + A + + Y+H G +HR
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKGIVHR 121
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +N+L+ D +K+ADFG+AR E +T GT +MAP
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAP 165
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 55/169 (32%), Positives = 90/169 (53%), Gaps = 13/169 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG +Y GE +A+K +E ++ E+ + ++E+ +L++L+H NIVR+
Sbjct: 10 RGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYY 65
Query: 203 GACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
G+ R I EY GGS+ L ++ +P + K + G+AY+H G +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNGIV 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAP 306
HRD+K N+L+ +D +K+ADFG A+ EG GT WMAP
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 63/175 (36%), Positives = 93/175 (53%), Gaps = 11/175 (6%)
Query: 136 KLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193
+G +GAFG +Y+G G+ VAIK + E E+A + QE+ +L L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS-LEKIKEEAL---KSIMQEIDLLKNL 56
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
KH NIV++IG+ I+ EYA+ GS+RQ + + P L V +G+AY
Sbjct: 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAY 114
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+H G IHRD+K+ N+L + D +K+ADFGVA ++ + GT WMAP
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAP 168
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-30
Identities = 52/170 (30%), Positives = 95/170 (55%), Gaps = 21/170 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++Y+ + G++VAIK++ +++ +++ E+ +L KH NIV++
Sbjct: 10 KGGFGEVYKARHKRTGKEVAIKVI------KLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-----VKQALDVARGMAYVHG 256
G+ +K +W IV E+ GGS++ L ++ L + K+ L +G+ Y+H
Sbjct: 64 GSYLKKDELW-IVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELL---KGLEYLHS 116
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G IHRD+K+ N+L+++D +K+ DFG++ T+ GT WMAP
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 58/177 (32%), Positives = 93/177 (52%), Gaps = 11/177 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W ++L+KL +G +G FG + +G Y G+ VA+K + K V Q F +E +
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNI--------KCDVTAQAFLEETAV 52
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ L H N+VR +G ++ IV E G++ FL R V + ++ +LDVA
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
GM Y+ +HRDL + N+L+S D K++DFG+AR+ + G+ +W AP
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG--SMGVDNSKLPVKWTAP 166
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 59/179 (32%), Positives = 92/179 (51%), Gaps = 13/179 (7%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W I+ ++L +G +G FG + G Y G+ VA+K L+ Q F E +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASV 53
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ TL+H N+V+ +G + IVTEY GS+ +L R + L + ALDV
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GM Y+ F+HRDL + N+L+S D K++DFG+A+ Q + ++G +W AP
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAP 168
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 48/151 (31%), Positives = 84/151 (55%), Gaps = 14/151 (9%)
Query: 145 QGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FGK+ Y+ GE VA+K L ++ F++E+ +L TL H NI
Sbjct: 14 EGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-----FEREIEILRTLDHENI 68
Query: 199 VRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V++ G C K ++ EY GS+R +L R +++ + LK + + + +GM Y+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGS 127
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+IHRDL + N+L+ ++ +KI+DFG+A++
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 52/171 (30%), Positives = 91/171 (53%), Gaps = 7/171 (4%)
Query: 139 MGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
G G+FG +Y G +G+ A+K + ++ + Q +Q +QE+ +L+ L+H
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG-QTGQEAVKQLEQEIALLSKLQHP 62
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQALDVARGMAYVH 255
NIV+++G R+ I E GGS+ + L + + P+ +L +Q L G+ Y+H
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL---GLEYLH 119
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L+ + +K+ADFG+A+ V+ G+ WMAP
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 60/181 (33%), Positives = 91/181 (50%), Gaps = 12/181 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ GT+NG VA+K L+ +PE F QE
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-------AFLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ C + IVTEY GS+ FL + + + L V A +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMA 305
GMAY+ +IHRDL + N+L+ + KIADFG+AR+ ++ + T G +W A
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTA 172
Query: 306 P 306
P
Sbjct: 173 P 173
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-27
Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 15/180 (8%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVM-EQQFQQEVMM 189
ID +L G FG ++ G + G+ DVAIK++ + M E F +E +
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI--------REGAMSEDDFIEEAKV 52
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
+ L H N+V+ G C K+ IVTEY G + +L R + + + + DV
Sbjct: 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCE 111
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
M Y+ GFIHRDL + N L+ D +K++DFG+AR + + T GT +W P
Sbjct: 112 AMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPP 170
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 66/212 (31%), Positives = 92/212 (43%), Gaps = 48/212 (22%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQ 181
EW + +L +G +GAFG++ + G D VA+K+L K E+
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--------KDDATEK 57
Query: 182 QFQQEV----MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
V MM KH NI+ +G C + +V EYA G++R FL R R
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL--RARRPPGE 115
Query: 238 KLA----------------VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
+ V A VARGM ++ IHRDL + N+L++ D +KIAD
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIAD 175
Query: 282 FGVAR-IEVQ------TEGMTPETGTYRWMAP 306
FG+AR I T G P +WMAP
Sbjct: 176 FGLARDIHHIDYYRKTTNGRLP----VKWMAP 203
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 59/179 (32%), Positives = 87/179 (48%), Gaps = 39/179 (21%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA G++Y+ T G++VAIK + + N E E++++ KH NIV +
Sbjct: 29 EGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-------NEILIMKDCKHPNIVDYY 81
Query: 203 GACR-KRMVWCIVTEYAKGGS----VRQF---LTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ +W +V EY GGS + Q + Q V +V +G+ Y+
Sbjct: 82 DSYLVGDELW-VVMEYMDGGSLTDIITQNFVRMNEPQIAYV--------CREVLQGLEYL 132
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-------GTYRWMAP 306
H IHRD+KSDN+L+S D S+K+ADFG A Q +T E GT WMAP
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA---AQ---LTKEKSKRNSVVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 60/190 (31%), Positives = 90/190 (47%), Gaps = 27/190 (14%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
+ + A GAFG++Y G Y G D + + + PE+ E+ E F E ++++
Sbjct: 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD---ESDFLMEALIMS 64
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-PLKLAVKQ----ALD 246
H NIVR IG +R+ I+ E GG ++ FL + R P L +K A D
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEVQTE-------GMTP 296
VA+G Y+ FIHRD+ + N L++ + KIADFG+AR + M P
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 297 ETGTYRWMAP 306
+WM P
Sbjct: 185 ----IKWMPP 190
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVM 188
W + L + G FG+++ G YNG VAIK L++ +PE F E
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-------FLAEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +VR + ++ I+TEY + GS+ FL + + + + A +A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMA++ +IHRDL++ N+L+S KIADFG+AR+ E E + +W AP
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-26
Identities = 61/180 (33%), Positives = 92/180 (51%), Gaps = 11/180 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ GT+NG VA+K L+ +PE F +E
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-------SFLEEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ + ++ IVTEY GS+ FL + RA+ L V A VA
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ + +IHRDL+S N+L+ KIADFG+AR+ E + + +W AP
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVME-QQFQQEV 187
W ID + + G FG+++ G +N VA+K L K M+ + F E
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL--------KPGTMDPKDFLAEA 52
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
++ L+H +++ C IVTE K GS+ ++L RA+ L + A V
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWM 304
A GMAY+ +IHRDL + N+L+ + K+ADFG+AR+ + G +W
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWT 171
Query: 305 AP 306
AP
Sbjct: 172 AP 173
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-26
Identities = 59/179 (32%), Positives = 92/179 (51%), Gaps = 17/179 (9%)
Query: 140 GTAFAQGAFGKLYRG--TYNGEDVAIKILERP----ENNPEKAQVMEQQFQQEVMMLATL 193
G +G +G++Y GE +A+K +E P + + + M + + E+ L L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGM 251
HLNIV+++G I EY GGS+ L R R ++ +Q L G+
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVL---EGL 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
AY+H G +HRDLK+DNLL+ AD KI+DFG+++ I + M+ + G+ WMAP
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAP 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-26
Identities = 59/180 (32%), Positives = 92/180 (51%), Gaps = 11/180 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + QG FG+++ GT+NG VAIK L+ +PE F QE
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-------FLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V+ + ++ IVTEY GS+ FL + + L V A +A
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAYV + ++HRDL++ N+L+ + K+ADFG+AR+ E + + +W AP
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-26
Identities = 54/174 (31%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPE-KAQVMEQQFQQEVMMLATLKHL 196
G QGAFG++Y G ++A+K + ++PE K +V + E+ +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV--NALECEIQLLKNLQHE 64
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IV++ G R I EY GGSV+ L + A+ + K + G+ Y+H
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L + ++K+ DFG ++ I GM TGT WM+P
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 57/173 (32%), Positives = 96/173 (55%), Gaps = 24/173 (13%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIV 199
+GA+G +YRG + G VA+KI+ + + + + Q+EV +L+ L+ NI
Sbjct: 11 RGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDI-----QREVALLSQLRQSQPPNIT 65
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK-----LAVKQALDVARGMAYV 254
++ G+ K I+ EYA+GGSVR + +A P+ + +++ L VA + Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVL-VA--LKYI 117
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM-TPETGTYRWMAP 306
H +G IHRD+K+ N+L++ ++K+ DFGVA + Q + GT WMAP
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 53/145 (36%), Positives = 84/145 (57%), Gaps = 7/145 (4%)
Query: 145 QGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G FG +Y+G G +VA+K R P+ ++++F QE +L H NIV+ IG
Sbjct: 5 KGNFGDVYKGVLKGNTEVAVKTC-RSTLPPD----LKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
C ++ IV E GGS+ FL +++NR + +K ++ +LD A GM Y+ IHRD
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 264 LKSDNLLISADKSIKIADFGVARIE 288
L + N L+ + +KI+DFG++R E
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREE 143
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIG 203
+G+FG++Y + VA+K+L + + K ++F +E+ +LA+L H NIV+
Sbjct: 10 EGSFGEVYLARDR-KLVALKVLAKKLESKSKEV---ERFLREIQILASLNHPPNIVKLYD 65
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ L + + A+ + + Y+H G IHR
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHR 125
Query: 263 DLKSDNLLISAD-KSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
D+K +N+L+ D + +K+ DFG+A++ + GT +MAP
Sbjct: 126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 58/188 (30%), Positives = 88/188 (46%), Gaps = 35/188 (18%)
Query: 145 QGAFGKLYRGT-YNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
+GAFGK++ G Y+ E VA+K L+ E A + F++E +L +H N
Sbjct: 15 EGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDA---RKDFEREAELLTNFQHEN 69
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR--------RQNRAVPLKLAVKQ----AL 245
IV+F G C + +V EY + G + +FL + + +L + Q A+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPET 298
+A GM Y+ F+HRDL + N L+ D +KI DFG++R V M P
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP-- 187
Query: 299 GTYRWMAP 306
RWM P
Sbjct: 188 --IRWMPP 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 17/171 (9%)
Query: 145 QGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G FG + +G Y +G+ +VA+K L+ E +++F +E ++A L H IV
Sbjct: 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
R IG C+ +V E A G + ++L ++ R +P+ + A VA GMAY+ F
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETG---TYRWMAP 306
+HRDL + N+L+ KI+DFG++R + ++ T +W AP
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 19/169 (11%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++Y+ + VAIK+++ E E + QQE+ L+ + I ++
Sbjct: 11 KGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDI-----QQEIQFLSQCRSPYITKYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLG 258
G+ K I+ EY GGS L A L+ +V G+ Y+H G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-------EVLLGLEYLHEEG 118
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 306
IHRD+K+ N+L+S + +K+ADFGV+ ++ GT WMAP
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 18/168 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G++G +Y+ + G+ VAIK++ E+ Q+ +E+ +L IV++
Sbjct: 13 EGSYGSVYKAIHKETGQVVAIKVVPVEEDL--------QEIIKEISILKQCDSPYIVKYY 64
Query: 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGF 259
G+ K +W IV EY GSV + ++A Q L +G+ Y+H
Sbjct: 65 GSYFKNTDLW-IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL---KGLEYLHSNKK 120
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTYRWMAP 306
IHRD+K+ N+L++ + K+ADFGV+ T GT WMAP
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQ 182
W + K+ + QG+FG +Y G G VAIK + N + +E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIE-- 55
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVP---- 236
F E ++ ++VR +G +V E G ++ +L R + P
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 237 --LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292
L+ ++ A ++A GMAY+ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 293 -----GMTPETGTYRWMAP 306
G+ P RWMAP
Sbjct: 176 RKGGKGLLP----VRWMAP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 9e-25
Identities = 62/180 (34%), Positives = 94/180 (52%), Gaps = 20/180 (11%)
Query: 140 GTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G +GA+G +Y G N G+ +A+K +E +N A+ ++ Q+EV +L +LKH+NI
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV-----KQALDVARGMAY 253
V+++G C I E+ GGS+ L NR PL V KQ LD G+AY
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILD---GVAY 117
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
+H +HRD+K +N+++ + IK+ DFG AR + + GT WMAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQ 184
+ I + +G +G FG +Y+G Y E VA+K + +P + +F
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVRE----KFL 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
QE ++ H +IV+ IG + VW IV E A G +R +L + + L + +
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYS-LDLASLILYS 113
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--R 302
++ +AY+ F+HRD+ + N+L+S+ +K+ DFG++R G +
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 303 WMAP 306
WMAP
Sbjct: 174 WMAP 177
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-24
Identities = 53/161 (32%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L RP+ + + F +EV +L+ L NI R +G C C++ EY +
Sbjct: 49 VAVKVL-RPDASDNARE----DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103
Query: 221 GSVRQFLTRRQNRAVPLKLAVKQ---------ALDVARGMAYVHGLGFIHRDLKSDNLLI 271
G + QFL + L K A +A GM Y+ L F+HRDL + N L+
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
Query: 272 SADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
+ +IKIADFG++R VQ P RWMA
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP----IRWMA 200
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-24
Identities = 59/180 (32%), Positives = 90/180 (50%), Gaps = 11/180 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + QG FG+++ GT+NG VAIK L+ PE F QE
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-------FLQEAQ 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ L+H +V + ++ IVTE+ GS+ FL + + L V A +A
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ + +IHRDL++ N+L+ + KIADFG+AR+ E + + +W AP
Sbjct: 113 DGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 6e-24
Identities = 61/172 (35%), Positives = 92/172 (53%), Gaps = 26/172 (15%)
Query: 146 GAFGKLY--RGTYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G +G +Y R GE VAIK+ LE ++ + QQE+ ML +H NIV +
Sbjct: 14 GTYGDVYKARDIATGELVAIKVIKLEPGDD--------FEIIQQEISMLKECRHPNIVAY 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLA--VKQALDVARGMAYVHGLG 258
G+ +R IV EY GGS+ Q + + + L++A ++ L +G+AY+H G
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPET---GTYRWMAP 306
IHRD+K N+L++ D +K+ADFGV A++ T + GT WMAP
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 7e-24
Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 15/170 (8%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FGK L R +G+ +K ++ + E+ EV +L L H NI+++
Sbjct: 10 KGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-----LNEVKILKKLNHPNIIKY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD----VARGMAYVHGL 257
+ ++ CIV EYA GG + Q + +++ P +Q LD + + Y+H
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP--EEQILDWFVQLCLALKYLHSR 122
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTYRWMAP 306
+HRD+K N+ ++++ +K+ DFG++++ T + GT +++P
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 8e-24
Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 15/183 (8%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVME-QQFQQE 186
W ++ + M G +G++Y G + VA+K L K ME ++F +E
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTMEVEEFLKE 52
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ +KH N+V+ +G C + + I+TE+ G++ +L + V + + A
Sbjct: 53 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 112
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRW 303
++ M Y+ FIHRDL + N L+ + +K+ADFG++R+ + + T G +W
Sbjct: 113 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKW 171
Query: 304 MAP 306
AP
Sbjct: 172 TAP 174
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-23
Identities = 62/193 (32%), Positives = 94/193 (48%), Gaps = 37/193 (19%)
Query: 142 AFAQGAFGKLYRG---TYNGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
+GAFGK+Y+G N VAIK L + P+ ++Q+F+QE +++ L+
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPK----VQQEFRQEAELMSDLQ 66
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALD---- 246
H NIV +G C K C++ EY G + +FL R A VK +LD
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 247 ------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEG 293
+A GM Y+ F+HRDL + N L+ ++KI+DFG++R VQ++
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 294 MTPETGTYRWMAP 306
+ P RWM P
Sbjct: 187 LLP----VRWMPP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-23
Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 32/187 (17%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
L GAFG +Y+G + E VAIK+L E KA ++ E ++
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKAN---KEILDEAYVM 63
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD---- 246
A++ H ++VR +G C V ++T+ G + ++ R ++ + + L+
Sbjct: 64 ASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYV--RNHKD---NIGSQYLLNWCVQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQ---TEGMTPETG 299
+A+GM+Y+ +HRDL + N+L+ + +KI DFG+A++ E + G P
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP--- 174
Query: 300 TYRWMAP 306
+WMA
Sbjct: 175 -IKWMAL 180
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 5e-23
Identities = 59/169 (34%), Positives = 91/169 (53%), Gaps = 13/169 (7%)
Query: 143 FAQGAFGKLYRGTYNGED-VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G FG++++GT + VA+K + E+ P++ ++ +F E +L H NIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK--EDLPQELKI---KFLSEARILKQYDHPNIVKL 57
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
IG C +R IV E GG FL R++ + K VK ALD A GMAY+ IH
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG----TYRWMAP 306
RDL + N L+ + +KI+DFG++R E +G+ +G +W AP
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAP 163
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 5e-23
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 20/172 (11%)
Query: 146 GAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLN 197
G FG++ RG DVAIK L KA ++Q F E ++ H N
Sbjct: 15 GEFGEVCRGRLKLPGKKEIDVAIKTL--------KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R G K I+TEY + GS+ +FL + +L V +A GM Y+ +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL-VGMLRGIASGMKYLSEM 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG---TYRWMAP 306
++HRDL + N+L++++ K++DFG++R +E G RW AP
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-22
Identities = 56/180 (31%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I L + G FG+++ TYN VA+K ++ P V + F E
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSV--EAFLAEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ TL+H +V+ K ++ I+TE+ GS+ FL + PL + + +A
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMA++ +IHRDL++ N+L+SA KIADFG+AR+ E E + +W AP
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-22
Identities = 61/186 (32%), Positives = 89/186 (47%), Gaps = 34/186 (18%)
Query: 146 GAFGKLYRGTYNGED--------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
GAFG++Y GT VA+K L + + EK + F +E +++ H N
Sbjct: 6 GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-----FLKEAHLMSNFNHPN 60
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFL-----TRRQNRAVPLKLAVKQALDVARGMA 252
IV+ +G C I+ E +GG + +L R + LK + LDVA+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 253 YVHGLGFIHRDLKSDNLLIS-----ADKSIKIADFGVAR-------IEVQTEGMTPETGT 300
Y+ + FIHRDL + N L+S AD+ +KI DFG+AR + EG+ P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP---- 176
Query: 301 YRWMAP 306
RWMAP
Sbjct: 177 VRWMAP 182
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-22
Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 15/180 (8%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W +++++L + +G FG + G Y G VA+K + K Q F E +
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDATAQAFLAEASV 52
Query: 190 LATLKHLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
+ L+H N+V+ +G ++ IVTEY GS+ +L R + +K +LDV
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 112
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
M Y+ F+HRDL + N+L+S D K++DFG+ + E + T +TG +W AP
Sbjct: 113 EAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTAP 168
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 13/179 (7%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
I +L + G FG ++ G + VAIK + + + E+ F +E ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-------EGAMSEEDFIEEAQVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C +R C+V E+ + G + +L R Q + + LDV G
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
MAY+ IHRDL + N L+ ++ +K++DFG+ R V + T TGT +W +P
Sbjct: 113 MAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSP 170
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-22
Identities = 60/192 (31%), Positives = 90/192 (46%), Gaps = 35/192 (18%)
Query: 145 QGAFGKLYR----GTYNGED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
QGAFG++++ G E VA+K+L+ E + M+ FQ+E ++A H N
Sbjct: 15 QGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-----EASADMQADFQREAALMAEFDHPN 69
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV----------------PLKLA- 240
IV+ +G C C++ EY G + +FL R RA PL L+
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 241 ---VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GM 294
+ A VA GMAY+ F+HRDL + N L+ + +KIADFG++R +
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 295 TPETGTYRWMAP 306
+ RWM P
Sbjct: 190 ENDAIPIRWMPP 201
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-22
Identities = 59/180 (32%), Positives = 87/180 (48%), Gaps = 10/180 (5%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
W I + + G FG+++ G Y N VA+K L+ P V Q F +E
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK-----PGTMSV--QAFLEEAN 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ TL+H +VR K I+TEY GS+ FL + V L + + +A
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
GMAY+ +IHRDL++ N+L+S KIADFG+AR+ E E + +W AP
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-22
Identities = 56/165 (33%), Positives = 89/165 (53%), Gaps = 10/165 (6%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FG+++ G + N VAIKIL+ ++ K Q FQ+EV L L+H +++
Sbjct: 16 SGYFGEVWEGLWKNRVRVAIKILKS--DDLLKQQ----DFQKEVQALKRLRHKHLISLFA 69
Query: 204 AC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
C V+ I+TE + GS+ FL + + +P+ + A VA GMAY+ IHR
Sbjct: 70 VCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-YRWMAP 306
DL + N+L+ D K+ADFG+AR+ + ++ + Y+W AP
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-22
Identities = 57/179 (31%), Positives = 88/179 (49%), Gaps = 13/179 (7%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID + L G FG + G + G+ DVAIK+++ + + E +F +E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C K+ IVTEY G + +L R P +L ++ DV G
Sbjct: 54 MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
MAY+ FIHRDL + N L+ +K++DFG++R + E T G+ RW P
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPP 170
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-22
Identities = 55/169 (32%), Positives = 81/169 (47%), Gaps = 33/169 (19%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+KIL P+ + F +EV +L+ LK NI+R +G C C++TEY +
Sbjct: 49 VAVKILR-----PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 221 GSVRQFLTRRQ--NRAVPLKLAVKQ---------------ALDVARGMAYVHGLGFIHRD 263
G + QFL+ ++ AV AL +A GM Y+ L F+HRD
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163
Query: 264 LKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
L + N L+ + +IKIADFG++R +Q + P RWMA
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP----IRWMA 208
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-22
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 13/148 (8%)
Query: 145 QGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G+FG + RG + G+ VA+K L+ +K + F +E ++ +L H N++
Sbjct: 5 DGSFGVVRRGEWSTSGGKVIPVAVKCLK-----SDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 200 RFIGACR-KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R G ++ +VTE A GS+ L + + A+ +A GM Y+
Sbjct: 60 RLYGVVLTHPLM--MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVAR 286
FIHRDL + N+L+++D +KI DFG+ R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 7e-22
Identities = 49/187 (26%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 141 TAFAQGAFGKLYRGTYNGED-------VAIKILE-RPENNPEKAQVMEQQFQQEVMMLAT 192
T +G FG+++ G + V +K L+ + N ++ +F++E+ M
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN------LQSEFRRELDMFRK 64
Query: 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK---LAVKQAL---- 245
L H N+VR +G CR+ ++ EY G ++QFL +++ LK L+ KQ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE------GMTPETG 299
+A GM ++ F+HRDL + N L+S+ + +K++ +++ +E + P
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--- 181
Query: 300 TYRWMAP 306
RW+AP
Sbjct: 182 -LRWLAP 187
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 62/193 (32%), Positives = 97/193 (50%), Gaps = 19/193 (9%)
Query: 127 YDE-WTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENNPEKAQV 178
YD W L+ G GAFGK+ T G D VA+K+L+ ++ E+ +
Sbjct: 26 YDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL 85
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
M E+ +++ L H NIV +GAC ++TEY G + FL R++ + L
Sbjct: 86 M-----SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
+ + + VA+GMA++ IHRDL + N+L++ K +KI DFG+AR ++ +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVV 199
Query: 298 TGTYR----WMAP 306
G R WMAP
Sbjct: 200 KGNARLPVKWMAP 212
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-21
Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
L QG+ G +Y+ + G+ A+K + + + +Q +E+ L + +
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-----EEFRKQLLRELKTLRSCE 57
Query: 195 HLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP---LKLAVKQALDVARG 250
+V+ GA ++ + IV EY GGS+ L ++ +P L +Q L G
Sbjct: 58 SPYVVKCYGAFYKEGEI-SIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILK---G 111
Query: 251 MAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
+ Y+H IHRD+K NLLI++ +KIADFG++++ T GT +M+P
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-21
Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 18/181 (9%)
Query: 140 GTAFAQGAFGKLYRG--TYNGEDVAIKILERP---ENNPEKAQVMEQQFQQEVMMLATLK 194
G G+FG +Y G +GE +A+K +E P ++ ++ + M +E+ +L L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQALDVARGMAY 253
H NIV+++G+ I EY GGSV L L + V+Q L +G+ Y
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNY 121
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR--------WMA 305
+H G IHRD+K N+L+ IKI+DFG+++ +++ ++ +T R WMA
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 306 P 306
P
Sbjct: 181 P 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-21
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 38/208 (18%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVM 179
+W +L +G +G FG++ R G D VA+K+L+ + + A ++
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI 65
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL------------ 227
+ E+M L KH NI+ +G C + ++ EYA G++R+FL
Sbjct: 66 SEM---ELMKLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121
Query: 228 --TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
T+ + K V A VARGM Y+ IHRDL + N+L++ D +KIADFG+A
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 286 R-------IEVQTEGMTPETGTYRWMAP 306
R + + G P +WMAP
Sbjct: 182 RGVHDIDYYKKTSNGRLP----VKWMAP 205
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-21
Identities = 57/162 (35%), Positives = 86/162 (53%), Gaps = 20/162 (12%)
Query: 135 RKLNMGTAFAQGAFGK--LYR------GTYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
R L +G FGK LY GT GE VA+K L+R E Q +++E
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGT--GEMVAVKTLKR-----ECGQQNTSGWKKE 56
Query: 187 VMMLATLKHLNIVRFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ +L TL H NIV++ G C ++ ++ EY GS+R +L + + L L +Q
Sbjct: 57 INILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ- 115
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ GMAY+H +IHRDL + N+L+ D+ +KI DFG+A+
Sbjct: 116 --ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-20
Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 26/162 (16%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L + + F +E+ +++ LK+ NI+R +G C C++TEY +
Sbjct: 47 VAVKMLR-----ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101
Query: 221 GSVRQFLTRRQNRA----------VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
G + QFL++R+ + V + + A+ +A GM Y+ L F+HRDL + N L
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161
Query: 271 ISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
+ +IKIADFG++R +Q + P RWMA
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP----IRWMA 199
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 38/208 (18%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVM 179
+W + +L +G +G FG++ G D VA+K+L+ + + + ++
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------- 231
+ MM KH NI+ +GAC + ++ EYA G++R++L R+
Sbjct: 66 SEM----EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121
Query: 232 ------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
+ K V A VARGM Y+ IHRDL + N+L++ D +KIADFG+A
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 286 R-------IEVQTEGMTPETGTYRWMAP 306
R + T G P +WMAP
Sbjct: 182 RDVHNIDYYKKTTNGRLP----VKWMAP 205
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 53/177 (29%), Positives = 90/177 (50%), Gaps = 23/177 (12%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200
+G +GK+Y+ + G+ VAIKI++ E+ E++ ++E +L H NI
Sbjct: 15 GEGTYGKVYKARHKKTGQLVAIKIMDIIED-------EEEEIKEEYNILRKYSNHPNIAT 67
Query: 201 FIGACRKR-------MVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGM 251
F GA K+ +W +V E GGSV + R++ + + + + RG+
Sbjct: 68 FYGAFIKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
AY+H IHRD+K N+L++ + +K+ DFGV+ ++ + T GT WMAP
Sbjct: 127 AYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMAP 182
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-19
Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA +Y N E VAIK + + EK Q + ++EV ++ H N+V++
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRI-----DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-PLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V Y GGS+ + R + +V +G+ Y+H G IH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-----GTYRWMAP 306
RD+K+ N+L+ D S+KIADFGV+ T + GT WMAP
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 55/188 (29%), Positives = 94/188 (50%), Gaps = 27/188 (14%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
R L +G FG + Y+ GE VA+K L+ A+ + + F++E+
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHL-RDFEREIE 57
Query: 189 MLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
+L +L+H NIV++ G C R +V EY GS+R +L + + R KL + A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-LLYASQ 116
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--------EVQTEGMTPET 298
+ +GM Y+ ++HRDL + N+L+ ++ +KI DFG+ ++ +V+ G +P
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP-- 174
Query: 299 GTYRWMAP 306
W AP
Sbjct: 175 --IFWYAP 180
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 43/219 (19%)
Query: 123 GLENYD-----EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILER 168
G+ Y+ W + +L +G +G FG++ G D VA+K+L+
Sbjct: 1 GVSEYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS 60
Query: 169 PENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT 228
+ + ++ + MM KH NI+ +GAC + ++ EYA G++R++L
Sbjct: 61 DATEKDLSDLISEM----EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 116
Query: 229 RRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
R+ + K V A VARGM Y+ IHRDL + N+L++ D
Sbjct: 117 ARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176
Query: 275 KSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAP 306
+KIADFG+AR + T G P +WMAP
Sbjct: 177 NVMKIADFGLARDIHHIDYYKKTTNGRLP----VKWMAP 211
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-19
Identities = 59/191 (30%), Positives = 87/191 (45%), Gaps = 37/191 (19%)
Query: 143 FAQGAFGKLYRGTYNG----ED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
+GAFGK++ + +D VA+K L+ E ++ Q FQ+E +L L+H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK------EASESARQDFQREAELLTVLQH 66
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR--------QNRAVPL-KLAVKQAL- 245
+IVRF G C + +V EY + G + +FL V +L + Q L
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 246 ---DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMT 295
+A GM Y+ L F+HRDL + N L+ +KI DFG++R V M
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 296 PETGTYRWMAP 306
P RWM P
Sbjct: 187 P----IRWMPP 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G FGK+Y GE +A+K + +N+P+ ++ E+ +L LKH N+V++
Sbjct: 9 GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK----TIKEIADEMKVLELLKHPNLVKY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
G R I EY GG++ + L R + + L + G+AY+H G +H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-----TGTYRWMAP 306
RD+K N+ + + IK+ DFG A E GT +MAP
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+ GE VAIK ++ + + + +E+ +L L H NI++ +
Sbjct: 9 EGTYGVVYKARDKLTGEIVAIKKIKLRFESE----GIPKTALREIKLLKELNHPNIIKLL 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
R + +V E+ + + + + + R +P L + +G+A+ H G +HR
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLI-KDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRW 303
DLK +NLLI+ + +K+ADFG+AR T T RW
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RW 163
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 25/161 (15%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220
VA+K+L N + F +E+ +++ LK NI+R + C C++TEY +
Sbjct: 49 VAVKMLREDANKNAR-----NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103
Query: 221 GSVRQFLTRRQNRAVPLKLAVK---------QALDVARGMAYVHGLGFIHRDLKSDNLLI 271
G + QFL+R + + K V A +A GM Y+ L F+HRDL + N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
Query: 272 SADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 305
+ +IKIADFG++R +Q + P RWM+
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLP----IRWMS 200
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-19
Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 11/167 (6%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG+++ G ++ + + E P ++ +F QE +L H NIVR IG
Sbjct: 5 RGNFGEVFSGRLRADNTPVAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264
C ++ IV E +GG FL R + + +K ++ + A GM Y+ IHRDL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 265 KSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR-----WMAP 306
+ N L++ +KI+DFG++R E +G+ TG + W AP
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREE--EDGVYASTGGMKQIPVKWTAP 165
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 4e-19
Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 18/151 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLK-HLN 197
+G+F + ++ AIKIL+ K Q+++++ + V + L L H
Sbjct: 11 EGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHG 256
I++ + V EYA G + Q++ + + + + L + Y+H
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL---ALEYLHS 120
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
G IHRDLK +N+L+ D IKI DFG A++
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKV 151
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-19
Identities = 44/171 (25%), Positives = 89/171 (52%), Gaps = 19/171 (11%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR- 200
+G++G +Y+ + A+K ++ + E+ + E+ +LA++ H NI+
Sbjct: 10 KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-----NEIRILASVNHPNIISY 64
Query: 201 ---FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVH 255
F+ + CIV EYA G + + +++R+ + +P + + + + RG+ +H
Sbjct: 65 KEAFLDGNK----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLKS N+L+ A+ +KI D G++++ + T + GT +MAP
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT-QIGTPHYMAP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 5e-19
Identities = 54/167 (32%), Positives = 84/167 (50%), Gaps = 22/167 (13%)
Query: 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFI 202
G FG +Y GE VAIK +++ + E+ + +EV L L H NIV+
Sbjct: 10 GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-----REVKSLRKLNEHPNIVKLK 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP---LKLAVKQALDVARGMAYVHGLGF 259
R+ V EY +G ++ Q + R+ + ++ + Q + +G+A++H GF
Sbjct: 65 EVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQ---ILQGLAHIHKHGF 120
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RW 303
HRDLK +NLL+S + +KIADFG+AR + P T Y RW
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYT-DYVSTRW 163
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 9e-19
Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+G + R GE VAIK E ++ K + +EV +L L+H NIV
Sbjct: 11 EGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-----REVKVLRQLRHENIVNL 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
A R++ +V EY ++ + L P ++ + Q L + +AY H
Sbjct: 66 KEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLL---QAIAYCHSHNI 121
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR 286
IHRD+K +N+L+S +K+ DFG AR
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 12/176 (6%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
G GAF Y R G +A+K + N + + + + ++E+ ++A L H +
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R +GA + + + E+ GGSV L++ A + + + RG++Y+H
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 258 GFIHRDLKSDNLLI-SADKSIKIADFGVA-RIEVQTEGMTPE-----TGTYRWMAP 306
IHRD+K NLLI S + ++IADFG A R+ + G E GT +MAP
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG-AGEFQGQLLGTIAFMAP 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVME 180
W KL +G +G FG++ G D VA+K+L+ ++ EK +
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKD--LS 65
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL------------- 227
+ MM KH NI+ +GAC + ++ EYA G++R++L
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 228 -TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
R + + K V VARGM Y+ IHRDL + N+L++ + +KIADFG+AR
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 287 -------IEVQTEGMTPETGTYRWMAP 306
+ T G P +WMAP
Sbjct: 186 DVNNIDYYKKTTNGRLP----VKWMAP 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-18
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 47/208 (22%)
Query: 136 KLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVM 188
L +G +G FGK+ + T VA+K+L+ ++ E ++ E
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLL-----SEFN 55
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------- 232
+L + H ++++ GAC + ++ EYAK GS+R FL +
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 233 ------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
RA+ + + A ++RGM Y+ + +HRDL + N+L++ + +KI+DFG++R
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 287 IEV--------QTEGMTPETGTYRWMAP 306
+V +++G P +WMA
Sbjct: 176 -DVYEEDSYVKRSKGRIP----VKWMAI 198
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-18
Identities = 51/162 (31%), Positives = 87/162 (53%), Gaps = 15/162 (9%)
Query: 143 FAQGAFGKLY------RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G FGK+ G GE VA+K L +PE+ ++E+ +L L H
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIA----DLKKEIEILRNLYHE 66
Query: 197 NIVRFIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
NIV++ G C + I + E+ GS++++L R +N+ + LK +K A+ + +GM Y+
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL 125
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMT 295
++HRDL + N+L+ ++ +KI DFG+ + IE E T
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-18
Identities = 53/175 (30%), Positives = 88/175 (50%), Gaps = 11/175 (6%)
Query: 140 GTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197
G QGAFG++Y G ++A K ++ +PE ++ + + E+ +L L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEV-SALECEIQLLKNLQHER 65
Query: 198 IVRFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV++ G R R I EY GGSV+ L + A+ + K + GM+Y+H
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLH 123
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L + ++K+ DFG ++ I + G+ TGT WM+P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-18
Identities = 59/192 (30%), Positives = 90/192 (46%), Gaps = 37/192 (19%)
Query: 143 FAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+ AFGK+Y+G + + VAIK L + NNP++ +FQQE ++A L H
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWG----EFQQEASLMAELHHP 67
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA-----VPLKLAVKQALD----- 246
NIV +G + C++ EY G + +FL R + VK +LD
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 247 -----VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGM 294
+A GM Y+ F+H+DL + N+LI +KI+D G++R VQ + +
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 295 TPETGTYRWMAP 306
P RWM P
Sbjct: 188 LP----IRWMPP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-18
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+ +GA G +++ GE VA+K + + Q +E+ L +H
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALREIKALQACQHP 59
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARG 250
+V+ + + +V EY + L Q ++ L +G
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL--------KG 111
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP 306
+AY+H G +HRDLK NLLISAD +KIADFG+AR+ + E + + T + AP
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 15/170 (8%)
Query: 146 GAFGKLYRGTYN--GED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG+++RG G VAIK L+ P + Q F E ++ H NI+R
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLK-----PGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
G K I+TEY + G++ ++L +L V +A GM Y+ + ++
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYLSDMNYV 129
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETG---TYRWMAP 306
HRDL + N+L++++ K++DFG++R+ E EG +G RW AP
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 43/167 (25%), Positives = 83/167 (49%), Gaps = 9/167 (5%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G+FG +++ + A+K ++ N E+ + ++ E +LA L I+R
Sbjct: 9 GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-----EARVLAKLDSSYIIR 63
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + IV EYA+ G + + L ++ R +P + + + G+A++H +
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
HRD+KS NL + A ++KI D GVA++ T GT +++P
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 19/187 (10%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
E+ + + +G +G +Y V I I E PE + Q + +E+
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL----HEEIA 57
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQA 244
+ + LKH NIV+++G+ + + I E GGS+ L + ++ + KQ
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSI-KIADFG----VARIEVQTEGMTPETG 299
L+ G+ Y+H +HRD+K DN+L++ + KI+DFG +A I TE TG
Sbjct: 118 LE---GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TG 171
Query: 300 TYRWMAP 306
T ++MAP
Sbjct: 172 TLQYMAP 178
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 17/172 (9%)
Query: 145 QGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G FG +Y GT D A+K L R + E Q F +E +++ H N++
Sbjct: 5 KGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-----FLKEGIIMKDFSHPNVL 59
Query: 200 RFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+G C +V Y K G +R F+ R + +K + L VA+GM Y+
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-----YRWMA 305
F+HRDL + N ++ ++K+ADFG+AR E + T +WMA
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 56/168 (33%), Positives = 87/168 (51%), Gaps = 15/168 (8%)
Query: 144 AQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++Y+G N E VAIKI++ E+A+ + QQE+ +L+ I R+
Sbjct: 13 GKGSFGEVYKGIDNRTKEVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--DVARGMAYVHGLGF 259
G+ K I+ EY GGS L + PL+ + ++ +G+ Y+H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 306
IHRD+K+ N+L+S +K+ADFGVA T+ GT WMAP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 45/167 (26%), Positives = 86/167 (51%), Gaps = 11/167 (6%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPE-NNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG+ LYR T + V K + + E+ + E+++L+ L+H NI+ +
Sbjct: 10 KGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-----NEIVILSLLQHPNIIAY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
I EYA GG++ + R++ + ++ + + ++Y+H G +H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
RD+K+ N+ ++ IK+ DFG+++I + +E ET GT +M+P
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAETVVGTPYYMSP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-17
Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G++Y+ GE VA+K + R EN E +E+ +L L+H NIVR
Sbjct: 9 EGTYGQVYKARNKKTGELVALKKI-RMENEKEG---FPITAIREIKLLQKLRHPNIVRLK 64
Query: 203 GACRKRMVWCIVTEYAKGG----------SVRQFLTRRQNR--AVPLKLAVKQALDVARG 250
IVT KG + L + + +K +KQ L G
Sbjct: 65 ---------EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---EG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ Y+H G +HRD+K N+LI+ D +K+ADFG+AR
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-17
Identities = 51/176 (28%), Positives = 89/176 (50%), Gaps = 11/176 (6%)
Query: 139 MGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G QGAFG++Y G ++A+K ++ +PE ++ + + E+ +L L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEV-NALECEIQLLKNLLHE 64
Query: 197 NIVRFIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV++ G R M I E+ GGS++ L + A+ + K + G++Y+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYL 122
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 306
H +HRD+K N+L + ++K+ DFG ++ I + GM TGT WM+P
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 4e-17
Identities = 58/175 (33%), Positives = 87/175 (49%), Gaps = 29/175 (16%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNI 198
+G +G +Y+ GE VA+K + R +N E+ E+ +L LKH NI
Sbjct: 9 EGTYGVVYKARDKKTGEIVALKKI-RLDNE-------EEGIPSTALREISLLKELKHPNI 60
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHG 256
V+ + +V EY ++++L +R P +K + Q L RG+AY H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL---RGLAYCHS 116
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK N+LI+ D +K+ADFG+AR I ++T T E T YR AP
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYR--AP 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-17
Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMML 190
I+ +L G FG ++ G + + VAIK + + + E+ F +E ++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN-------EGAMSEEDFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C ++ IVTE+ + G + +L +RQ + + + DV G
Sbjct: 54 MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEG 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 306
M Y+ FIHRDL + N L+S+ +K++DFG+ R + E + + +W P
Sbjct: 113 MEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPP 170
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-17
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 33/200 (16%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ- 181
W + K+ M QG+FG +Y G G VAIK + E A + E+
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN------EAASMRERI 54
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL----TRRQNRAV-- 235
+F E ++ ++VR +G + ++ E G ++ +L +N V
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 236 --PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292
LK ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
Query: 293 ------GMTPETGTYRWMAP 306
G+ P RWM+P
Sbjct: 175 YRKGGKGLLP----VRWMSP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-17
Identities = 56/170 (32%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G +G +Y R + GE A+KI++ + QQE+ M+ KH NIV + G
Sbjct: 20 GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL------IQQEIFMVKECKHCNIVAYFG 73
Query: 204 A--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGL 257
+ R+++ C+ EY GGS++ V L+ Q V R G+AY+H
Sbjct: 74 SYLSREKLWICM--EYCGGGSLQDIY------HVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
G +HRD+K N+L++ + +K+ADFGV A+I GT WMAP
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 8e-17
Identities = 61/189 (32%), Positives = 89/189 (47%), Gaps = 35/189 (18%)
Query: 143 FAQGAFGKLYRGT-YN---GED---VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
+GAFGK++ YN +D VA+K L+ +N K F +E +L L+H
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK------DFHREAELLTNLQH 66
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV-------PLKLAVKQALDVA 248
+IV+F G C + +V EY K G + +FL AV P +L Q L +A
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 249 R----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------GMTPE 297
+ GM Y+ F+HRDL + N L+ + +KI DFG++R T+ M P
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP- 185
Query: 298 TGTYRWMAP 306
RWM P
Sbjct: 186 ---IRWMPP 191
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-17
Identities = 54/166 (32%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 146 GAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFGK+Y+ G A K++E K++ + + E+ +LAT H IV+ +G
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIE------TKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A I+ E+ GG+V + R +++ +Q L+ + Y+H + IH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSMKIIH 133
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
RDLK+ N+L++ D IK+ADFGV+ V+T + GT WMAP
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-17
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 38/203 (18%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRG-------TYNGEDVAIKILERPENNPEKAQVMEQQFQ 184
I R + + +GAFGK++ T + VA+K L+ P K FQ
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK------DFQ 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--------------TRR 230
+E +L L+H +IV+F G C +V EY K G + +FL R+
Sbjct: 56 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---- 286
+ L + A +A GM Y+ F+HRDL + N L+ A+ +KI DFG++R
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175
Query: 287 ---IEVQTEGMTPETGTYRWMAP 306
V M P RWM P
Sbjct: 176 TDYYRVGGHTMLP----IRWMPP 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 52/172 (30%), Positives = 90/172 (52%), Gaps = 16/172 (9%)
Query: 143 FAQGAFGKLYRGTY--NGEDV----AIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
GAFG +Y+G + GE V AIKIL E KA V +F E +++A++ H
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANV---EFMDEALIMASMDHP 69
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
++VR +G C + +VT+ G + ++ ++ + +L + + +A+GM Y+
Sbjct: 70 HLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEE 127
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTY--RWMA 305
+HRDL + N+L+ + +KI DFG+AR +E + + G +WMA
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 33/200 (16%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGT----YNGE---DVAIKILERPENNPEKAQVMEQ- 181
W + K+ + QG+FG +Y G GE VA+K + E A + E+
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERI 54
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-------TRRQNRA 234
+F E ++ ++VR +G K +V E G ++ +L R
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 235 VP-LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292
P L+ ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R +T+
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 293 ------GMTPETGTYRWMAP 306
G+ P RWMAP
Sbjct: 175 YRKGGKGLLP----VRWMAP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 161 VAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L KA E+Q F E ++ H NI+ G K IVTEY
Sbjct: 35 VAIKTL--------KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ GS+ FL + + ++L V +A GM Y+ +G++HRDL + N+L++++
Sbjct: 87 MENGSLDAFLRKHDGQFTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC 145
Query: 278 KIADFGVARI-EVQTEGMTPETG---TYRWMAP 306
K++DFG++R+ E E G RW AP
Sbjct: 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 17/154 (11%)
Query: 142 AFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQF-QQEVMMLATLKHLNI 198
+G+FGK+Y + + E IK E + K V E++ ++EV++LA +KH NI
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIK-----EIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL----DVARGMAYV 254
V F + ++ IV EY GG L +R NR + + Q L ++ G+ ++
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGD----LMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 255 HGLGFIHRDLKSDNLLISADKSI-KIADFGVARI 287
H +HRD+KS N+ +S + + K+ DFG+AR
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 161 VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAK 219
+A+K + N + Q++ +E+ +L IV F GA + I EY
Sbjct: 29 MAVKTIRLEINEAIQKQIL-----RELDILHKCNSPYIVGFYGAFYNNGDIS-ICMEYMD 82
Query: 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIK 278
GGS+ + L Q R +P ++ K A+ V +G+ Y+H IHRD+K N+L+++ IK
Sbjct: 83 GGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIK 141
Query: 279 IADFGVARIEVQTEGMTPETGTYRWMAP 306
+ DFGV+ V + T GT +MAP
Sbjct: 142 LCDFGVSGQLVNSLAKT-FVGTSSYMAP 168
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 57/183 (31%), Positives = 89/183 (48%), Gaps = 30/183 (16%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R E VAIK + + +++ Q +EV L
Sbjct: 19 DLREI------GHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69
Query: 191 ATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALD 246
L+H N + + G C R+ W +V EY G S L ++ + V + AL
Sbjct: 70 QQLRHPNTIEYKG-CYLREHTAW-LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQ 126
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRW 303
G+AY+H IHRD+K+ N+L++ ++K+ADFG A + ++P GT W
Sbjct: 127 ---GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYW 177
Query: 304 MAP 306
MAP
Sbjct: 178 MAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 57/168 (33%), Positives = 85/168 (50%), Gaps = 19/168 (11%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G +G +Y R GE AIK++ + E + A V QQE++M+ KH NIV + G
Sbjct: 20 GTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAVV-----QQEIIMMKDCKHSNIVAYFG 73
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLGF 259
+ +R I E+ GGS++ V L+ Q V+R G+ Y+H G
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIY------HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
+HRD+K N+L++ + +K+ADFGV A+I GT WMAP
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 19/172 (11%)
Query: 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFI 202
G +G++Y+G + G+ AIK+++ E+ E++ + E+ ML H NI +
Sbjct: 27 GTYGQVYKGRHVKTGQLAAIKVMDVTEDE-------EEEIKLEINMLKKYSHHRNIATYY 79
Query: 203 GACRKR-------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
GA K+ +W +V E+ GSV + + A+ ++ RG+A++H
Sbjct: 80 GAFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
IHRD+K N+L++ + +K+ DFGV A+++ GT WMAP
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-16
Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAIK + + P+K ++ E++++ KH NIV ++
Sbjct: 29 QGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELII-----NEILVMRENKHPNIVNYL 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ +T + ++ L + + ++H IHR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQVIHR 139
Query: 263 DLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
D+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-16
Identities = 55/173 (31%), Positives = 84/173 (48%), Gaps = 28/173 (16%)
Query: 146 GAFGKLYRGTYNGEDV--AIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ + + A KI++ E E F E+ +L+ KH NIV
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELE-------DFMVEIDILSECKHPNIVGLY 68
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQF-------LTRRQNRAVPLKLAVKQALDVARGMAYV 254
A + +W I+ E+ GG++ LT Q R V +Q L+ + ++
Sbjct: 69 EAYFYENKLW-ILIEFCDGGALDSIMLELERGLTEPQIRYV-----CRQMLE---ALNFL 119
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
H IHRDLK+ N+L++ D +K+ADFGV A+ + + GT WMAP
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 8e-16
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 25/159 (15%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNI 198
+GA+G +Y+ G VA+K + P + + + +E+ +L L+ H NI
Sbjct: 8 GEGAYGTVYKARDLNTGRFVALKKVRVPLS----EEGIPLSTLREIALLKQLESFEHPNI 63
Query: 199 VRFIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA---- 248
VR + C R+ + +V E+ V Q L ++ L + D+
Sbjct: 64 VRLLDVCHGPRTDRELKLT-LVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
RG+ ++H +HRDLK N+L+++D +KIADFG+ARI
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 9e-16
Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 17/169 (10%)
Query: 144 AQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++++G N VAIKI++ E+A+ + QQE+ +L+ + ++
Sbjct: 13 GKGSFGEVFKGIDNRTQQVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-KLAVKQAL-DVARGMAYVHGLGF 259
G+ K I+ EY GGS L RA P + + L ++ +G+ Y+H
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
IHRD+K+ N+L+S +K+ADFGVA T+ + T GT WMAP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 52/178 (29%), Positives = 86/178 (48%), Gaps = 23/178 (12%)
Query: 141 TAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
G FG + +G Y + VA+KIL+ N+P ++ + +E ++ L +
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IVR IG C W +V E A+ G + +FL ++N+ V K + V+ GM Y+
Sbjct: 57 YIVRMIGICEAE-SWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 306
F+HRDL + N+L+ KI+DFG+++ + +T G P +W AP
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP----VKWYAP 167
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 38/143 (26%), Positives = 73/143 (51%), Gaps = 7/143 (4%)
Query: 143 FAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
++GA+G+++ + G+ AIK++++ + K QV Q E +L+ + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKK-ADMIRKNQV--DQVLTERDILSQAQSPYVVK 57
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + +V EY GG + L ++ +A ++ + Y+H G I
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 261 HRDLKSDNLLISADKSIKIADFG 283
HRDLK DN+LI ++ +K+ DFG
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFG 138
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-15
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 25/168 (14%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
L +G +G FG + G + +D VA+K ++ + +++ E F E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL--DIHTYSEIEE--FLSEAACMK 56
Query: 192 TLKHLNIVRFIGAC---------RKRMVWCIVTEYAKGGSVRQFL----TRRQNRAVPLK 238
H N+++ IG C K MV + + K G + FL +PL+
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMV---ILPFMKHGDLHSFLLYSRLGGLPEKLPLQ 113
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+K +D+A GM Y+ FIHRDL + N ++ D ++ +ADFG+++
Sbjct: 114 TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 10/164 (6%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
GAFGK+Y+ ++ +L + K++ + + E+ +LA+ H NIV+ + A
Sbjct: 16 GAFGKVYKA----QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
I+ E+ GG+V + R +++ KQ L+ + Y+H IHRD
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHENKIIHRD 128
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
LK+ N+L + D IK+ADFGV+ +T + GT WMAP
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-15
Identities = 49/145 (33%), Positives = 78/145 (53%), Gaps = 11/145 (7%)
Query: 146 GAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
G FG + +G Y DVAIK+L+ N EK+ E + E+M L + IVR
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMH--QLDNPYIVRM 60
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
IG C + +V E A GG + +FL+ +++ + + V+ V+ GM Y+ G F+H
Sbjct: 61 IGVCEAEALM-LVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 262 RDLKSDNLLISADKSIKIADFGVAR 286
RDL + N+L+ KI+DFG+++
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-15
Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 23/189 (12%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYN--GED---VAIKILERPENNPEKAQVMEQQ---F 183
ID+ + + G FG++ RG G+ VAIK L K+ E+Q F
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--------KSGYTEKQRRDF 52
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
E ++ H NI+ G K I+TE+ + G++ FL + + ++L V
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGM 111
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY-- 301
+A GM Y+ + ++HRDL + N+L++++ K++DFG++R T +
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 302 ----RWMAP 306
RW AP
Sbjct: 172 KIPIRWTAP 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-15
Identities = 47/173 (27%), Positives = 85/173 (49%), Gaps = 17/173 (9%)
Query: 145 QGAFGKLYRGT----YNGEDVAIKILERPENNPEKAQVMEQ-QFQQEVMMLATLKHLNIV 199
G FGK+ G Y V +K L A V EQ +F +E +L+H N++
Sbjct: 5 NGWFGKVILGEVNSGYTPAQVVVKELR------VSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQ-ALDVARGMAYVHG 256
+ +G C + + +V E+ G ++ +L R+ P +++ A ++A G+ ++H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 306
FIH DL N L++AD ++KI D+G++ + + + + RW+AP
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-15
Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 23/175 (13%)
Query: 146 GAFGKLYRG-TYNGEDVAIKILERPENNPEKAQVMEQ-QFQQEVMMLATLKHLNIVRFIG 203
G FGK+ G + G A +++ + A EQ F QEV L H N+++ +G
Sbjct: 6 GWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGLG 258
C + + + +V E+ G ++ +L R NR + + A +VA G+ ++H
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAP 306
FIH DL N ++AD S+KI D+G+A + P RW+AP
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP----LRWLAP 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-15
Identities = 42/146 (28%), Positives = 79/146 (54%), Gaps = 8/146 (5%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVME-QQFQQEVMMLATLKHLNIVRF 201
+G+FGK L + +G+ IK E N K E ++ ++EV +L+ +KH NIV++
Sbjct: 10 EGSFGKAILVKSKEDGKQYVIK-----EINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + IV +Y +GG + + + ++ P + + + + +VH +H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARI 287
RD+KS N+ ++ D +IK+ DFG+AR+
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARV 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 4e-15
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 34/178 (19%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQV----MEQQFQQEVMMLATLKHLNI 198
+G+FGK+ R G+ A+K+L+ K ++ + E +L+ + H I
Sbjct: 3 KGSFGKVLLVRKKDTGKLYAMKVLK-------KKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 199 VRFIGACRKRMVWCI--------VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
V+ + + V EYA GG + L + + A A ++
Sbjct: 56 VK--------LHYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA 105
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ Y+H LG I+RDLK +N+L+ AD IK+ DFG+A+ EG T GT ++AP
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-15
Identities = 48/177 (27%), Positives = 91/177 (51%), Gaps = 13/177 (7%)
Query: 139 MGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G +GAFG++Y G ++A+K + ++ E ++ + + E+ +L L+H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV-NALECEIQLLKNLRHD 64
Query: 197 NIVRFIGACR--KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV++ G R + I EY GGS++ L + A+ + + + +G++Y+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYL 122
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-----EGMTPETGTYRWMAP 306
H +HRD+K N+L + ++K+ DFG ++ +QT G+ TGT WM+P
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-15
Identities = 51/166 (30%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 144 AQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG++++G N VAIKI++ E+A+ + QQE+ +L+ + ++
Sbjct: 13 GKGSFGEVFKGIDNRTQKVVAIKIIDL-----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
G+ K I+ EY GGS L + +++ L +G+ Y+H IH
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKKIH 124
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 306
RD+K+ N+L+S +K+ADFGVA T+ GT WMAP
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 9e-15
Identities = 41/130 (31%), Positives = 64/130 (49%), Gaps = 8/130 (6%)
Query: 158 GEDVAIKI-LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216
G+ VAIK LE ++ K M +E+ ML L+H N+V I R++ +V E
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80
Query: 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+ +V L + N + K + RG+ + H IHRD+K +N+L+S
Sbjct: 81 FVDH-TVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV 138
Query: 277 IKIADFGVAR 286
+K+ DFG AR
Sbjct: 139 VKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-15
Identities = 40/160 (25%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL 196
L +G +G FG + G N +D +K+ + + + F E + + H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 197 NIVRFIGACRKRM------VWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALD 246
N++R IG C + + ++ + K G + FL + +P ++ VK D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+A GM Y+ FIHRDL + N +++ + ++ +ADFG+++
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-15
Identities = 61/189 (32%), Positives = 88/189 (46%), Gaps = 40/189 (21%)
Query: 144 AQGAFGKLYRGTY----NGEDVAIKILER--PENNPEKAQVMEQQFQQEVMMLATL-KHL 196
+G FG++ R + AIK+L+ EN+ + F E+ +L L H
Sbjct: 11 GEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND-------HRDFAGELEVLCKLGHHP 63
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ------------- 243
NI+ +GAC R I EYA G++ FL R++R + A +
Sbjct: 64 NIINLLGACENRGYLYIAIEYAPYGNLLDFL--RKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 244 ---ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE----VQTEGMTP 296
A DVA GM Y+ FIHRDL + N+L+ + + KIADFG++R E +T G P
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 297 ETGTYRWMA 305
RWMA
Sbjct: 182 ----VRWMA 186
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 8/161 (4%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G++G ++ R G+ VAIK E++P V+++ +E+ ML LKH N+V I
Sbjct: 11 EGSYGVVFKCRNRETGQIVAIKKFVESEDDP----VIKKIALREIRMLKQLKHPNLVNLI 66
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
R++ +V EY +V L + R VP L K + + + H IHR
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
D+K +N+LI+ IK+ DFG ARI + RW
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW 165
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 13/165 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQV-MEQQFQQEVMMLATLKHLNIVRF 201
+G + +Y+ G VAIK ++ ++A+ + +E+ +L LKH NI+
Sbjct: 10 EGTYAVVYKARDKETGRIVAIKKIK--LGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-VKQ-ALDVARGMAYVHGLGF 259
+ + +V E+ + + + +++++ L A +K L RG+ Y+H
Sbjct: 68 LDVFGHKSNINLVFEFM-ETDLEKVI---KDKSIVLTPADIKSYMLMTLRGLEYLHSNWI 123
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPETGTYRW 303
+HRDLK +NLLI++D +K+ADFG+AR MT + T RW
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RW 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 12/166 (7%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G ++ G++VAIK + + P+K ++ E++++ LK+ NIV F
Sbjct: 28 GQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELII-----NEILVMKELKNPNIVNF 81
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALEFLHANQVIH 138
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ +G VA+K ++ E KA+ Q +E+ +L L H N+++++
Sbjct: 12 KGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR---QDCLKEIDLLKQLDHPNVIKYL 68
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + IV E A G + + + ++Q R +P + K + + + ++H +
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 62/183 (33%), Positives = 91/183 (49%), Gaps = 29/183 (15%)
Query: 132 IDLRKLNMGTAFAQGAFGKL--YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
+DL+ + MG AFG + R G++VAIK + +P + P V+ ++ +E+ +
Sbjct: 13 VDLQPVGMG------AFGLVCSARDQLTGQNVAIKKIMKPFSTP----VLAKRTYRELKL 62
Query: 190 LATLKHLNIVR----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ-- 243
L L+H NI+ FI VTE G + + LT R PL+ Q
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIY---FVTELL-GTDLHRLLTSR-----PLEKQFIQYF 113
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
+ RG+ YVH G +HRDLK N+LI+ + +KI DFG+ARI Q MT T +
Sbjct: 114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRYY 171
Query: 304 MAP 306
AP
Sbjct: 172 RAP 174
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 20/176 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G+FG + R +G+ + K ++ EK QQ EV +L LKH NIVR+
Sbjct: 10 KGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-----QQLVSEVNILRELKHPNIVRY 64
Query: 202 IGAC--RKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R IV EY +GG + Q + +++ + + + + + + H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 258 G-----FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+HRDLK N+ + A+ ++K+ DFG+A+I + + +T GT +M+P
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSP 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 27/173 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
G+FG+ L R +G+ A+KIL KA++++ + + V+ +L +++H +
Sbjct: 11 TGSFGRVMLVRHKGSGKYYALKILS-------KAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 199 VRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V G+ + +V EY GG + L R++ P +A A V + Y+H
Sbjct: 64 VNLYGSFQDDSNLY--LVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 306
L ++RDLK +NLL+ +D IKI DFG A R++ +T + TPE ++AP
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE-----YLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 29/159 (18%)
Query: 164 KILERPENNPEKAQVM--------EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215
K++ RP +V+ +Q +E+ +L + H N+V+ ++
Sbjct: 92 KVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151
Query: 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVAR----GMAYVHGLGFIHRDLKSDNLL 270
E+ GGS+ + +A +Q L DVAR G+AY+H +HRD+K NLL
Sbjct: 152 EFMDGGSL-------EGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL 200
Query: 271 ISADKSIKIADFGVARIEVQTEGMTP---ETGTYRWMAP 306
I++ K++KIADFGV+RI QT M P GT +M+P
Sbjct: 201 INSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSP 237
|
Length = 353 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-14
Identities = 47/174 (27%), Positives = 86/174 (49%), Gaps = 19/174 (10%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVR 200
G +G++Y+G + G+ AIK+++ + E++ +QE+ ML H NI
Sbjct: 15 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIAT 67
Query: 201 FIGACRKR-------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
+ GA K+ +W +V E+ GSV + + + + ++ RG+++
Sbjct: 68 YYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
+H IHRD+K N+L++ + +K+ DFGV A+++ GT WMAP
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 38/175 (21%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIK-ILERPENN--PEKAQVMEQQFQQEVM 188
LR + +G FG++Y+ G VA+K IL E + P A +E+
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-------REIK 59
Query: 189 MLATLKHLNIVRFI--------GACRKRMVWCIVTEYA--------KGGSVRQFLTRRQN 232
+L LKH N+V I + RKR +VT Y + SV+ LT Q
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQ- 116
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+K + Q L+ G+ Y+H +HRD+K+ N+LI +KIADFG+AR
Sbjct: 117 ----IKCYMLQLLE---GINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 31/190 (16%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVME-----QQFQQ 185
+LRKL + G FG +++G + E +IKI P + ++ Q FQ+
Sbjct: 6 ETELRKLKL---LGSGVFGTVHKGIWIPEGDSIKI-------PVAIKTIQDRSGRQTFQE 55
Query: 186 ---EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++ + +L H IVR +G C + +VT+ + GS+ + + ++ P +L +
Sbjct: 56 ITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRL-LN 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMT 295
+ +A+GM Y+ +HR+L + N+L+ +D ++IADFGVA + +E T
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 296 PETGTYRWMA 305
P +WMA
Sbjct: 174 P----IKWMA 179
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIV 214
G A+K + + NP+ +++Q +E+ + + K IV++ GA I
Sbjct: 25 TGMIFALKTITT-DPNPD----LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79
Query: 215 TEYAKGGSVRQFL--TRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
EY +GGS+ +++ + K+ K A V +G++Y+H IHRD+K N+L++
Sbjct: 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139
Query: 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+K+ DFGV+ V + T TGT +MAP
Sbjct: 140 RKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAP 172
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRG----TYNGED---VAIKILERPENNPEKAQV-MEQQF 183
I+L + + FGK+Y+G T GE VAIK L+ +KA+ + ++F
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK------DKAEGPLREEF 55
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR----AVPLKL 239
+ E MM + L+H NIV +G K ++ Y + +FL R +
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 240 AVKQALD----------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289
VK L+ +A GM ++ +H+DL + N+L+ ++KI+D G+ R EV
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR-EV 174
Query: 290 QTEGMTPETGT----YRWMAP 306
G RWM+P
Sbjct: 175 YAADYYKLMGNSLLPIRWMSP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-14
Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAFG ++ R + + V IK + + ++ Q E +L L H NI+ +
Sbjct: 10 RGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYY 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ IV EYA GG++ +++ +R N + + + + + +VH +HR
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 263 DLKSDNLLISADKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK+ N+L+ K + KI DFG+++I GT +++P
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 5e-14
Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 31/176 (17%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + G VAIK + ++ A+ + +E+ +L L+H NI+
Sbjct: 10 SGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK----RILREIKLLRHLRHENIIGLL 65
Query: 201 --FIGACRKRM--VWCIVTEYAKG--GSV---RQFLTRRQNRAVPLKLAVKQALDVARGM 251
+ V+ IVTE + V Q LT ++ + Q L RG+
Sbjct: 66 DILRPPSPEDFNDVY-IVTELMETDLHKVIKSPQPLTDDH-----IQYFLYQIL---RGL 116
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRW 303
Y+H IHRDLK N+L++++ +KI DFG+AR E + +T T RW
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT-RW 171
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-14
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 36/187 (19%)
Query: 144 AQGAFGKLYRGTYNGE----DVAIKILER--PENNPEKAQVMEQQFQQEVMMLATL-KHL 196
+G FG++ + + D AIK ++ +++ + F E+ +L L H
Sbjct: 4 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------HRDFAGELEVLCKLGHHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------NRAVPLKLAVKQAL- 245
NI+ +GAC R + EYA G++ FL + + + L+ +Q L
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 246 ---DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE----VQTEGMTPET 298
DVARGM Y+ FIHRDL + N+L+ + KIADFG++R + +T G P
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 174
Query: 299 GTYRWMA 305
RWMA
Sbjct: 175 --VRWMA 179
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-14
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 30/211 (14%)
Query: 101 VTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGK--LYRGTYNG 158
VTH AL + ++D P LENY +G+ G + R ++G
Sbjct: 1 VTHEQFKAAL-RMVVDQGDPRSLLENY-------------IKIGEGSTGIVCIAREKHSG 46
Query: 159 EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-FIGACRKRMVWCIVTEY 217
VA+K+++ K Q E F EV+++ +H N+V + +W ++ E+
Sbjct: 47 RQVAVKMMDL-----RKQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELW-VLMEF 99
Query: 218 AKGGSVRQFLTRRQNRAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+GG++ ++ Q R ++A V ++ V + + Y+H G IHRD+KSD++L++ D
Sbjct: 100 LQGGALTDIVS--QTRLNEEQIATVCES--VLQALCYLHSQGVIHRDIKSDSILLTLDGR 155
Query: 277 IKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
+K++DFG A+I GT WMAP
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-14
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 36/199 (18%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEV 187
++ + +G FG++ + + D AIK ++ + + + F E+
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGEL 58
Query: 188 MMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--------- 237
+L L H NI+ +GAC R + EYA G++ FL R++R +
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANS 116
Query: 238 ---KLAVKQAL----DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEV 289
L+ +Q L DVARGM Y+ FIHRDL + N+L+ + KIADFG++R EV
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 290 ---QTEGMTPETGTYRWMA 305
+T G P RWMA
Sbjct: 177 YVKKTMGRLP----VRWMA 191
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-14
Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
++GAFG +Y + G+ AIK+L + + K QV + ++ +MM+ + +
Sbjct: 5 SKGAFGSVYLAKKRSTGDYFAIKVL-KKSDMIAKNQVTNVKAERAIMMIQGESP-YVAKL 62
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + + +V EY GG + + +P A + +V G+ +H G IH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 306
RD+K +NLLI +K+ DFG++R G+ + GT ++AP
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAP 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPE---NNPEKAQVMEQQFQQEVMMLATLKHLNI 198
++GAFGK+Y R N + A+K++++ + N M Q Q E LA K I
Sbjct: 13 SRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKN------MVHQVQAERDALALSKSPFI 66
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V + + +V EY GG V+ L + AVK +VA + Y+H G
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM--AVKYISEVALALDYLHRHG 124
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
IHRDLK DN+LIS + IK+ DFG++++ + E
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 51/182 (28%), Positives = 94/182 (51%), Gaps = 19/182 (10%)
Query: 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQE 186
+L+K+ + GAFG +Y+G + +GE+ VAIK+L EN KA ++ E
Sbjct: 8 ELKKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR--ENTSPKAN---KEILDE 59
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++A + + R +G C V +VT+ G + ++ ++R L + +
Sbjct: 60 AYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTY--RW 303
+A+GM+Y+ + +HRDL + N+L+ + +KI DFG+AR +++ + G +W
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 304 MA 305
MA
Sbjct: 178 MA 179
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 44/146 (30%), Positives = 66/146 (45%), Gaps = 11/146 (7%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G + +Y+G GE VA+K L+ E P A +E+ ++ LKH NIVR
Sbjct: 10 EGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-------REISLMKELKHENIVR 62
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+V EY + T A+ + +G+A+ H +
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 261 HRDLKSDNLLISADKSIKIADFGVAR 286
HRDLK NLLI+ +K+ADFG+AR
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 26/178 (14%)
Query: 144 AQGAFGKLYR--GTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVR 200
+G +GK+++ NG A+KIL+ + ++++ + E +L L H N+V+
Sbjct: 27 GKGTYGKVFKVLNKKNGSKAAVKILDPIHD-------IDEEIEAEYNILKALSDHPNVVK 79
Query: 201 FIGACRKRMV------WCIVTEYAKGGSV----RQFLTRRQNRAVPL-KLAVKQALDVAR 249
F G K+ V W +V E GGSV + FL R + P+ + +AL
Sbjct: 80 FYGMYYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL---M 135
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
G+ ++H IHRD+K +N+L++ + +K+ DFGV A++ GT WMAP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 48/155 (30%), Positives = 82/155 (52%), Gaps = 20/155 (12%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV----WCI 213
G VA+K + + K Q E F EV+++ +H NIV + +V W +
Sbjct: 44 GRQVAVKKM-----DLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSS---YLVGDELW-V 93
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
V E+ +GG++ +T R ++A V A V + ++++H G IHRD+KSD++L++
Sbjct: 94 VMEFLEGGALTDIVT--HTRMNEEQIATVCLA--VLKALSFLHAQGVIHRDIKSDSILLT 149
Query: 273 ADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
+D +K++DFG A++ + GT WMAP
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-13
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G +Y G++VAIK + + P+K ++ E++++ K+ NIV +
Sbjct: 28 GQGASGTVYTAIDIATGQEVAIKQMNL-QQQPKKELII-----NEILVMRENKNPNIVNY 81
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSNQVIH 138
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 41/160 (25%), Positives = 79/160 (49%), Gaps = 23/160 (14%)
Query: 144 AQGAFGKLY---RGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G++Y R G++ AIK + E+ + Q +E+ +L LKH N+V
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGD---KEQYTGISQSACREIALLRELKHENVV 65
Query: 200 RFIGACRKRM---VWCIVTEYAKG--GSVRQFLTRRQNRAVP---LKLAVKQALDVARGM 251
+ + V+ ++ +YA+ + +F + + ++P +K + Q L+ G+
Sbjct: 66 SLVEVFLEHADKSVY-LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN---GV 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKS----IKIADFGVARI 287
Y+H +HRDLK N+L+ + +KI D G+AR+
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 59/180 (32%), Positives = 87/180 (48%), Gaps = 26/180 (14%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEV 187
++L KL +G++ +Y+G NG+ VA+K+ ++ E P A +E
Sbjct: 8 LNLEKL------GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-------REA 54
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQAL 245
+L LKH NIV + V EY + Q++ + P ++L + Q L
Sbjct: 55 SLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL 113
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGTYR 302
RG+AY+HG +HRDLK NLLIS +K+ADFG+AR I QT T YR
Sbjct: 114 ---RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYR 170
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 32/176 (18%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG+++ R + VA+K + EN E + + E+ +L LKH N+V I
Sbjct: 22 QGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALR---EIKILQLLKHENVVNLI 77
Query: 203 GACRKR--------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--D 246
CR + +C E+ G L N+ V L+ + +
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFC---EHDLAG----LL---SNKNVKFTLSEIKKVMKM 127
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
+ G+ Y+H +HRD+K+ N+LI+ D +K+ADFG+AR ++ P T R
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-13
Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 12/166 (7%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
QGA G +Y G++VAI+ + + P+K ++ E++++ K+ NIV +
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII-----NEILVMRENKNPNIVNY 82
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ + +V EY GGS+ +T + ++ L + + ++H IH
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQVIH 139
Query: 262 RDLKSDNLLISADKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
RD+KSDN+L+ D S+K+ DFG A+I + + GT WMAP
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-13
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILE---RPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y R GE VA+K + E P A +E+ +L L H NIV
Sbjct: 10 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-------REISLLKELNHPNIV 62
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + +V E+ +++F+ +PL L + +G+A+ H
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+HRDLK NLLI+ + +IK+ADFG+AR V T E T + AP
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 47/173 (27%), Positives = 85/173 (49%), Gaps = 24/173 (13%)
Query: 146 GAFGKLYRGTYN--GED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GAFG +Y+G + GE VAIK L R +P+ ++ E ++A++ + ++
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK----ANKEILDEAYVMASVDNPHVC 72
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
R +G C V ++T+ G + ++ ++ L + + +A+GM Y+
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNYLEERRL 130
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARI------EVQTE-GMTPETGTYRWMA 305
+HRDL + N+L+ + +KI DFG+A++ E E G P +WMA
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP----IKWMA 179
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-13
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 100 KVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YN 157
+V+H AL Q ++ P E L+++ + +G +G+ G + T +
Sbjct: 1 RVSHEQFRAAL-QLVVSPGDPREYLDSF---------IKIG----EGSTGIVCIATEKHT 46
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
G+ VA+K ++ K Q E F EV+++ H N+V + +V E+
Sbjct: 47 GKQVAVKKMDL-----RKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100
Query: 218 AKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+GG++ +T R N + L V R ++Y+H G IHRD+KSD++L+++D
Sbjct: 101 LEGGALTDIVTHTRMNE----EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR 156
Query: 277 IKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
IK++DFG A++ + GT WMAP
Sbjct: 157 IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-13
Identities = 42/169 (24%), Positives = 85/169 (50%), Gaps = 11/169 (6%)
Query: 143 FAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
F + ++Y T V +K L+ ++ E + +F Q+ L+H NI++ +
Sbjct: 8 FGKVLLSEIYTDT-GVARVVVKELKANASSKE-----QNEFLQQGDPYRILQHPNILQCL 61
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVKQALDVARGMAYVHGLGFI 260
G C + + + +V EY + G ++ +L++ Q R L L + A ++A G+ ++H F+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 306
H DL N +++D ++K+ D+G+ + + + E RW+AP
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200
+G +GK+Y+ T +G A+KIL+ + ++++ + E +L +L H N+V+
Sbjct: 31 GKGTYGKVYKVTNKKDGSLAAVKILDPISD-------VDEEIEAEYNILQSLPNHPNVVK 83
Query: 201 FIGA------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL--DVARGMA 252
F G +W +V E GGSV + + L A+ + G+
Sbjct: 84 FYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
++H IHRD+K +N+L++ + +K+ DFGV A++ GT WMAP
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 36/186 (19%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R N E VAIK + + +++ Q +EV L
Sbjct: 19 DLREI------GHGSFGAVYFARDVRNSEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA-- 248
L+H N +++ G + +V EY G + ++ PL Q +++A
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PL-----QEVEIAAV 120
Query: 249 -----RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GT 300
+G+AY+H IHRD+K+ N+L+S +K+ DFG A I M P GT
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGT 174
Query: 301 YRWMAP 306
WMAP
Sbjct: 175 PYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 50/150 (33%), Positives = 76/150 (50%), Gaps = 17/150 (11%)
Query: 143 FAQGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G++ +Y+G NG+ VA+K+ L+ E P A +E +L LKH NI
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-------REASLLKGLKHANI 65
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHG 256
V + +V EY + Q++ + P +KL + Q L RG++Y+H
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQ 121
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+HRDLK NLLIS +K+ADFG+AR
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQ---QEVMMLATLKHLNI 198
G+FG +Y T + E VA+K + + +++Q +EV L LKH N
Sbjct: 30 GHGSFGAVYFATNSHTNEVVAVKKMSY------SGKQTNEKWQDIIKEVKFLQQLKHPNT 83
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQF-LTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + G K +V EY G + + ++ + V + AL +G+AY+H
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSH 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K+ N+L++ +K+ADFG A GT WMAP
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAP 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 18/177 (10%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED---VAIKILERPENNPEKAQVMEQQFQQEVM----M 189
N G+FG++ TY ED VAIK E K+++++Q+ V +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE-------KSKIIKQKQVDHVFSERKI 84
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
L + H V G+ + +V E+ GG FL R+N+ P + A +
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVL 142
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
Y+ L ++RDLK +NLL+ D IK+ DFG A++ V T T GT ++AP
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT-LCGTPEYIAP 197
|
Length = 340 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 47/145 (32%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+G + R E VAIK + E N E +++ +E+ ML TLK NIV
Sbjct: 10 GEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVEL 65
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A R+R +V EY + ++ + L N P K+ + + + + H +H
Sbjct: 66 KEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKNDIVH 123
Query: 262 RDLKSDNLLISADKSIKIADFGVAR 286
RD+K +NLLIS + +K+ DFG AR
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 44/168 (26%), Positives = 84/168 (50%), Gaps = 8/168 (4%)
Query: 144 AQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G F ++YR T + + VA+K ++ E KA+ Q +E+ +L L H N++++
Sbjct: 11 GRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR---QDCVKEIDLLKQLNHPNVIKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + IV E A G + Q + ++Q R +P + K + + + ++H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 22/176 (12%)
Query: 142 AFAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQF-QQEVMMLATLKHLNI 198
+G++G+ L R +G+ IK L N A E++ +QE +L+ LKH NI
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKL-----NLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 199 VRFIGACRKRMVW-------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
V + R W IV + +GG + L ++ + +P V+ + +A +
Sbjct: 62 VAY------RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
Y+H +HRDLK+ N+ ++ IK+ D G+AR+ E Q + + GT +M+P
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 17/148 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G++ +Y+G G+ VA+K LE E P A +E +L LKH NIV
Sbjct: 15 EGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-------REASLLKDLKHANIVT 67
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLG 258
+ +V EY ++Q++ ++L + Q L RG+AY H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCHQRR 123
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVAR 286
+HRDLK NLLIS +K+ADFG+AR
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 43/168 (25%), Positives = 82/168 (48%), Gaps = 8/168 (4%)
Query: 144 AQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G F ++YR T +G VA+K ++ + KA+ +E+ +L L H N++++
Sbjct: 11 GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIKY 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + IV E A G + + + ++Q R +P K K + + + ++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 27/169 (15%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVME----QQFQQEV 187
+G +G FG + ED VA+K+L KA + ++F +E
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML--------KADIFSSSDIEEFLREA 52
Query: 188 MMLATLKHLNIVRFIG-ACRKRM-----VWCIVTEYAKGGSVRQFL--TR--RQNRAVPL 237
+ H N+++ IG + R R + ++ + K G + FL +R + +PL
Sbjct: 53 ACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL 112
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ V+ +D+A GM Y+ FIHRDL + N +++ + ++ +ADFG+++
Sbjct: 113 QTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 53/175 (30%), Positives = 89/175 (50%), Gaps = 23/175 (13%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIVR 200
GA+G +Y R ++G VA+K + R + N + + +EV +L L+ NIVR
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPL---STVREVALLKRLEAFDHPNIVR 66
Query: 201 FIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGM 251
+ C R+ V +V E+ +R +L + +P K ++Q L RG+
Sbjct: 67 LMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGL 121
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++H +HRDLK +N+L+++ +K+ADFG+ARI +TP T + AP
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAP 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 134 LRKLNMGTAFAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
L MG G+FG++ ++GT GE AIK L++ E K QV Q QE +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMK-QV--QHVAQEKSI 71
Query: 190 LATLKHLNIVRFI-GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
L L H IV + + V+ + E+ GG + F R+ P +A ++
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVY-FLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELV 128
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
Y+H I+RDLK +NLL+ +K+ DFG A+ +V + GT ++AP
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KV-PDRTFTLCGTPEYLAP 184
|
Length = 329 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 32/184 (17%)
Query: 133 DLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
DLR++ G+FG +Y R E VAIK + + +++ Q +EV L
Sbjct: 29 DLREI------GHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVKFL 79
Query: 191 ATLKHLNIVRFIGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA- 248
+KH N + + G R+ W +V EY G + ++ PL Q +++A
Sbjct: 80 QRIKHPNSIEYKGCYLREHTAW-LVMEYCLGSASDLLEVHKK----PL-----QEVEIAA 129
Query: 249 ------RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
+G+AY+H IHRD+K+ N+L++ +K+ADFG A I GT
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPY 186
Query: 303 WMAP 306
WMAP
Sbjct: 187 WMAP 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-12
Identities = 32/121 (26%), Positives = 57/121 (47%), Gaps = 2/121 (1%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E M+L + H +++R + C+V + + +LT+R +R +P+ A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKR-SRPLPIDQALIIEK 164
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMA 305
+ G+ Y+H IHRD+K++N+ I+ + I D G A+ V GT A
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224
Query: 306 P 306
P
Sbjct: 225 P 225
|
Length = 357 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 39/145 (26%), Positives = 76/145 (52%), Gaps = 7/145 (4%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG+ L + + + A+K + P K+ + ++E ++LA +KH NIV F
Sbjct: 10 EGSFGRALLVQHVNSDQKYAMKEIRLP-----KSSSAVEDSRKEAVLLAKMKHPNIVAFK 64
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ IV EY GG + Q + ++ + P ++ + + G+ ++H +HR
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVARI 287
D+KS N+ ++ + +K+ DFG AR+
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARL 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 49/172 (28%), Positives = 88/172 (51%), Gaps = 17/172 (9%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKIL-ERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G+FG +Y + + +K+L E P E NP + Q QE +L+ L H IV
Sbjct: 10 KGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV----QANQEAQLLSKLDHPAIV 65
Query: 200 RFIGACRKRMVWCIVTEYAKGG----SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+F + +R +CI+TEY +G + + + + + + + + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEEL--KHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM-TPETGTYRWMAP 306
+HRDLK+ N+ + + +KI DFGV+R+ + + + T TGT +M+P
Sbjct: 124 QRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271
V EY GG + F +R R A A ++ G+ ++H G I+RDLK DN+L+
Sbjct: 72 FFVMEYVNGGDL-MFHIQRSGR-FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 272 SADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++ IKIADFG+ + E G+T T GT ++AP
Sbjct: 130 DSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 18/171 (10%)
Query: 146 GAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG ++ T +G+ VA+K + N V ++ +E+ ML KH N++ +
Sbjct: 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQN----LVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 204 ACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHGL 257
+ + +VTE + + + + Q + +K+ + Q L RG+ Y+H
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLHSA 122
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP 306
G +HRD+K NLL++++ +KI DFG+AR+E E MT E T + AP
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 25/59 (42%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
RG+ Y+H +HRDLK NLL++A+ +KI DFG+AR + MT T + AP
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L R G A+KIL R E K +V + V+ L ++
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ R+ C V EYA GG + L+R R + A ++ + Y+H +
Sbjct: 62 YAFQTHDRL--CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+RD+K +NL++ D IKI DFG+ + E ++G T +T GT ++AP
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 39/130 (30%), Positives = 66/130 (50%), Gaps = 11/130 (8%)
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
+++Q E+ +L I+ F GA R+ C TE+ GGS+ + R +P
Sbjct: 42 LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC--TEFMDGGSLDVY------RKIP 93
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
+ + A+ V +G+ Y+ L +HRD+K N+L++ +K+ DFGV+ V + T
Sbjct: 94 EHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT- 152
Query: 297 ETGTYRWMAP 306
GT +MAP
Sbjct: 153 YVGTNAYMAP 162
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 60/179 (33%), Positives = 88/179 (49%), Gaps = 20/179 (11%)
Query: 136 KLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL 193
KLN +G +G +YR T +GE VA+K + R +N + + + E+ +L L
Sbjct: 11 KLNR---IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLR---EITLLLNL 63
Query: 194 KHLNIVRFIGACRKRMVWCI--VTEYAKGGSVRQFLTRR-QNRAVPLKLA-VKQ-ALDVA 248
+H NIV + + I V EY + Q L N P + VK L +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCE-----QDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
RG+ Y+H IHRDLK NLL++ +KIADFG+AR + + MTP+ T + AP
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 37/107 (34%), Positives = 49/107 (45%), Gaps = 26/107 (24%)
Query: 212 CIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265
C V EYA GG + F R AV A V G+ Y+H ++RDLK
Sbjct: 78 CFVMEYAAGGDLMMHIHTDVFSEPR---------AVFYAACVVLGLQYLHENKIVYRDLK 128
Query: 266 SDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
DNLL+ + +KIADFG+ + EGM GT ++AP
Sbjct: 129 LDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFLAP 170
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 24/158 (15%)
Query: 145 QGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG+++ G E +V +K ++ ++ + QV QE +L L H NI
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK---DHASEIQV--TLLLQESCLLYGLSHQNI 70
Query: 199 VRFIGAC----RKRMVWCIVTEYAKGGSVRQFLTR------RQNRAVPLKLAVKQALDVA 248
+ + C V + Y G+++ FL + +A+ + V A+ +A
Sbjct: 71 LPILHVCIEDGEPPFV---LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
GM+Y+H G IH+D+ + N +I + +KI D ++R
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 22/153 (14%)
Query: 139 MGTAFAQGAFGKLYRGTYNGEDVAIKI--LERPENNPEKAQVME--QQFQQEVMMLATLK 194
+G F L + VA+K L+ + E + QQE++ L+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLD--------SCSKEDLKLLQQEIITSRQLQ 57
Query: 195 HLNIVR----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVAR 249
H NI+ FI ++ +V+ GS L +P +LA+ L DV
Sbjct: 58 HPNILPYVTSFI---VDSELY-VVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLN 112
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
+ Y+H GFIHR +K+ ++L+S D + ++
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 15/148 (10%)
Query: 144 AQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLN 197
+GAFG+ L R G+ A+K+L K+ ++++ V +LA
Sbjct: 10 GRGAFGEVWLVRDKDTGQVYAMKVLR-------KSDMIKRNQIAHVRAERDILADADSPW 62
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
IV+ + + +V EY GG + L R+ P + A ++ + VH L
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKL 120
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA 285
GFIHRD+K DN+LI AD IK+ADFG+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIK---ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +++ E VA+K + + E P A +E+ +L LKH NIV
Sbjct: 10 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-------REICLLKELKHKNIV 62
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGL 257
R +V EY ++++ P +K + Q L +G+A+ H
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHSH 118
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR 286
+HRDLK NLLI+ + +K+ADFG+AR
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 64/253 (25%), Positives = 98/253 (38%), Gaps = 84/253 (33%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ 181
+W +L +G +GAFGK+ + + G VA+K+L+ E +M
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGACRKR----MVWCIVTEYAKGG-------SVRQFLTR 229
E+ +L + HLN+V +GAC K MV + EY K G S R+ +
Sbjct: 59 ---TELKILIHIGHHLNVVNLLGACTKPGGPLMV---IVEYCKFGNLSNYLRSKRECFSP 112
Query: 230 RQNRAVPLKLAV-----KQALD-------------------------------------- 246
+N++ + KQ LD
Sbjct: 113 YRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTL 172
Query: 247 ---------VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297
VARGM ++ IHRDL + N+L+S + +KI DFG+AR ++ +
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVR 231
Query: 298 TGTYR----WMAP 306
G R WMAP
Sbjct: 232 KGDARLPLKWMAP 244
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 53/179 (29%), Positives = 81/179 (45%), Gaps = 26/179 (14%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK--ILERPENN-PEKAQVMEQQFQQEVMMLATLKHLN-I 198
+G +GK+Y R G+ VA+K LE E P A +E+ +L L I
Sbjct: 11 EGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-------REISLLQMLSESIYI 63
Query: 199 VRFIGA------CRKRMVWCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVAR 249
VR + K ++ +V EY +++F+ R R +P K + +
Sbjct: 64 VRLLDVEHVEEKNGKPSLY-LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKS-IKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
G+A+ H G +HRDLK NLL+ K +KIAD G+ R + + T E T + AP
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 41/132 (31%), Positives = 66/132 (50%), Gaps = 11/132 (8%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI--GACRKRMVWCIVT 215
G +VAIK+L + PE+ +F++E + A L H NIV + G +++ V
Sbjct: 3 GHEVAIKLLR--TDAPEEEH-QRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VF 58
Query: 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-- 273
EY G ++R+ L + A+P + L V +A H G +HRDLK N+++S
Sbjct: 59 EYVPGRTLREVLA--ADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 274 -DKSIKIADFGV 284
K+ DFG+
Sbjct: 117 VRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 16/154 (10%)
Query: 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216
+G+ VA+K ++ K Q E F EV+++ +H N+V + +V E
Sbjct: 44 SGKLVAVKKMDL-----RKQQRRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVME 97
Query: 217 YAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
+ +GG++ +T + + + LAV +AL V +H G IHRD+KSD++L++
Sbjct: 98 FLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV------LHAQGVIHRDIKSDSILLTH 151
Query: 274 DKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 306
D +K++DFG A++ + GT WMAP
Sbjct: 152 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 9/163 (5%)
Query: 146 GAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FG+++ R + A+K++ PE K EQ E +L + H I+R
Sbjct: 12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLK---QEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ ++ EY GG + +L R + + A ++ + Y+H ++RD
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126
Query: 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
LK +N+L+ + IK+ DFG A+ +++ T GT ++AP
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAK-KLRDRTWT-LCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + C+V EY +GG L + A+P+ +A + + Y+H
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287
G +HRDLK DNLLI++ IK+ DFG+++I
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 48/175 (27%), Positives = 84/175 (48%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G+FGK L + +G A+K+L+ K +++++ Q +M +L LKH
Sbjct: 5 KGSFGKVLLAKRKSDGSFYAVKVLQ-------KKTILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + V +Y GG + F ++ R A A +VA + Y+H L
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAP 306
I+RDLK +N+L+ + + + DFG+ + EG+ PE GT ++AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGVEPEETTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 41/153 (26%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
G +VA+K L RP N Q ++ +E+++L + H NI+ + + + E+
Sbjct: 46 GINVAVKKLSRPFQN----QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS---LEEF 98
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQA----LDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V + + + + ++L ++ + G+ ++H G IHRDLK N+++ +
Sbjct: 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 158
Query: 274 DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D ++KI DFG+AR MTP T + AP
Sbjct: 159 DCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 64/190 (33%), Positives = 86/190 (45%), Gaps = 29/190 (15%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIK--ILERPENNPEKAQVM 179
LE Y I L KL GT + +Y+G D VA+K LE E P A
Sbjct: 5 LETY----IKLDKLGEGT------YATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-- 52
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPL 237
+EV +L LKH NIV +V EY ++Q+L N +
Sbjct: 53 -----REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNV 106
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTP 296
KL + Q L RG+ Y H +HRDLK NLLI+ +K+ADFG+AR + + T+ +
Sbjct: 107 KLFLFQLL---RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163
Query: 297 ETGTYRWMAP 306
E T W P
Sbjct: 164 EVVTL-WYRP 172
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 18/170 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FGK L R G+ A+KIL++ E K +V + V+ L +++
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKK-EVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLG 258
R+ C V EYA GG + L+R ++RA + AL Y+H
Sbjct: 64 FQTHDRL--CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHSCD 115
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + + ++G T +T GT ++AP
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 27/184 (14%)
Query: 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
+L+ + G AQG Y T G++VAIK L RP N A+ + +++ V+M
Sbjct: 20 NLKPIGSG---AQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMK-L 71
Query: 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--- 249
+ H NI+ + + + E+ V + + L ++ LD R
Sbjct: 72 VNHKNIIGLLNVFTPQKS---LEEFQDVYLVMELMDAN------LCQVIQMDLDHERMSY 122
Query: 250 -------GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
G+ ++H G IHRDLK N+++ +D ++KI DFG+AR + MTP T
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 303 WMAP 306
+ AP
Sbjct: 183 YRAP 186
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIK-I-LE-RPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y R GE VA+K I LE E P A +E+ +L L H NIV
Sbjct: 9 EGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-------REISLLKELNHPNIV 61
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R + ++ +V E+ +++++ + L + +G+AY H
Sbjct: 62 RLLDVVHSENKLY--LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK NLLI + ++K+ADFG+AR
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 19/195 (9%)
Query: 124 LENYDEWTIDLRKLNMGT-------AFAQGAFG--KLYRGTYNGEDVAIKILERPENNPE 174
L Y + +R L M +GAFG +L R + A+K+L + E
Sbjct: 25 LNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 84
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
F +E ++A +V+ A + +V EY GG + ++ N
Sbjct: 85 SDSAF---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---NYD 138
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294
VP K A +V + +H +GFIHRD+K DN+L+ +K+ADFG +++ EGM
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGM 197
Query: 295 T---PETGTYRWMAP 306
GT +++P
Sbjct: 198 VRCDTAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 19/147 (12%)
Query: 146 GAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG+L RG VAI L ++ ++ + F E + L H NIVR
Sbjct: 16 GRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-----RGFLAEALTLGQFDHSNIVR 70
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD----VARGMAYVHG 256
G + IVTEY G++ FL + + +L Q + +A GM Y+
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSE 125
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFG 283
+G++H+ L + +L+++D KI+ F
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 55/251 (21%), Positives = 89/251 (35%), Gaps = 79/251 (31%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQ 181
+W +L +G GAFGK+ + G VA+K+L+ E +M
Sbjct: 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGAC-RKRMVWCIVTEYAK-------------------- 219
E+ +L + HLN+V +GAC + ++ E+ K
Sbjct: 59 ---SELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYRE 115
Query: 220 -----------------------GGSVR----QFLTRRQNRAVPLKLA------------ 240
G +F P +
Sbjct: 116 KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMED 175
Query: 241 -VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
+ + VARGM ++ IHRDL + N+L+S + +KI DFG+AR ++ + G
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKG 234
Query: 300 TYR----WMAP 306
+ R WMAP
Sbjct: 235 SARLPLKWMAP 245
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 144 AQGAFGKLYRG---TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+GA+GK+++ G VA+K + R + E + + + L T +H N+VR
Sbjct: 10 GEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 201 FIGACR-----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
C + +V E+ + +L + VP + + RG+ ++H
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK N+L+++ IK+ADFG+ARI
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 20/172 (11%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM---MLATLKHL 196
QG+FGK++ G G+ A+K+L+ KA + + + M +LA + H
Sbjct: 6 QGSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLKVRDRVRTKMERDILAEVNHP 58
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMAYVH 255
IV+ A + ++ ++ +GG + TR + + VK L ++A + ++H
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
LG I+RDLK +N+L+ + IK+ DFG+++ + E GT +MAP
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 40/142 (28%), Positives = 75/142 (52%), Gaps = 9/142 (6%)
Query: 145 QGAFGKLY----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G G+++ +GT G+ A+K+L++ E +V +QE+ LATL H +
Sbjct: 11 KGDVGRVFLVRLKGT--GKLFALKVLDKKEMIKRN-KVKRVLTEQEI--LATLDHPFLPT 65
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + C+V +Y GG + + L R+ + + ++A A +V + Y+H LG +
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 261 HRDLKSDNLLISADKSIKIADF 282
+RDLK +N+L+ I ++DF
Sbjct: 126 YRDLKPENILLHESGHIMLSDF 147
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 34/178 (19%)
Query: 145 QGAFGKL--YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G++ T G VAIK L RP + A+ + +E+ +L + H N++ +
Sbjct: 25 SGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK----RTYRELRLLKHMDHENVIGLL 80
Query: 203 GACRKRMVWC------------IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
V+ +VT G + + ++ ++ V Q L RG
Sbjct: 81 D------VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL---RG 130
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRW-MAP 306
+ Y+H G IHRDLK N+ ++ D +KI DFG+AR T+ MT T RW AP
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVAT-RWYRAP 184
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 57/174 (32%), Positives = 77/174 (44%), Gaps = 27/174 (15%)
Query: 148 FGKLYRGTY----------NGEDVAIK--ILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
KL GTY VA+K LE E P A +EV +L LKH
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKNLKH 62
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAY 253
NIV +V EY ++Q+L N +K+ + Q L RG++Y
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSY 118
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTYRWMAP 306
H +HRDLK NLLI+ +K+ADFG+AR + V T+ + E T W P
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL-WYRP 171
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 57/179 (31%), Positives = 82/179 (45%), Gaps = 21/179 (11%)
Query: 138 NMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMM-----L 190
N +G+FGK+ G D AIKIL K V+ Q E M L
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKIL--------KKDVIIQDDDVECTMVEKRVL 54
Query: 191 ATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A + + +C + M V EY GG + + + P AV A ++A
Sbjct: 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH--AVFYAAEIAI 112
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
G+ ++H G I+RDLK DN+++ A+ IKIADFG+ + E G T T GT ++AP
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 12/167 (7%)
Query: 144 AQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
AQG Y + +VAIK L RP N Q ++ +E++++ + H NI+ +
Sbjct: 29 AQGIVCAAYDAVLD-RNVAIKKLSRPFQN----QTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA----LDVARGMAYVHGLGF 259
+ + E+ V + + + + ++L ++ + G+ ++H G
Sbjct: 84 VFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 140
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRDLK N+++ +D ++KI DFG+AR + MTP T + AP
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 27/63 (42%), Positives = 36/63 (57%), Gaps = 6/63 (9%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWM 304
RG+ Y+H +HRDLK NLL++ + +KI DFG+ARI T +T T RW
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RWY 175
Query: 305 -AP 306
AP
Sbjct: 176 RAP 178
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 26/166 (15%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLA 191
+ +G G+FG +Y E VAIK +L+ P Q +E++++
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----------QYKNRELLIMK 114
Query: 192 TLKHLNIVRF--------IGACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAV 241
L H+NI+ K + +V E+ +V +++ R N A+PL L
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVAR 286
+ + R +AY+H HRDLK NLLI + ++K+ DFG A+
Sbjct: 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 37/164 (22%)
Query: 160 DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219
+VAIK L RP N Q ++ +E++++ + H NI+ + +
Sbjct: 51 NVAIKKLSRPFQN----QTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTP 94
Query: 220 GGSVRQFLTRRQNRAVPLKL-------AVKQALDVAR----------GMAYVHGLGFIHR 262
S+ +F Q+ + ++L ++ LD R G+ ++H G IHR
Sbjct: 95 QKSLEEF----QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK N+++ +D ++KI DFG+AR + MTP T + AP
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 46/164 (28%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQ-------QEVMMLATLKH 195
+G +G +YR GE VA+K L+ ME++ + +E+ +L L+H
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLK-----------MEKEKEGFPITSLREINILLKLQH 63
Query: 196 LNIVRFIGACRKRMVW-------CIVTEYAKGGSVRQFL-----TRRQNRAVP-LKLAVK 242
NIV K +V +V EY V L T +Q +K +
Sbjct: 64 PNIVTV-----KEVVVGSNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLML 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
Q L G+A++H +HRDLK+ NLL++ +KI DFG+AR
Sbjct: 114 QLL---SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-------FAQGAFG--KLYRG 154
AL D AL ++ L Y++ + KL M +GAFG +L R
Sbjct: 5 ALVYDCDIPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRH 64
Query: 155 TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLN---IVRFIGACRKRM 209
+ + A+K+L + E + A E++ ++M H N IV+ A +
Sbjct: 65 KSSKQVYAMKLLSKFEMIKRSDSAFFWEER---DIM-----AHANSEWIVQLHYAFQDDK 116
Query: 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269
+V EY GG + ++ N +P K A +V + +H +GFIHRD+K DN+
Sbjct: 117 YLYMVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173
Query: 270 LISADKSIKIADFGVARIEVQTEGM 294
L+ +K+ADFG +++ GM
Sbjct: 174 LLDKSGHLKLADFGTC-MKMDANGM 197
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 27/64 (42%), Positives = 34/64 (53%), Gaps = 7/64 (10%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRW 303
RG+ Y+H IHRDLK NLL++ D ++I DFG+AR MT T RW
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RW 176
Query: 304 M-AP 306
AP
Sbjct: 177 YRAP 180
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 42/168 (25%), Positives = 87/168 (51%), Gaps = 11/168 (6%)
Query: 144 AQGAFGK--LYRGTYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G+FGK L + +G+ A+K+L++ N E+ +M ++ ++L +KH +V
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAER----NVLLKNVKHPFLV 59
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + V ++ GG + F ++ R+ P A A ++A + Y+H +
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTPETGTYRWMAP 306
++RDLK +N+L+ + + + DFG+ + + Q++ T GT ++AP
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 43/174 (24%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 141 TAFAQGAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM-----MLATL 193
+G+FGK+ + + A+K+L+ K +++++ Q+ +M +L +
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQ-------KKAILKKKEQKHIMAERNVLLKNV 53
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
KH +V + + V +Y GG + L R R+ P A A ++A + Y
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGY 111
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
+H L I+RDLK +N+L+ + + + DFG+ + ++ T GT ++AP
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + + + P AV A +++ G+ ++H G I+RDLK DN+++ +
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQ--AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 274 DKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ IKIADFG+ + E +G+T T GT ++AP
Sbjct: 137 EGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVA---IKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y+ E +A I++ + E P A +E+ +L ++H NIV
Sbjct: 12 EGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-------REISLLKEMQHGNIV 64
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
R + KR+ +V EY +++ + + A +L + RG+AY H
Sbjct: 65 RLQDVVHSEKRLY--LVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 258 GFIHRDLKSDNLLIS-ADKSIKIADFGVAR---IEVQTEGMTPETGTYRWMAP 306
+HRDLK NLLI ++K+ADFG+AR I V+T T E T + AP
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAP 172
|
Length = 294 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 43/171 (25%), Positives = 84/171 (49%), Gaps = 17/171 (9%)
Query: 144 AQGAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHL 196
+G+FGK+ + E+ A+K+L+ K +++++ ++ +M +L +KH
Sbjct: 4 GKGSFGKVLLARHKAEEKFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+V + + V +Y GG + L R + P A A ++A + Y+H
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR--ARFYAAEIASALGYLHS 114
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
L ++RDLK +N+L+ + I + DFG+ + ++ G T GT ++AP
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 60/185 (32%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIK--ILERPENNPEKAQVMEQQFQ 184
E I L KL GT + +++G + VA+K LE E P A
Sbjct: 6 ETYIKLEKLGEGT------YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI------- 52
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVK 242
+EV +L LKH NIV +V EY ++Q++ N +K+ +
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTPETGTY 301
Q L RG+AY H +HRDLK NLLI+ +K+ADFG+AR + V T+ + E T
Sbjct: 112 QIL---RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168
Query: 302 RWMAP 306
W P
Sbjct: 169 -WYRP 172
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 56/180 (31%), Positives = 85/180 (47%), Gaps = 21/180 (11%)
Query: 137 LNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMM----- 189
N +G+FGK+ G D AIKIL K V+ Q E M
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKIL--------KKDVVIQDDDVECTMVEKRV 53
Query: 190 LATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
LA + + +C + M V EY GG + + + P AV A ++A
Sbjct: 54 LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH--AVFYAAEIA 111
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
G+ ++H G I+RDLK DN+++ ++ IKIADFG+ + E +G+T +T GT ++AP
Sbjct: 112 IGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L R +G+ A+KIL++ E K +V + V+ L ++
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKK-EVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHG 256
+ + R+ C V EY GG + L+R ++R + ALD Y+H
Sbjct: 62 YSFQTKDRL--CFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD------YLHS 113
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + E T+ T +T GT ++AP
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 40/146 (27%), Positives = 75/146 (51%), Gaps = 13/146 (8%)
Query: 144 AQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG +L + G A+KIL R + EK QV + ++++++ A L +V+
Sbjct: 10 GRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKEQVGHIRAERDILVEA--DSLWVVKM 66
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLG 258
+ + ++ ++ E+ GG + L ++ +A + + +H LG
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-----ETVLAIDSIHQLG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGV 284
FIHRD+K DNLL+ + +K++DFG+
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG+ L A+K L R ++ + QV + ++++ LA + +V+
Sbjct: 12 GAFGEVCLACKVDTHALYAMKTL-RKKDVLNRNQVAHVKAERDI--LAEADNEWVVKLYY 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ + + V +Y GG + L R + P LA ++ + VH +GFIHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 264 LKSDNLLISADKSIKIADFGV 284
+K DN+LI D IK+ DFG+
Sbjct: 127 IKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 39/144 (27%), Positives = 69/144 (47%), Gaps = 6/144 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+G G+ VA+K + R E+ E + +E+ +L L+H NIV
Sbjct: 10 EGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEG---VPSTAIREISLLKELQHPNIVCLQ 65
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ ++ E+ + + + + + +L + +G+ + H +HR
Sbjct: 66 DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHR 125
Query: 263 DLKSDNLLISADKSIKIADFGVAR 286
DLK NLLI IK+ADFG+AR
Sbjct: 126 DLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 108 DALAQALMDHRYPT--------EGLENYDEWTIDLRKLNMGT-------AFAQGAFG--K 150
D L ++D +P L Y++ +RKL M +GAFG +
Sbjct: 1 DGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQ 60
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210
L R + + A+K+L + E F +E ++A +V+ A +
Sbjct: 61 LVRHKSSQKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQLFCAFQDDKY 117
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V EY GG + ++ N VP K A +V + +H +G IHRD+K DN+L
Sbjct: 118 LYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNML 174
Query: 271 ISADKSIKIADFGVARIEVQTEGMT---PETGTYRWMAP 306
+ +K+ADFG +++ GM GT +++P
Sbjct: 175 LDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 43/145 (29%), Positives = 65/145 (44%), Gaps = 15/145 (10%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIV 199
GAFG+ L R A+K L KA V+ + + E +LA + +V
Sbjct: 12 GAFGEVCLVRKVDTNALYAMKTLR-------KADVLMRNQAAHVKAERDILAEADNEWVV 64
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + + V +Y GG + L R LA ++ + VH +GF
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGF 122
Query: 260 IHRDLKSDNLLISADKSIKIADFGV 284
IHRD+K DN+LI D IK+ DFG+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 17/152 (11%)
Query: 141 TAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQ-----QFQQEVMMLATL 193
T QG +G+++ + GE VA+K + K ++ + E +L T
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRM--------KKSLLFKLNEVRHVLTERDILTTT 58
Query: 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
K +V+ + A + + EY GG R L + A ++ +
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDA 116
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
+H LG+IHRDLK +N LI A IK+ DFG++
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 18/38 (47%), Positives = 28/38 (73%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ + Y+H IHRDLK N+L+++D +K+ADFG+AR
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + + + + A A ++ G+ ++H G I+RDLK DN+L+
Sbjct: 74 VMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
D IKIADFG+ + + EG GT ++AP
Sbjct: 132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 8/125 (6%)
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ- 243
E +L L H +V + + +V + GG +R L+++ V +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKF 104
Query: 244 -ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-GTY 301
++ + Y+H G IHRD+K DN+L+ + I DF +A V + +T T GT
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLTTSTSGTP 163
Query: 302 RWMAP 306
+MAP
Sbjct: 164 GYMAP 168
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 26/63 (41%), Positives = 34/63 (53%), Gaps = 5/63 (7%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR----IEVQTEGMTPETGTYRWM 304
G+ Y+H +HRDLK NLL++AD +KI DFG+AR + G E RW
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 305 -AP 306
AP
Sbjct: 176 RAP 178
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 17/184 (9%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
W + R N+ + GA+G + T G VA+K L RP ++ + ++ +E+
Sbjct: 13 WEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 67
Query: 188 MMLATLKHLNIVRFI-----GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+L +KH N++ + + + + G + + ++ ++ +
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
Q L RG+ Y+H IHRDLK NL ++ D +KI DFG+AR + MT T
Sbjct: 128 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 182
Query: 303 WMAP 306
+ AP
Sbjct: 183 YRAP 186
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 22/171 (12%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQF 183
N W + R ++ GA+G + GE VAIK L RP ++++ ++
Sbjct: 7 NKTVWELPERYTSL-KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF----QSEIFAKRA 61
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMV-WCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-- 240
+E+ +L ++H N++ E+ V ++ + + L+
Sbjct: 62 YRELTLLKHMQHENVIGL----LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED 117
Query: 241 -----VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
V Q L G+ Y+H G IHRDLK NL ++ D +KI DFG+AR
Sbjct: 118 KVQYLVYQML---CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 34/163 (20%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF- 201
+G +G++Y R GE VA+K + R +N E + + E+ +L L H NIV
Sbjct: 17 EGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIR---EIKILRQLNHRNIVNLK 72
Query: 202 ---------IGACRKRMVWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ + + + +V EY + G V + ++ +KQ
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--FSEDHIKSF-----MKQL 125
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
L+ G+ Y H F+HRD+K N+L++ IK+ADFG+AR+
Sbjct: 126 LE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 11/169 (6%)
Query: 143 FAQGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G FGK L + G A+KIL++ E K +V + V+ + L ++
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGF 259
+ R+ C V EYA GG + L+R R A ++ + Y+H
Sbjct: 62 YSFQTHDRL--CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + E +G T +T GT ++AP
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQF 183
N W + R N+ T GA+G + T + VA+K L RP ++ + ++
Sbjct: 7 NKTVWEVPERYQNL-TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF----QSLIHARRT 61
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK- 242
+E+ +L +KH N++ + + T + + L VK
Sbjct: 62 YRELRLLKHMKHENVIGLLD---------VFTPATSIENFNEVYLVTNLMGADLNNIVKC 112
Query: 243 QAL----------DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291
Q L + RG+ Y+H G IHRDLK N+ ++ D ++I DFG+AR Q
Sbjct: 113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QAD 169
Query: 292 EGMTPETGTYRWMAP 306
+ MT T + AP
Sbjct: 170 DEMTGYVATRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-09
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 9/166 (5%)
Query: 145 QGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+ G D AIK+L++ + + V ++ ++ LA KH +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAA-KHPFLTALH 62
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + V EY GG + F +R +R + A +V + ++H G I+R
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL-MFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
DLK DN+L+ A+ K+ADFG+ + E G+T T GT ++AP
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 165 ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224
I+ R + E + Q +E+ +L IV F GA I E+ GGS+
Sbjct: 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHRDLKSDNLLISADKSIKIAD 281
Q L ++ + +P ++ K ++ V RG+AY+ H + +HRD+K N+L+++ IK+ D
Sbjct: 92 QVL--KEAKRIPEEILGKVSIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCD 147
Query: 282 FGVARIEVQTEGMTPETGTYRWMAP 306
FGV+ + + + GT +M+P
Sbjct: 148 FGVSGQLIDSMANS-FVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 22/137 (16%)
Query: 185 QEVMMLATLKHLNIVRF--------------IGACRKRMVWCIVTEYAKGGSVRQFLTRR 230
+E+ ++ L H NIV+ +G+ + IV EY + + L +
Sbjct: 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG 109
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI-KIADFGVARI-- 287
+L + Q L RG+ Y+H +HRDLK N+ I+ + + KI DFG+ARI
Sbjct: 110 PLSEEHARLFMYQLL---RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166
Query: 288 -EVQTEGMTPETGTYRW 303
+G E +W
Sbjct: 167 PHYSHKGYLSEGLVTKW 183
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 142 AFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
GA+G + G VAIK L RP ++++ ++ +E+ +L +KH N++
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPF----QSELFAKRAYRELRLLKHMKHENVI 77
Query: 200 RFIGACRKRMVWCIVTEYA-----KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ + ++ G + + + + ++ V Q L +G+ Y+
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML---KGLKYI 134
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
H G IHRDLK NL ++ D +KI DFG+AR QT+ MT T + AP
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 13/100 (13%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V EY GG + F +RQ R +P + A A ++ + ++H G I+RDLK DN+L+
Sbjct: 73 LVIEYVNGGDL-MFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 273 ADKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAP 306
AD IK+ D+G+ + EG+ P GT ++AP
Sbjct: 131 ADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
GAFG+ L R A+K L R ++ + QV + ++++ LA + +VR
Sbjct: 12 GAFGEVCLARKVDTKALYAMKTL-RKKDVLLRNQVAHVKAERDI--LAEADNEWVVRLYY 68
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ + + V +Y GG + L R P LA ++ + VH +GFIHRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 264 LKSDNLLISADKSIKIADFGV 284
+K DN+LI D IK+ DFG+
Sbjct: 127 IKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 39/133 (29%), Positives = 62/133 (46%), Gaps = 19/133 (14%)
Query: 184 QQEVMMLATLKHLN---IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
Q + L L N IV F GA I E+ GGS+ Q L ++ +P +
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENIL 101
Query: 241 VKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET- 298
K ++ V RG+ Y+ +HRD+K N+L+++ IK+ DFGV+ G ++
Sbjct: 102 GKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSM 154
Query: 299 -----GTYRWMAP 306
GT +M+P
Sbjct: 155 ANSFVGTRSYMSP 167
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 24/175 (13%)
Query: 145 QGAFGKLYR-----GTYNGEDVAIKILERPENNPEKAQVMEQQ-----FQQEVMMLATLK 194
+G +GK+++ G G+ A+K+L+ KA ++ Q + E +L +K
Sbjct: 6 KGGYGKVFQVRKVTGADTGKIFAMKVLK-------KATIVRNQKDTAHTKAERNILEAVK 58
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL-DVARGMAY 253
H IV I A + ++ EY GG + L R + ++ L +++ + +
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE---GIFMEDTACFYLSEISLALEH 115
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+H G I+RDLK +N+L+ A +K+ DFG+ + + EG T GT +MAP
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFCGTIEYMAP 169
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 13/146 (8%)
Query: 144 AQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GAFG +L + G A+KIL R + EK QV + ++++++ A + + F
Sbjct: 10 GRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEADGAWV-VKMF 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLG 258
KR ++ I+ E+ GG + L ++ A +A + + +H LG
Sbjct: 68 YSFQDKRNLYLIM-EFLPGGDMMTLLMKKDTLSEEATQFYIA-----ETVLAIDAIHQLG 121
Query: 259 FIHRDLKSDNLLISADKSIKIADFGV 284
FIHRD+K DNLL+ A +K++DFG+
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 18/30 (60%), Positives = 24/30 (80%)
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+H LG+IHRD+K DNLL+ A IK++DFG
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 9/168 (5%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M +Q +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKRLEKKRIKKRKGESMALNEKQ---ILEKVNSQFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + N + A+ A ++ G+ +H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK +N+L+ I+I+D G+A + E + GT +MAP
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 25/134 (18%), Positives = 61/134 (45%), Gaps = 10/134 (7%)
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR----FIGACR 206
+Y+G +N ++V I+ ++ +V+ + E+ L + NI++ I
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKG---HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLK 265
++ EY G +R+ L + + + K + A+D +G+ ++ +++L
Sbjct: 93 DLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150
Query: 266 SDNLLISADKSIKI 279
S + L++ + +KI
Sbjct: 151 SVSFLVTENYKLKI 164
|
Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 15/171 (8%)
Query: 143 FAQGAFGKLYRGTYNGED--VAIKILERP----ENNPEKAQVMEQQFQQEVMMLATLKHL 196
+G+FGK++ G + AIK L++ +++ E V ++ V+ LA +H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLA-WEHP 56
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + + V EY GG + F + ++ L A A ++ G+ ++H
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDL-MFHIQSCHK-FDLPRATFYAAEIICGLQFLHS 114
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
G ++RDLK DN+L+ D IKIADFG+ + + + T GT ++AP
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 33/95 (34%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V E+ GG + F +RQ R +P + A + +++ + ++H G I+RDLK DN+L+ A
Sbjct: 74 VIEFVSGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ IK+ D+G+ + E G T T GT ++AP
Sbjct: 132 EGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 8e-08
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 13/99 (13%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V EY GG + F +RQ R +P + A + +++ + Y+H G I+RDLK DN+L+ +
Sbjct: 74 VIEYVNGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 274 DKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAP 306
+ IK+ D+G+ + EG+ P GT ++AP
Sbjct: 132 EGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 11/167 (6%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++ + G+ A K L++ K EQ E +L + IV
Sbjct: 3 KGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVSLA 59
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + C+V GG ++ + P A+ A + G+ ++H ++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
DLK +N+L+ +++I+D G+A V+ +G GT +MAP
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAGTPGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 14/115 (12%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQV 178
YD W + L +G GAFG++ T +G VA+K+L+ + EK +
Sbjct: 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQAL 87
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
M E+ +++ L HLNIV +GAC K I+TEY + G + +L R ++
Sbjct: 88 M-----SELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 11/115 (9%)
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
KA + +E+ +L T+ H I+ I A R + C+V K L +R+
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD-----LFTYVDRS 179
Query: 235 VPLKLAVKQALDVARGM----AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
PL L +QA+ + R + AY+HG G IHRD+K++N+ + ++ + DFG A
Sbjct: 180 GPLPL--EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENN 172
PT+ L ++W L G GAFGK+ T G ED VA+K+L+ +
Sbjct: 24 PTQ-LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT 82
Query: 173 PEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ 231
E+ +M E+ +L+ L +H NIV +GAC ++TEY G + FL ++
Sbjct: 83 DEREALM-----SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137
Query: 232 NRAVPLKLAVKQALD 246
+ +A+ + +
Sbjct: 138 ETFLNFVMALPEISE 152
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 19/32 (59%), Positives = 25/32 (78%)
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
VH LGFIHRD+K DN+LI IK++DFG++
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 10/140 (7%)
Query: 175 KAQVMEQQFQQEVMML----ATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTR 229
+A V Q+ ++ +M L ++ V F GA R+ VW I E S+ +F +
Sbjct: 35 RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW-ICMEVMDT-SLDKFYKK 92
Query: 230 --RQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ +P + K A+ + + + Y+H L IHRD+K N+LI+ + +K+ DFG++
Sbjct: 93 VYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152
Query: 287 IEVQTEGMTPETGTYRWMAP 306
V + T + G +MAP
Sbjct: 153 YLVDSVAKTIDAGCKPYMAP 172
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIK---ILERPENNPEKAQVMEQ-- 181
++I R + G +G +GK+ + T G+ VAIK I+E + + Q++
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 182 -QFQ--QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-L 237
F +E+ ++ +KH NI+ + + +V + +++ + R+ +
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQV 121
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-------- 289
K + Q L G+ +H F+HRDL N+ I++ KIADFG+AR
Sbjct: 122 KCILLQIL---NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 290 -------QTEGMTPETGTYRWMAP 306
+ E MT + T + AP
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAP 202
|
Length = 335 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 30/123 (24%), Positives = 52/123 (42%), Gaps = 13/123 (10%)
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
F + +++ L H ++V+ G C R +V EY K G + FL R+
Sbjct: 38 LGSDHRDSLAFFETASLMSQLSHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFL-HREK 95
Query: 233 RAVPL--KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-------IKIADFG 283
V L KL V + L A + Y+ +H ++ N+L++ IK++D G
Sbjct: 96 NNVSLHWKLDVAKQL--ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153
Query: 284 VAR 286
+
Sbjct: 154 IPI 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M +Q +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMALNEKQ---ILEKVNSRFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + AV A ++ G+ +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK +N+L+ I+I+D G+A + + + GT +MAP
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 14/119 (11%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQ 181
+W +L +G +GAFG++ G D VA+K+L+ + E +M
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-- 58
Query: 182 QFQQEVMMLATL-KHLNIVRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
E+ +L + HLN+V +GAC K ++ E+ K G++ +L ++ VP K
Sbjct: 59 ---SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYK 114
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 146 GAFGKLYRGTYNGEDV--AIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNIV 199
G FG++ ++ A+K ++ K ++E Q+ + +L H IV
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVK-------KRHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + ++ EY GG + L R A V Y+H G
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
I+RDLK +NLL+ ++ +K+ DFG A+ ++++ T T GT ++AP
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKT-WTFCGTPEYVAP 161
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 154 GTYNGEDVAIKILERPEN--------NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
G NG V K+ +P + E + Q +E+ +L IV F GA
Sbjct: 14 GAGNG-GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHR 262
I E+ GGS+ Q L ++ +P ++ K ++ V +G+ Y+ H + +HR
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHR 128
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D+K N+L+++ IK+ DFGV+ + + + GT +M+P
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 19/39 (48%), Positives = 26/39 (66%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
R + Y+H HRDLK N+L +AD +KI DFG+AR+
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 3/89 (3%)
Query: 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280
V+ L+ + + + VARGM ++ +HRDL + N+L++ K +KI
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279
Query: 281 DFGVARIEVQTEGMTPETGTY---RWMAP 306
DFG+AR + + T+ +WMAP
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFLPVKWMAP 308
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 42/131 (32%), Positives = 59/131 (45%), Gaps = 15/131 (11%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQV 178
YD W L +G GAFGK+ GT G VA+K+L+ + EK +
Sbjct: 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQAL 87
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVP 236
M E+ ++ L HLNIV +GAC K I+TEY G + +L + R N
Sbjct: 88 M-----SELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSR 142
Query: 237 LKLAVKQALDV 247
K+ LD+
Sbjct: 143 HPEKPKKDLDI 153
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 28/133 (21%), Positives = 63/133 (47%), Gaps = 6/133 (4%)
Query: 174 EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR 233
EK ++E++ +L + IV A + C+V GG ++ + R
Sbjct: 37 EKMALLEKE------ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGER 90
Query: 234 AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293
+ ++ + + + G+ ++H + ++RD+K +N+L+ + +++D G+A +
Sbjct: 91 GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150
Query: 294 MTPETGTYRWMAP 306
+T GT +MAP
Sbjct: 151 ITQRAGTNGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 14/115 (12%)
Query: 127 YD-EWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---ED----VAIKILERPENNPEKAQV 178
YD +W +L+ G GAFGK+ T G D VA+K+L+ + E+ +
Sbjct: 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREAL 85
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
M E+ +L+ L H+NIV +GAC ++TEY G + FL R+++
Sbjct: 86 M-----SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRD 135
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
V E+ GG + F + + R L A A ++ G+ ++H G I+RDLK DN+++
Sbjct: 74 VMEFLNGGDL-MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 274 DKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
D IKIADFG+ + V + + GT ++AP
Sbjct: 132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 25/57 (43%), Positives = 35/57 (61%), Gaps = 6/57 (10%)
Query: 233 RAVPLKLAVKQALDVAR----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
R PL LA Q VAR + Y+HG G IHRD+K++N+L++ + I + DFG A
Sbjct: 253 RLRPLGLA--QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 24/63 (38%), Positives = 36/63 (57%), Gaps = 3/63 (4%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY---RW 303
VA GM ++ +HRDL + N+LI K +KI DFG+AR ++ + T+ +W
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307
Query: 304 MAP 306
MAP
Sbjct: 308 MAP 310
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 45/181 (24%), Positives = 85/181 (46%), Gaps = 24/181 (13%)
Query: 138 NMGTAFAQGAFG--KLYRGTYNGEDVAIKILERPENNPEKAQVMEQ----QFQQEVMMLA 191
++ + +G FG ++ R G+ A+K+++ K+ ++ Q F++E +L+
Sbjct: 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-------KSVLLAQETVSFFEEERDILS 56
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR----AVPLKLAVKQALDV 247
I + A + + +V EY GG + L R +++ LA ++
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-----EL 111
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG-VARIEV-QTEGMTPETGTYRWMA 305
+ VH +G++HRD+K +N+LI IK+ADFG AR+ + GT ++A
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 306 P 306
P
Sbjct: 172 P 172
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 25/67 (37%), Positives = 38/67 (56%), Gaps = 5/67 (7%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR- 302
+ VA+GM ++ IHRDL + N+L+S + +KI DFG+AR ++ + G R
Sbjct: 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL 243
Query: 303 ---WMAP 306
WMAP
Sbjct: 244 PLKWMAP 250
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 43/177 (24%), Positives = 86/177 (48%), Gaps = 28/177 (15%)
Query: 146 GAFGKLY-----RGTYNGEDVAIKILERP---------ENNPEKAQVMEQQFQQEVMMLA 191
GA+GK++ G +G+ A+K+L++ E+ + QV+E Q L
Sbjct: 11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP--FLV 68
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
TL + A + ++ +Y GG + L++R+ R ++ + ++ +
Sbjct: 69 TLHY--------AFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSG-EIVLAL 118
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGMTPETGTYRWMAP 306
++H LG I+RD+K +N+L+ ++ + + DFG+++ E + E GT +MAP
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 36/131 (27%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ +Q +E+ ++ + IV F GA C+ E+ GS L R + P+
Sbjct: 46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS----LDRIYKKGGPIP 101
Query: 239 LAV--KQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT 295
+ + K A+ V G+ Y++ +HRD+K N+L+++ IK+ DFGV+ + + T
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT 161
Query: 296 PETGTYRWMAP 306
GT +M+P
Sbjct: 162 -FVGTSTYMSP 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 18/154 (11%)
Query: 145 QGAFGKLYRGTYN---GEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G G++Y Y+ VA+K I E NP +++++F +E + A L H IV
Sbjct: 12 KGGMGEVYLA-YDPVCSRRVALKKIREDLSENP----LLKKRFLREAKIAADLIHPGIVP 66
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQAL--------DVARGM 251
C Y +G +++ L + Q ++ +LA K ++ + +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
YVH G +HRDLK DN+L+ + I D+G A
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160
|
Length = 932 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 28/100 (28%), Positives = 55/100 (55%), Gaps = 12/100 (12%)
Query: 213 IVTEYAKGGSVRQFLTRRQN---RAVPLKLA-VKQALDVARGMAYVHGLGFIHRDLKSDN 268
++ +Y GG + L +R++ V + +A + ALD ++H LG I+RD+K +N
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD------HLHQLGIIYRDIKLEN 135
Query: 269 LLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+L+ ++ + + DFG+++ + E + GT +MAP
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 24/64 (37%), Positives = 38/64 (59%), Gaps = 5/64 (7%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR---- 302
VA+GM+++ IHRDL + N+L++ + KI DFG+AR +++ + G R
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-DIRNDSNYVVKGNARLPVK 281
Query: 303 WMAP 306
WMAP
Sbjct: 282 WMAP 285
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 28/96 (29%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + VH L ++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 273 ADKSIKIADFG--VARIEVQTEGMTPETGTYRWMAP 306
+ I++ADFG + +E T + GT +++P
Sbjct: 137 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 27/100 (27%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E +L + H +I++ G C++ K + +L ++N A+ LA++++
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERS- 190
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
V R + Y+H IHRD+K++N+ I+ + + DFG A
Sbjct: 191 -VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 23/65 (35%), Positives = 38/65 (58%), Gaps = 3/65 (4%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTY 301
A ++ + ++H G I+RDLK DN+L+ + K+ADFG+ + + G T T GT
Sbjct: 102 AAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTP 160
Query: 302 RWMAP 306
++AP
Sbjct: 161 DYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 49/176 (27%), Positives = 72/176 (40%), Gaps = 30/176 (17%)
Query: 149 GKLYRGTYNGEDVAIKILERPEN-----NPEKAQVMEQQFQQEVMMLATLKHLN---IVR 200
+L +G Y K+L RP + ++ E +F Q +M L L IV
Sbjct: 7 DELGKGNYG---SVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLT-RRQNRAVPLKLAVKQALDVARGMAY--VHGL 257
F GA + EY GS+ + +P DV R + Y V GL
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE--------DVLRRITYAVVKGL 115
Query: 258 GF-------IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
F IHRD+K N+L++ + +K+ DFGV+ V + T G +MAP
Sbjct: 116 KFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAP 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 44/179 (24%), Positives = 82/179 (45%), Gaps = 27/179 (15%)
Query: 145 QGAFGKLYRGTYN-----GE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
QG F K+++G GE +V +K+L++ N E F+ MM + L H
Sbjct: 5 QGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN-----YSESFFEAASMM-SQLSH 58
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
++V G C +V EY K GS+ +L + +N + + ++ A +A + ++
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE 117
Query: 256 GLGFIHRDLKSDNLLIS---ADKS-----IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G H ++ + N+L+ K+ IK++D G++ I V + + E W+ P
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLE--RIPWVPP 173
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 24/71 (33%), Positives = 44/71 (61%), Gaps = 1/71 (1%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + VH LG++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136
Query: 273 ADKSIKIADFG 283
+ I++ADFG
Sbjct: 137 KNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 41/174 (23%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 146 GAFGKLY--RGTYNGED-VAIKILERPENNP-------EKAQVMEQQFQQEVMMLATLKH 195
GAFG +Y R NG++ +A+K E +NP E+ + + + ++ L+H
Sbjct: 11 GAFGCVYKVRKKNNGQNLLALK--EINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRH 68
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLT--RRQNRAVPLKLAVKQALDVARGMAY 253
NIVR+ + IV + +G + + + + + + + + + Y
Sbjct: 69 PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128
Query: 254 VHGLGFI-HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H I HRDL +N+++ D + I DFG+A+ + +T GT + P
Sbjct: 129 LHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCP 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 18/39 (46%), Positives = 27/39 (69%)
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
V G+ +H +G +HRD+K +NLL++ D +KI DFG A
Sbjct: 318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 23/67 (34%), Positives = 37/67 (55%), Gaps = 5/67 (7%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR- 302
+ VA+GM ++ IHRD+ + N+L++ + KI DFG+AR ++ + G R
Sbjct: 218 SSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMNDSNYVVKGNARL 276
Query: 303 ---WMAP 306
WMAP
Sbjct: 277 PVKWMAP 283
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 147 AFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206
A GK+Y A K LE+ K + M +Q +L + +V A
Sbjct: 23 ATGKMY---------ACKKLEKKRIKKRKGEAMALNEKQ---ILEKVNSRFVVSLAYAYE 70
Query: 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266
+ C+V GG ++ + N + AV A ++ G+ +H ++RDLK
Sbjct: 71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130
Query: 267 DNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+N+L+ I+I+D G+A + E + GT +MAP
Sbjct: 131 ENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 24/97 (24%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVK-QALDVARGMAYVHGLGFIHRDLKSDNLLI 271
++ +Y GG + L +R N + + V+ + ++ + ++H LG ++RD+K +N+L+
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138
Query: 272 SADKSIKIADFGVAR--IEVQTEGMTPETGTYRWMAP 306
++ + + DFG+++ + + E GT +MAP
Sbjct: 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 22/71 (30%), Positives = 43/71 (60%), Gaps = 1/71 (1%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+V +Y GG + L++ ++R +P +A ++ + +H L ++HRD+K DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 273 ADKSIKIADFG 283
+ I++ADFG
Sbjct: 137 MNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 27/105 (25%), Positives = 47/105 (44%), Gaps = 2/105 (1%)
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
+ E+ LA H IV+ + ++ EY GG + + + +R +P +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 244 AL--DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
L + + VH +HRDLKS N+ + IK+ DFG ++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217
|
Length = 478 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 25/83 (30%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 227 LTRRQNRAVPLKLAVKQALDVARGMAYV---HGLGFIHRDLKSDNLLISADKSIKIADFG 283
L +R +P + K + + + + Y+ HG+ IHRD+K N+L+ A ++K+ DFG
Sbjct: 103 LLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFG 160
Query: 284 VARIEVQTEGMTPETGTYRWMAP 306
++ V ++ T G +MAP
Sbjct: 161 ISGRLVDSKAKTRSAGCAAYMAP 183
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 22/153 (14%)
Query: 153 RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW- 211
+ +GE A+K+++ + + + Q EV L +IV+ C +
Sbjct: 52 KRVSDGEPFAVKVVDMEGMSEAD----KNRAQAEVCCLLNCDFFSIVK----CHEDFAKK 103
Query: 212 -----------CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLG 258
+V +YA G +RQ + R NR A + V + +VH
Sbjct: 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH 163
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291
IHRD+KS N+L+ ++ +K+ DFG +++ T
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT 196
|
Length = 496 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 143 FAQGAFGKL----YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
+G FG++ R T G+ A K LE+ K + M E +L + +
Sbjct: 8 LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMALN---EKRILEKVNSRFV 62
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
V A + C+V GG ++ + N + A+ A ++ G+ +
Sbjct: 63 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK +N+L+ I+I+D G+A + E + GT +MAP
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G +G +G +Y+ +G+D L++ E + +E+ +L LKH N+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNV 60
Query: 199 V---RFIGACRKRMVWCIVTEYAKGG--SVRQFLTRRQNRAVPLKLA---VKQAL-DVAR 249
+ + + R VW ++ +YA+ + +F + P++L VK L +
Sbjct: 61 IALQKVFLSHSDRKVW-LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 250 GMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287
G+ Y+H +HRDLK N+L+ + +KIAD G AR+
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 26/165 (15%)
Query: 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195
G +G +G +Y+ + D A+K +E + +E+ +L LKH
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE--------GTGISMSACREIALLRELKH 57
Query: 196 LNIV---RFIGACRKRMVWCIVTEYAKGG--SVRQFLTRRQNRAVPLKLA---VKQAL-D 246
N++ + + R VW ++ +YA+ + +F + P++L VK L
Sbjct: 58 PNVISLQKVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287
+ G+ Y+H +HRDLK N+L+ + +KIAD G AR+
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 14/129 (10%)
Query: 151 LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF-----IGAC 205
L R T G V ++I + E + + Q EV++ +H NI+ G+
Sbjct: 18 LARHTPTGTLVTVRITDLENCTEEHLKAL----QNEVVLSHFFRHPNIMTSWTVFTTGS- 72
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265
+W +++ + GS L + L RG+ Y+H G+IHR++K
Sbjct: 73 ---WLW-VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIK 128
Query: 266 SDNLLISAD 274
+ ++LIS D
Sbjct: 129 ASHILISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-05
Identities = 29/149 (19%), Positives = 49/149 (32%), Gaps = 26/149 (17%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI----VRF 201
G ++Y ED +KI + ++EV +L L + V
Sbjct: 9 GLTNRVYLLGTKDEDYVLKINPS--------REKGADREREVAILQLLARKGLPVPKVLA 60
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---G 258
G ++ E+ +G + L A +A +A +H L
Sbjct: 61 SGESDGWSY--LLMEWIEG----ETLDEVSEEEKE-----DIAEQLAELLAKLHQLPLLV 109
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
H DL N+L+ K + I D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 9e-05
Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 11/128 (8%)
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL--TRRQNRAVPLKLAVKQ 243
E +LA + IV A + + C+V GG +R + +N P A
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-----QTEGMTPET 298
+ G+ ++H I+RDLK +N+L+ D +++I+D G+A +E+ +T+G
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGY---A 158
Query: 299 GTYRWMAP 306
GT +MAP
Sbjct: 159 GTPGFMAP 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 39/166 (23%), Positives = 74/166 (44%), Gaps = 9/166 (5%)
Query: 146 GAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFIGA 204
GAFG + + + + + EK Q ++ ++ +++ + IV+F GA
Sbjct: 15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ---KRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYV-HGLGFI 260
+ I E S+ +F +P ++ K A+ + + Y+ L I
Sbjct: 72 LFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKII 130
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K N+L+ + +IK+ DFG++ V + T + G +MAP
Sbjct: 131 HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 176
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 16/38 (42%), Positives = 25/38 (65%), Gaps = 1/38 (2%)
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ + ++H G HRD+K +N+LI D +K+ADFG R
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 24/95 (25%), Positives = 46/95 (48%), Gaps = 3/95 (3%)
Query: 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272
+VT+Y GG + F ++ A ++ + ++H ++RDLK +N+L+
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 273 ADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
A I + DFG+++ + T GT ++AP
Sbjct: 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP 165
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 37/165 (22%), Positives = 75/165 (45%), Gaps = 5/165 (3%)
Query: 144 AQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G FG++Y R G+ A+K L++ ++ + + + + +++T IV
Sbjct: 3 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 62
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A C + + GG + L+ Q+ K A ++ G+ ++H ++
Sbjct: 63 TYAFHTPDKLCFILDLMNGGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
RDLK N+L+ ++I+D G+A + + GT+ +MAP
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.001
Identities = 33/157 (21%), Positives = 67/157 (42%), Gaps = 29/157 (18%)
Query: 143 FAQGAFGKLYRGTYNGEDVAIKI-LERPENNPEKAQVM-EQQFQQEVMMLATLKHLNI-- 198
+GA ++Y G + G IK + + +PE + + ++ ++E +++ + +
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNV 63
Query: 199 --------VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
FI IV EY +G ++ + + L + ++ R
Sbjct: 64 PAVYFVDPENFI----------IVMEYIEGEPLKDLINSNGMEELEL------SREIGRL 107
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+ +H G IH DL + N+++S K I + DFG+A
Sbjct: 108 VGKLHSAGIIHGDLTTSNMILSGGK-IYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.001
Identities = 31/150 (20%), Positives = 60/150 (40%), Gaps = 20/150 (13%)
Query: 144 AQGAFGKLYRGTYNGEDVAIKI-LERPENNPEKAQ-VMEQQFQQEVMMLATLKHLNI--- 198
QGA +Y + G +K + + +PE + + ++ ++E +LA + +
Sbjct: 5 KQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVP 64
Query: 199 -VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
V + IV EY +G ++ L L + V + +H
Sbjct: 65 IVYDVDPDNGL----IVMEYIEGELLKDALEEA-----RPDLLREVGRLVGK----LHKA 111
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287
G +H DL + N+++S + I DFG+
Sbjct: 112 GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 18/63 (28%), Positives = 35/63 (55%), Gaps = 1/63 (1%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
A ++ G+ ++H ++RDLK N+L+ ++I+D G+A + + GT+ +
Sbjct: 103 AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGY 161
Query: 304 MAP 306
MAP
Sbjct: 162 MAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 306 | |||
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.98 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.98 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.95 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.94 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.94 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.94 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.94 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.94 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.93 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.93 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.93 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.93 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.93 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.93 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.93 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.92 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.92 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.91 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.9 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.88 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.79 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.7 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.67 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.6 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.59 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.58 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.57 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.53 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.5 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.49 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.47 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.36 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.34 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.28 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.24 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.22 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.17 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.14 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.0 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.0 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.98 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.94 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.93 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.92 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.87 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.71 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.65 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.62 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.62 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.47 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.41 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.33 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.2 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.18 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.13 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.0 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.96 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.92 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.83 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.83 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.78 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.77 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.59 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.5 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.41 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.25 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.22 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.13 | |
| PLN02236 | 344 | choline kinase | 97.07 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.99 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.99 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.99 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.93 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.82 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.71 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.63 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.62 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.58 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.47 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.23 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.23 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.17 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 95.96 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.77 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.6 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.04 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.96 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.72 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=347.92 Aligned_cols=256 Identities=29% Similarity=0.495 Sum_probs=218.3
Q ss_pred hcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Ccee--Eeeeeeee--cCCcccc-ccCchH
Q 021897 36 LGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYS--VSVGQSVF--RPGKVTH-ALNDDA 109 (306)
Q Consensus 36 ~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~~--i~~~~~~~--~~~~v~~-~~~~~~ 109 (306)
..+|+|++++|++ ..|+|++|+++...+.. ...++||.|+..+ +.+. ++ ...+| .+..+.| ..+.++
T Consensus 102 ~~~G~flvR~se~---~~g~yslsv~~~~~~~~---~~~v~hyri~~~~~~~~~~~~~-~~~~F~~l~~lv~~~~~~~~g 174 (468)
T KOG0197|consen 102 NKEGAFLVRESES---DKGDYSLSVREGDSGGL---GAKVKHYRIRQLDGGGLYPYID-ERELFSSLQQLVNYYSKNADG 174 (468)
T ss_pred CCccceeeecccC---CcCCeeEEEEeccccCC---ccceeeeeeeEcCCCCeecCCC-HHHhhhhHHHHHhhhhccCcc
Confidence 4469999998876 78999999999887663 3578999999998 5465 55 34445 2555655 789999
Q ss_pred HHHHHhcCCCC------CCCCCCCCcceeeccCceecceeeeeccEEEEEEEECCe-eEEEEEeeCCCCChhHHHHHHHH
Q 021897 110 LAQALMDHRYP------TEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ 182 (306)
Q Consensus 110 l~~~l~~~~~~------~~~~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~ 182 (306)
++..+..++.. .......+.|+|+.+.+++.+.||+|.||+||.|+|++. +||+|.++...+.+ +.
T Consensus 175 l~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~-------~~ 247 (468)
T KOG0197|consen 175 LCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP-------EA 247 (468)
T ss_pred hhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh-------hH
Confidence 99999998863 221122799999999999999999999999999999887 99999999876664 47
Q ss_pred HHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021897 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (306)
Q Consensus 183 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHr 262 (306)
|.+|+++|++|+|+|||++|++|..+..+|||||||+.|+|.++|+...+..+.....+.++.|||+||+||+++++|||
T Consensus 248 f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHR 327 (468)
T KOG0197|consen 248 FLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHR 327 (468)
T ss_pred HHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccch
Confidence 88999999999999999999999998899999999999999999998677889999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCC---CcccCC
Q 021897 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306 (306)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt---~~y~AP 306 (306)
||.++||||+++..|||+||||||...++. ++...|. ..|+||
T Consensus 328 DLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~kfPIkWtAP 373 (468)
T KOG0197|consen 328 DLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGKFPIKWTAP 373 (468)
T ss_pred hhhhhheeeccCceEEEcccccccccCCCc-eeecCCCCCCceecCH
Confidence 999999999999999999999999554433 4333443 789998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=293.48 Aligned_cols=166 Identities=31% Similarity=0.529 Sum_probs=149.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|.+.+.||.|+|++||+|++ ++..||||.+........ ..+.+..|+.+|+.++|||||.+++++..++.+|
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k----~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKK----LVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHH----HHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 5677888899999999999988 678999999977654332 2356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC------CcEEEEcccCee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD------KSIKIADFGVAR 286 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~------~~vkl~DFGla~ 286 (306)
+|||||.||+|.+|++++ +.+++.++..++.|++.||++||+++||||||||.|||++.. -.+||+|||+||
T Consensus 86 lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999999875 369999999999999999999999999999999999999865 468999999999
Q ss_pred eeecCCCccCCCCCCcccCC
Q 021897 287 IEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~AP 306 (306)
....+.-..+.||+|.||||
T Consensus 164 ~L~~~~~a~tlcGSplYMAP 183 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAP 183 (429)
T ss_pred hCCchhHHHHhhCCccccCH
Confidence 88877767788999999999
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=299.15 Aligned_cols=177 Identities=46% Similarity=0.846 Sum_probs=160.7
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEECCee-EEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
...+|.|+..++...+.||+|+||+||+|.|.|+. ||||++......... .+.|.+|+.+|.+++|||||+++|+
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES----RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH----HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 45778999999999999999999999999999998 999999876655443 5789999999999999999999999
Q ss_pred EEeCC-eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCcEEEcCCC-cEEEEc
Q 021897 205 CRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIHRDLKSDNLLISADK-SIKIAD 281 (306)
Q Consensus 205 ~~~~~-~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~-iiHrDlkp~NILv~~~~-~vkl~D 281 (306)
|.++. ..+||||||++|+|.+++.......+++..++.+|.||+.||+|||+++ ||||||||+||||+.++ ++||+|
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence 99988 7999999999999999998755677999999999999999999999999 99999999999999998 999999
Q ss_pred ccCeeeeecC-CCccCCCCCCcccCC
Q 021897 282 FGVARIEVQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~-~~~~~~~gt~~y~AP 306 (306)
||+++..... ...+...||+.||||
T Consensus 188 FGlsr~~~~~~~~~~~~~GT~~wMAP 213 (362)
T KOG0192|consen 188 FGLSREKVISKTSMTSVAGTYRWMAP 213 (362)
T ss_pred CccceeeccccccccCCCCCccccCh
Confidence 9999976654 345557899999999
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=287.38 Aligned_cols=171 Identities=28% Similarity=0.409 Sum_probs=150.1
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHH-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKA-QVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
...|.+.+.||+|+||.|-+|.. +++.||||++++........ ..-.....+|+++|++|+|||||++++++..+..
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35677889999999999999965 88999999998765543221 1112346799999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC---CcEEEEcccCeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARI 287 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~---~~vkl~DFGla~~ 287 (306)
.|||||||+||+|.+++... +.+.+.....++.|++.|+.|||+.||+||||||+|||++.+ -.+||+|||+|++
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999764 557888889999999999999999999999999999999866 6799999999999
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
......+.+.||||.|.||
T Consensus 329 ~g~~sfm~TlCGTpsYvAP 347 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAP 347 (475)
T ss_pred cccceehhhhcCCccccCh
Confidence 8888889999999999999
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=274.94 Aligned_cols=170 Identities=25% Similarity=0.436 Sum_probs=151.3
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+..++|++++.||+|+||+||.++. +++.+|+|++++......+. .+...+|..+|.+++||+||+++-.|++..
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e---~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKE---VRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhh---HHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 4567889999999999999999976 78899999998765543321 356789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+|+||+.||.|...|++. ..+++..+..++.+|+.||.|||++|||||||||+|||++.+|+++|+|||||+...
T Consensus 99 kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred eEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999999999864 569999999999999999999999999999999999999999999999999999543
Q ss_pred -cCCCccCCCCCCcccCC
Q 021897 290 -QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 -~~~~~~~~~gt~~y~AP 306 (306)
.+....+.|||+.||||
T Consensus 177 ~~~~~t~tfcGT~eYmAP 194 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAP 194 (357)
T ss_pred cCCCccccccCCccccCh
Confidence 33455667999999999
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=274.60 Aligned_cols=168 Identities=32% Similarity=0.465 Sum_probs=150.5
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
.+...+++.++.||+|..|.||++.+ +++.+|+|++...... ...+++.+|+++++.++||+||.+||+|..+
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~-----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP-----ALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH-----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 35667888889999999999999988 6889999999543332 2347899999999999999999999999999
Q ss_pred C-eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 209 M-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 209 ~-~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
. .++|+||||++|+|.+++... +.+++..+-+++.+|++||.|||+ ++||||||||+||||+..|.|||||||.++
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 8 599999999999999999865 569999999999999999999995 899999999999999999999999999999
Q ss_pred eeecCCCccCCCCCCcccCC
Q 021897 287 IEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~AP 306 (306)
..... ...+++||..||||
T Consensus 228 ~lvnS-~a~tfvGT~~YMsP 246 (364)
T KOG0581|consen 228 ILVNS-IANTFVGTSAYMSP 246 (364)
T ss_pred Hhhhh-hcccccccccccCh
Confidence 87666 45778999999999
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=284.87 Aligned_cols=167 Identities=30% Similarity=0.471 Sum_probs=152.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
..|..++.||+|+|+.||+++. +|+.||+|++.+........ .+.+.+|++|.++|+|||||++|++|++.+.+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~---reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQ---REKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcch---HHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 6789999999999999999987 88999999998754443322 357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee-cC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~-~~ 291 (306)
||+|+|+.++|..++++ .+.+++..++.++.||+.||.|||+++|||||||..|++++++.+|||+|||||...+ +.
T Consensus 95 ivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999999984 4679999999999999999999999999999999999999999999999999998766 44
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
+...+.||||.|+||
T Consensus 173 Erk~TlCGTPNYIAP 187 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAP 187 (592)
T ss_pred cccceecCCCcccCh
Confidence 778889999999999
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=289.89 Aligned_cols=248 Identities=26% Similarity=0.469 Sum_probs=209.5
Q ss_pred CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-CceeEeeeeeeec--CCcccc-ccCchHHHHH
Q 021897 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (306)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~ 113 (306)
.|+|+++.|++ .+|-||+|++..- .+-||+|+... +..+++ .++.|+ .+.|.| ..-+|+|+..
T Consensus 173 nGSFLVRESEs---SpgQ~sISlRyeG---------RVyHYRINt~~dgK~yvt-~EsrF~TLaELVHHHStvADGLitt 239 (1157)
T KOG4278|consen 173 NGSFLVRESES---SPGQYSISLRYEG---------RVYHYRINTDNDGKMYVT-QESRFRTLAELVHHHSTVADGLITT 239 (1157)
T ss_pred ccceEEeeccC---CCcceeEEEEecc---------eEEEEEeeccCCccEEEe-ehhhhhHHHHHHhhccccccceeEe
Confidence 57788888775 5688888888532 56899999876 777777 566664 455654 7788999998
Q ss_pred HhcCCCCCC------CCCCCCcceeeccCceecceeeeeccEEEEEEEECC--eeEEEEEeeCCCCChhHHHHHHHHHHH
Q 021897 114 LMDHRYPTE------GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQ 185 (306)
Q Consensus 114 l~~~~~~~~------~~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~ 185 (306)
|..|..... ..+..|+|+++..++.+..+||-|+||.||.|.|.. -.||||.++...+. .++|+.
T Consensus 240 LhYPApK~nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-------veEFLk 312 (1157)
T KOG4278|consen 240 LHYPAPKKNKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLK 312 (1157)
T ss_pred eeccCccCCCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-------HHHHHH
Confidence 887754221 123469999999999999999999999999999954 57999999876654 368999
Q ss_pred HHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021897 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (306)
Q Consensus 186 E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlk 265 (306)
|+.+|+.++|||+|+|+|+|..+..+|||+|||..|+|.++|++.....++.-.++.||.||..||+||..+++|||||.
T Consensus 313 EAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLA 392 (1157)
T KOG4278|consen 313 EAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLA 392 (1157)
T ss_pred HHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhh
Confidence 99999999999999999999999999999999999999999998777778888899999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCC---CcccCC
Q 021897 266 SDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306 (306)
Q Consensus 266 p~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt---~~y~AP 306 (306)
++|+||+++..|||+||||+|++..+ .++...|. +.|+||
T Consensus 393 ARNCLVgEnhiVKvADFGLsRlMtgD-TYTAHAGAKFPIKWTAP 435 (1157)
T KOG4278|consen 393 ARNCLVGENHIVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAP 435 (1157)
T ss_pred hhhccccccceEEeeccchhhhhcCC-ceecccCccCcccccCc
Confidence 99999999999999999999976543 35555554 789998
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=277.94 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=183.0
Q ss_pred CCCCCCcccccccCCCCcE-EEEEeeCCCCCCCCcccccccCCccccCCceeEeeeeeeec--CCccccccCchHHHHHH
Q 021897 38 EGTNMSIDSLQTSNAGGSV-SMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTHALNDDALAQAL 114 (306)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~-s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~v~~~~~~~~l~~~l 114 (306)
.|+|+.+.+.......... -+|+.-+ ...-+.|+.++...+.++.. ....|. +..+.+......-+.
T Consensus 68 ~GDfLvR~s~~~~~~~~~~~vlSv~~~-------~~~~~~h~vi~~~~~~~~~~-~~~~F~si~~li~~~~~~~~~~~-- 137 (474)
T KOG0194|consen 68 DGDFLVRASEPKEGEKREFVVLSVKWS-------VFKKIKHYVIKRNGNLFFFE-GLRKFPTISELVNYYKFSKLEIT-- 137 (474)
T ss_pred CCceEEEeecccCCcceeEEEEEEEee-------cCCceeEEEEEEcCCeeEEe-ccccCCcHHHHHHHHHhccccee--
Confidence 6899999887754444433 6666643 01134588888877644433 222221 222222111100000
Q ss_pred hcCCCCCCCCCCCCcceeeccCceecceeeeeccEEEEEEEE---CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHH
Q 021897 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY---NG---EDVAIKILERPENNPEKAQVMEQQFQQEVM 188 (306)
Q Consensus 115 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~---~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~ 188 (306)
..+....-.-....|++.-+++.+.++||+|+||+||+|++ ++ .+||||..+..... .....++|++|++
T Consensus 138 -~~~~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~---~~~~~~e~m~EAr 213 (474)
T KOG0194|consen 138 -GKNFFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL---TKEQIKEFMKEAR 213 (474)
T ss_pred -ccceeecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc---cHHHHHHHHHHHH
Confidence 00111111123578999999999999999999999999987 22 23899988753322 2233578999999
Q ss_pred HHHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 021897 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDN 268 (306)
Q Consensus 189 ~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~N 268 (306)
+|++++|||||++||++..+.+++||||+|+||+|.++|++... .++....+.++.+.+.||+|||++++|||||.++|
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARN 292 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARN 292 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHH
Confidence 99999999999999999999999999999999999999998653 69999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEcccCeeeeecCCCccCC-CCCCcccCC
Q 021897 269 LLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306 (306)
Q Consensus 269 ILv~~~~~vkl~DFGla~~~~~~~~~~~~-~gt~~y~AP 306 (306)
+|++.++.+||+|||+++........... .--.+|+||
T Consensus 293 cL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAP 331 (474)
T KOG0194|consen 293 CLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAP 331 (474)
T ss_pred heecCCCeEEeCccccccCCcceeeccccccCcceecCh
Confidence 99999999999999999864322212212 234789998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=258.01 Aligned_cols=168 Identities=26% Similarity=0.412 Sum_probs=150.8
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
..+.+|+..+.||.|+||.|.+++. +|..+|+|++.+...-..++ .+...+|..+|+.+.||+++++++.|.+..
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQ---veH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQ---VEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHH---HHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 3457888999999999999999987 78899999997654433322 356789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+||||++||.|..+|++. +++++..++.+|+||+.||+|||+++|++|||||+|||+|++|.+||+|||+|+...
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999999999875 569999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.. ..+.||||.|+||
T Consensus 196 ~r--T~TlCGTPeYLAP 210 (355)
T KOG0616|consen 196 GR--TWTLCGTPEYLAP 210 (355)
T ss_pred Cc--EEEecCCccccCh
Confidence 43 6778999999999
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=264.62 Aligned_cols=170 Identities=26% Similarity=0.461 Sum_probs=146.8
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE-EEEeC-
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG-ACRKR- 208 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~- 208 (306)
++.+|++.++||.|+||+||++.. +|..||.|.++-...+... .+.+..|+.+|++|+|||||++|+ .+.++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~----rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKA----RQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHH----HHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 457889999999999999999975 8999999999854444322 367889999999999999999999 44444
Q ss_pred CeEEEEEeecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCcEEEcCCCcEEEEcc
Q 021897 209 MVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHG--LG--FIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gl~yLH~--~~--iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
+.++||||++.+|+|.++++. .+.+.++++.+|+++.|+|.||..||+ .+ |+||||||+||+++.+|.|||.||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 459999999999999999985 456779999999999999999999998 45 999999999999999999999999
Q ss_pred cCeeeeecCCC-ccCCCCCCcccCC
Q 021897 283 GVARIEVQTEG-MTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~-~~~~~gt~~y~AP 306 (306)
||++.+..... ..+.+|||+||+|
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSP 197 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSP 197 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCH
Confidence 99998765443 3556899999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=269.97 Aligned_cols=172 Identities=28% Similarity=0.533 Sum_probs=151.8
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 208 (306)
.....|.+++.||+|.||+|+.|.+ +++.||+|++.+....... ....+.+.+|+.++++++ ||||+++++++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3457889999999999999999977 7899999988765332111 223456778999999999 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEcccCeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARI 287 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~-~~vkl~DFGla~~ 287 (306)
..+|+||||+.+|+|.+++.. ..++.+..+.+++.|++.|++|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 999999999999999999987 3568899999999999999999999999999999999999999 9999999999998
Q ss_pred e-ecCCCccCCCCCCcccCC
Q 021897 288 E-VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~-~~~~~~~~~~gt~~y~AP 306 (306)
. .......+.|||+.|+||
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aP 190 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAP 190 (370)
T ss_pred cCCCCCcccCCCCCcccCCH
Confidence 7 456678889999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=260.15 Aligned_cols=166 Identities=30% Similarity=0.457 Sum_probs=147.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|+.+.++|+|++|.||+++. +|+.||||.+.....++. ..+-.+||+++|++|+|||+|.++++|..+..++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~----VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPV----VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHH----HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence 3567778999999999999987 889999999976655433 3356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee-cC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~-~~ 291 (306)
+|+||++. ++.+-|.+.. ..++...+.+++.|++.|+.|||++++|||||||+||||+.+|.+||||||+||... ++
T Consensus 78 LVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred EEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99999987 6666676654 458999999999999999999999999999999999999999999999999999876 66
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
..++..+-|-+|.||
T Consensus 156 d~YTDYVATRWYRaP 170 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAP 170 (396)
T ss_pred chhhhhhhhhhccCh
Confidence 678888999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=268.02 Aligned_cols=168 Identities=32% Similarity=0.601 Sum_probs=143.4
Q ss_pred eccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-e
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-V 210 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~ 210 (306)
..++|.....||+|+||.||+|.. +++.||||.+....... .++|.+|+.++.+++|||+|+|+|+|.+.. .
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG------EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc------hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 345666678999999999999998 45899999776544321 246999999999999999999999999988 5
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG---FIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
.+||+|||++|+|.++|.......++|..+++||.++|.||+|||+.. ||||||||+|||+|++.++||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 999999999999999998754337899999999999999999999853 99999999999999999999999999976
Q ss_pred eec-CCCccCC-CCCCcccCC
Q 021897 288 EVQ-TEGMTPE-TGTYRWMAP 306 (306)
Q Consensus 288 ~~~-~~~~~~~-~gt~~y~AP 306 (306)
... ....... .||..|+||
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~P 247 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAP 247 (361)
T ss_pred CCccccceeeecCCCCccCCh
Confidence 543 3333333 899999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=266.18 Aligned_cols=167 Identities=23% Similarity=0.366 Sum_probs=146.9
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--C
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--M 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 209 (306)
...|+.+++||+|.||+||+|+. +|+.||+|.++......+. ..-..+||.||++|.||||++|.+...+. .
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~----~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF----PITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc----hHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 36788999999999999999987 7889999999876654432 24567999999999999999999999887 6
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+|+|||+. +|.-++... .-.+++..+..++.|++.||+|||++||+|||||.+||||+.+|.+||+|||||+++.
T Consensus 192 siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred eEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 89999999987 998888753 3468999999999999999999999999999999999999999999999999999765
Q ss_pred cCC--CccCCCCCCcccCC
Q 021897 290 QTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~--~~~~~~gt~~y~AP 306 (306)
... .++..+-|.+|.||
T Consensus 270 ~~~~~~~T~rVvTLWYRpP 288 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPP 288 (560)
T ss_pred CCCCcccccceEEeeccCh
Confidence 433 46777889999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=267.45 Aligned_cols=166 Identities=31% Similarity=0.445 Sum_probs=150.4
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC-
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~- 209 (306)
..+|.++++||.|.||.||+|+. ++..||||.+++....-+.. .=+||++.|+++. |||||++.+++.+..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-----~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-----MNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-----HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 36788999999999999999976 78899999998765542221 3459999999998 999999999999988
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+|||||+ .+|+++++.+ ++.+++..+..|+.||+.||+|+|.+|++|||+||+||||.....+||+|||+||...
T Consensus 84 ~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 84 ILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 9999999995 5999999987 7889999999999999999999999999999999999999999999999999999888
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
..+.++..+.|-+|+||
T Consensus 162 SkpPYTeYVSTRWYRAP 178 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAP 178 (538)
T ss_pred cCCCcchhhhcccccch
Confidence 88888999999999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=266.22 Aligned_cols=170 Identities=26% Similarity=0.422 Sum_probs=149.0
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (306)
-...+|.+++.||+|+|++|++|+. +++.+|||++.+.....++. .+-+.+|-..|.+| .||.|++||-.|++.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K---vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK---VKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc---cchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 3458999999999999999999987 78899999997665544433 24567888889999 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+|+|+||+++|+|.+++.+. +.+.+.+++.++++|+.||+|||++|||||||||+|||+++++++||+|||-|++.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999999876 56999999999999999999999999999999999999999999999999999875
Q ss_pred ecCCCc--------------cCCCCCCcccCC
Q 021897 289 VQTEGM--------------TPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~--------------~~~~gt~~y~AP 306 (306)
.+.... ..++||..|.+|
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP 256 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSP 256 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCH
Confidence 432211 447899999988
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=252.77 Aligned_cols=166 Identities=31% Similarity=0.588 Sum_probs=143.9
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (306)
..+|..++.||+|+||.||+++. +|+..|||......... .+.+.+|+.+|++++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~ 89 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT------SESLEREIRILSRLNHPNIVQYYGSSSSREND 89 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh------HHHHHHHHHHHHhCCCCCEEeeCCccccccCe
Confidence 45678889999999999999988 47999999987652211 357889999999999999999999754444
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEcccCeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIE 288 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~-~~~vkl~DFGla~~~ 288 (306)
.++|+|||+++|+|.+++....+ .+++..++.++.||++||+|||++|||||||||+||||+. ++.+||+|||+|+..
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 68999999999999999998766 7999999999999999999999999999999999999999 799999999999865
Q ss_pred ec----CCCccCCCCCCcccCC
Q 021897 289 VQ----TEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~----~~~~~~~~gt~~y~AP 306 (306)
.. ........||+.||||
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maP 190 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAP 190 (313)
T ss_pred ccccccccccccccCCccccCc
Confidence 52 2223456899999999
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=250.73 Aligned_cols=175 Identities=26% Similarity=0.409 Sum_probs=154.2
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
..+|-+..++|++...||.|..+.||+|.. .++.||||++...... .....+.+|+..|+.+.||||++++..
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~-----~~ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN-----NDLDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh-----hhHHHHHHHHHHhhhcCCCCcceEEEE
Confidence 356777889999999999999999999987 7789999999764433 335789999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
|..+..+|+||.||.+|++.++++..-...+++..+..|+.++++||.|||.+|.||||||+.||||+.+|.|||+|||+
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999999999999987666799999999999999999999999999999999999999999999999998
Q ss_pred eeeee-cCCCc----cCCCCCCcccCC
Q 021897 285 ARIEV-QTEGM----TPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~-~~~~~----~~~~gt~~y~AP 306 (306)
+-... .+... ...+|||+||||
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAP 199 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAP 199 (516)
T ss_pred eeeecccCceeeEeeccccCcccccCh
Confidence 65332 22221 456899999999
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=240.72 Aligned_cols=166 Identities=28% Similarity=0.414 Sum_probs=144.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|...+.||+|.||.||+|++ +|+.||||.++.......- ....+||++.|+.++|+||+.++++|.....+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi----~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI----NRTALREIKLLQELKHPNIIELIDVFPHKSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc----cHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence 3567778999999999999987 7899999999876543221 235679999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
||+|||+. +|...++.. ...+....+..++.+++.||+|||++.|+||||||.|+||+++|.+||+|||+|+.+....
T Consensus 78 lVfEfm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 78 LVFEFMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEEeccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99999976 999999865 4568899999999999999999999999999999999999999999999999999876443
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
..+..+-|-+|.||
T Consensus 156 ~~~~~~V~TRWYRAP 170 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAP 170 (318)
T ss_pred cccccceeeeeccCh
Confidence 33444788999998
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=241.69 Aligned_cols=170 Identities=26% Similarity=0.417 Sum_probs=152.6
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
.+++|++++.||.|-||.||.|+. ++-.||+|++.+.... ....++++.+|++|.+.|+||||+++|++|.+...
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~---~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL---KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH---HhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 447899999999999999999987 5568999999764422 22235789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+|+++||...|+|+..|+......+.+..+..+..|++.|+.|+|.++||||||||+|+|++..+.+||+|||.+....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999999998778889999999999999999999999999999999999999999999999999997655
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
.....+.|||..|.+|
T Consensus 176 ~~kR~tlcgt~dyl~p 191 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPP 191 (281)
T ss_pred CCCceeeecccccCCH
Confidence 4456778999999998
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=257.64 Aligned_cols=172 Identities=30% Similarity=0.463 Sum_probs=142.3
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhH--------HHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEK--------AQVMEQQFQQEVMMLATLKHLNIVRF 201 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l 201 (306)
..+++|++++.||+|+||.|-+|.. +++.||||++.+....... ...-.++..+|+.+|++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4568999999999999999999987 7889999999754432211 01112578899999999999999999
Q ss_pred EEEEEeC--CeEEEEEeecCCCCHHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 021897 202 IGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRA-VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (306)
Q Consensus 202 ~~~~~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vk 278 (306)
+++..++ ..+|||+|||..|.+...- .... +.+.++++++.+++.||+|||.+|||||||||+|+||+++|+||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 9999765 5799999999988875442 2344 89999999999999999999999999999999999999999999
Q ss_pred EEcccCeeeeecC------CCccCCCCCCcccCC
Q 021897 279 IADFGVARIEVQT------EGMTPETGTYRWMAP 306 (306)
Q Consensus 279 l~DFGla~~~~~~------~~~~~~~gt~~y~AP 306 (306)
|+|||.+.....+ ......+|||.|+||
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP 284 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP 284 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccch
Confidence 9999999865222 112335799999999
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=257.30 Aligned_cols=151 Identities=28% Similarity=0.466 Sum_probs=138.1
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
.+..++|+++++||+|+||+||+|+. +|..+|+|++++..+....+ .+....|-.+|.....|.||+||-.|++.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Q---v~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQ---VEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhh---HHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 46778999999999999999999976 88999999998876653322 35678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
..+||||||++||++..+|... ..+++.+++.++.+++.|++-||+.|+|||||||+|+|||..|++||+|||||.
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999999864 579999999999999999999999999999999999999999999999999984
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=254.62 Aligned_cols=168 Identities=24% Similarity=0.454 Sum_probs=154.6
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
..+|++.+.||.|.||+|-+|.. .|+.||||.+++.....++. .-.+.+|++||..|+||||+.+|.+|+..+.+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD---lvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD---LVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH---HHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 35788899999999999999965 89999999998877665432 24688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
.|||||..+|.|++++.+. +.+++..++.++.||+.|+.|||.++++|||||.+|||+|.++++||+||||+-.+.+.
T Consensus 129 vivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999999875 46999999999999999999999999999999999999999999999999999999888
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
....++||+|-|.+|
T Consensus 207 kfLqTFCGSPLYASP 221 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASP 221 (668)
T ss_pred cHHHHhcCCcccCCc
Confidence 888999999999988
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=260.54 Aligned_cols=173 Identities=35% Similarity=0.713 Sum_probs=155.3
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.++|+|..+++.+++.||+|.||+||+|.|-| +||||+++.....++. .+.|.+|+..+++.+|.||+-+.|+|.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~q----lqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQ----LQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHH----HHHHHHHHHHHhhcchhhheeeehhhc
Confidence 47899999999999999999999999999987 6899999988877663 478999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
.++. .||+-+|+|-+|+.+|+..+ ..+.....+.||+||+.||.|||.++|||||||..||++.+++.|||.||||+.
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred CCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence 9887 89999999999999998654 458888999999999999999999999999999999999999999999999997
Q ss_pred eeecC---CCccCCCCCCcccCC
Q 021897 287 IEVQT---EGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~---~~~~~~~gt~~y~AP 306 (306)
..... .......|..-||||
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAP 559 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAP 559 (678)
T ss_pred eeeeeccccccCCCccchhhhcH
Confidence 54432 234455688999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=260.98 Aligned_cols=167 Identities=27% Similarity=0.510 Sum_probs=151.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.-|++++.||.|+.|.|-+|++ +|+.+|||++......... ....+.+|+-||+.+.||||+++|++++....+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s---~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSS---QPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccc---cccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 3467889999999999999988 8999999999766332221 1346889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+|+||+++|.|++++.+. +++++..+.+++.||+.|+.|||..+|+||||||+|+|++..+++||+|||+|.+...+.
T Consensus 89 lvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999999999865 569999999999999999999999999999999999999999999999999999988888
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
...+.||+|.|.||
T Consensus 167 lLeTSCGSPHYA~P 180 (786)
T KOG0588|consen 167 LLETSCGSPHYAAP 180 (786)
T ss_pred cccccCCCcccCCc
Confidence 88899999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=261.49 Aligned_cols=171 Identities=26% Similarity=0.406 Sum_probs=148.4
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACR 206 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 206 (306)
..+...+|.+.++||+|.||+|+++.. +++.+|||++++...-..+ ..+..+.|.+|+.... ||.++.++.+|+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d---~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRD---EVESLMCEKRIFELANRHPFLVNLFSCFQ 439 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccc---cHHHHHHHHHHHHHhccCCeEeecccccc
Confidence 356778999999999999999999987 6679999999987654322 2356778888887775 999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
.+.++|+||||+.||++..+.+ ...+++..++.+|+.|+.||.|||++||||||||.+|||+|.+|.+||+|||+++
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999999999544433 3569999999999999999999999999999999999999999999999999998
Q ss_pred eee-cCCCccCCCCCCcccCC
Q 021897 287 IEV-QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~-~~~~~~~~~gt~~y~AP 306 (306)
-.. .+....+.||||.||||
T Consensus 517 e~m~~g~~TsTfCGTpey~aP 537 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAP 537 (694)
T ss_pred ccCCCCCccccccCChhhcCh
Confidence 643 45567788999999999
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=242.70 Aligned_cols=168 Identities=28% Similarity=0.467 Sum_probs=144.8
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEEeCC-
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRM- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~- 209 (306)
...|+..++||+|+||+||+|+. +|+.||+|.++....... ......+|+.+++.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG----~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG----VPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC----CCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 45677788999999999999976 889999999986644211 1134569999999999999 999999998877
Q ss_pred -----eEEEEEeecCCCCHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 210 -----VWCIVTEYAKGGSVRQFLTRRQN--RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 210 -----~~~iv~E~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
.+++|+||++. +|.+++..... ..++...+..++.||+.||+|||+++|+||||||.||||+++|.+||+||
T Consensus 86 ~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence 89999999965 99999987543 35777899999999999999999999999999999999999999999999
Q ss_pred cCeeeee-cCCCccCCCCCCcccCC
Q 021897 283 GVARIEV-QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~-~~~~~~~~~gt~~y~AP 306 (306)
|+|+... +....++.++|..|.||
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaP 189 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAP 189 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCH
Confidence 9999765 44457778899999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=257.90 Aligned_cols=165 Identities=30% Similarity=0.534 Sum_probs=146.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|.+.+.||+|.||.||+|+. +.+.||+|.+.+....... .+.+.+|++|++.++|||||.++++|+...++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~----l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE----LKNLRQEVRILRSLKHPNIVEMLESFETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH----HHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence 4677889999999999999976 6779999999765544322 356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+|+||+.| +|..+|.. +..++++.+..++.|++.||.|||+.+|+|||+||.|||++..|.+|+||||+||......
T Consensus 78 vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred EEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 99999977 99999976 4569999999999999999999999999999999999999999999999999999776544
Q ss_pred C-ccCCCCCCcccCC
Q 021897 293 G-MTPETGTYRWMAP 306 (306)
Q Consensus 293 ~-~~~~~gt~~y~AP 306 (306)
. .+...|||.||||
T Consensus 155 ~vltsikGtPlYmAP 169 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAP 169 (808)
T ss_pred eeeeeccCcccccCH
Confidence 3 3455799999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=257.67 Aligned_cols=163 Identities=29% Similarity=0.500 Sum_probs=145.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
..|..-++||+|+.|.||.|+. +++.||||.+....... .+.+.+|+.+|+..+|+|||.+++.+...+.+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~------keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK------KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc------hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 4566678999999999999976 77889999998765543 257889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+|||||++|+|.+.+... .+.+..+..|+.+++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+....
T Consensus 347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999999999763 48999999999999999999999999999999999999999999999999987654433
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
...+.+|||+||||
T Consensus 424 ~KR~TmVGTPYWMAP 438 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAP 438 (550)
T ss_pred CccccccCCCCccch
Confidence 56677999999998
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=240.10 Aligned_cols=167 Identities=23% Similarity=0.319 Sum_probs=144.4
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|+..+.||+|+||.||+|.. +++.||+|++........ .....+.+|+.++++++|++|+++++++.+...+++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh---hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 56778999999999999986 788999999875432211 1234678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~ 294 (306)
|||+++|+|.+++.......+++..++.++.|++.||+|||+.+|+||||||+|||+++++.+||+|||++.........
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 99999999998887655556899999999999999999999999999999999999999999999999999875444444
Q ss_pred cCCCCCCcccCC
Q 021897 295 TPETGTYRWMAP 306 (306)
Q Consensus 295 ~~~~gt~~y~AP 306 (306)
....||+.|+||
T Consensus 159 ~~~~g~~~y~aP 170 (285)
T cd05631 159 RGRVGTVGYMAP 170 (285)
T ss_pred cCCCCCCCccCH
Confidence 556799999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=249.34 Aligned_cols=149 Identities=23% Similarity=0.396 Sum_probs=131.9
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|.. +++.||||+++..... .......+.+|+.++..++||+|+++++.+.+...+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML---EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH---HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEE
Confidence 3678889999999999999987 6789999999753221 1122356888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
+||||+++|+|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 999999999999999764 46899999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=245.98 Aligned_cols=173 Identities=27% Similarity=0.404 Sum_probs=148.3
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEEC---CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (306)
...+.+...+|++.+.||+|+||.||+|.+. +..||+|++....... ....+.+.+|+.+++.++||||+++++
T Consensus 22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~ 98 (340)
T PTZ00426 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK---QKQVDHVFSERKILNYINHPFCVNLYG 98 (340)
T ss_pred ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCCcceEE
Confidence 3446677789999999999999999999862 2589999986532211 112356889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
++.+...+|+||||+++|+|.+++... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 99 SFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCC
Confidence 999999999999999999999999764 458999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+++..... ....+||+.|+||
T Consensus 177 ~a~~~~~~--~~~~~gt~~y~aP 197 (340)
T PTZ00426 177 FAKVVDTR--TYTLCGTPEYIAP 197 (340)
T ss_pred CCeecCCC--cceecCChhhcCH
Confidence 99865432 3455799999998
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=246.37 Aligned_cols=173 Identities=29% Similarity=0.576 Sum_probs=142.2
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeee
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 200 (306)
.|+++.++|++++.||+|+||.||+|.+ .++.||||+++...... ..+.+.+|+.+++.+ +||||++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~ 75 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS-----EHKALMSELKILIHIGNHLNVVN 75 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH-----HHHHHHHHHHHHHHhccCcceee
Confidence 4889999999999999999999999974 23579999987543221 135788999999999 8999999
Q ss_pred EEEEEEeC-CeEEEEEeecCCCCHHHHHHhhC------------------------------------------------
Q 021897 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ------------------------------------------------ 231 (306)
Q Consensus 201 l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~------------------------------------------------ 231 (306)
++++|... ..+++||||+++|+|.+++....
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (338)
T cd05102 76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG 155 (338)
T ss_pred EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence 99998764 46899999999999999997532
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccC
Q 021897 232 ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTP 296 (306)
Q Consensus 232 ------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~ 296 (306)
...+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccC
Confidence 12467788899999999999999999999999999999999999999999999985432221 112
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
..+++.|+||
T Consensus 236 ~~~~~~y~aP 245 (338)
T cd05102 236 ARLPLKWMAP 245 (338)
T ss_pred CCCCccccCc
Confidence 3456789998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=248.43 Aligned_cols=172 Identities=24% Similarity=0.369 Sum_probs=146.4
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
+..+..++|++.+.||+|+||.||++++ +++.+|+|++........ ...+.+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3445567899999999999999999988 578999999865322211 12346789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
.+..+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999999998643 48899999999999999999999999999999999999999999999999998
Q ss_pred eeecCC--CccCCCCCCcccCC
Q 021897 287 IEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~--~~~~~~gt~~y~AP 306 (306)
...... .....+||+.|+||
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aP 212 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISP 212 (370)
T ss_pred ecccCCceecccCCCCcccCCH
Confidence 654322 12355799999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=244.62 Aligned_cols=167 Identities=28% Similarity=0.409 Sum_probs=145.2
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
...+|++.+.||+|+||.||+|++ +++.||||+++...... ....+.+.+|+.++++++||||+++++++.....
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK---MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 357899999999999999999988 67899999997532211 1123578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999999999764 4588999999999999999999999999999999999999999999999999986543
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
. ....+||+.|+||
T Consensus 171 ~--~~~~~gt~~y~aP 184 (329)
T PTZ00263 171 R--TFTLCGTPEYLAP 184 (329)
T ss_pred C--cceecCChhhcCH
Confidence 2 2345799999998
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-33 Score=255.34 Aligned_cols=167 Identities=33% Similarity=0.569 Sum_probs=151.9
Q ss_pred CCCCcceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
..-+.|+|+++.+..++=||.|+.|.||+|+..++.||||.++. .=..+|+-|++|+||||+.|.|+
T Consensus 114 qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e-------------lkETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 114 QQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------------LKETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh-------------hhhhhHHHHHhccCcceeeEeee
Confidence 34578999999999999999999999999999999999997642 22367888999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
|...+.+|||||||..|.|...|+.. ..+....+..+..+|+.||.|||.+.|||||||.-||||+.+..|||+|||-
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999999999864 5688899999999999999999999999999999999999999999999999
Q ss_pred eeeeecCCCccCCCCCCcccCC
Q 021897 285 ARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~AP 306 (306)
++...+...+..++||..||||
T Consensus 259 S~e~~~~STkMSFaGTVaWMAP 280 (904)
T KOG4721|consen 259 SKELSDKSTKMSFAGTVAWMAP 280 (904)
T ss_pred hHhhhhhhhhhhhhhhHhhhCH
Confidence 9876655556778999999998
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=242.00 Aligned_cols=165 Identities=27% Similarity=0.401 Sum_probs=143.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|++ +++.||||+++...... ....+.+.+|+.+++.++||||+++++++......|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK---LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEE
Confidence 3678899999999999999988 57899999997532211 112357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
|||||+++++|.+++... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 78 lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999999753 4588999999999999999999999999999999999999999999999999986543
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
.....+||+.|+||
T Consensus 154 ~~~~~~gt~~y~aP 167 (333)
T cd05600 154 YANSVVGSPDYMAP 167 (333)
T ss_pred ccCCcccCccccCh
Confidence 23456799999998
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=245.83 Aligned_cols=149 Identities=24% Similarity=0.357 Sum_probs=132.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|+. +++.||||+++...... ......+.+|+.+++.++||||+++++++.....+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE---KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEE
Confidence 3678889999999999999987 67899999997532211 122356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 78 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred EEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 999999999999999764 45899999999999999999999999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=246.21 Aligned_cols=147 Identities=27% Similarity=0.373 Sum_probs=130.6
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
.|++++.||+|+||.||+|+. +++.||||+++...... ....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN---RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence 577889999999999999987 67899999997533221 1223578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||||+.++++||+|||+++.
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 79 VMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 99999999999999764 4588999999999999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=246.56 Aligned_cols=147 Identities=24% Similarity=0.359 Sum_probs=130.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||++.. +++.||||++...... .....+.+.+|+.+++.+.||||+++++++.+...+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF---KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH---HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeE
Confidence 3678889999999999999987 7789999998653221 1122457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999753 468899999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=245.90 Aligned_cols=173 Identities=24% Similarity=0.366 Sum_probs=147.2
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
.++.+...+|++.+.||+|+||.||+++. +++.||+|++....... ......+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK---RSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 45566778999999999999999999987 67899999996432211 11124577899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.....+|+||||+++|+|.+++.. ..+++.++..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 999999999999999999999865 34888999999999999999999999999999999999999999999999999
Q ss_pred eeeecCC--CccCCCCCCcccCC
Q 021897 286 RIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~--~~~~~~gt~~y~AP 306 (306)
+...... .....+||+.|+||
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aP 212 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISP 212 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECH
Confidence 8654322 12345799999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=245.78 Aligned_cols=146 Identities=27% Similarity=0.390 Sum_probs=129.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
.|++++.||+|+||.||+|.. +++.+|+|++...... .....+.+.+|+.++++++||||+++++.+.+...+|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~---~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL---LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence 577889999999999999987 6789999998753221 12224578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 79 VMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 99999999999999764 458899999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=245.63 Aligned_cols=147 Identities=26% Similarity=0.365 Sum_probs=130.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+.+|+.+++.++||||+++++.+.+...+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL---MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH---hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEE
Confidence 3688899999999999999987 6789999998643211 1112356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|.
T Consensus 78 lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 999999999999999764 458899999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=236.60 Aligned_cols=168 Identities=27% Similarity=0.360 Sum_probs=143.4
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--C
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--R 208 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~ 208 (306)
..++|+.+..|++|.||.||+|++ +++.||+|.++....... +.-.-++|+.+|.+++|||||.+-.+... -
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G----FPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG----FPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC----CcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 346788899999999999999987 678999999986543221 11245799999999999999999988754 3
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
+.+|||||||+. +|..++.... .++....+..++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+||-+
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 579999999987 9999998654 57888999999999999999999999999999999999999999999999999976
Q ss_pred ecC-CCccCCCCCCcccCC
Q 021897 289 VQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~-~~~~~~~gt~~y~AP 306 (306)
... ..+++.+-|.+|.||
T Consensus 228 gsp~k~~T~lVVTLWYRaP 246 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAP 246 (419)
T ss_pred cCCcccCcceEEEeeecCH
Confidence 543 446777899999998
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=244.17 Aligned_cols=166 Identities=28% Similarity=0.496 Sum_probs=149.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 211 (306)
..|++++.||.|.||.||+++. +|+.+|+|++.+....... ....+.+|+.+|+++. |||||.+++++.....+
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~---~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE---DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc---cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 5788889999999999999987 6889999999876654322 2357889999999999 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC----CcEEEEcccCeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~----~~vkl~DFGla~~ 287 (306)
++|||++.||.|.+.+... . +++..+..++.|++.+++|||+.||+||||||+|+|+... +.+|++|||+|..
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999999999999876 3 9999999999999999999999999999999999999633 4799999999998
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
..........+||+.|+||
T Consensus 189 ~~~~~~~~~~~Gtp~y~AP 207 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAP 207 (382)
T ss_pred ccCCceEeeecCCccccCc
Confidence 8776667888999999999
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=261.40 Aligned_cols=176 Identities=31% Similarity=0.550 Sum_probs=149.2
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 198 (306)
.....+|+++++++.+.||+|+||+||+|... .+.||||.++...... ..++|.+|++++..|+||||
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~-----~~~dF~REaeLla~l~H~nI 551 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ-----ARQDFRREAELLAELQHPNI 551 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH-----HHHHHHHHHHHHHhccCCCe
Confidence 35667889999999999999999999999762 3479999997654432 34789999999999999999
Q ss_pred eeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 021897 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRA----VPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266 (306)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------~~~----~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp 266 (306)
|+|+|+|.+++..|+|+|||..|+|.+||+... +.. ++....+.||.|||.||+||-++.++||||..
T Consensus 552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT 631 (774)
T KOG1026|consen 552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT 631 (774)
T ss_pred EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence 999999999999999999999999999998542 122 77888999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEcccCeeeeecCCCccCC---CCCCcccCC
Q 021897 267 DNLLISADKSIKIADFGVARIEVQTEGMTPE---TGTYRWMAP 306 (306)
Q Consensus 267 ~NILv~~~~~vkl~DFGla~~~~~~~~~~~~---~gt~~y~AP 306 (306)
+|+||+++..|||+||||+|..-..+-+... .--.+||||
T Consensus 632 RNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMpp 674 (774)
T KOG1026|consen 632 RNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP 674 (774)
T ss_pred hhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCH
Confidence 9999999999999999999854433322222 223899998
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=240.69 Aligned_cols=161 Identities=27% Similarity=0.400 Sum_probs=137.9
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeec
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~ 218 (306)
+.||+|+||.||+++. +++.||||+++...... ......+.+|+.++++++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA---KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 4699999999999987 67899999997532211 122356789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccCC
Q 021897 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (306)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~~ 297 (306)
++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... .......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 999999998753 4689999999999999999999999999999999999999999999999999975322 2223445
Q ss_pred CCCCcccCC
Q 021897 298 TGTYRWMAP 306 (306)
Q Consensus 298 ~gt~~y~AP 306 (306)
+||+.|+||
T Consensus 156 ~gt~~y~aP 164 (323)
T cd05571 156 CGTPEYLAP 164 (323)
T ss_pred ecCccccCh
Confidence 799999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=244.24 Aligned_cols=174 Identities=24% Similarity=0.363 Sum_probs=148.0
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
..++.+..++|++.+.||+|+||.||++.+ +++.+|+|++........ ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFYA 111 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhh---HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 344566778999999999999999999988 678999999864322111 123467899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
+.....+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 112 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999999998653 488899999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC--CccCCCCCCcccCC
Q 021897 285 ARIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~AP 306 (306)
|+...... .....+||+.|+||
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aP 212 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISP 212 (371)
T ss_pred eeEcCcCCcccccCcccCccccCH
Confidence 98654322 22345799999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=238.95 Aligned_cols=164 Identities=24% Similarity=0.362 Sum_probs=142.5
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||+|.. +++.||+|++........ ...+.+.+|+.++++++||||+++++++.+...+|+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL---KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhh---HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 577889999999999999987 588999999975332211 123568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 99999999999999764 45889999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
....+||+.|+||
T Consensus 155 ~~~~~gt~~y~aP 167 (291)
T cd05612 155 TWTLCGTPEYLAP 167 (291)
T ss_pred cccccCChhhcCH
Confidence 2345799999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=248.59 Aligned_cols=171 Identities=32% Similarity=0.546 Sum_probs=146.6
Q ss_pred eeeccCceecceeeeeccEEEEEEEECC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+++.+.+.++++||+|.||+|.++...+ ..||||.++....... ..+|.+|+++|.+|+|||||.++|+|..++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~-----r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA-----RNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH-----HHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 4677888999999999999999998866 8999999987655443 468999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+++|+|||++|+|.+||.+.......-+...+|+.||+.||+||.+.+++||||.++|+|++.++++||+|||++|..-
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999999999998654444556678899999999999999999999999999999999999999999999544
Q ss_pred cCCCccC---CCCCCcccCC
Q 021897 290 QTEGMTP---ETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~---~~gt~~y~AP 306 (306)
..+-+.. .+-.++||||
T Consensus 689 sg~yy~vqgr~vlpiRwmaw 708 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAW 708 (807)
T ss_pred cCCceeeecceeeeeeehhH
Confidence 3332221 1344889886
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=232.33 Aligned_cols=168 Identities=24% Similarity=0.328 Sum_probs=144.4
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
.|+..+.||+|+||.||++.. +++.||||++........ .....+.+|+.+++.++||||+++++.+..+..+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhh---hhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEE
Confidence 366778999999999999987 678999999875332211 123467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
||||+++++|.+++.......+++..+..++.|++.||+|||+.+++||||||+||++++++.++|+|||+++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999999988765555689999999999999999999999999999999999999999999999999987544433
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
....+||+.|+||
T Consensus 158 ~~~~~~~~~y~aP 170 (285)
T cd05605 158 IRGRVGTVGYMAP 170 (285)
T ss_pred cccccCCCCccCc
Confidence 4455799999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=234.04 Aligned_cols=169 Identities=33% Similarity=0.525 Sum_probs=139.6
Q ss_pred eccCceecceeeeeccEEEEEEEEC------------------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYN------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 194 (306)
...+|++.++||+|+||.||+|.+. +..||+|+++..... ....++.+|+.++++++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~ 77 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-----NARNDFLKEVKILSRLK 77 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-----HHHHHHHHHHHHHhhcC
Confidence 4567888999999999999999752 236999998754321 12357899999999999
Q ss_pred CCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 021897 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----------------RAVPLKLAVKQALDVARGMAYVHGL 257 (306)
Q Consensus 195 h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~-----------------~~~~~~~~~~i~~qi~~gl~yLH~~ 257 (306)
||||+++++++.+....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999999999999999999999999999865321 2367788999999999999999999
Q ss_pred CccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 258 ~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
||+||||||+|||++.++.+||+|||+++....... .....+++.|+||
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW 209 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence 999999999999999999999999999975433221 1223457889998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=237.62 Aligned_cols=161 Identities=25% Similarity=0.391 Sum_probs=137.9
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeec
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~ 218 (306)
+.||+|+||.||++.. +++.||||+++....... .....+.+|+.+++.+.||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK---DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 3689999999999987 678999999975432211 12357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccCC
Q 021897 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (306)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~~ 297 (306)
++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 78 NGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 999999888653 4689999999999999999999999999999999999999999999999999975322 2223445
Q ss_pred CCCCcccCC
Q 021897 298 TGTYRWMAP 306 (306)
Q Consensus 298 ~gt~~y~AP 306 (306)
+||+.|+||
T Consensus 156 ~gt~~y~aP 164 (328)
T cd05593 156 CGTPEYLAP 164 (328)
T ss_pred cCCcCccCh
Confidence 799999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=237.96 Aligned_cols=168 Identities=24% Similarity=0.372 Sum_probs=142.9
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+++. +++.||||++.+.... .....+.+.+|+.+++.++|+||+++++++.....+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML---KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEE
Confidence 3678899999999999999987 6789999998642211 1122356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999999753 3458999999999999999999999999999999999999999999999999997654322
Q ss_pred C--ccCCCCCCcccCC
Q 021897 293 G--MTPETGTYRWMAP 306 (306)
Q Consensus 293 ~--~~~~~gt~~y~AP 306 (306)
. ....+||+.|+||
T Consensus 157 ~~~~~~~~gt~~y~aP 172 (331)
T cd05597 157 TVQSNVAVGTPDYISP 172 (331)
T ss_pred CccccceeccccccCH
Confidence 2 1234699999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=237.93 Aligned_cols=161 Identities=27% Similarity=0.395 Sum_probs=137.5
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeec
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~ 218 (306)
+.||+|+||.||++.. +++.||+|+++...... ......+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 4689999999999987 67899999997532211 112356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccCC
Q 021897 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPE 297 (306)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~~ 297 (306)
++++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 78 NGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 999999888653 4689999999999999999999999999999999999999999999999999875322 2223445
Q ss_pred CCCCcccCC
Q 021897 298 TGTYRWMAP 306 (306)
Q Consensus 298 ~gt~~y~AP 306 (306)
+||+.|+||
T Consensus 156 ~gt~~y~aP 164 (323)
T cd05595 156 CGTPEYLAP 164 (323)
T ss_pred cCCcCcCCc
Confidence 799999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=236.03 Aligned_cols=160 Identities=29% Similarity=0.452 Sum_probs=135.5
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 209 (306)
.|...+.+|.|+||.||+|.. ++++||||..-....- -.+|+.+|+.+.|||||+++-+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 455668999999999999987 6679999987543322 128999999999999999998885431
Q ss_pred -eEEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEcccCe
Q 021897 210 -VWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVA 285 (306)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~-~~vkl~DFGla 285 (306)
...+|||||+. +|.++++.. .+..++...+..++.||++||+|||+.||+||||||.|+|||.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 45689999986 999999852 34568888889999999999999999999999999999999965 89999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+....++...+..-|-+|+||
T Consensus 174 K~L~~~epniSYicSRyYRaP 194 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAP 194 (364)
T ss_pred eeeccCCCceeEEEeccccCH
Confidence 998887777777778899998
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=241.12 Aligned_cols=151 Identities=29% Similarity=0.446 Sum_probs=133.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|+. +++.||||+++...... ....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK---RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh---ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEE
Confidence 3678889999999999999988 58899999997532211 122357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999999865 5689999999999999999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=229.18 Aligned_cols=169 Identities=24% Similarity=0.382 Sum_probs=150.6
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCC--ChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCe
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPEN--NPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 210 (306)
.|.-.+.||.|..+.|.++.+ ++..+|+|++..... ..+....+.++-.+|+.||+++. ||+|+++.++++.+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 445567899999999998866 788999999864322 23345666778889999999985 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+++|+|.|+.|.|.|+|... -.++++..++|+.|+.+|++|||.++|+||||||+|||++++.++||+|||+|+....
T Consensus 98 ~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999864 4589999999999999999999999999999999999999999999999999999998
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
++.....||||.|+||
T Consensus 176 GekLrelCGTPgYLAP 191 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAP 191 (411)
T ss_pred chhHHHhcCCCcccCh
Confidence 8888899999999999
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=240.00 Aligned_cols=147 Identities=23% Similarity=0.389 Sum_probs=130.5
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|+..+.||+|+||.||++.. +++.||||+++..... .......+.+|+.++..++||+|+++++.+.....+|+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML---EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 577889999999999999987 6789999999743221 11224578889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
||||+++|+|.+++.+. ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 79 v~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 79 IMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred EEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 99999999999999754 4589999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=241.52 Aligned_cols=176 Identities=31% Similarity=0.527 Sum_probs=146.2
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (306)
...+|.++.++|++++.||+|+||.||+|++ .+..||||+++....... .+.+.+|+.+++.+ +|||
T Consensus 26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~Ei~il~~l~~Hpn 100 (375)
T cd05104 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHIN 100 (375)
T ss_pred CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHH-----HHHHHHHHHHHHHhcCCcc
Confidence 3457889999999999999999999999974 345899999975433221 35788999999999 8999
Q ss_pred eeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC----------------------------------------------
Q 021897 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ---------------------------------------------- 231 (306)
Q Consensus 198 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~---------------------------------------------- 231 (306)
|++++++|......++||||+++|+|.+++....
T Consensus 101 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 180 (375)
T cd05104 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP 180 (375)
T ss_pred eeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence 9999999999999999999999999999997532
Q ss_pred ---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 232 ---------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 232 ---------------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
...+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~ 260 (375)
T cd05104 181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL 260 (375)
T ss_pred cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcc
Confidence 12467888999999999999999999999999999999999999999999999
Q ss_pred eeeeecCCCc---cCCCCCCcccCC
Q 021897 285 ARIEVQTEGM---TPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~~---~~~~gt~~y~AP 306 (306)
++........ ....+++.|+||
T Consensus 261 a~~~~~~~~~~~~~~~~~~~~y~aP 285 (375)
T cd05104 261 ARDIRNDSNYVVKGNARLPVKWMAP 285 (375)
T ss_pred ceeccCcccccccCCCCCCcceeCh
Confidence 9865432211 112345679998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=236.21 Aligned_cols=168 Identities=23% Similarity=0.346 Sum_probs=142.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+++. +++.||+|++...... .....+.+.+|..++..+.|++|+++++++......|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML---KRAETACFREERNVLVNGDCQWITTLHYAFQDENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3678899999999999999987 6678999998642211 1122356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999999997642 458899999999999999999999999999999999999999999999999998654332
Q ss_pred Cc--cCCCCCCcccCC
Q 021897 293 GM--TPETGTYRWMAP 306 (306)
Q Consensus 293 ~~--~~~~gt~~y~AP 306 (306)
.. ...+||+.|+||
T Consensus 157 ~~~~~~~~gt~~y~aP 172 (331)
T cd05624 157 TVQSSVAVGTPDYISP 172 (331)
T ss_pred ceeeccccCCcccCCH
Confidence 21 234799999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=236.08 Aligned_cols=168 Identities=25% Similarity=0.371 Sum_probs=144.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||++.. +++.||||+++..... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL---AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEE
Confidence 3678889999999999999987 6789999999754321 1223457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+|+......
T Consensus 78 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999999998652 468999999999999999999999999999999999999999999999999998654332
Q ss_pred C--ccCCCCCCcccCC
Q 021897 293 G--MTPETGTYRWMAP 306 (306)
Q Consensus 293 ~--~~~~~gt~~y~AP 306 (306)
. .....||+.|+||
T Consensus 157 ~~~~~~~~gt~~y~aP 172 (330)
T cd05601 157 MVNSKLPVGTPDYIAP 172 (330)
T ss_pred ceeeecccCCccccCH
Confidence 2 2234799999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=235.25 Aligned_cols=159 Identities=21% Similarity=0.326 Sum_probs=136.5
Q ss_pred eeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCC
Q 021897 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (306)
Q Consensus 143 lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~ 220 (306)
||+|+||.||+|++ +++.||+|+++...... ......+.+|+.++++++||||+++++++.....+|+||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS---RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 68999999999988 57789999997532211 11235678999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccCCCC
Q 021897 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPETG 299 (306)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~~~g 299 (306)
|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.... .......+|
T Consensus 78 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 78 GELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 9999999763 4589999999999999999999999999999999999999999999999999985432 222344579
Q ss_pred CCcccCC
Q 021897 300 TYRWMAP 306 (306)
Q Consensus 300 t~~y~AP 306 (306)
|+.|+||
T Consensus 156 t~~y~aP 162 (312)
T cd05585 156 TPEYLAP 162 (312)
T ss_pred CcccCCH
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=230.37 Aligned_cols=166 Identities=26% Similarity=0.411 Sum_probs=140.8
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++.+.||+|+||.||+|.. +++.||+|+++....... ...+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKNLKHANIVTLHDIIHTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-----chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 46788899999999999999987 678999999875432211 13567999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||+++ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred EEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 999999975 999988754 345789999999999999999999999999999999999999999999999999764322
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......+|+.|+||
T Consensus 157 ~~~~~~~~~~~~y~aP 172 (288)
T cd07871 157 TKTYSNEVVTLWYRPP 172 (288)
T ss_pred CccccCceecccccCh
Confidence 2 23345789999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=241.45 Aligned_cols=178 Identities=30% Similarity=0.534 Sum_probs=147.6
Q ss_pred CCCCCcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CC
Q 021897 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KH 195 (306)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 195 (306)
++..+.|.++.++|++++.||+|+||.||+|.+ ++..||||+++....... .+.+.+|+.+++.+ +|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~~h 101 (374)
T cd05106 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-----REALMSELKILSHLGQH 101 (374)
T ss_pred ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH-----HHHHHHHHHHHHhhccC
Confidence 455688999999999999999999999999975 224799999975433221 35688999999999 89
Q ss_pred CCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------------------------------------------
Q 021897 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------------------------------------------- 231 (306)
Q Consensus 196 ~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~-------------------------------------------- 231 (306)
|||++++++|.....+++||||+++|+|.+++....
T Consensus 102 ~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (374)
T cd05106 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTY 181 (374)
T ss_pred CceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccc
Confidence 999999999999999999999999999999986431
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 232 ------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 232 ------------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
..++++..+++++.||+.||+|||++||+||||||+|||+++++.+||+|||+++.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~ 261 (374)
T cd05106 182 VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARD 261 (374)
T ss_pred cccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeee
Confidence 12467888999999999999999999999999999999999999999999999975
Q ss_pred eecCCCc---cCCCCCCcccCC
Q 021897 288 EVQTEGM---TPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~---~~~~gt~~y~AP 306 (306)
....... ....+++.|+||
T Consensus 262 ~~~~~~~~~~~~~~~~~~y~aP 283 (374)
T cd05106 262 IMNDSNYVVKGNARLPVKWMAP 283 (374)
T ss_pred ccCCcceeeccCCCCccceeCH
Confidence 4332211 112345779998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=234.52 Aligned_cols=161 Identities=27% Similarity=0.394 Sum_probs=136.9
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeec
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~ 218 (306)
+.||+|+||.||++.. +++.||+|+++....... .....+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK---DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 4689999999999987 778999999975432211 12356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCeeeee-cCCCccC
Q 021897 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (306)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~-~~~~~~~ 296 (306)
++|+|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 999999988653 468999999999999999999997 799999999999999999999999999997532 2222344
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (325)
T cd05594 156 FCGTPEYLAP 165 (325)
T ss_pred ccCCcccCCH
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=230.70 Aligned_cols=165 Identities=27% Similarity=0.434 Sum_probs=140.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++.+.||+|+||.||+|+. +++.||||+++....... ...+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-----chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 5788899999999999999987 678999999875433221 135678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~- 291 (306)
+||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9999995 6888888754 345888999999999999999999999999999999999999999999999999754322
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
.......||+.|+||
T Consensus 158 ~~~~~~~~~~~y~aP 172 (303)
T cd07869 158 HTYSNEVVTLWYRPP 172 (303)
T ss_pred ccCCCCcccCCCCCh
Confidence 223445789999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=232.50 Aligned_cols=164 Identities=30% Similarity=0.420 Sum_probs=141.0
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----C
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-----R 208 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 208 (306)
.|...+.||.|++|.|+.+.. +|+.||||.+....... ..-++..+|+++|+.++|+||+.+++++.. -
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~----~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ----IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch----HHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344478999999999999987 78899999986443332 234678899999999999999999999866 3
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+|+|+|+|+ .+|.+.++.. ..++...+..+++|+++||+|+|+.+|+||||||.|+|++.+..+||+|||+||..
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 47899999994 5999999764 44899999999999999999999999999999999999999999999999999987
Q ss_pred ec---CCCccCCCCCCcccCC
Q 021897 289 VQ---TEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~---~~~~~~~~gt~~y~AP 306 (306)
.. ...++..+-|-+|.||
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAP 196 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAP 196 (359)
T ss_pred cccCcccchhcceeeeeecCH
Confidence 53 4456777899999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=244.07 Aligned_cols=173 Identities=28% Similarity=0.595 Sum_probs=152.5
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEEC----Ce--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN----GE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~----~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (306)
...++++.+.+.+.+.||.|.||.||+|.+. |+ .||||+.+....... .+.|+.|+.+|+++.|||||+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-----tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-----TEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-----HHHHHHHHHHHHhCCCcchhh
Confidence 4567888999999999999999999999882 22 589999887555433 257999999999999999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
++|+|.+.+ .|||||.++-|.|..||+.++ ..++...+..++.||+.+|.|||+.+.+||||.++||||.....|||+
T Consensus 456 LIGv~~e~P-~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 456 LIGVCVEQP-MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred eeeeeeccc-eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeec
Confidence 999998876 589999999999999999764 469999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCCCccCCCCC--CcccCC
Q 021897 281 DFGVARIEVQTEGMTPETGT--YRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~~~~~~gt--~~y~AP 306 (306)
|||++|..++..-+++..|. ..||||
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaP 561 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAP 561 (974)
T ss_pred ccchhhhccccchhhccccccceeecCc
Confidence 99999988877666665554 789998
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=238.58 Aligned_cols=162 Identities=26% Similarity=0.451 Sum_probs=144.0
Q ss_pred cceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
.+.||+|.||.||-|++ +|+.||||++.+-.....+ +.++.+|+.||+++.||.||.+---|+.++.+++|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq----esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ----ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch----HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence 46899999999999976 8999999999876665443 25788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEcccCeeeeecCCCc
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEVQTEGM 294 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~---~vkl~DFGla~~~~~~~~~ 294 (306)
+. |++.+++-.....++++.....+..||+.||+|||-++|+|+||||+|||+.... ++||||||+||++......
T Consensus 645 l~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 645 LH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 94 5777777666667899999999999999999999999999999999999997543 7999999999998877777
Q ss_pred cCCCCCCcccCC
Q 021897 295 TPETGTYRWMAP 306 (306)
Q Consensus 295 ~~~~gt~~y~AP 306 (306)
...+|||.|+||
T Consensus 724 rsVVGTPAYLaP 735 (888)
T KOG4236|consen 724 RSVVGTPAYLAP 735 (888)
T ss_pred hhhcCCccccCH
Confidence 788999999998
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=242.59 Aligned_cols=169 Identities=25% Similarity=0.425 Sum_probs=151.3
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe-
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV- 210 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 210 (306)
..+|..++++|+|+||.++.+++ +++.+++|.++......... +...+|+.++++++|||||.+++.|.++..
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r----~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER----RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh----HHHHHHHHHHHhccCCCeeeeccchhcCCce
Confidence 35788899999999999988866 67799999998766554321 367799999999999999999999999888
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
++|||+|++||+|.+.+.+.++..++++.++.++.|++.|+.|||+.+|+|||||+.||++++++.|||.|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999999999988778899999999999999999999999999999999999999999999999999998776
Q ss_pred CC-CccCCCCCCcccCC
Q 021897 291 TE-GMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~-~~~~~~gt~~y~AP 306 (306)
.. ...+..|||.||.|
T Consensus 159 ~~~~a~tvvGTp~YmcP 175 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCP 175 (426)
T ss_pred chhhhheecCCCcccCH
Confidence 65 55667899999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=251.38 Aligned_cols=170 Identities=29% Similarity=0.537 Sum_probs=149.3
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
+|+...+.+.+.||.|.||+||+|++ .+ ..||||.++....... ..+|+.|+.||.++.||||++|-|+.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekq-----rrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQ-----RRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHH-----HhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 67888889999999999999999987 33 4799999987654332 36899999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.....++||+|||++|+|+.||+...+ .+..-++..|++.|+.||+||-+.+++||||.++||||+.+..||++||||+
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999999998764 4888889999999999999999999999999999999999999999999999
Q ss_pred eeeecCC--CccCCCCC--CcccCC
Q 021897 286 RIEVQTE--GMTPETGT--YRWMAP 306 (306)
Q Consensus 286 ~~~~~~~--~~~~~~gt--~~y~AP 306 (306)
|..+++. .+++..|. .+|+||
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAP 803 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAP 803 (996)
T ss_pred eecccCCCccccccCCccceeecCh
Confidence 9876554 22333343 799998
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=234.92 Aligned_cols=164 Identities=28% Similarity=0.418 Sum_probs=136.0
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHH---HhCCCCCeeeEEEEEEeCCeE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML---ATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~ 211 (306)
|++.+.||+|+||.||+|.+ +++.||||+++........ ..+.+.+|+.++ +.++||||+++++++......
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD---EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh---HHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence 45678999999999999987 6789999999754321111 124566666554 567899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~- 290 (306)
|+||||+++++|..++.. ..+++..++.++.||+.||+|||+.|++||||||+|||+++++.+||+|||+++....
T Consensus 78 ~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999999888754 4589999999999999999999999999999999999999999999999999875322
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
.......+||+.|+||
T Consensus 155 ~~~~~~~~g~~~y~aP 170 (324)
T cd05589 155 GDRTSTFCGTPEFLAP 170 (324)
T ss_pred CCcccccccCccccCH
Confidence 2223446799999998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=234.50 Aligned_cols=161 Identities=23% Similarity=0.371 Sum_probs=137.4
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|++ +++.||||+++....... ...+.+.+|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD---EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 4689999999999987 678999999976432221 1235678899999888 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee-ecCCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~-~~~~~~~~ 296 (306)
+++|+|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.. ........
T Consensus 78 ~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 78 VSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 9999999888653 46999999999999999999999999999999999999999999999999998742 22233445
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (329)
T cd05588 156 FCGTPNYIAP 165 (329)
T ss_pred ccCCccccCH
Confidence 6899999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=233.74 Aligned_cols=162 Identities=26% Similarity=0.397 Sum_probs=136.5
Q ss_pred ceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEE
Q 021897 141 TAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~ 215 (306)
+.||+|+||.||+++. .++.||||+++...... .......+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR--NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh--hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 6799999999999975 46789999997532211 1112346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-CCc
Q 021897 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGM 294 (306)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~-~~~ 294 (306)
||+++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 80 EYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred eCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence 999999999998754 45788889999999999999999999999999999999999999999999999753322 223
Q ss_pred cCCCCCCcccCC
Q 021897 295 TPETGTYRWMAP 306 (306)
Q Consensus 295 ~~~~gt~~y~AP 306 (306)
...+||+.|+||
T Consensus 158 ~~~~gt~~y~aP 169 (323)
T cd05584 158 HTFCGTIEYMAP 169 (323)
T ss_pred cccCCCccccCh
Confidence 345799999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=232.33 Aligned_cols=168 Identities=23% Similarity=0.355 Sum_probs=141.9
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||++.+ .++.+|+|++.+.... .....+.+.+|+.++..++|++|+++++++.....+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML---KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEE
Confidence 3678889999999999999988 5678999998642211 1122345788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 78 lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999999997642 458999999999999999999999999999999999999999999999999997543222
Q ss_pred C--ccCCCCCCcccCC
Q 021897 293 G--MTPETGTYRWMAP 306 (306)
Q Consensus 293 ~--~~~~~gt~~y~AP 306 (306)
. ....+||+.|+||
T Consensus 157 ~~~~~~~~gt~~y~aP 172 (332)
T cd05623 157 TVQSSVAVGTPDYISP 172 (332)
T ss_pred cceecccccCccccCH
Confidence 1 2235799999998
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=233.66 Aligned_cols=167 Identities=20% Similarity=0.341 Sum_probs=140.6
Q ss_pred CceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM 209 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 209 (306)
+|++++.||+|+||.||+++. +++.||+|++.+..... .....+.+.+|+.+++.++ ||+|+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ--KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 477889999999999999875 56789999997532211 1122356788999999995 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999999999754 458999999999999999999999999999999999999999999999999998543
Q ss_pred cCC--CccCCCCCCcccCC
Q 021897 290 QTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~--~~~~~~gt~~y~AP 306 (306)
... .....+||+.|+||
T Consensus 157 ~~~~~~~~~~~gt~~y~aP 175 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAP 175 (332)
T ss_pred ccCCCccccccCCccccCH
Confidence 222 22345799999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=227.60 Aligned_cols=167 Identities=27% Similarity=0.458 Sum_probs=137.3
Q ss_pred cCceecceeeeeccEEEEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEe-
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~- 207 (306)
++|++.+.||+|+||.||+|+. .++.||+|+++........ ...+.+|+.+++.+ .||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM----PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc----hHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 3678889999999999999986 3578999998765433221 12445666666655 69999999999852
Q ss_pred ----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 208 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
...+++||||++ ++|.+++.......+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999996 599999987655668999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+++............||+.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aP 178 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAP 178 (290)
T ss_pred ceEeccCCcccccccccccccCh
Confidence 99876544444556799999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=232.34 Aligned_cols=166 Identities=27% Similarity=0.348 Sum_probs=138.8
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEEeCCeEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWC 212 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~ 212 (306)
+|++.+.||+|+||.||+|.. +++.||||+++...... ....+.+..|..++..+.|+ +|+++++++.....+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence 467889999999999999987 56789999997533211 11235678899999999765 5888999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee-cC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~-~~ 291 (306)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999999998754 458899999999999999999999999999999999999999999999999987432 22
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
......+||+.|+||
T Consensus 156 ~~~~~~~gt~~y~aP 170 (324)
T cd05587 156 KTTRTFCGTPDYIAP 170 (324)
T ss_pred CceeeecCCccccCh
Confidence 223445799999998
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=238.31 Aligned_cols=174 Identities=32% Similarity=0.538 Sum_probs=145.5
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCee
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIV 199 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv 199 (306)
..|+++...|++++.||+|+||.||+|++. +..||||+++...... ..+.+.+|+.+++++. ||||+
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS-----EKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH-----HHHHHHHHHHHHHhcCCCCCee
Confidence 578999999999999999999999999862 2369999996543321 1357899999999996 99999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC------------------------------------------------
Q 021897 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------------------------------------------ 231 (306)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~------------------------------------------------ 231 (306)
+++++|.+...+||||||+++|+|.+++....
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (400)
T cd05105 105 NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD 184 (400)
T ss_pred eEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence 99999999999999999999999999986531
Q ss_pred ----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021897 232 ----------------------------------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (306)
Q Consensus 232 ----------------------------------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlk 265 (306)
...+++..++.++.||+.||+|||+.+++|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik 264 (400)
T cd05105 185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264 (400)
T ss_pred ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 1246778889999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 266 p~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|+|||+++++.+||+|||+++....... .....+++.|+||
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP 308 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP 308 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence 9999999999999999999986433221 1223467889998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=225.86 Aligned_cols=167 Identities=23% Similarity=0.326 Sum_probs=143.4
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|+..+.||+|+||+||+|++ +++.+|+|.+........ .....+.+|+.+++.++|++|+.+++.+..++.+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR---KGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 55668899999999999988 678999999865433221 1234577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~ 294 (306)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+|+||||||+||++++++.+||+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99999999999887655557999999999999999999999999999999999999999999999999999765443334
Q ss_pred cCCCCCCcccCC
Q 021897 295 TPETGTYRWMAP 306 (306)
Q Consensus 295 ~~~~gt~~y~AP 306 (306)
....|++.|+||
T Consensus 159 ~~~~g~~~~~aP 170 (285)
T cd05632 159 RGRVGTVGYMAP 170 (285)
T ss_pred cCCCCCcCccCh
Confidence 456789999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=245.44 Aligned_cols=162 Identities=30% Similarity=0.451 Sum_probs=140.4
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|.-++.||.|+||.||-|+. +.+.||||.+.-.... .....++++.|++.|++++|||+|.+-|++..+...|+|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ---s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ---SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccc---cHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 44567899999999999987 6789999988643322 222347899999999999999999999999999899999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~ 294 (306)
||||- |+-.|++.-. .+++.+..+..|+.+.+.||+|||+++.||||||+.|||+++.|.|||+|||.|.+..+ .
T Consensus 105 MEYCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---A 179 (948)
T KOG0577|consen 105 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---A 179 (948)
T ss_pred HHHHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---h
Confidence 99995 5888888754 36789999999999999999999999999999999999999999999999999987653 4
Q ss_pred cCCCCCCcccCC
Q 021897 295 TPETGTYRWMAP 306 (306)
Q Consensus 295 ~~~~gt~~y~AP 306 (306)
.+++|||+||||
T Consensus 180 nsFvGTPywMAP 191 (948)
T KOG0577|consen 180 NSFVGTPYWMAP 191 (948)
T ss_pred hcccCCccccch
Confidence 668999999999
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=225.41 Aligned_cols=167 Identities=23% Similarity=0.328 Sum_probs=143.6
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|+..+.||+|+||.||++.+ +++.+|||.+........ .....+.+|+.++++++|++|+.+++.+.....+++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch---HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 55668899999999999987 678999999875433221 1224577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~ 294 (306)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||++.........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999999999987655556899999999999999999999999999999999999999999999999999865444334
Q ss_pred cCCCCCCcccCC
Q 021897 295 TPETGTYRWMAP 306 (306)
Q Consensus 295 ~~~~gt~~y~AP 306 (306)
....||+.|+||
T Consensus 159 ~~~~g~~~y~aP 170 (285)
T cd05630 159 KGRVGTVGYMAP 170 (285)
T ss_pred cCCCCCccccCh
Confidence 445799999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=232.18 Aligned_cols=161 Identities=23% Similarity=0.382 Sum_probs=136.2
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|+. +++.+|+|++++...... ...+.+.+|+.++.++ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch---hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 4699999999999987 677999999986432221 1234677888888776 799999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee-cCCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~-~~~~~~~ 296 (306)
+++++|..++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 78 VNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 9999999888653 468999999999999999999999999999999999999999999999999997532 2223344
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (329)
T cd05618 156 FCGTPNYIAP 165 (329)
T ss_pred ccCCccccCH
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=231.08 Aligned_cols=166 Identities=27% Similarity=0.346 Sum_probs=138.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 212 (306)
+|++.+.||+|+||.||+|.. +++.||||+++....... ...+.+..|..++..+ .|++|+++++++.....+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD---DDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence 467889999999999999987 567999999975432211 1234566788888777 5899999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee-cC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QT 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~-~~ 291 (306)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999999998754 458899999999999999999999999999999999999999999999999997533 22
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
......+||+.|+||
T Consensus 156 ~~~~~~~gt~~y~aP 170 (323)
T cd05616 156 VTTKTFCGTPDYIAP 170 (323)
T ss_pred CccccCCCChhhcCH
Confidence 233456799999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=257.18 Aligned_cols=170 Identities=34% Similarity=0.615 Sum_probs=143.5
Q ss_pred eeccCceecceeeeeccEEEEEEEE---CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY---NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~---~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
++...+++.+.||+|+||.||+|++ ++. .||||.+++.....+ +.+|++|+.+|+.+.|||||+++|+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~-----~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQE-----VSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHH-----HHHHHHHHHHHhcCCCcceeeEEEe
Confidence 4578889999999999999999987 332 488888876544332 4689999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ-----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl 279 (306)
|.+....+|++|||++|+|..||++.+ ...+....++.++.|||.|++||+++++|||||.++|+|++....|||
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEE
Confidence 999999999999999999999999752 345788999999999999999999999999999999999999999999
Q ss_pred EcccCeeeeecCCCcc--CC-CCCCcccCC
Q 021897 280 ADFGVARIEVQTEGMT--PE-TGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~~~--~~-~gt~~y~AP 306 (306)
+|||+||.+.+..-+. .. .--.+||||
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~P 873 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPP 873 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCH
Confidence 9999999443332111 11 122799998
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=231.85 Aligned_cols=160 Identities=25% Similarity=0.396 Sum_probs=137.0
Q ss_pred ceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEE
Q 021897 141 TAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~ 215 (306)
+.||+|+||.||++.. +++.+|+|+++....... ....+.+|+.++++++||||+++++++.....+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR----DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh----hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 5799999999999864 568999999975332211 1245678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-CCc
Q 021897 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGM 294 (306)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~-~~~ 294 (306)
||+++++|.+++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 78 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 999999999998653 45899999999999999999999999999999999999999999999999999865433 223
Q ss_pred cCCCCCCcccCC
Q 021897 295 TPETGTYRWMAP 306 (306)
Q Consensus 295 ~~~~gt~~y~AP 306 (306)
...+||+.|+||
T Consensus 156 ~~~~g~~~y~aP 167 (318)
T cd05582 156 YSFCGTVEYMAP 167 (318)
T ss_pred ecccCChhhcCH
Confidence 445799999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=231.65 Aligned_cols=161 Identities=27% Similarity=0.351 Sum_probs=135.4
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|++ +++.||||+++...... ....+.+..|..++..+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ---DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh---hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 3689999999999988 56799999997532211 11234577888888866 799999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~ 296 (306)
+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 78 VNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 9999999988754 4588999999999999999999999999999999999999999999999999975322 223344
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (321)
T cd05591 156 FCGTPDYIAP 165 (321)
T ss_pred cccCccccCH
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=223.25 Aligned_cols=170 Identities=33% Similarity=0.546 Sum_probs=147.0
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
|.|+.++|++.++||+|+||.||+|.. ++..||+|.+...... .+.+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-------VQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh-------HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 788999999999999999999999987 5678999987653221 25788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
...+++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 99999999999999999998765567889999999999999999999999999999999999999999999999999865
Q ss_pred ecCCC--ccCCCCCCcccCC
Q 021897 289 VQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~--~~~~~gt~~y~AP 306 (306)
..... .....++..|+||
T Consensus 154 ~~~~~~~~~~~~~~~~y~aP 173 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAP 173 (261)
T ss_pred CCCceeccCCCccceecCCH
Confidence 43221 1223456779887
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=231.15 Aligned_cols=161 Identities=25% Similarity=0.438 Sum_probs=133.5
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||+||+|+. +++.||||++........ ...+.+.+|.. +++.++||||+++++.+.....+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK---KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 4699999999999988 688999999975322111 11234455544 56889999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~ 296 (306)
+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 9999999998753 4689999999999999999999999999999999999999999999999999875322 222344
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (323)
T cd05575 156 FCGTPEYLAP 165 (323)
T ss_pred ccCChhhcCh
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=237.96 Aligned_cols=167 Identities=29% Similarity=0.476 Sum_probs=151.9
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
...|.+.+.||.|.|++|.+|++ ++..||||++.+...+... .+.+.+|+.+|+.+.|||||+++.+...+..+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~----~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK----RQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH----HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 35677889999999999999987 8899999999876665443 24588999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||||+.+|.+++++.+. ..+.+..+..++.|++.+++|||+++|+|||||++|||++.+.++||+|||++..+...
T Consensus 131 ylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999999875 44667899999999999999999999999999999999999999999999999998877
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
....+.||++.|.||
T Consensus 209 ~~lqt~cgsppyAaP 223 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAP 223 (596)
T ss_pred ccccccCCCCCccCh
Confidence 778889999999998
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=231.34 Aligned_cols=161 Identities=25% Similarity=0.435 Sum_probs=133.7
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||+||+|+. +++.+|+|++........ .....+.+|.. +++.++||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR---KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 4689999999999987 688999999975422211 11234555554 57789999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee-cCCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~-~~~~~~~ 296 (306)
+++|+|..++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 9999999888653 468999999999999999999999999999999999999999999999999987532 2223345
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (325)
T cd05604 156 FCGTPEYLAP 165 (325)
T ss_pred ccCChhhCCH
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=231.09 Aligned_cols=161 Identities=27% Similarity=0.430 Sum_probs=133.2
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|+. +++.||+|++........ .....+.+|. .+++.++||||+++++++.....+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK---KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh---hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 3699999999999988 678999999975322111 1123455555 467889999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~ 296 (306)
+++++|...+... ..+++..+..++.||+.||+|||+.+|+||||||+||||+.++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 78 VNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 9999999888653 4588899999999999999999999999999999999999999999999999875322 222344
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (321)
T cd05603 156 FCGTPEYLAP 165 (321)
T ss_pred ccCCcccCCH
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=240.50 Aligned_cols=167 Identities=20% Similarity=0.301 Sum_probs=141.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--C-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--N-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
...|.+.+.||+|+||.||+|.. + ++.||+|.+..... . ....+.+|+.+++.++|||||++++++.....
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---~---~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---R---QAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---H---HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 34588999999999999999976 3 57889997643221 1 12467789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
+||||||+++|+|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999999988642 2346889999999999999999999999999999999999999999999999999865
Q ss_pred ecCCC---ccCCCCCCcccCC
Q 021897 289 VQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~---~~~~~gt~~y~AP 306 (306)
..... ....+||+.|+||
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aP 240 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAP 240 (478)
T ss_pred CCccccccccccCCCccccCH
Confidence 43321 3345799999998
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=230.60 Aligned_cols=161 Identities=24% Similarity=0.377 Sum_probs=137.2
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|.. +++.+|+|+++...... ....+.+.+|+.++.++ .||+|+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD---DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 4699999999999987 66899999997643221 12235678899999888 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee-cCCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~-~~~~~~~ 296 (306)
+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 78 VNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 9999999988653 459999999999999999999999999999999999999999999999999997532 2223445
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (327)
T cd05617 156 FCGTPNYIAP 165 (327)
T ss_pred ccCCcccCCH
Confidence 6799999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=231.60 Aligned_cols=161 Identities=23% Similarity=0.354 Sum_probs=135.4
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|.. +++.||||+++...... ....+.+.+|..++..+ .||||+++++++.....+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ---DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh---ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 3689999999999987 57899999997532211 11234677888888776 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee-cCCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-QTEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~-~~~~~~~ 296 (306)
+++|+|.+++... ..+++..++.++.|++.||+|||+++++||||||+|||++.++.+||+|||+++... .......
T Consensus 78 ~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 78 VNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 9999999988754 458999999999999999999999999999999999999999999999999987532 2223344
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (320)
T cd05590 156 FCGTPDYIAP 165 (320)
T ss_pred cccCccccCH
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=230.23 Aligned_cols=161 Identities=27% Similarity=0.363 Sum_probs=133.2
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|++ +++.||||+++....... ...+.+..|..++.. .+||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED---DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 3699999999999987 567899999975322111 112345566666664 4899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~ 296 (306)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+|+.... ......
T Consensus 78 ~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 78 LNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 9999999998754 4589999999999999999999999999999999999999999999999999985432 223345
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (316)
T cd05592 156 FCGTPDYIAP 165 (316)
T ss_pred ccCCccccCH
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=229.59 Aligned_cols=167 Identities=26% Similarity=0.382 Sum_probs=144.6
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+..++|++.+.||+|+||.||++++ ++..+|+|++..... ....+.+.+|+.++++++||||+++++++....
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 3457888999999999999999988 577899999875322 122457899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 999999999999999999764 4589999999999999999999986 6999999999999999999999999999765
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
... ......||+.|+||
T Consensus 155 ~~~-~~~~~~g~~~y~aP 171 (331)
T cd06649 155 IDS-MANSFVGTRSYMSP 171 (331)
T ss_pred ccc-ccccCCCCcCcCCH
Confidence 432 23445799999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=235.20 Aligned_cols=175 Identities=33% Similarity=0.564 Sum_probs=146.2
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCe
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNI 198 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni 198 (306)
...|+++.+++.+++.||+|+||.||+|++. ++.||||+++....... .+.+.+|+.++.++. ||||
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~E~~~l~~l~~H~ni 103 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-----KQALMSELKIMSHLGPHLNI 103 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH-----HHHHHHHHHHHHhcCCCCCe
Confidence 4569999999999999999999999999863 25799999975433221 246889999999997 9999
Q ss_pred eeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCC----------------------------------------------
Q 021897 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------------------------------------- 232 (306)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------------------------------------------- 232 (306)
++++++|.....+++||||+++|+|.+++.+...
T Consensus 104 v~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 9999999999999999999999999999975321
Q ss_pred --------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021897 233 --------------------------------------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (306)
Q Consensus 233 --------------------------------------------------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHr 262 (306)
..+++..++.++.||+.||+|||+.+++||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 263 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcc
Confidence 135667788999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
||||+|||+++++.+||+|||+++....... .....+++.|+||
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP 310 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP 310 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence 9999999999999999999999986432221 1223567889998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=235.38 Aligned_cols=164 Identities=29% Similarity=0.460 Sum_probs=139.5
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
....+|+.++.||+|+||.||+|++ +++.||||++...... ...+.+.+|+.+++.++|+||+++++++....
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED-----TVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH-----HHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 3456788889999999999999987 5789999998653321 22357889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+++||||+++++|.+. ...++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 146 ~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred eEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 99999999999998643 235677788999999999999999999999999999999999999999999998654
Q ss_pred cCC-CccCCCCCCcccCC
Q 021897 290 QTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~-~~~~~~gt~~y~AP 306 (306)
... ......||+.|+||
T Consensus 220 ~~~~~~~~~~gt~~y~aP 237 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSP 237 (353)
T ss_pred cccccccccccCccccCc
Confidence 322 23445799999998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=223.66 Aligned_cols=169 Identities=26% Similarity=0.453 Sum_probs=141.8
Q ss_pred eeccCceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
++.++|++.+.||+|+||.||+|++ .+..||+|.++...... ....+.+|+.++++++||||+++++++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-----QRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH-----HHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 5667899999999999999999976 24689999987543221 1357889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
.....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++++||||||+|||++.++.+|++|||.+.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999999999997643 468999999999999999999999999999999999999999999999999876
Q ss_pred eeecCCCcc--CCCCCCcccCC
Q 021897 287 IEVQTEGMT--PETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~--~~~gt~~y~AP 306 (306)
......... ...+++.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aP 177 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAP 177 (266)
T ss_pred cccccchhcccCCCCceeecCH
Confidence 532221111 22356789988
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=235.65 Aligned_cols=160 Identities=24% Similarity=0.357 Sum_probs=138.3
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+....|++.+.||+|+||.||++.. +++.||+|.... +.+.+|+.++++++||||+++++++....
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------------~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------------GGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 4456799999999999999999987 678999996431 34679999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
..++|+|++. ++|..++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 157 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 157 FTCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred eeEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 9999999995 6898888654 458899999999999999999999999999999999999999999999999997532
Q ss_pred cC--CCccCCCCCCcccCC
Q 021897 290 QT--EGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~--~~~~~~~gt~~y~AP 306 (306)
.. ......+||+.|+||
T Consensus 234 ~~~~~~~~~~~gt~~y~aP 252 (391)
T PHA03212 234 DINANKYYGWAGTIATNAP 252 (391)
T ss_pred cccccccccccCccCCCCh
Confidence 21 123345799999998
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=223.80 Aligned_cols=161 Identities=21% Similarity=0.376 Sum_probs=137.6
Q ss_pred eeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCC
Q 021897 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (306)
Q Consensus 143 lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~ 220 (306)
||+|+||.||++.. +++.+|+|.+........ ...+.+..|+.++++++||||+++++++.....+|+||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK---SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc---hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 68999999999987 688999999864322111 1124556799999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCC
Q 021897 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (306)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt 300 (306)
++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.............||
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 99999987655566899999999999999999999999999999999999999999999999999866544444456789
Q ss_pred CcccCC
Q 021897 301 YRWMAP 306 (306)
Q Consensus 301 ~~y~AP 306 (306)
+.|+||
T Consensus 158 ~~y~aP 163 (277)
T cd05607 158 NGYMAP 163 (277)
T ss_pred CCccCH
Confidence 999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=245.97 Aligned_cols=164 Identities=29% Similarity=0.511 Sum_probs=141.8
Q ss_pred eecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC------
Q 021897 138 NMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM------ 209 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 209 (306)
...+.||+|+||.||+|+. +|+.||||+++....... .++..+|+++|++++|||||+++++-.+..
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~-----~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP-----RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccch-----HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 3457899999999999986 899999999986543322 257889999999999999999999865443
Q ss_pred eEEEEEeecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc--CCC--cEEEEcccC
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADK--SIKIADFGV 284 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~--~~~--~vkl~DFGl 284 (306)
...+|||||.+|+|...+.+..+ ..+++...+.+..+++.||.|||++||+||||||.||++- .+| .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 45799999999999999987544 4699999999999999999999999999999999999984 445 469999999
Q ss_pred eeeeecCCCccCCCCCCcccCC
Q 021897 285 ARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~AP 306 (306)
||-..+.....+..||+.|++|
T Consensus 171 Arel~d~s~~~S~vGT~~YLhP 192 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHP 192 (732)
T ss_pred cccCCCCCeeeeecCchhhcCh
Confidence 9988888888888999999998
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=229.93 Aligned_cols=161 Identities=25% Similarity=0.405 Sum_probs=132.3
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|.+ +++.+|+|++........ .....+.+|. .+++.++||||+++++++.....+|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh---hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 3699999999999988 567899999975322111 1123344444 457889999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~ 296 (306)
+++++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+.... ......
T Consensus 78 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 78 INGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 9999999999753 4578888999999999999999999999999999999999999999999999975322 222345
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (325)
T cd05602 156 FCGTPEYLAP 165 (325)
T ss_pred ccCCccccCH
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=223.66 Aligned_cols=170 Identities=16% Similarity=0.292 Sum_probs=142.7
Q ss_pred ceeeccCceec--ceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 130 WTIDLRKLNMG--TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 130 ~~i~~~~~~~~--~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
+.|+.++++.. ..|++|++|.||+|.++++.||||+++...... ....+.+.+|+.+|++++||||+++++++.+
T Consensus 13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 89 (283)
T PHA02988 13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH---KVLIDITENEIKNLRRIDSNNILKIYGFIID 89 (283)
T ss_pred eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc---HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence 34455555555 689999999999999999999999997643322 2234678899999999999999999999876
Q ss_pred ----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEcc
Q 021897 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 208 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
...+++||||+++|+|.+++... ..+++...+.++.|++.||.|||+. +++||||||+|||+++++.+||+||
T Consensus 90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~df 167 (283)
T PHA02988 90 IVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICH 167 (283)
T ss_pred cccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEccc
Confidence 35789999999999999999764 4588999999999999999999984 9999999999999999999999999
Q ss_pred cCeeeeecCCCccCCCCCCcccCC
Q 021897 283 GVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|+++..... .....||+.|+||
T Consensus 168 g~~~~~~~~--~~~~~~~~~y~aP 189 (283)
T PHA02988 168 GLEKILSSP--PFKNVNFMVYFSY 189 (283)
T ss_pred chHhhhccc--cccccCcccccCH
Confidence 999865432 2345788999998
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=223.49 Aligned_cols=161 Identities=25% Similarity=0.343 Sum_probs=136.0
Q ss_pred eeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCC
Q 021897 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (306)
Q Consensus 143 lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~ 220 (306)
||+|+||+||++.+ +++.+|+|.+........ ...+.+..|+.+++.++||||+++++++.....+|+||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR---KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhh---HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 68999999999987 678999999865432211 1235678899999999999999999999999999999999999
Q ss_pred CCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC-ccCC
Q 021897 221 GSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPE 297 (306)
Q Consensus 221 gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~-~~~~ 297 (306)
|+|.+++... ....+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++........ ....
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 9999887542 335689999999999999999999999999999999999999999999999999976543222 2345
Q ss_pred CCCCcccCC
Q 021897 298 TGTYRWMAP 306 (306)
Q Consensus 298 ~gt~~y~AP 306 (306)
.||+.|+||
T Consensus 158 ~g~~~y~aP 166 (280)
T cd05608 158 AGTPGFMAP 166 (280)
T ss_pred CCCcCccCH
Confidence 789999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=228.92 Aligned_cols=164 Identities=24% Similarity=0.366 Sum_probs=136.2
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 208 (306)
+|++.+.||+|+||.||+|.. +++.||||.++........ ...+.+|+.++++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 76 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD----ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchh----HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCC
Confidence 477889999999999999987 6789999998643322111 24688999999999999999999988543
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 77 KDIYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred ceEEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 35899999995 6899988753 45899999999999999999999999999999999999999999999999999854
Q ss_pred ecCC----CccCCCCCCcccCC
Q 021897 289 VQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~----~~~~~~gt~~y~AP 306 (306)
.... ......||+.|+||
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aP 175 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAP 175 (338)
T ss_pred ccccCccccccCCCCCCCcCCH
Confidence 2211 12345799999998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=219.62 Aligned_cols=169 Identities=31% Similarity=0.583 Sum_probs=145.6
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
|+++.++|++.+.||+|++|.||+|.+ .++.||+|.++..... .+.+.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-------PKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc-------HHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 678889999999999999999999987 5568999998754332 24688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
...+++|||+++++|.+++.......+++..++.++.|++.||.|||+.+++||||||+||++++++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 99999999999999999998755557899999999999999999999999999999999999999999999999999865
Q ss_pred ecCCCccCCCC---CCcccCC
Q 021897 289 VQTEGMTPETG---TYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~g---t~~y~AP 306 (306)
.... .....| +..|+||
T Consensus 154 ~~~~-~~~~~~~~~~~~y~aP 173 (261)
T cd05068 154 KEDI-YEAREGAKFPIKWTAP 173 (261)
T ss_pred cCCc-ccccCCCcCceeccCc
Confidence 4322 111222 3578888
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=224.43 Aligned_cols=165 Identities=29% Similarity=0.413 Sum_probs=139.1
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||+|++ +++.+|||+++....... ..+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc----chhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 578889999999999999988 577999999976543321 13567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
||||++++.+..+.. . ...+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 78 v~e~~~~~~l~~~~~-~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 78 VFEYVEKNMLELLEE-M-PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEecCCCCHHHHHHh-c-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 999998876654433 2 3468999999999999999999999999999999999999999999999999998654322
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......||+.|+||
T Consensus 156 ~~~~~~~~~~~y~aP 170 (287)
T cd07848 156 ANYTEYVATRWYRSP 170 (287)
T ss_pred ccccccccccccCCc
Confidence 22345689999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=228.66 Aligned_cols=167 Identities=25% Similarity=0.389 Sum_probs=143.7
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+..++|++.+.||+|+||.||++.+ ++..+|+|++...... .....+.+|++++++++||||+++++++....
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-----HHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 4457888999999999999999988 5778999988754321 12357889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999999999999763 4588999999999999999999975 7999999999999999999999999999754
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
... ......||+.|+||
T Consensus 155 ~~~-~~~~~~~~~~y~aP 171 (333)
T cd06650 155 IDS-MANSFVGTRSYMSP 171 (333)
T ss_pred hhh-ccccCCCCccccCH
Confidence 322 23445799999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=228.68 Aligned_cols=153 Identities=24% Similarity=0.406 Sum_probs=140.1
Q ss_pred eeeccCceecceeeeeccEEEEEEEECC--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
.+.++.+++++.||+|.-|.||++...+ ..+|+|++.+..... .....+.+.|-.||+.+.||.++.||..++.+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~---rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS---RKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh---hhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 4567889999999999999999999855 789999997655543 22346788899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
...|++||||+||+|..+++++.++.+++..++.++++|+.||+|||-.|||+|||||+||||-++|++.|+||.|+.
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccc
Confidence 999999999999999999999989999999999999999999999999999999999999999999999999999874
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=228.54 Aligned_cols=166 Identities=26% Similarity=0.334 Sum_probs=138.3
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 212 (306)
+|++.+.||+|+||.||+|.. +++.||||+++...... ....+.+..|..+++.+. |++|+++++++.....+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEE
Confidence 356778999999999999987 67899999997532211 112356778888888886 577888999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~- 291 (306)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999999998754 45899999999999999999999999999999999999999999999999999754322
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
......+||+.|+||
T Consensus 156 ~~~~~~~gt~~y~aP 170 (323)
T cd05615 156 VTTRTFCGTPDYIAP 170 (323)
T ss_pred ccccCccCCccccCH
Confidence 223345799999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-31 Score=236.82 Aligned_cols=165 Identities=32% Similarity=0.458 Sum_probs=144.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
..|...+.||+|.||.||+|.. +++.||+|++.......+ .+++++|+.+|.+++++||.++|+.+..+..+|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-----Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-----IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchh-----hHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 3455568999999999999987 778999999987555433 467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
|+||||.||++.+.++.. ..+.+....-++.+++.|+.|||+.+.||||||++|||+..+|.+||+|||++.......
T Consensus 88 iiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999999999753 344777777889999999999999999999999999999999999999999987654433
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
...+++|||.||||
T Consensus 166 ~rr~tfvGTPfwMAP 180 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAP 180 (467)
T ss_pred hccccccccccccch
Confidence 34778999999999
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=229.79 Aligned_cols=164 Identities=27% Similarity=0.384 Sum_probs=137.9
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (306)
.++|++.+.||+|+||.||++.. +++.||||++........ ....+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchh----HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 36788899999999999999987 678999999975533222 2356789999999999999999999986543
Q ss_pred ----eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.+|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999965 67666642 3788889999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+............||+.|+||
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aP 191 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAP 191 (359)
T ss_pred cccccCccCCCCcccCCCCCc
Confidence 865444444556899999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=246.96 Aligned_cols=169 Identities=22% Similarity=0.348 Sum_probs=141.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++.++||+|+||.||+|.+ +++.||||+++...... ....+++.+|+.++++++||||+++++++.+....|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~---e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN---PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC---HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence 4688899999999999999987 67899999997543322 223467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 213 IVTEYAKGGSVRQFLTRRQ---------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
+||||+++++|.+++.... ....++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999999987421 1234567788999999999999999999999999999999999999999999
Q ss_pred CeeeeecC-------------------CCccCCCCCCcccCC
Q 021897 284 VARIEVQT-------------------EGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~-------------------~~~~~~~gt~~y~AP 306 (306)
+|+..... ......+||+.|+||
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP 200 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence 99865110 011224699999998
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=217.65 Aligned_cols=168 Identities=35% Similarity=0.636 Sum_probs=146.9
Q ss_pred ceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
|.++.++|++.+.||.|+||.||+|...++.||+|.++.... ..+++.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 567788999999999999999999999999999999975432 2357889999999999999999999999888
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
..++||||+++++|.+++.......+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++...
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999999999999987654568999999999999999999999999999999999999999999999999998653
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
... .....+..|+||
T Consensus 154 ~~~--~~~~~~~~~~ap 168 (256)
T cd05039 154 QGQ--DSGKLPVKWTAP 168 (256)
T ss_pred ccc--ccCCCcccccCc
Confidence 222 223445668777
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=227.32 Aligned_cols=161 Identities=26% Similarity=0.379 Sum_probs=134.2
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|++ +++.||+|+++....... ...+.+..|..++.. +.||+|+++++++.....+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID---DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc---chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 4699999999999988 678999999975322111 112456677777765 4899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~ 296 (306)
+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 78 LNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 9999999998753 4588999999999999999999999999999999999999999999999999874321 222345
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (316)
T cd05620 156 FCGTPDYIAP 165 (316)
T ss_pred cCCCcCccCH
Confidence 6799999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=220.24 Aligned_cols=170 Identities=26% Similarity=0.548 Sum_probs=145.7
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
|+++..+|.+.+.||+|+||.||+|.+ .++.||+|++...... ...+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH-------HHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 778889999999999999999999987 5789999998643221 2468899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
...++++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|||+++.
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999999999875556689999999999999999999999999999999999999999999999999986
Q ss_pred eecCCCc--cCCCCCCcccCC
Q 021897 288 EVQTEGM--TPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~--~~~~gt~~y~AP 306 (306)
....... ....+++.|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aP 174 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAP 174 (263)
T ss_pred cccceeeccCCCCCccccCCH
Confidence 5432211 112245678887
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=218.62 Aligned_cols=167 Identities=31% Similarity=0.593 Sum_probs=144.1
Q ss_pred ceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KR 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~ 208 (306)
|.++.++|++.+.||+|+||.||++...++.+|+|.++.... .+.+.+|+.++++++|++++++++++. ..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch--------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 678889999999999999999999999999999999854321 246889999999999999999999764 45
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
...+++|||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||+++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceec
Confidence 67899999999999999998765556899999999999999999999999999999999999999999999999999854
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
.... ....++..|+||
T Consensus 153 ~~~~--~~~~~~~~y~aP 168 (256)
T cd05082 153 SSTQ--DTGKLPVKWTAP 168 (256)
T ss_pred cccC--CCCccceeecCH
Confidence 3322 233455678887
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=235.72 Aligned_cols=163 Identities=27% Similarity=0.475 Sum_probs=135.1
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 208 (306)
..++|++++.||+|+||.||+|.. +++.||||.+..... ...+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----------~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----------YKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----------hHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 346789999999999999999987 678999998854321 234799999999999999999886432
Q ss_pred ------CeEEEEEeecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEE
Q 021897 209 ------MVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKI 279 (306)
Q Consensus 209 ------~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-~vkl 279 (306)
..+++||||+++ +|.+++.. .....+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||
T Consensus 134 ~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred ccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence 257799999975 78777753 2345689999999999999999999999999999999999999665 7999
Q ss_pred EcccCeeeeecCCCccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|||+|+............||+.|+||
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aP 239 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAP 239 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCH
Confidence 999999866544444556789999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=227.89 Aligned_cols=160 Identities=36% Similarity=0.597 Sum_probs=137.6
Q ss_pred cCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh--CCCCCeeeEEEEEEeC----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKR---- 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~---- 208 (306)
+++++.+.||+|.||+||+|.|.|+.||||++..... +.+.+|.+|.+. |+|+||+.|++.-..+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccch---------hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 6788999999999999999999999999999964322 346677777665 6999999999886443
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCcEEEcCCCcEEEE
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG--------LGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~--------~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
..+|||++|.+.|||+|||.+ ..+..+..++++..++.||++||- -.|.|||||..||||.+++.+-|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 368999999999999999986 469999999999999999999994 249999999999999999999999
Q ss_pred cccCeeeeecCC-----CccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTE-----GMTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~-----~~~~~~gt~~y~AP 306 (306)
|+|||-.+.... ..++.+||.+||||
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAP 389 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAP 389 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccCh
Confidence 999997654432 35677999999999
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=226.41 Aligned_cols=161 Identities=25% Similarity=0.374 Sum_probs=133.8
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|++ +++.||||+++....... ...+.+..|..++.. +.||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc---chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 4699999999999988 567899999975432111 112345677777775 5899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~ 296 (306)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+|||+++++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 78 LNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 9999999999753 4588999999999999999999999999999999999999999999999999975322 222344
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (316)
T cd05619 156 FCGTPDYIAP 165 (316)
T ss_pred ecCCccccCH
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=217.96 Aligned_cols=166 Identities=28% Similarity=0.524 Sum_probs=140.1
Q ss_pred eccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
+.++|++.+.||+|+||.||++++ .+..+|+|.++..... ...+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc-------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 457788899999999999999988 4568999988654332 24688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999999999987543 35889999999999999999999999999999999999999999999999998754322
Q ss_pred CCc--cCCCCCCcccCC
Q 021897 292 EGM--TPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~--~~~~gt~~y~AP 306 (306)
... ....++..|+||
T Consensus 154 ~~~~~~~~~~~~~y~aP 170 (256)
T cd05114 154 EYTSSSGAKFPVKWSPP 170 (256)
T ss_pred ceeccCCCCCchhhCCh
Confidence 211 122345678887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=218.27 Aligned_cols=164 Identities=30% Similarity=0.600 Sum_probs=141.4
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|++++.||+|+||.||++.. +++.+|+|++......... .....+|+.++++++||||+++++++......++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE----REENIREIKILRRLRHPNIVQILDVFQDDNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH----HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc----cchhhhhhhcccccccccccccccccccccccccc
Confidence 67889999999999999998 5668999999875433222 22345699999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee-ecCCC
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE-VQTEG 293 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~-~~~~~ 293 (306)
||++++++|.+++... ..+++..++.++.|++.||++||+.+++|+||||+||+++.++.++|+|||.+... .....
T Consensus 77 ~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999843 45899999999999999999999999999999999999999999999999999753 23333
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....+|+.|+||
T Consensus 155 ~~~~~~~~~y~aP 167 (260)
T PF00069_consen 155 FNPFVGTPEYMAP 167 (260)
T ss_dssp BSSSSSSGGGSCH
T ss_pred ccccccccccccc
Confidence 4556789999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=222.50 Aligned_cols=166 Identities=25% Similarity=0.397 Sum_probs=140.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|.+.+.||+|+||.||+|+. +++.||+|.++....... ...+.+|+.++++++||||+++++++..+...
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence 36788899999999999999987 677899999875433221 13567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||+++ +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred EEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 999999975 888888654 345788999999999999999999999999999999999999999999999999754322
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......+|+.|+||
T Consensus 158 ~~~~~~~~~~~~y~aP 173 (309)
T cd07872 158 TKTYSNEVVTLWYRPP 173 (309)
T ss_pred ccccccccccccccCC
Confidence 2 22344688999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=218.07 Aligned_cols=169 Identities=33% Similarity=0.562 Sum_probs=142.2
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
|.++..+|++.++||+|+||.||+|++ ....||+|.++..... .+.+.+|+.+++.++||||+++++.+.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~-------~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-------PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC-------HHHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 677888999999999999999999988 3457999998753332 1468899999999999999999998754
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
...++||||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|||+++..
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence 45799999999999999998654556889999999999999999999999999999999999999999999999999865
Q ss_pred ecCCCc--cCCCCCCcccCC
Q 021897 289 VQTEGM--TPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~--~~~~gt~~y~AP 306 (306)
...... ....++..|+||
T Consensus 153 ~~~~~~~~~~~~~~~~y~~P 172 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAP 172 (262)
T ss_pred cccccccccCCcccceecCH
Confidence 433221 122356779988
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=227.19 Aligned_cols=159 Identities=22% Similarity=0.325 Sum_probs=131.7
Q ss_pred eeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEeCCeEEEEEee
Q 021897 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 143 lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
||+|+||.||+|+. +++.||||++........ .....+..|..++..+ .||+|+++++++.....+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK---KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh---hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 68999999999987 678999999864322111 1123455667776655 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~ 296 (306)
+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... ......
T Consensus 78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 78 MSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 9999999998753 4689999999999999999999999999999999999999999999999999875322 222345
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~gt~~y~aP 165 (330)
T cd05586 156 FCGTTEYLAP 165 (330)
T ss_pred ccCCccccCH
Confidence 6799999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=219.22 Aligned_cols=172 Identities=27% Similarity=0.498 Sum_probs=141.8
Q ss_pred ceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
|.+..++|++.+.||+|+||.||+|.+. +..||||+++...... ...++.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence 6778889999999999999999999763 3579999886433221 124688999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 021897 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~ 274 (306)
+++.+....++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+++||||||+||+++++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC
Confidence 999998999999999999999999975321 235678889999999999999999999999999999999999
Q ss_pred CcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 275 ~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+.+||+|||+++....... .....+++.|+||
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcCh
Confidence 9999999999875432211 1123457789998
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=225.62 Aligned_cols=161 Identities=27% Similarity=0.376 Sum_probs=135.5
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|.+ +++.||||+++....... .....+.+|..+++.+ +||||+++++++.....+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD---DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 4699999999999988 567999999975432111 1234677888898887 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-CCCccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~-~~~~~~ 296 (306)
+++++|..++... ..+++..+..++.|++.||+|||+.+++||||||+|||+++++.+||+|||+++.... ......
T Consensus 78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 78 VNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 9999999988754 4689999999999999999999999999999999999999999999999999975322 222334
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
.+||+.|+||
T Consensus 156 ~~g~~~y~aP 165 (318)
T cd05570 156 FCGTPDYIAP 165 (318)
T ss_pred eecCccccCH
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=235.25 Aligned_cols=170 Identities=26% Similarity=0.388 Sum_probs=143.0
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 209 (306)
..++|++.+.||+|+||.||+|++ +++.||||++......... ...+.+|+.++..++|+||++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~----~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD----KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 447899999999999999999987 7889999999765543322 356789999999999999999988775432
Q ss_pred -------eEEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 210 -------VWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 210 -------~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
.+++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence 378999999999999999753 23568999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecC---CCccCCCCCCcccCC
Q 021897 281 DFGVARIEVQT---EGMTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~---~~~~~~~gt~~y~AP 306 (306)
|||+++..... ......+||+.|+||
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP 214 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAP 214 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCH
Confidence 99999864322 122345799999998
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=219.02 Aligned_cols=164 Identities=29% Similarity=0.590 Sum_probs=134.7
Q ss_pred eecceeeeeccEEEEEEEEC------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 138 NMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.+.+.||.|+||.||+|++. +..|+||+++.... .. ..+.+.+|++++++++||||++++|++......
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-~~----~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-EE----EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-HH----HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc-cc----cceeeeecccccccccccccccccccccccccc
Confidence 45689999999999999987 57899999954222 11 146889999999999999999999999988889
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++|+||+++|+|.+++.......+++..++.++.||+.||.|||+++++|+||+++|||++.++.+||+|||+++.....
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999875567999999999999999999999999999999999999999999999999999865221
Q ss_pred CC---ccCCCCCCcccCC
Q 021897 292 EG---MTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~---~~~~~gt~~y~AP 306 (306)
.. .........|+||
T Consensus 157 ~~~~~~~~~~~~~~~~aP 174 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAP 174 (259)
T ss_dssp SSEEESTTSESGGGGS-H
T ss_pred cccccccccccccccccc
Confidence 11 1223466788887
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=219.36 Aligned_cols=172 Identities=28% Similarity=0.488 Sum_probs=144.3
Q ss_pred ceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
|+++.++|++.+.||+|+||.||+|.+. +..||+|.+....... ....+.+|+.+++.+.||||++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-----ERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH-----HHHHHHHHHHHHHhCCCCceeEEE
Confidence 7788899999999999999999999863 2579999986443221 124688999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 021897 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~ 274 (306)
+++......++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+++||||||+||+++++
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~ 155 (277)
T cd05032 76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED 155 (277)
T ss_pred EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC
Confidence 99999999999999999999999997532 1246788999999999999999999999999999999999999
Q ss_pred CcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 275 ~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+.+||+|||+++....... .....++..|+||
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCH
Confidence 9999999999975433221 2233567889988
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=219.35 Aligned_cols=166 Identities=28% Similarity=0.466 Sum_probs=136.0
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEe---
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK--- 207 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 207 (306)
+|++.+.||+|+||.||+|.. +++.||+|.++......... ..+.+|+.+++.+ .||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP----LSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc----hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 467889999999999999987 67899999987543322111 2344666666554 79999999999864
Q ss_pred --CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 208 --~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
...++++|||+++ +|.+++.......+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 3458999999974 8999987655556899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+............||+.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aP 176 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAP 176 (288)
T ss_pred ccccCcccCCCccccccccCc
Confidence 876544444556789999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=224.35 Aligned_cols=167 Identities=24% Similarity=0.482 Sum_probs=137.5
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
...+|+..+.||+|+||.||+|++ +++ .||+|+++..... ...+++.+|+.+++.++||||++++++|.
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----KANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 456788999999999999999987 343 4899998643221 12357889999999999999999999997
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
... .++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~-~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 80 TST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred CCC-ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence 754 679999999999999998643 458889999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCc---cCCCCCCcccCC
Q 021897 287 IEVQTEGM---TPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~---~~~~gt~~y~AP 306 (306)
........ ....++..|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~ap 180 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMAL 180 (316)
T ss_pred cccCCCcceeccCCccceeecCh
Confidence 65433221 112345779988
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=228.08 Aligned_cols=164 Identities=26% Similarity=0.371 Sum_probs=138.5
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 208 (306)
.++|++.+.||+|+||.||++.. .++.||||++........ ..+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH----HHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 46888999999999999999976 678999999876543322 235677999999999999999999998643
Q ss_pred ---CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
..+|+||||+++ +|.+.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999965 77777643 3788899999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+............||+.|+||
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aP 187 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAP 187 (355)
T ss_pred ccCCCccccCCccccCCccCH
Confidence 876544444556899999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=215.71 Aligned_cols=169 Identities=34% Similarity=0.582 Sum_probs=143.5
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
|+++.++|++.+.||+|+||.||+|.+ .+..+|+|.+....... +.+.+|+.++++++|++++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-------ESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH-------HHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 778888999999999999999999987 55689999987644432 468899999999999999999998854
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
...+++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|||++...
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 45789999999999999998655566899999999999999999999999999999999999999999999999999865
Q ss_pred ecCCCc--cCCCCCCcccCC
Q 021897 289 VQTEGM--TPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~--~~~~gt~~y~AP 306 (306)
...... ....++..|+||
T Consensus 153 ~~~~~~~~~~~~~~~~y~aP 172 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAP 172 (260)
T ss_pred cCcccccccCCCCCccccCh
Confidence 432211 122345679988
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=229.58 Aligned_cols=158 Identities=24% Similarity=0.419 Sum_probs=137.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
..|++.+.||+|+||.||+|++ +++.||+|+.... ....|+.++++++||||+++++++......+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 5688999999999999999998 5568999975321 2347899999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+|||++. ++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 134 lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9999995 5899888754 3568999999999999999999999999999999999999999999999999998644433
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......||+.|+||
T Consensus 212 ~~~~~~gt~~y~aP 225 (357)
T PHA03209 212 AFLGLAGTVETNAP 225 (357)
T ss_pred ccccccccccccCC
Confidence 44456799999998
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=216.61 Aligned_cols=166 Identities=31% Similarity=0.550 Sum_probs=140.2
Q ss_pred eccCceecceeeeeccEEEEEEEECC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
+.++|++.+.||+|+||.||+|.+.+ ..+|||.++..... ...+.+|+.++++++||||+++++++.....+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc-------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 45778899999999999999998854 46999998754332 24688999999999999999999999988889
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+++|+||||+||+++.++.+||+|||+++.....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999999999999997643 36899999999999999999999999999999999999999999999999998854332
Q ss_pred CCc--cCCCCCCcccCC
Q 021897 292 EGM--TPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~--~~~~gt~~y~AP 306 (306)
... ....++..|+||
T Consensus 154 ~~~~~~~~~~~~~y~~p 170 (256)
T cd05113 154 EYTSSVGSKFPVRWSPP 170 (256)
T ss_pred ceeecCCCccChhhCCH
Confidence 211 112345678887
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=227.21 Aligned_cols=173 Identities=29% Similarity=0.579 Sum_probs=140.8
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeee
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 200 (306)
+|.++.++|++++.||+|+||.||+|.+ .++.||||+++....... ...+.+|+.++.++ +||||++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~h~niv~ 75 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----HRALMSELKILIHIGHHLNVVN 75 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH-----HHHHHHHHHHHHhccCCccHhh
Confidence 4888889999999999999999999974 457899999975432211 35688999999999 6899999
Q ss_pred EEEEEEeC-CeEEEEEeecCCCCHHHHHHhhCC-----------------------------------------------
Q 021897 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQN----------------------------------------------- 232 (306)
Q Consensus 201 l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~~----------------------------------------------- 232 (306)
+++++... ..+++||||+++|+|.+++.....
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (343)
T cd05103 76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE 155 (343)
T ss_pred hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence 99988654 567999999999999999875321
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC-
Q 021897 233 ------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG- 293 (306)
Q Consensus 233 ------------------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~- 293 (306)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 2367788899999999999999999999999999999999999999999999975432211
Q ss_pred --ccCCCCCCcccCC
Q 021897 294 --MTPETGTYRWMAP 306 (306)
Q Consensus 294 --~~~~~gt~~y~AP 306 (306)
.....+++.|+||
T Consensus 236 ~~~~~~~~~~~y~aP 250 (343)
T cd05103 236 VRKGDARLPLKWMAP 250 (343)
T ss_pred hhcCCCCCCcceECc
Confidence 1112345779988
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=212.43 Aligned_cols=166 Identities=25% Similarity=0.431 Sum_probs=143.3
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||++.+ +++.+|+|.++...... ..+.+.+|+.+++.++||||+++++.+.....+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS-----AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 467889999999999999987 67899999987543221 13567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
+|||+++++|.+++.......+++..++.++.|++.||+|||+++++|+||||+||++++++.++|+|||+++.......
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999999998765566789999999999999999999999999999999999999999999999999986543222
Q ss_pred -ccCCCCCCcccCC
Q 021897 294 -MTPETGTYRWMAP 306 (306)
Q Consensus 294 -~~~~~gt~~y~AP 306 (306)
.....|++.|+||
T Consensus 156 ~~~~~~~~~~~~aP 169 (255)
T cd08219 156 YACTYVGTPYYVPP 169 (255)
T ss_pred ccccccCCccccCH
Confidence 2335688899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=227.23 Aligned_cols=173 Identities=30% Similarity=0.580 Sum_probs=142.1
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeee
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVR 200 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 200 (306)
+|.++.++|++.+.||+|+||.||+|.+ +++.||+|+++...... ..+.+.+|+.+++++ .|+||++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~E~~~~~~l~~h~niv~ 75 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-----EYKALMTELKILIHIGHHLNVVN 75 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-----HHHHHHHHHHHHHhhccCcchhh
Confidence 5889999999999999999999999964 23689999986533221 135678899999999 7999999
Q ss_pred EEEEEEeC-CeEEEEEeecCCCCHHHHHHhhCC-----------------------------------------------
Q 021897 201 FIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQN----------------------------------------------- 232 (306)
Q Consensus 201 l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~~----------------------------------------------- 232 (306)
++++|... ..++++|||+++++|.+++.....
T Consensus 76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (337)
T cd05054 76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155 (337)
T ss_pred eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence 99988654 578999999999999999864321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCC
Q 021897 233 ------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPE 297 (306)
Q Consensus 233 ------------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~ 297 (306)
..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCC
Confidence 2578899999999999999999999999999999999999999999999999986432221 1223
Q ss_pred CCCCcccCC
Q 021897 298 TGTYRWMAP 306 (306)
Q Consensus 298 ~gt~~y~AP 306 (306)
.+++.|+||
T Consensus 236 ~~~~~y~aP 244 (337)
T cd05054 236 RLPLKWMAP 244 (337)
T ss_pred CCCccccCc
Confidence 456789998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=215.82 Aligned_cols=169 Identities=31% Similarity=0.561 Sum_probs=144.5
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
|+|..++|++.++||+|+||.||+|.. +++.+|+|.+....... .++.+|+.++++++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-------EAFLAEANLMKQLQHPRLVRLYAVVTQ- 72 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH-------HHHHHHHHHHHhcCCcCeeeEEEEEcc-
Confidence 778889999999999999999999987 67899999987544432 468899999999999999999998754
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
...+++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||++++++.++|+|||++...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 46799999999999999998765667899999999999999999999999999999999999999999999999999765
Q ss_pred ecCCCc--cCCCCCCcccCC
Q 021897 289 VQTEGM--TPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~--~~~~gt~~y~AP 306 (306)
...... ....+++.|+||
T Consensus 153 ~~~~~~~~~~~~~~~~y~~p 172 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAP 172 (260)
T ss_pred CCCCcccccCCcccccccCH
Confidence 422211 122456778887
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=220.38 Aligned_cols=175 Identities=32% Similarity=0.551 Sum_probs=144.6
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCC
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (306)
...|++...+|.+++.||+|+||.||++.+. ...+|+|.++...... ....+.+|+.+++.+ +||
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~h~ 84 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-----DLSDLISEMEMMKMIGKHK 84 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH-----HHHHHHHHHHHHHHhcCCC
Confidence 4568888999999999999999999999762 2469999987542211 125688899999999 799
Q ss_pred CeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021897 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (306)
Q Consensus 197 niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHr 262 (306)
||+++++++......|+||||+++++|.+++..... ..+++..++.++.|++.||+|||+.|++||
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred CEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999999999999999999999999999976421 347889999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
||||+||++++++.+||+|||+++....... .....+++.|+||
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 211 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 211 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence 9999999999999999999999975432211 1112345789998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=215.07 Aligned_cols=170 Identities=33% Similarity=0.584 Sum_probs=145.7
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
|+++.++|.+.+.||+|+||.||+|.. .++.+|||.+....... +++.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-------EAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCH-------HHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 778899999999999999999999987 45689999987544332 4688999999999999999999999988
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+++||||+++++|.+++.......+++..++.++.|++.||+|||+.+++|+||||+||++++++.+||+|||+++..
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 88999999999999999998765567899999999999999999999999999999999999999999999999999765
Q ss_pred ecCCC--ccCCCCCCcccCC
Q 021897 289 VQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~--~~~~~gt~~y~AP 306 (306)
..... .....++..|+||
T Consensus 154 ~~~~~~~~~~~~~~~~y~~P 173 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAP 173 (261)
T ss_pred cchhhhhhhccCCCccccCH
Confidence 42211 1112244678887
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=218.43 Aligned_cols=172 Identities=28% Similarity=0.498 Sum_probs=141.0
Q ss_pred ceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
|+++..+|++.+.||+|+||.||+|... +..||+|.+........ ...+.+|+.+++.+.||||++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-----RIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHH-----HHHHHHHHHHHHhCCCCCeeeEE
Confidence 7888999999999999999999999652 34799998764332211 24678999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 021897 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~ 274 (306)
+++......++||||+++|+|.+++..... .......++.++.|++.||.|||+++++||||||+|||++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~ 155 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD 155 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence 999998899999999999999999975321 234567788999999999999999999999999999999999
Q ss_pred CcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 275 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 275 ~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+.+||+|||+++....... .....++..|+||
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p 190 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCH
Confidence 9999999999975432211 1112346778887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=218.83 Aligned_cols=170 Identities=33% Similarity=0.605 Sum_probs=141.9
Q ss_pred eeccCceecceeeeeccEEEEEEEECC-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
++.++|++.+.||+|+||.||+|...+ ..||+|.++..... .....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-----HHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 456788999999999999999998632 46999988644321 123578899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NIL 270 (306)
+......+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.+++||||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 156 (283)
T cd05048 77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL 156 (283)
T ss_pred EcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence 9998899999999999999999976421 45788899999999999999999999999999999999
Q ss_pred EcCCCcEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 271 ISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 271 v~~~~~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
+++++.+||+|||+++...... ......+++.|+||
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP 195 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCH
Confidence 9999999999999998543222 12233567889998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=218.40 Aligned_cols=165 Identities=27% Similarity=0.424 Sum_probs=143.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||++.+ +++.+|+|++....... ....+.+.+|+++++++.||||+++++++.....+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK---LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEE
Confidence 3678889999999999999987 67899999987543221 112357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+|+.++.+||+|||+++.....
T Consensus 78 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999999764 46899999999999999999999999999999999999999999999999999865443
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
....+|++.|+||
T Consensus 155 -~~~~~~~~~y~aP 167 (290)
T cd05580 155 -TYTLCGTPEYLAP 167 (290)
T ss_pred -CCCCCCCccccCh
Confidence 3445789999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=214.00 Aligned_cols=165 Identities=30% Similarity=0.492 Sum_probs=142.4
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
..+|++.+.||+|+||.||+|+. +++.||+|++....... ...+.+|+.++++++||||+++++.+.....+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD------FSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 46788999999999999999987 67899999987543221 23577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999999999998753 45899999999999999999999999999999999999999999999999999865322
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......|++.|+||
T Consensus 160 ~~~~~~~~~~~~y~~P 175 (267)
T cd06646 160 IAKRKSFIGTPYWMAP 175 (267)
T ss_pred ccccCccccCccccCH
Confidence 2 22345688999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=211.82 Aligned_cols=167 Identities=25% Similarity=0.419 Sum_probs=144.3
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|.+.+.||+|++|.||+|++ +++.|++|.+........ ..+.+.+|+.+++.++||||+++++.+.....+|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR----EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH----HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEE
Confidence 366778999999999999987 678999999875433322 23578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
||||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||||+||+++.++.+||+|||+++.......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999999999876556789999999999999999999999999999999999999999999999999986543322
Q ss_pred -ccCCCCCCcccCC
Q 021897 294 -MTPETGTYRWMAP 306 (306)
Q Consensus 294 -~~~~~gt~~y~AP 306 (306)
.....|++.|+||
T Consensus 157 ~~~~~~~~~~y~aP 170 (256)
T cd08529 157 FANTIVGTPYYLSP 170 (256)
T ss_pred hhhccccCccccCH
Confidence 2334688999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=219.40 Aligned_cols=174 Identities=32% Similarity=0.572 Sum_probs=144.1
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE---------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY---------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (306)
..|++...+|.+++.||+|+||.||+|++ ++..||+|.+....... ..+.+.+|+.+++.+ +|||
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-----DLSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchH-----HHHHHHHHHHHHHhhccCCC
Confidence 35788889999999999999999999975 23469999886432211 135788999999999 7999
Q ss_pred eeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021897 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (306)
Q Consensus 198 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrD 263 (306)
|+++++.+......|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++|||
T Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d 162 (304)
T cd05101 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162 (304)
T ss_pred chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 9999999999999999999999999999997642 13477888999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 264 lkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|||+|||++.++.+||+|||+++....... .....+++.|+||
T Consensus 163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP 208 (304)
T cd05101 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP 208 (304)
T ss_pred cccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence 999999999999999999999986532211 1223456789998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=217.78 Aligned_cols=171 Identities=32% Similarity=0.561 Sum_probs=145.9
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
|+....+|++++.||.|+||.||+|.+ .++.+|+|++....... ...+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK------QQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh------HHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 455667899999999999999999988 56789999986543311 24688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+++||||+++++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999999999999998766667899999999999999999999999999999999999999999999999999765
Q ss_pred ecCCC-ccCCCCCCcccCC
Q 021897 289 VQTEG-MTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~-~~~~~gt~~y~AP 306 (306)
..... .....+++.|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~~P 173 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAP 173 (261)
T ss_pred CCccccccCCCCceEecCH
Confidence 33221 1223456778887
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=217.50 Aligned_cols=170 Identities=31% Similarity=0.519 Sum_probs=140.3
Q ss_pred eeccCceecceeeeeccEEEEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
++++++++.+.||+|+||.||+|++ .+..+|+|.++..... .....+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-----QQWGEFQQEASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-----HHHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence 4567888999999999999999975 3468999998643321 1235788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ---------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NIL 270 (306)
......|+||||+++++|.+++.... ...+++..++.++.|++.||+|||+++++||||||+|||
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil 156 (283)
T cd05090 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL 156 (283)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence 99999999999999999999986432 134788889999999999999999999999999999999
Q ss_pred EcCCCcEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 271 ISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 271 v~~~~~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
+++++.+||+|||+++...... ......++..|+||
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecCh
Confidence 9999999999999997543221 12233456779887
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=214.47 Aligned_cols=166 Identities=30% Similarity=0.537 Sum_probs=139.6
Q ss_pred eccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
+..+|++.+.||+|+||.||++.+ .+..+|+|++....... ..+.+|+.+++.++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-------DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH-------HHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 456788899999999999999988 44589999986543322 3678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++...+.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999999999999997643 36899999999999999999999999999999999999999999999999999865432
Q ss_pred CCc--cCCCCCCcccCC
Q 021897 292 EGM--TPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~--~~~~gt~~y~AP 306 (306)
... ....++..|+||
T Consensus 154 ~~~~~~~~~~~~~y~~P 170 (256)
T cd05059 154 QYTSSQGTKFPVKWAPP 170 (256)
T ss_pred cccccCCCCCCccccCH
Confidence 211 111234578887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=244.06 Aligned_cols=176 Identities=24% Similarity=0.345 Sum_probs=145.6
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
++.......+|++++.||+|+||.||+|++ .+..+|+|++........ ....+.+|+.++++|+|||||+++++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~----~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER----EKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH----HHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 344556678999999999999999999988 667899999876544322 23578899999999999999999998
Q ss_pred EEe--CCeEEEEEeecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCcEEEcC
Q 021897 205 CRK--RMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGL-------GFIHRDLKSDNLLISA 273 (306)
Q Consensus 205 ~~~--~~~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~-------~iiHrDlkp~NILv~~ 273 (306)
|.. ...+||||||+++++|.++|.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 854 457899999999999999997532 34689999999999999999999984 4999999999999964
Q ss_pred -----------------CCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 274 -----------------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 274 -----------------~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
.+.+||+|||+++...........+||+.|+||
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAP 210 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSP 210 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCH
Confidence 235899999999865444334455799999998
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=219.51 Aligned_cols=174 Identities=31% Similarity=0.533 Sum_probs=145.8
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCee
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 199 (306)
.+|.+..++|.+.+.||+|+||.||++++ .+..+|||.++...... ..+.+.+|+.+++++ +||||+
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv 102 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-----EREALMSELKIMSHLGNHENIV 102 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH-----HHHHHHHHHHHHHhccCCCCcc
Confidence 45778888999999999999999999975 23479999886543221 135788999999999 799999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 021897 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl 279 (306)
++++.+......|+||||+++++|.+++.......+++..++.++.|++.||+|||+.+++|+||||+|||++.++.+||
T Consensus 103 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred eEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEE
Confidence 99999999999999999999999999998654455899999999999999999999999999999999999999999999
Q ss_pred EcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+|||+++....... .....+++.|+||
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 212 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAP 212 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCH
Confidence 99999985432221 1122456789988
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=213.56 Aligned_cols=169 Identities=25% Similarity=0.416 Sum_probs=143.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++.+.||+|+||.||+|+. +++.||||.++........ ....+.+|+.+++.++||||+++++.+......+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK---ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHH---HHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEE
Confidence 5678889999999999999987 7789999988654332222 2357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+++||+++++|.+++... ....+++..++.++.|++.||+|||+++++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999999988642 234578899999999999999999999999999999999999999999999999886543
Q ss_pred CCC-ccCCCCCCcccCC
Q 021897 291 TEG-MTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~-~~~~~gt~~y~AP 306 (306)
... .....|++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~aP 175 (267)
T cd08228 159 KTTAAHSLVGTPYYMSP 175 (267)
T ss_pred hhHHHhcCCCCccccCh
Confidence 221 2234688899998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=214.63 Aligned_cols=168 Identities=30% Similarity=0.514 Sum_probs=140.6
Q ss_pred eccCceecceeeeeccEEEEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
+.++|++.+.||+|+||.||+|.+. ...||||+++...... ....|.+|+.++++++||||+++++.+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-----QRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH-----HHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 4567889999999999999999872 3479999886543222 13578899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
....+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+.+|+||||||+|||+++++.+||+|||+++.
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999999999997643 3689999999999999999999999999999999999999999999999999986
Q ss_pred eecCC-Ccc--CCCCCCcccCC
Q 021897 288 EVQTE-GMT--PETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~-~~~--~~~gt~~y~AP 306 (306)
..... ... ...+++.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~P 177 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAP 177 (266)
T ss_pred ccccccceeccCCCCCccccCh
Confidence 54211 111 12345778887
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=226.97 Aligned_cols=164 Identities=28% Similarity=0.434 Sum_probs=137.7
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 209 (306)
+|++++.||+|+||.||++.. +++.||||.+........ ..+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 76 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV----SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF 76 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH----HHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence 467789999999999999986 788999999864332211 2356889999999999999999999998776
Q ss_pred -eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||+|+..
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 77 EEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred ceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 7899999996 588888754 346899999999999999999999999999999999999999999999999999865
Q ss_pred ecCC--CccCCCCCCcccCC
Q 021897 289 VQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~--~~~~~~gt~~y~AP 306 (306)
.... ......+|+.|+||
T Consensus 154 ~~~~~~~~~~~~~~~~y~aP 173 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAP 173 (372)
T ss_pred ccCccccCCCCCcCCCcCCH
Confidence 4322 22344688999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=213.89 Aligned_cols=169 Identities=34% Similarity=0.575 Sum_probs=141.4
Q ss_pred ceeeccCceecceeeeeccEEEEEEEECC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
|++...+|++.+.||+|++|.||+|++.+ ..+|+|.+...... .+.+.+|+.++++++|||++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-------PEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc-------HHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 66777889999999999999999998843 57999987654322 2468899999999999999999998864
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
...+++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++|+||||+||++++++.+||+|||+++..
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 45789999999999999998755556889999999999999999999999999999999999999999999999999865
Q ss_pred ecCCCc--cCCCCCCcccCC
Q 021897 289 VQTEGM--TPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~--~~~~gt~~y~AP 306 (306)
...... ....++..|+||
T Consensus 153 ~~~~~~~~~~~~~~~~y~~P 172 (260)
T cd05069 153 EDNEYTARQGAKFPIKWTAP 172 (260)
T ss_pred cCCcccccCCCccchhhCCH
Confidence 432211 122356778887
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=219.84 Aligned_cols=166 Identities=26% Similarity=0.408 Sum_probs=144.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++-+.||+|+|+.|+++.+ +|+.+|+|++......... .+++.+|++|.+.|+|||||++.+...+....|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~----~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcccc----HHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 5677788999999999999976 8899999998765554432 367889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEcccCeeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEV 289 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~~~vkl~DFGla~~~~ 289 (306)
||+|+|+|++|..-+-.+ ...++..+-..++||+++|.|+|.++|||||+||.|+|+.. ..-+||+|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999987666544 34788889999999999999999999999999999999953 3469999999999877
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.....-.++|||.||||
T Consensus 165 ~g~~~~G~~GtP~fmaP 181 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSP 181 (355)
T ss_pred CccccccccCCCcccCH
Confidence 66667778999999998
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=225.99 Aligned_cols=164 Identities=27% Similarity=0.374 Sum_probs=138.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 208 (306)
.++|++.+.||+|+||.||++.. .++.||||++......... .+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh----HHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 46788999999999999999987 6789999998754432221 25677999999999999999999987543
Q ss_pred ---CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
..+|+||||+++ +|.+.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999965 78777753 3788889999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+............||+.|+||
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aP 194 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAP 194 (364)
T ss_pred cccCCCCcccCCcccCCcCCH
Confidence 876544444556899999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=240.73 Aligned_cols=163 Identities=28% Similarity=0.443 Sum_probs=139.5
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|.++..||.|+||+||+|.. ++-..|.|++..... ...++++-|+.||..+.||+||++|+.+...+.+||+
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse------EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE------EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch------hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 34567899999999999976 344567888754322 2346899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee-eecCCC
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-EVQTEG 293 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~-~~~~~~ 293 (306)
.|||.||-...++-.. ++.+.+..+.-+++|+|.||.|||+.+|||||||+.|||++-+|.++|+|||++.. ......
T Consensus 108 iEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 9999999998887764 46799999999999999999999999999999999999999999999999998653 333334
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
..++.|||+||||
T Consensus 187 RDsFIGTPYWMAP 199 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAP 199 (1187)
T ss_pred hccccCCcccccc
Confidence 5678899999999
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-28 Score=212.52 Aligned_cols=169 Identities=33% Similarity=0.570 Sum_probs=143.1
Q ss_pred CceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
+|+.++.||+|+||.||+|.. +++.+|+|.++.............+.+.+|+.++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467789999999999999987 7788999998765443333333446789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec----
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ---- 290 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~---- 290 (306)
+||+++++|.+++.+. ..+++..++.++.|++.||+|||+.+++|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999999754 3588999999999999999999999999999999999999999999999999874321
Q ss_pred ---CCCccCCCCCCcccCC
Q 021897 291 ---TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ---~~~~~~~~gt~~y~AP 306 (306)
........|++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~p 177 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAP 177 (265)
T ss_pred ccccccccccCCCccccCh
Confidence 1112334688899988
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=210.39 Aligned_cols=167 Identities=22% Similarity=0.368 Sum_probs=144.1
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|+..+.||.|+||.||.++. +++.+++|.+......... .+++.+|+.++++++|+||+++++++.+...+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE----RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH----HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEE
Confidence 477889999999999988876 6789999998755433322 3568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
+|||+++++|.+++.+.....+++..+..++.|++.||+|||+.+++|+||+|+||++++++.+||+|||+++......
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999999987655668999999999999999999999999999999999999999999999999998654332
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......|++.|+||
T Consensus 157 ~~~~~~~~~~y~ap 170 (256)
T cd08221 157 MAETVVGTPYYMSP 170 (256)
T ss_pred cccccCCCccccCH
Confidence 23345688999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=240.48 Aligned_cols=168 Identities=32% Similarity=0.452 Sum_probs=144.3
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++.++||+|+||.||+|.+ +++.||||+++....... .....+.+|+.+++.++||||+++++++.....+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK---NMVHQVQAERDALALSKSPFIVHLYYSLQSANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCH---HHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence 46788899999999999999998 488999999976443222 2235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
||||||+++++|.+++... ..+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+++.....
T Consensus 80 ~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 9999999999999999754 45888999999999999999999999999999999999999999999999999865433
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......+|+.|+||
T Consensus 158 ~~~~~~~~~t~~~~~p 173 (669)
T cd05610 158 ELNMMDILTTPSMAKP 173 (669)
T ss_pred cccccccccCccccCc
Confidence 2 23345688888877
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=211.18 Aligned_cols=169 Identities=30% Similarity=0.506 Sum_probs=142.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|++|.||++.. +++++|+|.+......... ....+.+.+|+.++++++||||+++++++.....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET-KKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 4577889999999999999976 6789999998755433221 222357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+|+||+++++|.+++... ..+++..++.++.|++.||.|||+.+++||||+|+||++++++.+||+|||+++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 999999999999998764 458899999999999999999999999999999999999999999999999997543211
Q ss_pred C----ccCCCCCCcccCC
Q 021897 293 G----MTPETGTYRWMAP 306 (306)
Q Consensus 293 ~----~~~~~gt~~y~AP 306 (306)
. .....|+..|+||
T Consensus 159 ~~~~~~~~~~~~~~y~aP 176 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSP 176 (263)
T ss_pred cccccccCCCcCccccCc
Confidence 1 1334678899998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=224.37 Aligned_cols=162 Identities=28% Similarity=0.465 Sum_probs=143.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
-|.++.+||+|++|.||+|.+ .|+.+|||.+..... .+++..|+.+|++++.|+||++||.+.....+||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--------HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 356778999999999999976 889999998754322 4689999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
|||||-.|+..++++.+ ++++.+..+..++.+.+.||+|||...-||||||+.|||++-+|..||+|||+|....+.-
T Consensus 106 VMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred ehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 99999999999999865 5789999999999999999999999999999999999999999999999999998654433
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
..++..|||.||||
T Consensus 185 KRNTVIGTPFWMAP 198 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAP 198 (502)
T ss_pred hhCccccCcccccH
Confidence 24556799999998
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=215.27 Aligned_cols=160 Identities=28% Similarity=0.477 Sum_probs=129.5
Q ss_pred eeeeeccEEEEEEEE-C---CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 142 AFAQGAFGKLYRGTY-N---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
.||+|+||.||+|+. . ...+|+|.+...... .....+.+|+.+++.++||||+++++.+......++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP-----DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh-----HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 589999999999975 3 346788876543221 1235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC--
Q 021897 218 AKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-- 292 (306)
+++|+|.+++..... ...++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999999976432 234678889999999999999999999999999999999999999999999987532211
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 157 ~~~~~~~~~~~y~aP 171 (269)
T cd05042 157 ITKDCHAVPLRWLAP 171 (269)
T ss_pred eccCCCCCcccccCH
Confidence 11223456779887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=214.22 Aligned_cols=166 Identities=33% Similarity=0.617 Sum_probs=141.7
Q ss_pred ceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
|-+...+|++.+.||+|+||.||++...++.+|+|.++.... .+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--------AQAFLEETAVMTKLHHKNLVRLLGVILHNG 72 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch--------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 556678899999999999999999999999999999864321 246889999999999999999999987654
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.++||||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus 73 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred -cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecc
Confidence 6999999999999999987655568999999999999999999999999999999999999999999999999997543
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.. ......+..|+||
T Consensus 152 ~~--~~~~~~~~~y~~p 166 (254)
T cd05083 152 MG--VDNSKLPVKWTAP 166 (254)
T ss_pred cc--CCCCCCCceecCH
Confidence 22 1222345678777
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=216.42 Aligned_cols=174 Identities=33% Similarity=0.574 Sum_probs=145.0
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCee
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 199 (306)
..|+++..+|++.+.||+|+||.||++.+. ...+|+|.+....... ....+.+|+.+++++ +||||+
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~ 79 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-----DLSDLVSEMEMMKMIGKHKNII 79 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-----HHHHHHHHHHHHHhhcCCCCee
Confidence 468889999999999999999999999863 2579999986533221 124688999999999 799999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021897 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRR--------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (306)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlk 265 (306)
++++++.....++++|||+++++|.+++... ....+++..++.++.|++.||+|||+.+++|||||
T Consensus 80 ~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 159 (293)
T cd05053 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159 (293)
T ss_pred eEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 9999999999999999999999999999752 23468889999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 266 p~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|+||+++.++.+||+|||+++....... .....+++.|+||
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 203 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP 203 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCH
Confidence 9999999999999999999986443221 1122345778888
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=252.69 Aligned_cols=174 Identities=23% Similarity=0.353 Sum_probs=150.2
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
.+......+|.+++.||+|+||.|..++. +++.+|+|++++..+-.... -..|..|-.+|.....+-|++++-+|
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~---tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAE---TACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchh---HHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 34456778999999999999999999987 67789999997644332111 14688999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
+++..+|+|||||+||+|..++.+.. .+|+++++.+++.|+.||.-||+.|+|||||||+|||+|..|++||+|||.|
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999999998764 6999999999999999999999999999999999999999999999999987
Q ss_pred eeee-cCC-CccCCCCCCcccCC
Q 021897 286 RIEV-QTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~-~~~-~~~~~~gt~~y~AP 306 (306)
-... ++. .....+|||.|++|
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISP 245 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISP 245 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCH
Confidence 5443 333 24556899999998
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-28 Score=214.34 Aligned_cols=159 Identities=26% Similarity=0.441 Sum_probs=137.5
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||+|.. +++.+|+|++....... ..+.+.+|+.+++++.||||+++++.+......++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-----LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH-----HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 567889999999999999986 67899999986543221 23578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
||||+++++|..+. .+++..+..++.|++.||.|||+.+++|+||||+|||++.++.+||+|||++...... .
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-c
Confidence 99999999996542 3788889999999999999999999999999999999999999999999999865432 2
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
....+||+.|+||
T Consensus 150 ~~~~~~~~~y~aP 162 (279)
T cd06619 150 AKTYVGTNAYMAP 162 (279)
T ss_pred ccCCCCChhhcCc
Confidence 3445799999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=212.69 Aligned_cols=169 Identities=31% Similarity=0.532 Sum_probs=143.7
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
|++...+|++.+.||+|+||.||++.+ .+..+|+|.++.... ..+.+.+|+.++++++|+||+++++.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-------SVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-------HHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 788899999999999999999999987 556899998864322 12578899999999999999999999887
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
...+++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 67899999999999999998755566888999999999999999999999999999999999999999999999999765
Q ss_pred ecCCCc--cCCCCCCcccCC
Q 021897 289 VQTEGM--TPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~--~~~~gt~~y~AP 306 (306)
...... ....++..|+||
T Consensus 153 ~~~~~~~~~~~~~~~~y~~P 172 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAP 172 (260)
T ss_pred cCCCcccccCCcccccccCH
Confidence 432211 122345678887
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=218.36 Aligned_cols=170 Identities=31% Similarity=0.525 Sum_probs=137.1
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCe--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (306)
+.+++|++.+.||+|+||.||+|.+ ++. .+|+|.++..... .....+.+|+.++.++ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-----DDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH-----HHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 4557888999999999999999987 444 4577766532211 1235788999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~ 272 (306)
....+|+||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 9999999999999999999997542 13578999999999999999999999999999999999999
Q ss_pred CCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 273 ~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+++.+||+|||+++............+++.|+||
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP 192 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 192 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCH
Confidence 9999999999998643221111222345678887
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=201.84 Aligned_cols=165 Identities=25% Similarity=0.427 Sum_probs=141.6
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|...++||+|.+|+||+|+. +++.||+|.++.......-. ...++|+.+++.++|.|||+++++...+..+-+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp----ssalreicllkelkhknivrl~dvlhsdkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP----SSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc----HHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence 455668999999999999976 67899999998766544322 356799999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
|+|||. .+|..+.... +..+..+.+..++.|+++||.++|++++.||||||.|+||+.+|.+||+|||+|+-+.-..
T Consensus 79 vfe~cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 79 VFEFCD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred eHHHhh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 999995 4899888765 4568999999999999999999999999999999999999999999999999999664332
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
-.+..+-|..|.+|
T Consensus 157 cysaevvtlwyrpp 170 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPP 170 (292)
T ss_pred eeeceeeeeeccCc
Confidence 34556778888887
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=224.44 Aligned_cols=161 Identities=24% Similarity=0.393 Sum_probs=136.7
Q ss_pred eeccCceecceeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
+...+|.+++.||+|+||.||++.. .+..||+|.+... +...+|+.++++++||||+++++++..
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----------~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----------KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----------ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 3346799999999999999999975 3467999987542 134589999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
...+|+|||++. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred CCEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 999999999995 689888843 35689999999999999999999999999999999999999999999999999975
Q ss_pred eecCCC---ccCCCCCCcccCC
Q 021897 288 EVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~---~~~~~gt~~y~AP 306 (306)
...... .....||+.|+||
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aP 256 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSP 256 (392)
T ss_pred cCcccccccccccccccCccCH
Confidence 433221 2234699999998
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=213.41 Aligned_cols=165 Identities=28% Similarity=0.486 Sum_probs=142.5
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++.+.||+|+||.||+|+. +++.||+|+++...... ...+.+|+.+++.++||||+++++.+.....+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED------FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 35788889999999999999987 67899999987543221 24577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999999999998754 46899999999999999999999999999999999999999999999999998754332
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......||+.|+||
T Consensus 160 ~~~~~~~~~~~~y~aP 175 (267)
T cd06645 160 IAKRKSFIGTPYWMAP 175 (267)
T ss_pred ccccccccCcccccCh
Confidence 2 22345789999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=226.57 Aligned_cols=162 Identities=34% Similarity=0.531 Sum_probs=139.3
Q ss_pred eccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh--CCCCCeeeEEEEEEeCC-
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKRM- 209 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~- 209 (306)
....+++.+.||+|.||.||+|.++++.||||++.... .+.|.+|-.|.+. ++|+||++|+++-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~---------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE---------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccCceeEEEecCHHH---------HHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 34677888999999999999999999999999985321 2467888888775 57999999999876544
Q ss_pred ---eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCccccCCCCCcEEEcCCCcE
Q 021897 210 ---VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG---------LGFIHRDLKSDNLLISADKSI 277 (306)
Q Consensus 210 ---~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---------~~iiHrDlkp~NILv~~~~~v 277 (306)
.++||+||.+.|+|.++|+. ..++|..+.+|+..+++||+|||+ ..|+|||||..||||-.|+++
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 78999999999999999986 458999999999999999999995 259999999999999999999
Q ss_pred EEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 278 KIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 278 kl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
.|+|||||.++..+.. ....+||.+||||
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAP 387 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAP 387 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCH
Confidence 9999999987764432 2346899999999
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-28 Score=218.07 Aligned_cols=175 Identities=31% Similarity=0.567 Sum_probs=143.8
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE---------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCC
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY---------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (306)
-.+|.++..+|.+++.||+|+||.||+++. ....+|+|.++...... ....+.+|+.+++++ .||
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~ 78 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-----DLADLISEMELMKLIGKHK 78 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChH-----HHHHHHHHHHHHHhccCCC
Confidence 356888889999999999999999999975 23468999886433221 135688999999999 599
Q ss_pred CeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021897 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (306)
Q Consensus 197 niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHr 262 (306)
||+++++++.....+|++|||+++|+|.+++.... ...+++..+..++.|++.||+|||++|++||
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 158 (314)
T cd05099 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR 158 (314)
T ss_pred CeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 99999999999889999999999999999997632 2347888999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
||||+|||++.++.+||+|||+++....... .....+++.|+||
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 205 (314)
T cd05099 159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP 205 (314)
T ss_pred cccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCH
Confidence 9999999999999999999999975432211 1112344679988
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=213.87 Aligned_cols=166 Identities=25% Similarity=0.388 Sum_probs=139.3
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|++|.||+|+. +++.||||.++....... ..+.+.+|+.+++++.||||+++++++..+..+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG----VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC----chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEE
Confidence 467789999999999999987 678999999865432221 12467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 214 VTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
||||++ ++|.+++.... ...+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 999997 58988887533 3568999999999999999999999999999999999999999999999999997543222
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 156 ~~~~~~~~~~~y~aP 170 (285)
T cd07861 156 RVYTHEVVTLWYRAP 170 (285)
T ss_pred ccccCCcccccccCh
Confidence 12334678899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=226.02 Aligned_cols=165 Identities=23% Similarity=0.434 Sum_probs=149.9
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|.+.+.||+|.|..|-+|++ +|..||||++.+........ ..+.+|++.|+.++|||||++|++......+|||
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st----~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST----GHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh----hHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 55668999999999999976 99999999998766654332 4677999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-cCCCcEEEEcccCeeeeecCCC
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv-~~~~~vkl~DFGla~~~~~~~~ 293 (306)
+|+-++|+|++|+.+.. ..+.+..+.+++.||+.|+.|||...++||||||+|+.+ .+-|-|||.|||++-.+.++..
T Consensus 96 LELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999999998764 459999999999999999999999999999999999987 5778999999999999988888
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.++.||++.|-||
T Consensus 175 L~TsCGSLAYSAP 187 (864)
T KOG4717|consen 175 LTTSCGSLAYSAP 187 (864)
T ss_pred hhcccchhhccCc
Confidence 9999999999998
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-28 Score=215.57 Aligned_cols=169 Identities=31% Similarity=0.543 Sum_probs=141.1
Q ss_pred eccCceecceeeeeccEEEEEEEECC------------------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYNG------------------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 194 (306)
...+|++++.||+|+||.||+|+... ..||+|.+...... ...+.+.+|+.++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~ 77 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-----NAREDFLKEVKILSRLS 77 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhcC
Confidence 45678899999999999999997632 45899998754332 22367889999999999
Q ss_pred CCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021897 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ---------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (306)
Q Consensus 195 h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlk 265 (306)
||||+++++++.....++++|||+++++|.+++.... ...+++..++.++.|++.||+|||+++++|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 9999999999999999999999999999999997643 1258999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 266 p~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|+||+++.++.+||+|||+++....... .....+++.|+||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW 201 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence 9999999999999999999975432211 1233467789998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=229.80 Aligned_cols=161 Identities=32% Similarity=0.477 Sum_probs=140.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-C-----CCeeeEEEEEEe
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-H-----LNIVRFIGACRK 207 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~ 207 (306)
+|.+.+.||+|.||+|.+|.+ +++.||||+++.... ...+-..|+++|..|+ | -|+|+++++|..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-------FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-------HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 778899999999999999987 788999999975332 2346678999999997 3 489999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC--cEEEEcccCe
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK--SIKIADFGVA 285 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~--~vkl~DFGla 285 (306)
.++.|||+|.+. .+|+++++..+-..++...++.|+.||+.||.+||+.+|||+||||+|||+.+.+ .|||+|||.|
T Consensus 260 r~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 999999999995 5999999998888899999999999999999999999999999999999997543 7999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+...+.. .+.+.+..|+||
T Consensus 339 c~~~q~v--ytYiQSRfYRAP 357 (586)
T KOG0667|consen 339 CFESQRV--YTYIQSRFYRAP 357 (586)
T ss_pred cccCCcc--eeeeeccccccc
Confidence 8765432 366788899998
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=218.54 Aligned_cols=158 Identities=24% Similarity=0.427 Sum_probs=129.4
Q ss_pred cceeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCeEEE
Q 021897 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVWCI 213 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~i 213 (306)
+++||+|+||.||+|++ +++.+|+|.++..... ..+.+|+.++++++||||+++++++.. ...+|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 46899999999999986 3468999998654322 346789999999999999999999854 457899
Q ss_pred EEeecCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE----cCCCcEEEEcc
Q 021897 214 VTEYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADF 282 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv----~~~~~vkl~DF 282 (306)
+|||+. ++|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 78 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 999995 58888876321 2358899999999999999999999999999999999999 45678999999
Q ss_pred cCeeeeecCC----CccCCCCCCcccCC
Q 021897 283 GVARIEVQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~----~~~~~~gt~~y~AP 306 (306)
|+|+...... ......||+.|+||
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aP 184 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAP 184 (317)
T ss_pred CceeccCCCCccccccCCccccccccCC
Confidence 9998654321 22345789999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=216.77 Aligned_cols=163 Identities=26% Similarity=0.377 Sum_probs=140.8
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||++.+ ++..+|+|.++.... .....++.+|++++++++||||+++++.+..+..+++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-----PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 578889999999999999987 577899998865322 1123568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred EeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999999999764 558999999999999999999997 59999999999999999999999999998754332
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......|++.|+||
T Consensus 154 ~~~~~~~~~~~~aP 167 (308)
T cd06615 154 MANSFVGTRSYMSP 167 (308)
T ss_pred ccccCCCCcCccCh
Confidence 23445788999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=212.91 Aligned_cols=161 Identities=26% Similarity=0.440 Sum_probs=132.0
Q ss_pred ceeeeeccEEEEEEEEC----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEe
Q 021897 141 TAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E 216 (306)
+.||+|+||.||+|.+. +..+|+|.++....... ...+.+|+.++++++||||+++++.+.+...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-----QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 36899999999999863 34789998865443211 2468899999999999999999999999888999999
Q ss_pred ecCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 217 YAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
|+++|+|.+++.... ....++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999999999997532 22456777889999999999999999999999999999999999999999999975332211
Q ss_pred ---ccCCCCCCcccCC
Q 021897 294 ---MTPETGTYRWMAP 306 (306)
Q Consensus 294 ---~~~~~gt~~y~AP 306 (306)
.....+++.|+||
T Consensus 156 ~~~~~~~~~~~~y~aP 171 (269)
T cd05087 156 YVTPDQLWVPLRWIAP 171 (269)
T ss_pred eecCCCcCCcccccCH
Confidence 1234577889998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=216.83 Aligned_cols=170 Identities=27% Similarity=0.481 Sum_probs=140.6
Q ss_pred eeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
++..+|++.+.||+|+||.||+|++. +..||||+++..... ...+.+.+|+.+++.++||||++++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-----PLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-----HHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 45567888999999999999999862 368999998754321 123568899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NIL 270 (306)
+......++++||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+
T Consensus 77 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil 156 (283)
T cd05091 77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156 (283)
T ss_pred EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence 999999999999999999999986321 234788889999999999999999999999999999999
Q ss_pred EcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 271 v~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+++++.+||+|||+++....... .....+++.|+||
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP 195 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCH
Confidence 99999999999999875432221 1233457889998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=219.59 Aligned_cols=174 Identities=32% Similarity=0.571 Sum_probs=143.7
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (306)
.+|++...+|++++.||+|+||.||+|.+. ...||+|+++...... ..+.+.+|+.+++++ +|||
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-----DLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHH-----HHHHHHHHHHHHHhhcCCCC
Confidence 578888899999999999999999999752 2368999886432221 135788999999999 7999
Q ss_pred eeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021897 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (306)
Q Consensus 198 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrD 263 (306)
|++++++|.....+++++||+++|+|.+++.+.. ...+++..++.++.|++.||+|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d 159 (334)
T cd05100 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159 (334)
T ss_pred eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 9999999999999999999999999999997632 23477888899999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 264 lkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|||+|||++.++.+||+|||+++....... .....+++.|+||
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 205 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP 205 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence 999999999999999999999986543221 1222345679988
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=209.67 Aligned_cols=169 Identities=29% Similarity=0.505 Sum_probs=139.8
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--Ce
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 210 (306)
.+|++++.||+|+||.||+|.. +++.||||.+.......... ...+.+.+|+.+++++.||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS-KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccH-HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 5678899999999999999987 67899999986433222111 1235788999999999999999999998763 56
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
++++|||+++++|.+++... ..+++..++.++.|++.||+|||+++++|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 88999999999999998754 3478888999999999999999999999999999999999999999999999875432
Q ss_pred C----CCccCCCCCCcccCC
Q 021897 291 T----EGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~----~~~~~~~gt~~y~AP 306 (306)
. .......|+..|+||
T Consensus 159 ~~~~~~~~~~~~~~~~y~aP 178 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSP 178 (265)
T ss_pred ccccccccccCCCCccccCh
Confidence 1 123344688999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=215.28 Aligned_cols=166 Identities=27% Similarity=0.408 Sum_probs=140.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++.+.||+|+||.||+|+. +++.||+|.++....... ...+.+|+.+++.++||||+++++++..+..+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-----hhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence 46788899999999999999987 578999999875433221 13567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||++ ++|.+++... ...+++..++.++.||+.||+|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 99999997 5999988754 345889999999999999999999999999999999999999999999999999754322
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......+++.|+||
T Consensus 158 ~~~~~~~~~~~~y~~P 173 (301)
T cd07873 158 TKTYSNEVVTLWYRPP 173 (301)
T ss_pred CCcccccceeecccCc
Confidence 2 22334678899998
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=216.38 Aligned_cols=170 Identities=31% Similarity=0.550 Sum_probs=139.1
Q ss_pred eeccCceecceeeeeccEEEEEEEECC----------------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTYNG----------------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 195 (306)
++.++|++.+.||+|+||.||++...+ ..||+|.++...... ....+.+|++++++++|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~ei~~l~~l~h 76 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT-----ARNDFLKEIKIMSRLKN 76 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHH-----HHHHHHHHHHHHHhCCC
Confidence 456788999999999999999987522 248999987543221 23578899999999999
Q ss_pred CCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021897 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (306)
Q Consensus 196 ~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlk 265 (306)
|||+++++++.....+++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+++|||||
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk 156 (295)
T cd05097 77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156 (295)
T ss_pred CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence 999999999999999999999999999999986532 1246888899999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 266 p~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|+||++++++.+||+|||+++....... .....+++.|+||
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 200 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW 200 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecCh
Confidence 9999999999999999999975432221 1122346789888
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-28 Score=212.41 Aligned_cols=168 Identities=28% Similarity=0.495 Sum_probs=139.0
Q ss_pred eccCceecceeeeeccEEEEEEEE--C---CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--N---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
+..+|++.+.||+|+||.||+|.+ + +..+|+|.++...... ..+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-----QRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 456788899999999999999976 2 2379999886543221 13578899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
....|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999999999997643 4589999999999999999999999999999999999999999999999999986
Q ss_pred eecCCC--c--cCCCCCCcccCC
Q 021897 288 EVQTEG--M--TPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~--~--~~~~gt~~y~AP 306 (306)
...... . ....+++.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~p 178 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAP 178 (267)
T ss_pred cccccceeeecCCCccceeecCH
Confidence 433221 1 111234678887
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=235.29 Aligned_cols=172 Identities=27% Similarity=0.447 Sum_probs=140.6
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE-CC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-NG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGAC 205 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 205 (306)
.+++...++++.+.|.+|+|+.||.|.. .+ .++|+|.+-.... ...+.+.+|+.+|++|+ |+|||.+++..
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de------~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE------EALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH------HHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 3556677888999999999999999988 34 8999998754321 22468889999999998 99999999943
Q ss_pred -Ee------CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCc
Q 021897 206 -RK------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKS 276 (306)
Q Consensus 206 -~~------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlkp~NILv~~~~~ 276 (306)
.. .-.++|+||||++|.|.+++..+....+++..+++|+.|+|+|+.+||... |||||||.+||||+.++.
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 21 125789999999999999999766666999999999999999999999987 999999999999999999
Q ss_pred EEEEcccCeeeeecCCCcc----------CCCCCCcccCC
Q 021897 277 IKIADFGVARIEVQTEGMT----------PETGTYRWMAP 306 (306)
Q Consensus 277 vkl~DFGla~~~~~~~~~~----------~~~gt~~y~AP 306 (306)
.||||||.|.-........ ..-.|+-|+||
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsP 224 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSP 224 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccCh
Confidence 9999999986322221110 01267999998
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=210.85 Aligned_cols=165 Identities=28% Similarity=0.508 Sum_probs=139.9
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC---
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR--- 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--- 208 (306)
..|++.+.||+|+||.||+|.+ +++.+|+|++...... ...+.+|+.+++++ +||||+++++.+...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4567778999999999999987 6789999998754322 24677899999998 699999999998653
Q ss_pred ---CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
..+|++|||+++++|.+++.......+++..++.++.|++.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 46899999999999999998755567899999999999999999999999999999999999999999999999999
Q ss_pred eeeecC-CCccCCCCCCcccCC
Q 021897 286 RIEVQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~AP 306 (306)
+..... .......|++.|+||
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aP 180 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAP 180 (272)
T ss_pred eecccccccCCcccccccccCH
Confidence 864332 223445789999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=212.69 Aligned_cols=167 Identities=26% Similarity=0.493 Sum_probs=137.5
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
...+|++.+.||+|+||.||+|++ +++ +||+|+++...... ..+.+.+|+.+++.+.||||+++++.+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-----ANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH-----HHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 456788899999999999999987 444 48999986543321 2357889999999999999999999997
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
... .++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||+++++.+||+|||+++
T Consensus 80 ~~~-~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 80 TST-VQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred CCC-cEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 654 689999999999999997543 458999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCc---cCCCCCCcccCC
Q 021897 287 IEVQTEGM---TPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~---~~~~gt~~y~AP 306 (306)
........ ....+++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~P 180 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMAL 180 (279)
T ss_pred ecccccceeecCCCccchhhCCH
Confidence 65432221 112345779887
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-29 Score=219.48 Aligned_cols=171 Identities=25% Similarity=0.383 Sum_probs=149.3
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
.+..++|.+++.||+|.||+|-+++- +++.+|+|++++...-... ....-+.|-++|+..+||.+..+--.|+..
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd---EVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD---EVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH---HhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 45667899999999999999999975 7889999999875443221 124566899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee-
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI- 287 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~- 287 (306)
..+|+||||+.||.|.-+|.+. +.+++..++.+-.+|+.||.|||+++||.||||.+|+|+|++|++||+|||+++-
T Consensus 241 drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred ceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999999888764 5689999999999999999999999999999999999999999999999999984
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
+..+..+++.||||.|+||
T Consensus 319 I~~g~t~kTFCGTPEYLAP 337 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAP 337 (516)
T ss_pred ccccceeccccCChhhcCc
Confidence 3344557889999999999
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=208.53 Aligned_cols=169 Identities=24% Similarity=0.418 Sum_probs=143.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++.+.||+|+||.||+|.. +++.||+|.++........ ..+.+.+|+.++++++|++|+++++.+......+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK---ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh---hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 4688889999999999999988 6889999998754433222 1357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+||||+++++|.+++... ....+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||+++....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999999998753 234588999999999999999999999999999999999999999999999999876543
Q ss_pred CC-CccCCCCCCcccCC
Q 021897 291 TE-GMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~-~~~~~~gt~~y~AP 306 (306)
.. ......+++.|+||
T Consensus 159 ~~~~~~~~~~~~~y~ap 175 (267)
T cd08224 159 KTTAAHSLVGTPYYMSP 175 (267)
T ss_pred CCcccceecCCccccCH
Confidence 22 12334688889988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=228.14 Aligned_cols=158 Identities=23% Similarity=0.330 Sum_probs=135.8
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
..|.+.+.||+|+||.||+|.+ .++.||||.... ..+.+|+.++++++|+|||++++++......+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 4688889999999999999988 567899995321 24568999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+|||++. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 237 lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9999995 6999888754 2468999999999999999999999999999999999999999999999999998653221
Q ss_pred C---ccCCCCCCcccCC
Q 021897 293 G---MTPETGTYRWMAP 306 (306)
Q Consensus 293 ~---~~~~~gt~~y~AP 306 (306)
. ....+||+.|+||
T Consensus 315 ~~~~~~~~~GT~~Y~AP 331 (461)
T PHA03211 315 STPFHYGIAGTVDTNAP 331 (461)
T ss_pred ccccccccCCCcCCcCH
Confidence 1 2235699999998
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=207.80 Aligned_cols=167 Identities=29% Similarity=0.530 Sum_probs=143.0
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|+..+.||+|++|+||+|.. +++.|++|.+........ .+...+.+.+|+.+++.++|+||+++++.+.....++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT-GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc-chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 56778999999999999987 678999999875443221 122246788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~ 294 (306)
+||+++++|.+++.+. ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 9999999999999754 45889999999999999999999999999999999999999999999999999865444334
Q ss_pred cCCCCCCcccCC
Q 021897 295 TPETGTYRWMAP 306 (306)
Q Consensus 295 ~~~~gt~~y~AP 306 (306)
....|++.|+||
T Consensus 159 ~~~~~~~~y~~p 170 (258)
T cd06632 159 KSFKGSPYWMAP 170 (258)
T ss_pred cccCCCcceeCH
Confidence 455788999987
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=207.38 Aligned_cols=167 Identities=25% Similarity=0.379 Sum_probs=143.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|+..+.||+|++|.||++.. +++.+|||.+......... .+.+.+|+.++++++||||+++++.+......++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH----HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEE
Confidence 467889999999999999977 6789999999765443222 3578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEcccCeeeeecCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTE 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~-~~vkl~DFGla~~~~~~~ 292 (306)
||||+++++|.+++.......+++..++.++.|++.+|+|||+++++|+||+|+||+++++ +.+||+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999999987656668999999999999999999999999999999999999855 468999999998655443
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......|++.|+||
T Consensus 157 ~~~~~~~~~~y~aP 170 (256)
T cd08220 157 KAYTVVGTPCYISP 170 (256)
T ss_pred cccccccCCcccCc
Confidence 33445788999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=211.59 Aligned_cols=169 Identities=24% Similarity=0.414 Sum_probs=143.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++.+.||+|+||.||++.+ +++.+|||.+......... ..+++.+|+.+++.+.||||+++++.+.+....+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK---ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHH---HHHHHHHHHHHHHHccCCchhhhhheeEeCCeEE
Confidence 4677889999999999999986 7889999988654332221 2357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
++|||+++++|.+++... ....+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999999998742 234689999999999999999999999999999999999999999999999999876543
Q ss_pred CCC-ccCCCCCCcccCC
Q 021897 291 TEG-MTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~-~~~~~gt~~y~AP 306 (306)
... .....|++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~ap 175 (267)
T cd08229 159 KTTAAHSLVGTPYYMSP 175 (267)
T ss_pred CCcccccccCCcCccCH
Confidence 222 2334688999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=211.34 Aligned_cols=166 Identities=24% Similarity=0.415 Sum_probs=137.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEEeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~ 211 (306)
++|++.+.||+|+||.||++.+ +++.||+|.++........ ..+..|+.+ ++.+.||||+++++++.....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-----KRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-----HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 3677889999999999999987 6889999998765433221 344456554 6677899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
|++|||++ ++|.+++... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999996 6898888653 234689999999999999999999997 9999999999999999999999999999865
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
......+...|+..|+||
T Consensus 155 ~~~~~~~~~~~~~~y~aP 172 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAP 172 (283)
T ss_pred ccccccccccCCccccCh
Confidence 443333445688889988
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=213.00 Aligned_cols=172 Identities=30% Similarity=0.439 Sum_probs=145.2
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
++|-.+.+.|++.+.||.|+||.||+|+. +++.+++|++..... ...+.+.+|+.+++.++||||+++++.+
T Consensus 5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (292)
T cd06644 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE------EELEDYMVEIEILATCNHPYIVKLLGAF 78 (292)
T ss_pred hcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCcEeeeEEEE
Confidence 44555567789999999999999999987 578999999865321 1235788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
..+..+|+||||+++++|..++.+.. ..+++..++.++.|++.+|+|||+.+++||||||+||+++.++.+||+|||++
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 79 YWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred EeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccc
Confidence 99999999999999999988876543 45899999999999999999999999999999999999999999999999998
Q ss_pred eeeecCC-CccCCCCCCcccCC
Q 021897 286 RIEVQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~-~~~~~~gt~~y~AP 306 (306)
....... ......+++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aP 179 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAP 179 (292)
T ss_pred eeccccccccceecCCccccCc
Confidence 7533221 22334688899998
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=206.51 Aligned_cols=167 Identities=25% Similarity=0.411 Sum_probs=141.5
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCeEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVWC 212 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 212 (306)
.|++.+.||.|++|.||++.. +++.+|+|.+........ ..+.+.+|+.++++++|+|++++++.+.. ...+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR----ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHH----HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEE
Confidence 367889999999999999987 667999999875443322 13567899999999999999999998764 44689
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
++|||+++++|.+++.......+++..++.++.|++.|++|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999999999987655678999999999999999999999999999999999999999999999999998654322
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 157 ~~~~~~~~~~~y~aP 171 (257)
T cd08223 157 DMASTLIGTPYYMSP 171 (257)
T ss_pred CccccccCCcCccCh
Confidence 22334688999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=221.76 Aligned_cols=166 Identities=26% Similarity=0.429 Sum_probs=138.3
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
|++ .++|++.+.||+|+||.||+|.. +++.||||.+....... ...+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07878 11 WEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL----IHARRTYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh----HHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence 444 36788899999999999999986 67799999986543221 123467799999999999999999998754
Q ss_pred C------CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEc
Q 021897 208 R------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (306)
Q Consensus 208 ~------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~D 281 (306)
. ...|+++|++ +++|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 86 ATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcC
Confidence 3 3579999998 7799888753 4589999999999999999999999999999999999999999999999
Q ss_pred ccCeeeeecCCCccCCCCCCcccCC
Q 021897 282 FGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
||+++.... ......||+.|+||
T Consensus 162 fg~~~~~~~--~~~~~~~t~~y~aP 184 (343)
T cd07878 162 FGLARQADD--EMTGYVATRWYRAP 184 (343)
T ss_pred CccceecCC--CcCCccccccccCc
Confidence 999986543 23455789999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=211.53 Aligned_cols=172 Identities=26% Similarity=0.444 Sum_probs=141.9
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 204 (306)
+.+....++|++.+.||+|+||.||++.. +++.+|+|++...... ...+.+|+.+++++ +||||++++++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------DEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-------HHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 44445667889999999999999999987 6789999987542221 24577899999999 69999999998
Q ss_pred EE-----eCCeEEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcE
Q 021897 205 CR-----KRMVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (306)
Q Consensus 205 ~~-----~~~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~v 277 (306)
+. ....+++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+++||||||+||++++++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence 84 345789999999999999988642 23468889999999999999999999999999999999999999999
Q ss_pred EEEcccCeeeeecCC-CccCCCCCCcccCC
Q 021897 278 KIADFGVARIEVQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 278 kl~DFGla~~~~~~~-~~~~~~gt~~y~AP 306 (306)
||+|||+++...... ......|++.|+||
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 193 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccCh
Confidence 999999998654322 22344689999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=212.80 Aligned_cols=169 Identities=31% Similarity=0.533 Sum_probs=140.9
Q ss_pred eccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
...+|.+.+.||+|+||.||+|++. ++.||||+++...... ..+.+.+|++++++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-----ARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH-----HHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 4567888899999999999999762 3689999986543321 236789999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~ 273 (306)
......++||||+++++|.+++.... ...+++..+..++.|++.||+|||+++++||||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 99999999999999999999997532 234788899999999999999999999999999999999999
Q ss_pred CCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 274 DKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 274 ~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
++.+||+|||+++....... .....+++.|+||
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP 193 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecCh
Confidence 99999999999975422211 1223457889998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=207.98 Aligned_cols=168 Identities=32% Similarity=0.553 Sum_probs=141.7
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChh---HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE---KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
|.+++.||+|++|.||+|.. +++.+|+|.+........ ......+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56778999999999999987 678999999876543322 2233446788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
+++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||+|+||++++++.+||+|||+++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 9999999999999999764 45888999999999999999999999999999999999999999999999998755421
Q ss_pred C-------CccCCCCCCcccCC
Q 021897 292 E-------GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-------~~~~~~gt~~y~AP 306 (306)
. ......|++.|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~p 181 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAP 181 (267)
T ss_pred cccCCccccccccCCCcCccCh
Confidence 1 11223578889988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=210.77 Aligned_cols=165 Identities=30% Similarity=0.470 Sum_probs=139.3
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||+|++ +++.||+|++........ ..+.+.+|+.++++++||||+++++.+......++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc----ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 577889999999999999988 578999999865432221 12467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
||||++++.|..++.. ...+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 78 VFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999999888777654 2458999999999999999999999999999999999999999999999999998654332
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......++..|+||
T Consensus 156 ~~~~~~~~~~~~aP 169 (286)
T cd07847 156 DYTDYVATRWYRAP 169 (286)
T ss_pred cccCcccccccCCH
Confidence 22334577888887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=211.01 Aligned_cols=165 Identities=29% Similarity=0.454 Sum_probs=143.0
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|++|.||+|++ +++.||+|++........ ..+.+.+|+.++++++||||+++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG----IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch----hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEE
Confidence 477889999999999999987 678999999976543221 13578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
|+||+ +++|.+++.... ..+++..++.++.||+.+|+|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999 999999987543 568999999999999999999999999999999999999999999999999998654432
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......|+..|+||
T Consensus 155 ~~~~~~~~~~~y~aP 169 (286)
T cd07832 155 RLYSHQVATRWYRAP 169 (286)
T ss_pred CccccccCcccccCc
Confidence 13345788999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=209.26 Aligned_cols=169 Identities=28% Similarity=0.480 Sum_probs=142.0
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|+.++.||+|++|.||++.. +++.+|+|++..............+.+.+|+.++++++|+||+++++.+.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 366778999999999999986 778999999975544333333345789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEcccCeeeeecCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-~vkl~DFGla~~~~~~~ 292 (306)
|+||+++++|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999754 4688999999999999999999999999999999999998776 69999999987543221
Q ss_pred C-----ccCCCCCCcccCC
Q 021897 293 G-----MTPETGTYRWMAP 306 (306)
Q Consensus 293 ~-----~~~~~gt~~y~AP 306 (306)
. .....||..|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~P 177 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAP 177 (268)
T ss_pred ccCCccccccccccceeCH
Confidence 1 1223578889988
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=231.05 Aligned_cols=174 Identities=27% Similarity=0.452 Sum_probs=148.6
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEEC---C--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (306)
-++--|..+++++.++||+|.||.|++|.|+ | ..||||.++...... ....|++|+.+|.+|+|||+++|
T Consensus 102 ~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-----~mddflrEas~M~~L~H~hliRL 176 (1039)
T KOG0199|consen 102 DLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-----IMDDFLREASHMLKLQHPHLIRL 176 (1039)
T ss_pred CcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-----hHHHHHHHHHHHHhccCcceeEE
Confidence 4455678889999999999999999999993 3 379999998766553 24689999999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEc
Q 021897 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (306)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~D 281 (306)
||+..+ +.+.+|+|+++.|+|.+.|++.....+....++.++.||+.||.||.++++|||||.++|+|+.....|||+|
T Consensus 177 yGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 177 YGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred eeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeec
Confidence 999988 5678999999999999999985566788899999999999999999999999999999999999999999999
Q ss_pred ccCeeeeecCCCccCCC----CCCcccCC
Q 021897 282 FGVARIEVQTEGMTPET----GTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~~~~~~~----gt~~y~AP 306 (306)
|||.|-....+.+.... --..|.||
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaP 284 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAP 284 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCH
Confidence 99999765544433222 22567776
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=207.60 Aligned_cols=160 Identities=30% Similarity=0.517 Sum_probs=132.4
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeec
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~ 218 (306)
+.||+|+||.||+|++ +++.+|+|.+...... .....+.+|+.+++++.||||+++++++.....+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeec
Confidence 3689999999999987 7889999987643221 12357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCcc---
Q 021897 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT--- 295 (306)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~--- 295 (306)
++++|.+++... ...+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.........
T Consensus 76 ~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 76 QGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred cCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999999998753 3458899999999999999999999999999999999999999999999999987543221111
Q ss_pred CCCCCCcccCC
Q 021897 296 PETGTYRWMAP 306 (306)
Q Consensus 296 ~~~gt~~y~AP 306 (306)
....+..|+||
T Consensus 155 ~~~~~~~y~aP 165 (252)
T cd05084 155 MKQIPVKWTAP 165 (252)
T ss_pred CCCCceeecCc
Confidence 01123568887
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=213.71 Aligned_cols=151 Identities=24% Similarity=0.440 Sum_probs=134.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|++|.||+|.. +++.+|+|.+....... ....+.+.+|+.+++.++||||+++++.+......|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK---RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch---HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEE
Confidence 3678889999999999999987 57899999997654332 112357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
+||||+++++|.+++.......+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 9999999999999998665567899999999999999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=206.74 Aligned_cols=166 Identities=32% Similarity=0.507 Sum_probs=143.3
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++.+.||+|+||.||+|.. +++.+++|++...... ..+.+.+|+.++++++||||+++++.+.....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD------DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh------hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEE
Confidence 36788889999999999999987 5678999999754332 235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|++|||+++++|.+++... ...+++..++.++.|++.||+|||+++++|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999999999998764 246899999999999999999999999999999999999999999999999998754432
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......++..|+||
T Consensus 155 ~~~~~~~~~~~~y~~P 170 (262)
T cd06613 155 IAKRKSFIGTPYWMAP 170 (262)
T ss_pred hhccccccCCccccCc
Confidence 2 23345688899998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=211.31 Aligned_cols=166 Identities=27% Similarity=0.430 Sum_probs=138.8
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++.+.||+|++|.||+|.. +++.||||.+......... ..+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-----FTAIREASLLKDLKHANIVTLHDIIHTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCc-----hhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence 36788899999999999999987 6789999998754322211 2466899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||+++ +|.+++.... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 999999975 9999887643 36889999999999999999999999999999999999999999999999998753221
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......+++.|+||
T Consensus 157 ~~~~~~~~~~~~~~aP 172 (291)
T cd07844 157 SKTYSNEVVTLWYRPP 172 (291)
T ss_pred CccccccccccccCCc
Confidence 1 12223567888887
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=213.12 Aligned_cols=167 Identities=33% Similarity=0.529 Sum_probs=134.8
Q ss_pred cCceecceeeeeccEEEEEEEE--CCe--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (306)
++|++.+.||+|+||+||+|.. ++. .+++|.++...... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN-----DHRDFAGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHH-----HHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence 5788899999999999999987 333 47888876322211 135688999999999 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~ 275 (306)
.+|+++||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||+++++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 9999999999999999997532 13478899999999999999999999999999999999999999
Q ss_pred cEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 276 SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 276 ~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
.+||+|||++..............+..|+||
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP 187 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAI 187 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCc
Confidence 9999999998643221111112234568887
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=212.49 Aligned_cols=165 Identities=28% Similarity=0.429 Sum_probs=141.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||.|+||.||++.+ ++..+|+|++...... ..+.+.+|+.++++++||||+++++.+..+...|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE------ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH------HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 5688889999999999999987 5789999998643211 2357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999999999987643 468999999999999999999999999999999999999999999999999986543221
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......+|+.|+||
T Consensus 158 ~~~~~~~~~~~y~~P 172 (280)
T cd06611 158 QKRDTFIGTPYWMAP 172 (280)
T ss_pred cccceeecchhhcCH
Confidence 22334688889987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=211.09 Aligned_cols=167 Identities=25% Similarity=0.488 Sum_probs=135.5
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
...+|++.+.||+|+||.||+|.+ +++ .+++|.+..... .....++..|+.+++++.||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-----RQTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-----hHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 346778889999999999999988 454 477777643221 122357788999999999999999999886
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
. ...++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||+++
T Consensus 80 ~-~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 80 G-ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred C-CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 4 45689999999999999997543 468999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC---ccCCCCCCcccCC
Q 021897 287 IEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~---~~~~~gt~~y~AP 306 (306)
....... .....++..|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~p 180 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMAL 180 (279)
T ss_pred eccCCCcccccCCCCCcccccCH
Confidence 6533221 2233466789887
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=210.99 Aligned_cols=165 Identities=30% Similarity=0.579 Sum_probs=135.2
Q ss_pred cCceecceeeeeccEEEEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 207 (306)
.+|++.+.||+|+||.||++.+ +++.||+|.+..... ...+.+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA------EHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 5678889999999999999974 467899999864321 113578899999999999999999998754
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
...+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 346899999999999999997542 358999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCc----cCCCCCCcccCC
Q 021897 287 IEVQTEGM----TPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~----~~~~gt~~y~AP 306 (306)
........ ....++..|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aP 180 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAP 180 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCH
Confidence 65432211 111234568887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=211.90 Aligned_cols=167 Identities=29% Similarity=0.530 Sum_probs=138.5
Q ss_pred ccCceecceeeeeccEEEEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
.+.|++.+.||+|+||.||++++ .+..||+|.++..... .....+.+|+.+++.+.||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-----NHIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 35678889999999999999975 4678999998643221 113578899999999999999999999977
Q ss_pred C--CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 208 R--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 208 ~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
. ..+++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccc
Confidence 5 56899999999999999987542 35899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC----ccCCCCCCcccCC
Q 021897 286 RIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~----~~~~~gt~~y~AP 306 (306)
+....... .....++..|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~ap 181 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAP 181 (284)
T ss_pred cccccCccceeecCCCCCCccccCH
Confidence 86543221 1234566778887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=210.04 Aligned_cols=167 Identities=26% Similarity=0.509 Sum_probs=138.0
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
...+|++.+.||+|+||.||+|.+ +++ .+|+|.+...... .....+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-----KANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 446788999999999999999986 333 6899988654431 12357889999999999999999999998
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
. ...++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||+++
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 7 67899999999999999997643 358999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCcc---CCCCCCcccCC
Q 021897 287 IEVQTEGMT---PETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~---~~~gt~~y~AP 306 (306)
......... ...+++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~P 180 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMAL 180 (279)
T ss_pred cccCcccceecCCCcccccccCH
Confidence 654322111 12235678887
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=213.70 Aligned_cols=158 Identities=23% Similarity=0.425 Sum_probs=128.6
Q ss_pred cceeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCeEEE
Q 021897 140 GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVWCI 213 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~i 213 (306)
+.+||+|+||.||+|+. ++..+|+|.+...... ..+.+|+.+++.++||||+++++++.. ...+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc--------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 46899999999999986 3468999998654322 356789999999999999999999854 567899
Q ss_pred EEeecCCCCHHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE----cCCCcEEEEcc
Q 021897 214 VTEYAKGGSVRQFLTRR-------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADF 282 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv----~~~~~vkl~DF 282 (306)
||||+++ +|.+++... ....+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9999964 888887532 12347889999999999999999999999999999999999 56679999999
Q ss_pred cCeeeeecCC----CccCCCCCCcccCC
Q 021897 283 GVARIEVQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~----~~~~~~gt~~y~AP 306 (306)
|+|+...... ......||+.|+||
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aP 184 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAP 184 (317)
T ss_pred cceeccCCCcccccccCcceecccccCc
Confidence 9998654322 12345689999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=210.36 Aligned_cols=161 Identities=24% Similarity=0.345 Sum_probs=137.7
Q ss_pred eeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCC
Q 021897 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (306)
Q Consensus 143 lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~ 220 (306)
||+|+||.||++.. +++.+|+|++....... ....+.+.+|+.++++++||||+++++.+......|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK---RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh---hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 68999999999976 68899999987533221 12235677899999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCC
Q 021897 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (306)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt 300 (306)
++|.+++.......+++..++.++.|++.||.|||+.+++||||+|+||++++++.+||+|||+++............++
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99999998765557899999999999999999999999999999999999999999999999999765443333445678
Q ss_pred CcccCC
Q 021897 301 YRWMAP 306 (306)
Q Consensus 301 ~~y~AP 306 (306)
..|+||
T Consensus 158 ~~y~~P 163 (277)
T cd05577 158 PGYMAP 163 (277)
T ss_pred CCcCCH
Confidence 889887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=215.13 Aligned_cols=164 Identities=19% Similarity=0.308 Sum_probs=135.4
Q ss_pred ecceeeee--ccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 139 MGTAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 139 ~~~~lG~G--~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
++++||+| +|++||+++. +++.||+|.+........ ..+.+.+|+.+++.++||||+++++++..+...|+|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE----MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH----HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence 45789999 7889999987 778999999865443222 235677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC--
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-- 292 (306)
|||+++++|.+++.......+++..++.++.|++.||+|||+++|+||||||+|||++.++.++++||+.+.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999999976544568999999999999999999999999999999999999999999999998653221110
Q ss_pred ------CccCCCCCCcccCC
Q 021897 293 ------GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ------~~~~~~gt~~y~AP 306 (306)
......++..|+||
T Consensus 158 ~~~~~~~~~~~~~~~~y~aP 177 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSP 177 (327)
T ss_pred ccccccccccccceecccCh
Confidence 01223467789988
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=223.17 Aligned_cols=174 Identities=21% Similarity=0.313 Sum_probs=154.2
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
+-+..+.|..-+.||+|+||+||-+.. +|+-+|+|.+.+..... +.-+...++|-.||.++..+.||.+--++..
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk---r~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK---RKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH---hhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 345667788889999999999998754 88999999886533322 2234567899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
++.+|+||..|.||+|.=+|....+..+++..++.+|++|+.||++||+.+|++|||||+|||+|+.|+|.|+|.|||..
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999999999888877667899999999999999999999999999999999999999999999999999998
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
+.........+||..||||
T Consensus 337 i~~g~~~~~rvGT~GYMAP 355 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAP 355 (591)
T ss_pred cCCCCccccccCcccccCH
Confidence 8888877888999999999
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=211.15 Aligned_cols=163 Identities=28% Similarity=0.454 Sum_probs=141.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||++.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++.+......|
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 6788889999999999999986 68899999987543322 246789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++.......
T Consensus 93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999999999864 347889999999999999999999999999999999999999999999999987643322
Q ss_pred C-ccCCCCCCcccCC
Q 021897 293 G-MTPETGTYRWMAP 306 (306)
Q Consensus 293 ~-~~~~~gt~~y~AP 306 (306)
. .....+++.|+||
T Consensus 170 ~~~~~~~~~~~y~aP 184 (297)
T cd06656 170 SKRSTMVGTPYWMAP 184 (297)
T ss_pred cCcCcccCCccccCH
Confidence 2 2334688899987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=206.19 Aligned_cols=161 Identities=32% Similarity=0.627 Sum_probs=139.2
Q ss_pred ceeeeeccEEEEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEE
Q 021897 141 TAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~ 215 (306)
+.||+|+||.||+|.+. +..+|+|+++...... ..+.+.+|+.+++.++|+||+++++++.....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEE
Confidence 46899999999999884 7799999997654432 2367889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 216 EYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 216 E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
||+++++|.+++.... ...+++..++.++.|++.||+|||+++++||||||+||++++++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 9999999999998642 356899999999999999999999999999999999999999999999999999865
Q ss_pred ecCC---CccCCCCCCcccCC
Q 021897 289 VQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~---~~~~~~gt~~y~AP 306 (306)
.... ......+++.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aP 176 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAP 176 (262)
T ss_pred ccccccccccCCCcCccccCH
Confidence 4432 12334578899998
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=209.26 Aligned_cols=164 Identities=32% Similarity=0.538 Sum_probs=134.5
Q ss_pred cCceecceeeeeccEEEEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
+.|++.+.||+|+||+||++++ +++.||+|+++...... ....+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-----NTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3447889999999999988764 46689999987543211 135688999999999999999999988653
Q ss_pred --CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
..++++|||+++++|.+++... .+++..++.++.|++.||+|||+++++||||||+|||+++++.+||+|||+++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccc
Confidence 4689999999999999999753 48999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC----ccCCCCCCcccCC
Q 021897 287 IEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~----~~~~~gt~~y~AP 306 (306)
....... .....++..|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~P 179 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAV 179 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCH
Confidence 6543221 1122355678887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=212.15 Aligned_cols=168 Identities=27% Similarity=0.409 Sum_probs=141.4
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|++|.||+|.. +++.||||.++....... .......+.+|+.++++++|+||+++++++......++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA-KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc-cchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 367778999999999999987 578999999976544311 11233567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||+++......
T Consensus 80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 99999 889999997543 368999999999999999999999999999999999999999999999999998654332
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 158 ~~~~~~~~~~y~aP 171 (298)
T cd07841 158 KMTHQVVTRWYRAP 171 (298)
T ss_pred cccccccceeeeCH
Confidence 23334567888887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=211.81 Aligned_cols=166 Identities=29% Similarity=0.553 Sum_probs=135.9
Q ss_pred CceecceeeeeccEEEEEEEECC-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 136 KLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
+|++.+.||+|+||.||+|+... ..+++|.+....... ..+++.+|+.+++.+.||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS-----ELRDLLSEFNLLKQVNHPHVIKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH-----HHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 36778899999999999998632 468898886433221 135788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQ----------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKS 266 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp 266 (306)
...++++||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+++||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 99999999999999999987531 13478889999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 267 DNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 267 ~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+|||+++++.+||+|||+++....... .....++..|+||
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap 198 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI 198 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence 999999999999999999975432211 1223456788887
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=207.61 Aligned_cols=166 Identities=25% Similarity=0.484 Sum_probs=134.6
Q ss_pred ceecceeeeeccEEEEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe-
Q 021897 137 LNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV- 210 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 210 (306)
|++++.||+|+||.||+|+.. +..||+|.++....... ....+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS----EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH----HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence 457789999999999999862 26799999875433321 13578899999999999999999999866543
Q ss_pred -----EEEEEeecCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEc
Q 021897 211 -----WCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (306)
Q Consensus 211 -----~~iv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~D 281 (306)
.++++||+++++|..++.... ...+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|
T Consensus 77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence 799999999999999986532 23589999999999999999999999999999999999999999999999
Q ss_pred ccCeeeeecCCCc---cCCCCCCcccCC
Q 021897 282 FGVARIEVQTEGM---TPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~~~---~~~~gt~~y~AP 306 (306)
||+++........ ....+++.|+||
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~p 184 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAI 184 (273)
T ss_pred ccceeeccccccccccccccCCccccCH
Confidence 9999865432211 112345678877
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-27 Score=208.79 Aligned_cols=165 Identities=28% Similarity=0.420 Sum_probs=137.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++.+.||+|+||.||+|.. +++.+|+|++........ ...+.+|+.+++.++|+||+++++++......|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-----cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 5788899999999999999976 678999999865433221 135678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~- 291 (306)
+|+||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+++|+||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9999995 68887776433 45788888999999999999999999999999999999999999999999999753321
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
.......+++.|+||
T Consensus 158 ~~~~~~~~~~~y~aP 172 (291)
T cd07870 158 QTYSSEVVTLWYRPP 172 (291)
T ss_pred CCCCCccccccccCC
Confidence 122334578899998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=211.53 Aligned_cols=169 Identities=30% Similarity=0.505 Sum_probs=140.1
Q ss_pred eeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
|...+|.+.+.||+|+||.||++.. ++..+|+|.+..... ...+.+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD------NARKDFHREAELLTNLQHEHIVKFYGV 75 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH------HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4567888999999999999999974 234689998864321 123578899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ-----------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~ 273 (306)
+.....+++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||+++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~ 155 (288)
T cd05093 76 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155 (288)
T ss_pred EecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999999997532 134899999999999999999999999999999999999999
Q ss_pred CCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 274 DKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 274 ~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
++.+||+|||+++....... .....+++.|+||
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 191 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCH
Confidence 99999999999975432211 1223456789998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=210.76 Aligned_cols=164 Identities=27% Similarity=0.447 Sum_probs=141.3
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
..+|++.+.||+|+||.||+|.. +++.+|+|.+....... .+.+.+|+.+++.+.||||+++++.+......
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 36788889999999999999986 67899999987544332 24678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999999999999864 34788999999999999999999999999999999999999999999999998754332
Q ss_pred CC-ccCCCCCCcccCC
Q 021897 292 EG-MTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~-~~~~~gt~~y~AP 306 (306)
.. .....|++.|+||
T Consensus 170 ~~~~~~~~~~~~y~aP 185 (296)
T cd06654 170 QSKRSTMVGTPYWMAP 185 (296)
T ss_pred ccccCcccCCccccCH
Confidence 21 2334788999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=208.71 Aligned_cols=160 Identities=26% Similarity=0.495 Sum_probs=129.5
Q ss_pred eeeeeccEEEEEEEE-CCe---eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 142 AFAQGAFGKLYRGTY-NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
.||+|+||.||+|.. ++. .+++|.++...... ..+.+.+|+.+++.++||||+++++.|......|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK-----EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChH-----HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 589999999999975 332 45666665432211 236789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC---
Q 021897 218 AKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE--- 292 (306)
Q Consensus 218 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~--- 292 (306)
+++|+|.+++.+.. ....++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999999997642 2346677788999999999999999999999999999999999999999999986422111
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
.....++++.|+||
T Consensus 157 ~~~~~~~~~~y~aP 170 (268)
T cd05086 157 TEDDKCVPLRWLAP 170 (268)
T ss_pred cccCCcCcccccCc
Confidence 12334678889988
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=209.11 Aligned_cols=151 Identities=27% Similarity=0.495 Sum_probs=131.2
Q ss_pred eccCceecceeeeeccEEEEEEEE--CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
+..+|++.+.||+|+||.||+|.+ ++ ..||||++...... ...+.|.+|+.+++.+.||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE-----KQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH-----HHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 345678899999999999999987 23 36999998653221 123578999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 999999999999999999987643 4588999999999999999999999999999999999999999999999999875
Q ss_pred ee
Q 021897 288 EV 289 (306)
Q Consensus 288 ~~ 289 (306)
..
T Consensus 156 ~~ 157 (269)
T cd05065 156 LE 157 (269)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=206.77 Aligned_cols=158 Identities=30% Similarity=0.578 Sum_probs=129.2
Q ss_pred eeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 142 AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
.||+|+||.||+|.+ .+..||+|++...... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-----SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh-----HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEe
Confidence 489999999999976 2446999998654321 123578899999999999999999999864 467999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC----
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~---- 293 (306)
+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 76 ASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999999998753 34689999999999999999999999999999999999999999999999999975432221
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....+++.|+||
T Consensus 155 ~~~~~~~~~y~aP 167 (257)
T cd05115 155 RSAGKWPLKWYAP 167 (257)
T ss_pred cCCCCCCcccCCH
Confidence 1112235778887
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=211.67 Aligned_cols=166 Identities=26% Similarity=0.343 Sum_probs=140.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--Ce
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 210 (306)
++|++.+.||+|+||.||+|++ +++.+|+|.++....... ....+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG----FPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc----chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 5788889999999999999998 578999999975443311 224567899999999999999999998877 88
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
.|+||||+++ +|.+++.... ..+++..++.++.||+.||+|||+.+++|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 81 IYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 9999999974 9999887643 3689999999999999999999999999999999999999999999999999986544
Q ss_pred C-CCccCCCCCCcccCC
Q 021897 291 T-EGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~-~~~~~~~gt~~y~AP 306 (306)
. .......+++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~aP 175 (293)
T cd07843 159 PLKPYTQLVVTLWYRAP 175 (293)
T ss_pred CccccccccccccccCc
Confidence 3 223344678899998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=211.80 Aligned_cols=165 Identities=23% Similarity=0.395 Sum_probs=140.6
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||++.+ .++.+|+|.++...... ....+.+|+.++++++||||+++++.+.....+|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES-----KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH-----HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 578889999999999999988 57899999886532211 12578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 214 VTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
||||+++++|..++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999999887532 2368999999999999999999996 59999999999999999999999999999755332
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 157 -~~~~~~~~~~y~aP 170 (286)
T cd06622 157 -LAKTNIGCQSYMAP 170 (286)
T ss_pred -ccccCCCccCccCc
Confidence 23344688889998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=211.59 Aligned_cols=169 Identities=30% Similarity=0.524 Sum_probs=137.5
Q ss_pred eccCceecceeeeeccEEEEEEEEC------------------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYN------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 194 (306)
+.++|++.+.||+|+||.||++.+. ...+|+|+++..... ...+.+.+|+.+++.++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~E~~~l~~l~ 77 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK-----NARNDFLKEIKIMSRLK 77 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH-----HHHHHHHHHHHHHHhCC
Confidence 4567899999999999999998542 236899998654321 12357889999999999
Q ss_pred CCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021897 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (306)
Q Consensus 195 h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlk 265 (306)
|+||+++++++......++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+++|||||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 99999999999999999999999999999999976321 236778899999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 266 p~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|+|||++.++.+||+|||+++....... .....+++.|+||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 201 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW 201 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence 9999999999999999999975432211 1112345678876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-27 Score=208.04 Aligned_cols=159 Identities=23% Similarity=0.332 Sum_probs=129.9
Q ss_pred eeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH---HHHhCCCCCeeeEEEEEEeCCeEEEEEe
Q 021897 142 AFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM---MLATLKHLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~iv~E 216 (306)
.||+|+||.||++.. +++.+|+|.+........... ..+.+|.. ++....||+|+.+++.+...+..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH---HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 379999999999987 678999999876543322211 22334443 3344579999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccC
Q 021897 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~ 296 (306)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+|||+++++.+||+|||++....... ...
T Consensus 78 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA 154 (279)
T ss_pred cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccC
Confidence 99999999998754 458999999999999999999999999999999999999999999999999997544322 234
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
..||+.|+||
T Consensus 155 ~~~~~~y~aP 164 (279)
T cd05633 155 SVGTHGYMAP 164 (279)
T ss_pred cCCCcCccCH
Confidence 5789999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=209.64 Aligned_cols=155 Identities=20% Similarity=0.412 Sum_probs=127.7
Q ss_pred eeeeeccEEEEEEEEC--------------------------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC
Q 021897 142 AFAQGAFGKLYRGTYN--------------------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH 195 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 195 (306)
.||+|+||.||+|.+. ...||+|++.... ....+.+.+|+.+++.++|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~~~~~~~l~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH------RDIALAFFETASLMSQVSH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH------HHHHHHHHHHHHHHhcCCC
Confidence 6899999999999741 1358888875321 1223578899999999999
Q ss_pred CCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 021897 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275 (306)
Q Consensus 196 ~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~ 275 (306)
|||+++++++.+....++||||+++++|..++... ...+++.+++.++.||+.||+|||+++|+||||||+|||+++.+
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 99999999999999999999999999999998753 34689999999999999999999999999999999999997654
Q ss_pred -------cEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 276 -------SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 276 -------~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
.+||+|||++..... .....+++.|+||
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aP 189 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAP 189 (274)
T ss_pred cccCccceeeecCCcccccccc---ccccccCCcccCc
Confidence 489999999864322 2234577889988
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=207.76 Aligned_cols=165 Identities=25% Similarity=0.491 Sum_probs=131.7
Q ss_pred eecceeeeeccEEEEEEEEC--Ce--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----
Q 021897 138 NMGTAFAQGAFGKLYRGTYN--GE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 208 (306)
.+++.||+|+||.||+|.+. +. .+|+|.++........ .+.+.+|+.+++.++||||+++++.+...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE----MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 46789999999999999873 32 6899988765433222 35788999999999999999999987432
Q ss_pred -CeEEEEEeecCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 209 -MVWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
...+++|||+++|+|.+++... ....+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 2568999999999999988532 22347899999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCC---ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+++....... .....+++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~p 183 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAI 183 (272)
T ss_pred cccccCcccceecCCcccCCcccCCH
Confidence 9986543221 1122355678876
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=209.51 Aligned_cols=166 Identities=23% Similarity=0.352 Sum_probs=143.7
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||.|+||.||+|.. +++.+|+|++........ ...+.+.+|+.++++++||||+++++.+......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK---GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch---hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEE
Confidence 477889999999999999988 578999999975433221 124678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 78 VVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999999999999764 4689999999999999999999999999999999999999999999999999886544333
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....|+..|+||
T Consensus 156 ~~~~~~~~~y~~P 168 (258)
T cd05578 156 TTSTSGTPGYMAP 168 (258)
T ss_pred ccccCCChhhcCH
Confidence 3445688889888
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=207.98 Aligned_cols=154 Identities=25% Similarity=0.478 Sum_probs=129.1
Q ss_pred ceeeeeccEEEEEEEECCe------------eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 141 TAFAQGAFGKLYRGTYNGE------------DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
+.||+|+||.||+|++... .+++|++...... ...+.+|+.++++++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-------SLAFFETASLMSQLSHKHLVKLYGVCVR- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-------HHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence 3689999999999988322 4778876543221 3578899999999999999999999988
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-------cEEEEc
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-------SIKIAD 281 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-------~vkl~D 281 (306)
...++||||+++++|.+++..... .+++..++.++.||+.||+|||+++++||||||+|||++.++ .+||+|
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 667999999999999999986532 689999999999999999999999999999999999999888 799999
Q ss_pred ccCeeeeecCCCccCCCCCCcccCC
Q 021897 282 FGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
||+++.... .....++..|+||
T Consensus 152 fg~a~~~~~---~~~~~~~~~y~aP 173 (259)
T cd05037 152 PGIPITVLS---REERVERIPWIAP 173 (259)
T ss_pred CCccccccc---ccccccCCCccCh
Confidence 999986433 2234566778887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=208.77 Aligned_cols=164 Identities=29% Similarity=0.450 Sum_probs=139.0
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
.|++.+.||+|+||.||+|.+ ++..+++|.+..... ...+.+.+|+.+++.+.||||+++++.+......|+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE------EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH------HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 356778999999999999988 567889998854321 113568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
|+||+++++|..++... ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999999999887653 3468999999999999999999999999999999999999999999999999987543221
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......+|+.|+||
T Consensus 159 ~~~~~~~~~~y~aP 172 (282)
T cd06643 159 RRDSFIGTPYWMAP 172 (282)
T ss_pred ccccccccccccCH
Confidence 22345688999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=209.85 Aligned_cols=169 Identities=33% Similarity=0.537 Sum_probs=139.8
Q ss_pred eeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
|..+++++.++||+|+||.||++.. ++..+|+|.+..... ...+.+.+|+.+++.++|+||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------SARQDFQREAELLTVLQHQHIVRFYGV 75 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH------HHHHHHHHHHHHHhcCCCCCCceEEEE
Confidence 4567888999999999999999964 345789998764322 123578899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQN-------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv 271 (306)
+......+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.+++||||||+|||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~ 155 (280)
T cd05092 76 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155 (280)
T ss_pred EecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence 9999999999999999999999975421 247889999999999999999999999999999999999
Q ss_pred cCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 272 ~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
++++.+||+|||+++....... .....+++.|+||
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 193 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCH
Confidence 9999999999999975432211 1122346789888
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=205.09 Aligned_cols=164 Identities=34% Similarity=0.653 Sum_probs=139.4
Q ss_pred eecceeeeeccEEEEEEEECC------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 138 NMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
++.+.||.|+||.||++.+.. ..||+|+++...... ..+.+.+|+.+++.+.|+||+++++++......
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 466899999999999998843 789999996554321 235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
+++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||+++.....
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999999998654333899999999999999999999999999999999999999999999999999865443
Q ss_pred CCcc--CCCCCCcccCC
Q 021897 292 EGMT--PETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~--~~~gt~~y~AP 306 (306)
.... ...+++.|+||
T Consensus 157 ~~~~~~~~~~~~~y~~P 173 (258)
T smart00219 157 DYYKKKGGKLPIRWMAP 173 (258)
T ss_pred cccccccCCCcccccCh
Confidence 2222 12367889988
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=206.15 Aligned_cols=158 Identities=32% Similarity=0.598 Sum_probs=131.1
Q ss_pred eeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 142 AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+||+|+||.||+|.+ ++..+|+|+++...... ...+.+.+|+.+++.+.||||+++++++.. ..+++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH----HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEec
Confidence 589999999999975 46789999987544332 234678899999999999999999998864 457899999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC----
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~---- 293 (306)
+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||+++.......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999999999753 4589999999999999999999999999999999999999999999999999975433221
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....+++.|+||
T Consensus 155 ~~~~~~~~~y~aP 167 (257)
T cd05116 155 KTHGKWPVKWYAP 167 (257)
T ss_pred cCCCCCCccccCH
Confidence 1122345789887
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=206.98 Aligned_cols=169 Identities=33% Similarity=0.535 Sum_probs=141.3
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCCh----hHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNP----EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+|...+.||+|+||.||+|.. +++.+|+|.++...... .......+.+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778999999999999976 67899999886432211 112233467889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||+++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999764 468899999999999999999999999999999999999999999999999997543
Q ss_pred cCC---CccCCCCCCcccCC
Q 021897 290 QTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~---~~~~~~gt~~y~AP 306 (306)
... ......|+..|+||
T Consensus 160 ~~~~~~~~~~~~~~~~y~~P 179 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAP 179 (272)
T ss_pred ccccccccccccCCccccCH
Confidence 211 12234678889987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=204.80 Aligned_cols=167 Identities=28% Similarity=0.434 Sum_probs=143.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||.|+||.||+|.. ++..+|+|++....... ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEE
Confidence 3678899999999999999987 67799999986544332 2357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 213 IVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
+|||++++++|.+++..... ..+++..++.++.|++.||+|||+.|++||||+|+||++++++.+||+|||++......
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999999999976433 46899999999999999999999999999999999999999999999999998754432
Q ss_pred CC-----ccCCCCCCcccCC
Q 021897 292 EG-----MTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~-----~~~~~gt~~y~AP 306 (306)
.. .....|++.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~y~~P 175 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAP 175 (267)
T ss_pred ccccccccccccCChhhcCh
Confidence 21 1334688999988
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=227.92 Aligned_cols=167 Identities=28% Similarity=0.480 Sum_probs=136.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--e
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--V 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~ 210 (306)
+..++...||+|+|-+||+|.+ +|..||=-.++... -.+.....++|..|+.+|+.|+||||+++|+.|.+.. .
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d--~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD--VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHH--hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 4456778999999999999977 55555522111111 1112223478999999999999999999999997754 5
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEc-CCCcEEEEcccCeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFGVARI 287 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlkp~NILv~-~~~~vkl~DFGla~~ 287 (306)
+-+|+|.|..|+|..|+++. +.+..+.+..|+.||++||.|||++. |||||||.+||+|+ ..|.|||.|+|||.+
T Consensus 118 in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 88999999999999999876 45889999999999999999999985 99999999999997 678999999999998
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
....... ...|||.||||
T Consensus 196 ~r~s~ak-svIGTPEFMAP 213 (632)
T KOG0584|consen 196 LRKSHAK-SVIGTPEFMAP 213 (632)
T ss_pred hhccccc-eeccCccccCh
Confidence 7665543 36899999999
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=208.20 Aligned_cols=156 Identities=21% Similarity=0.424 Sum_probs=129.7
Q ss_pred ceeeeeccEEEEEEEEC--------------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 141 TAFAQGAFGKLYRGTYN--------------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
+.||+|+||.||+|++. ...|++|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~------~~~~~~~~~~~~l~~l~hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR------DISLAFFETASMMRQVSHKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh------hHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 36899999999999852 12588888754221 12357889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc-------EEE
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-------IKI 279 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~-------vkl 279 (306)
.+...++||||+++++|..++... ...+++..++.++.||+.||+|||+.+++||||||+|||++.++. +|+
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 988899999999999999888653 345899999999999999999999999999999999999987664 899
Q ss_pred EcccCeeeeecCCCccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|||++..... .....+++.|+||
T Consensus 154 ~d~g~~~~~~~---~~~~~~~~~y~aP 177 (262)
T cd05077 154 SDPGIPITVLS---RQECVERIPWIAP 177 (262)
T ss_pred CCCCCCccccC---cccccccccccCh
Confidence 99999875432 2334678889998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=204.14 Aligned_cols=166 Identities=27% Similarity=0.533 Sum_probs=140.0
Q ss_pred eccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
+..+|++.+.||+|+||.||++.+ .++.+|+|.+....... ..+.+|+.+++++.||+++++++++......
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-------EDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH-------HHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 456788899999999999999988 47889999886544331 3688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||+++++|.+++.... ..++++.++.++.|++.+|+|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999999999987543 45789999999999999999999999999999999999999999999999998754322
Q ss_pred CC--ccCCCCCCcccCC
Q 021897 292 EG--MTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~--~~~~~gt~~y~AP 306 (306)
.. .....++..|+||
T Consensus 154 ~~~~~~~~~~~~~~~aP 170 (256)
T cd05112 154 QYTSSTGTKFPVKWSSP 170 (256)
T ss_pred cccccCCCccchhhcCH
Confidence 11 1122345678887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=209.51 Aligned_cols=147 Identities=27% Similarity=0.449 Sum_probs=130.1
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||++.. .++.||+|.+....... ....+.+.+|+.+++.++||||+++++.+..+..+++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL---RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh---HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 577889999999999999987 56799999987543211 1223578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.
T Consensus 79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 79 VMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999999764 4589999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=208.44 Aligned_cols=164 Identities=28% Similarity=0.462 Sum_probs=141.9
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
...|++.+.||.|++|.||+|.. +++.||+|.+....... .+.+.+|+.+++.++||||+++++.+.....+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK------KELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch------HHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 35788999999999999999986 78899999986543321 24678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+|+||+++++|.+++.. ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999999999998864 35899999999999999999999999999999999999999999999999998754332
Q ss_pred CC-ccCCCCCCcccCC
Q 021897 292 EG-MTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~-~~~~~gt~~y~AP 306 (306)
.. .....+++.|+||
T Consensus 169 ~~~~~~~~~~~~y~aP 184 (296)
T cd06655 169 QSKRSTMVGTPYWMAP 184 (296)
T ss_pred cccCCCcCCCccccCc
Confidence 22 2334688999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=197.96 Aligned_cols=171 Identities=25% Similarity=0.393 Sum_probs=146.4
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (306)
++++-.++..+..||+|++|.|=+-++ +|+..|+|.++......+. ++.+.|+.+..+. .+|.+|.+||...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q-----~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQ-----KRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHH-----HHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 556667777788999999998766655 8999999999876664433 5677888876554 6999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEccc
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
....+||.||.|+ .+|..|.++ .++..+++..+-+||..|+.||.|||++ .+||||+||+||||+.+|+|||||||
T Consensus 116 regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 116 REGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence 9999999999995 599888764 3567799999999999999999999987 89999999999999999999999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
.+.+..++-..+...|...||||
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaP 217 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAP 217 (282)
T ss_pred cceeehhhhHHHHhcCCCccCCh
Confidence 99988877766667899999998
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=210.36 Aligned_cols=168 Identities=32% Similarity=0.535 Sum_probs=139.1
Q ss_pred eccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
..++|.+.+.||+|+||.||+|.+ ++..+++|.+..... ...+.+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL------AARKDFQREAELLTNLQHEHIVKFYGVC 76 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH------HHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence 456788889999999999999975 234688888754322 1135788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv 271 (306)
......++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++++||||||+|||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 99999999999999999999997532 2347899999999999999999999999999999999999
Q ss_pred cCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 272 ~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+.++.+||+|||+++....... .....+++.|+||
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 194 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 194 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence 9999999999999975432211 1223467889998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=204.22 Aligned_cols=169 Identities=30% Similarity=0.514 Sum_probs=139.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCe
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMV 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 210 (306)
.+|+..+.||+|+||.||+|.. +++.||+|.+......... ....+.+.+|+.++++++||||+++++.+.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET-SKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh-HHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 3677889999999999999986 6789999998755433221 1223578899999999999999999999865 367
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+++++||+++++|.+++... ..+++...+.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 89999999999999999754 3588899999999999999999999999999999999999999999999999875322
Q ss_pred ----CCCccCCCCCCcccCC
Q 021897 291 ----TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ----~~~~~~~~gt~~y~AP 306 (306)
........++..|+||
T Consensus 159 ~~~~~~~~~~~~~~~~y~aP 178 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSP 178 (266)
T ss_pred ccccCCccccCCccccccCH
Confidence 1112334588899998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=207.93 Aligned_cols=169 Identities=26% Similarity=0.496 Sum_probs=139.8
Q ss_pred eccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
..++|+..+.||+|+||.||+|+. ..+.+++|.+...... ...+.+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-----NLQSEFRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-----HHHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 456788889999999999999986 2357999987543221 1235788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN-------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vk 278 (306)
.+....++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+|
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEE
Confidence 998899999999999999999986542 1589999999999999999999999999999999999999999999
Q ss_pred EEcccCeeeeecCC--CccCCCCCCcccCC
Q 021897 279 IADFGVARIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 279 l~DFGla~~~~~~~--~~~~~~gt~~y~AP 306 (306)
|+|||+++...... ......+++.|+||
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 187 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecCh
Confidence 99999987432211 12233456778887
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=206.74 Aligned_cols=169 Identities=27% Similarity=0.515 Sum_probs=137.9
Q ss_pred eeeccCceecceeeeeccEEEEEEEECC-----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
++...+|.+.+.||+|+||.||+|.+.. ..||||........ ...+.+.+|+.+++++.||||+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-----SVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-----HHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 4566788899999999999999998722 36899987643321 1235788999999999999999999998
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
... ..|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++
T Consensus 77 ~~~-~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 77 TEN-PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred cCC-CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence 765 4689999999999999997643 35899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCc--cCCCCCCcccCC
Q 021897 286 RIEVQTEGM--TPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~--~~~~gt~~y~AP 306 (306)
+........ ....+++.|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aP 177 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAP 177 (270)
T ss_pred eecccccceecCCCCccccccCh
Confidence 865433211 112344678887
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=204.71 Aligned_cols=168 Identities=25% Similarity=0.446 Sum_probs=138.0
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
++..+......||+|+||.||+|++ +++.||+|.+...... ..+.+.+|+.++++++|+||+++++++....
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR------YVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH------HHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 3444455556899999999999987 5678999988653321 1357889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEcccCee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVAR 286 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~-~~~vkl~DFGla~ 286 (306)
.+++|+||+++++|.+++.... ..+ ++..+..++.||+.||+|||+.+|+||||||+||+++. ++.+||+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999999997642 234 78888899999999999999999999999999999986 6799999999987
Q ss_pred eeecCC-CccCCCCCCcccCC
Q 021897 287 IEVQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~-~~~~~~gt~~y~AP 306 (306)
...... ......|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aP 178 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAP 178 (268)
T ss_pred ecccCCCccccCCCCccccCh
Confidence 543222 22334578899988
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=209.53 Aligned_cols=170 Identities=31% Similarity=0.527 Sum_probs=139.6
Q ss_pred eeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
++..+|++.+.||+|+||.||+|.+ ++..+|+|++...... ...+.+.+|+.+++++.||||++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-----HHHHHHHHHHHHHHhcCCCchheEEEE
Confidence 4567888999999999999999986 3468999998643321 123578899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL 264 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDl 264 (306)
+......+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+.+++||||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 156 (288)
T cd05050 77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156 (288)
T ss_pred EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 999889999999999999999997532 124678888999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 265 KSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 265 kp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
||+||+++.++.+||+|||+++....... ......++.|+||
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP 201 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence 99999999999999999999875432211 1122345678887
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=206.33 Aligned_cols=159 Identities=21% Similarity=0.293 Sum_probs=130.1
Q ss_pred eeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHH---HHHHHhCCCCCeeeEEEEEEeCCeEEEEEe
Q 021897 142 AFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE---VMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~iv~E 216 (306)
.||+|+||.||++.. +++.||+|++........... ..+..| +.+++...||+|+++++.+.....+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH---HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 379999999999976 678999999876543322111 123333 344555689999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccC
Q 021897 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~ 296 (306)
|+++++|.+++... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++..... ....
T Consensus 78 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA 154 (278)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcC
Confidence 99999999988653 46899999999999999999999999999999999999999999999999998754332 2334
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
..|++.|+||
T Consensus 155 ~~~~~~y~aP 164 (278)
T cd05606 155 SVGTHGYMAP 164 (278)
T ss_pred cCCCcCCcCc
Confidence 5799999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=203.51 Aligned_cols=167 Identities=26% Similarity=0.443 Sum_probs=142.2
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||+++. +++.+|+|.+......... .+++.+|+.++++++||||+++++++......++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE----REESRKEVAVLSNMKHPNIVQYQESFEENGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHH----HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEE
Confidence 467889999999999999987 6789999998754332221 2578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
|+||+++++|.+++.......+++..++.++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999999999865555689999999999999999999999999999999999999999999999999976433221
Q ss_pred -ccCCCCCCcccCC
Q 021897 294 -MTPETGTYRWMAP 306 (306)
Q Consensus 294 -~~~~~gt~~y~AP 306 (306)
.....|++.|+||
T Consensus 157 ~~~~~~~~~~~~~p 170 (256)
T cd08218 157 LARTCIGTPYYLSP 170 (256)
T ss_pred hhhhccCCccccCH
Confidence 2233578889887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=202.99 Aligned_cols=160 Identities=34% Similarity=0.561 Sum_probs=133.3
Q ss_pred ceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecC
Q 021897 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~ 219 (306)
+.||+|+||.||+|.. +++.+|+|+++..... .....+.+|+.+++.++||||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-----ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH-----HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 3689999999999987 6678999998654321 123468899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc--cCC
Q 021897 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM--TPE 297 (306)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~--~~~ 297 (306)
+++|.+++.... ..+++..++.++.|++.+|.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 76 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 76 GGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 999999987543 45789999999999999999999999999999999999999999999999999754322211 112
Q ss_pred CCCCcccCC
Q 021897 298 TGTYRWMAP 306 (306)
Q Consensus 298 ~gt~~y~AP 306 (306)
.+++.|+||
T Consensus 155 ~~~~~y~aP 163 (250)
T cd05085 155 QIPIKWTAP 163 (250)
T ss_pred CCcccccCH
Confidence 345678887
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=205.37 Aligned_cols=163 Identities=30% Similarity=0.483 Sum_probs=141.7
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||.|++|.||+|.. +++.+|+|++....... ....+.+|+.+++.++||||+++++.+.+...+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-----EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch-----HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 577788999999999999987 67899999987543221 12467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-C
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~-~ 292 (306)
|+||+++++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||++++++.++|+|||+++..... .
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999999999998753 6899999999999999999999999999999999999999999999999999876543 2
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 154 ~~~~~~~~~~y~~P 167 (274)
T cd06609 154 KRNTFVGTPFWMAP 167 (274)
T ss_pred ccccccCCccccCh
Confidence 23445788899998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=208.25 Aligned_cols=167 Identities=21% Similarity=0.354 Sum_probs=139.5
Q ss_pred CceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (306)
+|++.+.||+|+||.||+++. +++.||+|+++...... .....+.+.+|+.+++++ +|++|+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ--KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh--cchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 367789999999999999976 67899999987532211 111235678899999999 5999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
..|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+|||++.++.+||+|||+++...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999999999764 458899999999999999999999999999999999999999999999999998653
Q ss_pred cCC--CccCCCCCCcccCC
Q 021897 290 QTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~--~~~~~~gt~~y~AP 306 (306)
... ......|+..|+||
T Consensus 157 ~~~~~~~~~~~~~~~y~aP 175 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAP 175 (290)
T ss_pred cccccccccccCCcccCCh
Confidence 322 12334688899988
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-26 Score=203.46 Aligned_cols=169 Identities=27% Similarity=0.505 Sum_probs=139.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--Ce
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 210 (306)
.+|++.+.||+|+||.||+|+. +++.+|+|++........ .......+.+|+.++++++||||+++++.+... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE-TSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch-hhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 4678899999999999999986 678999998854322211 112245788999999999999999999998664 46
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+++++||+++++|.+++... ..+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 89999999999999998753 3478899999999999999999999999999999999999999999999999975432
Q ss_pred ----CCCccCCCCCCcccCC
Q 021897 291 ----TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ----~~~~~~~~gt~~y~AP 306 (306)
........++..|+||
T Consensus 159 ~~~~~~~~~~~~~~~~y~aP 178 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSP 178 (264)
T ss_pred ccccCccccccCCcccccCH
Confidence 1122334688899998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=205.23 Aligned_cols=169 Identities=28% Similarity=0.499 Sum_probs=138.8
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
|...+|+..+.||+|+||.||+|+. ++ ..+|+|.++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK-----QRQDFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH-----HHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 3456788889999999999999987 33 368999886543221 1356889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
.....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 9999999999999999999987543 468999999999999999999999999999999999999999999999999997
Q ss_pred eeecCCCc--c--CCCCCCcccCC
Q 021897 287 IEVQTEGM--T--PETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~--~--~~~gt~~y~AP 306 (306)
........ . ....++.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~P 179 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAP 179 (268)
T ss_pred ecccccccceeccCCCcCceecCH
Confidence 55332211 1 11223568887
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-26 Score=202.85 Aligned_cols=165 Identities=30% Similarity=0.522 Sum_probs=141.8
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|+..+.||+|+||.||+|.. +++.+|+|+++..... ....+.+.+|+.+++.++|+||+++++.+.....+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc----hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEE
Confidence 467789999999999999987 6789999999765543 2234688999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
|+||+++++|.+++... ..+++..++.++.|++.||+|||+.+++|+||+|+||++++++.+||+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 77 FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999999999753 3578889999999999999999999999999999999999999999999999876543222
Q ss_pred c-----cCCCCCCcccCC
Q 021897 294 M-----TPETGTYRWMAP 306 (306)
Q Consensus 294 ~-----~~~~gt~~y~AP 306 (306)
. ....+++.|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~P 172 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAP 172 (264)
T ss_pred cccccccCCcCCcCccCh
Confidence 1 124578889988
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=204.16 Aligned_cols=159 Identities=24% Similarity=0.338 Sum_probs=137.5
Q ss_pred eeeeccEEEEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCC
Q 021897 143 FAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (306)
Q Consensus 143 lG~G~fG~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~ 220 (306)
||.|++|.||+++.. ++.+|+|++........ ...+.+.+|+.+++.++||||+++++.+.++..+++++||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET---GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh---hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 689999999999984 78999999975443221 2246789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCC
Q 021897 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (306)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt 300 (306)
++|.+++.+. ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.+||+|||+++............++
T Consensus 78 ~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 78 GELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence 9999999764 45889999999999999999999999999999999999999999999999999865543333345688
Q ss_pred CcccCC
Q 021897 301 YRWMAP 306 (306)
Q Consensus 301 ~~y~AP 306 (306)
+.|+||
T Consensus 156 ~~~~~P 161 (262)
T cd05572 156 PEYVAP 161 (262)
T ss_pred cCccCh
Confidence 899998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=205.26 Aligned_cols=163 Identities=33% Similarity=0.561 Sum_probs=139.3
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCe
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMV 210 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~ 210 (306)
.|+..+.||+|+||.||+|.+ +++.+|+|.++....... ..++.+|+.++++++ |||++++++++.....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-----VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh-----HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 366778999999999999987 678999999875433221 246778999999986 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999999999864 3688999999999999999999999999999999999999999999999999986543
Q ss_pred CCC-ccCCCCCCcccCC
Q 021897 291 TEG-MTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~-~~~~~gt~~y~AP 306 (306)
... .....|++.|+||
T Consensus 154 ~~~~~~~~~~~~~y~aP 170 (277)
T cd06917 154 NSSKRSTFVGTPYWMAP 170 (277)
T ss_pred CccccccccCCcceeCH
Confidence 322 2334688999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=205.56 Aligned_cols=160 Identities=33% Similarity=0.542 Sum_probs=129.0
Q ss_pred eeeeeccEEEEEEEE--CCe--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEEEEEe
Q 021897 142 AFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~E 216 (306)
.||+|+||.||+|++ ++. .+++|.++...... ..+.+.+|+.+++++ +||||+++++++.....+++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHH-----HHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 589999999999987 333 56888876322211 135788999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 217 YAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
|+++++|.+++.... ...+++..++.++.|++.||+|||+.+++||||||+|||+++++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 999999999997532 124788999999999999999999999999999999999999999999999
Q ss_pred cCeeeeecCCCccCCCCCCcccCC
Q 021897 283 GVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|+++.............++.|+||
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~ap 180 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAI 180 (270)
T ss_pred CCccccchhhhccCCCCccccCCh
Confidence 998643221111222335678887
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=209.30 Aligned_cols=165 Identities=25% Similarity=0.436 Sum_probs=138.8
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||+|++ +|+.+|+|.++....... ....+.+|+.++++++||||+++++++.+...+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc----CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEE
Confidence 367788999999999999988 688999999875433211 12457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
|+||++ ++|.+++... ...+++..++.++.||+.||.|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 77 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 77 VFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred EEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 999996 5888887654 3458999999999999999999999999999999999999999999999999998543322
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 155 ~~~~~~~~~~y~aP 168 (284)
T cd07839 155 CYSAEVVTLWYRPP 168 (284)
T ss_pred CcCCCccccCCcCh
Confidence 22334678899998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=207.73 Aligned_cols=166 Identities=23% Similarity=0.407 Sum_probs=142.3
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
..++|++.+.||+|+||.||++.+ +++.+|+|++...... ...+.+.+|+.+++.++||||+++++.+.....
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-----SVRKQILRELQIMHECRSPYIVSFYGAFLNENN 77 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc-----hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence 346788899999999999999987 5889999998653321 123578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
+++||||+++++|.+++... ..+++..+..++.+++.+|.|||+ .+++||||||+||++++++.++|+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999999988753 458999999999999999999997 699999999999999999999999999987543
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.. .....+||..|+||
T Consensus 156 ~~-~~~~~~~~~~~~aP 171 (284)
T cd06620 156 NS-IADTFVGTSTYMSP 171 (284)
T ss_pred hh-ccCccccCcccCCH
Confidence 22 22345789999988
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=205.87 Aligned_cols=170 Identities=25% Similarity=0.434 Sum_probs=140.1
Q ss_pred eeccCceecceeeeeccEEEEEEEEC------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
++.++|++.+.||+|+||.||+|.+. +..|++|.+...... ...+.+.+|+.+++++.||||+++++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE-----IQVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 56678899999999999999999873 478999988643221 1235788999999999999999999988
Q ss_pred Ee-CCeEEEEEeecCCCCHHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 021897 206 RK-RMVWCIVTEYAKGGSVRQFLTRRQN------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (306)
Q Consensus 206 ~~-~~~~~iv~E~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vk 278 (306)
.. ....++++||+++++|.+++..... ..+++..++.++.|++.||+|||+.+++||||||+||++++++.+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEE
Confidence 66 4678999999999999999976432 4588999999999999999999999999999999999999999999
Q ss_pred EEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 279 IADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 279 l~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|+|||+++....... .....++..|+||
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap 188 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCH
Confidence 999999985432221 1223456778887
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=202.36 Aligned_cols=164 Identities=29% Similarity=0.472 Sum_probs=142.4
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|+..+.||+|+||.||+|.+ +++.+++|.++.... .+++.+|+.++++++||||+++++.+......
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDL 73 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence 35788889999999999999988 468999999864321 36789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+++||+++++|.+++... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 9999999999999998753 356899999999999999999999999999999999999999999999999999865433
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......++..|+||
T Consensus 153 ~~~~~~~~~~~~y~~P 168 (256)
T cd06612 153 MAKRNTVIGTPFWMAP 168 (256)
T ss_pred ccccccccCCccccCH
Confidence 2 22334588899988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-26 Score=201.72 Aligned_cols=167 Identities=26% Similarity=0.441 Sum_probs=141.0
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCeE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMVW 211 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 211 (306)
+|++.+.||.|+||.||++.. +++.+|+|++......... .+++.+|+.++++++||||+++++.+.. ....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE----KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEE
Confidence 467788999999999999987 6789999998765443322 3578899999999999999999998754 4578
Q ss_pred EEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVH-----GLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH-----~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
+++|||+++++|.+++... ....+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.+||+|||+
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999999999753 2356899999999999999999999 89999999999999999999999999999
Q ss_pred eeeeecCCC-ccCCCCCCcccCC
Q 021897 285 ARIEVQTEG-MTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~-~~~~~gt~~y~AP 306 (306)
+........ .....+++.|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~p 179 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSP 179 (265)
T ss_pred cccccCCcccccccccCCCccCh
Confidence 987554332 3345688999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=206.15 Aligned_cols=167 Identities=26% Similarity=0.420 Sum_probs=138.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|++|.||+|++ +++.||+|.+........ ..+.+.+|+.++++++||||+++++++.....+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc----chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence 4688889999999999999987 678999999865433211 1246789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEcccCeeeeecC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQT 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~-~~~vkl~DFGla~~~~~~ 291 (306)
+||||++ ++|.+++.......+++..++.++.||+.||+|||+++++||||+|+||++++ ++.+||+|||++......
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9999996 58888887655455688889999999999999999999999999999999985 557999999999754322
Q ss_pred -CCccCCCCCCcccCC
Q 021897 292 -EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 -~~~~~~~gt~~y~AP 306 (306)
.......+++.|+||
T Consensus 157 ~~~~~~~~~~~~y~~P 172 (294)
T PLN00009 157 VRTFTHEVVTLWYRAP 172 (294)
T ss_pred ccccccCceeecccCH
Confidence 122334678889887
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=206.10 Aligned_cols=169 Identities=32% Similarity=0.528 Sum_probs=136.6
Q ss_pred eccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
..++|++.+.||+|++|.||+|.+. +..||+|.+....... .+..+.+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-----DESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4467888999999999999999883 3578889875432221 135688999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cE
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SI 277 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~---~v 277 (306)
.+....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++++||||||+||+++.++ .+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 998889999999999999999976432 2588999999999999999999999999999999999998765 69
Q ss_pred EEEcccCeeeeecCCCc---cCCCCCCcccCC
Q 021897 278 KIADFGVARIEVQTEGM---TPETGTYRWMAP 306 (306)
Q Consensus 278 kl~DFGla~~~~~~~~~---~~~~gt~~y~AP 306 (306)
||+|||+++........ .....++.|+||
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 190 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCH
Confidence 99999999865322111 111234678887
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=204.38 Aligned_cols=167 Identities=32% Similarity=0.618 Sum_probs=138.7
Q ss_pred ccCceecceeeeeccEEEEEEEEC------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
.++|++.+.||+|+||.||+|+++ ++.+|||+++..... ...+.+.+|+.+++.+.||||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~ 77 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-----QHRSDFEREIEILRTLDHENIVKYKGVCEK 77 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-----HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence 356778899999999999999863 578999999754432 123679999999999999999999999977
Q ss_pred --CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 208 --RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 208 --~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
....+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 557899999999999999997643 35899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCc----cCCCCCCcccCC
Q 021897 286 RIEVQTEGM----TPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~----~~~~gt~~y~AP 306 (306)
......... ....++..|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~P 181 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAP 181 (284)
T ss_pred cccccCCcceeccCCCCCcccccCc
Confidence 865422111 122344567777
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=203.74 Aligned_cols=166 Identities=31% Similarity=0.504 Sum_probs=140.8
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC-
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 209 (306)
..+|++.+.||+|++|.||+|.. +++.+++|++...... .+.+.+|+.+++++ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-------EEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-------HHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 46788899999999999999988 5678999998754321 24688999999999 6999999999997644
Q ss_pred -----eEEEEEeecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 210 -----VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 210 -----~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
.+|+||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999987643 457899999999999999999999999999999999999999999999999
Q ss_pred cCeeeeecCC-CccCCCCCCcccCC
Q 021897 283 GVARIEVQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~-~~~~~~gt~~y~AP 306 (306)
|++....... ......|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aP 182 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAP 182 (275)
T ss_pred ccceecccchhhhcCccccccccCH
Confidence 9987543222 22345688899988
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=207.19 Aligned_cols=166 Identities=28% Similarity=0.465 Sum_probs=140.5
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|+..+.||.|++|.||+|+. +++.||||.++....... ..+.+.+|+.++++++||||+++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc----cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEE
Confidence 367788999999999999987 678999998865433221 12468899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
||||+. ++|.+++.......+++..++.++.|++.||+|||+.+++||||+|+||+++.++.+||+|||+++......
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 999996 689999877656678999999999999999999999999999999999999999999999999987543222
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 156 ~~~~~~~~~~y~aP 169 (284)
T cd07860 156 TYTHEVVTLWYRAP 169 (284)
T ss_pred ccccccccccccCC
Confidence 22334578889988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=204.73 Aligned_cols=165 Identities=26% Similarity=0.418 Sum_probs=139.0
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|+..+.||.|++|.||+|+. +++.||||+++....... ...+.+|+.++++++||||+++++.+...+.+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-----PSTAIREISLMKELKHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc-----hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEE
Confidence 467889999999999999998 688999999876443221 2456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 214 VTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
||||+++ +|.+++.... ...+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|||+++......
T Consensus 76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9999975 8988887543 2458999999999999999999999999999999999999999999999999997543221
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......+|+.|+||
T Consensus 155 ~~~~~~~~~~~y~~P 169 (284)
T cd07836 155 NTFSNEVVTLWYRAP 169 (284)
T ss_pred cccccccccccccCh
Confidence 12334678889887
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=206.66 Aligned_cols=165 Identities=28% Similarity=0.415 Sum_probs=138.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|+||.||+|.+ +++.||+|.++...... ...+.+.+|+.+++++.|+||+++++++.....+++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE----DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc----cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 578889999999999999988 57899999986543322 123578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
||||++++.+..+... ...+++..++.++.||+.||.|||+.+++|+||+|+||++++++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 78 VFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999988666555543 2458999999999999999999999999999999999999999999999999988654332
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......++..|+||
T Consensus 156 ~~~~~~~~~~~~~~P 170 (288)
T cd07833 156 SPLTDYVATRWYRAP 170 (288)
T ss_pred ccccCcccccCCcCC
Confidence 23345678889998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=212.53 Aligned_cols=164 Identities=27% Similarity=0.391 Sum_probs=137.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 208 (306)
.++|+..+.||+|+||.||+|.. +++.||||++......... ...+.+|+.++++++||||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH----AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhH----HHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 36788889999999999999987 7889999998654332221 24577899999999999999999998643
Q ss_pred ---CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
...|+||||+. ++|.+.+... ++...+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999996 5888887542 888899999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+............+|+.|+||
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aP 186 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAP 186 (353)
T ss_pred eeCCCCCCCCCCcccccccCH
Confidence 865544334445788999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=203.32 Aligned_cols=163 Identities=29% Similarity=0.454 Sum_probs=139.6
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
.|+..+.||.|+||.||+|.+ .++.||+|++...... ...+.+.+|+.+++.+.||||+++++.+.+...+|+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 466778999999999999987 5789999998754322 123678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 80 IMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999999999864 3588889999999999999999999999999999999999999999999999976543221
Q ss_pred -ccCCCCCCcccCC
Q 021897 294 -MTPETGTYRWMAP 306 (306)
Q Consensus 294 -~~~~~gt~~y~AP 306 (306)
.....++..|+||
T Consensus 157 ~~~~~~~~~~y~ap 170 (277)
T cd06640 157 KRNTFVGTPFWMAP 170 (277)
T ss_pred ccccccCcccccCH
Confidence 2234578889887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=220.07 Aligned_cols=164 Identities=18% Similarity=0.348 Sum_probs=130.9
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC------CCCeeeEE
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK------HLNIVRFI 202 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~ 202 (306)
.+...+|++.+.||+|+||.||+|.+ .++.||||+++..... ...+..|+.+++.++ |+++++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-------TRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh-------HHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 34457899999999999999999987 6788999999642211 123445666665554 45689999
Q ss_pred EEEEeC-CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCC-----
Q 021897 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADK----- 275 (306)
Q Consensus 203 ~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~----- 275 (306)
+++... ..+|||||++ +++|.+++.+. ..+++..+..++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 988764 5789999998 77899988754 468999999999999999999998 5999999999999998765
Q ss_pred -----------cEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 276 -----------SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 276 -----------~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
.+||+|||++.... ......+||+.|+||
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~AP 314 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSP 314 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc--cccccccCCccccCc
Confidence 49999999986432 234456899999999
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=205.54 Aligned_cols=166 Identities=29% Similarity=0.499 Sum_probs=139.1
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe---
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK--- 207 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 207 (306)
...|++.+.||+|+||.||+|.+ .++.+|+|++..... ...++..|+.+++++ .||||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-------EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-------HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 35677788999999999999988 678999999864321 124577899999988 69999999999853
Q ss_pred ---CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 208 ---RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 208 ---~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
...+|++|||+++++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||++++++.+||+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 45789999999999999999876666788999999999999999999999999999999999999999999999999
Q ss_pred eeeeecC-CCccCCCCCCcccCC
Q 021897 285 ARIEVQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~-~~~~~~~gt~~y~AP 306 (306)
+...... .......|++.|+||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aP 190 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAP 190 (282)
T ss_pred hhhhhccccCCCcccccccccCH
Confidence 8754321 123345688999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=202.24 Aligned_cols=160 Identities=31% Similarity=0.509 Sum_probs=134.8
Q ss_pred ceeeeeccEEEEEEEEC---C--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEE
Q 021897 141 TAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~ 215 (306)
+.||+|++|.||+|.+. + ..||||.+...... ...+.+.+|+.++++++||||+++++.+.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence 36899999999999872 2 36999998764442 234688999999999999999999999988 8899999
Q ss_pred eecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC--
Q 021897 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293 (306)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~-- 293 (306)
||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999999999875435689999999999999999999999999999999999999999999999999986543211
Q ss_pred --ccCCCCCCcccCC
Q 021897 294 --MTPETGTYRWMAP 306 (306)
Q Consensus 294 --~~~~~gt~~y~AP 306 (306)
.....++..|+||
T Consensus 155 ~~~~~~~~~~~y~~p 169 (257)
T cd05040 155 VMEEHLKVPFAWCAP 169 (257)
T ss_pred ecccCCCCCceecCH
Confidence 1123467788887
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=200.20 Aligned_cols=164 Identities=29% Similarity=0.464 Sum_probs=142.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|++|.||+|+. +++.++||.+...... ...+.+.+|+..+++++||||+++++.+......++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 577889999999999999988 5789999998765432 123678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
|+||+++++|.+++... ..+++...+.++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999999999764 568999999999999999999999 999999999999999999999999999998654333
Q ss_pred Cc-cCCCCCCcccCC
Q 021897 293 GM-TPETGTYRWMAP 306 (306)
Q Consensus 293 ~~-~~~~gt~~y~AP 306 (306)
.. ....++..|+||
T Consensus 155 ~~~~~~~~~~~y~~p 169 (264)
T cd06623 155 DQCNTFVGTVTYMSP 169 (264)
T ss_pred CcccceeecccccCH
Confidence 22 234678889887
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=203.67 Aligned_cols=166 Identities=28% Similarity=0.470 Sum_probs=138.7
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR-- 208 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-- 208 (306)
..+|++.+.||+|+||.||+++. +++.+|+|++...... ...+.+|+.+++++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-------DEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-------HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 46788899999999999999987 6789999998643221 24577899999998 799999999998654
Q ss_pred ---CeEEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 209 ---MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
..+|+||||+++++|.+++... ....+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 3589999999999999998642 34568999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCC-CccCCCCCCcccCC
Q 021897 284 VARIEVQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~-~~~~~~gt~~y~AP 306 (306)
+++...... ......|++.|+||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aP 197 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAP 197 (291)
T ss_pred cchhcccccccccCccCCccccCh
Confidence 987643322 22334688889988
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=202.91 Aligned_cols=163 Identities=29% Similarity=0.468 Sum_probs=138.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
-|+..+.||.|+||.||+|.. +++.+|||++...... ...+.+.+|+.+++++.||||+++++.+......|+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 356778999999999999986 6789999988643322 123578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
||||+++++|.+++.. ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 80 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999999999864 358899999999999999999999999999999999999999999999999987543321
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......++..|+||
T Consensus 157 ~~~~~~~~~~y~~P 170 (277)
T cd06641 157 KRNTFVGTPFWMAP 170 (277)
T ss_pred hhccccCCccccCh
Confidence 22334678889887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=207.48 Aligned_cols=166 Identities=25% Similarity=0.402 Sum_probs=140.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|.+ .++.+|+|++....... ...+.+.+|+.+++.++||||+++++++......|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK----MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc----hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEE
Confidence 3577889999999999999998 57899999986544332 12356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+|+||+++++|.++.... ..+++..++.++.||+.||+|||+.+++|+||+|+||++++++.+||+|||++.......
T Consensus 77 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999998888776542 348999999999999999999999999999999999999999999999999998643322
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......++..|+||
T Consensus 155 ~~~~~~~~~~~y~aP 169 (286)
T cd07846 155 EVYTDYVATRWYRAP 169 (286)
T ss_pred cccCcccceeeccCc
Confidence 22334678889988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=205.35 Aligned_cols=164 Identities=30% Similarity=0.448 Sum_probs=141.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|++|.||++.. +++.+|+|.+...... ...+++.+|+.+++++.||||+++++.+.....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-----AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-----HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 567788999999999999988 5789999998764432 223678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
++||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999999997643 568999999999999999999999 999999999999999999999999999987553322
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
. ....+++.|+||
T Consensus 156 ~-~~~~~~~~y~~P 168 (265)
T cd06605 156 A-KTFVGTSSYMAP 168 (265)
T ss_pred h-hcccCChhccCH
Confidence 2 226788889988
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=225.04 Aligned_cols=172 Identities=22% Similarity=0.290 Sum_probs=130.6
Q ss_pred ccCceecceeeeeccEEEEEEEEC---CeeEEEEEeeCCCCC-----------hhHHHHHHHHHHHHHHHHHhCCCCCee
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENN-----------PEKAQVMEQQFQQEVMMLATLKHLNIV 199 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~~---~~~vavK~~~~~~~~-----------~~~~~~~~~~~~~E~~~l~~l~h~niv 199 (306)
..+|++++.||+|+||+||++.+. +...++|.+...... ..........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 368999999999999999998752 222233311100000 000112235688999999999999999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 021897 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276 (306)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~ 276 (306)
++++++......|+|+|++. ++|.+++.... ........++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 58888775422 112345667889999999999999999999999999999999999
Q ss_pred EEEEcccCeeeeecCCC--ccCCCCCCcccCC
Q 021897 277 IKIADFGVARIEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 277 vkl~DFGla~~~~~~~~--~~~~~gt~~y~AP 306 (306)
+||+|||+|+....... ....+||+.|+||
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aP 337 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSP 337 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCc
Confidence 99999999986543322 2335799999998
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=212.30 Aligned_cols=160 Identities=17% Similarity=0.198 Sum_probs=121.4
Q ss_pred eccCceecceeeeeccEEEEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee-EEEEEEeC
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-FIGACRKR 208 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~ 208 (306)
-...|.+.+.||+|+||+||+|.+ +++.+|||++........ .....+.+.+|+.+|++++|+|++. +++.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~-~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS-KPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc-cHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 346788999999999999999976 467789998753211000 1122356899999999999999985 5442
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEEcCCCcEEEEcccCeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL-KSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDl-kp~NILv~~~~~vkl~DFGla~~ 287 (306)
...||||||+++++|... .. .. ...++.|++.+|+|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 347999999999999632 11 11 1467889999999999999999999 99999999999999999999986
Q ss_pred eecCC---------CccCCCCCCcccCC
Q 021897 288 EVQTE---------GMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~---------~~~~~~gt~~y~AP 306 (306)
..... ..+..++++.|+||
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~p 189 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAP 189 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCc
Confidence 54322 11334577778887
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=208.31 Aligned_cols=167 Identities=29% Similarity=0.559 Sum_probs=135.7
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
...+|+..+.||+|+||.||+|.+ ++. .+|+|.+....... ....+.+|+.+++.+.||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-----ANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 346777889999999999999987 444 57888876433221 1246889999999999999999999997
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
... .++++||+++|+|.+++... ...+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~-~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 80 SPT-IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CCC-ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 654 67999999999999998754 2358899999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC---ccCCCCCCcccCC
Q 021897 287 IEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~---~~~~~gt~~y~AP 306 (306)
....... .....++..|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~P 180 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMAL 180 (303)
T ss_pred cccCcccccccCCCccccccCCH
Confidence 6543221 1223356789887
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=200.65 Aligned_cols=158 Identities=32% Similarity=0.569 Sum_probs=130.7
Q ss_pred ceeeeeccEEEEEEEE--CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEE
Q 021897 141 TAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~ 215 (306)
+.||+|+||.||+|.+ .+ ..+|+|.+...... ...+++.+|+.+++.+.||||+++++++.. ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-----AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEE
Confidence 4689999999999987 22 57999998765443 223578899999999999999999998764 4579999
Q ss_pred eecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc-
Q 021897 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM- 294 (306)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~- 294 (306)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++........
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999999997643 6899999999999999999999999999999999999999999999999999865433221
Q ss_pred ---cCCCCCCcccCC
Q 021897 295 ---TPETGTYRWMAP 306 (306)
Q Consensus 295 ---~~~~gt~~y~AP 306 (306)
....++..|+||
T Consensus 153 ~~~~~~~~~~~y~aP 167 (257)
T cd05060 153 RATTAGRWPLKWYAP 167 (257)
T ss_pred ccccCccccccccCH
Confidence 111234678887
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=220.17 Aligned_cols=165 Identities=29% Similarity=0.495 Sum_probs=143.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK---- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~---- 207 (306)
..|++.+.||.|.+|.||+++. +++.+|+|++....... +++..|.++++.+. |||++.+||++..
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-------eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-------EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-------HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3455678999999999999875 88999999987655443 46778899998875 9999999999854
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
++.+|||||||.+|+..|+++...+..+.|.++..|++.++.|+.+||...+||||||-.|||++.++.|||+|||++.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 4689999999999999999998778889999999999999999999999999999999999999999999999999987
Q ss_pred eeec-CCCccCCCCCCcccCC
Q 021897 287 IEVQ-TEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~-~~~~~~~~gt~~y~AP 306 (306)
.... .....+..|||.||||
T Consensus 172 QldsT~grRnT~iGtP~WMAP 192 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAP 192 (953)
T ss_pred eeecccccccCcCCCcccccc
Confidence 5443 3345667899999999
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=206.29 Aligned_cols=172 Identities=24% Similarity=0.432 Sum_probs=142.9
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA 204 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 204 (306)
.+|.++.++|++.+.||+|+||.||+|.+. ++.||||.++....... ...+.+|+.++.++. ||||++++++
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-----HHHHHHHHHHHHhccCCCchHhhhee
Confidence 457778899999999999999999999984 88999999976543221 245667777666664 9999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
+......|++|||+. ++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 83 FITDSDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eecCCeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence 999999999999995 47887776543 468999999999999999999997 599999999999999999999999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
++.............+++.|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aP 183 (296)
T cd06618 161 ISGRLVDSKAKTRSAGCAAYMAP 183 (296)
T ss_pred cchhccCCCcccCCCCCccccCH
Confidence 99865544434445678889988
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=206.68 Aligned_cols=168 Identities=29% Similarity=0.413 Sum_probs=138.9
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 208 (306)
+..+|++.+.||+|+||.||+|.. +++.||+|+++........ ...+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI----PISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC----cchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 456788999999999999999987 6889999998754332211 12456899999999999999999998755
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+++||||+++ +|.+++.... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 81 DSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred CeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 568999999964 8988887543 56899999999999999999999999999999999999999999999999999865
Q ss_pred ecC-CCccCCCCCCcccCC
Q 021897 289 VQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~-~~~~~~~gt~~y~AP 306 (306)
... .......+++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~y~aP 177 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAP 177 (309)
T ss_pred CCccCCCCcccccccccCh
Confidence 432 222333567889988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=198.63 Aligned_cols=167 Identities=24% Similarity=0.494 Sum_probs=143.5
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||.|+||.||++.+ +++.+++|++......... .+.+.+|+++++.++|||++++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE----REDALNEVKILKKLNHPNIIKYYESFEEKGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHH----HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEE
Confidence 467788999999999999988 4789999999765443222 3568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 214 VTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||+++++|.+++.... ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999999998653 466899999999999999999999999999999999999999999999999999865433
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......|++.|+||
T Consensus 157 ~~~~~~~~~~~~y~~p 172 (258)
T cd08215 157 VDLAKTVVGTPYYLSP 172 (258)
T ss_pred cceecceeeeecccCh
Confidence 2 22334688889987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=208.23 Aligned_cols=166 Identities=23% Similarity=0.429 Sum_probs=136.0
Q ss_pred ceecceeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--Ce
Q 021897 137 LNMGTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MV 210 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 210 (306)
|++.+.||+|+||.||+|.. .++.||+|.+........ ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT---GISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc---CccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 66788999999999999987 468999999976432111 1124677899999999999999999999888 88
Q ss_pred EEEEEeecCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC----CCcEEEEccc
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA----DKSIKIADFG 283 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~----~~~vkl~DFG 283 (306)
+++||||+++ +|.+++.... ...+++..++.++.||+.||.|||+.+++||||||+||+++. ++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999965 7777775432 236889999999999999999999999999999999999999 9999999999
Q ss_pred CeeeeecCCC----ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~AP 306 (306)
+++....... .....+|+.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aP 184 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAP 184 (316)
T ss_pred cccccCCCcccccccCCccccccccCH
Confidence 9986432221 2334678889998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-28 Score=225.73 Aligned_cols=170 Identities=26% Similarity=0.325 Sum_probs=154.7
Q ss_pred eeccCceecceeeeeccEEEEEEEECCee--EEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+.+++++.+..||-|+||.|=+++.+++. +|+|++++......+++ +.+..|-.+|..++.|.||++|..|.+..
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQq---eHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQ---EHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHH---HHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 45678888899999999999999886665 89999987666544432 56789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|++||-|-||.|..+|+.+ ..+...++..++..+++|++|||++|||+|||||+|++++.+|-+||.|||+|+...
T Consensus 494 yvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999999999875 458999999999999999999999999999999999999999999999999999988
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.+...+++||||.|.||
T Consensus 572 ~g~KTwTFcGTpEYVAP 588 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAP 588 (732)
T ss_pred cCCceeeecCCcccccc
Confidence 88889999999999999
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=204.42 Aligned_cols=166 Identities=27% Similarity=0.415 Sum_probs=135.7
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCe--
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV-- 210 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-- 210 (306)
+|+..+.||+|+||.||+|.+ +++.||||.++....... ....+.+|+.+++++. ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG----IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC----CchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 577889999999999999987 678999999865432211 1246778999999995 6999999999977665
Q ss_pred ---EEEEEeecCCCCHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEccc
Q 021897 211 ---WCIVTEYAKGGSVRQFLTRRQ---NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFG 283 (306)
Q Consensus 211 ---~~iv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~-~~~vkl~DFG 283 (306)
+|+||||+++ +|.+++.... ...+++..++.++.||+.||+|||+.+++||||||+||+++. ++.+||+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 8988887542 245799999999999999999999999999999999999998 8899999999
Q ss_pred CeeeeecC-CCccCCCCCCcccCC
Q 021897 284 VARIEVQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~-~~~~~~~gt~~y~AP 306 (306)
+++..... .......+++.|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aP 180 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAP 180 (295)
T ss_pred cceecCCCccccCCcccccCCCCh
Confidence 99854322 122333567889888
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=196.61 Aligned_cols=165 Identities=36% Similarity=0.589 Sum_probs=142.7
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|++|.||+++. .++.+++|.+....... ...+.+.+|++++++++|||++++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE----EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH----HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Confidence 367789999999999999987 56799999997654331 223678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
+|||+++++|.+++... ..+++..++.++.|++.+|.|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 77 ILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999999999764 5689999999999999999999999999999999999999999999999999986554332
Q ss_pred -ccCCCCCCcccCC
Q 021897 294 -MTPETGTYRWMAP 306 (306)
Q Consensus 294 -~~~~~gt~~y~AP 306 (306)
.....+++.|+||
T Consensus 155 ~~~~~~~~~~y~~p 168 (254)
T cd06627 155 DDASVVGTPYWMAP 168 (254)
T ss_pred cccccccchhhcCH
Confidence 2334688889887
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=206.46 Aligned_cols=163 Identities=32% Similarity=0.492 Sum_probs=139.0
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
.|+..+.||+|+||.||+|.+ +++.||+|.+....... ..+.+.+|+.+++++.||||+++++.+.....+|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-----HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 456678899999999999987 67899999986443221 23578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+++|+||+|+||++++++.+||+|||+++......
T Consensus 80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999999998864 458899999999999999999999999999999999999999999999999997654322
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......|+..|+||
T Consensus 157 ~~~~~~~~~~y~aP 170 (277)
T cd06642 157 KRNTFVGTPFWMAP 170 (277)
T ss_pred hhhcccCcccccCH
Confidence 12334678889987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=205.84 Aligned_cols=155 Identities=26% Similarity=0.389 Sum_probs=135.1
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe----CCeEEE
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK----RMVWCI 213 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~i 213 (306)
.+||-|-.|+|..+.+ +++.+|+|++... ....+|+++--.. .|||||.+++++.. ...+.|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 5799999999999976 7889999998531 2345788775444 59999999999853 468899
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEcccCeeeeec
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQ 290 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~~~vkl~DFGla~~~~~ 290 (306)
|||.|+||.|++.++.+....++++.+-.|+.||+.|+.|||+.+|.||||||+|+|... +..+||+|||+|+....
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999999999999988889999999999999999999999999999999999999964 55799999999997765
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
.....+.|-||+|.||
T Consensus 217 ~~~L~TPc~TPyYvaP 232 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAP 232 (400)
T ss_pred CccccCCcccccccCH
Confidence 5667788999999998
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=202.43 Aligned_cols=162 Identities=25% Similarity=0.370 Sum_probs=135.3
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC--CeE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR--MVW 211 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~ 211 (306)
|++.+.||+|+||.||+|+. +++.+|+|.++........ ....+|+.+++++. |+||+++++++.+. ..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-----VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-----hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 45678999999999999987 6789999998754322211 23457888888885 99999999999887 889
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+++||||+|+||+++. +.+||+|||+++.....
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 99999996 58888887532 46899999999999999999999999999999999999999 99999999999866544
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
.......+++.|+||
T Consensus 153 ~~~~~~~~~~~y~aP 167 (282)
T cd07831 153 PPYTEYISTRWYRAP 167 (282)
T ss_pred CCcCCCCCCcccCCh
Confidence 444445688999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-25 Score=195.82 Aligned_cols=165 Identities=33% Similarity=0.568 Sum_probs=143.5
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CeE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVW 211 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 211 (306)
+|+..+.||+|++|.||+|.. +++.|++|++....... ...+.+.+|+.++++++||||+++++.+... ..+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE----EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTL 76 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccch----HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeE
Confidence 356778999999999999988 48899999987655431 2246788999999999999999999999988 889
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++++||+++++|.+++.... .+++..++.++.|++.+|+|||+.+++|+||+|+||+++.++.+||+|||.+......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999999998653 6899999999999999999999999999999999999999999999999999876554
Q ss_pred CC---ccCCCCCCcccCC
Q 021897 292 EG---MTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~---~~~~~gt~~y~AP 306 (306)
.. .....++..|+||
T Consensus 155 ~~~~~~~~~~~~~~y~~p 172 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAP 172 (260)
T ss_pred cccccccCCCCCccccCH
Confidence 32 3445688889887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=203.83 Aligned_cols=164 Identities=28% Similarity=0.437 Sum_probs=138.9
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|+..+.||+|+||.||+|+. +++.||+|++........ ...+.+.+|+.+++.++||||+++++++......|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 4577889999999999999987 678999999865433221 12357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9999996 58888776432 4589999999999999999999999999999999999999999999999999976432
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
.....+++.|+||
T Consensus 168 -~~~~~~~~~y~aP 180 (307)
T cd06607 168 -ANSFVGTPYWMAP 180 (307)
T ss_pred -CCCccCCccccCc
Confidence 2334678889998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=201.26 Aligned_cols=173 Identities=23% Similarity=0.407 Sum_probs=149.2
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIG 203 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~ 203 (306)
-+.+..++++++.+..||.|..|+||++++ +|...|||.+.+..+..+. ++++..+.++.... +|.||+.+|
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~-----kRILmDldvv~~s~dcpyIV~c~G 158 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEEN-----KRILMDLDVVLKSHDCPYIVQCFG 158 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHH-----HHHHHhhhHHhhccCCCeeeeeee
Confidence 456677889999999999999999999998 5689999999887665443 56777777766654 999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
+|..+..++|-||.|. ..+..++++. .+++|+..+-++...++.||.||.+ ++|||||+||+|||+|+.|++|||||
T Consensus 159 yFi~n~dV~IcMelMs-~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 159 YFITNTDVFICMELMS-TCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred EEeeCchHHHHHHHHH-HHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecc
Confidence 9999999999999993 3556666554 4679999999999999999999996 58999999999999999999999999
Q ss_pred cCeeeeecCCCccCCCCCCcccCC
Q 021897 283 GVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|.+....+....+...|.+.||||
T Consensus 237 GIsGrlvdSkAhtrsAGC~~YMaP 260 (391)
T KOG0983|consen 237 GISGRLVDSKAHTRSAGCAAYMAP 260 (391)
T ss_pred cccceeecccccccccCCccccCc
Confidence 999988877777778899999998
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-27 Score=206.04 Aligned_cols=158 Identities=24% Similarity=0.440 Sum_probs=135.7
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+++.|--+.. ++..+|||++.+..... ..+..+|++++..++ |+||++++++|+++..+|||||-
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs------R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS------RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchH------HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 6899999999988764 89999999998764432 357889999999996 99999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEcccCeeeee-----
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEV----- 289 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~---~vkl~DFGla~~~~----- 289 (306)
|.||+|...+.++ .-+++..+.++..+|+.||.|||.+||.||||||+|||..... -||||||.|+.-..
T Consensus 158 m~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999999999875 4599999999999999999999999999999999999997554 47999999975322
Q ss_pred ---cCCCccCCCCCCcccCC
Q 021897 290 ---QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ---~~~~~~~~~gt~~y~AP 306 (306)
..+...+.+|+..||||
T Consensus 236 spastP~L~tPvGSAEfMAP 255 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAP 255 (463)
T ss_pred CCCCCccccCcccchhhcch
Confidence 12223456799999998
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=206.24 Aligned_cols=166 Identities=24% Similarity=0.381 Sum_probs=136.8
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 211 (306)
.+++..+.||+|+||.||++.+ +++.+|+|.+....... ....+.+|+.++.++. ||||+++++++..+...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-----EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChH-----HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 4566778999999999999987 67899999987543321 2357889999999996 99999999999988889
Q ss_pred EEEEeecCCCCHHHHHH---hhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 212 CIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
+++|||+. ++|.++.. ......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 99999985 46665543 2334568999999999999999999997 4999999999999999999999999999976
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
...........|++.|+||
T Consensus 158 ~~~~~~~~~~~~~~~y~aP 176 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAP 176 (288)
T ss_pred hccCCccccccCccCccCH
Confidence 5443333445788999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=201.09 Aligned_cols=165 Identities=28% Similarity=0.414 Sum_probs=137.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CeE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVW 211 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 211 (306)
+|...+.||.|++|.||++.. +++.+|+|.+...... ....++.+|++++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-----DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 567788999999999999988 6789999998754332 1235788999999999999999999998653 478
Q ss_pred EEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 212 CIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
|+||||+++++|.+++... ....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999999987642 23558899999999999999999999999999999999999999999999999987543
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
... .....++..|+||
T Consensus 157 ~~~-~~~~~~~~~y~~p 172 (287)
T cd06621 157 NSL-AGTFTGTSFYMAP 172 (287)
T ss_pred ccc-cccccCCccccCH
Confidence 221 2234577888887
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=204.19 Aligned_cols=164 Identities=32% Similarity=0.451 Sum_probs=140.3
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~i 213 (306)
|++.+.||+|++|.||+|+. +++.||||.+........ .....+|+..+++++ ||||+++++.+......++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-----ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-----HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 46778999999999999998 568899999865433221 124457899999999 9999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
||||+ +++|.+++.......+++..++.++.|++.+|.|||+++++|+||+|+||++++++.++|+|||++........
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99999 78999998875545689999999999999999999999999999999999999999999999999986654444
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....++..|+||
T Consensus 155 ~~~~~~~~~~~aP 167 (283)
T cd07830 155 YTDYVSTRWYRAP 167 (283)
T ss_pred cCCCCCcccccCc
Confidence 4555788889988
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=204.42 Aligned_cols=168 Identities=27% Similarity=0.442 Sum_probs=136.9
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 209 (306)
+.++|+..+.||+|+||.||+|.. +++.||||.+........ ....+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC----chhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 346788999999999999999987 678999999865432211 1134568999999999999999999986653
Q ss_pred -------eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 210 -------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 210 -------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
..++||||+. ++|.+++... ...+++..++.++.||+.||+|||+++++|+||||+||+++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 4599999996 4888887653 346899999999999999999999999999999999999999999999999
Q ss_pred cCeeeeecCCC-----ccCCCCCCcccCC
Q 021897 283 GVARIEVQTEG-----MTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~-----~~~~~gt~~y~AP 306 (306)
|++........ .....++..|+||
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aP 192 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPP 192 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCc
Confidence 99975433221 1234577889998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=204.24 Aligned_cols=164 Identities=28% Similarity=0.458 Sum_probs=140.0
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
..+|++.+.||+|+||.||++.. +++.+|+|.+....... .+.+.+|+.+++.++||||+++++.+......
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK------KELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH------HHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 36778889999999999999976 67899999985432221 25688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+|+||+++++|.+++.+ ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999999999875 34788899999999999999999999999999999999999999999999998754432
Q ss_pred CC-ccCCCCCCcccCC
Q 021897 292 EG-MTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~-~~~~~gt~~y~AP 306 (306)
.. .....|++.|+||
T Consensus 169 ~~~~~~~~~~~~y~~P 184 (293)
T cd06647 169 QSKRSTMVGTPYWMAP 184 (293)
T ss_pred ccccccccCChhhcCc
Confidence 22 2334688889998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=208.79 Aligned_cols=163 Identities=28% Similarity=0.416 Sum_probs=135.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (306)
++|++.+.||+|+||.||+|.+ +++.||||++...... .....+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-----TFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-----hhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 5788899999999999999987 6789999998642221 1235677899999999999999999987654
Q ss_pred -CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
..+|+|+||+++ +|.+++.. ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred cceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 357999999964 88877753 4589999999999999999999999999999999999999999999999999976
Q ss_pred eecCCC----ccCCCCCCcccCC
Q 021897 288 EVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~----~~~~~gt~~y~AP 306 (306)
...... .....||+.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aP 178 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAP 178 (336)
T ss_pred ccccccccCCcCCcCcCCCccCh
Confidence 433221 1234688999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=200.24 Aligned_cols=167 Identities=26% Similarity=0.457 Sum_probs=140.8
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|.+.+.||+|+||.||++.. ++..+|+|.+......... .+.+.+|+.+++.++|+||+++++.+......++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE----KEASKKEVILLAKMKHPNIVTFFASFQENGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchh----hHHHHHHHHHHHhCCCCChhhhhheeccCCeEEE
Confidence 367789999999999999987 6789999998764332211 2467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEcccCeeeeecCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-~vkl~DFGla~~~~~~~ 292 (306)
|+||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||||+||++++++ .+||+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999999999875555689999999999999999999999999999999999999886 46999999987654322
Q ss_pred C-ccCCCCCCcccCC
Q 021897 293 G-MTPETGTYRWMAP 306 (306)
Q Consensus 293 ~-~~~~~gt~~y~AP 306 (306)
. .....|++.|+||
T Consensus 157 ~~~~~~~~~~~~~ap 171 (257)
T cd08225 157 ELAYTCVGTPYYLSP 171 (257)
T ss_pred ccccccCCCccccCH
Confidence 1 2233588889988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=200.42 Aligned_cols=170 Identities=21% Similarity=0.350 Sum_probs=140.0
Q ss_pred ceecceeeeeccEEEEEEEEC---CeeEEEEEeeCCCCChh----HHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEeC
Q 021897 137 LNMGTAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKR 208 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~~---~~~vavK~~~~~~~~~~----~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~ 208 (306)
|++.+.||+|+||.||+|.+. ++.+|+|.+........ .......++.+|+.++.+ ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 667789999999999999883 47899998864332211 112234567789988865 7999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
...+++|||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 9999999999999999998642 34568999999999999999999996 68999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
.............|++.|+||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~P 182 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCP 182 (269)
T ss_pred eecccccccccccCcccCcCh
Confidence 875544334455788899988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=207.59 Aligned_cols=161 Identities=24% Similarity=0.435 Sum_probs=136.8
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|.....||+|+||.||++.. +++.||+|++....... .+.+.+|+.+++.+.||||+++++.+......|+|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch------HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 33445799999999999987 68899999986533221 24678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-C
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-~ 293 (306)
+||+++++|.+++.. ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++....... .
T Consensus 97 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 97 MEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred EecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 999999999998754 358899999999999999999999999999999999999999999999999987543222 2
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....|++.|+||
T Consensus 174 ~~~~~~~~~y~aP 186 (297)
T cd06659 174 RKSLVGTPYWMAP 186 (297)
T ss_pred ccceecCccccCH
Confidence 2345688999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=199.40 Aligned_cols=160 Identities=30% Similarity=0.502 Sum_probs=128.1
Q ss_pred ceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCeEEEE
Q 021897 141 TAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVWCIV 214 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~iv 214 (306)
+.||+|+||.||+|.+ ....+|+|.+...... ...+.+.+|+.+++.++||||+++++++.. +...+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-----EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH-----HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEE
Confidence 3689999999999986 2347999987532221 113578899999999999999999998754 5567999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC--
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-- 292 (306)
|||+++++|.+++.... ...++..++.++.|++.||+|||+.+++||||||+|||+++++.+||+|||+++......
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999999997543 346777788999999999999999999999999999999999999999999997543211
Q ss_pred ---CccCCCCCCcccCC
Q 021897 293 ---GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ---~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 155 ~~~~~~~~~~~~~y~aP 171 (262)
T cd05058 155 SVHNHTGAKLPVKWMAL 171 (262)
T ss_pred eecccccCcCCccccCh
Confidence 11223456789888
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=208.39 Aligned_cols=161 Identities=27% Similarity=0.455 Sum_probs=136.2
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
+.....||+|+||.||++.. ++..||||.+..... ...+.+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ------QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH------HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 33446799999999999987 678999998854221 1235688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-C
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-~ 293 (306)
|||+++++|.+++.. ..+++..++.++.||+.||+|||+++++||||||+||++++++.+||+|||++....... .
T Consensus 98 ~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 98 MEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 999999999998854 348899999999999999999999999999999999999999999999999987543222 2
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....|++.|+||
T Consensus 175 ~~~~~~~~~y~aP 187 (292)
T cd06658 175 RKSLVGTPYWMAP 187 (292)
T ss_pred CceeecCccccCH
Confidence 2334688999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-26 Score=200.75 Aligned_cols=164 Identities=26% Similarity=0.410 Sum_probs=138.3
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CeEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--MVWC 212 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 212 (306)
|++.+.||+|++|.||+|++ +++.+|+|.+........ ..+.+.+|+.+++++.|||++++++++... ...+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccccc----chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEE
Confidence 45678999999999999988 568999999986542211 124678999999999999999999999888 8899
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+|+||+++ +|.+++.... ..+++..++.++.||+.||+|||+.+++|+||+|+||++++++.+||+|||++.......
T Consensus 77 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 77 MVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred EEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 99999975 8988887542 468999999999999999999999999999999999999999999999999998654432
Q ss_pred --CccCCCCCCcccCC
Q 021897 293 --GMTPETGTYRWMAP 306 (306)
Q Consensus 293 --~~~~~~gt~~y~AP 306 (306)
......++..|+||
T Consensus 155 ~~~~~~~~~~~~y~~P 170 (287)
T cd07840 155 SADYTNRVITLWYRPP 170 (287)
T ss_pred cccccccccccccCCc
Confidence 13334678889998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=204.53 Aligned_cols=168 Identities=25% Similarity=0.404 Sum_probs=137.9
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 209 (306)
...+|++.+.||+|+||.||+|++ +++.||+|+++....... ....+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG----FPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC----chHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 346788889999999999999998 678999999975433221 1245678999999999999999999987654
Q ss_pred ---------eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 210 ---------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 210 ---------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
.+++|+||+++ ++.+++... ...+++..++.++.|++.||+|||+.+|+||||||+||++++++.+||+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 787777653 3468999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCCC--ccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~--~~~~~gt~~y~AP 306 (306)
|||++........ .....+++.|+||
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~P 186 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPP 186 (302)
T ss_pred cccccccccCCcccccccceeccCccCh
Confidence 9999986543221 1223457788887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=204.35 Aligned_cols=156 Identities=22% Similarity=0.440 Sum_probs=129.7
Q ss_pred ceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 141 TAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
+.||+|+||.||+|.+. ..++|+|.+.... ....+.+.+|+.+++.+.||||+++++++......
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH------RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh------HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc
Confidence 36899999999999762 2348888774322 12235788999999999999999999999998889
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc--------EEEEccc
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--------IKIADFG 283 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~--------vkl~DFG 283 (306)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++++||||||+||+++.++. +|++|||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999999997643 35889999999999999999999999999999999999987765 6999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
++..... .....+++.|+||
T Consensus 154 ~~~~~~~---~~~~~~~~~y~aP 173 (258)
T cd05078 154 ISITVLP---KEILLERIPWVPP 173 (258)
T ss_pred cccccCC---chhccccCCccCc
Confidence 9875432 2334678889998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=224.51 Aligned_cols=174 Identities=34% Similarity=0.619 Sum_probs=148.6
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCC
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLN 197 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 197 (306)
..|+++.+++++.+.||+|+||+|++|... ...||||.++......+ .+.+..|+++|+.+. |||
T Consensus 289 ~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~-----~~~~~~El~~m~~~g~H~n 363 (609)
T KOG0200|consen 289 PKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSE-----KKDLMSELNVLKELGKHPN 363 (609)
T ss_pred CceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHH-----HHHHHHHHHHHHHhcCCcc
Confidence 489999999999999999999999999741 34799999987665532 368999999999985 999
Q ss_pred eeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021897 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------N--RAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (306)
Q Consensus 198 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrD 263 (306)
|+.++|+|..+..+++|+||++.|+|.++|+..+ . ..+....++.++.||+.||+||++..+||||
T Consensus 364 iv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRD 443 (609)
T KOG0200|consen 364 IVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRD 443 (609)
T ss_pred hhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchh
Confidence 9999999999999999999999999999999765 0 1388899999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEcccCeeeeecCCCcc--CCCCC--CcccCC
Q 021897 264 LKSDNLLISADKSIKIADFGVARIEVQTEGMT--PETGT--YRWMAP 306 (306)
Q Consensus 264 lkp~NILv~~~~~vkl~DFGla~~~~~~~~~~--~~~gt--~~y~AP 306 (306)
|.++|||+.++..+||+|||+||.......+. ...|| ..||||
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmAp 490 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAP 490 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCH
Confidence 99999999999999999999999655444332 22333 459998
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=196.64 Aligned_cols=160 Identities=32% Similarity=0.563 Sum_probs=133.4
Q ss_pred ceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecC
Q 021897 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~ 219 (306)
++||+|+||.||++.+ .++.||+|.+...... .....+.+|+.+++++.||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 4689999999999987 4789999988764432 123578899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc---cC
Q 021897 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---TP 296 (306)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~---~~ 296 (306)
+++|.+++.... ..+++..++.++.+++.+|+|||+++++||||||+||+++.++.+||+|||+++........ ..
T Consensus 76 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 76 GGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999999997643 45788999999999999999999999999999999999999999999999999754321110 11
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
...+..|+||
T Consensus 155 ~~~~~~y~~P 164 (251)
T cd05041 155 KQIPIKWTAP 164 (251)
T ss_pred CcceeccCCh
Confidence 1234568877
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=199.45 Aligned_cols=166 Identities=23% Similarity=0.474 Sum_probs=132.0
Q ss_pred ceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021897 137 LNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (306)
|++.+.||+|+||.||+|.+ +++.||||++......... .+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD----IEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH----HHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence 45678899999999999975 3578999999765433322 356889999999999999999999886432
Q ss_pred ----eEEEEEeecCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEc
Q 021897 210 ----VWCIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (306)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~D 281 (306)
..++++||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence 3578999999999998875321 12478899999999999999999999999999999999999999999999
Q ss_pred ccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 282 FGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
||+++....... .....+++.|++|
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~p 184 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLAL 184 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCH
Confidence 999985432221 1222345667776
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=207.04 Aligned_cols=168 Identities=23% Similarity=0.399 Sum_probs=137.7
Q ss_pred ccCceecceeeeeccEEEEEEEE----C--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY----N--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~----~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
+..|+....||+|.+|.||+|.. + ..++|||.++.......- -....+|+.+++.++||||+.+..++..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi----S~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI----SMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc----CHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 45678889999999999999954 2 237899999765322111 1245699999999999999999999977
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC----CcEEE
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRR---QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKI 279 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~----~~vkl 279 (306)
+..+++++||.+. +|.++++-. ..+.++...+..|+.||+.|+.|||++=|+||||||+||||..+ |.|||
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 7899999999987 999988742 33568999999999999999999999999999999999999877 89999
Q ss_pred EcccCeeeeecCCC----ccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~----~~~~~gt~~y~AP 306 (306)
+|||+||++...-. ....+-|..|.||
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAP 208 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAP 208 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecCh
Confidence 99999997654321 2344678999998
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=199.71 Aligned_cols=159 Identities=25% Similarity=0.452 Sum_probs=135.3
Q ss_pred eeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCC
Q 021897 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (306)
Q Consensus 143 lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~ 220 (306)
||.|+||.||++.+ +++.+++|++....... ....+.+.+|+.++++++||||+++++.+......|+++||+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR---KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh---hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 58899999999998 48899999986543321 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC--------
Q 021897 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------- 292 (306)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-------- 292 (306)
++|.+++.+.. .+++..++.++.||+.||+|||+.+++|+||+|+||++++++.+||+|||++.......
T Consensus 78 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 78 GDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99999997643 68999999999999999999999999999999999999999999999999987543221
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 156 ~~~~~~~~~~~~~~P 170 (265)
T cd05579 156 KEDKRIVGTPDYIAP 170 (265)
T ss_pred ccccCcccCccccCH
Confidence 12234577889887
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-25 Score=193.46 Aligned_cols=164 Identities=29% Similarity=0.577 Sum_probs=142.3
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|...+.||+|++|.||++.. +++.+++|++...... ..+.+.+|+.++++++||+++++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE------KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 366778999999999999988 4789999999764431 23578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~ 293 (306)
++||+++++|.+++.... ..+++..++.++.|++.+|+|||+.+++|+||+|+||++++++.+||+|||.+........
T Consensus 75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999999999987643 4689999999999999999999999999999999999999999999999999986554332
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....++..|+||
T Consensus 154 ~~~~~~~~~~~~P 166 (253)
T cd05122 154 RNTMVGTPYWMAP 166 (253)
T ss_pred ccceecCCcccCH
Confidence 3445688889887
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=214.71 Aligned_cols=168 Identities=24% Similarity=0.357 Sum_probs=142.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHH---HHHHHHHHHHHhCC---CCCeeeEEEEEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVME---QQFQQEVMMLATLK---HLNIVRFIGACR 206 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~---~~~~~E~~~l~~l~---h~niv~l~~~~~ 206 (306)
.+|...+++|+|+||+|+.|.+ +...|+||.+.+...-. ..++.. -.+--|++||..++ |+||++++++|+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~-DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILV-DTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhh-hhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4678899999999999999998 45689999886533221 111111 12346999999998 999999999999
Q ss_pred eCCeEEEEEeec-CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 207 KRMVWCIVTEYA-KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 207 ~~~~~~iv~E~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
+++.+||+||-- ++.+|.+++... ..+.+..+..|+.||+.|+++||+.||||||||-+|+.++.+|-+||+|||.|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 999999999976 567999999764 45899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
.....++ ...++||..|.||
T Consensus 718 a~~ksgp-fd~f~gtv~~aap 737 (772)
T KOG1152|consen 718 AYTKSGP-FDVFVGTVDYAAP 737 (772)
T ss_pred hhhcCCC-cceeeeeccccch
Confidence 8766554 6778999999998
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-25 Score=198.45 Aligned_cols=165 Identities=28% Similarity=0.468 Sum_probs=136.1
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEeCCe-
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRKRMV- 210 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~- 210 (306)
|++.+.||+|+||.||+|++ +++.+|+|.++........ ...+.+|+.+++++ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI----PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchh----hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 46778999999999999998 4789999999754432211 23455777776655 59999999999988776
Q ss_pred ----EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 211 ----WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 211 ----~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
++++|||+.+ +|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||++++++.+||+|||++.
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999999964 89998876544568999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCccCCCCCCcccCC
Q 021897 287 IEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~AP 306 (306)
............+++.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~P 175 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAP 175 (287)
T ss_pred eccCCcccccccccccccCh
Confidence 76444333444678889988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=203.95 Aligned_cols=165 Identities=21% Similarity=0.316 Sum_probs=137.0
Q ss_pred eecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
.+++.+|.|+++.|++++.+++.||||+++....... ..+.+.+|+.+++.++||||+++++++......+++|||
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKE----DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchh----HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 3556666777777777777899999999976533322 235789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC----
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---- 293 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~---- 293 (306)
+++++|.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999999999876556689999999999999999999999999999999999999999999999998864432111
Q ss_pred ----ccCCCCCCcccCC
Q 021897 294 ----MTPETGTYRWMAP 306 (306)
Q Consensus 294 ----~~~~~gt~~y~AP 306 (306)
.....++..|+||
T Consensus 161 ~~~~~~~~~~~~~y~aP 177 (314)
T cd08216 161 VHDFPKSSVKNLPWLSP 177 (314)
T ss_pred cccccccccccccccCH
Confidence 1233467788887
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=200.72 Aligned_cols=165 Identities=27% Similarity=0.420 Sum_probs=138.5
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|+..+.||.|++|.||+|.+ +++.||+|++........ ....+.+|+.+++.++|||++++++++......|++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG----VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEE
Confidence 45678999999999999987 688999999875432211 124677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-C
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-~ 293 (306)
|||++ ++|.+++.......+++..++.++.|++.||+|||+.+++||||+|+||++++++.+||+|||+++...... .
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 99995 699999876554568999999999999999999999999999999999999999999999999997543221 1
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....+++.|+||
T Consensus 156 ~~~~~~~~~~~aP 168 (283)
T cd07835 156 YTHEVVTLWYRAP 168 (283)
T ss_pred cCccccccCCCCC
Confidence 2333568889998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-25 Score=196.50 Aligned_cols=158 Identities=25% Similarity=0.445 Sum_probs=130.0
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+.||+|+||.||+|+. +++.||||+++....... .....+..|..+ .....|||++++++++.....+|+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK---NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH---HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 5789999999999987 678999999865432211 112234445444 4556899999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE 297 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~ 297 (306)
+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||++++++.+||+|||+++.... ....
T Consensus 79 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 79 LNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence 9999999999754 4589999999999999999999999999999999999999999999999999875432 2334
Q ss_pred CCCCcccCC
Q 021897 298 TGTYRWMAP 306 (306)
Q Consensus 298 ~gt~~y~AP 306 (306)
.+++.|+||
T Consensus 154 ~~~~~y~~p 162 (260)
T cd05611 154 VGTPDYLAP 162 (260)
T ss_pred CCCcCccCh
Confidence 688889887
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=202.05 Aligned_cols=150 Identities=28% Similarity=0.453 Sum_probs=132.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 211 (306)
++|++.+.||+|+||.||+++. +++.||+|++......... ..+.+.+|+.+++++. ||||+++++++......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK---KVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchH---HHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence 3678889999999999999987 6889999998764332221 2357889999999998 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
++||||+++++|.+++.+. ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999999764 369999999999999999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=200.29 Aligned_cols=160 Identities=33% Similarity=0.572 Sum_probs=130.8
Q ss_pred eeeeeccEEEEEEEECC--------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 142 AFAQGAFGKLYRGTYNG--------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
.||+|+||.||+|++.. +.+|+|.+....... ....+.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-----EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchh-----hHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 68999999999998632 579999886432211 13578899999999999999999999999889999
Q ss_pred EEeecCCCCHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-----cEEEEccc
Q 021897 214 VTEYAKGGSVRQFLTRRQ-----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-----SIKIADFG 283 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-----~vkl~DFG 283 (306)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+++|+||||+||+++.++ .+||+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999999997532 23478899999999999999999999999999999999999877 89999999
Q ss_pred CeeeeecCCC---ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+++....... .....++..|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aP 182 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAP 182 (269)
T ss_pred cccccccccccccCcccCCCccccCH
Confidence 9875432211 1122456788887
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-25 Score=205.64 Aligned_cols=163 Identities=26% Similarity=0.433 Sum_probs=136.4
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (306)
..+|++.+.||+|+||.||++.. +++.||||.+....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch----HHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 35688899999999999999976 67899999986543221 12346789999999999999999999986543
Q ss_pred ----eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 7799888763 45899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
..... ......+++.|+||
T Consensus 166 ~~~~~--~~~~~~~~~~y~aP 184 (343)
T cd07880 166 RQTDS--EMTGYVVTRWYRAP 184 (343)
T ss_pred ccccc--CccccccCCcccCH
Confidence 75432 22344678889887
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=200.69 Aligned_cols=164 Identities=29% Similarity=0.450 Sum_probs=138.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|...+.||+|+||.||+++. ++..+|+|.+........ ...+.+.+|+.++++++|||++++++++......+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch---HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 3466778999999999999987 678999999875433221 22357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++ +|.+++... ...+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 99999964 888877643 34589999999999999999999999999999999999999999999999999875432
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
.....|++.|+||
T Consensus 178 -~~~~~~~~~y~aP 190 (317)
T cd06635 178 -ANSFVGTPYWMAP 190 (317)
T ss_pred -cccccCCccccCh
Confidence 2345688899988
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=204.64 Aligned_cols=142 Identities=20% Similarity=0.342 Sum_probs=124.9
Q ss_pred ceeeee--ccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEe
Q 021897 141 TAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 141 ~~lG~G--~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E 216 (306)
..||.| +||+||++.+ +++.||+|++........ ..+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE----HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 356666 9999999987 789999999876543322 23678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
|+.+++|.+++.......+++..+..++.|++.||+|||+++++||||||+|||++.++.+|++||+.+.
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 9999999999987655568999999999999999999999999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=204.60 Aligned_cols=169 Identities=25% Similarity=0.366 Sum_probs=137.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHH--------HHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQ--------VMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
+...+.+.||+|+||.||+|.. .++.||||+++.......... .....+.+|+.++++++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 3445667899999999999986 678999999875543321100 011257799999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
+......++||||++ ++|.+++... ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 999999999999996 5999998653 4589999999999999999999999999999999999999999999999999
Q ss_pred eeeeec---------------CCCccCCCCCCcccCC
Q 021897 285 ARIEVQ---------------TEGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~---------------~~~~~~~~gt~~y~AP 306 (306)
++.... ........+++.|+||
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 202 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAP 202 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCC
Confidence 975431 1112233567889988
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=230.48 Aligned_cols=166 Identities=28% Similarity=0.480 Sum_probs=134.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (306)
.+|+.++.||+|+||.||+++. +|+.+|||.+.... . ......+.+|+..+++|+|||||++|..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s----~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-S----DKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-H----HHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 5677889999999999999976 99999999997654 2 2224678899999999999999999864410
Q ss_pred --------------------------------------------------C-----------------------------
Q 021897 208 --------------------------------------------------R----------------------------- 208 (306)
Q Consensus 208 --------------------------------------------------~----------------------------- 208 (306)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 021897 209 -----------------------------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (306)
Q Consensus 209 -----------------------------------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~y 253 (306)
..+||-||||+...|.+++++..-. -....+|+++++|++||.|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHH
Confidence 1258999999997888887654211 1567899999999999999
Q ss_pred HHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee-------------------cCCCccCCCCCCcccCC
Q 021897 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV-------------------QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 254 LH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~-------------------~~~~~~~~~gt~~y~AP 306 (306)
+|+.|+|||||||.||++++++.|||.|||+|.... .....+..+||.-|+||
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 999999999999999999999999999999997511 11123556799999998
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=196.13 Aligned_cols=166 Identities=25% Similarity=0.472 Sum_probs=141.6
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|++.+.||+|++|.||+++. +++.+|+|.+......... ...+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE----REDAVNEIRILASVNHPNIISYKEAFLDGNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHH----HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEE
Confidence 367788999999999999987 6789999998754433221 3567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 214 VTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||+++++|.+++.+. ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||+++.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999999998763 2356889999999999999999999999999999999999999999999999999865543
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 157 -~~~~~~~~~~~~~P 170 (256)
T cd08530 157 -MAKTQIGTPHYMAP 170 (256)
T ss_pred -CcccccCCccccCH
Confidence 23345678888887
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=199.82 Aligned_cols=167 Identities=21% Similarity=0.355 Sum_probs=138.7
Q ss_pred CceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (306)
+|++.+.||+|++|.||+++. +++.+|||+++..... ......+.+.+|+.++.++ .||+|+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV--QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH--hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 367789999999999999975 4578999998753221 1122235688999999999 5999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+++||||+++++|.+++... ..+++..++.++.|++.+|+|||+.+++||||+|+||+++.++.++|+|||+++...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999999998753 458899999999999999999999999999999999999999999999999987644
Q ss_pred cCCC--ccCCCCCCcccCC
Q 021897 290 QTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~--~~~~~gt~~y~AP 306 (306)
.... .....|++.|+||
T Consensus 157 ~~~~~~~~~~~~~~~y~aP 175 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAP 175 (288)
T ss_pred cccccccccccCCccccCH
Confidence 3221 1234688899987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=198.56 Aligned_cols=161 Identities=26% Similarity=0.450 Sum_probs=136.4
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
+...+.||+|++|.||++.. +++.+++|++...... ..+.+.+|+.+++.+.||||+++++++......+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ------RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh------HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 33446899999999999986 6789999988643221 124688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-C
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-~ 293 (306)
+||+++++|.+++.. ..+++..++.++.|++.||+|||+++++||||+|+||+++.++.++|+|||++....... .
T Consensus 95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 95 MEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred EeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 999999999999876 358899999999999999999999999999999999999999999999999887543221 2
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....|++.|+||
T Consensus 172 ~~~~~~~~~y~aP 184 (285)
T cd06648 172 RKSLVGTPYWMAP 184 (285)
T ss_pred cccccCCccccCH
Confidence 2334688999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-27 Score=210.55 Aligned_cols=171 Identities=28% Similarity=0.381 Sum_probs=144.2
Q ss_pred eeeccCceecceeeeeccEEEEEEEECC--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 207 (306)
.|...+|.++..||.|+||+|.+|...| +.+|||++++...-.... .+.-+.|-++|+.. +-|.+++++.+|+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD---vectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD---VECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc---ccceehhhhheecCCCCchHHHHHHHhhh
Confidence 5667899999999999999999998754 579999998754322111 23455677777766 47889999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
-+.+|+||||+.||+|.-.+++. ..+.+..+..+|++|+-||-+||++|||+||||.+||+++.+|++||+|||+++-
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999998888764 4588899999999999999999999999999999999999999999999999984
Q ss_pred e-ecCCCccCCCCCCcccCC
Q 021897 288 E-VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~-~~~~~~~~~~gt~~y~AP 306 (306)
. .......+.||||.|+||
T Consensus 500 ni~~~~TTkTFCGTPdYiAP 519 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAP 519 (683)
T ss_pred cccCCcceeeecCCCccccc
Confidence 3 233456778999999999
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=214.03 Aligned_cols=153 Identities=27% Similarity=0.362 Sum_probs=133.2
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.-..+.+-|..++.||-|+||+|.+++. +...+|+|.+++...-... + ......|-.||..-..+-||+||-.|+
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rn-Q--vaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRN-Q--VAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhh-h--hhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 3456778899999999999999999976 5557999998754332211 1 134567888999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
+++.+|+||||++||++..+|.+. ..+++.+++.+++++.+|+++.|..|+|||||||+|||||.+|++||.|||||.
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence 999999999999999999999875 569999999999999999999999999999999999999999999999999984
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=206.17 Aligned_cols=165 Identities=25% Similarity=0.389 Sum_probs=136.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----C
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----R 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~ 208 (306)
++|++.+.||+|+||.||+|+. +++.||+|++........ ..+.+.+|+.++++++||||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT----LAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc----chHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 5677889999999999999987 688999999875432211 13567789999999999999999998753 3
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+++||||+. ++|.+++... ..+++..++.++.||+.||+|||+++++||||||+||++++++.+||+|||+++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 56899999995 5898888643 45899999999999999999999999999999999999999999999999999765
Q ss_pred ecCCC-----ccCCCCCCcccCC
Q 021897 289 VQTEG-----MTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~-----~~~~~gt~~y~AP 306 (306)
..... .....|+..|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~P 180 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAP 180 (334)
T ss_pred cccCcCCCcccccccccccccCh
Confidence 33221 1234688889988
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-27 Score=234.66 Aligned_cols=165 Identities=30% Similarity=0.475 Sum_probs=141.9
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|+.+..||.|.||.||-|.. +|+..|+|.++-..... .....+.+|..++..++|||+|++||+-.+.+..+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~----k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDH----KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCcccc----ccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 566778999999999999976 88899999887554441 123568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
.||||++|+|.+.+... +..++....-+..|++.|++|||++||+||||||+||+++.+|.+|+.|||.|.......
T Consensus 1312 FMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999999864 447777778889999999999999999999999999999999999999999998654332
Q ss_pred ----CccCCCCCCcccCC
Q 021897 293 ----GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ----~~~~~~gt~~y~AP 306 (306)
.....+||+-||||
T Consensus 1390 ~~~~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAP 1407 (1509)
T ss_pred cCCHHHHhhcCCchhcCc
Confidence 12345799999999
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=197.05 Aligned_cols=164 Identities=31% Similarity=0.486 Sum_probs=141.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|+..+.||+|++|.||+|.+ +++.+++|++..... ..+.+.+|+.+++.++|+||+++++.+......|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 4577788999999999999988 478999999975433 1357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+++||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999999998753 368999999999999999999999999999999999999999999999999986543221
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 171 ~~~~~~~~~~~y~~P 185 (286)
T cd06614 171 SKRNSVVGTPYWMAP 185 (286)
T ss_pred hhhccccCCcccCCH
Confidence 12334577889887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=197.80 Aligned_cols=172 Identities=17% Similarity=0.266 Sum_probs=125.5
Q ss_pred eeccCceecceeeeeccEEEEEEEEC-----CeeEEEEEeeCCCCChhHHH-----HHHHHHHHHHHHHHhCCCCCeeeE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQ-----VMEQQFQQEVMMLATLKHLNIVRF 201 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~~-----~~~vavK~~~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l 201 (306)
+..++|++.+.||+|+||.||+|.+. +..+|+|+............ ........+...+..+.|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 34468899999999999999999873 34677776443222111100 011223344455667889999999
Q ss_pred EEEEEeCC----eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcE
Q 021897 202 IGACRKRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (306)
Q Consensus 202 ~~~~~~~~----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~v 277 (306)
++++.... ..++++|++. .++.+++... ...++..++.++.|++.||+|||+.+|+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 99875543 3478888874 4777776543 336788899999999999999999999999999999999999999
Q ss_pred EEEcccCeeeeecCC--------CccCCCCCCcccCC
Q 021897 278 KIADFGVARIEVQTE--------GMTPETGTYRWMAP 306 (306)
Q Consensus 278 kl~DFGla~~~~~~~--------~~~~~~gt~~y~AP 306 (306)
||+|||+|+...... ......||+.|+||
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap 202 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL 202 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence 999999998653211 11234699999997
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=221.25 Aligned_cols=171 Identities=27% Similarity=0.526 Sum_probs=141.5
Q ss_pred Ccceeec-cCceecceeeeeccEEEEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021897 128 DEWTIDL-RKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (306)
Q Consensus 128 ~~~~i~~-~~~~~~~~lG~G~fG~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (306)
-...|.. .+.+..++||+|+||.||+|.| .++ +||||++........ -+++++|+-+|.++.|||+++
T Consensus 688 ~~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~-----s~e~LdeAl~masldHpnl~R 762 (1177)
T KOG1025|consen 688 ALLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA-----SIELLDEALRMASLDHPNLLR 762 (1177)
T ss_pred hheeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh-----hHHHHHHHHHHhcCCCchHHH
Confidence 3344444 3556778999999999999998 443 799999976555432 257999999999999999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
++++|.... +.||++||+.|.|.++++..+ ..+..+..+.|+.||++||.|||+++++||||.++|+||.....+||.
T Consensus 763 LLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 763 LLGVCMLST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred Hhhhcccch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEE
Confidence 999998876 789999999999999999754 468889999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCC-CccCCCC--CCcccC
Q 021897 281 DFGVARIEVQTE-GMTPETG--TYRWMA 305 (306)
Q Consensus 281 DFGla~~~~~~~-~~~~~~g--t~~y~A 305 (306)
|||+|+...... .++...| .+.|||
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwma 868 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMA 868 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHH
Confidence 999999765433 2333333 266765
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=204.88 Aligned_cols=165 Identities=27% Similarity=0.369 Sum_probs=136.8
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (306)
++|++.+.||+|+||.||+|+. +++.||||.+......... ...+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID----AKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch----hHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 4688889999999999999987 6789999998754322211 24567899999999999999999988654
Q ss_pred -CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
...|+|+||+. ++|.+++... ..+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 34799999995 6898888653 4689999999999999999999999999999999999999999999999999986
Q ss_pred eecC-CCccCCCCCCcccCC
Q 021897 288 EVQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~AP 306 (306)
.... .......++..|+||
T Consensus 158 ~~~~~~~~~~~~~~~~y~aP 177 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAP 177 (337)
T ss_pred cCCCcccccccccccCccCh
Confidence 5432 222344688899998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=204.56 Aligned_cols=164 Identities=27% Similarity=0.413 Sum_probs=135.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--C
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR--M 209 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~ 209 (306)
.+|++.+.||+|+||.||+|.+ +++.+|||.+......... ...+.+|+.+++++ +||||+++++++... .
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD----AQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh----hhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 5678889999999999999987 5789999988643222211 24567899999999 999999999998653 4
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+||||++ ++|.+++... .+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 6899999997 5998888653 67888899999999999999999999999999999999999999999999997543
Q ss_pred cCC------CccCCCCCCcccCC
Q 021897 290 QTE------GMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~------~~~~~~gt~~y~AP 306 (306)
... ......||+.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aP 181 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAP 181 (337)
T ss_pred cccccccCcchhcccccccccCc
Confidence 221 12234688899998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=199.83 Aligned_cols=158 Identities=25% Similarity=0.419 Sum_probs=134.7
Q ss_pred cceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
..+||+|+||.||++.. +++.||||.+..... .....+.+|+.+++.++|+||+++++.+......++||||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 36899999999999987 678999998753221 1235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-CccC
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMTP 296 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-~~~~ 296 (306)
+++++|.+++.. ..+++..++.++.|++.+|+|||+.|++|+||+|+||++++++.++|+|||++....... ....
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 999999998754 347899999999999999999999999999999999999999999999999987543222 2233
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
..|++.|+||
T Consensus 176 ~~~~~~y~~p 185 (292)
T cd06657 176 LVGTPYWMAP 185 (292)
T ss_pred cccCccccCH
Confidence 4688899987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=202.32 Aligned_cols=162 Identities=27% Similarity=0.394 Sum_probs=135.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (306)
++|+..+.||+|+||.||+|.. +++.||+|++........ ..+.+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH----HHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 6788999999999999999976 678999999875432211 134677899999999999999999988543
Q ss_pred --CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
...|++++++ +++|.+++.. ..+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|||+++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3478888887 7799888764 358999999999999999999999999999999999999999999999999997
Q ss_pred eeecCCCccCCCCCCcccCC
Q 021897 287 IEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~AP 306 (306)
.... ......+|+.|+||
T Consensus 169 ~~~~--~~~~~~~~~~y~aP 186 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAP 186 (345)
T ss_pred cccc--cccccccCCCccCH
Confidence 5432 23445688899988
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=204.33 Aligned_cols=164 Identities=26% Similarity=0.398 Sum_probs=139.0
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM---- 209 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 209 (306)
+|++.+.||+|++|.||+|+. .++.+|||.+....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL----IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc----hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccc
Confidence 467889999999999999987 57899999987543221 12357889999999999999999999997775
Q ss_pred -eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.+|++|||++ ++|.+++... ..+++..++.++.|++.||+|||+.|++||||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 77 NDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 7899999997 4898888653 36899999999999999999999999999999999999999999999999999865
Q ss_pred ecCC----CccCCCCCCcccCC
Q 021897 289 VQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~----~~~~~~gt~~y~AP 306 (306)
.... ......+|+.|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aP 175 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAP 175 (330)
T ss_pred cccccccccccccccccCcCCc
Confidence 5432 23345678899998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.3e-26 Score=213.97 Aligned_cols=159 Identities=27% Similarity=0.476 Sum_probs=135.8
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeec
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~ 218 (306)
-+||+|.+|.||-|++ +...+|||-+...... ..+-+.+|+.+-++|+|.|||+++|.|.+.+.+-|.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr------~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR------EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccch------hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecC
Confidence 4799999999999987 5557899987543322 2467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEcccCeeeeecC-CCc
Q 021897 219 KGGSVRQFLTRRQNRAV--PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQT-EGM 294 (306)
Q Consensus 219 ~~gsL~~~l~~~~~~~~--~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~-~~~~vkl~DFGla~~~~~~-~~~ 294 (306)
+||+|.++|+..= +++ .+.+.-.+..||++||+|||+..|+|||||-+|+||+ -.|.+||+|||-++....- +-.
T Consensus 655 PGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred CCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 9999999998642 344 6778888999999999999999999999999999997 5789999999988765432 334
Q ss_pred cCCCCCCcccCC
Q 021897 295 TPETGTYRWMAP 306 (306)
Q Consensus 295 ~~~~gt~~y~AP 306 (306)
.++.||..||||
T Consensus 734 ETFTGTLQYMAP 745 (1226)
T KOG4279|consen 734 ETFTGTLQYMAP 745 (1226)
T ss_pred cccccchhhhCh
Confidence 567899999999
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-25 Score=200.76 Aligned_cols=164 Identities=25% Similarity=0.343 Sum_probs=133.1
Q ss_pred CceecceeeeeccEEEEEEEEC----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--
Q 021897 136 KLNMGTAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR-- 208 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-- 208 (306)
+|++.+.||+|+||.||++... +..+|+|.+....... ...+.+.+|+.+++++ .||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK----ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc----hhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 3677889999999999999883 6689999986432221 1235678999999999 599999999976432
Q ss_pred --CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
..+|+++||+. ++|.+++.. ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++
T Consensus 77 ~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 77 NFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 45789999985 689988864 3568999999999999999999999999999999999999999999999999998
Q ss_pred eeecCC-----CccCCCCCCcccCC
Q 021897 287 IEVQTE-----GMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~-----~~~~~~gt~~y~AP 306 (306)
...... ......||+.|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aP 178 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAP 178 (332)
T ss_pred ecccccccccccccCcccCccccCc
Confidence 543221 12334689999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-24 Score=196.18 Aligned_cols=162 Identities=30% Similarity=0.444 Sum_probs=136.2
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|...+.||+|+||.||+|+. +++.+++|.+........ ...+.+.+|+.+++.++|||++++++++.+....|+|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN---EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 44456799999999999987 678999999875433221 1235688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM 294 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~ 294 (306)
|||+. ++|.+++... ...+++..++.++.|++.+|+|||+.|++|+||+|+||+++.++.+||+|||++.... ..
T Consensus 100 ~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 100 MEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PA 174 (313)
T ss_pred EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CC
Confidence 99996 5888887653 3468999999999999999999999999999999999999999999999999986432 23
Q ss_pred cCCCCCCcccCC
Q 021897 295 TPETGTYRWMAP 306 (306)
Q Consensus 295 ~~~~gt~~y~AP 306 (306)
....|+..|+||
T Consensus 175 ~~~~~~~~y~aP 186 (313)
T cd06633 175 NSFVGTPYWMAP 186 (313)
T ss_pred CCccccccccCh
Confidence 345788899998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=196.15 Aligned_cols=164 Identities=29% Similarity=0.459 Sum_probs=138.9
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|+..+.||+|++|.||+|.. +++.+++|.+........ ....+.+|+.++++++|++|+++++++..+..+++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG----IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEE
Confidence 34568899999999999987 678999999876544321 235778899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-C
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-~ 293 (306)
+||+++ +|.+++.... ..+++..++.++.|++.||+|||+.+++|+||||+||+++.++.+||+|||++....... .
T Consensus 77 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 77 FEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred EeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 999975 8988887643 568999999999999999999999999999999999999999999999999997654432 2
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....++..|+||
T Consensus 155 ~~~~~~~~~~~~P 167 (283)
T cd05118 155 YTHYVVTRWYRAP 167 (283)
T ss_pred ccCccCcccccCc
Confidence 2334578889888
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-24 Score=198.59 Aligned_cols=162 Identities=31% Similarity=0.478 Sum_probs=135.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 211 (306)
.+|+..+.||.|+||.||+|.. +++.||||.+........ ..+.+.+|+.+++.++||||+++++++.. ....
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV----LAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc----hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 5688999999999999999986 678999998865433221 12567799999999999999999999865 4578
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+++||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+++||||+|+||++++++.+||+|||++.....
T Consensus 86 ~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP- 160 (328)
T ss_pred EEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence 9999999 5689888764 3578888899999999999999999999999999999999999999999999875432
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
......+++.|+||
T Consensus 161 -~~~~~~~~~~y~aP 174 (328)
T cd07856 161 -QMTGYVSTRYYRAP 174 (328)
T ss_pred -CcCCCcccccccCc
Confidence 22344678889888
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-27 Score=199.72 Aligned_cols=173 Identities=24% Similarity=0.341 Sum_probs=144.3
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HHhCCCCCeeeEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGA 204 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~ 204 (306)
..|++...+++-+..||.|+||.|++-.+ .|+..|||.++......++ ++++.|... ++.-+.||||++||+
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq-----~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQ-----KRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHH-----HHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 34566667777788999999999999987 7889999999876553332 567777765 555679999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHH---hhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEE
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLT---RRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
+..+..-||-||.|+ .+|..+.+ ..+...+++..+-.|+...+.||.||.+ ..|||||+||+|||++..|.+|||
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeee
Confidence 988888899999995 47766654 3445679999999999999999999996 489999999999999999999999
Q ss_pred cccCeeeeecCCCccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|||.+....++-..+...|...||||
T Consensus 211 DFGIcGqLv~SiAkT~daGCrpYmAP 236 (361)
T KOG1006|consen 211 DFGICGQLVDSIAKTVDAGCRPYMAP 236 (361)
T ss_pred cccchHhHHHHHHhhhccCCccccCh
Confidence 99999877766666777899999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=210.40 Aligned_cols=176 Identities=20% Similarity=0.316 Sum_probs=131.0
Q ss_pred eeeccCceecceeeeeccEEEEEEEE------------------CCeeEEEEEeeCCCCChhHH--------HHHHHHHH
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY------------------NGEDVAIKILERPENNPEKA--------QVMEQQFQ 184 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~------------------~~~~vavK~~~~~~~~~~~~--------~~~~~~~~ 184 (306)
.+..++|++.++||+|+||.||+|.+ .++.||||.++......... ....+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 44678999999999999999999964 34579999986432211100 00112344
Q ss_pred HHHHHHHhCCCCCe-----eeEEEEEEe--------CCeEEEEEeecCCCCHHHHHHhhCC-------------------
Q 021897 185 QEVMMLATLKHLNI-----VRFIGACRK--------RMVWCIVTEYAKGGSVRQFLTRRQN------------------- 232 (306)
Q Consensus 185 ~E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~iv~E~~~~gsL~~~l~~~~~------------------- 232 (306)
.|+.++.+++|.++ ++++++|.. +...++||||+++++|.+++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777888876654 677777643 3467999999999999999874211
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCC--CCCCcccCC
Q 021897 233 ---RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 306 (306)
Q Consensus 233 ---~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~--~gt~~y~AP 306 (306)
..+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||+++........... .+|+.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12456778899999999999999999999999999999999999999999999764433222322 347899998
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=198.94 Aligned_cols=167 Identities=27% Similarity=0.377 Sum_probs=135.3
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 208 (306)
..+|++.+.||+|+||.||+|++ +++.+|||++......... ...+.+|+.++++++||||+++++.+.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF----PITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc----chhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 46888999999999999999987 6789999998754432211 13466899999999999999999987543
Q ss_pred -----CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 209 -----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 209 -----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
..+++|+||+.+ +|...+... ...+++..+..++.|++.||+|||+.|++||||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 356999999965 777777643 3469999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCC------------ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG------------MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~------------~~~~~gt~~y~AP 306 (306)
+++....... .+...+++.|+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP 195 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCCh
Confidence 9975432211 1223467889988
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-24 Score=192.74 Aligned_cols=155 Identities=19% Similarity=0.292 Sum_probs=126.5
Q ss_pred Cceecce--eeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEeCCe
Q 021897 136 KLNMGTA--FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 136 ~~~~~~~--lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~ 210 (306)
+|++.+. ||+|+||.||++.. ++..+|+|++....... .|+..... .+||||+++++.+.....
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 3334444 59999999999986 67889999986543221 12222221 269999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEcccCeeeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEV 289 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-~vkl~DFGla~~~~ 289 (306)
.|+||||+++++|.+++... ..+++..++.++.|++.||+|||+.+++||||||+||+++.++ .++|+|||+++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999999764 3689999999999999999999999999999999999999988 99999999987653
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.. ....+++.|+||
T Consensus 162 ~~---~~~~~~~~y~aP 175 (267)
T PHA03390 162 TP---SCYDGTLDYFSP 175 (267)
T ss_pred CC---ccCCCCCcccCh
Confidence 22 234688999998
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=204.93 Aligned_cols=171 Identities=25% Similarity=0.411 Sum_probs=145.4
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCC-CCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCC
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERP-ENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KRM 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~ 209 (306)
-++|-++.+||+|+|++||+|-+ ..+.||||+-... .+..++...+.+...+|..|-+.|.||.||++|+++. +..
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35778889999999999999976 6789999997654 4455667777788999999999999999999999985 456
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCcEEEc---CCCcEEEEcccC
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--GFIHRDLKSDNLLIS---ADKSIKIADFGV 284 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~--~iiHrDlkp~NILv~---~~~~vkl~DFGl 284 (306)
.+|-|+|||+|.+|.=+|+.. +.++++.++.|+.||+.||.||.+. -|||-||||.|||+. .-|.+||.||||
T Consensus 542 sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 789999999999999888764 5699999999999999999999986 499999999999995 456899999999
Q ss_pred eeeeecCCC--------ccCCCCCCcccCC
Q 021897 285 ARIEVQTEG--------MTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~--------~~~~~gt~~y~AP 306 (306)
+++..+..- .+...||++|++|
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPP 649 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPP 649 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCc
Confidence 998754321 2345699999998
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-25 Score=190.81 Aligned_cols=159 Identities=29% Similarity=0.426 Sum_probs=136.7
Q ss_pred eeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCC
Q 021897 143 FAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (306)
Q Consensus 143 lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~ 220 (306)
||+|+||.||++.. +++.+|+|+++....... .....+.+|+.++++++||||+++++.+.....+++||||+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch---HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 68999999999988 578999999876543321 1235788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-CCccCCCC
Q 021897 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETG 299 (306)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~-~~~~~~~g 299 (306)
++|.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus 78 ~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 78 GELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 9999999764 35899999999999999999999999999999999999999999999999999865433 22344568
Q ss_pred CCcccCC
Q 021897 300 TYRWMAP 306 (306)
Q Consensus 300 t~~y~AP 306 (306)
+..|+||
T Consensus 156 ~~~~~~P 162 (250)
T cd05123 156 TPEYLAP 162 (250)
T ss_pred CccccCh
Confidence 8889887
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-27 Score=204.93 Aligned_cols=163 Identities=26% Similarity=0.426 Sum_probs=134.6
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM----- 209 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 209 (306)
++-.+.||-|+||.||.+++ +|+.||+|.+..-... -..-+++.+|+++|..++|.|++..++..+...
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~----L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN----LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH----HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 44558999999999999998 8899999987432221 122367889999999999999999999886653
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+++|.|.. +|.+++-.. ..++.+.+.-+.+||++||+|||+.+|+||||||.|+||+.+..+||||||+||..+
T Consensus 131 EiYV~TELmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 131 ELYVLTELMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence 46889999955 888887653 458888888899999999999999999999999999999999999999999999866
Q ss_pred cCC--CccCCCCCCcccCC
Q 021897 290 QTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~--~~~~~~gt~~y~AP 306 (306)
... .++..+-|.+|.||
T Consensus 208 ~d~~~hMTqEVVTQYYRAP 226 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAP 226 (449)
T ss_pred hhhhhhhHHHHHHHHhccH
Confidence 444 34556678899887
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=195.91 Aligned_cols=164 Identities=29% Similarity=0.454 Sum_probs=137.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|+..+.||+|+||.||+|+. +++.+|+|.+........ ...+++.+|+.+++.++|+|++++++++......+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh---HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 4466678899999999999987 677899999865322221 12356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+. |+|.+++... ...+++..++.++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence 9999996 5888877643 34588999999999999999999999999999999999999999999999999876432
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
.....+++.|+||
T Consensus 168 -~~~~~~~~~y~aP 180 (308)
T cd06634 168 -ANXFVGTPYWMAP 180 (308)
T ss_pred -cccccCCccccCH
Confidence 2344688899988
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=194.85 Aligned_cols=164 Identities=29% Similarity=0.467 Sum_probs=137.7
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|+..+.||+|.+|.||+|+. +++.+|+|++........ ..+.+.+|+.++++++|+||+++++++.....+++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc----ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEE
Confidence 34567899999999999988 578999999976542211 124677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-C
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-G 293 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-~ 293 (306)
+||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+++||||+|+||++++++.+||+|||+++...... .
T Consensus 77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 99997 59999998643 458999999999999999999999999999999999999999999999999997654322 2
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
.....+++.|+||
T Consensus 155 ~~~~~~~~~~~aP 167 (282)
T cd07829 155 YTHEVVTLWYRAP 167 (282)
T ss_pred cCccccCcCcCCh
Confidence 2334567888887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-27 Score=201.99 Aligned_cols=171 Identities=27% Similarity=0.464 Sum_probs=137.4
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
+-+..+.|....+||+|.||+||+|+. .++.||+|.+--...... +-...++|+.+|..++|+|++.+++.|..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG----fpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC----CcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 344557777888999999999999976 677889886532111100 11345699999999999999999998843
Q ss_pred --------CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 021897 208 --------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 208 --------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl 279 (306)
...+|+|+.+|+. +|.-+|... ...++...+.+++.+++.||.|+|+..|+|||+||+|+||+.+|.+||
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence 3468999999987 999888754 356899999999999999999999999999999999999999999999
Q ss_pred EcccCeeeeecCC-----CccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTE-----GMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~-----~~~~~~gt~~y~AP 306 (306)
+|||+||.+.... .++..+-|.+|.+|
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrpp 197 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPP 197 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCH
Confidence 9999998655332 34555678888876
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=200.11 Aligned_cols=166 Identities=27% Similarity=0.453 Sum_probs=135.6
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.|++. .+|...+.||+|+||.||+|.+ +++.||||.+........ ....+.+|+.+++.+.||||+++++++.
T Consensus 10 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 10 VWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred hhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc----chhHHHHHHHHHHhcCCCCccchhheec
Confidence 35553 4688889999999999999986 688999999875432211 1246789999999999999999999986
Q ss_pred eC------CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 207 KR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 207 ~~------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
.. ..+|+|+||+.. +|.+++ ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~ 159 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKIL 159 (342)
T ss_pred ccccCCCCceEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence 54 246999999964 776654 2358899999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCCCccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|||+++.... ......+|+.|+||
T Consensus 160 dfg~~~~~~~--~~~~~~~~~~y~aP 183 (342)
T cd07879 160 DFGLARHADA--EMTGYVVTRWYRAP 183 (342)
T ss_pred eCCCCcCCCC--CCCCceeeecccCh
Confidence 9999975432 23345678889998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=189.02 Aligned_cols=173 Identities=19% Similarity=0.232 Sum_probs=142.3
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
+...|+.++|++.+.||+|+|.-||+++. +++.+|+|.+.-.... .++..++|+...++++||||+++++++
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~------~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE------DIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH------HHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 34457889999999999999999999985 7889999988654422 135788999999999999999999887
Q ss_pred EeC-----CeEEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCc
Q 021897 206 RKR-----MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKS 276 (306)
Q Consensus 206 ~~~-----~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlkp~NILv~~~~~ 276 (306)
..+ ...||+++|...|+|.+.+... ++..+++...+.|+.+||+||++||+.. +.||||||+|||+++++.
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence 433 3589999999999999998854 3446899999999999999999999998 999999999999999999
Q ss_pred EEEEcccCeeeee---cCC-------CccCCCCCCcccCC
Q 021897 277 IKIADFGVARIEV---QTE-------GMTPETGTYRWMAP 306 (306)
Q Consensus 277 vkl~DFGla~~~~---~~~-------~~~~~~gt~~y~AP 306 (306)
++|.|||.+.... .+. ......-|..|+||
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAP 207 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAP 207 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCc
Confidence 9999999875311 110 01223367889888
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=197.40 Aligned_cols=174 Identities=21% Similarity=0.354 Sum_probs=147.6
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 204 (306)
..|.+.+.+|.+++.||+|++.+|..+++ +.+.+|+|++++...+.... ..-.+.|-.+..+. +||.+|.+..+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded---idwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED---IDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc---chhHHhhHHHHHhccCCCeEEehhhh
Confidence 56888899999999999999999999987 66789999998664443211 12344566665554 69999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
|+.+..+++|.||++||+|.=.+++. +.+|++.++.+..+|+.||.|||++|||+||||.+|+|++.+|++||.|+|+
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence 99999999999999999997666543 5699999999999999999999999999999999999999999999999999
Q ss_pred eeee-ecCCCccCCCCCCcccCC
Q 021897 285 ARIE-VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~-~~~~~~~~~~gt~~y~AP 306 (306)
++-. .++...++.||||.|+||
T Consensus 398 cke~l~~gd~tstfcgtpnyiap 420 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAP 420 (593)
T ss_pred hhcCCCCCcccccccCCCcccch
Confidence 9853 445556788999999998
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=183.05 Aligned_cols=144 Identities=20% Similarity=0.185 Sum_probs=109.4
Q ss_pred cceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhH--------------------HHHHHHHHHHHHHHHHhCCCCCe
Q 021897 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMMLATLKHLNI 198 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~l~~l~h~ni 198 (306)
...||+|+||.||+|.. +|++||||+++........ .+.......+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999987 7899999999865322111 01112334569999999987776
Q ss_pred eeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCcEEEcCCCcE
Q 021897 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV-HGLGFIHRDLKSDNLLISADKSI 277 (306)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yL-H~~~iiHrDlkp~NILv~~~~~v 277 (306)
........ .. .+|||||++++++...... ...++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILL-KS-HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEe-cC-CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 43332222 22 2899999998777655332 24688999999999999999999 799999999999999998 5789
Q ss_pred EEEcccCeeee
Q 021897 278 KIADFGVARIE 288 (306)
Q Consensus 278 kl~DFGla~~~ 288 (306)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=192.09 Aligned_cols=169 Identities=27% Similarity=0.440 Sum_probs=135.1
Q ss_pred CceecceeeeeccEEEEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
+|.+.+.||+|+||.||++.+. +..+++|+++.......... ....+.+|+.+++.++||||+++++.+.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN-ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcc-hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence 3677899999999999999873 44567777654332211111 12356689999999999999999999998889999
Q ss_pred EEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 214 VTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||+++++|.+++... ....+++..++.++.|++.||.|||+.+++|+||+|+||+++. +.+||+|||+++.....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999988742 3456899999999999999999999999999999999999974 67999999999765332
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......|++.|+||
T Consensus 159 ~~~~~~~~~~~~~~~p 174 (260)
T cd08222 159 CDLATTFTGTPYYMSP 174 (260)
T ss_pred cccccCCCCCcCccCH
Confidence 2 22344688889887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=202.67 Aligned_cols=172 Identities=19% Similarity=0.278 Sum_probs=142.8
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGAC 205 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 205 (306)
+.+.+.-+.|+.+++||+|+.++||++.. +.+.+|+|.+.....+. ....-|.+|+..|.+|+ |.+||++|++-
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~----qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN----QTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH----HHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 44567778999999999999999999988 55677877665433332 23467999999999997 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
..++.+||||||=+ .+|..+|++.... .+.-.+..+..||+.++.++|.+||||.||||+|+|+- .|.+||+|||.|
T Consensus 430 v~d~~lYmvmE~Gd-~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA 506 (677)
T KOG0596|consen 430 VTDGYLYMVMECGD-IDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIA 506 (677)
T ss_pred ccCceEEEEeeccc-ccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechh
Confidence 99999999999984 5999999876443 33337788889999999999999999999999999997 689999999999
Q ss_pred eeeecCCC---ccCCCCCCcccCC
Q 021897 286 RIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~AP 306 (306)
........ ....+||+.||+|
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsP 530 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSP 530 (677)
T ss_pred cccCccccceeeccccCcccccCH
Confidence 86554332 3556899999998
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=200.55 Aligned_cols=167 Identities=26% Similarity=0.438 Sum_probs=138.8
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.|++ .++|+..+.||+|++|.||+|.+ +++.||||++........ ..+.+.+|+.+++++.||||+++++++.
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07851 10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMDHENVIGLLDVFT 84 (343)
T ss_pred eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh----HHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence 3444 35688999999999999999988 578999999865432221 2246778999999999999999998876
Q ss_pred eCCe------EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 207 KRMV------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 207 ~~~~------~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
.... .++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 85 PASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEc
Confidence 6554 89999999 6699998864 458999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCCCccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|||++...... .....+|+.|+||
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aP 184 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAP 184 (343)
T ss_pred ccccccccccc--ccCCcccccccCH
Confidence 99999865332 3445678889988
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=198.00 Aligned_cols=162 Identities=24% Similarity=0.349 Sum_probs=132.8
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (306)
.+|.+.+.||.|+||.||+|.. +++.||+|.+....... .+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS------VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch------HHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 5788899999999999999987 67899999986544321 25678999999999999999999876543
Q ss_pred ----------CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcE
Q 021897 209 ----------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSI 277 (306)
Q Consensus 209 ----------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~-~~~v 277 (306)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||+|||+.|++||||||+||+++. ++.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 35799999997 589888753 35889999999999999999999999999999999999984 5678
Q ss_pred EEEcccCeeeeecCCC----ccCCCCCCcccCC
Q 021897 278 KIADFGVARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 278 kl~DFGla~~~~~~~~----~~~~~gt~~y~AP 306 (306)
||+|||+++....... .....++..|+||
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 187 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCH
Confidence 9999999975432111 1223578889998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=178.15 Aligned_cols=145 Identities=18% Similarity=0.152 Sum_probs=111.8
Q ss_pred cceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhH--------------------HHHHHHHHHHHHHHHHhCCCCCe
Q 021897 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMMLATLKHLNI 198 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~l~~l~h~ni 198 (306)
.+.||+|++|+||+|+. +|+.||||+++........ .......+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987 6999999999876322111 11112335689999999999987
Q ss_pred eeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcE
Q 021897 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSI 277 (306)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~v 277 (306)
.....+.... .+|||||++++++...... ...++...+..++.|++.+|.+||+ .||+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 5444333333 3899999988755443222 2347788899999999999999999 9999999999999999 8999
Q ss_pred EEEcccCeeeee
Q 021897 278 KIADFGVARIEV 289 (306)
Q Consensus 278 kl~DFGla~~~~ 289 (306)
+|+|||+|+...
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-26 Score=213.51 Aligned_cols=165 Identities=28% Similarity=0.478 Sum_probs=144.9
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
..+|.++..+|.|.+|.||+++. .++..|+|+++......- +-+++|+-+++.++|||||.++|.+.....+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~------~~iqqei~~~~dc~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF------SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc------cccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence 45778888999999999999987 788999999987665542 4677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~- 290 (306)
||.||||.+|+|.++.+- ..++++..+...+++.+.|++|||+.|-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 88 wicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 999999999999998754 46788888999999999999999999999999999999999999999999999764332
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
-.....+.|||+||||
T Consensus 166 i~KrksfiGtpywmap 181 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAP 181 (829)
T ss_pred hhhhhcccCCccccch
Confidence 2234667899999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=209.09 Aligned_cols=168 Identities=18% Similarity=0.234 Sum_probs=119.1
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--C----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--N----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
.+....++|++.+.||+|+||.||+|++ + +..||||.+....... .+.+| .++...+.+++.++
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--------~~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--------IWMNE--RVRRACPNSCADFV 195 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--------HHHHH--HHHhhchhhHHHHH
Confidence 4556778999999999999999999988 4 6799999876432111 11111 11111222222211
Q ss_pred EE------EEeCCeEEEEEeecCCCCHHHHHHhhCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 021897 203 GA------CRKRMVWCIVTEYAKGGSVRQFLTRRQNR------------------AVPLKLAVKQALDVARGMAYVHGLG 258 (306)
Q Consensus 203 ~~------~~~~~~~~iv~E~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~qi~~gl~yLH~~~ 258 (306)
.. +.....+++||||+++++|.+++...... ......+..++.||+.||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 11 24556789999999999999998753210 1123345679999999999999999
Q ss_pred ccccCCCCCcEEEcC-CCcEEEEcccCeeeeecCC--CccCCCCCCcccCC
Q 021897 259 FIHRDLKSDNLLISA-DKSIKIADFGVARIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 259 iiHrDlkp~NILv~~-~~~vkl~DFGla~~~~~~~--~~~~~~gt~~y~AP 306 (306)
|+||||||+|||++. ++.+||+|||+|+...... .....++|+.|+||
T Consensus 276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~AP 326 (566)
T PLN03225 276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAP 326 (566)
T ss_pred EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccCh
Confidence 999999999999985 6799999999998543222 23456789999998
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=183.76 Aligned_cols=146 Identities=17% Similarity=0.231 Sum_probs=123.0
Q ss_pred eccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCH
Q 021897 146 GAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSV 223 (306)
Q Consensus 146 G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL 223 (306)
|.+|.||++.. +++.+|+|.++... .+.+|...+....||||+++++++.....+++||||+++++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence 88999999987 77899999986532 123455555566799999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCCCcc
Q 021897 224 RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303 (306)
Q Consensus 224 ~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y 303 (306)
.+++.+. ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++...... .....++..|
T Consensus 73 ~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccc
Confidence 9999764 34899999999999999999999999999999999999999999999999987654322 2334566778
Q ss_pred cCC
Q 021897 304 MAP 306 (306)
Q Consensus 304 ~AP 306 (306)
+||
T Consensus 149 ~aP 151 (237)
T cd05576 149 CAP 151 (237)
T ss_pred cCC
Confidence 887
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=216.34 Aligned_cols=152 Identities=20% Similarity=0.387 Sum_probs=127.6
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
.+...+.||+|+||.||+|++ ++..||||.++..... ..+|+.++++++|||||+++++|.+....|+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 445567899999999999986 7789999988643321 1246888999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH---GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
||||+++|+|.++++. +++..+.+++.||+.||+||| +.+|+||||||+||+++.++.+++. ||.+.....
T Consensus 761 v~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 9999999999999953 789999999999999999999 6699999999999999999888876 776654322
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
.....||+.|+||
T Consensus 835 ---~~~~~~t~~y~aP 847 (968)
T PLN00113 835 ---DTKCFISSAYVAP 847 (968)
T ss_pred ---CCCccccccccCc
Confidence 2234788999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-23 Score=174.72 Aligned_cols=164 Identities=32% Similarity=0.581 Sum_probs=139.9
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv 214 (306)
|.+.+.||+|++|.||++.. +++.+|+|.+...... ...+.+.+|+..+++++|+|++++++.+......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEE
Confidence 35678999999999999988 3689999999765433 1236788999999999999999999999998999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC--
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-- 292 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-- 292 (306)
+|++++++|.+++..... .+++...+.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999999999976432 17889999999999999999999999999999999999999999999999998765432
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......++..|++|
T Consensus 155 ~~~~~~~~~~~~~p 168 (225)
T smart00221 155 LLKTVKGTPFYLAP 168 (225)
T ss_pred cccceeccCCcCCH
Confidence 23445677888887
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=202.49 Aligned_cols=160 Identities=28% Similarity=0.470 Sum_probs=127.6
Q ss_pred ceecceeeeeccE-EEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFG-KLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG-~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv 214 (306)
+.-.+.+|.|+-| .||+|.+.+++||||.+-. .......+|+..|+.- .|||||++|+.-+++...||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~---------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE---------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhh---------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 3444678899987 6899999999999997743 2234567999999887 599999999999999999999
Q ss_pred EeecCCCCHHHHHHhh-CCCCC-CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---C--CcEEEEcccCeee
Q 021897 215 TEYAKGGSVRQFLTRR-QNRAV-PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---D--KSIKIADFGVARI 287 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~-~~~~~-~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~--~~vkl~DFGla~~ 287 (306)
.|.|. .+|.+++... ..... .-...+....|++.||++||+.+||||||||.||||+. + .+++|+|||+++.
T Consensus 582 lELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 99994 5999999863 11111 11345778899999999999999999999999999975 3 3789999999986
Q ss_pred eecCCC----ccCCCCCCcccCC
Q 021897 288 EVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~----~~~~~gt~~y~AP 306 (306)
...+.. .....||.+|+||
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~AP 683 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAP 683 (903)
T ss_pred cCCCcchhhcccCCCCcccccCH
Confidence 543321 3445699999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-24 Score=178.34 Aligned_cols=157 Identities=18% Similarity=0.412 Sum_probs=130.9
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC-
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR- 208 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~- 208 (306)
...+|++.+++|+|-+++||.|.. +.+.++||++++.. .+.+.+|+.||..|. ||||++++++..++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---------KKKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---------HHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 347889999999999999999985 78899999997522 257889999999998 99999999999765
Q ss_pred -CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEcccCee
Q 021897 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVAR 286 (306)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~-~~vkl~DFGla~ 286 (306)
....+++||+.+.+...+... ++...+..++.+++.||.|||+.||+|||+||.|++|+.. ..++|+|+|+|.
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 467899999998877766543 6777889999999999999999999999999999999954 479999999998
Q ss_pred eeecCCCccCCCCCCcc
Q 021897 287 IEVQTEGMTPETGTYRW 303 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y 303 (306)
...+....+..+.+-+|
T Consensus 182 FYHp~~eYnVRVASRyf 198 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYF 198 (338)
T ss_pred hcCCCceeeeeeehhhc
Confidence 76665555544444333
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-22 Score=166.82 Aligned_cols=158 Identities=30% Similarity=0.618 Sum_probs=134.6
Q ss_pred eeeeccEEEEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCC
Q 021897 143 FAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKG 220 (306)
Q Consensus 143 lG~G~fG~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~ 220 (306)
||+|++|.||++... ++.+++|++....... ..+.+.+|+..++.++|++|+++++++......++++|++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 688999999999985 8899999997654432 235788999999999999999999999998999999999998
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEcccCeeeeecCC-CccCCC
Q 021897 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQTE-GMTPET 298 (306)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~-~~~vkl~DFGla~~~~~~~-~~~~~~ 298 (306)
++|.+++.... ..+++..++.++.+++.++++||+.+++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 99999987642 35889999999999999999999999999999999999998 8999999999998654332 122235
Q ss_pred CCCcccCC
Q 021897 299 GTYRWMAP 306 (306)
Q Consensus 299 gt~~y~AP 306 (306)
+...|++|
T Consensus 155 ~~~~~~~p 162 (215)
T cd00180 155 GTPAYMAP 162 (215)
T ss_pred CCCCccCh
Confidence 66777776
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=180.19 Aligned_cols=161 Identities=28% Similarity=0.393 Sum_probs=134.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 211 (306)
-.|+++++||+|.||+++.|+. ++++||||.-.+....+ ++..|.+..+.|. .+.|...|-+..+..+-
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP--------QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP--------QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcc--------hHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 4688999999999999999975 99999999765444332 5667888888775 78999999888888888
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-----cEEEEcccCee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-----SIKIADFGVAR 286 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-----~vkl~DFGla~ 286 (306)
.||+|++ |-+|.|++.- .++.++.++++.+|.|++.-|+|+|++.+|.|||||+|+||+..+ .+.|+|||+|+
T Consensus 100 iLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 9999999 7799888764 467799999999999999999999999999999999999998654 58999999998
Q ss_pred eeecCCC--------ccCCCCCCcccC
Q 021897 287 IEVQTEG--------MTPETGTYRWMA 305 (306)
Q Consensus 287 ~~~~~~~--------~~~~~gt~~y~A 305 (306)
...+... .+...||.+||+
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred hhcCccccccCccccccccccceeeeE
Confidence 6544332 234569999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=172.82 Aligned_cols=153 Identities=34% Similarity=0.542 Sum_probs=133.1
Q ss_pred ccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHH
Q 021897 147 AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224 (306)
Q Consensus 147 ~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~ 224 (306)
+||.||+|.+ +++.+|+|++........ .+.+.+|+..+++++|++|+++++.+......++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 5899999998 468999999976544321 357889999999999999999999999989999999999999999
Q ss_pred HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCCCccc
Q 021897 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWM 304 (306)
Q Consensus 225 ~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~ 304 (306)
+++.... .+++..++.++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||++.............+++.|+
T Consensus 76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 9987643 28899999999999999999999999999999999999999999999999998765543445567888898
Q ss_pred CC
Q 021897 305 AP 306 (306)
Q Consensus 305 AP 306 (306)
||
T Consensus 154 ~p 155 (244)
T smart00220 154 AP 155 (244)
T ss_pred CH
Confidence 87
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=168.28 Aligned_cols=164 Identities=27% Similarity=0.390 Sum_probs=132.9
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~ 208 (306)
|...+|+++++||+|+||.+|.|.. .|+.||||+-......+ ++.-|..+.+.|++ ..|..+..+..+.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--------qL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--------QLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--------chhHHHHHHHHhccCCCCchhhhhcccc
Confidence 4567899999999999999999987 89999999865544332 57789999998874 6677777788888
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC---CcEEEEcccCe
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVA 285 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~---~~vkl~DFGla 285 (306)
..-.+|||.+ |-+|.+++.-- .+.++.++.+-.|.|++.-++|+|.+++|||||||+|+|++-+ ..+.|+|||+|
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred ccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 8889999999 77898887643 4568999999999999999999999999999999999999743 36899999999
Q ss_pred eeeecCCC--------ccCCCCCCcccC
Q 021897 286 RIEVQTEG--------MTPETGTYRWMA 305 (306)
Q Consensus 286 ~~~~~~~~--------~~~~~gt~~y~A 305 (306)
+.+.+... -....||.+|.+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred hhhccccccccCccccCCccceeeeehh
Confidence 86543221 123358888754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=167.69 Aligned_cols=136 Identities=16% Similarity=0.286 Sum_probs=104.3
Q ss_pred cceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEeCC---e-
Q 021897 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-----KHLNIVRFIGACRKRM---V- 210 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~- 210 (306)
.+.||+|+||.||.-..++.. +||++....... .+.+.+|+.+++.+ .||||+++||++..+. .
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGG------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccch------HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 368999999999962224344 799886543221 24688999999999 5799999999998873 3
Q ss_pred EEEEEee--cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCcEEEcCC----CcEEEEc-c
Q 021897 211 WCIVTEY--AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM-AYVHGLGFIHRDLKSDNLLISAD----KSIKIAD-F 282 (306)
Q Consensus 211 ~~iv~E~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl-~yLH~~~iiHrDlkp~NILv~~~----~~vkl~D-F 282 (306)
+.+|+|| +++++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. ..++|+| |
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3478999 5579999999652 25555 35577888777 99999999999999999999743 3799999 5
Q ss_pred cCeee
Q 021897 283 GVARI 287 (306)
Q Consensus 283 Gla~~ 287 (306)
|.+..
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 54443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-23 Score=179.32 Aligned_cols=163 Identities=26% Similarity=0.351 Sum_probs=134.4
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (306)
..+|.-++.++.|+- .|.-+-+ .+++||+|.+-.+...... -++..+|..++..+.|+||++++.++....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~----akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH----AKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc----chhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 356667788888887 5665543 7889999988665322111 246779999999999999999999996543
Q ss_pred ----eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
..|+|||+|. .+|...+.. .+.-+++..+..|+++|++|||+.||+||||||+||++..+..+||.|||+|
T Consensus 91 ~~~~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 91 EEFQEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence 5799999995 488888873 2667788999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+.....-.+++.+.|-+|.||
T Consensus 166 r~e~~~~~mtpyVvtRyyrap 186 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAP 186 (369)
T ss_pred cccCcccccCchhheeeccCc
Confidence 976665567788899999998
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=179.46 Aligned_cols=163 Identities=25% Similarity=0.382 Sum_probs=137.4
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--C----CeeeEEEEE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--L----NIVRFIGAC 205 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~ 205 (306)
..+|.+.+.+|+|.||+|.++.+ .+..||||+++.-. .+.++.+-|+++|.++.+ | .+|++.++|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-------kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-------KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-------HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 47888999999999999999976 56789999986422 223456678999999842 2 378899999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-----------
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----------- 274 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~----------- 274 (306)
.-.+++|||+|.+ |-++.+++....-.+++...++.|+.|++.+|+|||+.+++|-||||+|||+.+.
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 6699999998878889999999999999999999999999999999999998322
Q ss_pred ---------CcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 275 ---------KSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 275 ---------~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
-.+||+|||.|....+.+ ++.+.|-.|.||
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAP 278 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAP 278 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCc
Confidence 248999999998755433 566889999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=166.90 Aligned_cols=140 Identities=19% Similarity=0.346 Sum_probs=116.7
Q ss_pred ceeeeeccEEEEEEEECCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeec
Q 021897 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~ 218 (306)
+.||+|++|.||+|.+.+..+++|+......... ........+.+|+.++..+.|++|+....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5789999999999999999999998765433221 11222356889999999999998877776766667789999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
+|++|.+++.... . ....++.+++.+|.+||+.+++|+|++|+|||++ ++.++|+|||+++.
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999986421 2 7788999999999999999999999999999999 78999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=178.21 Aligned_cols=164 Identities=21% Similarity=0.368 Sum_probs=130.4
Q ss_pred CceecceeeeeccEEEEEEEECC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC----CCCeeeEEEEE-Ee
Q 021897 136 KLNMGTAFAQGAFGKLYRGTYNG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK----HLNIVRFIGAC-RK 207 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~l~~~~-~~ 207 (306)
.|.+.++||+|+||.||.+.... ..+|+|+......... ..+..|..++..+. -+++..+++.. ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC------ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence 78899999999999999998743 4689998765433221 13557777777776 26889999988 47
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-----CcEEEEcc
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-----KSIKIADF 282 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~-----~~vkl~DF 282 (306)
...-||||+.+ |.+|.++......+.++..++..++.|++.+|++||+.|+|||||||+|++++.. ..+.|.||
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 77889999988 7899998876666789999999999999999999999999999999999999865 46999999
Q ss_pred cCee--eeecCC-------C--ccCCCCCCcccCC
Q 021897 283 GVAR--IEVQTE-------G--MTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~--~~~~~~-------~--~~~~~gt~~y~AP 306 (306)
|+|+ ...... . .....||.+|+++
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~ 206 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI 206 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccH
Confidence 9998 321111 0 1234599999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=164.32 Aligned_cols=137 Identities=19% Similarity=0.317 Sum_probs=110.0
Q ss_pred eeeeeccEEEEEEEECCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecC
Q 021897 142 AFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAK 219 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~ 219 (306)
.||+|+||.||+|.+++.++++|+......... .......++.+|+.+++.+.|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 379999999999999999999999765432211 122223578899999999998865544444445556689999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
|++|.+++.... . .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||+++..
T Consensus 81 g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999875421 0 7789999999999999999999999999999 899999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=165.90 Aligned_cols=144 Identities=10% Similarity=0.153 Sum_probs=116.2
Q ss_pred ccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHH---HHHHHHHHHHHHhCCCCCeeeEEEEEEeC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM---EQQFQQEVMMLATLKHLNIVRFIGACRKR-- 208 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 208 (306)
..+|+..+.||.|+||.||++..++..+|||++++.....+..... ...+.+|+..+.++.||+|....+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 3678899999999999999987778899999997655443322110 12268999999999999999998886533
Q ss_pred ------CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 209 ------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 209 ------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
...+|||||++|.+|.++.. ++. ....+++.+|..||+.|++|||++|+||+++++| ++|+||
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35799999999999988732 222 2356899999999999999999999999999988 999999
Q ss_pred cCeeee
Q 021897 283 GVARIE 288 (306)
Q Consensus 283 Gla~~~ 288 (306)
|..+..
T Consensus 179 g~~~~~ 184 (232)
T PRK10359 179 SGKRCT 184 (232)
T ss_pred CCcccc
Confidence 988654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-22 Score=186.48 Aligned_cols=158 Identities=20% Similarity=0.335 Sum_probs=131.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCe
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 210 (306)
..+|.+...+|.|+|+.|-++.. +++..++|++.+.... -.+|+.++... +||||+++.+++.+...
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----------~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----------NQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc----------cccccchhhhhcCCCcceeecceecCCce
Confidence 45677788899999999999976 7788999999776322 33677665555 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-cCCCcEEEEcccCeeeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIADFGVARIEV 289 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv-~~~~~vkl~DFGla~~~~ 289 (306)
.|+|||.+.++-|.+.+.... .....+..|+.+|+.++.|||++|+|||||||+|||+ +..++++|+|||.++...
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999999998888876532 2226677899999999999999999999999999999 689999999999998654
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.. ..+.|-|..|.||
T Consensus 468 ~~--~~tp~~t~~y~AP 482 (612)
T KOG0603|consen 468 RS--CDTPALTLQYVAP 482 (612)
T ss_pred hh--hcccchhhcccCh
Confidence 43 4455778888888
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=186.23 Aligned_cols=140 Identities=20% Similarity=0.279 Sum_probs=115.2
Q ss_pred eecceeeeeccEEEEEEEECCeeEEEEEeeCCCCCh--hHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEE
Q 021897 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNP--EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~ 215 (306)
...+.||+|+||.||+|.+.+..+++|+........ .......+++.+|+.+++.++|++++..+.++......++||
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 457899999999999999987777777643322111 112223467889999999999999988877777766779999
Q ss_pred eecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
||+++++|.+++. ....++.+++.+|.|||+.+++||||||+|||+ .++.++|+|||+|+..
T Consensus 416 E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999885 246788999999999999999999999999999 5789999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=167.74 Aligned_cols=146 Identities=18% Similarity=0.213 Sum_probs=111.8
Q ss_pred CceecceeeeeccEEEEEEE-E--CCeeEEEEEeeCCCCChh------------------HHHHHHHHHHHHHHHHHhCC
Q 021897 136 KLNMGTAFAQGAFGKLYRGT-Y--NGEDVAIKILERPENNPE------------------KAQVMEQQFQQEVMMLATLK 194 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~-~--~~~~vavK~~~~~~~~~~------------------~~~~~~~~~~~E~~~l~~l~ 194 (306)
-|++.+.||+|+||.||+|. . +|+.||||+++....... ..+.....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36677899999999999998 3 789999999976432110 11112245678999999997
Q ss_pred CC--CeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCcEEE
Q 021897 195 HL--NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIHRDLKSDNLLI 271 (306)
Q Consensus 195 h~--niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~-iiHrDlkp~NILv 271 (306)
+. .+++.++. . ..++||||+++.+|...... ........+..++.|++.+|.+||+.| ++||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34455543 2 24899999999888765432 233556667889999999999999999 9999999999999
Q ss_pred cCCCcEEEEcccCeeee
Q 021897 272 SADKSIKIADFGVARIE 288 (306)
Q Consensus 272 ~~~~~vkl~DFGla~~~ 288 (306)
+ ++.++|+|||.|...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999998753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-22 Score=168.20 Aligned_cols=143 Identities=22% Similarity=0.404 Sum_probs=119.8
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEE-EEeCCe
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA-CRKRMV 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~ 210 (306)
..|.+.+.||+|.||.+-++.+ ..+.+++|.+.++... .++|.+|..---.| .|.||+.-|++ |+..+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-------QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-------HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 4567789999999999999998 5578999988664433 36788998765555 49999998876 566778
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc--CCCcEEEEcccCeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADKSIKIADFGVARI 287 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~--~~~~vkl~DFGla~~ 287 (306)
+.+++||++.|+|.+-+.. ..+.+....+++.|++.|+.|||+.+++|||||.+||||- +..+|||||||+.+.
T Consensus 97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 8899999999999887754 4578888899999999999999999999999999999994 445899999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-20 Score=156.93 Aligned_cols=136 Identities=19% Similarity=0.160 Sum_probs=108.1
Q ss_pred ecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeEEEEEee
Q 021897 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 139 ~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
....|++|+||+|+.+...+++++.+.+......... .....+.+|+++|++|. |+++++++++ ...+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~--~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRG--VAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhh--HHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3468999999999998888889998877654442211 11236889999999995 5889999886 335999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEEcCCCcEEEEcccCeeeee
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDL-KSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDl-kp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
++|.+|.+.+.. . ...++.|++.+|++||++||+|||| ||+|||++.++.++|+|||+|....
T Consensus 80 I~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 80 LAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred ecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 999888654321 1 1346789999999999999999999 7999999999999999999998543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=159.03 Aligned_cols=140 Identities=20% Similarity=0.210 Sum_probs=108.2
Q ss_pred ceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHH----------------HHHHHHHHHHHHHHHhCCCC--C
Q 021897 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------QVMEQQFQQEVMMLATLKHL--N 197 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~--n 197 (306)
|.+.+.||+|+||.||++.. +++.||||+++......... ......+.+|..++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 55668999999999999988 78999999987543211100 01112467889999999877 4
Q ss_pred eeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcE
Q 021897 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (306)
Q Consensus 198 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~v 277 (306)
++..++. ...++||||+++++|.++... .....++.+++.++.++|+.|++||||||+||++++++.+
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 5555543 234899999999998765421 2346788899999999999999999999999999999999
Q ss_pred EEEcccCeeee
Q 021897 278 KIADFGVARIE 288 (306)
Q Consensus 278 kl~DFGla~~~ 288 (306)
+|+|||+|...
T Consensus 165 ~liDfg~~~~~ 175 (198)
T cd05144 165 YIIDWPQMVST 175 (198)
T ss_pred EEEECCccccC
Confidence 99999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-21 Score=177.32 Aligned_cols=164 Identities=26% Similarity=0.415 Sum_probs=135.9
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC------CCCeeeEEEEE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK------HLNIVRFIGAC 205 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~ 205 (306)
...|.+..-.|+|-|+.|.+|.. .+..||||+++... .+.+.=++|+++|++|. ..++++|+..|
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-------~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-------VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-------HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 35677778889999999999987 67799999997532 34456779999999996 35789999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEccc
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFG 283 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-~vkl~DFG 283 (306)
...+++|||+|-+ ..+|.++|++.. +-.+.++.+..++.|+..||..|-.+||+|.||||+||||.+.. .+||||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999999998 559999998753 45688999999999999999999999999999999999998654 68999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
.|......+ .++..-+-.|.||
T Consensus 583 SA~~~~ene-itPYLVSRFYRaP 604 (752)
T KOG0670|consen 583 SASFASENE-ITPYLVSRFYRAP 604 (752)
T ss_pred ccccccccc-ccHHHHHHhccCc
Confidence 997655433 3444555567776
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-19 Score=158.60 Aligned_cols=166 Identities=28% Similarity=0.485 Sum_probs=140.0
Q ss_pred ceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEEeCCeEEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~iv~ 215 (306)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.+++.+.|+ +++++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS---KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch---hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 566788999999999999888 8889999876555432 1246789999999999988 7999999998888789999
Q ss_pred eecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEcccCeeeeecCC-
Q 021897 216 EYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTE- 292 (306)
Q Consensus 216 E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-~vkl~DFGla~~~~~~~- 292 (306)
|++.++++.+++..... ..++......++.|++.+++|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999999977765321 2688999999999999999999999999999999999999988 79999999998544332
Q ss_pred ------CccCCCCCCcccCC
Q 021897 293 ------GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ------~~~~~~gt~~y~AP 306 (306)
......||..|+||
T Consensus 158 ~~~~~~~~~~~~~t~~~~~p 177 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAP 177 (384)
T ss_pred cccccccccccccccccCCH
Confidence 23556899999998
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.3e-20 Score=167.00 Aligned_cols=132 Identities=23% Similarity=0.420 Sum_probs=115.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-----C---CCeeeEEEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----H---LNIVRFIGA 204 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~ 204 (306)
.+|.+.++||-|.|++||++.+ ..+.||+|+.+. ++.+-+..+.||++|++++ | .+||+|++.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 6889999999999999999977 667999999975 3444567789999999884 2 469999999
Q ss_pred EEe----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCC
Q 021897 205 CRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISAD 274 (306)
Q Consensus 205 ~~~----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~ 274 (306)
|.. ..++|+|+|++ |.+|..++....-+.++...+..|+.||+.||.|||+ +||||-||||+|||+..+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 965 45899999999 7799999998888889999999999999999999995 699999999999999754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.7e-20 Score=164.35 Aligned_cols=139 Identities=24% Similarity=0.381 Sum_probs=123.4
Q ss_pred cCceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 208 (306)
+.|....+||+|.|+.||+++. ..+.||+|.+...... .++.+|+++|..+. +.||+++.+++..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--------~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--------SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--------hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 4567788999999999999975 3468999998764443 46889999999985 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEcccCee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVAR 286 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~-~~~~vkl~DFGla~ 286 (306)
+...+|+||++.....+++.. ++...+..++..++.||+++|..|||||||||.|+|.+ ..+.-.|+|||+|.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 999999999999999999865 66888999999999999999999999999999999998 46678999999997
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=146.49 Aligned_cols=141 Identities=21% Similarity=0.209 Sum_probs=100.0
Q ss_pred cceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHH------------------HHHHHHHHHHHHhCCCC--Ce
Q 021897 140 GTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVM------------------EQQFQQEVMMLATLKHL--NI 198 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~------------------~~~~~~E~~~l~~l~h~--ni 198 (306)
++.||+|+||.||+|.. ++++||||+++............ ......|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999988 58999999987654332211110 01123566666666443 34
Q ss_pred eeEEEEEEeCCeEEEEEeecCCCCHHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCc
Q 021897 199 VRFIGACRKRMVWCIVTEYAKGGSVRQ-FLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKS 276 (306)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~ 276 (306)
.+.++.. ..++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .+++||||||+||+++ ++.
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 5555432 2489999999854322 121110 11 5578899999999999999 9999999999999999 899
Q ss_pred EEEEcccCeeeee
Q 021897 277 IKIADFGVARIEV 289 (306)
Q Consensus 277 vkl~DFGla~~~~ 289 (306)
++|+|||.|....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-18 Score=150.13 Aligned_cols=141 Identities=18% Similarity=0.189 Sum_probs=108.4
Q ss_pred ceee-eeccEEEEEEEECCeeEEEEEeeCCCCChh-------HHHHHHHHHHHHHHHHHhCCCCCe--eeEEEEEEeCC-
Q 021897 141 TAFA-QGAFGKLYRGTYNGEDVAIKILERPENNPE-------KAQVMEQQFQQEVMMLATLKHLNI--VRFIGACRKRM- 209 (306)
Q Consensus 141 ~~lG-~G~fG~V~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~- 209 (306)
..|| .|+.|.||.+...+..++||.+++...-.. .......++.+|+.++..+.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 5677 888999999999899999999865332100 001123567899999999998775 67777654332
Q ss_pred ---eEEEEEeecCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 210 ---VWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 210 ---~~~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
..++|||++++ .+|.+++.. ..++... +.+++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 23599999997 689888764 2355443 568899999999999999999999999999999999999998
Q ss_pred eee
Q 021897 286 RIE 288 (306)
Q Consensus 286 ~~~ 288 (306)
+..
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.7e-18 Score=136.26 Aligned_cols=132 Identities=21% Similarity=0.262 Sum_probs=112.3
Q ss_pred cceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCCeEEEEEee
Q 021897 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~iv~E~ 217 (306)
.+.||+|.++.||+++..+..+++|....... ...+.+|+.+++.++| ..+++++.+....+..+++|||
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46799999999999999888999999865433 1467899999999976 5899999988887888999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
+++..+..+ +......++.+++.+|++||.. +++|+|++|+||++++.+.++++|||.++..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 988777544 4455677889999999999985 6999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3e-18 Score=171.31 Aligned_cols=152 Identities=24% Similarity=0.398 Sum_probs=119.0
Q ss_pred CCCCcceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---CCCeee
Q 021897 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVR 200 (306)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~ 200 (306)
....++++....|.+.+.||+|+||+||+|+. +++.||+|+-+++... +|.--.+++.+|+ -+-|..
T Consensus 688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---------EfYI~~q~~~RLk~~~~~~~~~ 758 (974)
T KOG1166|consen 688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---------EFYICLQVMERLKPQMLPSIMH 758 (974)
T ss_pred CccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---------eeeehHHHHHhhchhhhcchHH
Confidence 33456677778899999999999999999987 7899999998765543 2333344555555 223333
Q ss_pred EEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-------
Q 021897 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA------- 273 (306)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~------- 273 (306)
+..+..-.+.-+||+||.+.|+|.+++. ..+.+++...+.++.|++.-++.||.++|||+||||+|+||..
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence 4444344445589999999999999998 4567999999999999999999999999999999999999942
Q ss_pred CCcEEEEcccCeee
Q 021897 274 DKSIKIADFGVARI 287 (306)
Q Consensus 274 ~~~vkl~DFGla~~ 287 (306)
..-++|+|||.|-.
T Consensus 837 ~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 837 SKGLYLIDFGRSID 850 (974)
T ss_pred ccceEEEeccccee
Confidence 33689999999853
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-17 Score=147.86 Aligned_cols=155 Identities=23% Similarity=0.388 Sum_probs=127.7
Q ss_pred cceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (306)
+..+...++++...+-+|.||.||+|.|. .+.|-+|.++... .+.-...++.|..++..+.|||+...
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-----S~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-----SQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-----cHHHHHHHHHHHHHHhcCcCCCccce
Confidence 34555667788889999999999999662 2356777765322 23335679999999999999999999
Q ss_pred EEEEEeC-CeEEEEEeecCCCCHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 021897 202 IGACRKR-MVWCIVTEYAKGGSVRQFLTRR------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274 (306)
Q Consensus 202 ~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~ 274 (306)
.+++.+. ...++++.++.-|+|..||..- ..+.+.......++.|++.||+|||++++||.||.++|++|++.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 9998654 5678999999889999999832 22456777788999999999999999999999999999999999
Q ss_pred CcEEEEcccCeeee
Q 021897 275 KSIKIADFGVARIE 288 (306)
Q Consensus 275 ~~vkl~DFGla~~~ 288 (306)
-+|||+|=.++|..
T Consensus 433 LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 433 LQVKLTDSALSRDL 446 (563)
T ss_pred eeEEeccchhcccc
Confidence 99999999999854
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-17 Score=166.93 Aligned_cols=94 Identities=18% Similarity=0.254 Sum_probs=74.7
Q ss_pred hCCC-CCeeeEEEEE-------EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021897 192 TLKH-LNIVRFIGAC-------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (306)
Q Consensus 192 ~l~h-~niv~l~~~~-------~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrD 263 (306)
.+.| +||..+++.| .+...+++++|++ +++|.+++... ...+++..++.++.||+.||+|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 4445 5777788877 2334678889988 56999999753 35689999999999999999999999999999
Q ss_pred CCCCcEEEcC-------------------CCcEEEEcccCeee
Q 021897 264 LKSDNLLISA-------------------DKSIKIADFGVARI 287 (306)
Q Consensus 264 lkp~NILv~~-------------------~~~vkl~DFGla~~ 287 (306)
|||+||||+. ++.+||+|||+++.
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~ 148 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR 148 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence 9999999954 44566777777653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.9e-16 Score=147.07 Aligned_cols=145 Identities=20% Similarity=0.254 Sum_probs=99.9
Q ss_pred ceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHH----------------------------HHH------HHHHHH
Q 021897 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------------------QVM------EQQFQQ 185 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~----------------------------~~~------~~~~~~ 185 (306)
+.||.|++|+||+|+. +|+.||||+.++.....-.. +.. +-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6899999999999988 89999999987543211000 000 113556
Q ss_pred HHHHHHhCC----CCCeeeEEEEEE-eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 021897 186 EVMMLATLK----HLNIVRFIGACR-KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR-GMAYVHGLGF 259 (306)
Q Consensus 186 E~~~l~~l~----h~niv~l~~~~~-~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~-gl~yLH~~~i 259 (306)
|+..+.++. +.+-+..-.++. .....+|||||++|++|.++....... .. ...++.+++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHhCCc
Confidence 776666653 332233222221 123358999999999999887543211 22 2345555555 4788999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 260 IHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 260 iHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
+|+|++|.||+++.++.++|+|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.8e-17 Score=157.34 Aligned_cols=166 Identities=22% Similarity=0.291 Sum_probs=126.0
Q ss_pred eecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEE
Q 021897 138 NMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~ 215 (306)
.....+|.|++|.|+.... .....+.|.++......+........+..|..+-..+.|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4667899999997777654 33334444433110011122222233778899999999999988877777766666669
Q ss_pred eecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC---
Q 021897 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE--- 292 (306)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~--- 292 (306)
||+++ +|..++... ..+....+..++.|++.|++|||+.||.|||||++|+++..+|.+||+|||.+..+....
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 99999 999999763 357788889999999999999999999999999999999999999999999998654322
Q ss_pred --CccCCCCCCcccCC
Q 021897 293 --GMTPETGTYRWMAP 306 (306)
Q Consensus 293 --~~~~~~gt~~y~AP 306 (306)
.....+|+..|+||
T Consensus 478 ~~~~~g~~gS~pY~ap 493 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAP 493 (601)
T ss_pred hhhhcCcccCCcCcCc
Confidence 23456799999998
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-16 Score=137.14 Aligned_cols=168 Identities=32% Similarity=0.535 Sum_probs=136.9
Q ss_pred eeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
.|+..++.+..+|.+...|+.|+|+|.|..+++|+++......... ++|..|...|+.+.||||+.++|.|..++.
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~ris----rdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARIS----RDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred CcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhc----chhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 3677788888999999999999999999999999998766654432 578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccc-CCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG-FIHR-DLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~-iiHr-Dlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
+.++..||+.|+|+..|....+-.+...++.+++.+|++||+|||+.. +|-| -|....++||++.+.+|+ .+-+++.
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs 340 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS 340 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee
Confidence 999999999999999999876666777889999999999999999874 5544 788899999999887764 2223322
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
-+. ....-.|.||+|
T Consensus 341 fqe---~gr~y~pawmsp 355 (448)
T KOG0195|consen 341 FQE---VGRAYSPAWMSP 355 (448)
T ss_pred eec---cccccCcccCCH
Confidence 111 112335788887
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-15 Score=145.73 Aligned_cols=151 Identities=19% Similarity=0.240 Sum_probs=94.9
Q ss_pred cCceecceeeeeccEEEEEEEE-C-CeeEEEEEeeCCCCCh----------------------------hHHHHHH----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY-N-GEDVAIKILERPENNP----------------------------EKAQVME---- 180 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~-~-~~~vavK~~~~~~~~~----------------------------~~~~~~~---- 180 (306)
.+|+. +.||+|++|+||+|+. + |+.||||+.++..... +-.++..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45555 7899999999999988 4 8999999998652110 0001111
Q ss_pred --HHHHHHHHHHHhCC----CCCeeeEEEEEEe-CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 021897 181 --QQFQQEVMMLATLK----HLNIVRFIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (306)
Q Consensus 181 --~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~y 253 (306)
-++.+|+..+.+++ +...+.+-.++.+ ....+|||||++|+++.++-.-.. .....+...... +..-+..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~la~~~--v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMKLLAERG--VEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHHHHHHHH--HHHHHHH
Confidence 23455555555543 4433433333322 233489999999999987532111 112222111111 1122344
Q ss_pred HHhCCccccCCCCCcEEEcCCC----cEEEEcccCeeeee
Q 021897 254 VHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIEV 289 (306)
Q Consensus 254 LH~~~iiHrDlkp~NILv~~~~----~vkl~DFGla~~~~ 289 (306)
+...|++|+|+||.||+++.++ +++++|||++....
T Consensus 276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 5579999999999999999888 99999999987653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.5e-15 Score=121.04 Aligned_cols=128 Identities=16% Similarity=0.183 Sum_probs=96.4
Q ss_pred ceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCeEEEEEeecC
Q 021897 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYAK 219 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~iv~E~~~ 219 (306)
+.|+.|.++.||+++..+..+++|+....... ...+.+|+.+++.+.+.++ ++++..... ..++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL-------LINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCccc-------ccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecC
Confidence 57888999999999999999999997543321 1235678888888765444 455555432 2479999999
Q ss_pred CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 220 GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF-----IHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 220 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~i-----iHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
+.++.+. . .. ...++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++||+.|...
T Consensus 75 G~~l~~~--~-----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 75 GSELLTE--D-----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred CCccccc--c-----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 9887543 0 11 12346789999999999885 9999999999999 678999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-16 Score=149.38 Aligned_cols=155 Identities=24% Similarity=0.375 Sum_probs=128.1
Q ss_pred eeeeccEEEEEEE-----ECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeEEEEEe
Q 021897 143 FAQGAFGKLYRGT-----YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 143 lG~G~fG~V~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~E 216 (306)
+|+|+||.|+++. ..+.-+|+|++++........ .....|..++..++ ||.+|++.-.++.+...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~----~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR----THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc----cccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 6899999999763 356778999887655433221 13446777888887 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccC
Q 021897 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~ 296 (306)
|..+|.|...+... ..+.+.....+...++.+++++|+.+++|||+|++||+++.+|++|+.|||+++...+.+..
T Consensus 78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99999998888654 34666677778889999999999999999999999999999999999999999876544322
Q ss_pred CCCCCcccCC
Q 021897 297 ETGTYRWMAP 306 (306)
Q Consensus 297 ~~gt~~y~AP 306 (306)
|||..||||
T Consensus 154 -cgt~eymAp 162 (612)
T KOG0603|consen 154 -CGTYEYRAP 162 (612)
T ss_pred -ccchhhhhh
Confidence 999999998
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.9e-14 Score=123.37 Aligned_cols=150 Identities=20% Similarity=0.383 Sum_probs=97.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC----------CCeeeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH----------LNIVRFI 202 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~ 202 (306)
+.+..++.||.|+++.||++++ +++++|||++......... ..+.+.+|.-....+.+ -.++.-+
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~---~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASAN---EYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTT---HHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchH---HHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 4667889999999999999999 6799999999766633222 23556666544444322 1222222
Q ss_pred EEEE---------eC---C-----eEEEEEeecCCCCHHHHHHh---hCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021897 203 GACR---------KR---M-----VWCIVTEYAKGGSVRQFLTR---RQNR--AVPLKLAVKQALDVARGMAYVHGLGFI 260 (306)
Q Consensus 203 ~~~~---------~~---~-----~~~iv~E~~~~gsL~~~l~~---~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~ii 260 (306)
+... .. . ..+++|+-+ .++|.+++.. .... .+.....+.+..|++..+++||+.|++
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 2221 11 1 237788888 4588888653 2211 122333456668999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 261 HRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 261 HrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
|+||+|+|++++++|.++|.||+.....
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~ 195 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRA 195 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEET
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeec
Confidence 9999999999999999999999987653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.3e-14 Score=129.01 Aligned_cols=152 Identities=24% Similarity=0.372 Sum_probs=107.5
Q ss_pred ceeeccCceecceeeeeccEEEEEEEEC--C-----------------------------------eeEEEEEeeCCCCC
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN--G-----------------------------------EDVAIKILERPENN 172 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~--~-----------------------------------~~vavK~~~~~~~~ 172 (306)
-.+.+++|++++.||+|.-..||.++.. + -+.|||.+-.-...
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 3455678999999999999999988531 0 03566655332222
Q ss_pred hhHHHHHHHHHHHHHH------HH--------Hh--------CCCCCeeeEEEEEEe-----------------------
Q 021897 173 PEKAQVMEQQFQQEVM------ML--------AT--------LKHLNIVRFIGACRK----------------------- 207 (306)
Q Consensus 173 ~~~~~~~~~~~~~E~~------~l--------~~--------l~h~niv~l~~~~~~----------------------- 207 (306)
.. .....+.+.+|.. ++ +. -+|||||++.++|.+
T Consensus 232 s~-~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~ 310 (598)
T KOG4158|consen 232 SG-DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS 310 (598)
T ss_pred Cc-hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence 21 1222233334421 10 11 359999999988732
Q ss_pred ----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc--CCC--cEEE
Q 021897 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADK--SIKI 279 (306)
Q Consensus 208 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~--~~~--~vkl 279 (306)
+..+|+||...+. +|.+++..+ ..+.....-++.|+++|+.|||.+||.|||+|.+||||. +|+ .+.|
T Consensus 311 g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 311 GAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred ccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence 2367999998854 999999764 356677788899999999999999999999999999984 444 5789
Q ss_pred EcccCee
Q 021897 280 ADFGVAR 286 (306)
Q Consensus 280 ~DFGla~ 286 (306)
+|||++-
T Consensus 387 aDFGCcL 393 (598)
T KOG4158|consen 387 ADFGCCL 393 (598)
T ss_pred cccceee
Confidence 9999873
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.1e-13 Score=109.67 Aligned_cols=139 Identities=22% Similarity=0.293 Sum_probs=102.7
Q ss_pred ceeeeeccEEEEEEEECCeeEEEEEeeC-CCCChh-HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeec
Q 021897 141 TAFAQGAFGKLYRGTYNGEDVAIKILER-PENNPE-KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~~~vavK~~~~-~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~ 218 (306)
..+++|+-..++.+.|-|.++++|.-.+ ....++ +......+-.+|+.++.+++--.|..-+=+..++....|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 3578899999999999888888886432 233332 23334466778999999887444433333333444557999999
Q ss_pred CCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 219 KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 219 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
+|-.|.+++... ...++..+-.-+.-||..||+|+||.++||+++.++ +.++||||+.+..
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 998888898753 144566777788899999999999999999998554 9999999998644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.2e-13 Score=111.36 Aligned_cols=140 Identities=14% Similarity=0.142 Sum_probs=98.8
Q ss_pred ceeeeeccEEEEEEEEC--------CeeEEEEEeeCCCCCh--------------------hHHHHHHHHHHHHHHHHHh
Q 021897 141 TAFAQGAFGKLYRGTYN--------GEDVAIKILERPENNP--------------------EKAQVMEQQFQQEVMMLAT 192 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~--------~~~vavK~~~~~~~~~--------------------~~~~~~~~~~~~E~~~l~~ 192 (306)
..||.|--+.||.|... +..+|||+++.....- ...........+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46889999999999753 3699999987332110 0011111223389999998
Q ss_pred CCC--CCeeeEEEEEEeCCeEEEEEeecCCCCHHH-HHHhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCc
Q 021897 193 LKH--LNIVRFIGACRKRMVWCIVTEYAKGGSVRQ-FLTRRQNRAVPLKLAVKQALDVARGMAYV-HGLGFIHRDLKSDN 268 (306)
Q Consensus 193 l~h--~niv~l~~~~~~~~~~~iv~E~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qi~~gl~yL-H~~~iiHrDlkp~N 268 (306)
+.. -++++.+++ ..-+|||||+.+..+.. .++. ..++...+..+..+++.+|..| |+.|+||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 863 466777765 23379999997643322 2222 2345556677789999999999 89999999999999
Q ss_pred EEEcCCCcEEEEcccCeeee
Q 021897 269 LLISADKSIKIADFGVARIE 288 (306)
Q Consensus 269 ILv~~~~~vkl~DFGla~~~ 288 (306)
||+. ++.+.|+|||.|...
T Consensus 156 IL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EEEE-CCcEEEEECCCceeC
Confidence 9997 578999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-12 Score=106.62 Aligned_cols=149 Identities=22% Similarity=0.285 Sum_probs=108.4
Q ss_pred cceeeeeccEEEEEEEECCeeEEEEEeeCC-CCCh-hHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEee
Q 021897 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERP-ENNP-EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~~~~~vavK~~~~~-~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
...+-+|+-+.|+++.+.|+...||.-... ...+ -..+...++..+|++++.++.--.|.--.=++.+...-.|+|||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 467889999999999999999999864322 2222 23344457788999999988643332222223333333789999
Q ss_pred cCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEcccCeeee
Q 021897 218 AKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIE 288 (306)
Q Consensus 218 ~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~---~vkl~DFGla~~~ 288 (306)
++| -++.+++...-...........++.+|-+.+.-||..+|||+||..+||++.+++ .+.++|||++.+.
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 976 4888888865444444444478889999999999999999999999999997665 4589999998754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.2e-12 Score=108.87 Aligned_cols=139 Identities=19% Similarity=0.270 Sum_probs=103.0
Q ss_pred ceeeeeccEEEEEEEECC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCC---eEEEE
Q 021897 141 TAFAQGAFGKLYRGTYNG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRM---VWCIV 214 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~iv 214 (306)
+.|+.|..+.||+++..+ +.+++|+........ ....+.+|+.+++.+.+ ..+++++.+..... ..++|
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~-----~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v 78 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP-----SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV 78 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCc-----ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence 578999999999998854 899999976543210 12367799999999875 44677787776542 56899
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-------------------------------------- 256 (306)
|||++|.++.+.+.. ..++......++.+++..|..||+
T Consensus 79 ~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 79 MERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999999887665421 235555566666677777777763
Q ss_pred ------------------CCccccCCCCCcEEEcC--CCcEEEEcccCeee
Q 021897 257 ------------------LGFIHRDLKSDNLLISA--DKSIKIADFGVARI 287 (306)
Q Consensus 257 ------------------~~iiHrDlkp~NILv~~--~~~vkl~DFGla~~ 287 (306)
..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23589999999999998 66789999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=6e-11 Score=105.19 Aligned_cols=140 Identities=16% Similarity=0.096 Sum_probs=98.2
Q ss_pred cEEEEEEEECCeeEEEEEeeCCCCChhHHH-----HHHHHHHHHHHHHHhCCCCC--eeeEEEEEEe-----CCeEEEEE
Q 021897 148 FGKLYRGTYNGEDVAIKILERPENNPEKAQ-----VMEQQFQQEVMMLATLKHLN--IVRFIGACRK-----RMVWCIVT 215 (306)
Q Consensus 148 fG~V~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~iv~ 215 (306)
...|++..+.|+.+.||............. .-...+.+|...+.+|...+ ++..+++... ...-+|||
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 345778888999999997743332100000 00013678888887774332 3344444432 22468999
Q ss_pred eecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-------CCcEEEEcccCeee
Q 021897 216 EYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-------DKSIKIADFGVARI 287 (306)
Q Consensus 216 E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~-------~~~vkl~DFGla~~ 287 (306)
|++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++. +..+.|+||+.++.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999875 8999986433344566777889999999999999999999999999999975 46899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.4e-11 Score=101.09 Aligned_cols=130 Identities=22% Similarity=0.288 Sum_probs=83.2
Q ss_pred EEEEEEE-CCeeEEEEEeeCCCCCh--------------------hHHHHHHHHHHHHHHHHHhCCCC--CeeeEEEEEE
Q 021897 150 KLYRGTY-NGEDVAIKILERPENNP--------------------EKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACR 206 (306)
Q Consensus 150 ~V~~~~~-~~~~vavK~~~~~~~~~--------------------~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 206 (306)
.||.|.. ++.++|||+.+.....- ...........+|.+.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3888976 78899999987432110 11122345677899999999865 567777552
Q ss_pred eCCeEEEEEeecC--CCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 207 KRMVWCIVTEYAK--GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY-VHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 207 ~~~~~~iv~E~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~y-LH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
+. .|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||
T Consensus 80 -~~--~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 -RN--VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp -TT--EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred -CC--EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 33 69999998 65555544322 1123345566777775555 579999999999999999977 99999999
Q ss_pred Ceeee
Q 021897 284 VARIE 288 (306)
Q Consensus 284 la~~~ 288 (306)
.|...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 98643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.4e-13 Score=130.55 Aligned_cols=169 Identities=21% Similarity=0.356 Sum_probs=132.4
Q ss_pred ccCceecceeeeeccEEEEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 209 (306)
...|.+.+.||+|+|+.|-.... ....+|+|.+...... .........|..+-+.+. |+|++.+++...+..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~----~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKS----EDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCc----cchhhhcCccccccccccccccccccCCccCCCc
Confidence 35566778899999999987755 3345677766544311 112245556888888887 999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEcCCC-cEEEEcccCeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADK-SIKIADFGVARI 287 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH-~~~iiHrDlkp~NILv~~~~-~vkl~DFGla~~ 287 (306)
..++++||.+++++.+.+........+...+-.++.|+..++.|+| ..++.||||||+|.+++..+ .+|++|||+|..
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999999998884222224666778889999999999999 99999999999999999999 999999999976
Q ss_pred eec-CC---CccCCCC-CCcccCC
Q 021897 288 EVQ-TE---GMTPETG-TYRWMAP 306 (306)
Q Consensus 288 ~~~-~~---~~~~~~g-t~~y~AP 306 (306)
+.. .. .....+| ++.|+||
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~ 198 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAP 198 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCc
Confidence 544 11 2344578 9999998
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.8e-11 Score=98.79 Aligned_cols=73 Identities=23% Similarity=0.271 Sum_probs=63.6
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCC
Q 021897 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300 (306)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt 300 (306)
|+|.+++... ...+++..++.++.||+.||+|||+.+ ||+|||++.++.+|+ ||+++..... ...||
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 6899999764 356999999999999999999999998 999999999999999 9999865432 23789
Q ss_pred CcccCC
Q 021897 301 YRWMAP 306 (306)
Q Consensus 301 ~~y~AP 306 (306)
+.||||
T Consensus 68 ~~y~aP 73 (176)
T smart00750 68 PYFMAP 73 (176)
T ss_pred ccccCh
Confidence 999998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.6e-12 Score=128.12 Aligned_cols=145 Identities=21% Similarity=0.262 Sum_probs=113.4
Q ss_pred CceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~ 215 (306)
++...+.||.+.|=+|.+|+++.-.|+||++-+....-. -+.. .+-++|++ .+..++||++.+.-+.......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~s-L~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTIS-LRPF-KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCC-chHH-HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 677789999999999999998655699999866543211 1112 23335555 66778999999988876677778898
Q ss_pred eecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
+|... +|+|.+..+ .-+......=|+.|++.||..+|..||+|+|||.+||||+.=.=+.|+||.-=+
T Consensus 101 qyvkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHHhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccC
Confidence 99965 999998754 235555566688999999999999999999999999999988889999997543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.7e-11 Score=122.07 Aligned_cols=127 Identities=28% Similarity=0.478 Sum_probs=89.9
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|..++.|-.|++|.||..++ +.+++|+|+-+. . .+++. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----------lilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----------LILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccccc-c-----------hhhhc--cccccCCccee-------------
Confidence 5788889999999999999987 477899964321 1 12221 33333344443
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~- 291 (306)
|+....++.. ..++-. ++.+++|||+.||+|||+||+|.||..-|++|+.|||+++.....
T Consensus 136 --------gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 --------GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred --------chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 5666666542 234322 377999999999999999999999999999999999998642110
Q ss_pred ---------------CCccCCCCCCcccCC
Q 021897 292 ---------------EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ---------------~~~~~~~gt~~y~AP 306 (306)
-..+..||||.|+||
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccCh
Confidence 012445899999998
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.2e-11 Score=111.45 Aligned_cols=99 Identities=28% Similarity=0.462 Sum_probs=88.9
Q ss_pred HHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCc
Q 021897 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF-IHRDLKSDN 268 (306)
Q Consensus 190 l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~i-iHrDlkp~N 268 (306)
|+.+.|.|+.+++|.+..++..++|++|+..|+|.+.+... ...+.+.-...+..+|+.||+|||..-| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 45788999999999999999999999999999999999863 3457777778889999999999998765 999999999
Q ss_pred EEEcCCCcEEEEcccCeeeee
Q 021897 269 LLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 269 ILv~~~~~vkl~DFGla~~~~ 289 (306)
++++..-.+||+|||+.....
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred ceeeeeEEEEechhhhccccc
Confidence 999999999999999987653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=1e-09 Score=93.83 Aligned_cols=106 Identities=21% Similarity=0.292 Sum_probs=82.4
Q ss_pred HHHHHHHHHHHhCCCC--CeeeEEEEEEeC----CeEEEEEeecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 021897 181 QQFQQEVMMLATLKHL--NIVRFIGACRKR----MVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (306)
Q Consensus 181 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~y 253 (306)
.+..+|...+..|... .+++.+++.... ...+||+|++++. +|.+++..... .+......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 4567788877776432 344555555442 2458999999874 79999876332 5566678889999999999
Q ss_pred HHhCCccccCCCCCcEEEcCCC---cEEEEcccCeeee
Q 021897 254 VHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIE 288 (306)
Q Consensus 254 LH~~~iiHrDlkp~NILv~~~~---~vkl~DFGla~~~ 288 (306)
||+.||+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999999887 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.1e-09 Score=103.18 Aligned_cols=119 Identities=15% Similarity=0.304 Sum_probs=100.1
Q ss_pred CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCC
Q 021897 157 NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236 (306)
Q Consensus 157 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~ 236 (306)
++.+|.|.+++.... +. .....+.++.|+.++||+|+++++.+.....+|||+|.+ -.|..++.+..
T Consensus 36 ~~~~vsVF~~~~~~~--~~----~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----- 102 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EV----TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----- 102 (690)
T ss_pred cCCceEEEEEeCCCc--hh----hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----
Confidence 677899988876554 11 245668889999999999999999999999999999999 48888887642
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 237 LKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 237 ~~~~~~i~~qi~~gl~yLH-~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.....--+.||+.||.||| +++++|++|..+-|+|++.|.+||.+|-++...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 4445566789999999998 678999999999999999999999999988643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.6e-09 Score=92.93 Aligned_cols=138 Identities=20% Similarity=0.217 Sum_probs=100.3
Q ss_pred eecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChh----------------HHHHHHHHHHHHHHHHHhCCCC--Ce
Q 021897 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE----------------KAQVMEQQFQQEVMMLATLKHL--NI 198 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~----------------~~~~~~~~~~~E~~~l~~l~h~--ni 198 (306)
.++.+||-|--+.||.|.. .|.++|||.-+....+-. ..........+|...|.+|.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3667999999999999988 699999997653322110 0112234567899999999754 67
Q ss_pred eeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 021897 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (306)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vk 278 (306)
++.+++- .-.+|||+++|-.|...- +..+..-.++..|++-++-+-..||||+|+.+=||+|+++|.+.
T Consensus 174 P~P~~~n----RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 174 PKPIAWN----RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCccccc----cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 7777653 337999999986665442 12233445566666666666689999999999999999999999
Q ss_pred EEcccCee
Q 021897 279 IADFGVAR 286 (306)
Q Consensus 279 l~DFGla~ 286 (306)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.98 E-value=9.7e-11 Score=109.26 Aligned_cols=94 Identities=31% Similarity=0.534 Sum_probs=81.0
Q ss_pred eEEEEEeecCCCCHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRR-QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.+||.|++|+..+|.+++.++ .....++.....++.|++.|++| ++.+|||+||.||....+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 579999999999999999743 34456778889999999999999 99999999999999999999999999998755
Q ss_pred ecCC-------CccCCCCCCcccCC
Q 021897 289 VQTE-------GMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~-------~~~~~~gt~~y~AP 306 (306)
.... ..+..+||..||+|
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsP 431 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSP 431 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCH
Confidence 4444 45666899999998
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.5e-08 Score=84.12 Aligned_cols=141 Identities=16% Similarity=0.214 Sum_probs=91.8
Q ss_pred cCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHH-HH--HHHHHHHHHHHhC---CCCCeeeEEEEEEe-
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQV-ME--QQFQQEVMMLATL---KHLNIVRFIGACRK- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~-~~--~~~~~E~~~l~~l---~h~niv~l~~~~~~- 207 (306)
.+|...+.+-......|.+-..++..+++|..+......++.-. +. ....+++..+.++ .......++-+...
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 45666667766777778888889999999987654433221100 00 1122333333333 23333343433322
Q ss_pred ----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 208 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
....+++|||++|..|.++.. +++ .++..+...|.-||+.|+.|+|..|.|++++.++ ++++||+
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 234568999999988877643 222 2345677789999999999999999999999555 9999998
Q ss_pred Cee
Q 021897 284 VAR 286 (306)
Q Consensus 284 la~ 286 (306)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.1e-08 Score=85.04 Aligned_cols=140 Identities=13% Similarity=0.144 Sum_probs=101.1
Q ss_pred eeeeccEEEEEEEECCeeEEEEEeeCC---CCC-hhHHHHHHHHHHHHHHHHHhCCCCC--eeeEEEEEE-e--C--CeE
Q 021897 143 FAQGAFGKLYRGTYNGEDVAIKILERP---ENN-PEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGACR-K--R--MVW 211 (306)
Q Consensus 143 lG~G~fG~V~~~~~~~~~vavK~~~~~---~~~-~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~--~--~~~ 211 (306)
-|.|+-+.|++..+.|..+=+|.-... ... +. -+..|.+|...+.+|...+ +++.. ++. . . -.-
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~----g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA 100 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPF----GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRA 100 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCC----CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEE
Confidence 355788889998888887778854300 000 11 1247889999988885322 44444 222 1 1 245
Q ss_pred EEEEeecCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc--EEEEcccCeee
Q 021897 212 CIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARI 287 (306)
Q Consensus 212 ~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~--vkl~DFGla~~ 287 (306)
+||+|-+++ -+|.+++....-.+.+......+..+|+..++-||+.|+.|+|+-+.|||++.++. ++++||--++.
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 899998864 48988886643345577777889999999999999999999999999999986676 99999987763
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=7.8e-09 Score=99.17 Aligned_cols=144 Identities=18% Similarity=0.260 Sum_probs=94.0
Q ss_pred ceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHH----------------------------HHH------HHHHHH
Q 021897 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA----------------------------QVM------EQQFQQ 185 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~----------------------------~~~------~~~~~~ 185 (306)
+.|+.++-|+||+|++ +|+.||||+.++.-...-.. .++ +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999 59999999987543322111 111 123555
Q ss_pred HHHHHHhCC-----CCCeeeEEEEEEe-CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 021897 186 EVMMLATLK-----HLNIVRFIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR-GMAYVHGLG 258 (306)
Q Consensus 186 E~~~l~~l~-----h~niv~l~~~~~~-~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~-gl~yLH~~~ 258 (306)
|+..+.+++ .+++ .+=.++.+ ...-.|+|||++|-.+.++..... .....+.+ +..++. -++.+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 666665553 2332 22222221 223379999999999998854332 33443332 222222 244455689
Q ss_pred ccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 259 FIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
++|.|..|.||+|..+|.+-+.|||+.....
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.6e-08 Score=85.49 Aligned_cols=136 Identities=13% Similarity=0.149 Sum_probs=84.7
Q ss_pred ceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC--CeeeEEEEEEeCCeEEEEEeec
Q 021897 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACRKRMVWCIVTEYA 218 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~iv~E~~ 218 (306)
.+||+|..+.||+. .+..+++|........ ....+|.++++.+..- .+.+.+++........+|||++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~--------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDK--------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCH--------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 57899999999984 3557788987643311 2456899888887633 2467788887777788999999
Q ss_pred CCCC-HHHH--------------HHh----hCC---CCCCHHHHHHHH-H----------HHHH-HHHHHHh----CCcc
Q 021897 219 KGGS-VRQF--------------LTR----RQN---RAVPLKLAVKQA-L----------DVAR-GMAYVHG----LGFI 260 (306)
Q Consensus 219 ~~gs-L~~~--------------l~~----~~~---~~~~~~~~~~i~-~----------qi~~-gl~yLH~----~~ii 260 (306)
+|.+ +... +.+ -.. ...+........ . ++.. ..++|.+ ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8863 1111 111 110 111111111000 0 1111 1223321 2478
Q ss_pred ccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 261 HRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 261 HrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.8e-09 Score=102.33 Aligned_cols=166 Identities=20% Similarity=0.288 Sum_probs=126.0
Q ss_pred cCceecceeee--eccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe
Q 021897 135 RKLNMGTAFAQ--GAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK 207 (306)
Q Consensus 135 ~~~~~~~~lG~--G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 207 (306)
..+...+.+|. |.+|.||.+.. ++..+|+|.-+.....+... ..=.+|+..-+++. |++.++.+..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~----~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS----KRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc----ccccchhhcccccCccccccccCccccc
Confidence 34455677898 99999998865 56788998744333221111 12236666666664 9999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCcEEEcCC-CcEEEEcc
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADF 282 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~----gl~yLH~~~iiHrDlkp~NILv~~~-~~vkl~DF 282 (306)
.+..|+-+|++ +.+|..+.... ...++...++....+... ||.++|+.+++|-|+||+||++..+ ..+++.||
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 99999999999 46888887754 345888899999999999 9999999999999999999999999 89999999
Q ss_pred cCeeeeecCCCc------cCCCCCCcccCC
Q 021897 283 GVARIEVQTEGM------TPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~~------~~~~gt~~y~AP 306 (306)
|+...+.+.... ....|...|++|
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~k 297 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAK 297 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeCh
Confidence 998765544311 111456667765
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.1e-08 Score=90.06 Aligned_cols=137 Identities=17% Similarity=0.259 Sum_probs=107.4
Q ss_pred EEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCeEEEEEeecCC-C
Q 021897 149 GKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKG-G 221 (306)
Q Consensus 149 G~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~iv~E~~~~-g 221 (306)
...|+++. +|..+++|.++-...... .....-+++++++.|+|||++.+++.. +..+++|++|.++ +
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQST------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCc------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 46788865 889999998842222111 112345778999999999999999863 4578999999976 5
Q ss_pred CHHHHHHhh-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 222 SVRQFLTRR-------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 222 sL~~~l~~~-------------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
+|.++.... .+...++..+|.++.|+..||.++|+.|+.-+-|.|.+||++.+.+++|+..|...+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 788776431 2345788999999999999999999999999999999999998889999988887765
Q ss_pred ecC
Q 021897 289 VQT 291 (306)
Q Consensus 289 ~~~ 291 (306)
...
T Consensus 444 ~~d 446 (655)
T KOG3741|consen 444 QED 446 (655)
T ss_pred cCC
Confidence 443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.2e-07 Score=77.69 Aligned_cols=134 Identities=22% Similarity=0.321 Sum_probs=95.8
Q ss_pred cCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCee-eEEEEEEeCCeEEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV-RFIGACRKRMVWCI 213 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~i 213 (306)
...+..+.|++|.+|.||+|.|.+.++|+|+-+.+... ..+..|+++|..++-.++. ++|.+-.+ ++
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r--------~~l~kEakiLeil~g~~~~p~vy~yg~~----~i 89 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPR--------RNLEKEAKILEILAGEGVTPEVYFYGED----FI 89 (201)
T ss_pred hhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcch--------hhHHHHHHHHHHhhhcCCCceEEEechh----hh
Confidence 44556688999999999999999999999997665443 4678999999999866654 34444322 46
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCcEEEcCCCcEEEEcccCeeeee
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK-SDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlk-p~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.|||+.|-+|.+..... ..+ ....+++.---|-..||-|..|. |...+|..++.+.|+||.-|+...
T Consensus 90 ~me~i~G~~L~~~~~~~-----~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG-----DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhcCcchhhhhhcc-----cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 69999988887775421 222 23445555445666799999885 555555556699999999998543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.4e-09 Score=98.21 Aligned_cols=147 Identities=22% Similarity=0.234 Sum_probs=116.0
Q ss_pred ccCceecceeeeeccEEEEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (306)
..++.++..||.|.|+.|+.... ++..+++|-+.......... ..-+.|+.+...+ .|.+++.++..+....
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d----i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD----IFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh----hcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 35788889999999999998865 45678888776543332211 1223555555555 4899999999888888
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEcccCee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVAR 286 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~-~~vkl~DFGla~ 286 (306)
..||-.||++++++.....-. ..+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||++.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 889999999999887766332 347777889999999999999999999999999999999986 788999999885
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3e-07 Score=79.37 Aligned_cols=139 Identities=20% Similarity=0.186 Sum_probs=93.7
Q ss_pred eeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHH------------------HHHHHHHHHHHHHHhCC--CCCeee
Q 021897 142 AFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQ------------------VMEQQFQQEVMMLATLK--HLNIVR 200 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~------------------~~~~~~~~E~~~l~~l~--h~niv~ 200 (306)
.|.+|--..||+|.- ++..+|||+++.....-.+.+ ....-..+|..-|+++. +-.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 566677778999875 789999999985544322211 11122346777777764 344455
Q ss_pred EEEEEEeCCeEEEEEeecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEE
Q 021897 201 FIGACRKRMVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIK 278 (306)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vk 278 (306)
-+++. .-.|||||+... .-.-.|+ .-.++...+..+..+++..|.-|-. .+++|+||+.=|||+. ++.+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 55443 226999999543 1111121 1223333577788888999998887 8999999999999999 88999
Q ss_pred EEcccCeeee
Q 021897 279 IADFGVARIE 288 (306)
Q Consensus 279 l~DFGla~~~ 288 (306)
|+|||-|...
T Consensus 207 iID~~QaV~~ 216 (268)
T COG1718 207 IIDVSQAVTI 216 (268)
T ss_pred EEECcccccc
Confidence 9999988644
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.62 E-value=8e-07 Score=74.96 Aligned_cols=132 Identities=18% Similarity=0.309 Sum_probs=95.4
Q ss_pred ccCceecceeeeecc-EEEEEEEECCeeEEEEEeeCCCCCh---------h------HHHHHHHHHHHHHHHHHhCC---
Q 021897 134 LRKLNMGTAFAQGAF-GKLYRGTYNGEDVAIKILERPENNP---------E------KAQVMEQQFQQEVMMLATLK--- 194 (306)
Q Consensus 134 ~~~~~~~~~lG~G~f-G~V~~~~~~~~~vavK~~~~~~~~~---------~------~~~~~~~~~~~E~~~l~~l~--- 194 (306)
..++++++.||.|.- |.||++...|+.+|+|+++.-.... . ........|..|++...+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 378899999999999 9999999999999999943211000 0 00123356888998877775
Q ss_pred CCCe--eeEEEEEEeC------------------CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 021897 195 HLNI--VRFIGACRKR------------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254 (306)
Q Consensus 195 h~ni--v~l~~~~~~~------------------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yL 254 (306)
+..+ |+.+|+..-. ..+.||-||++... .+ ..+-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHHH
Confidence 4455 8999987211 24578888886633 12 223356777889999
Q ss_pred HhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 255 H~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
|..||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999985 2488999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.3e-07 Score=87.96 Aligned_cols=143 Identities=19% Similarity=0.309 Sum_probs=91.8
Q ss_pred ceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHH-------------------------HHH------HHHHHHHHH
Q 021897 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKA-------------------------QVM------EQQFQQEVM 188 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~-------------------------~~~------~~~~~~E~~ 188 (306)
+.||.-+.|+||+|+. +|+.||||+-++.-...-.. .++ +-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999987 88999999976543322100 001 123556665
Q ss_pred HHHh----CCCCC------eeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 021897 189 MLAT----LKHLN------IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG-MAYVHGL 257 (306)
Q Consensus 189 ~l~~----l~h~n------iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~g-l~yLH~~ 257 (306)
-..+ ++|-+ |+++|..+..+ -.|+||||+|..+.|.-.-.. ..++...+ +..+.++ .+-|=..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~--RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i---~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTK--RVLTMEYVDGIKINDLDAIDK-RGISPHDI---LNKLVEAYLEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcc--eEEEEEecCCccCCCHHHHHH-cCCCHHHH---HHHHHHHHHHHHHhc
Confidence 4443 34555 45555444333 379999999988777644222 23544433 3333322 2233357
Q ss_pred CccccCCCCCcEEEcC----CCcEEEEcccCeeeee
Q 021897 258 GFIHRDLKSDNLLISA----DKSIKIADFGVARIEV 289 (306)
Q Consensus 258 ~iiHrDlkp~NILv~~----~~~vkl~DFGla~~~~ 289 (306)
|++|+|-.|.||+|.+ ++.+.+.|||+.....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 8999999999999984 5689999999986543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.7e-07 Score=78.64 Aligned_cols=137 Identities=16% Similarity=0.142 Sum_probs=85.0
Q ss_pred eeeeecc-EEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeEEEEEeecC
Q 021897 142 AFAQGAF-GKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYAK 219 (306)
Q Consensus 142 ~lG~G~f-G~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~E~~~ 219 (306)
.|-.|+. ..||+....+..+.||+..... . ..+.+|+.+++.+. +--+++++++.......++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-~--------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-T--------YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-c--------cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence 4555666 6899998877888999875432 1 24557888877774 3446678887776666789999999
Q ss_pred CCCHHHHH----------------HhhCCC-----CCCHH--HHHHHHHH--------------------HHHHHHHHH-
Q 021897 220 GGSVRQFL----------------TRRQNR-----AVPLK--LAVKQALD--------------------VARGMAYVH- 255 (306)
Q Consensus 220 ~gsL~~~l----------------~~~~~~-----~~~~~--~~~~i~~q--------------------i~~gl~yLH- 255 (306)
|.+|.... .+.... ..... ........ +...+..|-
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 97776432 111110 11100 00000000 111122221
Q ss_pred ------hCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 256 ------GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 256 ------~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
...++|+|+.|.|||++.++.+.|+||+.|.+
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12489999999999999888889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.2e-08 Score=85.70 Aligned_cols=93 Identities=30% Similarity=0.441 Sum_probs=79.3
Q ss_pred HHHHhCCCCCeeeEEEEEEeC-----CeEEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 021897 188 MMLATLKHLNIVRFIGACRKR-----MVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG-- 258 (306)
Q Consensus 188 ~~l~~l~h~niv~l~~~~~~~-----~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~-- 258 (306)
..+-++.|.|||+++.++.+. ....+++|||..|+|..+|++. ....+..+...+|+.||+.||.|||++.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 345566799999999988543 4578999999999999999863 3356788888999999999999999985
Q ss_pred ccccCCCCCcEEEcCCCcEEEE
Q 021897 259 FIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~ 280 (306)
|+|+++..+-|++..+|-+||.
T Consensus 199 iihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cccCCcchhheeecCCceEEec
Confidence 9999999999999999988884
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.47 E-value=5e-06 Score=71.38 Aligned_cols=140 Identities=19% Similarity=0.224 Sum_probs=83.7
Q ss_pred ceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC--CeeeEEEEEEe---CCeEEEEE
Q 021897 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGACRK---RMVWCIVT 215 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~iv~ 215 (306)
+.|+.|..+.||+.+..+..+++|..... .....+.+|..+++.+... .+.+++..+.. ....+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 67899999999999997789999997543 1124667888888777532 35667765433 34579999
Q ss_pred eecCCCCHHH----------------HHHh---h--CCCCCCHHH---------HHHH------------HHHHHH-HHH
Q 021897 216 EYAKGGSVRQ----------------FLTR---R--QNRAVPLKL---------AVKQ------------ALDVAR-GMA 252 (306)
Q Consensus 216 E~~~~gsL~~----------------~l~~---~--~~~~~~~~~---------~~~i------------~~qi~~-gl~ 252 (306)
+++++..+.. .+.. . ......... .... ...+.. .++
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 1211 1 011111100 0000 111222 333
Q ss_pred HHHh-------CCccccCCCCCcEEEc-CCCcEEEEcccCeeee
Q 021897 253 YVHG-------LGFIHRDLKSDNLLIS-ADKSIKIADFGVARIE 288 (306)
Q Consensus 253 yLH~-------~~iiHrDlkp~NILv~-~~~~vkl~DFGla~~~ 288 (306)
.+++ ..++|+|+.|.|||++ +++.+-|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 3432 3599999999999999 6666789999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.1e-06 Score=85.86 Aligned_cols=77 Identities=13% Similarity=0.198 Sum_probs=55.0
Q ss_pred ceeeeeccEEEEEEEECC----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCe--eeEEEEEEeC---Ce
Q 021897 141 TAFAQGAFGKLYRGTYNG----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNI--VRFIGACRKR---MV 210 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~ 210 (306)
+.++.|.+..+|+.+..+ ..+++|.......... ...+.+|+.+++.+. |+++ ++.+.+|.+. ..
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-----~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-----AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-----HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 678999999999988744 4677776543222111 135779999999985 6654 7888888764 35
Q ss_pred EEEEEeecCCCC
Q 021897 211 WCIVTEYAKGGS 222 (306)
Q Consensus 211 ~~iv~E~~~~gs 222 (306)
.|+||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 689999998754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.8e-06 Score=72.58 Aligned_cols=101 Identities=23% Similarity=0.319 Sum_probs=80.1
Q ss_pred HHHHHHHHhCCC-CCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 021897 184 QQEVMMLATLKH-LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVHG---LG 258 (306)
Q Consensus 184 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ 258 (306)
..|.-+++.+++ +++++++|+|.. ++|.||...+++...... .+-...+|..+.+||.++++.+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999986 699999999944 679999987766432100 011236899999999999999999997 34
Q ss_pred ccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 259 FIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
+.-.|++|+|+-|++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777899999999999999999999977543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.20 E-value=6.5e-06 Score=71.65 Aligned_cols=30 Identities=30% Similarity=0.555 Sum_probs=26.2
Q ss_pred CccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 258 ~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
.++|+|+.+.||+++.++.+-|+||+.|.+
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 489999999999999776678999998864
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.8e-05 Score=69.36 Aligned_cols=77 Identities=14% Similarity=0.080 Sum_probs=56.6
Q ss_pred ecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC---CCeeeEEEEEEeC---CeEE
Q 021897 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH---LNIVRFIGACRKR---MVWC 212 (306)
Q Consensus 139 ~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~ 212 (306)
-.+.||.|..+.||+....+..+.+|+.+..... ..+.+|+..|+.+.. ..+++.+++|... ...+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~--------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMARSFSTP--------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEecccccc--------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3467999999999999875556778885431111 367799999988853 4678888887543 5679
Q ss_pred EEEeecCCCCH
Q 021897 213 IVTEYAKGGSV 223 (306)
Q Consensus 213 iv~E~~~~gsL 223 (306)
||||++++.++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.4e-05 Score=63.71 Aligned_cols=133 Identities=17% Similarity=0.274 Sum_probs=90.2
Q ss_pred ceeeeeccEEEEEEEECCeeEEEEEeeCCCCChh----------HHHHHHHHHHHHHHHHHhCC------CCCeeeEEEE
Q 021897 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE----------KAQVMEQQFQQEVMMLATLK------HLNIVRFIGA 204 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~ 204 (306)
..||+|+.=.||.-- .....+||+......... ......++..+|+.-...+. +.+|.++||+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 578999988887432 344578899876550000 00011245666766655555 8889999999
Q ss_pred EEeCCeEEEEEeecCC------CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---
Q 021897 205 CRKRMVWCIVTEYAKG------GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK--- 275 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~--- 275 (306)
.+.+..+-+|+|.+.+ -+|.++++.. .++. .+ ...+-+-.+||-+.+|+.+|++|.||++....
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999888999998743 3688888542 3444 22 23333566788899999999999999996432
Q ss_pred -cEEEEc
Q 021897 276 -SIKIAD 281 (306)
Q Consensus 276 -~vkl~D 281 (306)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.0001 Score=66.87 Aligned_cols=140 Identities=18% Similarity=0.214 Sum_probs=80.5
Q ss_pred ecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEE------EeCCe
Q 021897 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGAC------RKRMV 210 (306)
Q Consensus 139 ~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~------~~~~~ 210 (306)
..+.++.|....+|+...++..+++|+.+.... . ..+..|..++..|.. -.+++.+... ...+.
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~-~-------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVGRYILTLYEKRVK-A-------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eccccCCccccceEEEEeCCCcEEEEEecCCCC-H-------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 346677777789999877666788998754221 1 133455555555532 1234444321 12356
Q ss_pred EEEEEeecCCCCHH-----------HHHHh----hCCC--C------C-CHHHHH------------HHHHHHHHHHHHH
Q 021897 211 WCIVTEYAKGGSVR-----------QFLTR----RQNR--A------V-PLKLAV------------KQALDVARGMAYV 254 (306)
Q Consensus 211 ~~iv~E~~~~gsL~-----------~~l~~----~~~~--~------~-~~~~~~------------~i~~qi~~gl~yL 254 (306)
.++++||++|..+. ..+.+ ...- . . .|.... .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999885431 11111 0000 0 0 000000 0011233445555
Q ss_pred Hh-------CCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 255 HG-------LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 255 H~-------~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 42 579999999999999988878999999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.1e-05 Score=67.71 Aligned_cols=139 Identities=19% Similarity=0.206 Sum_probs=83.1
Q ss_pred cceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC--CeeeEEEE------EEeCCeE
Q 021897 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVRFIGA------CRKRMVW 211 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~ 211 (306)
.+.|..|....+|+...++..+++|+... ... ..+..|+.++..+.+. .+++.+.. ....+..
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~~-------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK--VSA-------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC--CCh-------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 35677787789999887777899998764 111 2455677766666422 24444432 1234456
Q ss_pred EEEEeecCCCCHHH-----------HHHhh----CC--C------CCCHHHHH----------HHHHHHHHHHHHHHh--
Q 021897 212 CIVTEYAKGGSVRQ-----------FLTRR----QN--R------AVPLKLAV----------KQALDVARGMAYVHG-- 256 (306)
Q Consensus 212 ~iv~E~~~~gsL~~-----------~l~~~----~~--~------~~~~~~~~----------~i~~qi~~gl~yLH~-- 256 (306)
++|+||++|..+.. .+.+- .. . ...+.... .....+...+.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999866421 11110 00 0 00111000 011122334455553
Q ss_pred -----CCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 257 -----LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 257 -----~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
.+++|+|+.|.|||+++++.+.|+||+.|..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999887789999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00012 Score=63.47 Aligned_cols=72 Identities=13% Similarity=0.204 Sum_probs=46.0
Q ss_pred ceeeeeccEEEEEEEEC---CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEEeCCeEEEEEe
Q 021897 141 TAFAQGAFGKLYRGTYN---GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~iv~E 216 (306)
+.|..|-...+|+.+.. +..+++|+........ ....+|+.+++.+... -.+++++.+. . .++||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-------~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-------IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-------ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence 46777888899999875 5789999875432111 1223677787777432 2345554432 2 47999
Q ss_pred ecCCCCH
Q 021897 217 YAKGGSV 223 (306)
Q Consensus 217 ~~~~gsL 223 (306)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.2e-05 Score=72.11 Aligned_cols=136 Identities=18% Similarity=0.260 Sum_probs=95.8
Q ss_pred eecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChh--------------HHHHHH--HHHHHHHHHHHhCCC--CCe
Q 021897 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE--------------KAQVME--QQFQQEVMMLATLKH--LNI 198 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~--------------~~~~~~--~~~~~E~~~l~~l~h--~ni 198 (306)
.++..||-|--+.||.+.+ .|++.++|+-+....+-. ..+... -...+|...|+.|.- --|
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 4678999999999999988 699999997543221110 011111 234578888888853 345
Q ss_pred eeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 021897 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (306)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vk 278 (306)
++.++++. -++|||++.+.+|.+.-.- .. ...+...+..-+.-|-.+|+||+|..-=||+|.+++.++
T Consensus 175 PkpiD~~R----H~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 175 PKPIDHNR----HCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCcccccc----eeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 56666543 3799999999888665422 11 223445555667778889999999999999999999999
Q ss_pred EEcccCe
Q 021897 279 IADFGVA 285 (306)
Q Consensus 279 l~DFGla 285 (306)
++||--.
T Consensus 243 vIDFPQm 249 (465)
T KOG2268|consen 243 VIDFPQM 249 (465)
T ss_pred EeechHh
Confidence 9999754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00013 Score=67.48 Aligned_cols=159 Identities=19% Similarity=0.236 Sum_probs=104.1
Q ss_pred eecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE-------EeCC
Q 021897 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGAC-------RKRM 209 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~-------~~~~ 209 (306)
..++.||+|+-+.+|-.---+ ..+.|++..+...... +.+..|... .||-+-.-+.|- ....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~-d~VAKIYh~Pppa~~a---------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR-DQVAKIYHAPPPAAQA---------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCCccccCCccceeeecchhh-chhheeecCCCchHHH---------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 356789999999988543222 3355888766554321 122233333 455443312221 1223
Q ss_pred eEEEEEeecCCC-CHHHHHHh---hC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 210 VWCIVTEYAKGG-SVRQFLTR---RQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 210 ~~~iv~E~~~~g-sL~~~l~~---~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
.+-++|..+.+. ....++.. ++ -....|..+++.+..++.+.+-||..|..-+|+.++|+||++++.|.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 477888888664 33334331 11 12357888999999999999999999999999999999999999999998665
Q ss_pred eeeeecCCCccCCCCCCcccCC
Q 021897 285 ARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~AP 306 (306)
-.+...+......+|.+.|++|
T Consensus 164 fqi~~ng~~~~cpVg~~eftPP 185 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPP 185 (637)
T ss_pred eeeccCCceEecccCccccCCH
Confidence 4444444445556788888877
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=1.6e-06 Score=87.43 Aligned_cols=151 Identities=19% Similarity=0.236 Sum_probs=108.5
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
+......+.+.+.+-+|+++.++.++- .+...++|+......-... ..+...++-.++-...+|.++...-.+..
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~---~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN---DYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccc---cccccCCccCccccCCCCceecccCCCCC
Confidence 456667778888999999999998865 4444555554432221100 01123334444444556777766555556
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
....+++++|+.+++|...|+... ....+-+......+..+.+|||+..++|||++|.|+|+..++..+++|||..
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccc
Confidence 677899999999999999987643 3455556677778889999999999999999999999999999999999843
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00035 Score=61.52 Aligned_cols=134 Identities=18% Similarity=0.202 Sum_probs=76.4
Q ss_pred eeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCeEEEEEeecCCC
Q 021897 143 FAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYAKGG 221 (306)
Q Consensus 143 lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~iv~E~~~~g 221 (306)
+..|-...+|+.+.++..+++|+......... -...+|..+++.+....+ ++++..+. . ++|+||++|.
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~i~~~~--~--~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALG------VDRQREYQILQALSALGLAPKPILVNE--H--WLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccccc------CcHHHHHHHHHHHHhcCCCCceEEEeC--C--EEEEEeccCc
Confidence 44577789999988888899997543221100 023467777777753322 34454432 2 6899999986
Q ss_pred CHHH--------------HHHhhCC-----CCCCHHH-HHHHHHH---------HHHHHHHHHh--------CCccccCC
Q 021897 222 SVRQ--------------FLTRRQN-----RAVPLKL-AVKQALD---------VARGMAYVHG--------LGFIHRDL 264 (306)
Q Consensus 222 sL~~--------------~l~~~~~-----~~~~~~~-~~~i~~q---------i~~gl~yLH~--------~~iiHrDl 264 (306)
.+.. .+.+-.. .++.... +..+..+ +...++.+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5431 1222111 1111111 1111111 1111222221 24899999
Q ss_pred CCCcEEEcCCCcEEEEcccCeee
Q 021897 265 KSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 265 kp~NILv~~~~~vkl~DFGla~~ 287 (306)
.|.||++++++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00072 Score=61.49 Aligned_cols=31 Identities=39% Similarity=0.462 Sum_probs=26.8
Q ss_pred CCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 257 ~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999999766668999998853
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00033 Score=65.59 Aligned_cols=80 Identities=13% Similarity=0.019 Sum_probs=51.5
Q ss_pred ceeeeeccEEEEEEEEC-C-eeEEEEEeeCCCCC-hhHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCeEEEE
Q 021897 141 TAFAQGAFGKLYRGTYN-G-EDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~-~-~~vavK~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~iv 214 (306)
+.||.|.+..||+++.. | +.++||.-.+.... .+.......++..|...|+.+. ...++++|.+.. ..-++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 57899999999999884 4 48999985422111 0000111245667777777653 346777887744 335899
Q ss_pred EeecCCCC
Q 021897 215 TEYAKGGS 222 (306)
Q Consensus 215 ~E~~~~gs 222 (306)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=1.2e-05 Score=77.64 Aligned_cols=162 Identities=21% Similarity=0.225 Sum_probs=108.5
Q ss_pred CCCCCCCcceeeccCceecceeeeeccEEEEEEEECCe-eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC-ee
Q 021897 122 EGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IV 199 (306)
Q Consensus 122 ~~~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv 199 (306)
+.+....+|.-.+ ..+++++.+++++.+...+ ....+.+... ....-++++|.+++||| .+
T Consensus 235 p~lkDk~kws~~f------h~fvK~altknpKkRptaeklL~h~fvs~~-----------l~~rl~~eLLdK~n~P~~~v 297 (829)
T KOG0576|consen 235 PTLKDKTKWSEFF------HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----------LSRRLAIELLDKVNNPNPVV 297 (829)
T ss_pred CcccCCccchHHH------HHHHHHHhcCCCccCCChhhheeceeeccc-----------hhhHHHHHHHHHccCCCCcc
Confidence 3344455565433 3457789999998876433 2334444321 12335788999999999 78
Q ss_pred eEEEEEEeCCeEEEEEeecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 021897 200 RFIGACRKRMVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278 (306)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vk 278 (306)
..++-++.+...+++++++.++ +........ .-.+.......+...-.+++++||+..-+||| ||+..+ +..|
T Consensus 298 ~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~ 371 (829)
T KOG0576|consen 298 RYLEDYDGEDYLWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVK 371 (829)
T ss_pred cccccCCcccccchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccc
Confidence 8888888888999999999776 221111100 01122333444556667889999998888998 777764 7899
Q ss_pred EEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 279 IADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 279 l~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
..||+.+.........++..+|+.|+||
T Consensus 372 ~~~~~v~~~L~~~~~~~t~~~~~~~~~p 399 (829)
T KOG0576|consen 372 LLDFAVPPQLTRTMKPRTAIGTPEPLAP 399 (829)
T ss_pred cccccCCcccCcccccccCCCCCCCCCc
Confidence 9999998765554445667899999998
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0011 Score=59.82 Aligned_cols=73 Identities=12% Similarity=0.225 Sum_probs=45.5
Q ss_pred ceeeeeccEEEEEEEEC--------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEEeCCeE
Q 021897 141 TAFAQGAFGKLYRGTYN--------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRMVW 211 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~ 211 (306)
+.+..|-...+|+.+.. ++.+++|+........ ....+|..+++.+.... .+++++.+..
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~r~~E~~~~~~l~~~g~~P~~~~~~~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELL-------IDRERELVVFARLSERNLGPKLYGIFPN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcce-------echHHHHHHHHHHHhCCCCCceEEEeCC----
Confidence 45566777789998764 4789999976533211 13447777777765322 3455655532
Q ss_pred EEEEeecCCCCHH
Q 021897 212 CIVTEYAKGGSVR 224 (306)
Q Consensus 212 ~iv~E~~~~gsL~ 224 (306)
.+|+||++|..+.
T Consensus 73 ~~v~e~i~G~~l~ 85 (302)
T cd05156 73 GRIEEFIPSRTLT 85 (302)
T ss_pred CchhheeCCCcCC
Confidence 3689999886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0016 Score=59.76 Aligned_cols=141 Identities=19% Similarity=0.164 Sum_probs=89.1
Q ss_pred ceeeeeccEEEEEEEE-CCeeEEEEEeeCCCC-------------------ChhHHHHHHH-HHHHHHHHHHhCCCCCee
Q 021897 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPEN-------------------NPEKAQVMEQ-QFQQEVMMLATLKHLNIV 199 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~-------------------~~~~~~~~~~-~~~~E~~~l~~l~h~niv 199 (306)
..|..|--.-||.|+- +|..+|||+++.... +....+.+.+ -...|++-|+++....|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4566677778999987 888999998873211 1111111222 233577777777543332
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEcCCCcEE
Q 021897 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIK 278 (306)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH-~~~iiHrDlkp~NILv~~~~~vk 278 (306)
.---. .-.. -.|||+|+-. +=.-.-. .....++...+..+-.+++.-|.-|- .++++|.||.-=|+|+- +|.+.
T Consensus 230 ~PePI-lLk~-hVLVM~FlGr-dgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ly 304 (520)
T KOG2270|consen 230 CPEPI-LLKN-HVLVMEFLGR-DGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLY 304 (520)
T ss_pred CCCce-eeec-ceEeeeeccC-CCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEE
Confidence 10000 0111 2689999943 2111111 12345677778888888888888776 57999999999999997 78899
Q ss_pred EEcccCee
Q 021897 279 IADFGVAR 286 (306)
Q Consensus 279 l~DFGla~ 286 (306)
|+|.+-+.
T Consensus 305 iIDVSQSV 312 (520)
T KOG2270|consen 305 IIDVSQSV 312 (520)
T ss_pred EEEccccc
Confidence 99998764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0092 Score=53.88 Aligned_cols=29 Identities=28% Similarity=0.565 Sum_probs=25.6
Q ss_pred CCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 257 LGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 257 ~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.003 Score=57.36 Aligned_cols=143 Identities=17% Similarity=0.291 Sum_probs=80.7
Q ss_pred eeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCC--eEEEEEee
Q 021897 142 AFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACRKRM--VWCIVTEY 217 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~iv~E~ 217 (306)
.+-.|.--.+|....+++++++. ..+....... .....+|..+++.+.- .-+...++.|.+.. ..|.||+|
T Consensus 32 ~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~----~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 32 EISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVES----AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eccCCcccceEEEecCCceEEEe-cCCccccchh----hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 33334444566666667888888 3221222111 2345577777777643 33456677776665 67999999
Q ss_pred cCCC------------------CHHHHHHhhCC-----------------CCC-CHHHHHHHH--------HHHHHHHHH
Q 021897 218 AKGG------------------SVRQFLTRRQN-----------------RAV-PLKLAVKQA--------LDVARGMAY 253 (306)
Q Consensus 218 ~~~g------------------sL~~~l~~~~~-----------------~~~-~~~~~~~i~--------~qi~~gl~y 253 (306)
++|. +|.++|..... +.+ .+...++.+ -....-..+
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 9882 22222221100 000 000001000 012223455
Q ss_pred HHhC--------CccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 254 VHGL--------GFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 254 LH~~--------~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
|+.+ .++|+|+.+.||+++..+-+=|+||+++.+-.
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 5542 37999999999999998889999999987543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0022 Score=57.27 Aligned_cols=31 Identities=26% Similarity=0.498 Sum_probs=26.1
Q ss_pred CccccCCCCCcEEEcCCCc-EEEEcccCeeee
Q 021897 258 GFIHRDLKSDNLLISADKS-IKIADFGVARIE 288 (306)
Q Consensus 258 ~iiHrDlkp~NILv~~~~~-vkl~DFGla~~~ 288 (306)
.++|+|+.|.|||+++++. +-|+||+.|.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 579999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0061 Score=56.27 Aligned_cols=141 Identities=15% Similarity=0.257 Sum_probs=79.0
Q ss_pred cCceecceeeeeccEEEEEEEEC------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEe
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRK 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~ 207 (306)
+.+.+ +.|-.|-.-.+|+.++. ++.+++|+.......- . .-.+|..+++.+....+ .++++.+..
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~------i-dR~~E~~~~~~l~~~gl~P~~~~~~~~ 108 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF------F-DRDDEIRTFECMSRHGQGPRLLGRFPN 108 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee------e-chHHHHHHHHHHHHcCCCCceEEEECC
Confidence 33334 34545778899999762 2578999875432111 1 12467777777754333 355665532
Q ss_pred CCeEEEEEeecCCCCHHHH--------------HHhhCC-----C--CCCHHHHHHHHHH-----------------HHH
Q 021897 208 RMVWCIVTEYAKGGSVRQF--------------LTRRQN-----R--AVPLKLAVKQALD-----------------VAR 249 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~--------------l~~~~~-----~--~~~~~~~~~i~~q-----------------i~~ 249 (306)
. .|.||+++.+|... +.+-.. . ...++.+..+..+ +..
T Consensus 109 g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~ 184 (344)
T PLN02236 109 G----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLED 184 (344)
T ss_pred c----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHH
Confidence 2 57999987665311 111111 0 1112222222211 111
Q ss_pred HHHHHH--------hCCccccCCCCCcEEEcC-CCcEEEEcccCeee
Q 021897 250 GMAYVH--------GLGFIHRDLKSDNLLISA-DKSIKIADFGVARI 287 (306)
Q Consensus 250 gl~yLH--------~~~iiHrDlkp~NILv~~-~~~vkl~DFGla~~ 287 (306)
-++.|. ...++|+|+++.|||+++ ++.+.|+||.+|..
T Consensus 185 ~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 185 EINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 122222 125899999999999986 47899999999874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.014 Score=54.86 Aligned_cols=79 Identities=11% Similarity=-0.030 Sum_probs=50.4
Q ss_pred cceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhH-HHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCeEEEEE
Q 021897 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK-AQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~iv~ 215 (306)
.+.||.|....||+.+..+..++||.-.+....... ......+-..|+..|+.+. ...++++|.++.+.. +++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~--vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMA--LIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCC--EEEE
Confidence 367899999999999887778999976522221000 0000122334455555443 357888999888554 7889
Q ss_pred eecCC
Q 021897 216 EYAKG 220 (306)
Q Consensus 216 E~~~~ 220 (306)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0096 Score=54.60 Aligned_cols=141 Identities=13% Similarity=0.216 Sum_probs=78.2
Q ss_pred cCceecceeeeeccEEEEEEEECC-----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeC
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTYNG-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKR 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~ 208 (306)
+++++ +.|..|-...+|+.+..+ ..|++|+........ -.-.+|..+++.+..-.+ +++++.+. .
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-------IdR~~E~~il~~l~~~gl~P~~l~~~~-~ 85 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-------IDRERELQAIKYLSAAGFGAKLLGVFG-N 85 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-------echHHHHHHHHHHHhcCCCCceeEEeC-C
Confidence 34444 344447778899987643 378999875432211 112367778777764444 35565553 2
Q ss_pred CeEEEEEeecCCCCHHH--------------HHHhhCCCC------C-CHHHHHHHHHH---------------------
Q 021897 209 MVWCIVTEYAKGGSVRQ--------------FLTRRQNRA------V-PLKLAVKQALD--------------------- 246 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~--------------~l~~~~~~~------~-~~~~~~~i~~q--------------------- 246 (306)
. +|.+|+++..|.. .+++-.... . .+..+.++..+
T Consensus 86 G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~ 162 (330)
T PLN02421 86 G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFE 162 (330)
T ss_pred c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHH
Confidence 2 5889997765421 111111111 1 12222222211
Q ss_pred -HHHHHHH----HHhCC----ccccCCCCCcEEEcC-CCcEEEEcccCeee
Q 021897 247 -VARGMAY----VHGLG----FIHRDLKSDNLLISA-DKSIKIADFGVARI 287 (306)
Q Consensus 247 -i~~gl~y----LH~~~----iiHrDlkp~NILv~~-~~~vkl~DFGla~~ 287 (306)
+..-+.. +...+ ++|.|+.+.|||+++ ++.++++||..|..
T Consensus 163 ~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 163 ELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1111222 21222 699999999999975 57899999999864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0039 Score=57.52 Aligned_cols=77 Identities=10% Similarity=-0.054 Sum_probs=44.1
Q ss_pred eeeeeccEEEEEEEECC--eeEEEEEeeCCCCC-hhHHHHHHHHHHHHHHHHHhCC--CC-CeeeEEEEEEeCCeEEEEE
Q 021897 142 AFAQGAFGKLYRGTYNG--EDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATLK--HL-NIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~~~--~~vavK~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~iv~ 215 (306)
.||.|-..-||++...+ +.|+||.-.+.... .+....-..+..-|...|+... -| .++++|.+-. ....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~--e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT--EMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc--ccceehH
Confidence 57888889999998743 58999975421110 0000011133445666665543 23 4556665433 3336899
Q ss_pred eecCC
Q 021897 216 EYAKG 220 (306)
Q Consensus 216 E~~~~ 220 (306)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.01 Score=53.35 Aligned_cols=75 Identities=16% Similarity=0.190 Sum_probs=48.1
Q ss_pred eecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCeEEEE
Q 021897 138 NMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~iv 214 (306)
+-.+.++-|....+|+.+.+++.+.||+-..... ..|..|+.-|+.|. .-.+++.+++......-|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~---------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR---------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC---------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhhH---------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3446788899999999998888999998763222 25778888887773 44577888888776666999
Q ss_pred EeecCCC
Q 021897 215 TEYAKGG 221 (306)
Q Consensus 215 ~E~~~~g 221 (306)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999875
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.02 Score=51.93 Aligned_cols=30 Identities=17% Similarity=0.262 Sum_probs=27.8
Q ss_pred CccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 258 GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 258 ~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
+++|+|+.++|+|++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0055 Score=56.24 Aligned_cols=72 Identities=18% Similarity=0.280 Sum_probs=55.4
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
....|++|++- |+++... ..-.++.+..|+.+.+.-+.-+... ..-|||+.-+||||+ +|+|.|+||-++|
T Consensus 298 ~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 34567777776 5555322 1245677888888887777777654 688999999999999 9999999999998
Q ss_pred e
Q 021897 287 I 287 (306)
Q Consensus 287 ~ 287 (306)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 5
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.053 Score=49.68 Aligned_cols=133 Identities=20% Similarity=0.228 Sum_probs=76.7
Q ss_pred ccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC------eeeEEE----EEEeCCeEEEEEe
Q 021897 147 AFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN------IVRFIG----ACRKRMVWCIVTE 216 (306)
Q Consensus 147 ~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~----~~~~~~~~~iv~E 216 (306)
.-..+|+.+..+..+++|+.++. ... .++..|...|.-|.-.. +..+=| ........+-+.+
T Consensus 37 ~eN~~f~~~~~~g~~iLki~~~~-~~~-------~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 37 EENSNFRVQTEDGRYILKIYRPG-WTR-------AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccCceEEEEecCCCeEEEEecCC-CCH-------HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 34578988886666699999876 332 24445555555543111 111111 1122246788999
Q ss_pred ecCCCCHHH------------HHHh----hCCC---------CCCHHH-------------HHHHHHHHHHHHHHHHh--
Q 021897 217 YAKGGSVRQ------------FLTR----RQNR---------AVPLKL-------------AVKQALDVARGMAYVHG-- 256 (306)
Q Consensus 217 ~~~~gsL~~------------~l~~----~~~~---------~~~~~~-------------~~~i~~qi~~gl~yLH~-- 256 (306)
|++|..+.. ++-+ .++. ...|.. -.....++...++.+.+
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999877762 1100 0000 112220 01123344555555553
Q ss_pred ------CC--ccccCCCCCcEEEcCCCc-EEEEcccCeee
Q 021897 257 ------LG--FIHRDLKSDNLLISADKS-IKIADFGVARI 287 (306)
Q Consensus 257 ------~~--iiHrDlkp~NILv~~~~~-vkl~DFGla~~ 287 (306)
.+ +||+|+.|+||+++.+.. +.++||+.|..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 23 999999999999998774 89999998863
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.007 Score=56.53 Aligned_cols=78 Identities=12% Similarity=0.078 Sum_probs=47.3
Q ss_pred ceeeeeccEEEEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CC-CeeeEEEEEEeCCeEEEEE
Q 021897 141 TAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HL-NIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~iv~ 215 (306)
+.||.|--.-||++... ++.|+||.-.+.....+....-.++..-|...|+.+. .| .++++|.+-.+ ...+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e--~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSV--MNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcH--HhhHHH
Confidence 67899999999999874 6689999754221111111111234556666666553 33 46666655333 336899
Q ss_pred eecCC
Q 021897 216 EYAKG 220 (306)
Q Consensus 216 E~~~~ 220 (306)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 99854
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.015 Score=50.26 Aligned_cols=75 Identities=19% Similarity=0.214 Sum_probs=54.4
Q ss_pred ceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
+++--|.--+.|+..+...++-||+-.. ..++.|..|+.-|..+. .-.+.+.+.+-.+..+.|+||||
T Consensus 22 ~~v~gG~inea~~v~dg~~~~FvK~n~~---------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 22 EEVSGGDINEAWRLRDGTDPFFVKCNQR---------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred cccCCccccceeEeecCCcceEEEecch---------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 4454455556677777778999997432 23457888887666664 45578889998999999999999
Q ss_pred cCCCCHH
Q 021897 218 AKGGSVR 224 (306)
Q Consensus 218 ~~~gsL~ 224 (306)
++-+.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9886654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.048 Score=51.04 Aligned_cols=30 Identities=33% Similarity=0.381 Sum_probs=24.9
Q ss_pred CCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 257 ~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
...+|.|+-+.|||.++ ..++++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 35699999999999764 5699999998864
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.023 Score=51.01 Aligned_cols=30 Identities=30% Similarity=0.533 Sum_probs=25.6
Q ss_pred ccccCCCCCcEEEcCC--C---cEEEEcccCeeee
Q 021897 259 FIHRDLKSDNLLISAD--K---SIKIADFGVARIE 288 (306)
Q Consensus 259 iiHrDlkp~NILv~~~--~---~vkl~DFGla~~~ 288 (306)
++|+|+++.|||+..+ | .++++||-+++..
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~g 251 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARYG 251 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccCC
Confidence 7999999999999654 3 6999999998753
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.011 Score=55.17 Aligned_cols=58 Identities=29% Similarity=0.384 Sum_probs=43.0
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEc
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLIS 272 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH-~~~iiHrDlkp~NILv~ 272 (306)
.++-+|+.|.++..++... ..+++...+++.-.+.++--+- -.+.+|.|+.|.||++-
T Consensus 321 vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 5667788899999998753 3566666667666555654433 46899999999999995
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.14 Score=46.73 Aligned_cols=29 Identities=31% Similarity=0.401 Sum_probs=24.5
Q ss_pred CCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 257 ~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 4 578999998763
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.0052 Score=60.20 Aligned_cols=43 Identities=23% Similarity=0.502 Sum_probs=38.3
Q ss_pred HHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 245 LDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 245 ~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
.+++.||.|+|. .++||++|.|++|.++..+.+||+.|+++..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~ 149 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVN 149 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhc
Confidence 445589999995 4899999999999999999999999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.16 Score=53.58 Aligned_cols=30 Identities=40% Similarity=0.584 Sum_probs=25.7
Q ss_pred CCccccCCCCCcEEEcCCC--cE-EEEcccCee
Q 021897 257 LGFIHRDLKSDNLLISADK--SI-KIADFGVAR 286 (306)
Q Consensus 257 ~~iiHrDlkp~NILv~~~~--~v-kl~DFGla~ 286 (306)
.++||+|+.+.|||++.++ .+ -|+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999775 45 499999875
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.14 Score=48.99 Aligned_cols=77 Identities=12% Similarity=0.188 Sum_probs=45.7
Q ss_pred cCceecceeeeeccEEEEEEEEC----------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCee-eEEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTYN----------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV-RFIG 203 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~ 203 (306)
+++ -.+.|..|-.-.+|+++.. ++.|.+++.-.....- . .-.+|..+++.+....|- ++++
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l------I-dR~~E~~v~~~ls~~gi~P~l~~ 177 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL------Y-NPISEFEVYKTMSKYRIAPQLLN 177 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce------e-CHHHHHHHHHHHHHCCCCCceEE
Confidence 444 3456766777899998753 4578888875432211 0 123566666666544443 4555
Q ss_pred EEEeCCeEEEEEeecCCCCH
Q 021897 204 ACRKRMVWCIVTEYAKGGSV 223 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL 223 (306)
.+. . +.|.||++|-+|
T Consensus 178 ~f~-g---g~I~efi~g~~l 193 (442)
T PTZ00296 178 TFS-G---GRIEEWLYGDPL 193 (442)
T ss_pred EeC-C---CEEEEeeCCccC
Confidence 542 2 467899987643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.084 Score=55.12 Aligned_cols=106 Identities=19% Similarity=0.282 Sum_probs=80.8
Q ss_pred HHHHHHHHHHhCCCCCeeeEEEEEEeCCeE----EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 021897 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVW----CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257 (306)
Q Consensus 182 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~ 257 (306)
...-|...+.++.|+|++.++.+..++... .+..|++..-++...+... ...+..+.+.+..+..+||+|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHh
Confidence 344567778889999999999988665433 3445778888888888764 4588899999999999999999999
Q ss_pred CccccCCCCC---cEEEcCCCcEEEE--cccCeeeee
Q 021897 258 GFIHRDLKSD---NLLISADKSIKIA--DFGVARIEV 289 (306)
Q Consensus 258 ~iiHrDlkp~---NILv~~~~~vkl~--DFGla~~~~ 289 (306)
...|.-|..+ +-.++.++.+.+. ||+..+...
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~ 342 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP 342 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCC
Confidence 7777766665 5556667777777 888776443
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.1 Score=45.89 Aligned_cols=77 Identities=16% Similarity=0.132 Sum_probs=52.9
Q ss_pred ceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeec-
Q 021897 141 TAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA- 218 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~- 218 (306)
..+..|..+.|+.++. +|+++++|+..+...... +. .....|+...-...|++++.-.+.. .|++|.+
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-------E~-~g~~~L~~w~G~GaVrll~~d~~~~--AlLLErl~ 77 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-------EA-RGEAALRWWNGRGAVRLLAADPERG--ALLLERLD 77 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-------hh-hHHhHhheeCCCCceeeeccccccc--hhhhhhcc
Confidence 4556688899999976 899999999865433211 11 1224577777777899998765444 6889998
Q ss_pred CCCCHHHHH
Q 021897 219 KGGSVRQFL 227 (306)
Q Consensus 219 ~~gsL~~~l 227 (306)
++.+|.++.
T Consensus 78 ~g~~L~~~~ 86 (253)
T PF04655_consen 78 PGRSLASLP 86 (253)
T ss_pred CCCchhhcc
Confidence 445776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.024 Score=47.47 Aligned_cols=28 Identities=29% Similarity=0.412 Sum_probs=25.2
Q ss_pred ccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
.+|+|+.|.||++++++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 59999999999998777 99999999864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 306 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 4e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 4e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 7e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-04 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 3e-84
Identities = 65/190 (34%), Positives = 102/190 (53%), Gaps = 8/190 (4%)
Query: 121 TEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVME 180
+G + D+ I LN+ G+FG ++R ++G DVA+KIL + + E
Sbjct: 23 FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE----RV 78
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKL 239
+F +EV ++ L+H NIV F+GA + IVTEY GS+ + L + R + +
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 240 AVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTP 296
+ A DVA+GM Y+H +HR+LKS NLL+ ++K+ DFG++R++ T
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 297 ETGTYRWMAP 306
GT WMAP
Sbjct: 199 AAGTPEWMAP 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 5e-81
Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 107 DDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKIL 166
+ +L A R ++ EW I +L +G +G FG++Y G ++G +VAI+++
Sbjct: 5 NLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLI 63
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQF 226
+ +N + + F++EVM +H N+V F+GAC I+T KG ++
Sbjct: 64 DIERDNED----QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 227 LTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ R + + + A ++ +GM Y+H G +H+DLKS N+ + + I DFG+
Sbjct: 120 V-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177
Query: 287 IE------VQTEGMTPETGTYRWMAP 306
I + + + + G +AP
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAP 203
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 7e-80
Identities = 62/194 (31%), Positives = 100/194 (51%), Gaps = 10/194 (5%)
Query: 116 DHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
H + + D+W I ++ +G G+FG +Y+G ++G DVA+K+L P+
Sbjct: 5 HHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ- 62
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
Q F+ EV +L +H+NI+ F+G + IVT++ +G S+ L
Sbjct: 63 ---QLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHL-HASETKF 117
Query: 236 PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293
+K + A ARGM Y+H IHRDLKS+N+ + D ++KI DFG+A + + G
Sbjct: 118 EMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 294 -MTPETGTYRWMAP 306
+G+ WMAP
Sbjct: 178 QFEQLSGSILWMAP 191
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 4e-78
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 12/183 (6%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
ID ++LN T + G+L++G + G D+ +K+L+ + + + F +E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR----KSRDFNEEC 58
Query: 188 MMLATLKHLNIVRFIGACRKRMVW--CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
L H N++ +GAC+ ++T + GS+ L N V AVK AL
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 246 DVARGMAYVHGLGF--IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
D+ARGMA++H L L S +++I D + +I+ V M W
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----YAPAW 174
Query: 304 MAP 306
+AP
Sbjct: 175 VAP 177
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 1e-77
Identities = 69/188 (36%), Positives = 102/188 (54%), Gaps = 17/188 (9%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
ID +L + G FGK+YR + G++VA+K R + + + +Q +E +QE +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAA-RHDPDEDISQTIEN-VRQEAKL 59
Query: 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A LKH NI+ G C K C+V E+A+GG + + L + +P + V A+ +AR
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIAR 116
Query: 250 GMAYVHGLG---FIHRDLKSDNLLIS--------ADKSIKIADFGVARIEVQTEGMTPET 298
GM Y+H IHRDLKS N+LI ++K +KI DFG+AR +T M+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AA 175
Query: 299 GTYRWMAP 306
G Y WMAP
Sbjct: 176 GAYAWMAP 183
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 4e-76
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 113 ALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPE 170
A+ +P T+ ++ +G FG +++G + VAIK L +
Sbjct: 2 AMGGSEFPK-----SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 171 NNPEKAQVME-QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTR 229
+ E + + Q+FQ+EV +++ L H NIV+ G +V E+ G + L
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL-L 113
Query: 230 RQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-----ADKSIKIADF 282
+ + + ++ LD+A G+ Y+ +HRDL+S N+ + A K+ADF
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
G+++ V + ++ G ++WMAP
Sbjct: 174 GLSQQSVHS--VSGLLGNFQWMAP 195
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 6e-74
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 24/197 (12%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQ 184
L G +G FG+ + T+ GE + +K L R + ++ F
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE------TQRTFL 55
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+EV ++ L+H N+++FIG K +TEY KGG++R + + + P V A
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFA 114
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE------------ 292
D+A GMAY+H + IHRDL S N L+ +K++ +ADFG+AR+ V +
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 293 ---GMTPETGTYRWMAP 306
G WMAP
Sbjct: 175 DRKKRYTVVGNPYWMAP 191
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-72
Identities = 60/183 (32%), Positives = 88/183 (48%), Gaps = 17/183 (9%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
ID +++ + +GAFG + + + +DVAIK +E + F E+
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--------ERKAFIVELR 53
Query: 189 MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDV 247
L+ + H NIV+ GAC + C+V EYA+GGS+ L A+ L
Sbjct: 54 QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 248 ARGMAYVHGL---GFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRW 303
++G+AY+H + IHRDLK NLL+ A +KI DFG A MT G+ W
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAW 169
Query: 304 MAP 306
MAP
Sbjct: 170 MAP 172
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 2e-69
Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+++ M +G +G+++ G + GE VA+K+ E + E+
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-------SWFRETEIY 83
Query: 189 MLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
++H NI+ FI A K ++T+Y + GS+ +L ++ + K +K A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLA 140
Query: 245 LDVARGMAYVHGLGF--------IHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293
G+ ++H F HRDLKS N+L+ + + IAD G+A +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 294 --MTPETGTYRWMAP 306
GT R+M P
Sbjct: 201 IPPNTRVGTKRYMPP 215
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-67
Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 27/189 (14%)
Query: 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
R + + +G +G+++RG++ GE+VA+KI + + E+ L+
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-------SWFRETELYNTVMLR 60
Query: 195 HLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
H NI+ FI + ++T Y + GS+ +L Q + ++ L +A G
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASG 117
Query: 251 MAYVHGLGF--------IHRDLKSDNLLISADKSIKIADFGVARIEVQTE-----GMTPE 297
+A++H F HRDLKS N+L+ + IAD G+A + Q+ G P
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 298 TGTYRWMAP 306
GT R+MAP
Sbjct: 178 VGTKRYMAP 186
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 9e-67
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 37/207 (17%)
Query: 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQ 184
E ++DL L + +G +G +Y+G+ + VA+K+ Q F
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---------RQNFI 53
Query: 185 QE--VMMLATLKHLNIVRFIGACRK-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
E + + ++H NI RFI + RM + +V EY GS+ ++L+
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDW 110
Query: 238 KLAVKQALDVARGMAYVHG---------LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288
+ + A V RG+AY+H HRDL S N+L+ D + I+DFG++
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 289 VQTE---------GMTPETGTYRWMAP 306
E GT R+MAP
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAP 197
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-66
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 117 HRYPTEGLE-NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
H + + G++ + L + A+G FG +++ E VA+KI +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ--- 61
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQ 231
Q + EV L +KH NI++FIGA ++ + ++T + + GS+ FL
Sbjct: 62 ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117
Query: 232 NRAVPLKLAVKQALDVARGMAYVHG----------LGFIHRDLKSDNLLISADKSIKIAD 281
V A +ARG+AY+H HRD+KS N+L+ + + IAD
Sbjct: 118 ---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 282 FGVARI---EVQTEGMTPETGTYRWMAP 306
FG+A + GT R+MAP
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAP 202
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-65
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
GL + TI R + + + +G FG+++RG + GE+VA+KI E
Sbjct: 28 SGSGLPLLVQRTI-ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER------- 79
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
+ E+ L+H NI+ FI A K +V++Y + GS+ +L R V
Sbjct: 80 SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TV 136
Query: 236 PLKLAVKQALDVARGMAYVHG--------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
++ +K AL A G+A++H HRDLKS N+L+ + + IAD G+A
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 288 EVQTE-----GMTPETGTYRWMAP 306
GT R+MAP
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAP 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-47
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 16/190 (8%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVM 179
+ W +++++L + +G FG + G Y G VA+K + K
Sbjct: 7 AQDEFY-RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDAT 57
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
Q F E ++ L+H N+V+ +G ++ IVTEY GS+ +L R +
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGMTP 296
+K +LDV M Y+ G F+HRDL + N+L+S D K++DFG+ + Q G P
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177
Query: 297 ETGTYRWMAP 306
+W AP
Sbjct: 178 ----VKWTAP 183
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-46
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 103 HALNDDALAQALMD-----HRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN 157
+ + D L L+ + W +++++L + +G FG + G Y
Sbjct: 156 YTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR 215
Query: 158 GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTE 216
G VA+K + K Q F E ++ L+H N+V+ +G ++ IVTE
Sbjct: 216 GNKVAVKCI--------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267
Query: 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
Y GS+ +L R + +K +LDV M Y+ G F+HRDL + N+L+S D
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 327
Query: 277 IKIADFGVAR--IEVQTEGMTPETGTYRWMAP 306
K++DFG+ + Q G P +W AP
Sbjct: 328 AKVSDFGLTKEASSTQDTGKLP----VKWTAP 355
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-46
Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE--DVAIKILERPENNPEKAQVME 180
G NYD+W ++ + M G +G++Y G + VA+K L K ME
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTME 52
Query: 181 QQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ F +E ++ +KH N+V+ +G C + + I+TE+ G++ +L + V +
Sbjct: 53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
+ A ++ M Y+ FIHRDL + N L+ + +K+ADFG++R+ + + T G
Sbjct: 113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAG 171
Query: 300 T---YRWMAP 306
+W AP
Sbjct: 172 AKFPIKWTAP 181
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-45
Identities = 58/184 (31%), Positives = 90/184 (48%), Gaps = 15/184 (8%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQ 185
DEW + L + G FG+++ G YNG VA+K L K M F
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLA 57
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E ++ L+H +VR + ++ I+TEY + GS+ FL + + + A
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YR 302
+A GMA++ +IHRDL++ N+L+S S KIADFG+AR+ ++ T G +
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIK 175
Query: 303 WMAP 306
W AP
Sbjct: 176 WTAP 179
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-45
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 22/213 (10%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE--D 160
L + D+W ++ L +G +G FG+++ G +
Sbjct: 85 LLSTQQPLTKKS---GVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL 141
Query: 161 VAIKILERPENNPEKAQVMEQQ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VA+K + + F QE +L H NIVR IG C ++ IV E
Sbjct: 142 VAVKSC--------RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+GG FL R + + +K ++ D A GM Y+ IHRDL + N L++ +
Sbjct: 194 VQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252
Query: 278 KIADFGVARIEVQTEGMTPETGT----YRWMAP 306
KI+DFG++R E G +W AP
Sbjct: 253 KISDFGMSREEADGV-YAASGGLRQVPVKWTAP 284
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-44
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 21/216 (9%)
Query: 103 HALNDDALAQAL------MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY 156
H+ D L L + NYD+W ++ + M G +G++Y G +
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVW 241
Query: 157 NGE--DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213
VA+K L K ME + F +E ++ +KH N+V+ +G C + + I
Sbjct: 242 KKYSLTVAVKTL--------KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
+TE+ G++ +L + V + + A ++ M Y+ FIHR+L + N L+
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE 353
Query: 274 DKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 306
+ +K+ADFG++R+ + + T G +W AP
Sbjct: 354 NHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAP 388
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-44
Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 16/191 (8%)
Query: 121 TEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVM 179
T GL Y W ID + L G FG + G + G+ DVAIK++ K M
Sbjct: 11 TAGLG-YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI--------KEGSM 61
Query: 180 EQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ F +E ++ L H +V+ G C K+ I+TEY G + +L R +
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQ 120
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET 298
++ DV M Y+ F+HRDL + N L++ +K++DFG++R V + T
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSV 179
Query: 299 GT---YRWMAP 306
G+ RW P
Sbjct: 180 GSKFPVRWSPP 190
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-44
Identities = 46/210 (21%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 118 RYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENN 172
R E ++ ID L +G +G FG + G ED VA+K + + +N+
Sbjct: 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNS 75
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC-----IVTEYAKGGSVRQFL 227
++ ++F E + H N++R +G C + ++ + K G + +L
Sbjct: 76 SQREI---EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
Query: 228 TRRQNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+ P + ++ +D+A GM Y+ F+HRDL + N ++ D ++ +ADFG
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192
Query: 284 VARI-------EVQTEGMTPETGTYRWMAP 306
+++ P +W+A
Sbjct: 193 LSKKIYSGDYYRQGRIAKMP----VKWIAI 218
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-44
Identities = 59/209 (28%), Positives = 86/209 (41%), Gaps = 38/209 (18%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQV 178
I R + + +GAFGK++ VA+K L +
Sbjct: 6 GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL------KDPTLA 59
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
+ FQ+E +L L+H +IV+F G C +V EY K G + +FL
Sbjct: 60 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 231 --QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
Q R +L + Q A +A GM Y+ F+HRDL + N L+ A+ +KI DFG+
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 285 ARI-------EVQTEGMTPETGTYRWMAP 306
+R V M P RWM P
Sbjct: 180 SRDVYSTDYYRVGGHTMLP----IRWMPP 204
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 115 MDHRYPTEGL--ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKIL 166
M H + D + R L + +G FG + Y+ VA+K L
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGGSVR 224
+ + P++ ++ FQ+E+ +L L IV++ G R +V EY G +R
Sbjct: 61 Q--HSGPDQ----QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
FL +R + + + + +GM Y+ +HRDL + N+L+ ++ +KIADFG+
Sbjct: 115 DFL-QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173
Query: 285 ARI--------EVQTEGMTPETGTYRWMAP 306
A++ V+ G +P W AP
Sbjct: 174 AKLLPLDKDYYVVREPGQSP----IFWYAP 199
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 26/264 (9%)
Query: 54 GSVSMSVDNSSVGSNDSLTH----ILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDA 109
GS S+SV + D++ H L + G + ++ + V + +D
Sbjct: 106 GSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDH-----YKKGNDG 160
Query: 110 LAQALMD--HRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKIL 166
L Q L + D W I L + G FG+++ TYN VA+K +
Sbjct: 161 LCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM 220
Query: 167 ERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
K M + F E ++ TL+H +V+ K ++ I+TE+ GS+
Sbjct: 221 --------KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLD 271
Query: 226 FLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
FL + PL + + +A GMA++ +IHRDL++ N+L+SA KIADFG+A
Sbjct: 272 FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
Query: 286 RIEVQTEGMTPETGT---YRWMAP 306
R+ ++ T G +W AP
Sbjct: 332 RV-IEDNEYTAREGAKFPIKWTAP 354
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 103 HALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG---- 158
H + + L + G D R L +G FGK+ Y+
Sbjct: 7 HHHHHHGALEVL----FQGPG----DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDG 58
Query: 159 --EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV--WCIV 214
E VA+K L + + P+ ++QE+ +L TL H +I+++ G C +V
Sbjct: 59 TGEMVAVKAL-KADAGPQ----HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113
Query: 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
EY GS+R +L ++ L + A + GMAY+H +IHRDL + N+L+ D
Sbjct: 114 MEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170
Query: 275 KSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 306
+ +KI DFG+A+ V+ +G +P W AP
Sbjct: 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VFWYAP 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-43
Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 15/183 (8%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQE 186
+W ID +L G FG ++ G + + VAIK + + M ++ F +E
Sbjct: 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--------REGAMSEEDFIEE 53
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ L H +V+ G C ++ C+VTE+ + G + +L ++ L + LD
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLD 112
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRW 303
V GMAY+ IHRDL + N L+ ++ IK++DFG+ R V + T TGT +W
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKW 171
Query: 304 MAP 306
+P
Sbjct: 172 ASP 174
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 112 QALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKI 165
+ L E+ D + R L +G FG + Y+ VA+K
Sbjct: 18 ENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK 77
Query: 166 LERPENNPEKAQVMEQQ--FQQEVMMLATLKHLNIVRFIGAC--RKRMVWCIVTEYAKGG 221
L + E F++E+ +L +L+H NIV++ G C R ++ EY G
Sbjct: 78 L--------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 222 SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
S+R +L + + R +KL ++ + +GM Y+ +IHRDL + N+L+ + +KI D
Sbjct: 130 SLRDYLQKHKERIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 188
Query: 282 FGVARI--------EVQTEGMTPETGTYRWMAP 306
FG+ ++ +V+ G +P W AP
Sbjct: 189 FGLTKVLPQDKEYYKVKEPGESP----IFWYAP 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-43
Identities = 43/201 (21%), Positives = 84/201 (41%), Gaps = 30/201 (14%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
++ I ++ +G +G FG + ED VA+K+L + + + E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML--KADIIASSDIEE-- 71
Query: 183 FQQEVMMLATLKHLNIVRFIGAC------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
F +E + H ++ + +G + + ++ + K G + FL + P
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 237 LKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----- 287
L ++ +D+A GM Y+ FIHRDL + N +++ D ++ +ADFG++R
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 288 --EVQTEGMTPETGTYRWMAP 306
P +W+A
Sbjct: 192 YYRQGCASKLP----VKWLAL 208
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-43
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 103 HALNDDALAQAL---MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE 159
++ + D L L P D W I L + QG FG+++ GT+NG
Sbjct: 149 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 208
Query: 160 -DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L K M + F QE ++ L+H +V+ + ++ IVTEY
Sbjct: 209 TRVAIKTL--------KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEY 259
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
GS+ FL + + L V A +A GMAYV + ++HRDL++ N+L+ +
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 319
Query: 278 KIADFGVARIEVQTEGMTPETGT---YRWMAP 306
K+ADFG+AR ++ T G +W AP
Sbjct: 320 KVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 350
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-43
Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 31/197 (15%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQ 181
D + R L +G FG + Y+ E VA+K L + E
Sbjct: 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--------QHSTEEH 54
Query: 182 Q--FQQEVMMLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
F++E+ +L +L+H NIV++ G C R ++ EY GS+R +L + + R +
Sbjct: 55 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--------EV 289
KL ++ + +GM Y+ +IHRDL + N+L+ + +KI DFG+ ++ +V
Sbjct: 115 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 290 QTEGMTPETGTYRWMAP 306
+ G +P W AP
Sbjct: 174 KEPGESP----IFWYAP 186
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-43
Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 18/191 (9%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQ 181
D + R L +G FGK+ Y GE VA+K L +PE+
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGN----HIA 68
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
++E+ +L L H NIV++ G C + ++ E+ GS++++L + +N+ +
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
+K A+ + +GM Y+ ++HRDL + N+L+ ++ +KI DFG+ + IE E T +
Sbjct: 129 -LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 299 GT---YRWMAP 306
W AP
Sbjct: 188 DRDSPVFWYAP 198
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-42
Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 15/182 (8%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-DVAIKILERPENNPEKAQVMEQQ-FQQEV 187
+ ++ + G FG + G + G+ DVA+K++ K M + F QE
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI--------KEGSMSEDEFFQEA 54
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+ L H +V+F G C K IVTEY G + +L R + + ++ DV
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDV 113
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YRWM 304
GMA++ FIHRDL + N L+ D +K++DFG+ R V + GT +W
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWS 172
Query: 305 AP 306
AP
Sbjct: 173 AP 174
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 103 HALNDDALAQAL---MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE 159
++ + D L L P D W I L + QG FG+++ GT+NG
Sbjct: 232 YSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT 291
Query: 160 -DVAIKILERPENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY 217
VAIK L K M + F QE ++ L+H +V+ + ++ IVTEY
Sbjct: 292 TRVAIKTL--------KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEY 342
Query: 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
GS+ FL + + L V A +A GMAYV + ++HRDL++ N+L+ +
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC 402
Query: 278 KIADFGVARIEVQTEGMTPETGT---YRWMAP 306
K+ADFG+AR ++ T G +W AP
Sbjct: 403 KVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 433
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-42
Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 41/208 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
I R + + +GAFGK++ + VA+K L E ++
Sbjct: 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL------KEASESAR 87
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR------- 233
Q FQ+E +L L+H +IVRF G C + +V EY + G + +FL R +
Sbjct: 88 QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKLLA 145
Query: 234 ----AVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
P L + Q A VA GM Y+ GL F+HRDL + N L+ +KI DFG++
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
Query: 286 R-------IEVQTEGMTPETGTYRWMAP 306
R V M P RWM P
Sbjct: 206 RDIYSTDYYRVGGRTMLP----IRWMPP 229
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
DEW + K+ M QG+FG +Y G G VAIK + N +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 72
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----QNRAVP 236
+F E ++ ++VR +G + ++ E G ++ +L N V
Sbjct: 73 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 237 LKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----- 287
++ + A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 288 --EVQTEGMTPETGTYRWMAP 306
+G+ P RWM+P
Sbjct: 193 YYRKGGKGLLP----VRWMSP 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 35/255 (13%)
Query: 77 HPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENY--DEWTIDL 134
+ + Y S + + + + + Y G + D +
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70
Query: 135 RKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQQ-FQQE 186
+ + + GAFG++Y G +G VA+K L PE ++ F E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL------PEVCSEQDELDFLME 124
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQ-- 243
++++ H NIVR IG + + I+ E GG ++ FL R + P LA+
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 244 --ALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVAR-------IEVQT 291
A D+A G Y+ FIHRD+ + N L++ + KI DFG+AR
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 292 EGMTPETGTYRWMAP 306
M P +WM P
Sbjct: 245 CAMLP----VKWMPP 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-42
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 35/213 (16%)
Query: 119 YPTEGLENY--DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERP 169
Y G + D + + + + GAFG++Y G +G VA+K L
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--- 68
Query: 170 ENNPEKAQVMEQQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL- 227
PE ++ F E ++++ H NIVR IG + + I+ E GG ++ FL
Sbjct: 69 ---PEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLR 125
Query: 228 TRRQNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIA 280
R + P LA+ A D+A G Y+ FIHRD+ + N L++ + KI
Sbjct: 126 ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185
Query: 281 DFGVAR-------IEVQTEGMTPETGTYRWMAP 306
DFG+AR M P +WM P
Sbjct: 186 DFGMARDIYRASYYRKGGCAMLP----VKWMPP 214
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-42
Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 37/205 (18%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVMEQQ 182
I L + + FGK+Y+G G VAIK L + + ++
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLR---EE 58
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR----------QN 232
F+ E M+ A L+H N+V +G K ++ Y G + +FL R +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 233 RAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI- 287
R V L +A GM Y+ +H+DL + N+L+ ++KI+D G+ R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 288 ------EVQTEGMTPETGTYRWMAP 306
++ + P RWMAP
Sbjct: 179 YAADYYKLLGNSLLP----IRWMAP 199
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 61/246 (24%), Positives = 91/246 (36%), Gaps = 53/246 (21%)
Query: 103 HALNDDALAQAL----MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG 158
L + L L M R P + +GAFG++++ G
Sbjct: 11 TTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70
Query: 159 ED-------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211
VA+K+L E Q FQ+E ++A + NIV+ +G C
Sbjct: 71 LLPYEPFTMVAVKML--KEEASADMQ---ADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125
Query: 212 CIVTEYAKGGSVRQFLTRRQNR--------------------AVPLKLAVKQ----ALDV 247
C++ EY G + +FL R P L+ + A V
Sbjct: 126 CLLFEYMAYGDLNEFL--RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTPETGT 300
A GMAY+ F+HRDL + N L+ + +KIADFG++R + P
Sbjct: 184 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP---- 239
Query: 301 YRWMAP 306
RWM P
Sbjct: 240 IRWMPP 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 44/188 (23%), Positives = 89/188 (47%), Gaps = 16/188 (8%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQ 181
++ I + + +G FG++Y G Y VA+K + ++
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDNKE 58
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+F E +++ L H +IV+ IG + W I+ E G + +L R ++ + V
Sbjct: 59 KFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYL-ERNKNSLKVLTLV 116
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT- 300
+L + + MAY+ + +HRD+ N+L+++ + +K+ DFG++R ++ E + T
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTR 175
Query: 301 --YRWMAP 306
+WM+P
Sbjct: 176 LPIKWMSP 183
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 53/188 (28%), Positives = 87/188 (46%), Gaps = 16/188 (8%)
Query: 128 DEWTIDLRKLNM-GTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQ 182
E +D + L + G FG + +G Y + VA+KIL + E N + +
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPAL---KDE 64
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E ++ L + IVR IG C +V E A+ G + ++L +QNR V K ++
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 121
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ + +T
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 301 --YRWMAP 306
+W AP
Sbjct: 182 WPVKWYAP 189
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-41
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 117 HRYPTEGLENY-DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED----VAIKILERPEN 171
H + + + +D + +G FG++ + + AIK +
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM----- 60
Query: 172 NPEKAQVMEQQ---FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFL 227
K + F E+ +L L H NI+ +GAC R + EYA G++ FL
Sbjct: 61 ---KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117
Query: 228 TRRQNRAVPL------------KLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLI 271
R++R + L+ +Q A DVARGM Y+ FIHRDL + N+L+
Sbjct: 118 --RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175
Query: 272 SADKSIKIADFGVARIE----VQTEGMTPETGTYRWMAP 306
+ KIADFG++R + +T G P RWMA
Sbjct: 176 GENYVAKIADFGLSRGQEVYVKKTMGRLP----VRWMAI 210
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-41
Identities = 55/191 (28%), Positives = 87/191 (45%), Gaps = 21/191 (10%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE-----DVAIKILERPENNPEKAQVMEQQ 182
I+ ++++ G G++ G VAIK L KA E+Q
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--------KAGYTERQ 93
Query: 183 ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
F E ++ H NI+R G + + IVTEY + GS+ FL + ++L
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
V V GM Y+ LG++HRDL + N+L+ ++ K++DFG++R +E + T
Sbjct: 154 -VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 299 GT---YRWMAP 306
G RW AP
Sbjct: 213 GGKIPIRWTAP 223
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGE------DVAIKILERPENNPEKAQVMEQ 181
I + G FG++Y+G VAIK L KA E+
Sbjct: 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--------KAGYTEK 88
Query: 182 Q---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
Q F E ++ H NI+R G K I+TEY + G++ +FL + L+
Sbjct: 89 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPE 297
L V +A GM Y+ + ++HRDL + N+L++++ K++DFG++R +E E
Sbjct: 149 L-VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 298 TGT---YRWMAP 306
+G RW AP
Sbjct: 208 SGGKIPIRWTAP 219
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-40
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 42/211 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W +L+ G GAFGK+ T G VA+K+L A + E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML------KPSAHLTE 69
Query: 181 QQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV--- 235
++ E+ +L+ L H+NIV +GAC ++TEY G + FL R+++ +
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 236 ---------PLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
L L ++ + VA+GMA++ IHRDL + N+L++ + KI DF
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAP 306
G+AR V+ P +WMAP
Sbjct: 190 GLARDIKNDSNYVVKGNARLP----VKWMAP 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 27/200 (13%)
Query: 124 LENYDEWTIDLR--KLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKA 176
++ I ++ +G FG +Y GT D A+K L
Sbjct: 12 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGE 69
Query: 177 QVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAV 235
QF E +++ H N++ +G C R +V Y K G +R F+ R +
Sbjct: 70 V---SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNP 125
Query: 236 PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--------- 286
+K + L VA+GM Y+ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS 185
Query: 287 IEVQTEGMTPETGTYRWMAP 306
+ +T P +WMA
Sbjct: 186 VHNKTGAKLP----VKWMAL 201
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-40
Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 14/188 (7%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
I + L + G+FG + RG ++ VA+K L+ + +A
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM---DD 67
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
F +EV + +L H N++R G + +VTE A GS+ L R+ L +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL-RKHQGHFLLGTLSR 125
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
A+ VA GM Y+ FIHRDL + NLL++ +KI DFG+ R + + +
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 301 --YRWMAP 306
+ W AP
Sbjct: 186 VPFAWCAP 193
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-40
Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 16/171 (9%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+F +Y+G T +VA L+ + Q+F++E ML L+H NIVRF
Sbjct: 36 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 203 GA----CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--G 256
+ + + +VTE G+++ +L R + + +K+ + +G+ ++H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 257 LGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRDLK DN+ I+ S+KI D G+A ++ + GT +MAP
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAP 199
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-40
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 51/218 (23%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W + L +G +G FGK+ + T VA+K+L E A E
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML------KENASPSE 69
Query: 181 QQ-FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ E +L + H ++++ GAC + ++ EYAK GS+R FL R++R V
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGY 127
Query: 240 AVKQ------------------------ALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275
A +++GM Y+ + +HRDL + N+L++ +
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 276 SIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
+KI+DFG++R +++G P +WMA
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIP----VKWMAI 221
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 55/191 (28%), Positives = 86/191 (45%), Gaps = 21/191 (10%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQ 182
+D +++ G FG++ G VAIK L K E+Q
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--------KVGYTEKQ 89
Query: 183 ---FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
F E ++ H NI+R G K IVTEY + GS+ FL + + ++L
Sbjct: 90 RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET 298
V +A GM Y+ +G++HRDL + N+LI+++ K++DFG+ R +E E
Sbjct: 150 -VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 299 GT---YRWMAP 306
G RW +P
Sbjct: 209 GGKIPIRWTSP 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-40
Identities = 66/267 (24%), Positives = 103/267 (38%), Gaps = 46/267 (17%)
Query: 74 ILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTID 133
+ + Y +G + L M L W +
Sbjct: 8 HHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELP 67
Query: 134 LRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVMEQQ-F 183
+L +G +GAFG++ G D VA+K+L A +
Sbjct: 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML------KSDATEKDLSDL 121
Query: 184 QQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E+ M+ + KH NI+ +GAC + ++ EYA G++R++L + R L+ +
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYN 179
Query: 243 Q----------------ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
A VARGM Y+ IHRDL + N+L++ D +KIADFG+AR
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 287 I-------EVQTEGMTPETGTYRWMAP 306
+ T G P +WMAP
Sbjct: 240 DIHHIDYYKKTTNGRLP----VKWMAP 262
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-40
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 42/211 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
+W KL +G +GAFG++ G D VA+K+L + A
Sbjct: 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML------KDDATE 81
Query: 179 MEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR------ 230
+ E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R
Sbjct: 82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 231 ----QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
NR ++ K +ARGM Y+ IHRDL + N+L++ + +KIADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAP 306
G+AR + T G P +WMAP
Sbjct: 202 GLARDINNIDYYKKTTNGRLP----VKWMAP 228
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-40
Identities = 49/201 (24%), Positives = 84/201 (41%), Gaps = 29/201 (14%)
Query: 124 LENYDEWTI--DLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKA 176
L + I + + +G FG +Y G Y + AIK L
Sbjct: 8 LAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL------SRIT 61
Query: 177 QVME-QQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
++ + + F +E +++ L H N++ IG + ++ Y G + QF+ R R
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRN 120
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-------- 286
+K + L VARGM Y+ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180
Query: 287 -IEVQTEGMTPETGTYRWMAP 306
++ P +W A
Sbjct: 181 SVQQHRHARLP----VKWTAL 197
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 56/207 (27%), Positives = 87/207 (42%), Gaps = 38/207 (18%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
++W L G GAFGK+ T G VA+K+L A E
Sbjct: 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML------KSTAHADE 92
Query: 181 QQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
++ E+ +++ L +H NIV +GAC ++TEY G + FL R+
Sbjct: 93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 231 QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286
+ + + VA+GMA++ IHRD+ + N+L++ KI DFG+AR
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 287 I-------EVQTEGMTPETGTYRWMAP 306
V+ P +WMAP
Sbjct: 213 DIMNDSNYIVKGNARLP----VKWMAP 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-40
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 42/211 (19%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
+W KL +G +G FG++ G D VA+K+L + A
Sbjct: 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML------KDDATE 127
Query: 179 MEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR------ 230
+ E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 231 ----QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
NR ++ K +ARGM Y+ IHRDL + N+L++ + +KIADF
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
Query: 283 GVARI-------EVQTEGMTPETGTYRWMAP 306
G+AR + T G P +WMAP
Sbjct: 248 GLARDINNIDYYKKTTNGRLP----VKWMAP 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-40
Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 39/209 (18%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQVME 180
+W +L +G +GAFG++ G D VA+K+L
Sbjct: 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEH 74
Query: 181 QQFQQEVMMLATL-KHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRR-------- 230
+ E+ +L + HLN+V +GAC + ++ E+ K G++ +L +
Sbjct: 75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 231 --QNRAVPLKLAVKQ----ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
L ++ + VA+GM ++ IHRDL + N+L+S +KI DFG+
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 285 ARI-------EVQTEGMTPETGTYRWMAP 306
AR + + P +WMAP
Sbjct: 195 ARDIYKDPDYVRKGDARLP----LKWMAP 219
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 42/187 (22%), Positives = 80/187 (42%), Gaps = 22/187 (11%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQ--- 182
+ + GAFG +Y+G + E VAIK L + +
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKE 63
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
E ++A++ + ++ R +G C V ++T+ G + ++ R + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-- 300
+ +A+GM Y+ +HRDL + N+L+ + +KI DFG+A++ E G
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 301 -YRWMAP 306
+WMA
Sbjct: 182 PIKWMAL 188
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 16/188 (8%)
Query: 128 DEWTIDLRKLNMG-TAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQ 182
+ + L + G FG + +G Y DVAIK+L + ++
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKA----DTEE 56
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+E ++ L + IVR IG C+ + +V E A GG + +FL + +P+ +
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL-VGKREEIPVSNVAE 114
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT- 300
V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ + T +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 301 --YRWMAP 306
+W AP
Sbjct: 175 WPLKWYAP 182
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-39
Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 16/188 (8%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQ 181
++ I ++ +G +G FG +++G Y + VAIK + + +
Sbjct: 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-----KNCTSDSVRE 61
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+F QE + + H +IV+ IG + VW I+ E G +R FL R+ L +
Sbjct: 62 KFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASL-I 119
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT- 300
A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R ++ +
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGK 178
Query: 301 --YRWMAP 306
+WMAP
Sbjct: 179 LPIKWMAP 186
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-39
Identities = 46/187 (24%), Positives = 87/187 (46%), Gaps = 18/187 (9%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQ- 182
+L G FG +++G + E V IK++E +K+ Q
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE------DKSGRQSFQA 61
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++ + +L H +IVR +G C + +VT+Y GS+ + R+ A+ +L +
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHV-RQHRGALGPQLLLN 119
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT-- 300
+ +A+GM Y+ G +HR+L + N+L+ + +++ADFGVA + + +
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 301 -YRWMAP 306
+WMA
Sbjct: 180 PIKWMAL 186
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-39
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 27/205 (13%)
Query: 119 YPTEGLENYDEWTIDLR--KLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPEN 171
E ++ I ++ +G FG +Y GT D A+K L
Sbjct: 71 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRI 128
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRR 230
QF E +++ H N++ +G C R +V Y K G +R F+ R
Sbjct: 129 TDIGE---VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RN 184
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---- 286
+ +K + L VA+GM ++ F+HRDL + N ++ ++K+ADFG+AR
Sbjct: 185 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 287 -----IEVQTEGMTPETGTYRWMAP 306
+ +T P +WMA
Sbjct: 245 KEFDSVHNKTGAKLP----VKWMAL 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 7e-38
Identities = 53/252 (21%), Positives = 103/252 (40%), Gaps = 27/252 (10%)
Query: 71 LTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENY--- 127
+ ++P + + + D+ + + Y
Sbjct: 321 VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMP 380
Query: 128 --DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVME 180
++ I ++ +G +G FG +++G Y + VAIK + +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-----KNCTSDSVR 435
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
++F QE + + H +IV+ IG + VW I+ E G +R FL R+ L
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASL- 493
Query: 241 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI------EVQTEGM 294
+ A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R ++G
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 295 TPETGTYRWMAP 306
P +WMAP
Sbjct: 554 LP----IKWMAP 561
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-38
Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 47/220 (21%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKA 176
E +W L G GAFGK+ T G VA+K+L EKA
Sbjct: 34 YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML------KEKA 87
Query: 177 QVMEQQ-FQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
E++ E+ M+ L H NIV +GAC ++ EY G + +L ++ +
Sbjct: 88 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 147
Query: 235 VPLKLAVKQ---------------------ALDVARGMAYVHGLGFIHRDLKSDNLLISA 273
++ + A VA+GM ++ +HRDL + N+L++
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207
Query: 274 DKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 306
K +KI DFG+AR V+ P +WMAP
Sbjct: 208 GKVVKICDFGLARDIMSDSNYVVRGNARLP----VKWMAP 243
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 42/184 (22%), Positives = 81/184 (44%), Gaps = 16/184 (8%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQ 185
+ + GAFG +Y+G + E VAIK L + ++
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-----REATSPKANKEILD 66
Query: 186 EVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
E ++A++ + ++ R +G C V ++T+ G + ++ R + + + +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124
Query: 246 DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT---YR 302
+A+GM Y+ +HRDL + N+L+ + +KI DFG+A++ E G +
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 303 WMAP 306
WMA
Sbjct: 185 WMAL 188
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 32/182 (17%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG++++ +G+ IK ++ ++EV LA L H+NIV
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVH 68
Query: 201 FIGA----------------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
+ G K I E+ G++ Q++ +R+ + LA++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWM 304
+ +G+ Y+H I+RDLK N+ + K +KI DFG+ T GT R+M
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 305 AP 306
+P
Sbjct: 189 SP 190
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 36/195 (18%), Positives = 77/195 (39%), Gaps = 29/195 (14%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQVME 180
I L + QG F K+++G V +K+L + +
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL------DKAHRNYS 56
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 240
+ F + M++ L H ++V G C +V E+ K GS+ +L ++ + +
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWK 115
Query: 241 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--------IKIADFGVAR-IEVQT 291
++ A +A M ++ IH ++ + N+L+ ++ IK++D G++ + +
Sbjct: 116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 292 EGMTPETGTYRWMAP 306
W+ P
Sbjct: 176 ILQER----IPWVPP 186
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 56/259 (21%), Positives = 95/259 (36%), Gaps = 23/259 (8%)
Query: 64 SVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEG 123
S SN S + P + + A M
Sbjct: 257 SSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFE 316
Query: 124 LENYDEWTIDLRKLNM--------GTAFAQGAFGKLYRGTYNGE----DVAIKILERPEN 171
D + +KL + G FG + +G Y DVAIK+L +
Sbjct: 317 SPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGT 375
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ 231
++ +E ++ L + IVR IG C+ + +V E A GG + +FL +
Sbjct: 376 EKA----DTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL-VGK 429
Query: 232 NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQ 290
+P+ + V+ GM Y+ F+HR+L + N+L+ KI+DFG+++ +
Sbjct: 430 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489
Query: 291 TEGMTPETGT---YRWMAP 306
T + +W AP
Sbjct: 490 DSYYTARSAGKWPLKWYAP 508
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-35
Identities = 42/166 (25%), Positives = 85/166 (51%), Gaps = 9/166 (5%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK L + T +G IK + K + ++ ++EV +LA +KH NIV++
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKER---EESRREVAVLANMKHPNIVQYR 89
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + IV +Y +GG + + + ++ + + + + +VH +HR
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
D+KS N+ ++ D ++++ DFG+AR+ T + GT +++P
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACIGTPYYLSP 194
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 40/218 (18%), Positives = 80/218 (36%), Gaps = 27/218 (12%)
Query: 110 LAQALMDHRYPTEGLENYDE---WTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIK 164
+ + H + + Y + ID + +G F + G ++G A+K
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALK 60
Query: 165 ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW----CIVTEYAKG 220
+ E ++ Q+E M H NI+R + C + ++ + K
Sbjct: 61 RILCHEQQ------DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114
Query: 221 GSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIK 278
G++ + R +++ L + L + RG+ +H G+ HRDLK N+L+ +
Sbjct: 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV 174
Query: 279 IADFGVARIE----------VQTEGMTPETGTYRWMAP 306
+ D G + + + T + AP
Sbjct: 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 53/173 (30%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y G N +AIK + E+ Q +E+ + LKH NIV+++
Sbjct: 32 KGTYGIVYAGRDLSNQVRIAIKEIP------ERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-------VKQALDVARGMAYVH 255
G+ + I E GGS+ L +++ PLK KQ L G+ Y+H
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQIL---EGLKYLH 139
Query: 256 GLGFIHRDLKSDNLLI-SADKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 306
+HRD+K DN+LI + +KI+DFG + R+ TGT ++MAP
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 38/167 (22%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F ++YR +G VA+K ++ + KA+ +E+ +L L H N++++
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIKYY 98
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK--LAVKQALDVARGMAYVHGLGFI 260
+ + IV E A G + + + + + + K + + + ++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
HRD+K N+ I+A +K+ D G+ R +T GT +M+P
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 21/177 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA + E VAIK + N EK Q + +E+ ++ H NIV +
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 203 GA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL------DVARGMAYVH 255
+ K +W +V + GGSV + + + ++ +V G+ Y+H
Sbjct: 80 TSFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G IHRD+K+ N+L+ D S++IADFGV+ +T GT WMAP
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 45/196 (22%), Positives = 77/196 (39%), Gaps = 46/196 (23%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGAFG++ + + AIK + + EVM+LA+L H +VR+
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKIR-------HTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 203 GA-------------CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR 249
A +K+ I EY + G++ + L + + R
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFR 123
Query: 250 ----GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------- 298
++Y+H G IHRDLK N+ I +++KI DFG+A+ ++ +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 299 --------GTYRWMAP 306
GT ++A
Sbjct: 184 SDNLTSAIGTAMYVAT 199
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 36/165 (21%), Positives = 66/165 (40%), Gaps = 9/165 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G++G++++ +G A+K P P+ + EV + +H VR
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRL 122
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
A + + + TE G S++Q ++P D +A++H G +H
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D+K N+ + K+ DFG+ + G R+MAP
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-34
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 28/174 (16%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG+++R G A+K + +E +E++ A L IV
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVR-----------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA---VKQALDVARGMAYVHGLGF 259
GA R+ I E +GGS+ Q + +Q +P A + QAL G+ Y+H
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQAL---EGLEYLHTRRI 171
Query: 260 IHRDLKSDNLLISAD-KSIKIADFGVA-RIEVQTEGMTPET-----GTYRWMAP 306
+H D+K+DN+L+S+D + DFG A ++ G + T GT MAP
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 39/190 (20%), Positives = 74/190 (38%), Gaps = 33/190 (17%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG + + + AIK + P + ++ +EV LA L+H IVR+
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-----EKVMREVKALAKLEHPGIVRYF 69
Query: 203 GAC------------RKRMVWCIVTEYAKGGSVRQFL-TRRQNRAVPLKLAVKQALDVAR 249
A ++ I + + +++ ++ R + + L +A
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------------EVQTEGMTP 296
+ ++H G +HRDLK N+ + D +K+ DFG+ T
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 297 ETGTYRWMAP 306
+ GT +M+P
Sbjct: 190 QVGTKLYMSP 199
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKL-NMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPEN 171
M H GL D +L +G+FG++++G N + VAIKI+
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII----- 55
Query: 172 NPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRR 230
+ E+A+ + QQE+ +L+ + ++ G+ K +W I+ EY GGS L
Sbjct: 56 DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPG 114
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290
+ +++ L +G+ Y+H IHRD+K+ N+L+S +K+ADFGVA Q
Sbjct: 115 PLDETQIATILREIL---KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQ 168
Query: 291 -TEGMTPET---GTYRWMAP 306
T+ GT WMAP
Sbjct: 169 LTDTQIKRNTFVGTPFWMAP 188
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 45/186 (24%), Positives = 69/186 (37%), Gaps = 31/186 (16%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G FG +++ +G AIK ++P EQ +EV A L +H ++VR+
Sbjct: 21 SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRY 76
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK--LAVKQALDVARGMAYVHGLGF 259
A + I EY GGS+ ++ K L V RG+ Y+H +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136
Query: 260 IHRDLKSDNLLISADKSI-------------------KIADFGVARIEVQTEGMTPETGT 300
+H D+K N+ IS KI D G + E G
Sbjct: 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISSPQVEEGD 193
Query: 301 YRWMAP 306
R++A
Sbjct: 194 SRFLAN 199
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ G A K++E ++ E + + E+ +LAT H IV+ +
Sbjct: 29 DGAFGKVYKAKNKETGALAAAKVIE-TKSEEEL-----EDYIVEIEILATCDHPYIVKLL 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGFI 260
GA I+ E+ GG+V + ++ V +Q L + ++H I
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLHSKRII 139
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
HRDLK+ N+L++ + I++ADFGV+ ++T + GT WMAP
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAP 186
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-32
Identities = 42/172 (24%), Positives = 65/172 (37%), Gaps = 16/172 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
QGA ++RG G+ AIK+ +E +L L H NIV+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 201 -FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKLAVKQALDVARGMAYVHGLG 258
R ++ E+ GS+ L N +P + DV GM ++ G
Sbjct: 74 AIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 259 FIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HR++K N++ K+ DFG AR E GT ++ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 33/168 (19%), Positives = 67/168 (39%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRF 201
G K+++ + AIK + E + + ++ E+ L L+ I+R
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD----SYRNEIAYLNKLQQHSDKIIRL 121
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
DLK N LI D +K+ DFG+A ++ T + ++ G +M P
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 42/172 (24%), Positives = 65/172 (37%), Gaps = 16/172 (9%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
QGA ++RG G+ AIK+ +E +L L H NIV+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 201 -FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-AVPLKLAVKQALDVARGMAYVHGLG 258
R ++ E+ GS+ L N +P + DV GM ++ G
Sbjct: 74 AIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 259 FIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HR++K N++ K+ DFG AR E GT ++ P
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 34/168 (20%), Positives = 69/168 (41%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRF 201
G K+++ + AIK + E + + ++ E+ L L+ + I+R
Sbjct: 38 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 150
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
DLK N LI D +K+ DFG+A ++ T + ++ GT +M P
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 34/168 (20%), Positives = 68/168 (40%), Gaps = 14/168 (8%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRF 201
G K+++ + AIK + E + + ++ E+ L L+ I+R
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD----SYRNEIAYLNKLQQHSDKIIRL 74
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+V E + +L ++++ + ++ + +H G +H
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVH 131
Query: 262 RDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
DLK N LI D +K+ DFG+A ++ T + ++ GT +M P
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 24/172 (13%)
Query: 144 AQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G +Y+ + G+ VAIK + E++ ++ +E+ ++ ++V++
Sbjct: 38 GEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQE-------IIKEISIMQQCDSPHVVKY 89
Query: 202 IGACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLG 258
G+ K +W IV EY GSV + R ++A + L +G+ Y+H +
Sbjct: 90 YGSYFKNTDLW-IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---KGLEYLHFMR 145
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPET---GTYRWMAP 306
IHRD+K+ N+L++ + K+ADFGVA Q T+ M GT WMAP
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNTVIGTPFWMAP 194
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-31
Identities = 52/174 (29%), Positives = 85/174 (48%), Gaps = 30/174 (17%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAI+ + + P+K + E++++ K+ NIV ++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMN-LQQQPKK-----ELIINEILVMRENKNPNIVNYL 83
Query: 203 GACRKRM-VWCIVTEYAKGGSVRQFLTRR-----QNRAVPLKLAVKQALDVARGMAYVHG 256
+ +W +V EY GGS+ +T Q AV ++ L + + ++H
Sbjct: 84 DSYLVGDELW-VVMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECL---QALEFLHS 134
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ-TEGMTPET---GTYRWMAP 306
IHRD+KSDN+L+ D S+K+ DFG Q T + + GT WMAP
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTMVGTPYWMAP 185
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 36/177 (20%), Positives = 66/177 (37%), Gaps = 26/177 (14%)
Query: 146 GAFGKLYRGTY--NGEDVAIKI--LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+ Y GE V ++ LE N M Q E+ + H NIV +
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNE------MVTFLQGELHVSKLFNHPNIVPY 91
Query: 202 IGA-CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAV--KQALDVARGMAYVHGL 257
+W +VT + GS + + + L +A + L + + Y+H +
Sbjct: 92 RATFIADNELW-VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHM 147
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA--------RIEVQTEGMTPETGTYRWMAP 306
G++HR +K+ ++LIS D + ++ R V + W++P
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 52/225 (23%), Positives = 100/225 (44%), Gaps = 28/225 (12%)
Query: 86 NYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQ 145
+ F+ G VTH AL + ++D P L++Y + +
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAAL-RMVVDQGDPRLLLDSYVK-------------IGE 55
Query: 146 GAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G+ G + G VA+K+++ + + EV+++ +H N+V
Sbjct: 56 GSTGIVCLAREKHSGRQVAVKMMD-LRKQQRR-----ELLFNEVVIMRDYQHFNVVEMYK 109
Query: 204 ACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +W ++ E+ +GG++ +++ + + + L + +AY+H G IHR
Sbjct: 110 SYLVGEELW-VLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---QALAYLHAQGVIHR 165
Query: 263 DLKSDNLLISADKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 306
D+KSD++L++ D +K++DFG A+I GT WMAP
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 16/167 (9%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y E VAIK + + Q +EV L L+H N +++
Sbjct: 64 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK---WQDIIKEVRFLQKLRHPNTIQYR 120
Query: 203 GACRKR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHGLGF 259
G + W +V EY GS L + +++A AL +G+AY+H
Sbjct: 121 GCYLREHTAW-LVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNM 175
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K+ N+L+S +K+ DFG A I GT WMAP
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAP 219
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 3e-30
Identities = 55/168 (32%), Positives = 84/168 (50%), Gaps = 10/168 (5%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG +Y+G N VA+K L + + ++QQF QE+ ++A +H N+V +G
Sbjct: 41 EGGFGVVYKGYVNNTTVAVKKLA-AMVDITTEE-LKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIHR 262
C+V Y GS+ L+ PL + K A A G+ ++H IHR
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
D+KS N+L+ + KI+DFG+AR + T T GT +MAP
Sbjct: 158 DIKSANILLDEAFTAKISDFGLARA-SEKFAQTVMTSRIVGTTAYMAP 204
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 25/176 (14%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRF 201
G +G++Y+G + G+ AIK+++ + E++ +QE+ ML H NI +
Sbjct: 34 NGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATY 86
Query: 202 IGACRKRMV-------WCIVTEYAKGGSVRQFLTRRQNRAVP-LKLAV--KQALDVARGM 251
GA K+ W +V E+ GSV + + + +A ++ L RG+
Sbjct: 87 YGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGL 142
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 306
+++H IHRD+K N+L++ + +K+ DFGV+ +T G GT WMAP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 30/204 (14%)
Query: 118 RYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEK 175
R P+ + W + +L G FG + R GE VAIK + E
Sbjct: 4 RSPSLPTQTCGPWEMK-ERLG------TGGFGYVLRWIHQDTGEQVAIKQCRQ-----EL 51
Query: 176 AQVMEQQFQQEVMMLATLKHLNIVRFI------GACRKRMVWCIVTEYAKGGSVRQFLTR 229
+ +++ E+ ++ L H N+V + + EY +GG +R++L +
Sbjct: 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ 111
Query: 230 RQNRAVPLKLAVKQAL----DVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADF 282
+N L D++ + Y+H IHRDLK +N+++ KI D
Sbjct: 112 FENCC---GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
G A+ Q E T GT +++AP
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAP 192
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-29
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 18/175 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G++G+ R +G+ + K L+ + +Q EV +L LKH NIVR+
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYY 71
Query: 203 GA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLG 258
R IV EY +GG + +T+ L + ++ + + H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 259 F-----IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+HRDLK N+ + +++K+ DFG+ARI +T GT +M+P
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFVGTPYYMSP 185
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 22/186 (11%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQV----MEQQ 182
+W ++ +G +G FG +Y R + +A+K+L KAQ+ +E Q
Sbjct: 5 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-------KAQLEKAGVEHQ 55
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++EV + + L+H NI+R G ++ EYA G+V + L ++ ++ +
Sbjct: 56 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSK-FDEQRTAT 113
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GT 300
++A ++Y H IHRD+K +NLL+ + +KIADFG + V GT
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGT 170
Query: 301 YRWMAP 306
++ P
Sbjct: 171 LDYLPP 176
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 44/170 (25%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+ +L + A+G F +Y + +G + A+K L E + QEV
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE------KNRAIIQEVC 77
Query: 189 MLATLK-HLNIVRFIGAC--------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ L H NIV+F A + + ++TE KG V +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 240 AVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGVARI 287
+K R + ++H IHRDLK +NLL+S +IK+ DFG A
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 59/172 (34%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G FGK+Y+G +G VA+K L+ E+ Q E QFQ EV M++ H N++R G
Sbjct: 40 RGGFGKVYKGRLADGTLVAVKRLKE-----ERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA--VKQALDVARGMAYVH---GLG 258
C +V Y GSV L R PL + AL ARG+AY+H
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
IHRD+K+ N+L+ + + DFG+A++ T T GT +AP
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDTHVTTAVRGTIGHIAP 204
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 20/172 (11%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
G FGK+Y+G +G VA+K PE +Q ++F+ E+ L+ +H ++V IG
Sbjct: 49 HGVFGKVYKGVLRDGAKVALKRR-----TPESSQ-GIEEFETEIETLSFCRHPHLVSLIG 102
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL--KLAVKQALDVARGMAYVHGLGFIH 261
C +R ++ +Y + G++++ L + + + ++ + ARG+ Y+H IH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 262 RDLKSDNLLISADKSIKIADFGVARIE-------VQTEGMTPETGTYRWMAP 306
RD+KS N+L+ + KI DFG+++ + T GT ++ P
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK----GTLGYIDP 210
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 36/188 (19%), Positives = 71/188 (37%), Gaps = 35/188 (18%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILER-----------PENNPEKAQVMEQQFQQEVMMLATL 193
QG F K+ + + A+K E+ N+ + F+ E+ ++ +
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 194 KHLNIVRFIGACRKRMVW------CIVTEYAKGGSV------RQFLTRRQNRAVPLKLAV 241
K+ + G + I+ EY + S+ L + +P+++
Sbjct: 101 KNEYCLTCEG------IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 242 KQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET-- 298
V +Y+H HRD+K N+L+ + +K++DFG + +
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES---EYMVDKKIKGSR 211
Query: 299 GTYRWMAP 306
GTY +M P
Sbjct: 212 GTYEFMPP 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-27
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 19/153 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+G++GK+ A+KIL++ + E ++E+ +L L+H N+++
Sbjct: 15 EGSYGKVKEVLDSETLCRRAVKILKK--KKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 201 --FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYV 254
+++M +V EY G + + V QA G+ Y+
Sbjct: 73 DVLYNEEKQKM--YMVMEYCVCGMQEML-----DSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
H G +H+D+K NLL++ ++KI+ GVA
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 7/154 (4%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
R+ G +G F K + + E A KI+ + ++ E+ +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHR 70
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+L H ++V F G +V E + S+ + RR +A+ A + G
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 128
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
Y+H IHRDLK NL ++ D +KI DFG+A
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 7/154 (4%)
Query: 134 LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA 191
R+ G +G F K + + E A KI+ + ++ E+ +
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHR 96
Query: 192 TLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+L H ++V F G +V E + S+ + RR +A+ A + G
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 154
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
Y+H IHRDLK NL ++ D +KI DFG+A
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 26/175 (14%)
Query: 145 QGAFGK-LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFI 202
GA G +YRG ++ DVA+K + PE ++ EV +L +H N++R+
Sbjct: 34 HGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADR----EVQLLRESDEHPNVIRYF 84
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA--VKQALDVARGMAYVHGLGFI 260
+ R I E ++++++ ++ + L+ ++Q G+A++H L +
Sbjct: 85 CTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS---GLAHLHSLNIV 140
Query: 261 HRDLKSDNLLISADKS-----IKIADFGVARIEVQTEG----MTPETGTYRWMAP 306
HRDLK N+LIS + I+DFG+ + + GT W+AP
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 14/182 (7%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
++TID ++G +G FG +Y R N +A+K+L + + E +E Q ++E
Sbjct: 10 KFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG---VEHQLRRE 64
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
+ + + L+H NI+R R ++ E+A G + + L + + + +
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEE 122
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWM 304
+A + Y H IHRD+K +NLL+ +KIADFG + V + T GT ++
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRTMCGTLDYL 179
Query: 305 AP 306
P
Sbjct: 180 PP 181
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 22/175 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GA G++ + VAI+I+ + + + E+ +L L H I++
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 201 FIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
IV E +GG + L + Q L + Y+
Sbjct: 205 IKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYL 255
Query: 255 HGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H G IHRDLK +N+L+S+ D IKI DFG ++I +T M GT ++AP
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-26
Identities = 40/174 (22%), Positives = 81/174 (46%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILER---PENNPEKAQVMEQQFQQEVMMLATLK-HLNI 198
+G + R + ++ A+KI++ + E+ Q + + +EV +L + H NI
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 199 VRFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
++ + +V + K G + + L+ ++ R + ++ L+V +
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-----MRALLEV---IC 138
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H L +HRDLK +N+L+ D +IK+ DFG + E + GT ++AP
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQV----MEQQFQQEVMMLATLKHLNI 198
+G+F +YR + G +VAIK+++ K + M Q+ Q EV + LKH +I
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMID-------KKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 199 VRFIG--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E G + ++L + + + A + GM Y+H
Sbjct: 74 LELYNYFEDSNYVY--LVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVA 285
G +HRDL NLL++ + +IKIADFG+A
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 42/169 (24%), Positives = 84/169 (49%), Gaps = 14/169 (8%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
+GA+G + + + G+ +A+K + R N ++ +++ ++ + + T+ V F
Sbjct: 17 RGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQE----QKRLLMDLDISMRTVDCPFTVTF 71
Query: 202 IGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--KQALDVARGMAYVHG-L 257
GA R+ VW I E S+ +F + ++ + + K A+ + + + ++H L
Sbjct: 72 YGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K N+LI+A +K+ DFG++ V + G +MAP
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 11/165 (6%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G G +++ ++ G +A K++ E P Q +E+ +L IV F
Sbjct: 43 AGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAI----RNQIIRELQVLHECNSPYIVGFY 97
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIH 261
GA I E+ GGS+ Q L ++ +P ++ K ++ V +G+ Y+ +H
Sbjct: 98 GAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 155
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
RD+K N+L+++ IK+ DFGV+ + + + GT +M+P
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 199
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 47/175 (26%), Positives = 73/175 (41%), Gaps = 22/175 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GA G++ + VAIKI+ + + + E+ +L L H I++
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 201 FIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ IV E +GG + L + Q L + Y+
Sbjct: 80 IKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYL 130
Query: 255 HGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H G IHRDLK +N+L+S+ D IKI DFG ++I +T M GT ++AP
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 36/173 (20%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERP--ENNPEKAQVMEQQFQQEVMMLATLK-HLNIV 199
+G + R + G + A+KI+E +PE+ + + + ++E +L + H +I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 200 RFIGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
I + +V + + G + + L+ ++ R++ ++ L+ +++
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MRSLLEA---VSF 215
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H +HRDLK +N+L+ + I+++DFG + E + GT ++AP
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAP 268
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ + ++ A+K++ + + +EV +L L H NI++
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLF 87
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ IV E GG R+ + + +KQ + Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139
Query: 257 LGFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +N+L+ + D IKI DFG++ Q M GT ++AP
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-25
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 18/172 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++ +G + IK + + +++QV +Q + E+ +L +L H NI++
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINK-----DRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAYVHGL 257
IV E +GG + + + Q R L +KQ ++ +AY H
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQ 143
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H+DLK +N+L S IKI DFG+A + E T GT +MAP
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-25
Identities = 39/169 (23%), Positives = 83/169 (49%), Gaps = 13/169 (7%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
+GA+G + + + G+ +A+K + R + ++ ++Q ++ +++ + IV+F
Sbjct: 32 RGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKE----QKQLLMDLDVVMRSSDCPYIVQF 86
Query: 202 IGAC-RKRMVWCIVTEYAKGGSVR--QFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-L 257
GA R+ W I E + +++ + +P ++ K L + + ++ L
Sbjct: 87 YGALFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K N+L+ +IK+ DFG++ V + T + G +MAP
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 194
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G +Y T VAIK + E ++F++EV + L H NIV
Sbjct: 20 GGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEE----TLKRFEREVHNSSQLSHQNIV 74
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
I + + +V EY +G ++ +++ + + + A+ + G+ + H +
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300
+HRD+K N+LI ++K++KI DFG+A+ + +T +T
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLT-QTNH 171
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F K+ G +VAIKI+++ + NP Q+ +EV ++ L H NIV+
Sbjct: 25 KGNFAKVKLARHILTGREVAIKIIDKTQLNPT----SLQKLFREVRIMKILNHPNIVKLF 80
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
++ EYA GG V +L ++ K+A R + Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+HRDLK++NLL+ AD +IKIADFG + T G + G + AP
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGAPPYAAP 182
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI++ ++A + ++E+ + L H N+V+F
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDM-----KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 203 G--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHG 256
G + EY GG + + + A G+ Y+HG
Sbjct: 72 GHRREGNIQ--YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+G HRD+K +NLL+ ++KI+DFG+A +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 40/187 (21%), Positives = 74/187 (39%), Gaps = 35/187 (18%)
Query: 145 QGAFGKL-YRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRFI 202
G+ G + ++G++ G VA+K + E+ ++ + H N++R+
Sbjct: 25 YGSSGTVVFQGSFQGRPVAVKRMLID---------FCDIALMEIKLLTESDDHPNVIRYY 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA-----LDVARGMAYVHGL 257
+ I E +++ + + LKL + +A G+A++H L
Sbjct: 76 CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 258 GFIHRDLKSDNLLISADKS-------------IKIADFGVARIEVQTEG-----MTPETG 299
IHRDLK N+L+S I I+DFG+ + + + +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 300 TYRWMAP 306
T W AP
Sbjct: 195 TSGWRAP 201
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 40/172 (23%), Positives = 75/172 (43%), Gaps = 23/172 (13%)
Query: 144 AQGAFGKLYRGT---YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
A G G +Y NG V +K L + E + E LA + H +IV+
Sbjct: 89 AHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAE----AQAMAMAERQFLAEVVHPSIVQ 143
Query: 201 ------FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+ + IV EY G S+++ ++ +P+ A+ L++ ++Y+
Sbjct: 144 IFNFVEHTDRHGDPVGY-IVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYL 198
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H +G ++ DLK +N++++ ++ +K+ D G G GT + AP
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSF-GYL--YGTPGFQAP 246
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 4e-24
Identities = 43/238 (18%), Positives = 80/238 (33%), Gaps = 44/238 (18%)
Query: 107 DDALAQALMDH-RYPTEGLENYDEWTIDLRKLNMGTAFA-------------QGAFGKLY 152
DD L L+ P N EW L + T F +GAF ++Y
Sbjct: 23 DDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVY 82
Query: 153 RGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205
T N + +K+ + NP + + Q + L ++F A
Sbjct: 83 EATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQ----LMERLKPSMQHMFMKFYSAH 136
Query: 206 RKRMVWCIVTEYAKGGSVRQFLTRRQN---RAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V E G++ + +N + +P L + A+ + + VH IH
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG 196
Query: 263 DLKSDNLLIS-----------ADKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 306
D+K DN ++ + + D G + +++ +G T +
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV 254
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-24
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 30/188 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILER--------------------PENNPEKAQVMEQQ 182
+G++G L + A+K+L + + + +Q
Sbjct: 23 KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82
Query: 183 FQQEVMMLATLKHLNIVRF---IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
QE+ +L L H N+V+ + + +V E G V +
Sbjct: 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKP-LSEDQ 138
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET- 298
A D+ +G+ Y+H IHRD+K NLL+ D IKIADFGV+ ++ + T
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198
Query: 299 GTYRWMAP 306
GT +MAP
Sbjct: 199 GTPAFMAP 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 39/180 (21%), Positives = 82/180 (45%), Gaps = 26/180 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILER-------PENNPEKAQVMEQQFQQEVMMLATLKH 195
GA+G++ + AIK++++ ++ + + ++ E+ +L +L H
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVAR 249
NI++ + + +VTE+ +GG + R + +KQ L
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-----MKQILSG-- 158
Query: 250 GMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+ Y+H +HRD+K +N+L+ ++ +IKI DFG++ + + GT ++AP
Sbjct: 159 -ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-24
Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI++ ++A + ++E+ + L H N+V+F
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDM-----KRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 203 G--ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHG 256
G + EY GG + + + A G+ Y+HG
Sbjct: 72 GHRREGNIQ--YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG 123
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287
+G HRD+K +NLL+ ++KI+DFG+A +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-24
Identities = 37/166 (22%), Positives = 73/166 (43%), Gaps = 11/166 (6%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G G++++ + G +A+K + R N E+ ++ ++ ++L + IV+
Sbjct: 35 SGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEE----NKRILMDLDVVLKSHDCPYIVQC 89
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFI 260
G I E + + L +R +P ++ K + + + + Y+ G I
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K N+L+ IK+ DFG++ V + G +MAP
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 8e-24
Identities = 28/204 (13%), Positives = 48/204 (23%), Gaps = 38/204 (18%)
Query: 135 RKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
RKL + G ++ ED A+K+ N ++ + A
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---ELERLHEATFAAAR 118
Query: 193 LKHLNIVRFIGACRKRMVW--------------------------CIVTEYAKG--GSVR 224
L + R + ++ A +
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 225 QFLTRRQNRAVPLKLAVKQAL--DVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282
L + L + R A + G +H DNL I D + + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 283 GVARIEVQTEGMTPETGTYRWMAP 306
P + AP
Sbjct: 239 SALWKVGTR---GPASSVPVTYAP 259
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 8e-24
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
G +++ + DVA+K+L R + +P +F++E A L H IV
Sbjct: 21 GFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPS----FYLRFRREAQNAAALNHPAIV 75
Query: 200 RF--IGACRKRMVWC--IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
G IV EY G ++R + + K A++ D + + + H
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 300
G IHRD+K N++ISA ++K+ DFG+AR + +T
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 9e-24
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 26/173 (15%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAF +++ G+ A+K +++ + + E+ +L +KH NIV
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKK------SPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V + GG R T + V ++Q L + Y+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSA---VKYLHE 124
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HRDLK +NLL + I I DFG++++E Q M+ GT ++AP
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAP 176
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-24
Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ G++ A+K++ + K + ++ +EV +L L H NI++
Sbjct: 36 KGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E GG + R+ + + ++Q L + Y+H
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-----IRQVLSG---ITYMHK 144
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +NLL+ S D +I+I DFG++ ++ M + GT ++AP
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 42/174 (24%), Positives = 70/174 (40%), Gaps = 27/174 (15%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQV-MEQQFQQEVMMLATLKHLNIVRF 201
+G++G++ A K + K V +F+QE+ ++ +L H NI+R
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIP-------KYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 202 IGACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+V E GG ++ + +K L +AY H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLSA---VAYCH 123
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
L HRDLK +N L S D +K+ DFG+A + M + GT +++P
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G++ + AIKI+ + + + +EV +L L H NI++
Sbjct: 47 SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLY 102
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + +V E KGG + R + +KQ L + Y+H
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVLSG---VTYLHK 154
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +NLL+ D IKI DFG++ + + M GT ++AP
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-23
Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FGK+ G G VA+KIL R + + + ++E+ L +H +I++
Sbjct: 21 VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD---VVGKIKREIQNLKLFRHPHIIKLY 77
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+ +V EY GG + ++ + ++ +A + + + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRHM 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK +N+L+ A + KIADFG++ +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNM 160
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R G + A KI+ + + Q+ ++E + L+H NIVR
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH 71
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ +V + GG R+F + ++Q L+ +AY H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAYCHS 123
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HR+LK +NLL+ + ++K+ADFG+A +E GT +++P
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-23
Identities = 39/174 (22%), Positives = 75/174 (43%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G++ A K +++ + + V ++ ++EV +L ++H NI+
Sbjct: 15 SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ E GG + ++ LT + +KQ LD G+ Y+H
Sbjct: 75 DIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYLHS 126
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H DLK +N+++ + IK+ DFG+A GT ++AP
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FG++ + ++ A+K++ + + +EV +L L H NI++
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLF 87
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ IV E GG + R+ + + +KQ + Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +N+L+ D IKI DFG++ Q M GT ++AP
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-23
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 33/176 (18%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FG R E VA+K +E + +++ Q+E++ +L+H NIVRF
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--------GMAYV 254
I+ EYA GG + + + + + D AR G++Y
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNAG------RFSE----DEARFFFQQLLSGVSYC 132
Query: 255 HGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
H + HRDLK +N L+ + +KI DFG ++ P++ GT ++AP
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAYIAP 186
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-23
Identities = 39/174 (22%), Positives = 74/174 (42%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G + A K +++ ++ + V ++ ++EV +L + H NI+
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
R ++ E GG + ++ L+ + + +KQ LD G+ Y+H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYLHT 133
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H DLK +N+++ IK+ DFG+A GT ++AP
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-23
Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G + A K +++ ++ + V ++ ++EV +L + H N++
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
R ++ E GG + ++ L+ + + +KQ LD G+ Y+H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYLHT 133
Query: 257 LGFIHRDLKSDNLLI----SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H DLK +N+++ IK+ DFG+A GT ++AP
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 27/173 (15%)
Query: 145 QGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA +YR + A+K+L++ + ++ + E+ +L L H NI++
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLK 114
Query: 203 GACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+V E GG + + + + R VKQ L+ +AY+H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILEA---VAYLHE 166
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HRDLK +NLL + D +KIADFG+++I M GT + AP
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 35/222 (15%), Positives = 77/222 (34%), Gaps = 15/222 (6%)
Query: 100 KVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLN-MGTAFAQGAFGKLYRGTYNG 158
+ + ++D A + E L KL G A+ + +
Sbjct: 24 EAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83
Query: 159 EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYA 218
E I + + + P + ++ + N V + ++ I +
Sbjct: 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143
Query: 219 KGGSVRQFLTRRQNRAVP-LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ +++ ++ RR + + + + +A + ++H G +HRDLK N+ + D +
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 203
Query: 278 KIADFGVARI-------------EVQTEGMTPETGTYRWMAP 306
K+ DFG+ T + GT +M+P
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R + G + A KI+ + + Q+ ++E + L+H NIVR
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH 94
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ +V + GG R+F + ++Q L+ +AY H
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAYCHS 146
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G +HR+LK +NLL+ + ++K+ADFG+A +E GT +++P
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 39/174 (22%), Positives = 71/174 (40%), Gaps = 20/174 (11%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G A K +++ + V + ++EV +L ++H N++
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ ++ E GG + ++ LT + +KQ L+ G+ Y+H
Sbjct: 81 EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GVYYLHS 132
Query: 257 LGFIHRDLKSDNLLIS----ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
L H DLK +N+++ IKI DFG+A GT ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 48/209 (22%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG++G + AIKI+ + + + +E+ + EV ++ L H NI R
Sbjct: 36 QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHHPNIARLY 94
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV--------------------- 241
C+V E GG + L + +
Sbjct: 95 EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154
Query: 242 -------------KQALDVAR----GMAYVHGLGFIHRDLKSDNLLISADKS--IKIADF 282
K ++ R + Y+H G HRD+K +N L S +KS IK+ DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 283 GVARI-----EVQTEGMTPETGTYRWMAP 306
G+++ + GMT + GT ++AP
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-22
Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 21/173 (12%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPE--NNPEKAQVMEQQFQQEVMMLATLKHLNIV 199
+G G +Y T VA+K++ ++P + Q+E L+ ++V
Sbjct: 43 GRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPV----FRTRMQREARTAGRLQEPHVV 97
Query: 200 RF--IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
G ++ + G + L R+ + AV + + H
Sbjct: 98 PIHDFGE-IDGQLY-VDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
G HRD+K +N+L+SAD + DFG+A E +T + GT +MAP
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLT-QLGNTVGTLYYMAP 204
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G + + G VAIK LE ++ K M +E+ +L L+H N+V
Sbjct: 35 EGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-----REIKLLKQLRHENLVNL 89
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
+ C+K+ W +V E+ ++ L N ++ + Q + G+ + H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCHSHNI 145
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT--YRWMAP 306
IHRD+K +N+L+S +K+ DFG AR + E E T YR AP
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--AP 193
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 29/171 (16%), Positives = 63/171 (36%), Gaps = 22/171 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG ++R + + K ++ + ++E+ +L +H NI+
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVK-------VKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGL 257
+ ++ E+ G + + + V V Q + + ++H
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY---VHQVCE---ALQFLHSH 121
Query: 258 GFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
H D++ +N++ +S IKI +FG AR + + AP
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-22
Identities = 34/145 (23%), Positives = 65/145 (44%), Gaps = 8/145 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL--NIVR 200
G FG +Y G + VAIK +E+ + + EV++L + ++R
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 201 FIGACRKRMVWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + ++ E + + F+T R + +LA V + + H G
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGV 170
Query: 260 IHRDLKSDNLLISADK-SIKIADFG 283
+HRD+K +N+LI ++ +K+ DFG
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFG 195
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-22
Identities = 50/170 (29%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+G++G +++ G+ VAIK LE ++ K + +E+ ML LKH N+V
Sbjct: 13 EGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-----REIRMLKQLKHPNLVNL 67
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGF 259
+ R++ +V EY +V L R Q +K Q L + + + H
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHKHNC 123
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT--YRWMAP 306
IHRD+K +N+LI+ IK+ DFG AR + ++ E T YR +P
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SP 171
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-22
Identities = 34/146 (23%), Positives = 68/146 (46%), Gaps = 7/146 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKIL--ERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
GAFG ++ ++V +K + E+ + + E+ +L+ ++H NI++
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93
Query: 201 FIGACRKRMVWCIVTE-YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + +V E + G + F+ R + LA + + Y+
Sbjct: 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 260 IHRDLKSDNLLISADKSIKIADFGVA 285
IHRD+K +N++I+ D +IK+ DFG A
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK+ T + VA+K + R M + ++E+ L L+H +I++
Sbjct: 19 EGSFGKVKLATHYKTQQKVALKFISRQLLKKSD---MHMRVEREISYLKLLRHPHIIKLY 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+V EYA GG + ++ ++ ++ + + + Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
+HRDLK +NLL+ + ++KIADFG++ I
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 15/149 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FGK+ G G VA+KIL R + + + ++E+ L +H +I++
Sbjct: 26 VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD---VVGKIRREIQNLKLFRHPHIIKLY 82
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR----GMAYVHGLG 258
+V EY GG + ++ + +L K++ + + G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRHM 136
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI 287
+HRDLK +N+L+ A + KIADFG++ +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNM 165
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 34/173 (19%), Positives = 71/173 (41%), Gaps = 25/173 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R T G + A K + + ++ ++E+ ++ L+H +V
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFV------MTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 203 GACRKRMVWCIVTEYAKGG-------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
A ++ E+ GG ++ + ++Q G+ ++H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQVCK---GLCHMH 272
Query: 256 GLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++H DLK +N++ + +K+ DFG+ + + TGT + AP
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 40/174 (22%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GAF + R G++ A I+ + + Q+ ++E + LKH NIVR
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLH 76
Query: 203 GACRKRMVWCIVTEYAKGG------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + ++ + GG R++ + ++Q L+ + + H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEA---VLHCHQ 128
Query: 257 LGFIHRDLKSDNLLI---SADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
+G +HR+LK +NLL+ ++K+ADFG+A +E + + GT +++P
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 34/171 (19%), Positives = 69/171 (40%), Gaps = 21/171 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R G K + + + + E+ ++ L H ++
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFI------NTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNR-----AVPLKLAVKQALDVARGMAYVHGL 257
A + ++ E+ GG + + + + ++QA + G+ ++H
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY---MRQACE---GLKHMHEH 168
Query: 258 GFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H D+K +N++ K+ +KI DFG+A E + T T + AP
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 30/205 (14%), Positives = 64/205 (31%), Gaps = 39/205 (19%)
Query: 135 RKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT 192
R L GT Q T GE + + E P A +Q ++EV+ L
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAI---KQMKEEVLRLRL 134
Query: 193 L----------------------KHLNIVRFIGACRKRMVWCIVTEY-------AKGGSV 223
L K + I +++ + + +
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 224 RQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281
+ L ++++ ++ L V R +A +H G +H L+ ++++ + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 282 FGVARIEVQTEGMTPETGTYRWMAP 306
F + ++P + P
Sbjct: 255 FEHLVRD-GASAVSPIGRGF--APP 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 4e-21
Identities = 35/259 (13%), Positives = 77/259 (29%), Gaps = 36/259 (13%)
Query: 78 PGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKL 137
PG + ++ +V + + D ++ +L + P E R L
Sbjct: 19 PGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERP---RTL 75
Query: 138 NMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQ------------------ 177
GT Q T GE + + E P A
Sbjct: 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 178 ----VMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEY----AKGGSVRQFLTR 229
+ +F ++ + ++R R V Y + + + L
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 230 --RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287
++++ ++ L V R +A +H G +H L+ ++++ + + F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL-- 253
Query: 288 EVQTEGMTPETGTYRWMAP 306
V+ + + + P
Sbjct: 254 -VRDGARVVSSVSRGFEPP 271
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 25/173 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G FG++++ G +A KI+ + +++ + E+ ++ L H N+++
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKII------KTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 203 GACRKRMVWCIVTEYAKGG-------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
A + +V EY GG LT +KQ + G+ ++H
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-----MKQICE---GIRHMH 204
Query: 256 GLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+ +H DLK +N+L K IKI DFG+AR E + GT ++AP
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 37/173 (21%), Positives = 68/173 (39%), Gaps = 15/173 (8%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F + R G+ A+KI++ + + ++E + LKH +IV +
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDV-AKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAYVHGL 257
+ +V E+ G + + +R + ++Q L+ + Y H
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHDN 149
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
IHRD+K +L+ +K+ FGVA + GT +MAP
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 37/176 (21%), Positives = 69/176 (39%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-NIVRF 201
+G F + + G++ A K L++ + + E+ +L K ++
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINL 94
Query: 202 IGACRKRMVWCIVTEYAKGG--------SVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
++ EYA GG + + ++ + +KQ L+ G+ Y
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE---GVYY 146
Query: 254 VHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+H +H DLK N+L+ IKI DFG++R + GT ++AP
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 36/180 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQ-EVMMLATLKHLNIVR 200
G+FG +Y+ +GE VAIK +L+ +++F+ E+ ++ L H NIVR
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQ------------DKRFKNRELQIMRKLDHCNIVR 111
Query: 201 ----FIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVAR 249
F + K+ + V +Y +V + L KL + Q R
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF---R 167
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGT--YRWMAP 306
+AY+H G HRD+K NLL+ D +K+ DFG A+ V+ E + YR AP
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--AP 225
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-20
Identities = 20/145 (13%), Positives = 46/145 (31%), Gaps = 9/145 (6%)
Query: 144 AQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+ ++ T VA+ ++ P+ Q+ + L+ + + R
Sbjct: 40 GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVL---QETLSRTLRLSRIDKPGVARV 96
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ R +V E+ +GGS+++ A++ +A H G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 262 RDLKSDNLLISADKSIKIADFGVAR 286
+ +S D + +A
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-20
Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 34/182 (18%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+GA ++ ++ A+KI+E+ + + + +EV ML + H N++
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEK------QPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
I + + +V E +GGS+ R+ + V V+ VA + ++H
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQD---VASALDFLH 128
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARI--------EVQTEGMTPETGTYRWM 304
G HRDLK +N+L + +KI DF + + T + G+ +M
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 305 AP 306
AP
Sbjct: 189 AP 190
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 31/147 (21%), Positives = 59/147 (40%), Gaps = 10/147 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL----KHLNI 198
+G FG ++ G + VAIK++ R EV +L + H +
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 199 VRFIGACRKRMVWCIVTEYA-KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+R + + + +V E + ++T + + + V + + H
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR 158
Query: 258 GFIHRDLKSDNLLISADK-SIKIADFG 283
G +HRD+K +N+LI + K+ DFG
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFG 185
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG++++ G+ VA+K + EN E + + E+ +L LKH N+V I
Sbjct: 27 QGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALR---EIKILQLLKHENVVNLI 82
Query: 203 GACRKRMVWC--------IVTEYA----KG--GSVRQFLTRRQNRAVPLKLAVKQALDVA 248
CR + +V ++ G +V T + +K ++ L
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-----IKRVMQMLL--- 134
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-----IEVQTEGMTPETGT--Y 301
G+ Y+H +HRD+K+ N+LI+ D +K+ADFG+AR Q T T Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 302 RWMAP 306
R P
Sbjct: 195 R--PP 197
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 40/172 (23%), Positives = 67/172 (38%), Gaps = 22/172 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ G+ A+K+L +QEV +IV
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYDSPK-----------ARQEVDHHWQASGGPHIVCI 87
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + I+ E +GG + + R ++A + A + D+ + ++H
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +NLL D +K+ DFG A+ Q TP T ++AP
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAP 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 39/175 (22%), Positives = 77/175 (44%), Gaps = 30/175 (17%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+G+F + + + A+KI+ + ME Q+E+ L + H NIV+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKR---------MEANTQKEITALKLCEGHPNIVKL 71
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
++ +V E GG + ++ + + + +++ + ++++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSHMH 123
Query: 256 GLGFIHRDLKSDNLLI---SADKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 306
+G +HRDLK +NLL + + IKI DFG AR+ + + T + AP
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 37/180 (20%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK--ILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G+FG +++ + E VAIK + ++ N +E+ ++ +KH N+V
Sbjct: 50 NGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN------------RELQIMRIVKHPNVVD 96
Query: 201 ----FIGACRKRMVWCI--VTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVAR 249
F K+ + V EY +V + + KL + Q L R
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL---R 152
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 306
+AY+H +G HRD+K NLL+ +K+ DFG A+I + E + YR AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--AP 210
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 21/172 (12%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ + E A+K+L+ + ++EV + + +IVR
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 120
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +NLL + +K+ DFG A+ +T T ++AP
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 50/228 (21%), Positives = 99/228 (43%), Gaps = 28/228 (12%)
Query: 88 SVSVGQSVFRPGKVTHALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGA 147
++ Q + V++ ++++ +D+++ + + +T+ ++ GA
Sbjct: 17 KIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEV-GDSTFTVL-KRYQNLKPIGSGA 74
Query: 148 FGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR----F 201
G + +VAIK L RP N A+ + +E++++ + H NI+ F
Sbjct: 75 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK----RAYRELVLMKCVNHKNIISLLNVF 130
Query: 202 IGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
V+ +V E ++ L + + + Q L G+ ++H
Sbjct: 131 TPQKTLEEFQDVY-LVMELMDANLCQVIQMELDHERMSYL-----LYQML---CGIKHLH 181
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
G IHRDLK N+++ +D ++KI DFG+AR + MTP T R+
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT-RY 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-18
Identities = 63/194 (32%), Positives = 85/194 (43%), Gaps = 36/194 (18%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIK--ILERPENNPEKAQVM 179
+E Y + L KL +G + +Y+G VA+K LE E P A
Sbjct: 1 METYIK----LDKLG------EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-- 48
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--L 237
+EV +L LKH NIV +V EY ++Q+L N +
Sbjct: 49 -----REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNV 102
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGM 294
KL + Q L RG+AY H +HRDLK NLLI+ +K+ADFG+AR I +T
Sbjct: 103 KLFLFQLL---RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--Y 157
Query: 295 TPETGT--YRWMAP 306
E T YR P
Sbjct: 158 DNEVVTLWYR--PP 169
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-18
Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 31/178 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-I-LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G + +Y+G G VA+K + L+ E P A +E+ ++ LKH NIVR
Sbjct: 15 NGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-------REISLMKELKHENIVR 67
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP-------LKLAVKQALDVARGMAY 253
+V E+ +++++ R P +K Q L +G+A+
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QGLAF 123
Query: 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
H +HRDLK NLLI+ +K+ DFG+AR I V T + E T YR AP
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYR--AP 177
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 46/214 (21%), Positives = 94/214 (43%), Gaps = 15/214 (7%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-F------AQGAFGK--LYRG 154
++ + A L +Y + L+ + + L+++ + F +GAF + + +
Sbjct: 23 GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKM 82
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIV 214
G+ A+KI+ + ++ +V F++E +L I + A + +V
Sbjct: 83 KQTGQVYAMKIM-NKWDMLKRGEV--SCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139
Query: 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD 274
EY GG + L + +P ++A ++ + VH LG++HRD+K DN+L+
Sbjct: 140 MEYYVGGDL-LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC 198
Query: 275 KSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
I++ADFG + GT +++P
Sbjct: 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G++ R + A+KI+++ + +P +E+ ++L +H NI+
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----------TEEIEILLRYGQHPNIITL 81
Query: 202 IGACRKRMVWCIVTEYAKGGSV------RQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
+VTE KGG + ++F + R+ AV + + + + Y+H
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFT---ITKTVEYLH 133
Query: 256 GLGFIHRDLKSDNLLISADK----SIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
G +HRDLK N+L + SI+I DFG A+ + + + T ++AP
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 22/163 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRF 201
G GK+ + E A+K+L+ ++EV + +IVR
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQDCPK-----------ARREVELHWRASQCPHIVRI 76
Query: 202 IGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 258 GFIHRDLKSDNLLI---SADKSIKIADFGVARIEVQTEGMTPE 297
HRD+K +NLL + +K+ DFG A+ E E
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTGEKYDKS 178
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 54/172 (31%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +Y+ GE VA+K + R + E +E+ +L L H NIV+ +
Sbjct: 13 EGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPS---TAIREISLLKELNHPNIVKLL 68
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGMAYVHGLGF 259
+V E+ +++F+ +PL K + Q L +G+A+ H
Sbjct: 69 DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL---QGLAFCHSHRV 124
Query: 260 IHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK NLLI+ + +IK+ADFG+AR + V+T T E T YR AP
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYR--AP 172
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 27/187 (14%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQE 186
+T+ R N+ GA G + +VAIK L RP N A+ + +E
Sbjct: 20 TFTVLKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK----RAYRE 74
Query: 187 VMMLATLKHLNIVR----FIGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVP 236
++++ + H NI+ F V+ IV E ++ L +
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHER----- 128
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
+ + Q L G+ ++H G IHRDLK N+++ +D ++KI DFG+AR + MTP
Sbjct: 129 MSYLLYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185
Query: 297 ETGTYRW 303
T R+
Sbjct: 186 YVVT-RY 191
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 47/218 (21%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-FA------QGAFGK--LYRG 154
L D+ L + E LE +T ++++ + F +GAFG+ + +
Sbjct: 36 CLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKL 95
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIVRFIGACRKRMV 210
+ A+KIL K +++++ F++E +L I A +
Sbjct: 96 KNADKVFAMKILN-------KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V +Y GG + L + +P ++A ++ + VH L ++HRD+K DN+L
Sbjct: 149 LYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207
Query: 271 ISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ + I++ADFG ++ + GT +++P
Sbjct: 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 28/171 (16%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + +GE VAIK L RP + A+ + +E+++L ++H N++
Sbjct: 34 SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK----RAYRELLLLKHMQHENVIGLL 89
Query: 201 --FIGACRKRM---VWCIVTEYAK---GGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
F A R + +V + + + + + ++ V Q L +G+
Sbjct: 90 DVFTPASSLRNFYDFY-LVMPFMQTDLQKIMGLKFSEEK-----IQYLVYQML---KGLK 140
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
Y+H G +HRDLK NL ++ D +KI DFG+AR MT T RW
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVT-RW 188
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 4e-17
Identities = 55/174 (31%), Positives = 80/174 (45%), Gaps = 28/174 (16%)
Query: 145 QGAFGKLYRGTYN-GEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLATLKHLNIV 199
+G +G +Y+ N GE A+K + R E E +E+ +L LKH NIV
Sbjct: 12 EGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTI-------REISILKELKHSNIV 63
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGL 257
+ + +V E+ +++ L + K + Q L G+AY H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR 119
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK NLLI+ + +KIADFG+AR I V+ T E T YR AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYR--AP 169
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 39/176 (22%), Positives = 72/176 (40%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQ-----EVMMLATLKHLNI 198
G++G + G + G VAIK + ++ ++ F E+ +L H NI
Sbjct: 32 SGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91
Query: 199 VR----FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDV 247
+ F+ M ++ +VTE + Q + ++ + + + + L
Sbjct: 92 LGLRDIFVHFEEPAMHKLY-LVTELM-RTDLAQVIHDQR---IVISPQHIQYFMYHIL-- 144
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
G+ +H G +HRDL N+L++ + I I DF +AR + T RW
Sbjct: 145 -LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH-RW 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-17
Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +++ E VA+K + R +++ E +E+ +L LKH NIVR
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPS---SALREICLLKELKHKNIVRLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGFI 260
+V E+ ++++ P +K + Q L +G+ + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSRNVL 123
Query: 261 HRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
HRDLK NLLI+ + +K+A+FG+AR I V+ + E T YR P
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYR--PP 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 20/170 (11%)
Query: 145 QGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G +G +Y+ G VA+K + R + E +E+ +L L H NIV I
Sbjct: 31 EGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPS---TAIREISLLKELHHPNIVSLID 86
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP--LKLAVKQALDVARGMAYVHGLGFIH 261
+V E+ + +++ L + +K+ + Q L RG+A+ H +H
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQHRILH 142
Query: 262 RDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
RDLK NLLI++D ++K+ADFG+AR I V++ T E T YR AP
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYR--AP 188
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-17
Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 22/177 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIV 199
GA+G +Y+ ++G VA+K + R N + +EV +L L+ H N+V
Sbjct: 19 VGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77
Query: 200 RFIGACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVPL---KLAVKQALDVARGM 251
R + C +V E+ +R +L + +P K ++Q L RG+
Sbjct: 78 RLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL---RGL 133
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT--YRWMAP 306
++H +HRDLK +N+L+++ ++K+ADFG+ARI +TP T YR AP
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR--AP 188
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 9e-17
Identities = 43/180 (23%), Positives = 73/180 (40%), Gaps = 36/180 (20%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
+G+F L R + AIKILE K ++++ V +++ L H
Sbjct: 40 EGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVAR--------G 250
V+ + YAK G + +++ + R
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIVSA 142
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
+ Y+HG G IHRDLK +N+L++ D I+I DFG A+ + E GT ++++P
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYVSP 201
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-17
Identities = 42/174 (24%), Positives = 82/174 (47%), Gaps = 24/174 (13%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ + VAIK + + + E + + +E+ +L L H NI+ +
Sbjct: 20 EGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-VK----QALDVARGMAYVHGL 257
A + +V ++ + + + ++ ++ L + +K L +G+ Y+H
Sbjct: 79 DAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYMLMTL---QGLEYLHQH 131
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 306
+HRDLK +NLL+ + +K+ADFG+A+ + T + T YR AP
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYR--AP 181
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 20/186 (10%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED-------VAIKILERPENNPEKAQV 178
+ +W +L +G +GAFG++ G D VA+K+L+ + E
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 69
Query: 179 MEQQFQQEV-MMLATLKHLNIVRFIGACRKRMV-WCIVTEYAKGGSVRQFLTRRQNRAVP 236
+ E+ +++ HLN+V +GAC K ++ E+ K G++ +L ++N VP
Sbjct: 70 --RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTP 296
K + +G Y +G I DLK I++ +S + F + E
Sbjct: 128 YKT---KGARFRQGKDY---VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181
Query: 297 ETGTYR 302
Y+
Sbjct: 182 PEDLYK 187
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 6e-14
Identities = 24/70 (34%), Positives = 36/70 (51%), Gaps = 11/70 (15%)
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-------EVQTEGMTP 296
+ VA+GM ++ IHRDL + N+L+S +KI DFG+AR + + P
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 297 ETGTYRWMAP 306
+WMAP
Sbjct: 259 ----LKWMAP 264
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 36/159 (22%), Positives = 70/159 (44%), Gaps = 22/159 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
+G+FG++ + + VA+K++ N +Q +E+ +L L+
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVR---NEKR----FHRQAAEEIRILEHLRKQDKDNTM 159
Query: 197 NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
N++ + R + C+ E ++ + + + + + L L K A + + + +
Sbjct: 160 NVIHMLENFTFRNHI--CMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 255 HGLGFIHRDLKSDN-LLISADKS-IKIADFGVARIEVQT 291
H IH DLK +N LL +S IK+ DFG + E Q
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 48/186 (25%), Positives = 75/186 (40%), Gaps = 42/186 (22%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQ----QEVMMLATLKHLN 197
QG FG + G G VAIK +++ P +F+ Q + LA L H N
Sbjct: 33 QGTFGTVQLGKEKSTGMSVAIKKVIQDP------------RFRNRELQIMQDLAVLHHPN 80
Query: 198 IVR----FIGACRKRMV---WCIVTEYAKGGSVRQFLTRRQNRAVPLKLA-VK----QAL 245
IV+ F + +V EY ++ + R V +K Q +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 246 DVARGMAYVH--GLGFIHRDLKSDNLLI-SADKSIKIADFGVARIEVQTEGMTPETGT-- 300
R + +H + HRD+K N+L+ AD ++K+ DFG A+ +E +
Sbjct: 140 ---RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 301 YRWMAP 306
YR AP
Sbjct: 197 YR--AP 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 104 ALNDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTA-FA------QGAFGK--LYRG 154
AL D AL ++ L Y + +R L M + +GAFG+ L R
Sbjct: 31 ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90
Query: 155 TYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNIVRFIGACRKRMV 210
+ A+K+L K +++++ F +E ++A +V+ A +
Sbjct: 91 KSTRKVYAMKLLS-------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143
Query: 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270
+V EY GG + N VP K A +V + +H +GFIHRD+K DN+L
Sbjct: 144 LYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200
Query: 271 ISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
+ +K+ADFG + + +T GT +++P
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-16
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 30/162 (18%)
Query: 145 QGAFGKLYRG----TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
+G +G +Y+ + +D A+K +E A +E+ +L LKH N++
Sbjct: 31 RGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSAC-------REIALLRELKHPNVIS 82
Query: 201 FIGACRKRMVWCI--VTEYA----KGGSVRQFLTRRQNRAVPLKLA-VK----QALDVAR 249
+ + +YA ++ + V L VK Q L
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---D 139
Query: 250 GMAYVHGLGFIHRDLKSDNLLISADKS----IKIADFGVARI 287
G+ Y+H +HRDLK N+L+ + +KIAD G AR+
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 37/208 (17%), Positives = 78/208 (37%), Gaps = 60/208 (28%)
Query: 145 QGAFGKLYRG--TYNGEDVAIK-ILERPENNPEKAQVMEQQFQQ-EVMMLATLKHLNIVR 200
G+FG + +G+ A+K +L+ + +++ E+ ++ L H+NI++
Sbjct: 17 TGSFGIVCEVFDIESGKRFALKKVLQ------------DPRYKNRELDIMKVLDHVNIIK 64
Query: 201 ----FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA---------------- 240
F + + + +++V + +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 241 ---------VKQALDVA----------RGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIA 280
+++ + R + ++H LG HRD+K NLL+ S D ++K+
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 281 DFGVARIEVQTEGMTPETGT--YRWMAP 306
DFG A+ + +E + YR AP
Sbjct: 185 DFGSAKKLIPSEPSVAYICSRFYR--AP 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 41/183 (22%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPE----KAQVMEQQFQQEVMMLATLKHLNI 198
+G +G++Y+ T E VAIK + R E+ E A +EV +L L+H NI
Sbjct: 44 EGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAI-------REVSLLKELQHRNI 95
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGMAY 253
+ ++ EY L + ++ + K + Q + G+ +
Sbjct: 96 IELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLI---NGVNF 147
Query: 254 VHGLGFIHRDLKSDNLLISADKS-----IKIADFGVAR---IEVQTEGMTPETGT--YRW 303
H +HRDLK NLL+S + +KI DFG+AR I ++ T E T YR
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYR- 204
Query: 304 MAP 306
P
Sbjct: 205 -PP 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 7e-16
Identities = 53/264 (20%), Positives = 101/264 (38%), Gaps = 32/264 (12%)
Query: 60 VDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFRPGKVTHALNDDALAQALMDHRY 119
N + L + + + +F+ L + L+ A
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQE---LTRLTHEYLSVAPFADYL 162
Query: 120 PTEGLENYDEWT-IDLRKLNMGTAFA------QGAFGKLY----RGTYNGEDVAIKILER 168
+ + +W ++ + + T F +G FG++ R T G+ A K LE
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNT-FRQYRVLGKGGFGEVCACQVRAT--GKMYACKKLE- 218
Query: 169 PENNPEKAQVMEQQFQQEVM----MLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVR 224
K ++ +++ + + +L + +V A + C+V GG ++
Sbjct: 219 ------KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 225 QFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284
+ P AV A ++ G+ +H ++RDLK +N+L+ I+I+D G+
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332
Query: 285 ARIEVQTEGMTPET--GTYRWMAP 306
A V EG T + GT +MAP
Sbjct: 333 AV-HV-PEGQTIKGRVGTVGYMAP 354
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 22/184 (11%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE 186
W + ++ GA+G + G VAIK L RP + A+ + +E
Sbjct: 20 AWEVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK----RAYRE 74
Query: 187 VMMLATLKHLNIVR----FIGACRKRM---VWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 239
+ +L ++H N++ F + +V + G + + + + ++
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFY-LVMPFM-GTDLGKLMKHEKLGEDRIQF 132
Query: 240 AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 299
V Q L +G+ Y+H G IHRDLK NL ++ D +KI DFG+AR MT
Sbjct: 133 LVYQML---KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVV 187
Query: 300 TYRW 303
T RW
Sbjct: 188 T-RW 190
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 31/167 (18%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVR- 200
+G + +++ N E V +KIL +P V +++ ++E+ +L L+ NI+
Sbjct: 46 RGKYSEVFEAINITNNEKVVVKIL-KP--------VKKKKIKREIKILENLRGGPNIITL 96
Query: 201 ---FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ +V E+ +Q + + + + + L + + Y H +
Sbjct: 97 ADIVKDPVSRTPA--LVFEHVNNTDFKQLYQTLTDYDI--RFYMYEIL---KALDYCHSM 149
Query: 258 GFIHRDLKSDNLLI-SADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
G +HRD+K N++I + +++ D+G+A + + R+
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RY 195
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 21/168 (12%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
GA+G + T G VA+K L RP + A+ + +E+ +L +KH N++
Sbjct: 39 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYRELRLLKHMKHENVIGLL 94
Query: 201 --FIGACRKRM---VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
F A V+ +VT G + + ++ ++ + Q L RG+ Y+H
Sbjct: 95 DVFTPARSLEEFNDVY-LVTHLM-GADLNNIVKCQKLTDDHVQFLIYQIL---RGLKYIH 149
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
IHRDLK NL ++ D +KI DFG+AR + MT T RW
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVAT-RW 194
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 39/170 (22%), Positives = 75/170 (44%), Gaps = 19/170 (11%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQ----FQQEVMMLATLKHLNI 198
+G+FGK + + + A+K + K + +E+ +E+ ++ L+H +
Sbjct: 25 KGSFGKVCIVQKNDTKKMYAMKYMN-------KQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 199 VRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
V + + M +V + GG +R L +QN + ++ + Y+
Sbjct: 78 VNLWYSFQDEEDM--FMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMALDYLQN 133
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRD+K DN+L+ + I DF +A + + +T GT +MAP
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 23/170 (13%)
Query: 146 GAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNIV 199
G+FG+ L + +G A+KIL+ K +V++ + + E +L + +V
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILD-------KQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ + + +V EY GG + F R+ A A + Y+H L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 260 IHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 306
I+RDLK +NLLI I++ DFG A R++ +T + TPE +AP
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE---A--LAP 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 18/172 (10%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLNI 198
+G FG+ + G+ A K L K ++ +++ Q M +LA + I
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLN-------KKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHG 256
V A + C+V GG +R + N A+ + G+ ++H
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
I+RDLK +N+L+ D +++I+D G+A E++ + GT +MAP
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFMAP 358
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 25/172 (14%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQ-----EVMMLATLKHLN 197
G+FG+ L R +NG A+K+L+ K V+ + Q E +ML+ + H
Sbjct: 16 TGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVRLK-QVEHTNDERLMLSIVTHPF 67
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
I+R G + ++ +Y +GG + L R+ R P +A A +V + Y+H
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQR-FPNPVAKFYAAEVCLALEYLHSK 125
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 306
I+RDLK +N+L+ + IKI DFG A + T + TP+ Y +AP
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD---Y--IAP 172
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 44/212 (20%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT---YNGEDVAIKILERPEN 171
M+ + Y+ + ++ +GA+GK+++ G VA+K + R +
Sbjct: 1 MEKDGLCRADQQYEC----VAEIG------EGAYGKVFKARDLKNGGRFVALKRV-RVQT 49
Query: 172 N----PEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWC-----IVTEYAK 219
P +EV +L L+ H N+VR C +V E+
Sbjct: 50 GEEGMPLSTI-------REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD 102
Query: 220 GGSVRQFLTRRQNRAVPL---KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276
+ +L + VP K + Q L RG+ ++H +HRDLK N+L+++
Sbjct: 103 Q-DLTTYLDKVPEPGVPTETIKDMMFQLL---RGLDFLHSHRVVHRDLKPQNILVTSSGQ 158
Query: 277 IKIADFGVARIEVQTEGMTPETGT--YRWMAP 306
IK+ADFG+ARI +T T YR AP
Sbjct: 159 IKLADFGLARIYSFQMALTSVVVTLWYR--AP 188
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 32/175 (18%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
G++G + VAIK + R + + + +E+ +L L H ++V+
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI----LREIAILNRLNHDHVVKVL 118
Query: 201 --FIGACRKRM--VWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
I ++ ++ +V E A + +LT +K + L
Sbjct: 119 DIVIPKDVEKFDELY-VVLEIADSDFKKLFRTP---VYLTELH-----IKTLLYNLL--- 166
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
G+ YVH G +HRDLK N L++ D S+K+ DFG+AR E +
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 6e-14
Identities = 40/231 (17%), Positives = 71/231 (30%), Gaps = 59/231 (25%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKI--LERPENN 172
H PTE L+ K+ +G FG++++ + VAIKI +E P+
Sbjct: 13 FSHCLPTEKLQR-------CEKI------GEGVFGEVFQTIADHTPVAIKIIAIEGPDLV 59
Query: 173 PEKAQVMEQQFQQEVMMLATLKHL---------NIVRFIGAC------------------ 205
Q ++ E+++ L L +
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 206 ------------RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
K IV E+ GG + + + + K + Q + +A
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQ---LTASLAV 176
Query: 254 VH-GLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYR 302
L F HRDL N+L+ K+ + + + G+ Y
Sbjct: 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-14
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 28/175 (16%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G FGK L R G A+KIL K ++ + + + L +H
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILR-------KEVIIAKD-EVAHTVTESRVLQNTRHPF 66
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ A + C V EYA GG + F + R + A ++ + Y+H
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
++RD+K +NL++ D IKI DFG+ + EG++ GT ++AP
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAP 174
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-14
Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 24/174 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRF 201
G+FG +Y GT GE+VAIK+ E + Q E + ++ + I
Sbjct: 19 SGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V E G S+ L +R LK + A + + Y+H FIH
Sbjct: 71 RWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128
Query: 262 RDLKSDNLLISADK---SIKIADFGVAR--IEVQTEGMTPE------TGTYRWM 304
RD+K DN L+ K + I DFG+A+ + +T P TGT R+
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 45/175 (25%), Positives = 72/175 (41%), Gaps = 26/175 (14%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+G++G +Y ++VAIK + R + + + +E+ +L LK I+R
Sbjct: 36 RGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK----RILREITILNRLKSDYIIRLY 91
Query: 201 --FIGACRKRM--VWCIVTEYA-----KGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
I + ++ IV E A K FLT +K + L G
Sbjct: 92 DLIIPDDLLKFDELY-IVLEIADSDLKKLFKTPIFLTEEH-----IKTILYNLL---LGE 142
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++H G IHRDLK N L++ D S+K+ DFG+AR + P
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 20/159 (12%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
+G+FG++ + E VAIKI++ N Q Q EV +L +
Sbjct: 64 KGSFGQVVKAYDRVEQEWVAIKIIK---NKKA----FLNQAQIEVRLLELMNKHDTEMKY 116
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
IV R C+V E ++ L R V L L K A + + ++
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 257 --LGFIHRDLKSDN-LLISADKS-IKIADFGVARIEVQT 291
L IH DLK +N LL + +S IKI DFG + Q
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L E A+KIL+ K V++ + M+ K
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + +Q AV A ++A G+ ++
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G I+RDLK DN+++ ++ IKIADFG+ + E + GT ++AP
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAP 511
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 33/176 (18%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+GA+G + N VAIK + E+ Q Q+ +E+ +L +H NI+
Sbjct: 37 EGAYGMVCSAYDNLNKVRVAIKKISPFEH-----QTYCQRTLREIKILLRFRHENIIGIN 91
Query: 201 --FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGM 251
++M V+ IV + + + L + L + Q L RG+
Sbjct: 92 DIIRAPTIEQMKDVY-IVQDLM-ETDLYKLL-----KTQHLSNDHICYFLYQIL---RGL 141
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRW 303
Y+H +HRDLK NLL++ +KI DFG+AR+ T +T T RW
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT-RW 196
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-13
Identities = 49/178 (27%), Positives = 69/178 (38%), Gaps = 26/178 (14%)
Query: 143 FAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIV 199
G FG+L G Y E VAIK+ E + Q E L I
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--------EPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGF 259
+ +V E G S+ L +R LK + A+ + M YVH
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 260 IHRDLKSDNLLI-----SADKSIKIADFGVAR--IEVQTEGMTPE------TGTYRWM 304
I+RD+K +N LI + I I DF +A+ I+ +T+ P TGT R+M
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 20/188 (10%), Positives = 61/188 (32%), Gaps = 32/188 (17%)
Query: 145 QGAFGKLYRGT----------YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK 194
+ G LY + ++K+ + ++ + Q + + + K
Sbjct: 52 RDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-D-AKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 195 HLNIVRFIGACRKRMVWCIVTEYAK--------GGSVRQFLTRRQNRAVPLKLAVKQALD 246
L + + V + G S++ L + + ++ A
Sbjct: 110 KLYSTPLLAIPT--CMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--------IEVQTEGMTP 296
+ + ++H ++H ++ ++N+ + + + +A +G A + +P
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227
Query: 297 ETGTYRWM 304
G ++
Sbjct: 228 HEGDLEFI 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 38/171 (22%), Positives = 73/171 (42%), Gaps = 19/171 (11%)
Query: 145 QGAFGKLY--RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM----MLATLKHLN- 197
+G FG++Y R G+ A+K L+ K ++ +Q + + ML+ + +
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 198 --IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV A + + GG + L Q+ A ++ G+ ++H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
++RDLK N+L+ ++I+D G+A + + GT+ +MAP
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAP 359
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 29/176 (16%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM------LATLKHL 196
+G+FGK L R G+ A+K+L+ K +++ E M H
Sbjct: 33 KGSFGKVMLARVKETGDLYAVKVLK-------KDVILQDD-DVECTMTEKRILSLARNHP 84
Query: 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ + + V E+ GG + +++R A A ++ + ++H
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G I+RDLK DN+L+ + K+ADFG+ + EG+ GT ++AP
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYIAP 193
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 44/175 (25%), Positives = 72/175 (41%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLKHLNI 198
+G FGK L + G A+KIL+ K ++ + + L +H +
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-L 257
+ + C V EYA GG + F + R A ++ + Y+H
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
++RDLK +NL++ D IKI DFG+ + EG+ GT ++AP
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAP 318
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 35/167 (20%), Positives = 66/167 (39%), Gaps = 36/167 (21%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------ 196
G F ++ N VA+KI+ +V + + E+ +L +
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 197 -----NIVR------FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQAL 245
+I++ G + +V E G ++ + + ++R +PL + +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHV--VMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 246 DVARGMAYVH-GLGFIHRDLKSDNLLIS------ADKSIKIADFGVA 285
+ G+ Y+H G IH D+K +N+L+ IKIAD G A
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 43/178 (24%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G++ K L R A+K+++ K V + + V H
Sbjct: 19 RGSYAKVLLVRLKKTDRIYAMKVVK-------KELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 198 IVRFIGAC---RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+V +C R+ V EY GG + ++ R +P + A + +++ + Y+
Sbjct: 72 LVGLH-SCFQTESRL--FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
H G I+RDLK DN+L+ ++ IK+ D+G+ + EG+ P GT ++AP
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 179
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 37/169 (21%), Positives = 59/169 (34%), Gaps = 40/169 (23%)
Query: 145 QGAFGKLYRGT---YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL----- 196
+GAFGK+ G VA+KI++ N + + E+ +L L
Sbjct: 24 EGAFGKVVECIDHKAGGRHVAVKIVK---NVDR----YCEAARSEIQVLEHLNTTDPNST 76
Query: 197 -NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
V+ + + CIV E G S F+ L K A + + + +
Sbjct: 77 FRCVQMLEWFEHHGHI--CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 254 VHGLGFIHRDLKSDNLLIS-------------------ADKSIKIADFG 283
+H H DLK +N+L + IK+ DFG
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 42/178 (23%), Positives = 78/178 (43%), Gaps = 33/178 (18%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM-----MLATLKHLN 197
+G++ K L R A+++++ K V + + V H
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVVK-------KELVNDDEDIDWVQTEKHVFEQASNHPF 114
Query: 198 IVRFIGAC---RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
+V +C R+ V EY GG + ++ R +P + A + +++ + Y+
Sbjct: 115 LVGLH-SCFQTESRL--FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
H G I+RDLK DN+L+ ++ IK+ D+G+ + EG+ P GT ++AP
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 45/175 (25%), Positives = 72/175 (41%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L + AIK L+ K V+ + M+ +H
Sbjct: 27 KGSFGKVFLAEFKKTNQFFAIKALK-------KDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + + L A A ++ G+ ++H
Sbjct: 80 LTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G ++RDLK DN+L+ D IKIADFG+ + E M + GT ++AP
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTPDYIAP 187
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRF 201
+G+FG ++ GT N + VAIK E + Q + E L I
Sbjct: 20 EGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
++ + +V + G S+ L R +K A + + +H ++
Sbjct: 72 YYFGQEGLHNVLVIDLL-GPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129
Query: 262 RDLKSDNLLISADKS-----IKIADFGVAR--IEVQTEGMTPE------TGTYRWM 304
RD+K DN LI S I + DFG+ + + T+ P +GT R+M
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 40/183 (21%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR-- 200
+GA+G + T+ GE VAIK + P + P A + +E+ +L KH NI+
Sbjct: 21 EGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFAL----RTLREIKILKHFKHENIITIF 75
Query: 201 --FIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL-----KLAVKQALDVARGM 251
+ V+ I+ E + + + L + + Q L R +
Sbjct: 76 NIQRPDSFENFNEVY-IIQELM-QTDLHRVI-----STQMLSDDHIQYFIYQTL---RAV 125
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----------EVQTEGMTPETGT 300
+HG IHRDLK NLLI+++ +K+ DFG+ARI Q GM T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 301 YRW 303
RW
Sbjct: 186 -RW 187
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L E A+KIL+ K V++ + M+ K
Sbjct: 30 KGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + + V EY GG + +Q AV A ++A G+ ++
Sbjct: 83 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
G I+RDLK DN+++ ++ IKIADFG+ + E + GT ++AP
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAP 190
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 39/177 (22%), Positives = 77/177 (43%), Gaps = 26/177 (14%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLK 194
GA+GK++ G G+ A+K+L+ KA ++++ E L ++
Sbjct: 64 TGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTRTERQVLEHIR 116
Query: 195 HLN-IVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 251
+V A ++ ++ +Y GG + F Q ++ +
Sbjct: 117 QSPFLVTLHYAFQTETKL--HLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 252 AYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++H LG I+RD+K +N+L+ ++ + + DFG+++ V E GT +MAP
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 37/171 (21%), Positives = 59/171 (34%), Gaps = 40/171 (23%)
Query: 145 QGAFGKLYR---GTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL----- 196
+G FGK+ VA+KI+ N + + + E+ +L +K
Sbjct: 29 EGTFGKVVECLDHARGKSQVALKIIR---NVGK----YREAARLEINVLKKIKEKDKENK 81
Query: 197 -NIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253
V M CI E G + +FL + PL A + + +
Sbjct: 82 FLCVLMSDWFNFHGHM--CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 254 VHGLGFIHRDLKSDNLLISADK-------------------SIKIADFGVA 285
+H H DLK +N+L + SI++ADFG A
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 8e-12
Identities = 42/176 (23%), Positives = 79/176 (44%), Gaps = 26/176 (14%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLK 194
+G +GK++ G G+ A+K+L+ KA ++ L +K
Sbjct: 27 KGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILEEVK 79
Query: 195 HLNIVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA 252
H IV I A ++ ++ EY GG + F+ + A +++ +
Sbjct: 80 HPFIVDLIYAFQTGGKL--YLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 253 YVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
++H G I+RDLK +N++++ +K+ DFG+ + + +T T GT +MAP
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAP 190
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 9e-12
Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 24/174 (13%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
G+FG++Y GT E+VAIK+ E + Q E + L+ I
Sbjct: 17 SGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
+ +V + G S+ L +R + LK + A + + +VH F+H
Sbjct: 69 RWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 262 RDLKSDNLLISADKS---IKIADFGVAR--IEVQTEGMTPE------TGTYRWM 304
RD+K DN L+ + + I DFG+A+ + T P TGT R+
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 42/175 (24%), Positives = 80/175 (45%), Gaps = 27/175 (15%)
Query: 145 QGAFGK--LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-----LATLKHLN 197
+G+FGK L R A+K+L+ K +++++ ++ +M L +KH
Sbjct: 48 KGSFGKVLLARHKAEEVFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+V + + V +Y GG + F ++ R A A ++A + Y+H L
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 306
++RDLK +N+L+ + I + DFG+ + E + + GT ++AP
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFCGTPEYLAP 208
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 46/184 (25%), Positives = 72/184 (39%), Gaps = 40/184 (21%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQ----EVMMLATLKHLNI 198
G G ++ + VAIK K + + Q + E+ ++ L H NI
Sbjct: 21 CGGNGLVFSAVDNDCDKRVAIK----------KIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 199 VR---FIGACRKRMVWC-----------IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
V+ +G ++ IV EY + L + +L + Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQL 129
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLI-SADKSIKIADFGVARI----EVQTEGMTPETG 299
L RG+ Y+H +HRDLK NL I + D +KI DFG+ARI ++
Sbjct: 130 L---RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 300 TYRW 303
T +W
Sbjct: 187 T-KW 189
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 22/173 (12%)
Query: 145 QGAFGKLY-----RGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM----LATLKH 195
QG+FGK++ G+ + A+K+L+ KA + + + M L + H
Sbjct: 34 QGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRD-RVRTKMERDILVEVNH 85
Query: 196 LNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV+ A + ++ ++ +GG + F + + ++A + ++H
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH 143
Query: 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 306
LG I+RDLK +N+L+ + IK+ DFG+++ + E + GT +MAP
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YSFCGTVEYMAP 195
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 32/173 (18%), Positives = 66/173 (38%), Gaps = 44/173 (25%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL-----N 197
G FG++ N + A+K++ N + + + E +L +++ N
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVKVVR---NIKK----YTRSAKIEADILKKIQNDDINNNN 97
Query: 198 IVRFIGA--CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255
IV++ G M C++ E G S+ + +TR ++ +++ + + Y+
Sbjct: 98 IVKYHGKFMYYDHM--CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 256 GLGFIHRDLKSDNLLI-------------------------SADKSIKIADFG 283
+ H DLK +N+L+ + IK+ DFG
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 31/168 (18%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRF 201
+GA+G +++ GE VA+K + N AQ + +E+M+L L H NIV
Sbjct: 19 KGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ----RTFREIMILTELSGHENIVNL 74
Query: 202 IGACR---KRMVWCIVTEYA--------KGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
+ R R V+ +V +Y + L + V Q + +
Sbjct: 75 LNVLRADNDRDVY-LVFDYMETDLHAVIRA----NILEPVH-----KQYVVYQLI---KV 121
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET 298
+ Y+H G +HRD+K N+L++A+ +K+ADFG++R V +T
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 35/186 (18%), Positives = 64/186 (34%), Gaps = 31/186 (16%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKI--LERPENNPEKAQVMEQQFQQEVM---MLATLKHLN 197
G FG +Y E A + +E EN P E +F Q V +
Sbjct: 47 SGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIERK 103
Query: 198 IVRFIGACRKRMVWCIVTEYAKGGS---VRQFL------TRRQNRAVPLKLAVKQALDVA 248
+ ++G +TE+ V + L QN ++ + +
Sbjct: 104 QLDYLGIPL--FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRML 161
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--------IEVQTEGMTPET 298
+ Y+H ++H D+K+ NLL+ + +AD+G++ + Q
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221
Query: 299 GTYRWM 304
GT +
Sbjct: 222 GTIEFT 227
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 35/204 (17%), Positives = 78/204 (38%), Gaps = 29/204 (14%)
Query: 116 DHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEK 175
+ + + ++ +RKL G + L + VA+K+++ E+ E
Sbjct: 24 GGYHLVKIGDLFNGRYHVIRKLGWGHF----STVWLSWDIQGKKFVAMKVVKSAEHYTET 79
Query: 176 AQVMEQQFQQEVMMLATLKHLN--------IVRFI------GACRKRMVWCIVTEYAKGG 221
A E+ +L ++++ + +V+ + G + C+V E G
Sbjct: 80 AL-------DEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI--CMVFEVL-GH 129
Query: 222 SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIA 280
+ +++ + + +PL K V +G+ Y+H IH D+K +N+L+S ++
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189
Query: 281 DFGVARIEVQTEGMTPETGTYRWM 304
A ++ P
Sbjct: 190 LAAEATEWQRSGAPPPSGSAVSTA 213
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 32/190 (16%), Positives = 63/190 (33%), Gaps = 36/190 (18%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQ--VMEQQFQQEV---MMLATLKHLNI 198
QG FG +Y + E V + P E +F Q +
Sbjct: 45 QGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104
Query: 199 VRFIGACRKRMVWCIVTEYAKG----------GSVRQFLTRRQNRAVPLK----LAVKQA 244
++++G + + + GS Q + + K L++ +
Sbjct: 105 LKYLGVPK--YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL-RI 161
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVAR--IEVQTEGMTPE--- 297
LD+ + Y+H ++H D+K+ NLL++ + + D+G+A
Sbjct: 162 LDI---LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218
Query: 298 ---TGTYRWM 304
GT +
Sbjct: 219 RCHDGTIEFT 228
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 37/184 (20%), Positives = 69/184 (37%), Gaps = 23/184 (12%)
Query: 118 RYPTEGLE-NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKI-LERPENNPE- 174
Y T+ +E N+ + ++ +GA + R +Y DV IK +++ +
Sbjct: 318 NYRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERL 377
Query: 175 KAQVMEQQFQQEVMMLATLKHLNI----VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR 230
+ + + +E LA +K I + + KR I+ Y G + +
Sbjct: 378 DENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR----IMMSYINGKLAKDVIEDN 433
Query: 231 QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290
+ A + + +H IH DL + N + DK + I DFG+ +I
Sbjct: 434 LDIAY----------KIGEIVGKLHKNDVIHNDLTTSNFIF--DKDLYIIDFGLGKISNL 481
Query: 291 TEGM 294
E
Sbjct: 482 DEDK 485
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 306 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.98 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.98 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.98 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.98 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.98 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.98 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.98 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.98 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.98 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.98 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.98 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.98 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.98 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.98 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.98 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.98 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.98 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.98 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.98 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.98 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.98 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.98 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.98 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.98 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.98 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.37 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.03 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.83 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.76 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.72 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.71 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.55 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.49 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.49 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.16 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.11 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 98.09 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.99 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.88 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.52 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.48 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.44 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.82 | |
| 1aot_F | 106 | FYN protein-tyrosine kinase; SH2 domain, signal tr | 96.13 | |
| 3maz_A | 125 | Signal-transducing adaptor protein 1; modular doma | 96.07 | |
| 3s9k_A | 118 | Tyrosine-protein kinase ITK/TSK; proline isomeriza | 95.73 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 95.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.15 | |
| 1blj_A | 114 | P55 BLK protein tyrosine kinase; signal transducti | 95.13 | |
| 3us4_A | 98 | Megakaryocyte-associated tyrosine-protein kinase; | 94.86 | |
| 1rja_A | 100 | Tyrosine-protein kinase 6; human protein tyrosine | 94.61 | |
| 3eaz_A | 106 | Tyrosine-protein kinase CSK; SH2, disulfide, oxidi | 94.26 | |
| 1lkk_A | 105 | Human P56 tyrosine kinase; complex (tyrosine kinas | 94.15 | |
| 3pqz_A | 117 | Growth factor receptor-bound protein 7; SH2, binds | 93.99 | |
| 2dly_A | 121 | FYN-related kinase; BRK family kinase, structural | 93.81 | |
| 2kno_A | 131 | Tensin-like C1 domain-containing phosphatase; SH2 | 93.55 | |
| 2ecd_A | 119 | Tyrosine-protein kinase ABL2; SH2 domain, phosphot | 93.49 | |
| 1nrv_A | 105 | Growth factor receptor-bound protein 10; dimer, si | 93.35 | |
| 2el8_A | 118 | Signal-transducing adaptor protein 2; SH2 domain, | 93.21 | |
| 3k2m_A | 112 | Proto-oncogene tyrosine-protein kinase ABL1; engin | 93.08 | |
| 1jyr_A | 96 | Growth factor receptor-bound protein 2; receptor b | 92.69 | |
| 2aug_A | 126 | Growth factor receptor-bound protein 14; phosphory | 92.53 | |
| 2ekx_A | 110 | Cytoplasmic tyrosine-protein kinase BMX; SH2 domai | 92.37 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 92.3 | |
| 2ge9_A | 125 | Tyrosine-protein kinase BTK; SH2 domain, structure | 92.17 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 91.78 | |
| 2dm0_A | 125 | Tyrosine-protein kinase TXK; TEC family kinase, st | 91.72 | |
| 2gsb_A | 119 | RAS GTPase-activating protein 1; GAP, RAS P21 prot | 91.55 | |
| 1d4t_A | 104 | T cell signal transduction molecule SAP; SH2 domai | 90.83 | |
| 1i3z_A | 103 | EWS/FLI1 activated transcript 2; SH2 domain phosph | 90.67 | |
| 1ka6_A | 128 | SH2 domain protein 1A; SH2 domain, protein-peptide | 90.63 | |
| 1r1p_A | 100 | GRB2-related adaptor protein 2; SH2, GADS, phospho | 89.8 | |
| 2lnw_A | 122 | VAV-2, guanine nucleotide exchange factor VAV2; si | 89.49 | |
| 4fbn_A | 246 | 1-phosphatidylinositol 4,5-bisphosphate phosphodi | 89.32 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 89.17 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 88.74 | |
| 3tkz_A | 109 | Tyrosine-protein phosphatase non-receptor type 11; | 88.46 | |
| 2bbu_A | 164 | Suppressor of cytokine signaling 3; SH2 domain, ex | 88.45 | |
| 2c9w_A | 169 | Suppressor of cytokine signaling 2; growth regulat | 88.26 | |
| 3ov1_A | 117 | Growth factor receptor-bound protein 2; GRB2 SH2 d | 88.21 | |
| 2vif_A | 141 | Suppressor of cytokine signalling 6; growth regula | 87.76 | |
| 2lqn_A | 303 | CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT | 87.37 | |
| 2dlz_A | 118 | Protein VAV-2; RHO family guanine nucleotide excha | 87.37 | |
| 2y3a_B | 302 | Phosphatidylinositol 3-kinase regulatory subunit; | 87.29 | |
| 2hmh_A | 152 | Suppressor of cytokine signaling 3; SOCS3, GP130, | 87.19 | |
| 2cia_A | 102 | Cytoplasmic protein NCK2; SH2-domain, SH3 domain, | 86.59 | |
| 2hdv_A | 111 | SH2-B PH domain containing signaling mediator 1 ga | 86.43 | |
| 2iug_A | 120 | Phosphatidylinositol 3-kinase regulatory alpha sub | 85.83 | |
| 2ysx_A | 119 | Signaling inositol polyphosphate phosphatase SHIP | 85.81 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.64 | |
| 1a81_A | 254 | SYK kinase; complex (transferase-peptide), SYK, ki | 85.13 | |
| 1h9o_A | 112 | Phosphatidylinositol 3-kinase; transferase/recepto | 84.85 | |
| 2oq1_A | 254 | Tyrosine-protein kinase ZAP-70; tandem SH2 domains | 84.64 | |
| 2cs0_A | 119 | Hematopoietic SH2 domain containing; ALX, FLJ14886 | 84.26 | |
| 1ju5_A | 109 | CRK; CRK, SH2, SH3, adaptor protein, phosphopeptid | 83.45 | |
| 2cr4_A | 126 | 3BP-2, SH3 domain-binding protein 2; structural ge | 83.38 | |
| 2eo3_A | 111 | CRK-like protein; phosphorylation, repeat, SH2 dom | 83.31 | |
| 2izv_A | 187 | Suppressor of cytokine signaling 4; signal transdu | 83.14 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 82.61 | |
| 2crh_A | 138 | VAV proto-oncogene; oncoprotein, structural genomi | 82.24 | |
| 2eob_A | 124 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 82.2 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.97 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=319.41 Aligned_cols=174 Identities=34% Similarity=0.632 Sum_probs=147.8
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
..+.|+|+.++++++++||+|+||+||+|++.+ .||||+++......+ ..+.|.+|+.+|++++|||||+++|+|
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~----~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPE----QFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 356799999999999999999999999999865 599999976554433 246899999999999999999999998
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.++ .+|||||||++|+|.++|... ...+++..++.|+.||+.||+|||+++||||||||+||||++++++||+|||+|
T Consensus 102 ~~~-~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 102 TKD-NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp CSS-SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred ECC-eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence 654 579999999999999999754 356999999999999999999999999999999999999999999999999999
Q ss_pred eeeecC---CCccCCCCCCcccCC
Q 021897 286 RIEVQT---EGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~---~~~~~~~gt~~y~AP 306 (306)
+..... ......+||+.||||
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAP 203 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAP 203 (307)
T ss_dssp BC------------CCCCTTSCCH
T ss_pred eecccCCcceeecccccCCCccCH
Confidence 865432 223456899999998
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=322.65 Aligned_cols=170 Identities=24% Similarity=0.397 Sum_probs=146.2
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
..++|++++.||+|+||+||+|++ +++.||||+++........ .+.+.+|+.+|++++|||||++++++.++..
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE----REESRREVAVLANMKHPNIVQYRESFEENGS 97 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHH----HHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence 357899999999999999999998 6899999999876554332 3678999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+|||||||++|+|.+++...+...+++..++.++.||+.||+|||++|||||||||+||||++++.+||+|||+|+....
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999999999877667789999999999999999999999999999999999999999999999999987654
Q ss_pred CC-CccCCCCCCcccCC
Q 021897 291 TE-GMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~-~~~~~~gt~~y~AP 306 (306)
.. ..+..+||+.||||
T Consensus 178 ~~~~~~~~~GT~~YmAP 194 (350)
T 4b9d_A 178 TVELARACIGTPYYLSP 194 (350)
T ss_dssp HHHHHHHHHSCCTTCCH
T ss_pred CcccccccCCCccccCH
Confidence 32 23456899999998
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=313.87 Aligned_cols=168 Identities=23% Similarity=0.395 Sum_probs=148.0
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++++.||+|+||+||+|++ +++.||||++.+..... ....+.+.+|+.+|++++|||||++++++.++..+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 46799999999999999999998 78899999997532111 11235789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
||||||++||+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999999999875 45999999999999999999999999999999999999999999999999999976432
Q ss_pred C---CccCCCCCCcccCC
Q 021897 292 E---GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~---~~~~~~gt~~y~AP 306 (306)
. ...+.+||+.||||
T Consensus 186 ~~~~~~~~~~GTp~YmAP 203 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSP 203 (311)
T ss_dssp TTCCCBCCCCSCGGGCCH
T ss_pred CCcccccCcccCcccCCH
Confidence 2 24567899999998
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=313.27 Aligned_cols=173 Identities=28% Similarity=0.489 Sum_probs=148.7
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (306)
-++|+..++++.++||+|+||+||+|++ +++.||||+++....... .++|.+|+.++++++|||||++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~-----~~~f~~E~~il~~l~HpNIV~l 94 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-----REEFRHEAMLRARLQHPNVVCL 94 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-C-----HHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHH-----HHHHHHHHHHHHhCCCCCCCCc
Confidence 3567888999999999999999999987 357899999975443322 3579999999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021897 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (306)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~ 267 (306)
+|+|.++..++||||||++|+|.++|.... ...+++..++.++.||+.||+|||+++||||||||+
T Consensus 95 ~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~ 174 (308)
T 4gt4_A 95 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR 174 (308)
T ss_dssp EEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999999999997532 235899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 268 NLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 268 NILv~~~~~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
||||++++++||+|||+|+...... .....+||+.||||
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 216 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCH
Confidence 9999999999999999998653322 23445799999998
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=314.09 Aligned_cols=164 Identities=25% Similarity=0.410 Sum_probs=146.9
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.+.|++.++||+|+||+||+|++ +|+.||||++....... .+.+.+|+.+|++++|||||++++++.+++.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR------RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS------GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35688999999999999999998 68999999997543332 14578999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|||||||++|+|.+++.+ ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 147 ~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999999999975 35999999999999999999999999999999999999999999999999999876443
Q ss_pred -CCccCCCCCCcccCC
Q 021897 292 -EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 -~~~~~~~gt~~y~AP 306 (306)
....+.+||+.||||
T Consensus 224 ~~~~~~~~GTp~YmAP 239 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAP 239 (346)
T ss_dssp SCCBCCCCSCGGGCCH
T ss_pred CCcccccccCcCcCCH
Confidence 345667999999998
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.40 Aligned_cols=171 Identities=29% Similarity=0.489 Sum_probs=146.0
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
+.|+.++|.+.++||+|+||+||+|++ +++.||||+++... . ...++|.+|+.+|++++|||||+++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~----~~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--D----NARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--H----HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--h----HHHHHHHHHHHHHHhCCCCCCccEE
Confidence 357788999999999999999999986 36789999997532 1 1246799999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 021897 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQ-----------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv 271 (306)
|+|.+++.+|||||||++|+|.++|+... ...+++..++.++.||+.||+|||+++||||||||+||||
T Consensus 82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl 161 (299)
T 4asz_A 82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 161 (299)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence 99999999999999999999999997632 3468999999999999999999999999999999999999
Q ss_pred cCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 272 ~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
++++.+||+|||+|+....... ....+||+.||||
T Consensus 162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP 199 (299)
T 4asz_A 162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 199 (299)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred CCCCcEEECCcccceecCCCCceeecCceecChhhcCH
Confidence 9999999999999986543322 1223689999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=311.64 Aligned_cols=172 Identities=34% Similarity=0.540 Sum_probs=142.4
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (306)
.+.|+.+++.+.++||+|+||+||+|++ +++.||||+++... . ...++|.+|+.+|++++|||||++
T Consensus 35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~---~~~~~f~~E~~il~~l~HpnIV~l 108 (329)
T 4aoj_A 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---E---SARQDFQREAELLTMLQHQHIVRF 108 (329)
T ss_dssp SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---H---HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---H---HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 4567788999999999999999999987 36789999996432 1 124679999999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 021897 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQ-------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDN 268 (306)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~N 268 (306)
+|+|.+...+|||||||++|+|.++++... ..++++..++.|+.||+.||+|||+++||||||||+|
T Consensus 109 ~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~N 188 (329)
T 4aoj_A 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN 188 (329)
T ss_dssp EEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhh
Confidence 999999999999999999999999997532 2458999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 269 LLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 269 ILv~~~~~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
|||++++.+||+|||+|+...... .....+||+.||||
T Consensus 189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP 229 (329)
T 4aoj_A 189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 229 (329)
T ss_dssp EEEETTTEEEECCCC----------------CCCCGGGCCH
T ss_pred EEECCCCcEEEcccccceeccCCCcceecCcccccccccCh
Confidence 999999999999999998654322 12345799999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=303.47 Aligned_cols=166 Identities=25% Similarity=0.467 Sum_probs=132.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++++.||+|+||+||+|++ +++.||||++++....... ..+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD---MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH---HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 5789999999999999999987 6899999999865443221 2357899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
|||||+ +|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||+++++++||+|||+|+......
T Consensus 90 ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999999 67999999764 469999999999999999999999999999999999999999999999999999776655
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
...+.+||+.||||
T Consensus 167 ~~~~~~GT~~Y~AP 180 (275)
T 3hyh_A 167 FLKTSCGSPNYAAP 180 (275)
T ss_dssp --------CTTSCH
T ss_pred ccCCeeECcccCCh
Confidence 56678999999998
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=316.35 Aligned_cols=164 Identities=25% Similarity=0.410 Sum_probs=147.5
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.+.|++.++||+|+||.||+|++ +|+.||||++........ +.+.+|+.+|++++|||||++++++.+...+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~------~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR------ELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 223 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG------GGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH------HHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence 46789999999999999999998 689999999986544322 4688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|||||||+||+|.+++.. ..+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 224 ~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 999999999999999975 34999999999999999999999999999999999999999999999999999876443
Q ss_pred -CCccCCCCCCcccCC
Q 021897 292 -EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 -~~~~~~~gt~~y~AP 306 (306)
......+||+.||||
T Consensus 301 ~~~~~~~~GTp~YmAP 316 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAP 316 (423)
T ss_dssp CCCBCCCEECTTTCCH
T ss_pred CccccccccCcCcCCH
Confidence 345667899999998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.09 Aligned_cols=162 Identities=27% Similarity=0.325 Sum_probs=141.5
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
.....|++.++||+|+||+||+|++ +|+.||||+++.... ..+|+.+|++++|||||++++++.+++
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----------RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3456788899999999999999998 688999999986433 237999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEcccCeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARIE 288 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-~vkl~DFGla~~~ 288 (306)
.+|||||||+||+|.+++++. ..+++..++.++.||+.||+|||+++||||||||+||||+.+| .+||+|||+|+..
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 999999999999999999875 4699999999999999999999999999999999999999988 6999999999875
Q ss_pred ecCCC------ccCCCCCCcccCC
Q 021897 289 VQTEG------MTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~------~~~~~gt~~y~AP 306 (306)
..... ....+||+.||||
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAP 225 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAP 225 (336)
T ss_dssp ------------CCCCCCGGGCCH
T ss_pred cCCCcccceecCCccccCccccCH
Confidence 43221 2235799999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=300.98 Aligned_cols=163 Identities=30% Similarity=0.510 Sum_probs=142.4
Q ss_pred ceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCe
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----RMV 210 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 210 (306)
+++.++||+|+||.||+|.+ +++.||||++........ ..+.|.+|+.+|++++|||||++++++.. +..
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 47778999999999999998 678999999976544432 23679999999999999999999999865 356
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEc-CCCcEEEEcccCeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFGVARI 287 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlkp~NILv~-~~~~vkl~DFGla~~ 287 (306)
+|||||||++|+|.+++.+. ..+++..++.++.||+.||+|||+++ ||||||||+||||+ .++.+||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 89999999999999999875 46999999999999999999999998 99999999999997 579999999999986
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
... ....+.+||+.||||
T Consensus 182 ~~~-~~~~~~~GTp~YmAP 199 (290)
T 3fpq_A 182 KRA-SFAKAVIGTPEFMAP 199 (290)
T ss_dssp CCT-TSBEESCSSCCCCCG
T ss_pred CCC-CccCCcccCccccCH
Confidence 543 334567999999999
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=309.73 Aligned_cols=170 Identities=23% Similarity=0.370 Sum_probs=142.2
Q ss_pred eeeccCceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
.++.++|++++.||+|+||+||+|+. +++.||||++++....... ..++.+|+.+|++++|||||++++++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD----RVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE----CC------CCCCCCCCTTEECEEEEE
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH----HHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 35668899999999999999999986 4578999999764332211 13577899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.++..+|||||||+||+|.+++.+. ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 9999999999999999999999875 46999999999999999999999999999999999999999999999999999
Q ss_pred eeeec-CCCccCCCCCCcccCC
Q 021897 286 RIEVQ-TEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~-~~~~~~~~gt~~y~AP 306 (306)
+.... .....+.+||+.||||
T Consensus 174 ~~~~~~~~~~~~~~GT~~YmAP 195 (304)
T 3ubd_A 174 KESIDHEKKAYSFCGTVEYMAP 195 (304)
T ss_dssp EC-----CCCCSCCCCGGGCCH
T ss_pred eeccCCCccccccccCcccCCH
Confidence 86443 3334567899999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=311.59 Aligned_cols=175 Identities=29% Similarity=0.555 Sum_probs=149.4
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEECC-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CCe
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNI 198 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni 198 (306)
.++|+|+.++|++++.||+|+||+||+|++.+ +.||||.++...... ..+.|.+|+.+|+++.| |||
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~-----~~~~~~~E~~il~~l~hhpnI 130 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLNV 130 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH-----HHHHHHHHHHHHHHcCCCCcE
Confidence 35799999999999999999999999998733 579999997644322 23679999999999975 899
Q ss_pred eeEEEEEEeC-CeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021897 199 VRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (306)
Q Consensus 199 v~l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrD 263 (306)
|+++|+|.++ ..+|||||||++|+|.++|+... ...+++..++.++.||+.||+|||+++|||||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD 210 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 210 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence 9999999764 57899999999999999998642 23488999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 264 lkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|||+|||+++++.+||+|||+|+....... ....+||+.||||
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP 256 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 256 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence 999999999999999999999986543322 2345789999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=300.63 Aligned_cols=167 Identities=25% Similarity=0.460 Sum_probs=133.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC---
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 209 (306)
++|++++.||+|+||+||+|++ +++.||||+++..... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-----LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 4688999999999999999998 6889999999764422 22357899999999999999999999987544
Q ss_pred ---------eEEEEEeecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 021897 210 ---------VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 210 ---------~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl 279 (306)
.+|||||||++|+|.+++..... ...++..++.++.||+.||+|||++|||||||||+||||+.++.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 47999999999999999986432 23456778999999999999999999999999999999999999999
Q ss_pred EcccCeeeeecCCC-------------ccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTEG-------------MTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~-------------~~~~~gt~~y~AP 306 (306)
+|||+|+....... .++.+||+.||||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP 199 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP 199 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCH
Confidence 99999986543221 2345799999998
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=298.09 Aligned_cols=162 Identities=34% Similarity=0.538 Sum_probs=135.7
Q ss_pred cCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----e
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM----V 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 210 (306)
++|.+.++||+|+||+||+|+++|+.||||+++... .. ...+.+|+..+.+++|||||+++++|.++. .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~-----~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG-----HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 468889999999999999999999999999986421 11 123345677778899999999999997653 6
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCcEEEcCCCcEEEEcc
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------GFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~--------~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
+|||||||++|+|.++++. ..+++..+++++.|++.||+|||++ +||||||||+||||+.++++||+||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 8999999999999999976 3589999999999999999999987 9999999999999999999999999
Q ss_pred cCeeeeecCCC-----ccCCCCCCcccCC
Q 021897 283 GVARIEVQTEG-----MTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~-----~~~~~gt~~y~AP 306 (306)
|+|+....... ....+||+.||||
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAP 181 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAP 181 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCH
T ss_pred CCCccccCCCCceeeecccccccccccCH
Confidence 99987654332 2235799999998
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=306.31 Aligned_cols=254 Identities=28% Similarity=0.437 Sum_probs=197.8
Q ss_pred cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-CceeEeeeeeeec--CCcccc-ccCchHHHH
Q 021897 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQ 112 (306)
Q Consensus 37 ~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~ 112 (306)
-.|+|+++.|.. ..|.|++|++..+... ...++|+.|.... +.|++. ....|. ...+.+ ....++++.
T Consensus 92 ~~G~FLvR~s~~---~~g~y~lsv~~~~~~~----~~~v~H~~I~~~~~g~~~i~-~~~~F~sl~eLv~~y~~~~~~l~~ 163 (454)
T 1qcf_A 92 MLGSFMIRDSET---TKGSYSLSVRDYDPRQ----GDTVKHYKIRTLDNGGFYIS-PRSTFSTLQELVDHYKKGNDGLCQ 163 (454)
T ss_dssp CTTCEEEEECSS---STTSEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS-SSSCBSSHHHHHHHHTSSCTTSSS
T ss_pred CCceEEEEECcC---CCCeEEEEEEecccCC----CCceEEEEEEEcCCCcEEEe-CccccCCHHHHHHHHHhccCCccc
Confidence 369999998865 5689999998754322 2468899998765 667765 223332 222332 334455555
Q ss_pred HHhcCCCCCCC--CCCCCcceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH
Q 021897 113 ALMDHRYPTEG--LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (306)
Q Consensus 113 ~l~~~~~~~~~--~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~ 189 (306)
.+..++..... ....+.|+++.++|++.+.||+|+||.||+|++ .+..||||+++..... .+.|.+|+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~~ 236 (454)
T 1qcf_A 164 KLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEANV 236 (454)
T ss_dssp CCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC-------HHHHHHHHHH
T ss_pred cccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc-------HHHHHHHHHH
Confidence 55545443222 223678999999999999999999999999999 5788999999764432 2578999999
Q ss_pred HHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 021897 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (306)
Q Consensus 190 l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NI 269 (306)
|++++||||+++++++. ...+|+||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 237 l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 315 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315 (454)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred HhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 99999999999999987 55679999999999999999865444688999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEcccCeeeeecCC--CccCCCCCCcccCC
Q 021897 270 LISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 270 Lv~~~~~vkl~DFGla~~~~~~~--~~~~~~gt~~y~AP 306 (306)
|++.++.+||+|||+|+...... ......+|+.|+||
T Consensus 316 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aP 354 (454)
T 1qcf_A 316 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 354 (454)
T ss_dssp EECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCH
T ss_pred EECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCH
Confidence 99999999999999998654321 12334567899998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=305.75 Aligned_cols=247 Identities=26% Similarity=0.457 Sum_probs=190.9
Q ss_pred cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCceeEeeeeeeec--CCcccc-ccCchHHHHH
Q 021897 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (306)
Q Consensus 37 ~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~ 113 (306)
..|+|+++.|++ ..|.+++++... ..++|+.+....+.|++. ....|. ...+.+ ....++++..
T Consensus 100 ~~G~FlvR~S~~---~~g~~~Lsv~~~---------~~v~H~~I~~~~~~~~i~-~~~~F~sl~eLv~~y~~~~~~~~~~ 166 (450)
T 1k9a_A 100 ETGLFLVRESTN---YPGDYTLCVSCE---------GKVEHYRIMYHASKLSID-EEVYFENLMQLVEHYTTDADGLCTR 166 (450)
T ss_dssp CTTEEEEEECSS---STTSEEEEEECS---------SSEEEEEEEEETTEEESS-SSSCBSSHHHHHHHHHHCCTTSSSC
T ss_pred CCceEEEEecCC---CCCceEEEEEeC---------CeeeEEEEEecCCceEec-cccccccHHHHHhhhcccccchhhh
Confidence 579999998865 578899999641 146889886656777765 222332 122222 2233344333
Q ss_pred HhcCCCCCCCCC-----CCCcceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH
Q 021897 114 LMDHRYPTEGLE-----NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188 (306)
Q Consensus 114 l~~~~~~~~~~~-----~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~ 188 (306)
+..++....... ..+.|+++.++|++.+.||+|+||.||+|++.++.||||+++.... .+.|.+|+.
T Consensus 167 l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~ 238 (450)
T 1k9a_A 167 LIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEAS 238 (450)
T ss_dssp CCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT--------SHHHHHHHH
T ss_pred ccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH--------HHHHHHHHH
Confidence 333332221110 1467999999999999999999999999999999999999976432 257889999
Q ss_pred HHHhCCCCCeeeEEEEEEeCC-eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021897 189 MLATLKHLNIVRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (306)
Q Consensus 189 ~l~~l~h~niv~l~~~~~~~~-~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~ 267 (306)
+|++++||||+++++++.+.. .+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+
T Consensus 239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~ 318 (450)
T 1k9a_A 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318 (450)
T ss_dssp HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence 999999999999999987765 7899999999999999999876556899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 268 NLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 268 NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|||++.++.+||+|||+++..... .....+|+.|+||
T Consensus 319 Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aP 355 (450)
T 1k9a_A 319 NVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAP 355 (450)
T ss_dssp GEEECTTSCEEECCCTTCEECC--------CCCTTTSCH
T ss_pred hEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCH
Confidence 999999999999999999854332 2333678999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=311.49 Aligned_cols=172 Identities=19% Similarity=0.281 Sum_probs=146.6
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+..++|++++.||+|+||+||+|+. +|+.||||++++................+++.+++.++|||||+++++++++.
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4567899999999999999999998 78899999997532221111111222334567778889999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|||||||+||+|.++|.+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999999999875 469999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.. ...+.+||+.||||
T Consensus 344 ~~-~~~t~~GTp~YmAP 359 (689)
T 3v5w_A 344 KK-KPHASVGTHGYMAP 359 (689)
T ss_dssp SC-CCCSCCSCGGGCCH
T ss_pred CC-CCCCccCCcCccCH
Confidence 44 34567999999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=307.95 Aligned_cols=251 Identities=24% Similarity=0.434 Sum_probs=197.8
Q ss_pred hcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-CceeEeeeeeeec--CCcccc-ccCchHHH
Q 021897 36 LGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALA 111 (306)
Q Consensus 36 ~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~ 111 (306)
...|+|+++.|.+ .+|.|++|++.. ..++|+.|.... +.+++. ....|. ...+.| ....++++
T Consensus 124 ~~~G~fLvR~s~~---~~~~~~lsv~~~---------~~v~h~~I~~~~~g~~~~~-~~~~F~sl~eLv~~~~~~~~g~~ 190 (495)
T 1opk_A 124 GINGSFLVRESES---SPGQRSISLRYE---------GRVYHYRINTASDGKLYVS-SESRFNTLAELVHHHSTVADGLI 190 (495)
T ss_dssp CCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEECEECTTSCEESS-TTSCBSSHHHHHHHHTTCCTTSS
T ss_pred CCCceEEEEeCCC---CCCceEEEEeeC---------CeEEEEEEEecCCCceEec-cCccchhHHHHhhhhcccccccc
Confidence 3479999998875 568999999852 267999998765 556554 233332 223333 34445555
Q ss_pred HHHhcCCCCC------CCCCCCCcceeeccCceecceeeeeccEEEEEEEEC--CeeEEEEEeeCCCCChhHHHHHHHHH
Q 021897 112 QALMDHRYPT------EGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GEDVAIKILERPENNPEKAQVMEQQF 183 (306)
Q Consensus 112 ~~l~~~~~~~------~~~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~ 183 (306)
..+..++... .....++.|++...+|++.+.||+|+||.||+|++. +..||||+++..... .+.|
T Consensus 191 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~ 263 (495)
T 1opk_A 191 TTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEF 263 (495)
T ss_dssp SCCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC-------HHHH
T ss_pred hhccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc-------hHHH
Confidence 4443333211 111246889999999999999999999999999984 789999999765433 2578
Q ss_pred HHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021897 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (306)
Q Consensus 184 ~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrD 263 (306)
.+|+.+|++++||||++++++|.....+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+|||
T Consensus 264 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrD 343 (495)
T 1opk_A 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343 (495)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 99999999999999999999999999999999999999999999876566799999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEcccCeeeeecCC--CccCCCCCCcccCC
Q 021897 264 LKSDNLLISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 264 lkp~NILv~~~~~vkl~DFGla~~~~~~~--~~~~~~gt~~y~AP 306 (306)
|||+||||+.++.+||+|||+|+...... ......+|+.|+||
T Consensus 344 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aP 388 (495)
T 1opk_A 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388 (495)
T ss_dssp CSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCH
T ss_pred CChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCH
Confidence 99999999999999999999998654322 12233567899998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=305.98 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=193.8
Q ss_pred CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-CceeEeeeeeeec--CCcccc-ccCchHHHHH
Q 021897 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (306)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~ 113 (306)
.|+|+++.|+. ..|.|++|++..+... ...++|+.|+... +.|++. ....|. +..+.+ ....++++..
T Consensus 88 ~G~FLvR~s~~---~~g~y~lsv~~~~~~~----~~~v~h~~I~~~~~g~~~~~-~~~~F~Sl~~Li~~y~~~~~~l~~~ 159 (452)
T 1fmk_A 88 RGTFLVRESET---TKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYIT-SRTQFNSLQQLVAYYSKHADGLCHR 159 (452)
T ss_dssp TTEEEEEECSS---STTCEEEEEEEEETTT----EEEEEEEEEEECTTSCEESS-TTSEESSHHHHHHHHTTCCTTSSSC
T ss_pred CceEEEEeCCC---CCCceEEEEEeeccCC----CCcEEEEEEEEcCCCCEEEe-cCcccCCHHHHHHHhhhccccchhh
Confidence 39999998875 5689999998644221 2367999998765 667766 333342 233333 4455666655
Q ss_pred HhcCCCCC---CCCCCCCcceeeccCceecceeeeeccEEEEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH
Q 021897 114 LMDHRYPT---EGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (306)
Q Consensus 114 l~~~~~~~---~~~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~ 189 (306)
+..++... ......+.|+++.++|++.+.||+|+||.||+|++. +..||||+++...... +.|.+|+.+
T Consensus 160 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~ 232 (452)
T 1fmk_A 160 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQV 232 (452)
T ss_dssp CCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHHH
T ss_pred ccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH-------HHHHHHHHH
Confidence 55544321 111236789999999999999999999999999995 4689999998654432 468899999
Q ss_pred HHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 021897 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (306)
Q Consensus 190 l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NI 269 (306)
|++++||||+++++++.+ ..+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 233 l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 311 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311 (452)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 999999999999999976 5679999999999999999865445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEcccCeeeeecCCC--ccCCCCCCcccCC
Q 021897 270 LISADKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 270 Lv~~~~~vkl~DFGla~~~~~~~~--~~~~~gt~~y~AP 306 (306)
|++.++.+||+|||+++....... .....+|+.|+||
T Consensus 312 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aP 350 (452)
T 1fmk_A 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350 (452)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCH
T ss_pred EECCCCCEEECCCccceecCCCceecccCCcccccccCH
Confidence 999999999999999986543221 2233577899998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=293.38 Aligned_cols=165 Identities=26% Similarity=0.380 Sum_probs=142.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (306)
++|++++.||+|+||+||+|++ +|+.||||+++........ .+.+.+|+.+|+.++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN----AKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH----HHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 5799999999999999999998 6899999999765444322 3578899999999999999999999864
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
...+|||||||+ |+|.+++.. ...+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred cCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 357899999996 689999965 3569999999999999999999999999999999999999999999999999998
Q ss_pred eeecC-----CCccCCCCCCcccCC
Q 021897 287 IEVQT-----EGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~-----~~~~~~~gt~~y~AP 306 (306)
..... ....+.+||+.||||
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~AP 231 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAP 231 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCH
T ss_pred ecccCccccccccccceeChHhcCH
Confidence 64322 234567899999998
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=309.63 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=197.7
Q ss_pred CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-CceeEeeeeeeec--CCcccc-ccCchHHHHH
Q 021897 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (306)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~ 113 (306)
.|+|+++.|+. ..|.|++||+...... ...++|+.|+... +.|++.. ...|. ...+.+ ..+.++++..
T Consensus 171 ~G~FLvR~S~~---~~g~y~lsv~~~~~~~----~~~v~h~~I~~~~~g~~~i~~-~~~F~SL~eLv~~y~~~~~~~~~~ 242 (535)
T 2h8h_A 171 RGTFLVRESET---TKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYITS-RTQFNSLQQLVAYYSKHADGLCHR 242 (535)
T ss_dssp TTEEEEEECSS---STTCEEEEEEEEETTT----EEEEEEEEEBC-CCSCEEEET-TEEESSHHHHHHHHHHCCTTSSSC
T ss_pred CCeEEEEecCC---CCCcEEEEEEeeccCC----CCceEEEEEEEcCCCcEEeec-cccccChHHhheeeccccCccccc
Confidence 49999998875 5789999998643221 1367999998865 6677763 33342 333333 4455666655
Q ss_pred HhcCCCCC---CCCCCCCcceeeccCceecceeeeeccEEEEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH
Q 021897 114 LMDHRYPT---EGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189 (306)
Q Consensus 114 l~~~~~~~---~~~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~ 189 (306)
+..++... ......+.|+++.++|++.+.||+|+||.||+|++. +..||||+++...... +.|.+|+.+
T Consensus 243 l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~ 315 (535)
T 2h8h_A 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQV 315 (535)
T ss_dssp CCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHH
T ss_pred cccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCH-------HHHHHHHHH
Confidence 55544321 111236789999999999999999999999999995 4689999998655432 468899999
Q ss_pred HHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 021897 190 LATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (306)
Q Consensus 190 l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NI 269 (306)
|++++||||+++++++.+ ..+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394 (535)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 999999999999999976 5679999999999999999865445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEcccCeeeeecCC--CccCCCCCCcccCC
Q 021897 270 LISADKSIKIADFGVARIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 270 Lv~~~~~vkl~DFGla~~~~~~~--~~~~~~gt~~y~AP 306 (306)
||+.++.+||+|||+++...... ......+|+.|+||
T Consensus 395 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aP 433 (535)
T 2h8h_A 395 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433 (535)
T ss_dssp EECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCH
T ss_pred EEcCCCcEEEcccccceecCCCceecccCCcCcccccCH
Confidence 99999999999999998654221 12334577899998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=282.86 Aligned_cols=159 Identities=23% Similarity=0.373 Sum_probs=137.0
Q ss_pred cCceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (306)
+.|+++++||+|+||+||+|+. +++.||||.+..... ..++.+|+.+|+.+ .|||||++++++.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--------PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--------HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--------HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 5689999999999999999976 357899999865432 13577999999998 699999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEcccCeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARI 287 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~-~~vkl~DFGla~~ 287 (306)
..+||||||+++|+|.+++. .+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999999983 38999999999999999999999999999999999999876 7999999999985
Q ss_pred eecCC-----------------------------CccCCCCCCcccCC
Q 021897 288 EVQTE-----------------------------GMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~-----------------------------~~~~~~gt~~y~AP 306 (306)
..+.. ..++.+||+.||||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 215 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAP 215 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCH
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCH
Confidence 43221 12445899999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=298.82 Aligned_cols=166 Identities=23% Similarity=0.430 Sum_probs=148.3
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++++.||+|+||.||+|+. +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+...+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh------hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 36899999999999999999998 7889999999764321 135688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC--CcEEEEcccCeeeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--KSIKIADFGVARIEV 289 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~--~~vkl~DFGla~~~~ 289 (306)
|||||||+||+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 230 ~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999999999653 3469999999999999999999999999999999999999854 899999999999877
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
........+||+.||||
T Consensus 309 ~~~~~~~~~GT~~y~AP 325 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAP 325 (573)
T ss_dssp TTSEEEEECSSGGGCCH
T ss_pred CCCceeeeEECccccCH
Confidence 66666677999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=290.21 Aligned_cols=263 Identities=26% Similarity=0.406 Sum_probs=186.0
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCcee
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYS 88 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~ 88 (306)
+||++.+. -..+....+ -.|+|++++|.+ .+ .|++|++.. ..++|+.|...++.|.
T Consensus 14 ~wyhg~i~---------r~~a~~lL~--~~G~flvR~s~~---~~-~~~lsv~~~---------~~~~h~~i~~~~~~~~ 69 (377)
T 3cbl_A 14 LWYHGAIP---------RAEVAELLV--HSGDFLVRESQG---KQ-EYVLSVLWD---------GLPRHFIIQSLDNLYR 69 (377)
T ss_dssp TTBCTTCC---------HHHHHHHCC--STTEEEEEECC-----C-CEEEEC--------------CCEEEC----CCCC
T ss_pred CccCCCCC---------HHHHHHHHh--cCCCEEEEEeCC---CC-cEEEEEEEC---------CCccchhhccccceEE
Confidence 78888774 223323332 469999999865 23 899999842 2568999987666554
Q ss_pred Eeeeeeeec--CCcccccc-CchHHHHHHhcCCCCCCCCCCCCcceeeccCceecceeeeeccEEEEEEEE--CCeeEEE
Q 021897 89 VSVGQSVFR--PGKVTHAL-NDDALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAI 163 (306)
Q Consensus 89 i~~~~~~~~--~~~v~~~~-~~~~l~~~l~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vav 163 (306)
+. + ..|. +..+.|.. +.+.+... ...........+.|.++.++|++++.||+|+||.||+|++ +++.|||
T Consensus 70 ~~-~-~~F~sl~~LI~~y~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vav 144 (377)
T 3cbl_A 70 LE-G-EGFPSIPLLIDHLLSTQQPLTKK---SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAV 144 (377)
T ss_dssp C------CCSHHHHHHHHHHHTCCC--------CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEE
T ss_pred ec-c-eeccchHHHHHHHhhccCCcccc---cCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEE
Confidence 43 2 2221 22333211 11111000 0011111123578999999999999999999999999998 5889999
Q ss_pred EEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHH
Q 021897 164 KILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243 (306)
Q Consensus 164 K~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i 243 (306)
|+++.... . ...+.+.+|+.++++++||||+++++++.....+|+||||+++|+|.+++.... ..+++..++.+
T Consensus 145 K~~~~~~~-~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~ 218 (377)
T 3cbl_A 145 KSCRETLP-P----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQM 218 (377)
T ss_dssp EECCTTSC-H----HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHH
T ss_pred EEccccCC-H----HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHH
Confidence 99875422 1 123578899999999999999999999999989999999999999999998643 45899999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc---cCCCCCCcccCC
Q 021897 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAP 306 (306)
Q Consensus 244 ~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~---~~~~gt~~y~AP 306 (306)
+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+........ ....+++.|+||
T Consensus 219 ~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aP 284 (377)
T 3cbl_A 219 VGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284 (377)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCH
T ss_pred HHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCH
Confidence 999999999999999999999999999999999999999999864332111 112346789998
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=293.93 Aligned_cols=268 Identities=22% Similarity=0.381 Sum_probs=190.5
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -..+....++.| .|+|++++| + ..|.|++|++.. ..++|+.|.... +
T Consensus 162 ~wyhg~i~---------r~~ae~~L~~~~~~~G~FLvR~s-~---~~~~~~lsv~~~---------~~v~h~~I~~~~~g 219 (613)
T 2ozo_A 162 PWYHSSLT---------REEAERKLYSGAQTDGKFLLRPR-K---EQGTYALSLIYG---------KTVYHYLISQDKAG 219 (613)
T ss_dssp TTBCTTCC---------HHHHHHHHSSSCCCTTCEEEEEC-S---STTEEEEEEEET---------TEEEEEEEEECTTC
T ss_pred CccccCCC---------HHHHHHHHhhcCCCCceEEEEec-C---CCCCEEEEEEEC---------CeEEEEEEEECCCC
Confidence 68887774 334444555434 799999987 2 468999999852 267899998654 6
Q ss_pred ceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCCCC-----------------------------------------
Q 021897 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYPT----------------------------------------- 121 (306)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~~----------------------------------------- 121 (306)
.|++. ....|. ++.|.| ..+.++++..|..+|...
T Consensus 220 ~~~~~-~~~~F~sl~~Lv~~y~~~~~~l~~~L~~pC~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (613)
T 2ozo_A 220 KYCIP-EGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPAR 298 (613)
T ss_dssp CEECT-TSCEESSHHHHHHHHHHCCTTCSSCCCSBCCC------------------------------------------
T ss_pred CEEEC-CCCCcCCHHHHHHHHhhCCCCceeccccccccccccccccccCcccCCCCccccccccccccccccCCCCCccc
Confidence 67765 233342 333332 233333332222222110
Q ss_pred --------------C-------CCC--CCCcceeeccCceecc-eeeeeccEEEEEEEE----CCeeEEEEEeeCCCCCh
Q 021897 122 --------------E-------GLE--NYDEWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNP 173 (306)
Q Consensus 122 --------------~-------~~~--~~~~~~i~~~~~~~~~-~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~ 173 (306)
. ... ....|.+...++.+.+ .||+|+||.||+|.+ ++..||||+++......
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~ 378 (613)
T 2ozo_A 299 ITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA 378 (613)
T ss_dssp -----------CCCCSCSSSSSCSCSSCCCCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST
T ss_pred cCCCCCCCCCCCccccccCCcCChhHhcccceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH
Confidence 0 000 0123555666666666 899999999999987 34579999997653322
Q ss_pred hHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Q 021897 174 EKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAY 253 (306)
Q Consensus 174 ~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~y 253 (306)
. .+.+.+|+.+|++++|||||++++++.. +.++|||||+++|+|.+++... ...+++..++.++.||+.||+|
T Consensus 379 ~-----~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~ 451 (613)
T 2ozo_A 379 D-----TEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKY 451 (613)
T ss_dssp T-----HHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHH
T ss_pred H-----HHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHH
Confidence 2 2578999999999999999999999977 4589999999999999999753 3568999999999999999999
Q ss_pred HHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC----ccCCCCCCcccCC
Q 021897 254 VHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 254 LH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~----~~~~~gt~~y~AP 306 (306)
||+++|+||||||+||||+.++.+||+|||+|+....... .....+|+.|+||
T Consensus 452 LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~AP 508 (613)
T 2ozo_A 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508 (613)
T ss_dssp HHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCH
T ss_pred HHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCH
Confidence 9999999999999999999999999999999986532221 1122456899998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=294.36 Aligned_cols=171 Identities=31% Similarity=0.563 Sum_probs=137.9
Q ss_pred cceeeccCceec-ceeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021897 129 EWTIDLRKLNMG-TAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (306)
Q Consensus 129 ~~~i~~~~~~~~-~~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (306)
+|.++.+.+.+. +.||+|+||.||+|.+ .++.||||+++....... ..+++.+|+.+|++++|||||++++
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~ 437 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMIG 437 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG----GHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 355555555554 4899999999999976 457899999976443322 1357899999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
++..+ .++|||||+++|+|.+++... ..+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||
T Consensus 438 ~~~~~-~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 438 ICEAE-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp EEESS-SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred EEecC-CEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcC
Confidence 99754 578999999999999999753 468999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCC----ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~AP 306 (306)
+|+....... .....+|+.|+||
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~AP 541 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAP 541 (635)
T ss_dssp HHHHTTC-------------CGGGSCH
T ss_pred CccccccCccccccccCCCCceeeeCh
Confidence 9986533221 2233567899998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=263.89 Aligned_cols=168 Identities=30% Similarity=0.474 Sum_probs=151.2
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
...+|++.+.||+|+||.||+|++ +++.||||++........ ..+.+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT----SLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 457899999999999999999997 788999999976554432 23578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999999999765 4599999999999999999999999999999999999999999999999999987665
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
.......+||+.|+||
T Consensus 167 ~~~~~~~~gt~~y~aP 182 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAP 182 (328)
T ss_dssp SCGGGTTSSSGGGCCH
T ss_pred CCccccccCCcceeCc
Confidence 5556677899999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=262.33 Aligned_cols=170 Identities=26% Similarity=0.392 Sum_probs=147.5
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+..++|++++.||+|+||.||+|+. +++.||||+++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence 4567899999999999999999998 6889999999743110 0111356889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999999999865 458999999999999999999999999999999999999999999999999998532
Q ss_pred -cCCCccCCCCCCcccCC
Q 021897 290 -QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 -~~~~~~~~~gt~~y~AP 306 (306)
........+||+.|+||
T Consensus 157 ~~~~~~~~~~gt~~y~aP 174 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAP 174 (337)
T ss_dssp CTTCCBCCCEECGGGCCG
T ss_pred cCCCcccccccChhhCCh
Confidence 33344566899999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=266.69 Aligned_cols=172 Identities=22% Similarity=0.376 Sum_probs=147.8
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (306)
..+..++|++++.||+|+||.||+|++ +++.||||++++....... ..+.+.+|..+++++ +||||+++++++.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~---~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHH---HHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 346678999999999999999999998 6789999999865433221 124577899999877 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
....+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence 999999999999999999999865 459999999999999999999999999999999999999999999999999998
Q ss_pred ee-ecCCCccCCCCCCcccCC
Q 021897 287 IE-VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~-~~~~~~~~~~gt~~y~AP 306 (306)
.. .........+||+.|+||
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aP 222 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAP 222 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCH
T ss_pred ecccCCCccccccCCcccCCc
Confidence 63 333445667899999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=258.56 Aligned_cols=176 Identities=36% Similarity=0.614 Sum_probs=143.6
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.+.|+++..+|++.+.||+|+||.||+|+++++.||||++......... .+.+.+|+.++++++||||+++++++.
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER----VNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4677888999999999999999999999999999999999766554332 357889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCcEEEEccc
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
....+++||||+++++|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 99999999999999999999975321 23899999999999999999999999 9999999999999999999999999
Q ss_pred CeeeeecCC-CccCCCCCCcccCC
Q 021897 284 VARIEVQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~-~~~~~~gt~~y~AP 306 (306)
+++...... ......||+.|+||
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aP 208 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAP 208 (309)
T ss_dssp -----------------CCTTSCH
T ss_pred CCccccccccccccCCCCccccCh
Confidence 998644332 23445799999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=261.27 Aligned_cols=170 Identities=22% Similarity=0.342 Sum_probs=140.9
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (306)
+..++|++.+.||+|+||.||+|++ +++.||||+++..... .....+.+.+|..+++.+ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~---~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL---QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc---chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 5568899999999999999999998 6789999999753211 111235678999999988 699999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999999999875 45999999999999999999999999999999999999999999999999999853
Q ss_pred e-cCCCccCCCCCCcccCC
Q 021897 289 V-QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~-~~~~~~~~~gt~~y~AP 306 (306)
. ........+||+.|+||
T Consensus 175 ~~~~~~~~~~~gt~~y~aP 193 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAP 193 (353)
T ss_dssp CC---------CCGGGCCH
T ss_pred ccCCccccccCCCcCeECh
Confidence 2 22334556899999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.31 Aligned_cols=171 Identities=35% Similarity=0.571 Sum_probs=147.8
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.+.+..++|++++.||+|+||.||+|++ +++.||+|++.... . ...+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 77 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--E----ETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--H----HHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence 4556788999999999999999999998 58899999885421 1 22367899999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
+....++||||+++++|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 78 KDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred cCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccce
Confidence 999999999999999999999864 3568999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCc---------------cCCCCCCcccCC
Q 021897 287 IEVQTEGM---------------TPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~---------------~~~~gt~~y~AP 306 (306)
........ ...+||+.|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCH
T ss_pred ecccccccccccccccccccccccccCCCcceeCH
Confidence 65432211 145799999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=267.20 Aligned_cols=173 Identities=20% Similarity=0.329 Sum_probs=152.7
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.+.+..++|++.+.||+|+||.||+|.+ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE---RNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4567788999999999999999999998 67889999986422111 111357889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
....+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 163 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence 999999999999999999999753 569999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCccCCCCCCcccCC
Q 021897 287 IEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~AP 306 (306)
...........+||+.|+||
T Consensus 164 ~~~~~~~~~~~~gt~~Y~aP 183 (384)
T 4fr4_A 164 MLPRETQITTMAGTKPYMAP 183 (384)
T ss_dssp ECCTTCCBCCCCSCGGGCCG
T ss_pred eccCCCceeccCCCccccCC
Confidence 77666666778999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=258.33 Aligned_cols=170 Identities=22% Similarity=0.392 Sum_probs=148.6
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (306)
+...+|++++.||+|+||.||+|++ +++.||||+++........ ..+.+.+|..+++++ +||||+++++++...
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHH---HHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchH---HHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 4567899999999999999999998 5789999999865443222 235688999999987 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999999999865 45999999999999999999999999999999999999999999999999999853
Q ss_pred e-cCCCccCCCCCCcccCC
Q 021897 289 V-QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~-~~~~~~~~~gt~~y~AP 306 (306)
. ........+||+.|+||
T Consensus 161 ~~~~~~~~~~~gt~~y~aP 179 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAP 179 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCH
T ss_pred cCCCCcccccCCCccccCc
Confidence 2 23344566899999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=262.77 Aligned_cols=170 Identities=22% Similarity=0.395 Sum_probs=148.8
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
..|++++.||+|+||.||+|+. +++.||||+++.............+.+.+|+.++++++||||+++++++.....+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 5688999999999999999998 68899999998655432211111357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEcccCeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~----~vkl~DFGla~~~ 288 (306)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 92 lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999653 4699999999999999999999999999999999999998777 7999999999977
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
.........+||+.|+||
T Consensus 170 ~~~~~~~~~~gt~~y~aP 187 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAP 187 (361)
T ss_dssp CTTCCCCCCCSCGGGCCH
T ss_pred CCCCccccCCCCccEECc
Confidence 665556667899999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=270.56 Aligned_cols=174 Identities=22% Similarity=0.338 Sum_probs=148.4
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
++.+..++|++++.||+|+||+||+|++ +++.||||++++...... ...+.+.+|..+++.++||||++++++|.
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR---AETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT---TTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 4456678999999999999999999998 578999999964211100 01124789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
+...+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+||||||||+||||+.++.+||+|||+|+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 999999999999999999999863 3569999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC--ccCCCCCCcccCC
Q 021897 287 IEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~AP 306 (306)
....... ....+||+.|+||
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~AP 245 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISP 245 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCH
T ss_pred hcccCCCcccccccCCcCeeCh
Confidence 6544332 2346899999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=269.48 Aligned_cols=172 Identities=24% Similarity=0.369 Sum_probs=147.8
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.+.+..++|++++.||+|+||.||+|++ +++.||+|++++...... ...+.+.+|+.+++.++||||+++++++.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT---CCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhh---HHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4556778999999999999999999998 678999999964211000 00134779999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
+...+|+||||+++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 99999999999999999999975 358999999999999999999999999999999999999999999999999998
Q ss_pred eeecCC--CccCCCCCCcccCC
Q 021897 287 IEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~--~~~~~~gt~~y~AP 306 (306)
...... .....+||+.|+||
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~AP 238 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISP 238 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCH
T ss_pred eeccCCcccccCCcCCccccCH
Confidence 654432 23456899999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=265.24 Aligned_cols=174 Identities=23% Similarity=0.333 Sum_probs=149.7
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
++.+..++|++.+.||+|+||+||+|+. +++.||||++++.... .....+.+.+|..++..++||||+++++++.
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~---~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML---KRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4556778999999999999999999998 6889999999642111 1111235789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
+...+|+||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 9999999999999999999998653 469999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC--ccCCCCCCcccCC
Q 021897 287 IEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~AP 306 (306)
....... ....+||+.|+||
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~AP 232 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSP 232 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCH
T ss_pred eccCCCccccceeccccCcCCH
Confidence 7654332 2345899999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=247.77 Aligned_cols=171 Identities=28% Similarity=0.553 Sum_probs=149.7
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
..|.++.++|++.+.||+|+||.||+|.+ +++.||+|++....... +.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH-------HHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 46899999999999999999999999998 77899999997654432 46889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
+....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 76 EQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred cCCceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence 999999999999999999999754 3468999999999999999999999999999999999999999999999999998
Q ss_pred eeecCC--CccCCCCCCcccCC
Q 021897 287 IEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~--~~~~~~gt~~y~AP 306 (306)
...... ......+|+.|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aP 176 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASP 176 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCH
T ss_pred cccccccccccCcccccccCCH
Confidence 543222 23344578889998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=249.80 Aligned_cols=164 Identities=27% Similarity=0.444 Sum_probs=145.4
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
..+|++.+.||+|+||.||+|.. +++.||||++....... .+.+.+|+.+++.++||||+++++++.....+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH------HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 46788999999999999999986 78899999997544332 24688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999999999763 5899999999999999999999999999999999999999999999999999865433
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. .....+||+.|+||
T Consensus 170 ~~~~~~~~gt~~y~aP 185 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAP 185 (297)
T ss_dssp TCCBCCCCSCGGGCCH
T ss_pred ccccCCccCCcCccCh
Confidence 3 23456899999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=259.90 Aligned_cols=175 Identities=31% Similarity=0.553 Sum_probs=149.1
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCC
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (306)
...|.+..++|++++.||+|+||.||+|++. +..||||+++..... ...+.+.+|+.+++++ +||
T Consensus 73 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp 147 (370)
T 2psq_A 73 DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIGKHK 147 (370)
T ss_dssp CTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-----HHHHHHHHHHHHHHHSCCCT
T ss_pred cccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-----HHHHHHHHHHHHHHHhcCCC
Confidence 3467888899999999999999999999862 347999999754321 1246789999999999 899
Q ss_pred CeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021897 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (306)
Q Consensus 197 niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHr 262 (306)
||+++++++.....+|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||
T Consensus 148 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 227 (370)
T 2psq_A 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227 (370)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 99999999999999999999999999999998643 2357899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 263 DLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
||||+||||+.++.+||+|||+|+...... ......+|+.|+||
T Consensus 228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 274 (370)
T 2psq_A 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274 (370)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence 999999999999999999999998654322 12334578899998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=248.68 Aligned_cols=168 Identities=25% Similarity=0.445 Sum_probs=142.8
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++.+.||+|+||.||+|++ +++.||+|++........ ...+.+.+|+.++++++||||+++++++.....+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE---ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH---HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 46899999999999999999987 678999999976544332 2346789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999999999865 45899999999999999999999999999999999999999999999999999865433
Q ss_pred C--CccCCCCCCcccCC
Q 021897 292 E--GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~--~~~~~~gt~~y~AP 306 (306)
. .....+||+.|+||
T Consensus 165 ~~~~~~~~~gt~~y~aP 181 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSP 181 (294)
T ss_dssp ----------CCSSCCH
T ss_pred cccccCccccCccccCH
Confidence 2 12335799999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=255.53 Aligned_cols=168 Identities=26% Similarity=0.421 Sum_probs=146.5
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+..++|++.+.||+|+||.||+|+. +++.||+|+++...... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 79 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 79 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence 3467899999999999999999988 68899999997422110 011356789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999999999864 458999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
. .....+||+.|+||
T Consensus 158 ~--~~~~~~gt~~y~aP 172 (318)
T 1fot_A 158 D--VTYTLCGTPDYIAP 172 (318)
T ss_dssp S--CBCCCCSCTTTCCH
T ss_pred C--ccccccCCccccCH
Confidence 3 23456899999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=258.30 Aligned_cols=173 Identities=18% Similarity=0.272 Sum_probs=148.9
Q ss_pred CCCCcceeeccCceecceeeeeccEEEEEEE-------ECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---
Q 021897 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT-------YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--- 194 (306)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--- 194 (306)
....++++..++|.+.+.||+|+||.||+|+ ..++.||||+++... ...+.+|+.+++.++
T Consensus 55 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~l~~~~ 125 (365)
T 3e7e_A 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---------PWEFYIGTQLMERLKPSM 125 (365)
T ss_dssp CSSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---------HHHHHHHHHHHHHSCGGG
T ss_pred ccceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---------hhHHHHHHHHHHHhhhhh
Confidence 3456778888999999999999999999993 267899999996532 135778888888887
Q ss_pred CCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 021897 195 HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRR---QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (306)
Q Consensus 195 h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv 271 (306)
|+||+++++++......||||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 126 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll 205 (365)
T 3e7e_A 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL 205 (365)
T ss_dssp GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE
T ss_pred hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEe
Confidence 999999999999999999999999999999999753 24569999999999999999999999999999999999999
Q ss_pred cC-----------CCcEEEEcccCeeeee---cCCCccCCCCCCcccCC
Q 021897 272 SA-----------DKSIKIADFGVARIEV---QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 272 ~~-----------~~~vkl~DFGla~~~~---~~~~~~~~~gt~~y~AP 306 (306)
+. ++.+||+|||+|+... ........+||+.|+||
T Consensus 206 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP 254 (365)
T 3e7e_A 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV 254 (365)
T ss_dssp CGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH
T ss_pred cccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCCh
Confidence 98 8999999999997543 22234556899999998
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=255.03 Aligned_cols=170 Identities=22% Similarity=0.392 Sum_probs=148.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
..|++++.||+|+||.||+|+. +++.||||+++.............+.+.+|+.++++++||||+++++++.....++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5688999999999999999998 58899999998654432111111357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEcccCeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~----~vkl~DFGla~~~ 288 (306)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999653 5689999999999999999999999999999999999999887 8999999999877
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
.........+||+.|+||
T Consensus 169 ~~~~~~~~~~gt~~y~aP 186 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAP 186 (326)
T ss_dssp CTTSCCCCCCSCTTTCCH
T ss_pred CCCCccccccCCcCcCCc
Confidence 655555667899999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=255.76 Aligned_cols=166 Identities=25% Similarity=0.408 Sum_probs=147.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++.+.||+|+||.||+|.+ +++.||||++......... .+.+.+|+.++++++||||+++++++.+....|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 5788999999999999999998 6889999999876554322 357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC---CcEEEEcccCeeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARIEV 289 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~---~~vkl~DFGla~~~~ 289 (306)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 105 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999998753 468999999999999999999999999999999999999865 459999999998766
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
........+||+.|+||
T Consensus 183 ~~~~~~~~~gt~~y~aP 199 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSP 199 (362)
T ss_dssp TCCSCCCSCSCTTTCCH
T ss_pred CCcccccCCCCccccCH
Confidence 55555667899999998
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=273.03 Aligned_cols=172 Identities=23% Similarity=0.339 Sum_probs=151.7
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+..++|++.+.||+|+||.||+|++ +++.||||++....... ......+.+|+.+++.++||||+++++++.+..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 5668899999999999999999998 68899999996422111 111356789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999999987655569999999999999999999999999999999999999999999999999998776
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
........+||+.|+||
T Consensus 338 ~~~~~~~~~GT~~Y~AP 354 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAP 354 (576)
T ss_dssp TTCCEECCCSCGGGCCH
T ss_pred cCccccccCCCccccCH
Confidence 55555667999999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=257.47 Aligned_cols=171 Identities=24% Similarity=0.379 Sum_probs=145.1
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRK 207 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 207 (306)
.+..++|++.+.||+|+||.||+|++ +++.||||+++...... ....+.+.+|..+++.+ +||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh---hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 35668999999999999999999998 68899999997532100 01124577899998876 89999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999999865 3589999999999999999999999999999999999999999999999999985
Q ss_pred eec-CCCccCCCCCCcccCC
Q 021897 288 EVQ-TEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~-~~~~~~~~gt~~y~AP 306 (306)
... .......+||+.|+||
T Consensus 168 ~~~~~~~~~~~~gt~~y~aP 187 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAP 187 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCH
T ss_pred cccCCCcccCCCCCcccCCh
Confidence 432 2334566899999998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=247.82 Aligned_cols=173 Identities=28% Similarity=0.544 Sum_probs=148.3
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
....|+++.++|++.+.||+|+||.||+|.+ ++..||||+++...... +++.+|+.++++++||||++++++
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH-------HHHHHHHHHHhcCCCCCEeeEEEE
Confidence 4678999999999999999999999999998 55689999998654432 468899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
+.....+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccc
Confidence 999999999999999999999997632 4599999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC--CccCCCCCCcccCC
Q 021897 285 ARIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~AP 306 (306)
++...... ......+|+.|+||
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aP 190 (283)
T 3gen_A 167 SRYVLDDEYTSSVGSKFPVRWSPP 190 (283)
T ss_dssp GGGBCCHHHHSTTSTTSCGGGCCH
T ss_pred cccccccccccccCCccCcccCCH
Confidence 97543221 22334577889998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=251.88 Aligned_cols=167 Identities=25% Similarity=0.453 Sum_probs=139.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC---
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 209 (306)
.+|++.+.||+|+||.||+|++ +++.||||+++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-----REKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH-----HHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 5788999999999999999998 688999999986543222 357899999999999999999999986543
Q ss_pred ------------------------------------------------------eEEEEEeecCCCCHHHHHHhhCC-CC
Q 021897 210 ------------------------------------------------------VWCIVTEYAKGGSVRQFLTRRQN-RA 234 (306)
Q Consensus 210 ------------------------------------------------------~~~iv~E~~~~gsL~~~l~~~~~-~~ 234 (306)
.+++||||+++++|.+++..... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999986432 23
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-------------CccCCCCCC
Q 021897 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-------------GMTPETGTY 301 (306)
Q Consensus 235 ~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-------------~~~~~~gt~ 301 (306)
.++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 5666789999999999999999999999999999999999999999999998754431 223457999
Q ss_pred cccCC
Q 021897 302 RWMAP 306 (306)
Q Consensus 302 ~y~AP 306 (306)
.|+||
T Consensus 241 ~y~aP 245 (332)
T 3qd2_B 241 LYMSP 245 (332)
T ss_dssp GGSCH
T ss_pred CccCh
Confidence 99998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=252.63 Aligned_cols=173 Identities=23% Similarity=0.344 Sum_probs=138.9
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
..+..++|++.+.||+|+||.||+++. +++.||||+++....... ......+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC----------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh--hhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 346678999999999999999999986 578999999976533211 1113467899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
+.....+|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999999999865 4589999999999999999999999999999999999999999999999999
Q ss_pred eeeeec-CCCccCCCCCCcccCC
Q 021897 285 ARIEVQ-TEGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~-~~~~~~~~gt~~y~AP 306 (306)
++.... .......+||+.|+||
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aP 190 (327)
T 3a62_A 168 CKESIHDGTVTHTFCGTIEYMAP 190 (327)
T ss_dssp C----------CTTSSCCTTSCH
T ss_pred ccccccCCccccccCCCcCccCH
Confidence 975432 2234456899999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=257.19 Aligned_cols=178 Identities=33% Similarity=0.551 Sum_probs=152.2
Q ss_pred CCCCCcceeeccCceecceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-
Q 021897 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL- 193 (306)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 193 (306)
......|++..++|++++.||+|+||.||+|++. +..||||+++..... ...+.+.+|+.+++++
T Consensus 58 ~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~ 132 (382)
T 3tt0_A 58 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-----KDLSDLISEMEMMKMIG 132 (382)
T ss_dssp CCCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHHHC
T ss_pred cccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-----HHHHHHHHHHHHHHHhc
Confidence 3445678999999999999999999999999862 257999999764322 1236788999999999
Q ss_pred CCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 021897 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGF 259 (306)
Q Consensus 194 ~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~i 259 (306)
+||||+++++++.....+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+|
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 212 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 89999999999999999999999999999999998754 2358999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 260 iHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
+||||||+||||+.++.+||+|||+|+...... ......+|+.|+||
T Consensus 213 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 262 (382)
T 3tt0_A 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 262 (382)
T ss_dssp CCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred ecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence 999999999999999999999999998654322 23334678899998
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=255.21 Aligned_cols=170 Identities=32% Similarity=0.455 Sum_probs=147.4
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
-..|.++..+|++++.||+|+||.||+|++.++.||||+++.... ....+.+|+.++++++||||+++++++.
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-------QSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCch-------HHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 356788999999999999999999999999999999999964211 1234567999999999999999999998
Q ss_pred eCC----eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCcEEEc
Q 021897 207 KRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL----------GFIHRDLKSDNLLIS 272 (306)
Q Consensus 207 ~~~----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~----------~iiHrDlkp~NILv~ 272 (306)
... .+++||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence 743 479999999999999999763 489999999999999999999999 999999999999999
Q ss_pred CCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 273 ADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 273 ~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
.++.+||+|||+|+....... ....+||+.|+||
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aP 202 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCH
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCH
Confidence 999999999999987554332 2335799999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=257.52 Aligned_cols=170 Identities=26% Similarity=0.343 Sum_probs=145.2
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (306)
+...+|++.+.||+|+||.||+|++ +++.||||+++...... ....+.+.+|..+++.+ +||+|+++++++...
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~---~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc---chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 4568899999999999999999998 46789999997532110 11135678999999988 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999999999865 35999999999999999999999999999999999999999999999999999853
Q ss_pred e-cCCCccCCCCCCcccCC
Q 021897 289 V-QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~-~~~~~~~~~gt~~y~AP 306 (306)
. ........+||+.|+||
T Consensus 172 ~~~~~~~~~~~gt~~y~aP 190 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAP 190 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCH
T ss_pred ccCCcccccccCCccccCh
Confidence 3 23334567899999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=256.94 Aligned_cols=167 Identities=25% Similarity=0.443 Sum_probs=146.8
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
..+|++.+.||+|+||.||+|++ +++.||||++...... .....+.+.+|+.+++.++||||+++++++..+..+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK---KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc---chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 46899999999999999999998 7889999998642111 011124688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||+ +|+|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999999 68999998765 45999999999999999999999999999999999999999999999999999876665
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
......+||+.|+||
T Consensus 162 ~~~~~~~gt~~y~aP 176 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAP 176 (336)
T ss_dssp BTTCCCTTSTTTSCG
T ss_pred cccccccCCcCcCCH
Confidence 556677899999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=256.45 Aligned_cols=166 Identities=28% Similarity=0.391 Sum_probs=137.8
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
....+|++.+.||+|+||.||+++. +++.||||++....... +.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-------ENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-------HHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-------HHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 4567899999999999999999998 68899999998654432 35779999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc--EEEEcccCeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARI 287 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~--vkl~DFGla~~ 287 (306)
.+|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+.
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999999999765 35999999999999999999999999999999999999987765 99999999985
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
..........+||+.|+||
T Consensus 168 ~~~~~~~~~~~gt~~y~aP 186 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAP 186 (361)
T ss_dssp -------------CTTSCH
T ss_pred ccccCCCCCCcCCCCcCCh
Confidence 5444445566899999998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=252.88 Aligned_cols=164 Identities=17% Similarity=0.272 Sum_probs=145.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|+||.||+|++ +++.+|+|+++.... ....+.+|+.+++.++||||+++++++.+...++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-------DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-------cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 6788999999999999999998 678999999864321 1246889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC--CCcEEEEcccCeeeeec
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEVQ 290 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~--~~~vkl~DFGla~~~~~ 290 (306)
+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999999999653 346899999999999999999999999999999999999987 78999999999987765
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
........||+.|+||
T Consensus 157 ~~~~~~~~gt~~y~aP 172 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAP 172 (321)
T ss_dssp TCEEEEEESCGGGSCH
T ss_pred CCccccccCChhhcCc
Confidence 5545556799999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=242.78 Aligned_cols=170 Identities=28% Similarity=0.520 Sum_probs=148.9
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
.|++..++|++.+.||+|+||.||+|++ ++..||||+++...... +.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-------DEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH-------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 5778889999999999999999999998 55689999997655432 468899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred CCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 99999999999999999999865 34589999999999999999999999999999999999999999999999999986
Q ss_pred eecCCC--ccCCCCCCcccCC
Q 021897 288 EVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~--~~~~~gt~~y~AP 306 (306)
...... .....+|+.|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aP 174 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAP 174 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCH
T ss_pred cchhhhhcccCCCcCcccCCH
Confidence 543322 2233567789998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=250.69 Aligned_cols=169 Identities=24% Similarity=0.350 Sum_probs=146.6
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 209 (306)
...+|++.+.||+|+||.||+|++ +++.||||+++....... .+.+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 346789999999999999999998 488999999975332211 246789999999999999999999998765
Q ss_pred -eEEEEEeecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE----cCCCcEEEEccc
Q 021897 210 -VWCIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADFG 283 (306)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv----~~~~~vkl~DFG 283 (306)
.+++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 78999999999999999986432 348999999999999999999999999999999999999 778889999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|+............||+.|+||
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aP 184 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHP 184 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCH
T ss_pred CceecCCCCceeecccCCCccCH
Confidence 99987666555667899999998
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=254.01 Aligned_cols=173 Identities=18% Similarity=0.287 Sum_probs=150.4
Q ss_pred ceeeccCceecceeeee--ccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 130 WTIDLRKLNMGTAFAQG--AFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G--~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
+.....+|++++.||+| +||.||+|++ +++.||||+++....... ..+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE----MVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH----HHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 34466889999999999 9999999998 588999999986544332 346788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.....+|+||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 99999999999999999999998765567999999999999999999999999999999999999999999999999998
Q ss_pred eeeecC--------CCccCCCCCCcccCC
Q 021897 286 RIEVQT--------EGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~--------~~~~~~~gt~~y~AP 306 (306)
...... ......+||+.|+||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 204 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSP 204 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred eeeccccccccccccccccccccccccCH
Confidence 643221 112334789999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=246.95 Aligned_cols=169 Identities=21% Similarity=0.278 Sum_probs=140.3
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~ 208 (306)
+-.++|++.++||+|+||.||+|.+ +++.||||++......... ...+.+|+..+.+ .+||||++++++|.+.
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH----HHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 3347899999999999999999998 6889999998765444322 2344455555544 4899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred CEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999999999 679999988753 56999999999999999999999999999999999999999999999999999876
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
..........||+.|+||
T Consensus 208 ~~~~~~~~~~gt~~y~aP 225 (311)
T 3p1a_A 208 GTAGAGEVQEGDPRYMAP 225 (311)
T ss_dssp C------CCCCCGGGCCG
T ss_pred ccCCCCcccCCCccccCH
Confidence 655555566799999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=256.29 Aligned_cols=168 Identities=25% Similarity=0.333 Sum_probs=146.8
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
....+|++++.||+|+||.||+|++ +++.||||+++...... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3457899999999999999999998 68899999996432111 111356889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999999999875 358999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.. ....+||+.|+||
T Consensus 193 ~~--~~~~~gt~~y~aP 207 (350)
T 1rdq_E 193 GR--TWTLCGTPEALAP 207 (350)
T ss_dssp SC--BCCCEECGGGCCH
T ss_pred CC--cccccCCccccCH
Confidence 32 3456899999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=251.42 Aligned_cols=171 Identities=28% Similarity=0.492 Sum_probs=144.3
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
+++...+|++.+.||+|+||.||+|.+ .+..||||+++...... ..+.+.+|+.++++++||||++++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-----QRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH-----HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 457778999999999999999999988 23469999997543221 23678999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
+.....+|+||||+++++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 99999999999999999999999754 34699999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCCC----ccCCCCCCcccCC
Q 021897 285 ARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~AP 306 (306)
++....... .....+|+.|+||
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aP 223 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAP 223 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCH
T ss_pred ccccccCccceeeccCCCCcccccCH
Confidence 986543221 2223467889998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=258.40 Aligned_cols=170 Identities=24% Similarity=0.375 Sum_probs=139.4
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMM-LATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~ 208 (306)
+..++|++++.||+|+||.||+|++ +++.||||+++........ ....+.+|..+ ++.++||||+++++++...
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~---~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK---EEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH---HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 4567899999999999999999998 5778999999765433221 12456677776 5778999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999999999865 45899999999999999999999999999999999999999999999999999853
Q ss_pred e-cCCCccCCCCCCcccCC
Q 021897 289 V-QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~-~~~~~~~~~gt~~y~AP 306 (306)
. ........+||+.|+||
T Consensus 190 ~~~~~~~~~~~gt~~y~aP 208 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAP 208 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCH
T ss_pred ccCCCccccccCCccccCH
Confidence 2 23344567899999998
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=242.31 Aligned_cols=170 Identities=29% Similarity=0.447 Sum_probs=150.9
Q ss_pred cceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
.+.++.++|++.+.||+|+||.||+|+++++.||||+++........ .+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRK----SRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHH----HHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHH----HHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 45678899999999999999999999999999999999876544332 35789999999999999999999999877
Q ss_pred --CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 209 --MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
..+++||||+++|+|.+++.......+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence 78899999999999999998765556899999999999999999999999 99999999999999999999999998
Q ss_pred eeeeecCCCccCCCCCCcccCC
Q 021897 285 ARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~AP 306 (306)
+... ......||+.|+||
T Consensus 160 ~~~~----~~~~~~~t~~y~aP 177 (271)
T 3kmu_A 160 KFSF----QSPGRMYAPAWVAP 177 (271)
T ss_dssp CCTT----SCTTCBSCGGGSCH
T ss_pred eeee----cccCccCCccccCh
Confidence 7642 23345789999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=243.47 Aligned_cols=166 Identities=23% Similarity=0.412 Sum_probs=144.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|++ +++.||||+++........ .+.+.+|+.++++++||||+++++++.....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc----chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence 5789999999999999999998 6789999999865543322 256789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~- 291 (306)
+||||+++ +|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred EEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99999975 777776653 356999999999999999999999999999999999999999999999999999865432
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
.......||+.|+||
T Consensus 156 ~~~~~~~~t~~y~aP 170 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPP 170 (292)
T ss_dssp SCCCSCCSCGGGCCH
T ss_pred ccccCCccccCCcCh
Confidence 234456799999998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=248.51 Aligned_cols=175 Identities=27% Similarity=0.566 Sum_probs=154.1
Q ss_pred CCCCcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
..++.|++..++|++.+.||+|+||.||+|.+ ++..||+|++...... .+.+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~ 75 (288)
T 3kfa_A 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLL 75 (288)
T ss_dssp TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH-------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH-------HHHHHHHHHHHHhCCCCCEeeEE
Confidence 45789999999999999999999999999998 4789999999753321 25788999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
+++......++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+||
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Df 155 (288)
T 3kfa_A 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 155 (288)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccC
Confidence 99999999999999999999999998766677999999999999999999999999999999999999999999999999
Q ss_pred cCeeeeecCCC--ccCCCCCCcccCC
Q 021897 283 GVARIEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~--~~~~~gt~~y~AP 306 (306)
|+++....... .....+|+.|+||
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~y~aP 181 (288)
T 3kfa_A 156 GLSRLMTGDTYTAHAGAKFPIKWTAP 181 (288)
T ss_dssp CGGGTSCSSSSEEETTEEECGGGCCH
T ss_pred ccceeccCCccccccCCccccCcCCh
Confidence 99986543321 2223467889998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=247.57 Aligned_cols=177 Identities=31% Similarity=0.525 Sum_probs=151.8
Q ss_pred CCCCcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCC
Q 021897 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHL 196 (306)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 196 (306)
....+|++..++|++++.||+|+||.||+|++ +++.||||+++...... ..+.+.+|+.+++++ +||
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~ 87 (313)
T 1t46_A 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-----EREALMSELKVLSYLGNHM 87 (313)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCT
T ss_pred CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH-----HHHHHHHHHHHHhhcccCC
Confidence 34577999999999999999999999999985 45789999997543321 236788999999999 899
Q ss_pred CeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021897 197 NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------------RAVPLKLAVKQALDVARGMAYVHGLGFI 260 (306)
Q Consensus 197 niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~qi~~gl~yLH~~~ii 260 (306)
||+++++++......++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+
T Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 167 (313)
T 1t46_A 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI 167 (313)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 999999999999999999999999999999986542 2489999999999999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 261 HRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 261 HrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
||||||+|||++.++.+||+|||+++....... .....||+.|+||
T Consensus 168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 216 (313)
T 1t46_A 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216 (313)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence 999999999999999999999999986543322 2233577889998
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=251.68 Aligned_cols=165 Identities=27% Similarity=0.487 Sum_probs=142.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|+||.||+|.+ +++.||||++....... ..+.+.+|+.+++.++||||+++++++.+....|
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-----hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 6788999999999999999988 68899999997543322 1246889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999999998643 459999999999999999999999999999999999999999999999999998654222
Q ss_pred ---CccCCCCCCcccCC
Q 021897 293 ---GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ---~~~~~~gt~~y~AP 306 (306)
.....+||+.|+||
T Consensus 160 ~~~~~~~~~gt~~y~aP 176 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAP 176 (323)
T ss_dssp EECCBCSCCSCGGGSCH
T ss_pred cccccCCCccCcCccCc
Confidence 23456899999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=264.39 Aligned_cols=173 Identities=25% Similarity=0.379 Sum_probs=139.1
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.+.+..++|++.+.||+|+||.||+|.. +++.||||+++...... ......+.+|+.+++.++||||+++++++.
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC----------------CCCCCSCTTSCCEEEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh---hHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 4556778999999999999999999987 68899999997532111 112356789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
....+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 999999999999999999999865 458999999999999999999998 99999999999999999999999999999
Q ss_pred eeee-cCCCccCCCCCCcccCC
Q 021897 286 RIEV-QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~-~~~~~~~~~gt~~y~AP 306 (306)
+... ........+||+.|+||
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aP 318 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAP 318 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCH
T ss_pred eeccCCCcccccccCCccccCH
Confidence 8532 23334567899999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=252.47 Aligned_cols=174 Identities=29% Similarity=0.509 Sum_probs=148.2
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEECC-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (306)
..|.+..++|++++.||+|+||.||+|++.+ +.||||+++..... ...+.+.+|+.++++++||||++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~ 114 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIVK 114 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEEE
Confidence 4567788999999999999999999998843 78999999754321 22467899999999999999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021897 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------------------NRAVPLKLAVKQALDVARGMAYVHGLG 258 (306)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~ 258 (306)
+++++......|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++|
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998642 156899999999999999999999999
Q ss_pred ccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
|+||||||+|||++.++.+||+|||+++...... ......+|+.|+||
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 245 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence 9999999999999999999999999997543221 12334678999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=247.47 Aligned_cols=176 Identities=27% Similarity=0.534 Sum_probs=150.6
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 198 (306)
....|++..++|++++.||+|+||.||+|++ +++.||||+++..... ...+.+.+|+.++++++||||
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~i 88 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP-----SELRDLLSEFNVLKQVNHPHV 88 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHTTCCCTTB
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH-----HHHHHHHHHHHHHhhCCCCce
Confidence 3467889999999999999999999999986 2378999999754321 123678899999999999999
Q ss_pred eeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCC----------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 021897 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN----------------------RAVPLKLAVKQALDVARGMAYVHG 256 (306)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~gl~yLH~ 256 (306)
+++++++......++||||+++++|.+++..... ..+++..++.++.||+.||+|||+
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999986432 348899999999999999999999
Q ss_pred CCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 257 ~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+||+||||||+|||++.++.+||+|||+++....... .....+|+.|+||
T Consensus 169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 221 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI 221 (314)
T ss_dssp TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence 9999999999999999999999999999986543322 2334578899998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=252.50 Aligned_cols=174 Identities=29% Similarity=0.508 Sum_probs=146.7
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCee
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 199 (306)
.+|+++.++|++++.||+|+||.||+|++ .++.||||+++...... ..+.+.+|+.+++++ .||||+
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-----EREALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH-----HHHHHHHHHHHHHhhcCCCCee
Confidence 46899999999999999999999999986 34589999997543221 135788999999999 899999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021897 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (306)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~gl~yLH~~~ 258 (306)
++++++.....+++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++|
T Consensus 113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986432 23789999999999999999999999
Q ss_pred ccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|+||||||+|||++.++.+||+|||+++....... .....||+.|+||
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 243 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 243 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence 99999999999999999999999999986543322 1233577899998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=258.40 Aligned_cols=166 Identities=23% Similarity=0.355 Sum_probs=144.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|+||.||+|.. +++.+|+|++......... .+.+.+|+.+++.++||||+++++++.+....|
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHH----HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 5788999999999999999987 7889999999876543222 357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc---CCCcEEEEcccCeeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEV 289 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~---~~~~vkl~DFGla~~~~ 289 (306)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999999864 4599999999999999999999999999999999999998 46789999999998654
Q ss_pred cCC-CccCCCCCCcccCC
Q 021897 290 QTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~-~~~~~~gt~~y~AP 306 (306)
... .....+||+.|+||
T Consensus 165 ~~~~~~~~~~gt~~Y~AP 182 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSP 182 (444)
T ss_dssp TTCCBCCCSCSCGGGCCH
T ss_pred CCCceeecccCCcccCCH
Confidence 432 23456899999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=263.77 Aligned_cols=170 Identities=26% Similarity=0.468 Sum_probs=150.0
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+...+|.+++.||+|+||.||+|++ +++.||||++...... .....+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR---SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH---HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4567899999999999999999998 6889999999742211 1112357889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999999999965 3569999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
........+||+.|+||
T Consensus 168 ~~~~~~~~~gt~~y~aP 184 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAP 184 (476)
T ss_dssp TTCCBCCCCSCSTTCCH
T ss_pred ccccccccCCCcCeECh
Confidence 65556677899999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=254.80 Aligned_cols=175 Identities=29% Similarity=0.552 Sum_probs=147.2
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCe
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNI 198 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 198 (306)
...|+++.++|++++.||+|+||.||+|++ +++.||||+++...... ..+.+.+|+.+++++ +||||
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-----HHHHHHHHHHHHHhhcCCcce
Confidence 467999999999999999999999999985 34789999997543322 135789999999999 78999
Q ss_pred eeEEEEEEeCC-eEEEEEeecCCCCHHHHHHhhCC---------------------------------------------
Q 021897 199 VRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQN--------------------------------------------- 232 (306)
Q Consensus 199 v~l~~~~~~~~-~~~iv~E~~~~gsL~~~l~~~~~--------------------------------------------- 232 (306)
+++++++.+.. .+++||||+++|+|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 99999998754 48999999999999999986432
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 233 -------------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 233 -------------------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 128899999999999999999999999999999999999999999999999998543322
Q ss_pred --CccCCCCCCcccCC
Q 021897 293 --GMTPETGTYRWMAP 306 (306)
Q Consensus 293 --~~~~~~gt~~y~AP 306 (306)
......||+.|+||
T Consensus 249 ~~~~~~~~~t~~y~aP 264 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAP 264 (359)
T ss_dssp CEEC--CEECGGGCCH
T ss_pred chhccccCCCceeECh
Confidence 12334688999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=242.13 Aligned_cols=171 Identities=32% Similarity=0.568 Sum_probs=148.0
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
++|++..++|++.+.||+|+||.||+|.+ .+..||||+++...... +.+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-------DAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccH-------HHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 67999999999999999999999999998 45689999997654332 46889999999999999999999987
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
.. ..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++
T Consensus 79 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 79 QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp SS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CC-CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 54 47899999999999999975433468999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC--ccCCCCCCcccCC
Q 021897 287 IEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~--~~~~~gt~~y~AP 306 (306)
....... .....+|+.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aP 179 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAP 179 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCH
T ss_pred cccCcccccccCCCCccCccCh
Confidence 6543321 2234577889998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=246.65 Aligned_cols=172 Identities=27% Similarity=0.394 Sum_probs=140.9
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhH--------------------HHHHHHHHHHHHHH
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEK--------------------AQVMEQQFQQEVMM 189 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~~E~~~ 189 (306)
+...+|++.+.||+|+||.||+|+. +++.||||++......... .....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4567899999999999999999987 6889999999765432110 01123568899999
Q ss_pred HHhCCCCCeeeEEEEEEe--CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021897 190 LATLKHLNIVRFIGACRK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (306)
Q Consensus 190 l~~l~h~niv~l~~~~~~--~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~ 267 (306)
+++++||||+++++++.. ...+|+||||+++++|.+++. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999999987 568999999999999988653 346999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEcccCeeeeecCC-CccCCCCCCcccCC
Q 021897 268 NLLISADKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 268 NILv~~~~~vkl~DFGla~~~~~~~-~~~~~~gt~~y~AP 306 (306)
|||++.++.+||+|||+++...... ......||+.|+||
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 206 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAP 206 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCG
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccCh
Confidence 9999999999999999998754332 23456799999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=246.40 Aligned_cols=167 Identities=27% Similarity=0.403 Sum_probs=141.1
Q ss_pred ccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.++|++.+.||+|+||.||+|++ +++.||||+++...... ...+.+.+|+.++++++||||+++++++.....++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE----GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC----------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc----hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 47889999999999999999998 78899999997543322 12357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~- 291 (306)
+||||+++ +|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99999975 888888754 345899999999999999999999999999999999999999999999999999865422
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
.......||+.|+||
T Consensus 174 ~~~~~~~~t~~y~aP 188 (311)
T 3niz_A 174 RSYTHEVVTLWYRAP 188 (311)
T ss_dssp C---CCCCCCTTCCH
T ss_pred ccccCCcccCCcCCH
Confidence 233455799999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=252.88 Aligned_cols=171 Identities=21% Similarity=0.348 Sum_probs=143.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|++.+.||+|+||.||+|++ +++.||||++......... ....+.+.+|+.+++.++||||+++++++.....+|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP-GLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS-SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc-cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5788999999999999999988 6889999998632110000 001256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc---EEEEcccCeee
Q 021897 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARI 287 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~---vkl~DFGla~~ 287 (306)
+||||+++++|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888653 2345899999999999999999999999999999999999986654 99999999987
Q ss_pred eecCCC-ccCCCCCCcccCC
Q 021897 288 EVQTEG-MTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~-~~~~~gt~~y~AP 306 (306)
...... ....+||+.|+||
T Consensus 183 ~~~~~~~~~~~~gt~~y~aP 202 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAP 202 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCH
T ss_pred ecCCCeeecCCcCCcCccCH
Confidence 654332 3456899999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=239.36 Aligned_cols=170 Identities=29% Similarity=0.565 Sum_probs=149.2
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
+|.++.++|++.+.||+|+||.||+|.+ +++.||+|+++...... +.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH-------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 6889999999999999999999999998 77899999997654432 468899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
....++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred CCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 99999999999999999999764 34689999999999999999999999999999999999999999999999999975
Q ss_pred eecCC--CccCCCCCCcccCC
Q 021897 288 EVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~--~~~~~~gt~~y~AP 306 (306)
..... ......+|+.|+||
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aP 174 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASP 174 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCH
T ss_pred cccccccccccccccccccCh
Confidence 43221 22334678899998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=265.32 Aligned_cols=172 Identities=23% Similarity=0.303 Sum_probs=148.6
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+...+|++.+.||+|+||.||+|++ +++.||||++....... ....+.+.+|+.++++++||||+++++++....
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK---RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh---hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 4567899999999999999999998 68899999996422111 111356889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
.+|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999999997643 34699999999999999999999999999999999999999999999999999987
Q ss_pred eecCCC-ccCCCCCCcccCC
Q 021897 288 EVQTEG-MTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~-~~~~~gt~~y~AP 306 (306)
...... ....+||+.|+||
T Consensus 339 ~~~~~~~~~~~~GT~~Y~AP 358 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAP 358 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCH
T ss_pred ccCCCcccccccCCccccCh
Confidence 654433 3345899999998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-32 Score=240.80 Aligned_cols=175 Identities=27% Similarity=0.517 Sum_probs=146.7
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCee
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV 199 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 199 (306)
..+...+..+.|++.+.||+|+||.||+|++ +++.||||+++....... .+.+.+|+.++++++||||+
T Consensus 12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~ 86 (302)
T 4e5w_A 12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-----IADLKKEIEILRNLYHENIV 86 (302)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC-----HHHHHHHHHHHHTCCCTTBC
T ss_pred ecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh-----HHHHHHHHHHHHhCCCCCee
Confidence 3455566778899999999999999999985 678999999975432211 25788999999999999999
Q ss_pred eEEEEEEeC--CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcE
Q 021897 200 RFIGACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277 (306)
Q Consensus 200 ~l~~~~~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~v 277 (306)
++++++... ..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp CEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCE
Confidence 999999876 67899999999999999997653 458999999999999999999999999999999999999999999
Q ss_pred EEEcccCeeeeecCC----CccCCCCCCcccCC
Q 021897 278 KIADFGVARIEVQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 278 kl~DFGla~~~~~~~----~~~~~~gt~~y~AP 306 (306)
||+|||+++...... ......||+.|+||
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 198 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCH
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCC
Confidence 999999998765432 12345688899998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=248.07 Aligned_cols=170 Identities=22% Similarity=0.393 Sum_probs=148.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|++++.||+|+||.||+|+. +++.||||+++.............+.+.+|+.++++++||||+++++++.....++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 5788999999999999999998 68899999998654432211111357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEcccCeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~----~vkl~DFGla~~~ 288 (306)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++ .+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999753 4689999999999999999999999999999999999999888 7999999999876
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
..........||+.|+||
T Consensus 170 ~~~~~~~~~~gt~~y~aP 187 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAP 187 (321)
T ss_dssp CTTCCCCCCCSCGGGCCH
T ss_pred CccccccccCCCCCccCc
Confidence 655555666899999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-32 Score=238.23 Aligned_cols=164 Identities=26% Similarity=0.395 Sum_probs=146.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|.+ ++..+|+|++....... .+.+.+|+.++++++||||+++++++......+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 5688999999999999999998 56689999997644332 247889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEcccCeeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEV 289 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv---~~~~~vkl~DFGla~~~~ 289 (306)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999999999765 458999999999999999999999999999999999999 788999999999998776
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.........||+.|+||
T Consensus 161 ~~~~~~~~~~t~~y~aP 177 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSP 177 (277)
T ss_dssp TTSCBCCCCSCTTTCCH
T ss_pred CccchhccCCCCCccCh
Confidence 65556667899999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-32 Score=241.76 Aligned_cols=167 Identities=26% Similarity=0.416 Sum_probs=140.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|.+.+.||+|+||.||+|+. ++..+|+|++........ .+.+.+|+.++++++||||+++++++......+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-----MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-----HHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 5788999999999999999998 678999999976543222 257889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEcccCeee
Q 021897 213 IVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv---~~~~~vkl~DFGla~~ 287 (306)
+||||+++++|.+++... ....+++..++.++.|++.||+|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998653 34669999999999999999999999999999999999999 4567899999999987
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
...........||+.|+||
T Consensus 177 ~~~~~~~~~~~~t~~y~aP 195 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAP 195 (285)
T ss_dssp ----------CTTGGGCCH
T ss_pred cCCcccCcCcccccCcCCh
Confidence 6655555667899999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-31 Score=237.41 Aligned_cols=166 Identities=25% Similarity=0.406 Sum_probs=147.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|.+ +++.||+|++......... .+.+.+|+.++++++||||+++++++......+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHH----HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 6788999999999999999988 5789999999865544322 357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc---EEEEcccCeeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARIEV 289 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~---vkl~DFGla~~~~ 289 (306)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999999998765 45899999999999999999999999999999999999986655 9999999998776
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.........||+.|+||
T Consensus 160 ~~~~~~~~~~~~~y~aP 176 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSP 176 (284)
T ss_dssp SSCBCCCSCSCGGGCCH
T ss_pred cCccccCCCCCcCCcCc
Confidence 65555667899999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=246.52 Aligned_cols=167 Identities=26% Similarity=0.434 Sum_probs=130.6
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++.+.||+|+||.||+|.+ +++.||||+++....... .+.+.+|+.++++++||||+++++++..+..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-----PSTAIREISLMKELKHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS-----CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence 46788999999999999999987 688999999976543221 14677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQ----NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
++||||++ ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99999997 59999987642 23589999999999999999999999999999999999999999999999999986
Q ss_pred eecC-CCccCCCCCCcccCC
Q 021897 288 EVQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~AP 306 (306)
.... ......+||+.|+||
T Consensus 158 ~~~~~~~~~~~~~t~~y~aP 177 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAP 177 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCH
T ss_pred cCCCcccCCCCcccccccCc
Confidence 5432 233455799999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-32 Score=246.90 Aligned_cols=178 Identities=31% Similarity=0.547 Sum_probs=150.9
Q ss_pred CCCCCcceeeccCceecceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-
Q 021897 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL- 193 (306)
Q Consensus 124 ~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 193 (306)
+.....|++..++|++++.||+|+||.||+|++. ++.||||+++..... ...+.+.+|+.+++++
T Consensus 24 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~ 98 (334)
T 2pvf_A 24 LPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIG 98 (334)
T ss_dssp CCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-----HHHHHHHHHHHHHHHHC
T ss_pred CCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-----HHHHHHHHHHHHHHHhh
Confidence 3455678999999999999999999999999863 467999999754321 1235788999999999
Q ss_pred CCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 021897 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGF 259 (306)
Q Consensus 194 ~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gl~yLH~~~i 259 (306)
+||||+++++++.....+|+||||+++++|.+++..... ..+++..++.++.||+.||+|||++||
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 178 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 899999999999999999999999999999999986432 248899999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 260 IHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 260 iHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+||||||+|||++.++.+||+|||+++....... .....+|+.|+||
T Consensus 179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 228 (334)
T 2pvf_A 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228 (334)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred eCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence 9999999999999999999999999986543321 2334578899998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-32 Score=253.13 Aligned_cols=165 Identities=20% Similarity=0.340 Sum_probs=145.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
..|++.+.||+|+||.||+|.. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+...++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL------DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh------hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 6789999999999999999988 6789999999754321 1246889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC--CCcEEEEcccCeeeeec
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEVQ 290 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~--~~~vkl~DFGla~~~~~ 290 (306)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 125 lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999999998753 346899999999999999999999999999999999999974 56899999999987665
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
.......+||+.|+||
T Consensus 204 ~~~~~~~~gt~~y~aP 219 (387)
T 1kob_A 204 DEIVKVTTATAEFAAP 219 (387)
T ss_dssp TSCEEEECSSGGGCCH
T ss_pred CcceeeeccCCCccCc
Confidence 5444556899999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-31 Score=237.77 Aligned_cols=171 Identities=23% Similarity=0.366 Sum_probs=151.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCC---ChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPEN---NPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK 207 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 207 (306)
.++|++.+.||+|+||.||+|++ +++.||||+++.... .........+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 47889999999999999999998 678999999976542 22333445578899999999996 9999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
....++||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999865 4589999999999999999999999999999999999999999999999999987
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
...........||+.|+||
T Consensus 174 ~~~~~~~~~~~~~~~y~aP 192 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAP 192 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCH
T ss_pred cCCCcccccccCCccccCH
Confidence 6655555666899999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=245.28 Aligned_cols=170 Identities=28% Similarity=0.531 Sum_probs=140.5
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (306)
.++..++|++++.||+|+||.||+|++ +++.||||++.... . ...+.+.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--E----EHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--H----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--H----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 346678999999999999999999985 57899999986432 1 12357889999999999999999999
Q ss_pred EEEeC--CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEc
Q 021897 204 ACRKR--MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (306)
Q Consensus 204 ~~~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~D 281 (306)
++... ..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEcc
Confidence 99653 55899999999999999998643 3589999999999999999999999999999999999999999999999
Q ss_pred ccCeeeeecCC----CccCCCCCCcccCC
Q 021897 282 FGVARIEVQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~----~~~~~~gt~~y~AP 306 (306)
||+++...... ......+|+.|+||
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aP 186 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAP 186 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCH
T ss_pred CcccccccCCcceeeeccCCCCccceeCc
Confidence 99998654332 12334577889998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-31 Score=243.03 Aligned_cols=162 Identities=24% Similarity=0.440 Sum_probs=142.7
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
.|+..+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++++++||||+++++++......++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 356667999999999999988 68999999997654332 2468899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
||||+++++|.+++.. ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 120 v~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp EECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 9999999999999864 458999999999999999999999999999999999999999999999999998654332
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......||+.|+||
T Consensus 197 ~~~~~~gt~~y~aP 210 (321)
T 2c30_A 197 KRKSLVGTPYWMAP 210 (321)
T ss_dssp CBCCCCSCGGGCCH
T ss_pred ccccccCCccccCH
Confidence 33456899999998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-32 Score=255.40 Aligned_cols=170 Identities=24% Similarity=0.328 Sum_probs=142.6
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.|.+ .++|++++.||+|+||.||+|++ +++.||||+++....... ..+++.+|+.+++.++||||+++++++.
T Consensus 21 ~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 21 NVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI----DCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp GCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHH----HHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred ccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChH----HHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3443 36899999999999999999988 678999999976543322 2367899999999999999999999997
Q ss_pred eC-----CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEc
Q 021897 207 KR-----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (306)
Q Consensus 207 ~~-----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~D 281 (306)
.. ..+|+||||++ ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~D 172 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEcc
Confidence 66 57899999996 599999975 35699999999999999999999999999999999999999999999999
Q ss_pred ccCeeeeecCC-----------------------CccCCCCCCcccCC
Q 021897 282 FGVARIEVQTE-----------------------GMTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~-----------------------~~~~~~gt~~y~AP 306 (306)
||+|+...... ..+..+||+.|+||
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 220 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP 220 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCH
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCH
Confidence 99998654322 13566899999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=247.29 Aligned_cols=168 Identities=26% Similarity=0.428 Sum_probs=137.7
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (306)
.++|++.+.||+|+||.||+|++ +++.||||+++....... ...+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH---HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH---HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 46789999999999999999997 788999999976544322 23467899999999999999999999987653
Q ss_pred --eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 210 --~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
..|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 359999999999999999865 4589999999999999999999999999999999999999999999999999986
Q ss_pred eecCC----CccCCCCCCcccCC
Q 021897 288 EVQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~----~~~~~~gt~~y~AP 306 (306)
..... .....+||+.|+||
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aP 188 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSP 188 (311)
T ss_dssp ----------------CCTTCCH
T ss_pred ccccccccccccccCcCcccCCH
Confidence 54322 12334689999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=259.85 Aligned_cols=165 Identities=24% Similarity=0.349 Sum_probs=130.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (306)
.+|++++.||+|+||.||+|.+ +++.||||++........ ..+++.+|+.+|+.++||||+++++++...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI----DCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHH----HHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 6799999999999999999987 678999999976543322 236788999999999999999999999443
Q ss_pred -CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
..+|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred CceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 5789999998 56999998753 5699999999999999999999999999999999999999999999999999986
Q ss_pred eecCC----------------------------CccCCCCCCcccCC
Q 021897 288 EVQTE----------------------------GMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~----------------------------~~~~~~gt~~y~AP 306 (306)
..... ..+..+||+.|+||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 252 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCH
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccCh
Confidence 43211 23445789999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-31 Score=246.77 Aligned_cols=170 Identities=22% Similarity=0.402 Sum_probs=151.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCC--ChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCC
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPEN--NPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRM 209 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 209 (306)
.+|++.+.||+|+||.||+|++ +|+.||||+++.... .........+.+.+|+.+++++ .||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5788999999999999999998 588999999986543 2233344557789999999999 7999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999999864 458999999999999999999999999999999999999999999999999998776
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
........+||+.|+||
T Consensus 252 ~~~~~~~~~gt~~y~aP 268 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAP 268 (365)
T ss_dssp TTCCBCCCCSCGGGCCH
T ss_pred CCcccccCCCCCCccCh
Confidence 55555667899999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=249.62 Aligned_cols=163 Identities=26% Similarity=0.419 Sum_probs=128.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
...|++.+.||+|+||.||+|++ +++.||||+++.... .+.+.+|+.++++++||||+++++++.....+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh--------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 35688999999999999999998 567899999975431 24678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEcccCeeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIE 288 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~~~vkl~DFGla~~~ 288 (306)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++. ++.+||+|||+++..
T Consensus 124 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999999999753 45899999999999999999999999999999999999975 889999999999876
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
.........+||+.|+||
T Consensus 202 ~~~~~~~~~~gt~~y~aP 219 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAP 219 (349)
T ss_dssp -----------CGGGSCH
T ss_pred CcccccccccCCCCccCH
Confidence 554445566899999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-33 Score=253.45 Aligned_cols=168 Identities=21% Similarity=0.254 Sum_probs=138.0
Q ss_pred eeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCC---------CCCeee
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLK---------HLNIVR 200 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~---------h~niv~ 200 (306)
+..++|++++.||+|+||.||+|+++++.||||+++....... ......+.+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4557899999999999999999999999999999986543200 00011246778888888775 888888
Q ss_pred EEEEEE------------------------------eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHH
Q 021897 201 FIGACR------------------------------KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250 (306)
Q Consensus 201 l~~~~~------------------------------~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~g 250 (306)
+++++. ....+||||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 888753 26789999999999977666643 458999999999999999
Q ss_pred HHHHH-hCCccccCCCCCcEEEcCCC--------------------cEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 251 MAYVH-GLGFIHRDLKSDNLLISADK--------------------SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 251 l~yLH-~~~iiHrDlkp~NILv~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|+||| ++||+||||||+||||+.++ .+||+|||+|+..... ..+||+.|+||
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence 99999 99999999999999999887 8999999999876532 34899999999
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-32 Score=240.21 Aligned_cols=170 Identities=22% Similarity=0.414 Sum_probs=143.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|++ +++.||+|+++.............+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5688999999999999999998 58899999998654432211111357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEcccCeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~----~vkl~DFGla~~~ 288 (306)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||+++..
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999764 4589999999999999999999999999999999999998877 8999999999876
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
..........||+.|+||
T Consensus 163 ~~~~~~~~~~~~~~y~aP 180 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAP 180 (283)
T ss_dssp C--------CCCGGGCCH
T ss_pred cCCCcccccCCCcCccCc
Confidence 554445556799999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=243.01 Aligned_cols=166 Identities=28% Similarity=0.402 Sum_probs=139.4
Q ss_pred cCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
++|++.+.||+|+||.||+|+. +++.||||+++........ .+.+.+|+.++++++||||+++++++.....+++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC----CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc----chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence 5788999999999999999998 5889999999754332211 2467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-C
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-E 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~-~ 292 (306)
||||+++ +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 78 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 9999975 999998754 346899999999999999999999999999999999999999999999999999764322 2
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......||+.|+||
T Consensus 156 ~~~~~~~t~~y~aP 169 (288)
T 1ob3_A 156 KYTHEIVTLWYRAP 169 (288)
T ss_dssp ------CCCTTCCH
T ss_pred ccccccccccccCc
Confidence 23445789999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=254.15 Aligned_cols=174 Identities=28% Similarity=0.459 Sum_probs=145.7
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (306)
+.+++..++|++++.||+|+||.||+|++ +++.||||+++...... ....+.+|+.++++++||||++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~ 138 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-----DELDFLMEALIISKFNHQNIVR 138 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHHHCCCTTBCC
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-----hHHHHHHHHHHHHhCCCCCCCe
Confidence 34567788999999999999999999985 35689999986433221 2357889999999999999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 021897 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275 (306)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~ 275 (306)
+++++......++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 139 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred EEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC
Confidence 99999999889999999999999999987532 4589999999999999999999999999999999999999555
Q ss_pred ---cEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 276 ---SIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 276 ---~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
.+||+|||+|+...... ......||+.|+||
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 255 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECH
Confidence 59999999997543221 12334678999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=254.51 Aligned_cols=169 Identities=24% Similarity=0.342 Sum_probs=145.9
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM- 209 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 209 (306)
...+|++.+.||+|+||.||+|++ +++.||||+++....... .+.+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 346789999999999999999998 488999999975332111 246789999999999999999999998765
Q ss_pred -eEEEEEeecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE----cCCCcEEEEccc
Q 021897 210 -VWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIKIADFG 283 (306)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv----~~~~~vkl~DFG 283 (306)
..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 7899999999999999997643 2348999999999999999999999999999999999999 777889999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|+...........+||+.|+||
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aP 184 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHP 184 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCH
T ss_pred CceEccCCCccccccCCccccCH
Confidence 99877655555667899999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=253.64 Aligned_cols=171 Identities=28% Similarity=0.500 Sum_probs=136.1
Q ss_pred ceeeccCceecceeeeeccEEEEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
.+++..+|++.+.||+|+||.||+|++. +..||||+++..... ...+.|.+|+.++++++||||++++++
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-----KQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3567789999999999999999999863 568999999754321 123679999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
+.....+++||||+++++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999999999999754 34689999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCCC----ccCCCCCCcccCC
Q 021897 285 ARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~----~~~~~gt~~y~AP 306 (306)
++....... .....+|+.|+||
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aP 219 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSP 219 (373)
T ss_dssp --------------------CTTSCH
T ss_pred ccccccCCccceeccCCCcCCCccCh
Confidence 986543221 1122356789998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=246.75 Aligned_cols=163 Identities=28% Similarity=0.345 Sum_probs=143.0
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCe
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 210 (306)
..+|++.+.||+|+||.||+|+. +++.||||++...... +.+.+|+.+++++ +||||+++++++.....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 46799999999999999999996 7889999999765432 2577999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc-----EEEEcccCe
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-----IKIADFGVA 285 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~-----vkl~DFGla 285 (306)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||+|
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred cEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99999999 89999999864 356999999999999999999999999999999999999998887 999999999
Q ss_pred eeeecCCC--------ccCCCCCCcccCC
Q 021897 286 RIEVQTEG--------MTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~--------~~~~~gt~~y~AP 306 (306)
+....... ....+||+.|+||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 186 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSI 186 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred eeeecCCCCccccccccCCcCCCccccCh
Confidence 86543322 2356799999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-32 Score=241.73 Aligned_cols=162 Identities=31% Similarity=0.560 Sum_probs=137.9
Q ss_pred eccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh--CCCCCeeeEEEEEEe---
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRK--- 207 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~--- 207 (306)
-.++|++.+.||+|+||.||+|+++++.||||++.... .+.+.+|.+++.. ++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc---------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 34788999999999999999999999999999986421 1345566666666 799999999999754
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCcEEEcCCCcEE
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--------GLGFIHRDLKSDNLLISADKSIK 278 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH--------~~~iiHrDlkp~NILv~~~~~vk 278 (306)
...+++||||+++|+|.++++. ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred CCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence 3468999999999999999953 46999999999999999999999 99999999999999999999999
Q ss_pred EEcccCeeeeecCCC-----ccCCCCCCcccCC
Q 021897 279 IADFGVARIEVQTEG-----MTPETGTYRWMAP 306 (306)
Q Consensus 279 l~DFGla~~~~~~~~-----~~~~~gt~~y~AP 306 (306)
|+|||+|+....... ....+||+.|+||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 186 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCH
T ss_pred EeeCCCeeecccccccccccccccccccceeCh
Confidence 999999986554332 2334799999998
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=241.17 Aligned_cols=173 Identities=27% Similarity=0.515 Sum_probs=135.7
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (306)
..+|++..++|++++.||+|+||.||+|.+. +..||+|+++.... ....+.+.+|+.++++++||||+++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~ 81 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-----DSVREKFLQEALTMRQFDHPHIVKL 81 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-----HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-----HHHHHHHHHHHHHHHhCCCCccceE
Confidence 3568889999999999999999999999872 34699998865322 1224678999999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEc
Q 021897 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (306)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~D 281 (306)
++++.+ ...|+||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 82 IGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp EEEECS-SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEcc-CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECc
Confidence 999854 5578999999999999999864 34689999999999999999999999999999999999999999999999
Q ss_pred ccCeeeeecCCC--ccCCCCCCcccCC
Q 021897 282 FGVARIEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~~--~~~~~gt~~y~AP 306 (306)
||+++....... .....+|+.|+||
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aP 186 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAP 186 (281)
T ss_dssp -------------------CCGGGCCH
T ss_pred cccccccCcccccccccCCCcccccCh
Confidence 999986544322 2233567899998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=245.77 Aligned_cols=176 Identities=27% Similarity=0.484 Sum_probs=149.8
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 198 (306)
..++|++..++|++.+.||+|+||.||+|++. ++.||||++....... ....+.+|+.++++++||||
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCCTTB
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH-----HHHHHHHHHHHHHhcCCCCE
Confidence 45789999999999999999999999999763 5689999987543221 23568899999999999999
Q ss_pred eeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 021897 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (306)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NIL 270 (306)
+++++++......++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence 999999999999999999999999999997532 145789999999999999999999999999999999999
Q ss_pred EcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 271 v~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
++.++.+||+|||+++....... .....+|+.|+||
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccCh
Confidence 99999999999999985433221 1233568899998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-32 Score=258.68 Aligned_cols=166 Identities=27% Similarity=0.413 Sum_probs=141.9
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|++++.||+|+||.||+|++ +++.||||+++........ ...+.+|+.+++.++||||+++++++.....+|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT----THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4688999999999999999998 6789999999865432221 246889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEcccCeeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIEV 289 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~~~vkl~DFGla~~~~ 289 (306)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 113 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999999998765 45899999999999999999999999999999999999976 4559999999999876
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
........+||+.|+||
T Consensus 191 ~~~~~~~~~gt~~y~aP 207 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAP 207 (494)
T ss_dssp TTBCBCCCCSCTTTCCH
T ss_pred CCccccccCCCcCeeCH
Confidence 66556677899999998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-32 Score=252.88 Aligned_cols=161 Identities=24% Similarity=0.384 Sum_probs=129.9
Q ss_pred cCceec-ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHH-HhCCCCCeeeEEEEEEe---
Q 021897 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML-ATLKHLNIVRFIGACRK--- 207 (306)
Q Consensus 135 ~~~~~~-~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~--- 207 (306)
.+|.+. +.||+|+||.||+|.+ +++.||||+++.. ..+.+|+.++ +..+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 456555 6899999999999998 6789999999631 2466888887 45589999999999875
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEccc
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~~~vkl~DFG 283 (306)
...+||||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 567899999999999999998755557999999999999999999999999999999999999997 7899999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|+...........+||+.|+||
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aP 232 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAP 232 (400)
T ss_dssp TCEECC-----------CTTCCG
T ss_pred cccccCCCCccccCCCCCCccCH
Confidence 99876554445667899999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=241.33 Aligned_cols=166 Identities=28% Similarity=0.460 Sum_probs=139.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|+||.||+|++ +++.||||++....... ...+.+.+|+.++++++||||+++++++......+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP----VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H----HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence 5788999999999999999998 58899999987654432 22467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 79 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999998887653 458999999999999999999999999999999999999999999999999998654322
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
......||+.|+||
T Consensus 157 ~~~~~~~~~~~y~aP 171 (311)
T 4agu_A 157 DYYDDEVATRWYRSP 171 (311)
T ss_dssp ---------GGGCCH
T ss_pred cccCCCcCCccccCh
Confidence 23455799999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=251.55 Aligned_cols=162 Identities=24% Similarity=0.395 Sum_probs=137.4
Q ss_pred eecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEE
Q 021897 138 NMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVT 215 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~ 215 (306)
...+.||+|+||.||+|+. +++.||+|+++..... ..+.+.+|+.++++++||||+++++++.....++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK------DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3467899999999999987 6889999999764321 1357889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE--cCCCcEEEEcccCeeeeecCCC
Q 021897 216 EYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI--SADKSIKIADFGVARIEVQTEG 293 (306)
Q Consensus 216 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv--~~~~~vkl~DFGla~~~~~~~~ 293 (306)
||+++++|.+++... ...+++..++.++.||+.||+|||+.+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 166 E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 166 EYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp ECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred eCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 999999999998753 2458999999999999999999999999999999999999 5678999999999997766555
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
....+||+.|+||
T Consensus 245 ~~~~~gt~~y~aP 257 (373)
T 2x4f_A 245 LKVNFGTPEFLAP 257 (373)
T ss_dssp CCCCCSSCTTCCH
T ss_pred cccccCCCcEeCh
Confidence 5666899999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=246.82 Aligned_cols=176 Identities=30% Similarity=0.529 Sum_probs=149.8
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEEC--C-----eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--G-----EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~--~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (306)
..+.|+++.++|++++.||+|+||.||+|++. + ..||+|+++...... ..+.+.+|+.+++++ +|||
T Consensus 37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~ 111 (333)
T 2i1m_A 37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-----EKEALMSELKIMSHLGQHEN 111 (333)
T ss_dssp CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH-----HHHHHHHHHHHHHhhcCCCC
Confidence 34679999999999999999999999999973 2 379999997544221 235788999999999 8999
Q ss_pred eeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021897 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLK 265 (306)
Q Consensus 198 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlk 265 (306)
|+++++++.....+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++||+|||||
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 191 (333)
T 2i1m_A 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191 (333)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcc
Confidence 9999999999999999999999999999997642 3457999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 266 SDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 266 p~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|+|||++.++.+||+|||+++....... .....||+.|+||
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 235 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP 235 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCH
Confidence 9999999999999999999986543322 1233567889998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=257.66 Aligned_cols=170 Identities=22% Similarity=0.431 Sum_probs=144.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChh-------HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE-------KAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
++|++++.||+|+||.||+|+. +++.||||+++....... ......+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 6788999999999999999998 678999999986543211 0012236788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEcc
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADF 282 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~---~vkl~DF 282 (306)
.....+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999765 4599999999999999999999999999999999999998776 6999999
Q ss_pred cCeeeeecCCCccCCCCCCcccCC
Q 021897 283 GVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|+|+...........+||+.|+||
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aP 217 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAP 217 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCH
T ss_pred CCCEEcCCCCccccccCCcCCCCH
Confidence 999987666556677899999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=242.02 Aligned_cols=170 Identities=31% Similarity=0.581 Sum_probs=140.9
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
...|.++.++|++.+.||+|+||.||+|+++++.||||+++.... .+.+.+|+.++++++||||+++++++.
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH--------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 356888999999999999999999999999999999999875432 257889999999999999999999975
Q ss_pred eC-CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 207 KR-MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 207 ~~-~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
+. ...++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred cCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccc
Confidence 54 47899999999999999998654444889999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+..... .....+|+.|+||
T Consensus 165 ~~~~~~--~~~~~~~~~y~aP 183 (278)
T 1byg_A 165 KEASST--QDTGKLPVKWTAP 183 (278)
T ss_dssp -------------CCTTTSCH
T ss_pred cccccc--ccCCCccccccCH
Confidence 865432 2334678999998
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-32 Score=237.44 Aligned_cols=170 Identities=38% Similarity=0.688 Sum_probs=134.9
Q ss_pred eeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
+++..+|++.+.||+|+||.||+|.+.++.||||+++...... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDED--ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCccc--HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4567899999999999999999999999999999987543322 11223578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCcEEEcC--------CCcEEE
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG---FIHRDLKSDNLLISA--------DKSIKI 279 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlkp~NILv~~--------~~~vkl 279 (306)
.++||||+++++|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999999853 46999999999999999999999999 999999999999986 778999
Q ss_pred EcccCeeeeecCCCccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|||+++...... .....||+.|+||
T Consensus 158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aP 183 (271)
T 3dtc_A 158 TDFGLAREWHRTT-KMSAAGAYAWMAP 183 (271)
T ss_dssp CCCCC--------------CCGGGSCH
T ss_pred ccCCccccccccc-ccCCCCccceeCH
Confidence 9999998654433 3345799999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-32 Score=241.26 Aligned_cols=174 Identities=34% Similarity=0.660 Sum_probs=138.0
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
..+.++|...+|++++.||+|+||.||+|++.+ .||||+++........ .+.+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHH----HHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 457788999999999999999999999998765 5999999765544322 36788999999999999999999966
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
. ....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 90 ~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 90 T-APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp C-SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred c-CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence 4 45579999999999999999654 356899999999999999999999999999999999999999999999999999
Q ss_pred eeeec---CCCccCCCCCCcccCC
Q 021897 286 RIEVQ---TEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~---~~~~~~~~gt~~y~AP 306 (306)
+.... ........||+.|+||
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aP 191 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAP 191 (289)
T ss_dssp ----------------CCCTTCCH
T ss_pred cccccccccccccccCCCccccCc
Confidence 75432 1223445799999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.6e-32 Score=239.46 Aligned_cols=172 Identities=23% Similarity=0.354 Sum_probs=135.5
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
|++..++|++.+.||+|+||.||+|++ +++.||||+++....... ..+.+.++...++.+.||||+++++++..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE----QKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH----HHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 567788999999999999999999998 789999999975433221 22345566666888999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
....++||||++ |+|.+++.. .....+++..++.++.|++.||+|||++ |++||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 78 EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 999999999997 599888764 2446799999999999999999999998 999999999999999999999999999
Q ss_pred eeeeecCCCccCCCCCCcccCC
Q 021897 285 ARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~AP 306 (306)
|+............||+.|+||
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aP 178 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAP 178 (290)
T ss_dssp -------------CCCCCCSCH
T ss_pred cccccccccccccCCCccccCh
Confidence 9876555545556899999998
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-32 Score=239.41 Aligned_cols=162 Identities=27% Similarity=0.505 Sum_probs=144.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (306)
.+|++.+.||+|+||.||+|.+ +++.||||+++... +.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 5788999999999999999998 58899999997543 246689999999999999999999864
Q ss_pred -----------CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 021897 208 -----------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS 276 (306)
Q Consensus 208 -----------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~ 276 (306)
...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence 445899999999999999998765567999999999999999999999999999999999999999999
Q ss_pred EEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 277 IKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 277 vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+||+|||+++............||+.|+||
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aP 190 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCH
T ss_pred EEECcchhheeccccccccccCCcccccCh
Confidence 999999999876655445566899999998
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-32 Score=244.18 Aligned_cols=177 Identities=23% Similarity=0.444 Sum_probs=132.5
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEEC--Ce---eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN--GE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~--~~---~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (306)
..+++.+..++|++++.||+|+||.||+|++. +. .||||+++........ .+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~ 89 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD----IEEFLREAACMKEFDHPHVAK 89 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH----HHHHHHHHHHHTTCCCTTBCC
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH----HHHHHHHHHHHHHCCCCceeh
Confidence 45667788899999999999999999999873 22 7999999765433222 367899999999999999999
Q ss_pred EEEEEEeCCeE------EEEEeecCCCCHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 021897 201 FIGACRKRMVW------CIVTEYAKGGSVRQFLTRRQN----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLL 270 (306)
Q Consensus 201 l~~~~~~~~~~------~iv~E~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NIL 270 (306)
+++++...... ++||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIl 169 (323)
T 3qup_A 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169 (323)
T ss_dssp CCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred hhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEE
Confidence 99999877654 999999999999999975421 25899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 271 ISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 271 v~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
++.++.+||+|||+|+....... .....+|+.|+||
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP 208 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL 208 (323)
T ss_dssp ECTTSCEEECCCCC-----------------CCGGGCCH
T ss_pred EcCCCCEEEeeccccccccccccccccccccCcccccCc
Confidence 99999999999999986543322 1233567889998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-31 Score=235.59 Aligned_cols=165 Identities=27% Similarity=0.397 Sum_probs=142.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 211 (306)
.+|++.+.||+|+||.||+|.+ +++.||||+++........ ...+.+|+..+..+ +||||+++++++.+...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH----HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH----HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 5788999999999999999998 6889999999865443322 35788999999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC---------------
Q 021897 212 CIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--------------- 274 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~--------------- 274 (306)
++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999999998642 2568999999999999999999999999999999999999844
Q ss_pred ----CcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 275 ----KSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 275 ----~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
..+||+|||++..... .....||+.|+||
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aP 199 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS---PQVEEGDSRFLAN 199 (289)
T ss_dssp ---CCCEEECCCTTCEETTC---SCCCCCCGGGCCH
T ss_pred cCCceEEEEcccccccccCC---ccccCCCccccCh
Confidence 4799999999986543 2334699999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.2e-32 Score=249.67 Aligned_cols=165 Identities=27% Similarity=0.433 Sum_probs=131.4
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCC-
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRM- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~- 209 (306)
.++|++++.||+|+||.||+|.+ +++.||||++......... .+.+.+|+.+++.+. ||||+++++++....
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD----AQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHH----HHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 36889999999999999999987 6889999998755433322 357789999999997 999999999997644
Q ss_pred -eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.+|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 7899999997 599999875 35899999999999999999999999999999999999999999999999999864
Q ss_pred ec----------------------CCCccCCCCCCcccCC
Q 021897 289 VQ----------------------TEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~----------------------~~~~~~~~gt~~y~AP 306 (306)
.. ....+..+||+.|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 199 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP 199 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCH
Confidence 32 1123445899999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-32 Score=258.79 Aligned_cols=168 Identities=26% Similarity=0.445 Sum_probs=147.7
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
..+|++.+.||+|+||.||+|+. +++.||||++.......... .+.+.+|+.++++++||||+++++++.....+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD---KESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH---HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 46789999999999999999998 68899999997654332111 25788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEcccCeeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv---~~~~~vkl~DFGla~~~ 288 (306)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+..
T Consensus 102 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999999999754 469999999999999999999999999999999999999 56789999999999876
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
.........+||+.|+||
T Consensus 180 ~~~~~~~~~~gt~~y~aP 197 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAP 197 (484)
T ss_dssp CCCCSHHHHTTGGGTCCH
T ss_pred ccccccccCCCCccccCc
Confidence 655555566899999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-31 Score=235.66 Aligned_cols=168 Identities=27% Similarity=0.346 Sum_probs=146.5
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++++.||+|+||.||+|.+ +++.+|+|++......... ..+.+.+|+.+++.++||||+++++++......
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHH---HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 36788999999999999999998 5789999999765433221 235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~- 290 (306)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999999998765 4589999999999999999999999999999999999999999999999999986542
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
........||+.|+||
T Consensus 169 ~~~~~~~~~~~~y~aP 184 (294)
T 2rku_A 169 GERKKVLCGTPNYIAP 184 (294)
T ss_dssp TCCBCCCCSCCSSCCH
T ss_pred ccccccccCCCCcCCc
Confidence 2233445799999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-31 Score=243.25 Aligned_cols=164 Identities=29% Similarity=0.454 Sum_probs=143.9
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|+..+.||+|+||.||+|+. +++.||||++........ ...+.+.+|+.++++++||||+++++++......+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 4588889999999999999987 788999999986544332 22467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||++ |+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 131 lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9999997 68988887543 5689999999999999999999999999999999999999999999999999986543
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
....+||+.|+||
T Consensus 207 -~~~~~gt~~y~aP 219 (348)
T 1u5q_A 207 -ANSFVGTPYWMAP 219 (348)
T ss_dssp -BCCCCSCGGGCCH
T ss_pred -CCcccCCcceeCH
Confidence 3446899999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=246.12 Aligned_cols=169 Identities=26% Similarity=0.492 Sum_probs=145.3
Q ss_pred eeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
...++|++.+.||+|+||.||+|++ +++.||||++....... .+.+.+|+.+++.++||||+++++++.....
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG------IEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH------HHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH------HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3457889999999999999999998 57899999987654322 3578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999999999986543 235899999999999999999999999999999999999999999999999999864
Q ss_pred ecCC---CccCCCCCCcccCC
Q 021897 289 VQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~---~~~~~~gt~~y~AP 306 (306)
.... ......||+.|+||
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aP 210 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDP 210 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCH
T ss_pred ccccccccccccCCCccccCH
Confidence 3221 12334589999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=240.94 Aligned_cols=168 Identities=27% Similarity=0.343 Sum_probs=146.8
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|.+++.||+|+||.||++++ +++.+|+|++........ ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 46789999999999999999998 577999999976543322 1235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999999998765 45899999999999999999999999999999999999999999999999999865422
Q ss_pred -CCccCCCCCCcccCC
Q 021897 292 -EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 -~~~~~~~gt~~y~AP 306 (306)
.......||+.|+||
T Consensus 195 ~~~~~~~~gt~~y~aP 210 (335)
T 2owb_A 195 GERKKVLCGTPNYIAP 210 (335)
T ss_dssp TCCBCCCCSCCSSCCH
T ss_pred cccccccCCCccccCH
Confidence 233455799999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=242.47 Aligned_cols=169 Identities=20% Similarity=0.332 Sum_probs=147.0
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-----CCCeee
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----HLNIVR 200 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 200 (306)
.+..+-.++|++.+.||+|+||.||+|++ +++.||||+++... ...+.+.+|+.+++.+. ||||++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-------KYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-------HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-------hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44445668999999999999999999998 78899999996321 12346778999999987 999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-------
Q 021897 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA------- 273 (306)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~------- 273 (306)
+++++......++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 999999999999999999 889999999876667999999999999999999999999999999999999975
Q ss_pred ------------------CCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 274 ------------------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 274 ------------------~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
++.+||+|||+|+.... ......||+.|+||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aP 228 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAP 228 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCc
Confidence 78999999999986443 23456899999998
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=235.97 Aligned_cols=170 Identities=26% Similarity=0.459 Sum_probs=139.3
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+...+|++++.||+|+||.||+|++ +++.||||++...... .....+.+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR---SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc---chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 4567899999999999999999998 5889999998642111 1112357889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
..++||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999999999865 358999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.........||+.|+||
T Consensus 163 ~~~~~~~~~~~~~y~aP 179 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAP 179 (276)
T ss_dssp C-------------CCT
T ss_pred CCcceecccCCccccCH
Confidence 54444556799999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=258.86 Aligned_cols=166 Identities=27% Similarity=0.469 Sum_probs=143.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|++ +++.||||++......... .+.+.+|+.++++++||||+++++++.....+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH----HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 6788999999999999999998 6889999998643211111 257889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc---CCCcEEEEcccCeeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEV 289 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~---~~~~vkl~DFGla~~~~ 289 (306)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 98 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999765 4589999999999999999999999999999999999995 45689999999998766
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
........+||+.|+||
T Consensus 176 ~~~~~~~~~gt~~y~aP 192 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAP 192 (486)
T ss_dssp CC----CCTTGGGGCCG
T ss_pred CCCccCCCcCCCCCCCH
Confidence 55555667899999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=237.00 Aligned_cols=169 Identities=27% Similarity=0.439 Sum_probs=142.7
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+..++|++++.||+|+||.||+|.+ +++.||||++...... .......+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE---KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc---hhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 4568899999999999999999988 5678999998642211 1112357889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999999999865 458999999999999999999999999999999999999999999999999986544
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.. ......||+.|+||
T Consensus 161 ~~-~~~~~~~~~~y~aP 176 (279)
T 3fdn_A 161 SS-RRTDLCGTLDYLPP 176 (279)
T ss_dssp --------CCCCTTCCH
T ss_pred cc-cccccCCCCCccCH
Confidence 32 23455799999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=243.79 Aligned_cols=171 Identities=27% Similarity=0.462 Sum_probs=140.7
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEeC
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRKR 208 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 208 (306)
.++|++.+.||+|+||.||+|++ +++.||||+++......... .....+.+|+.+++.+ .||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG-GLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS-CCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc-ccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46899999999999999999996 78899999997433211100 0012455677766665 499999999999875
Q ss_pred C-----eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 209 M-----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 209 ~-----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
. .+++||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4 5899999996 599999987665669999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|+...........+||+.|+||
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aP 188 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAP 188 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCH
T ss_pred cccccCCCcccCCccccccccCc
Confidence 99876555555667899999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=247.62 Aligned_cols=166 Identities=24% Similarity=0.468 Sum_probs=139.9
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
++...++|++++.||+|+||.||+|+. +++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----------~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----------KNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----------CCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----------HHHHHHHHHHcCCCCccchhheeee
Confidence 345567899999999999999999988 7889999998754332 2379999999999999999999844
Q ss_pred --------------------------------------CCeEEEEEeecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHH
Q 021897 208 --------------------------------------RMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDV 247 (306)
Q Consensus 208 --------------------------------------~~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi 247 (306)
...+++||||++ ++|.+.+.. .....+++..++.++.||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 334899999997 588888764 345679999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 248 ARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 248 ~~gl~yLH~~~iiHrDlkp~NILv~-~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+.||+|||++||+||||||+|||++ .++.+||+|||+|+............||+.|+||
T Consensus 151 ~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP 210 (383)
T 3eb0_A 151 FRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP 210 (383)
T ss_dssp HHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCH
T ss_pred HHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCH
Confidence 9999999999999999999999997 6899999999999977666556667899999998
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=256.63 Aligned_cols=164 Identities=26% Similarity=0.371 Sum_probs=135.8
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR--- 208 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 208 (306)
.++|++++.||+|+||.||+|.+ +++.||||++....... ...+++.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ----THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh----HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 47899999999999999999987 68899999997643222 2246788999999999999999999999654
Q ss_pred ---CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 209 ---MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 209 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
..+||||||+++ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 467999999976 57776642 3899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+........+..+||+.|+||
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aP 232 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAP 232 (464)
T ss_dssp -----CCCC----CCCTTCCH
T ss_pred eecCCCcccCCCcccccccCH
Confidence 977665556677899999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=247.66 Aligned_cols=175 Identities=31% Similarity=0.504 Sum_probs=148.1
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
..++.+..++|++.+.||+|+||.||+|++ +++.||||++........ ...+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-----ELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-----CCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-----HHHHHHHHHHHHhccCCCccceEEEE
Confidence 345556678899999999999999999987 688999999875433221 13588999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEEcCCCcEEEE
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQ--NRAVPLKLAVKQALDVARGMAYVHGL---GFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
......++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998643 23489999999999999999999999 99999999999999999999999
Q ss_pred cccCeeeeecCCC--ccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~--~~~~~gt~~y~AP 306 (306)
|||+|+....... .....||+.|+||
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aP 204 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAP 204 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCH
T ss_pred cCccccccCcccccccccccCCcCccCH
Confidence 9999986543222 3344699999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=250.40 Aligned_cols=170 Identities=22% Similarity=0.371 Sum_probs=146.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhH--HHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEK--AQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
++|++.+.||+|+||.||+|.+ +++.||||+++........ .....+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5788999999999999999987 7889999999875432210 00011356789999999999999999999999999
Q ss_pred EEEEEeecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 211 WCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 211 ~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
+++||||+.+| +|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999776 999999753 469999999999999999999999999999999999999999999999999998776
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
........+||+.|+||
T Consensus 182 ~~~~~~~~~gt~~y~aP 198 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAP 198 (335)
T ss_dssp TTCCBCEECSCGGGCCH
T ss_pred CCCceeccCCCccccCh
Confidence 65555566899999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=268.22 Aligned_cols=173 Identities=25% Similarity=0.328 Sum_probs=145.7
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGAC 205 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 205 (306)
...+...+|++++.||+|+||.||+|++ +++.||||+++..... .....+.+.+|..++..+ +||+|+++++++
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI---QDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH---HTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 3456678999999999999999999998 6778999999742111 011124677899999987 699999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.....+||||||+++|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|
T Consensus 412 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 412 QTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp BCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence 9999999999999999999999875 35999999999999999999999999999999999999999999999999999
Q ss_pred eeee-cCCCccCCCCCCcccCC
Q 021897 286 RIEV-QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~-~~~~~~~~~gt~~y~AP 306 (306)
+... ........+||+.|+||
T Consensus 490 ~~~~~~~~~~~~~~GT~~Y~AP 511 (674)
T 3pfq_A 490 KENIWDGVTTKTFCGTPDYIAP 511 (674)
T ss_dssp EECCCTTCCBCCCCSCSSSCCH
T ss_pred eccccCCcccccccCCCcccCH
Confidence 8633 33345567899999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=241.47 Aligned_cols=170 Identities=31% Similarity=0.523 Sum_probs=141.6
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCee--EEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED--VAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~--vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (306)
++.++|++.+.||+|+||.||+|++ ++.. +|||.++...... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-----HHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 4568899999999999999999987 5664 4999987533221 135688999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~ 272 (306)
.....|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 9999999999999999999997642 24689999999999999999999999999999999999999
Q ss_pred CCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 273 ~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
.++.+||+|||+++............+|+.|+||
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aP 210 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 210 (327)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCH
T ss_pred CCCeEEEcccCcCccccccccccCCCCCccccCh
Confidence 9999999999999854433333445678899998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=238.59 Aligned_cols=167 Identities=32% Similarity=0.542 Sum_probs=142.1
Q ss_pred eeccCceecceeeeeccEEEEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
+..+.|++++.||+|+||.||++.+ +++.||||+++..... ...+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP-----QHRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh-----HHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 4456669999999999999999876 6788999999764321 1235788999999999999999999999
Q ss_pred Ee--CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 206 RK--RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 206 ~~--~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
.. ...+++||||+++++|.+++... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcc
Confidence 87 46889999999999999999753 48999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCC----ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~AP 306 (306)
+++....... .....||+.|+||
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aP 206 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAP 206 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCH
T ss_pred ccccccccccccccccCCCCCceeeCh
Confidence 9987654321 2334688899998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=236.88 Aligned_cols=171 Identities=25% Similarity=0.414 Sum_probs=146.9
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
..+..++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE---KEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc---hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 345668899999999999999999998 5779999998642211 11113578899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
....++||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 99999999999999999999875 3589999999999999999999999999999999999999999999999999976
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
.... ......||+.|+||
T Consensus 164 ~~~~-~~~~~~~~~~y~aP 181 (284)
T 2vgo_A 164 APSL-RRRTMCGTLDYLPP 181 (284)
T ss_dssp CSSS-CBCCCCSCGGGCCH
T ss_pred Cccc-ccccccCCCCcCCH
Confidence 5432 23456799999998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=242.72 Aligned_cols=169 Identities=20% Similarity=0.303 Sum_probs=142.0
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGACR 206 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~ 206 (306)
..+..+.|++.+.||+|+||.||++.. +++.||||++........ ..+.+.+|+.++++++| |||+++++++.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchH----HHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 345667899999999999999999987 678899999986654432 23578899999999987 99999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
....+|+|||+ .+++|.+++... ..+++..++.++.||+.||+|||+.+|+||||||+|||++ ++.+||+|||+|+
T Consensus 80 ~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 80 TDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp CSSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred eCCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 99999999995 578999999864 4689999999999999999999999999999999999997 6889999999998
Q ss_pred eeecCCC---ccCCCCCCcccCC
Q 021897 287 IEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~---~~~~~gt~~y~AP 306 (306)
....... ....+||+.|+||
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aP 178 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPP 178 (343)
T ss_dssp CC------------CCCCSSCCH
T ss_pred ccCcccccccCCCCcCCcCcCCH
Confidence 6543321 2345799999998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=235.40 Aligned_cols=169 Identities=29% Similarity=0.475 Sum_probs=134.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+.+|+.++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh---hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 36788999999999999999997 7889999999642211 111235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999999999754 356899999999999999999999999999999999999999999999999999865422
Q ss_pred -CCccCCCCCCcccCC
Q 021897 292 -EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 -~~~~~~~gt~~y~AP 306 (306)
.......||+.|+||
T Consensus 166 ~~~~~~~~~~~~y~aP 181 (278)
T 3cok_A 166 HEKHYTLCGTPNYISP 181 (278)
T ss_dssp ----------------
T ss_pred CCcceeccCCCCcCCc
Confidence 223345799999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=253.54 Aligned_cols=170 Identities=26% Similarity=0.362 Sum_probs=134.0
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
.++|.+.+.||+|+||.||+|.. +++.||||++........ ........+.+|+.++++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 36789999999999999999988 678999999975432111 111122357899999999999999999999855 4
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEcccCee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVAR 286 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~---~vkl~DFGla~ 286 (306)
.+|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+|+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 57999999999999998864 35699999999999999999999999999999999999997544 59999999998
Q ss_pred eeecCCCccCCCCCCcccCC
Q 021897 287 IEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~AP 306 (306)
...........+||+.|+||
T Consensus 291 ~~~~~~~~~~~~gt~~y~aP 310 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAP 310 (419)
T ss_dssp SCC-----------CTTCCT
T ss_pred ecCCCccccccCCCCCccCc
Confidence 76655555667899999999
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=242.24 Aligned_cols=160 Identities=24% Similarity=0.392 Sum_probs=138.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 211 (306)
++|++.+.||+|+||.||+|.+ +++.||||+++..... ..+|+.++.++ +||||+++++++.+...+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 5788999999999999999998 6889999999765432 33678888777 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC----CcEEEEcccCeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD----KSIKIADFGVARI 287 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~----~~vkl~DFGla~~ 287 (306)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||+|+.
T Consensus 92 ~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999999999753 469999999999999999999999999999999999998533 3599999999986
Q ss_pred eecC-CCccCCCCCCcccCC
Q 021897 288 EVQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~-~~~~~~~gt~~y~AP 306 (306)
.... ......+||+.|+||
T Consensus 170 ~~~~~~~~~~~~gt~~y~aP 189 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAP 189 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCH
T ss_pred CcCCCCceeccCCCccccCH
Confidence 5433 234556899999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=239.78 Aligned_cols=166 Identities=23% Similarity=0.438 Sum_probs=142.1
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CC-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeE
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 201 (306)
++..++|++.+.||+|+||.||+|++ ++ ..||+|++...... ..+.+.+|+.++++++||||+++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN------YSESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG------GHHHHHHHHHHHHTSCCTTBCCE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH------HHHHHHHHHHHHHhCCCCCEeEE
Confidence 45678999999999999999999987 33 57999998643221 13578899999999999999999
Q ss_pred EEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc-----
Q 021897 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS----- 276 (306)
Q Consensus 202 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~----- 276 (306)
++++......++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccc
Confidence 999999999999999999999999998642 34899999999999999999999999999999999999998887
Q ss_pred ---EEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 277 ---IKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 277 ---vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+||+|||+++.... .....||+.|+||
T Consensus 157 ~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aP 186 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLP---KDILQERIPWVPP 186 (289)
T ss_dssp CCEEEECCCCSCTTTSC---HHHHHHTTTTSCH
T ss_pred cceeeeccCcccccccC---ccccCCcCcccCH
Confidence 99999999864322 1223578899998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=236.80 Aligned_cols=168 Identities=31% Similarity=0.485 Sum_probs=143.3
Q ss_pred ceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEe
Q 021897 137 LNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E 216 (306)
+..++.||+|+||.||+|+++++.||||++........ ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT--TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcch--HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 34568999999999999999999999999975432211 1123678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC--
Q 021897 217 YAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG-- 293 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~-- 293 (306)
|+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999999997532 35689999999999999999999999999999999999999999999999999986543221
Q ss_pred -ccCCCCCCcccCC
Q 021897 294 -MTPETGTYRWMAP 306 (306)
Q Consensus 294 -~~~~~gt~~y~AP 306 (306)
.....||+.|+||
T Consensus 191 ~~~~~~g~~~y~aP 204 (307)
T 2nru_A 191 MTSRIVGTTAYMAP 204 (307)
T ss_dssp ECSSCCSCGGGCCH
T ss_pred cccccCCCcCcCCh
Confidence 2335799999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=249.35 Aligned_cols=171 Identities=21% Similarity=0.364 Sum_probs=144.3
Q ss_pred eeccCceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGAC 205 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 205 (306)
+...+|++.+.||+|+||.||+|+. +++.||||+++........ ...+.+.+|+.+++.+ .||||+++++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh--hHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 4557899999999999999999987 6789999998643211000 0013466899999999 699999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.....+++||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999999999865 35899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCC--CccCCCCCCcccCC
Q 021897 286 RIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~--~~~~~~gt~~y~AP 306 (306)
+...... .....+||+.|+||
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aP 229 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAP 229 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCH
T ss_pred eecccCCCCcccCcccCcCccCh
Confidence 8654322 23345799999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=242.47 Aligned_cols=166 Identities=33% Similarity=0.546 Sum_probs=135.9
Q ss_pred cceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH--HHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVM--MLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~ 206 (306)
++.++.++|++++.||+|+||.||+|+++++.||||++..... +.+..|.. .+..++||||+++++.+.
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---------QNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---------hhHHHHHHHHHHHhccCcchhhheeccc
Confidence 4557789999999999999999999999999999999964221 23334444 455689999999998664
Q ss_pred e-----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCcEEEc
Q 021897 207 K-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---------GFIHRDLKSDNLLIS 272 (306)
Q Consensus 207 ~-----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---------~iiHrDlkp~NILv~ 272 (306)
. ...+++||||+++|+|.+++... ..++..++.++.||+.||+|||+. +|+||||||+||||+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence 3 23679999999999999999763 358899999999999999999999 999999999999999
Q ss_pred CCCcEEEEcccCeeeeecCC---------CccCCCCCCcccCC
Q 021897 273 ADKSIKIADFGVARIEVQTE---------GMTPETGTYRWMAP 306 (306)
Q Consensus 273 ~~~~vkl~DFGla~~~~~~~---------~~~~~~gt~~y~AP 306 (306)
.++.+||+|||+|+...... .....+||+.|+||
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 197 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP 197 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCH
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCc
Confidence 99999999999998653221 12345799999998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=234.43 Aligned_cols=171 Identities=27% Similarity=0.523 Sum_probs=144.8
Q ss_pred cceeeccCceecc-eeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021897 129 EWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (306)
Q Consensus 129 ~~~i~~~~~~~~~-~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (306)
+|.+..++|.+.+ .||+|+||.||+|++ .+..||||+++..... ...+.+.+|+.++++++||||+++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~ 77 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-----ADTEEMMREAQIMHQLDNPYIVRLIG 77 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-----hHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 5677788888887 999999999999986 5678999999764321 12367889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
++. ....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus 78 ~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 78 VCQ-AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EEE-SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred Eec-CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccc
Confidence 994 45689999999999999999743 3568999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCC----ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~AP 306 (306)
+++....... .....+|+.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aP 182 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAP 182 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCH
T ss_pred ceeeeccCcceeeccccccccccccCH
Confidence 9986543222 2233578999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=238.97 Aligned_cols=168 Identities=29% Similarity=0.498 Sum_probs=144.0
Q ss_pred eeccCceecceeeeeccEEEEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
+..++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP------DQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH------HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH------HHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 4568899999999999999999985 567999999875321 1235788999999999999999999998
Q ss_pred E--eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 206 R--KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 206 ~--~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
. ....+++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 7 4567899999999999999998643 358999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCC----CccCCCCCCcccCC
Q 021897 284 VARIEVQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~----~~~~~~gt~~y~AP 306 (306)
+++...... ......||+.|+||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aP 199 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAP 199 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCH
T ss_pred cceecccCCccceeeccCCccccccCH
Confidence 998654332 12334688899998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=236.35 Aligned_cols=164 Identities=25% Similarity=0.393 Sum_probs=136.3
Q ss_pred cCceec-ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCe
Q 021897 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMV 210 (306)
Q Consensus 135 ~~~~~~-~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 210 (306)
..|++. +.||+|+||.||+|.. +++.||||+++...... .+.+.+|+.++.++ +||||+++++++.....
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI------RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 456664 7899999999999987 78899999997654322 24688999999885 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc---EEEEcccCeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARI 287 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~---vkl~DFGla~~ 287 (306)
+|+||||+++++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999999999875 45899999999999999999999999999999999999998775 99999999875
Q ss_pred eecC--------CCccCCCCCCcccCC
Q 021897 288 EVQT--------EGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~--------~~~~~~~gt~~y~AP 306 (306)
.... ......+||+.|+||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aP 190 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAP 190 (316)
T ss_dssp ------------------CCSGGGCCH
T ss_pred cccCCccccccccccccccCCcCccCh
Confidence 4321 112334699999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=238.54 Aligned_cols=160 Identities=18% Similarity=0.380 Sum_probs=142.4
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe--
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRK-- 207 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-- 207 (306)
...+|++++.||+|+||.||+|+. +++.||||+++... .+.+.+|+.++++++ ||||+++++++..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 347899999999999999999987 78899999996422 146889999999997 9999999999987
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEcccCee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVAR 286 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-~vkl~DFGla~ 286 (306)
....++||||+++++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 5678999999999999998853 88999999999999999999999999999999999999777 89999999998
Q ss_pred eeecCCCccCCCCCCcccCC
Q 021897 287 IEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~AP 306 (306)
............||+.|+||
T Consensus 180 ~~~~~~~~~~~~~~~~y~aP 199 (330)
T 3nsz_A 180 FYHPGQEYNVRVASRYFKGP 199 (330)
T ss_dssp ECCTTCCCCSCCSCGGGCCH
T ss_pred EcCCCCccccccccccccCh
Confidence 77665556667899999998
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=240.90 Aligned_cols=171 Identities=27% Similarity=0.476 Sum_probs=140.3
Q ss_pred ceeeccCceecceeeeeccEEEEEEEEC------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYN------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (306)
+++..++|++.+.||+|+||.||+|.+. +..||||+++..... .....+.+|+.++++++||||+++++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-----KQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-----HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 4677889999999999999999999872 235999999754321 12357889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
++......++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999999999999999764 3568999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCC----ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~AP 306 (306)
+++....... .....+|+.|+||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aP 219 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAP 219 (333)
T ss_dssp C-----------------CCCGGGSCH
T ss_pred cchhhccccccccccCCCCccccccCc
Confidence 9986543221 1223467889998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=237.64 Aligned_cols=170 Identities=26% Similarity=0.464 Sum_probs=142.1
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (306)
+.....+|++.+.||+|+||.||+|++ +++.||||++....... +.+.+|+.+++++ +||||+++++++.
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-------EEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT-------HHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH-------HHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 334567899999999999999999998 78899999997654332 4678999999998 7999999999997
Q ss_pred e------CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 207 K------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 207 ~------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
. ...+++||||+++++|.+++.......+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 7 4678999999999999999987655679999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCC-CccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~-~~~~~~gt~~y~AP 306 (306)
|||++....... ......||+.|+||
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aP 198 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAP 198 (326)
T ss_dssp CCTTTC-------------CCGGGCCH
T ss_pred eCcCceecCcCccccccccCCccccCh
Confidence 999998654322 23445799999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=240.86 Aligned_cols=156 Identities=25% Similarity=0.420 Sum_probs=124.6
Q ss_pred cceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeEEEEEe
Q 021897 140 GTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~E 216 (306)
.+.||+|+||.||+|.+ +++.||||++.... ...+.+|+.+++.+. ||||+++++++.+....|+|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 37899999999999998 57899999996421 246779999999997 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEEcccCeeeeecC-C
Q 021897 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK---SIKIADFGVARIEVQT-E 292 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~---~vkl~DFGla~~~~~~-~ 292 (306)
|+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999999999864 5699999999999999999999999999999999999998766 8999999999865432 2
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
.....+||+.|+||
T Consensus 165 ~~~~~~~t~~y~aP 178 (325)
T 3kn6_A 165 PLKTPCFTLHYAAP 178 (325)
T ss_dssp --------------
T ss_pred cccccCCCcCccCH
Confidence 33456789999998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=245.11 Aligned_cols=169 Identities=20% Similarity=0.294 Sum_probs=142.5
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACR 206 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 206 (306)
..+..+.|++++.||+|+||.||+|.. .++.||||++........ ..+.+.+|+.++++++ ||||+++++++.
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHH----HHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 344556799999999999999999987 678999999987554332 2367899999999997 599999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
....+||||| +.+++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++ ++.+||+|||+|+
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 9999999999 5578999999864 4688999999999999999999999999999999999996 6899999999998
Q ss_pred eeecCC---CccCCCCCCcccCC
Q 021897 287 IEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~---~~~~~~gt~~y~AP 306 (306)
...... .....+||+.|+||
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aP 225 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPP 225 (390)
T ss_dssp CC---------CCSCCCGGGCCH
T ss_pred cccCCCccccCCCCCcCCCccCh
Confidence 654322 13456799999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=239.32 Aligned_cols=161 Identities=30% Similarity=0.517 Sum_probs=136.1
Q ss_pred ccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh--CCCCCeeeEEEEEEeC---
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKR--- 208 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~--- 208 (306)
.++|++.+.||+|+||.||+|++.++.||||++.... ...+.+|..++.. ++||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3688999999999999999999999999999986421 1234455555554 4899999999999887
Q ss_pred -CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCcEEEcCCCcEEE
Q 021897 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------GFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~--------~iiHrDlkp~NILv~~~~~vkl 279 (306)
..+++||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7899999999999999999753 589999999999999999999998 9999999999999999999999
Q ss_pred EcccCeeeeecCCC-----ccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTEG-----MTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~-----~~~~~gt~~y~AP 306 (306)
+|||+|+....... ....+||+.|+||
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 215 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCH
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeCh
Confidence 99999976543222 1245799999998
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=234.68 Aligned_cols=171 Identities=23% Similarity=0.427 Sum_probs=136.1
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
...+|++.+.||+|+||.||+|.. +++.||||+++........ ..+.+.+|+.++++++||||+++++++.....
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK---ARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 456899999999999999999987 7889999999764433222 23678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 211 WCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.++||||+++++|.+++.. .....+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||+++..
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999999975 23456899999999999999999999999999999999999999999999999999865
Q ss_pred ecCC-CccCCCCCCcccCC
Q 021897 289 VQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~-~~~~~~gt~~y~AP 306 (306)
.... ......||+.|+||
T Consensus 187 ~~~~~~~~~~~~~~~y~aP 205 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSP 205 (310)
T ss_dssp ------------CCSSCCH
T ss_pred cCCCccccccCCCeeEeCh
Confidence 4322 22345789999998
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=243.36 Aligned_cols=164 Identities=27% Similarity=0.369 Sum_probs=132.0
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (306)
.++|++.+.||+|+||.||+|.. +++.||||++........ ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH----HHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 46899999999999999999987 688999999986543322 2357889999999999999999999997654
Q ss_pred ----eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.+|+||||+++ +|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 88888852 4889999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+...........+||+.|+||
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aP 195 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAP 195 (371)
T ss_dssp ---------------CTTCCH
T ss_pred cccccccccCCceecCCccCH
Confidence 876554445566899999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=237.33 Aligned_cols=177 Identities=24% Similarity=0.469 Sum_probs=139.7
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (306)
..+.+.++.++|.+++.||+|+||.||+|++ .++.||||+++........ .+.+.+|+.++++++||||++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~ 100 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE----IEEFLSEAACMKDFSHPNVIR 100 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHH----HHHHHHHHHHHHTCCCTTBCC
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhH----HHHHHHHHHHHhcCCCCCeee
Confidence 4577888999999999999999999999986 2348999999765544322 357889999999999999999
Q ss_pred EEEEEEeCC-----eEEEEEeecCCCCHHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 021897 201 FIGACRKRM-----VWCIVTEYAKGGSVRQFLTRR----QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (306)
Q Consensus 201 l~~~~~~~~-----~~~iv~E~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv 271 (306)
+++++.... ..++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli 180 (313)
T 3brb_A 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180 (313)
T ss_dssp CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE
T ss_pred eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 999997754 359999999999999999642 33568999999999999999999999999999999999999
Q ss_pred cCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 272 SADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 272 ~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+.++.+||+|||+++....... .....+++.|+||
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 218 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCH
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCc
Confidence 9999999999999986543221 2233578889998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=243.52 Aligned_cols=168 Identities=24% Similarity=0.388 Sum_probs=145.4
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
++...+|++.+.||+|+||.||+|++ +++.||+|++...... ...+.+.+|+.++++++||||+++++++...
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH-----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH-----HHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 34567899999999999999999998 5889999999865321 2236789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
..+++||||+++++|.+++... ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999999999875 3589999999999999999999996 999999999999999999999999999975
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
.... ......||+.|+||
T Consensus 182 ~~~~-~~~~~~gt~~y~aP 199 (360)
T 3eqc_A 182 LIDS-MANSFVGTRSYMSP 199 (360)
T ss_dssp HHHH-C----CCCCTTCCH
T ss_pred cccc-cccCCCCCCCeECH
Confidence 4332 23455899999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=234.42 Aligned_cols=172 Identities=31% Similarity=0.558 Sum_probs=141.5
Q ss_pred CcceeeccCceecc-eeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 128 DEWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 128 ~~~~i~~~~~~~~~-~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
.++.++.++|++.+ .||+|+||.||+|.+ .++.||||+++...... ...+.+.+|+.+++.++||||++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~ 84 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAEANVMQQLDNPYIVRMI 84 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH----HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 45677888999988 999999999999965 35789999997653322 1236789999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
+++ ....+++||||+++++|.+++... ..+++..++.++.||+.||+|||+.|++||||||+|||++.++.+||+||
T Consensus 85 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 85 GIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEE-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEE-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccC
Confidence 999 556689999999999999999864 45899999999999999999999999999999999999999999999999
Q ss_pred cCeeeeecCCC----ccCCCCCCcccCC
Q 021897 283 GVARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~----~~~~~gt~~y~AP 306 (306)
|+++....... .....+|+.|+||
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aP 189 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAP 189 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCH
T ss_pred CcceeeccCCCcccccccCCCCceeeCh
Confidence 99986543322 1223467889998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=242.22 Aligned_cols=167 Identities=25% Similarity=0.430 Sum_probs=134.1
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
...+|++.+.||+|+||.||+|.. +++.||||+++...... ...+.+.+|+.++++++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE----GVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC------------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc----ccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 356889999999999999999987 78899999997554322 123567899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-----cCCCcEEEEcccCe
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI-----SADKSIKIADFGVA 285 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv-----~~~~~vkl~DFGla 285 (306)
+++||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999999997 4999999764 458999999999999999999999999999999999999 45556999999999
Q ss_pred eeeecC-CCccCCCCCCcccCC
Q 021897 286 RIEVQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~-~~~~~~~gt~~y~AP 306 (306)
+..... ......+||+.|+||
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aP 206 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPP 206 (329)
T ss_dssp HHHC-----------CCTTCCH
T ss_pred cccCCcccccCCCcCCccccCH
Confidence 765422 233455789999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=232.44 Aligned_cols=165 Identities=24% Similarity=0.350 Sum_probs=143.6
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 208 (306)
+..++|++++.||+|+||.||+|+. +++.||||++...... +.+.+|+.+++.+ +|++++++++++...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--------HHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 4457899999999999999999996 7899999998754432 2577899999999 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc-----EEEEccc
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS-----IKIADFG 283 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~-----vkl~DFG 283 (306)
...++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999999 99999999864 346999999999999999999999999999999999999987776 9999999
Q ss_pred CeeeeecCCC--------ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG--------MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~--------~~~~~gt~~y~AP 306 (306)
+|+....... .....||+.|+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 187 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSI 187 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred cccccccccccccccccCccCCCCCcccCCc
Confidence 9986554322 2445799999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=239.72 Aligned_cols=170 Identities=24% Similarity=0.445 Sum_probs=142.5
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
....++|++.+.||+|+||.||+|++ +++.||||++........ ..+.+.+|+.++++++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchH----HHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 34568899999999999999999998 588999999976554432 235688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+++||||+++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999999998888876543 45999999999999999999999999999999999999999999999999999764
Q ss_pred ecC-CCccCCCCCCcccCC
Q 021897 289 VQT-EGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~-~~~~~~~gt~~y~AP 306 (306)
... .......||+.|+||
T Consensus 175 ~~~~~~~~~~~~t~~y~aP 193 (331)
T 4aaa_A 175 AAPGEVYDDEVATRWYRAP 193 (331)
T ss_dssp ---------CCCCCTTCCH
T ss_pred cCCccccCCCcCCccccCc
Confidence 432 233456799999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=241.65 Aligned_cols=168 Identities=21% Similarity=0.349 Sum_probs=140.0
Q ss_pred cCceec-ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCe
Q 021897 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (306)
Q Consensus 135 ~~~~~~-~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 210 (306)
..|.+. +.||+|+||.||+|.. +++.||||+++........ ...+.+|+.+++.+. ||||+++++++.....
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 345555 8899999999999988 5889999999865433221 246889999999995 6999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEcccCeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARI 287 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~~~vkl~DFGla~~ 287 (306)
+++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 999999999999999987655567999999999999999999999999999999999999997 78999999999987
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
..........+||+.|+||
T Consensus 184 ~~~~~~~~~~~gt~~y~aP 202 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAP 202 (327)
T ss_dssp C---------CCCGGGCCH
T ss_pred cCCccccccccCCcCccCC
Confidence 6655555566899999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=232.26 Aligned_cols=167 Identities=31% Similarity=0.510 Sum_probs=143.8
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--- 207 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 207 (306)
+.+.|++.+.||+|+||.||+|.+ ++..||+|++......... .+.+.+|+.++++++||||+++++++..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHH----HHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 345688899999999999999988 6678999999865544322 3678899999999999999999999865
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEc-CCCcEEEEccc
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFG 283 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlkp~NILv~-~~~~vkl~DFG 283 (306)
...+++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 45689999999999999999865 45899999999999999999999999 99999999999997 78999999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
++...... ......||+.|+||
T Consensus 178 ~~~~~~~~-~~~~~~~t~~y~aP 199 (290)
T 1t4h_A 178 LATLKRAS-FAKAVIGTPEFMAP 199 (290)
T ss_dssp GGGGCCTT-SBEESCSSCCCCCG
T ss_pred Cccccccc-ccccccCCcCcCCH
Confidence 99754433 23445799999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=240.89 Aligned_cols=168 Identities=24% Similarity=0.488 Sum_probs=135.7
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
+..++|++.+.||+|+||.||+|++ +++ +||+|.++..... ...+.+.+|+.++++++||||++++++|
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----KANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC------------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH-----HHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 3457899999999999999999987 444 4688877543221 1235789999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.... .++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 87 ~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred ecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 8866 689999999999999998643 56899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC---ccCCCCCCcccCC
Q 021897 286 RIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+....... .....+|+.|+||
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aP 188 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMAL 188 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCH
T ss_pred eEccCCcccccccCCCccccccCh
Confidence 86543322 2233568899998
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=235.54 Aligned_cols=168 Identities=27% Similarity=0.470 Sum_probs=142.5
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++.+.||+|+||.||+|+. +++.||||+++....... ..+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKL 77 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchh----hHHHHHHHHHHHHHcCCCCeeeEEEEEecCCce
Confidence 46789999999999999999998 688999999865432211 124678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||++ ++|.+++.......+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 156 (299)
T 2r3i_A 78 YLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156 (299)
T ss_dssp EEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred EEEEEccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCC
Confidence 99999997 59999998766567899999999999999999999999999999999999999999999999999764322
Q ss_pred -CCccCCCCCCcccCC
Q 021897 292 -EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 -~~~~~~~gt~~y~AP 306 (306)
.......||+.|+||
T Consensus 157 ~~~~~~~~~~~~y~aP 172 (299)
T 2r3i_A 157 VRTYTHEVVTLWYRAP 172 (299)
T ss_dssp SBCTTSCBCCCTTCCH
T ss_pred ccccCcccccccccCc
Confidence 223445789999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=243.16 Aligned_cols=165 Identities=27% Similarity=0.405 Sum_probs=135.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|+||.||+|+. +++.||||+++....... ...+.+|+.++++++||||+++++++......+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-----chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence 5788999999999999999998 678999999965432211 124558999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~- 291 (306)
+||||++ ++|.+++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+.....
T Consensus 77 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred EEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 9999997 5999998864 346899999999999999999999999999999999999999999999999999865422
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
.......||+.|+||
T Consensus 155 ~~~~~~~~t~~y~aP 169 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPP 169 (324)
T ss_dssp --------CGGGCCH
T ss_pred cccccccCcccccCh
Confidence 223445789999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=240.96 Aligned_cols=174 Identities=26% Similarity=0.394 Sum_probs=129.3
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
..|.+..++|++.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.++++++||||+++++++
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-----TSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC---------------------CCCCCCCTTBCCEEEEE
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-----hhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 45788889999999999999999999976 7889999988643321 1235788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRR------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl 279 (306)
......++||||+++++|.+++... ....+++..++.++.||+.||+|||++|++||||||+||+++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 9999999999999999999999752 2345899999999999999999999999999999999999999999999
Q ss_pred EcccCeeeeecCC------CccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTE------GMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~------~~~~~~gt~~y~AP 306 (306)
+|||+++...... ......||+.|+||
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCH
Confidence 9999987543221 12345799999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=233.41 Aligned_cols=165 Identities=30% Similarity=0.473 Sum_probs=145.6
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.+.|+..+.||+|+||.||+|+. +++.||||++........ .+.+.+|+.+++.++||||+++++++.....+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH-----HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 35688999999999999999987 678999999986544322 35788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999999999864 46899999999999999999999999999999999999999999999999999865543
Q ss_pred C-CccCCCCCCcccCC
Q 021897 292 E-GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~-~~~~~~gt~~y~AP 306 (306)
. ......||+.|+||
T Consensus 173 ~~~~~~~~~~~~y~aP 188 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAP 188 (303)
T ss_dssp BCCBCCCCSCGGGCCH
T ss_pred ccccCccCCCcCccCH
Confidence 2 23445799999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=236.15 Aligned_cols=168 Identities=21% Similarity=0.342 Sum_probs=139.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
..+|++.+.||+|+||.||+|++ +++.||||++....... ....+.+.+|+.++++++||||+++++++.....+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD---PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC---HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 47889999999999999999997 68899999986543221 22346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||||+++++|.+++... ..+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 9999999999999999865 45899999999999999999999999999999999999999999999999999765432
Q ss_pred C--CccCCCCCCcccCC
Q 021897 292 E--GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~--~~~~~~gt~~y~AP 306 (306)
. ......||+.|+||
T Consensus 188 ~~~~~~~~~~~~~y~aP 204 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAP 204 (309)
T ss_dssp ---------CCGGGCCG
T ss_pred ccccccccCCCcCccCH
Confidence 2 22345799999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=244.75 Aligned_cols=172 Identities=17% Similarity=0.291 Sum_probs=138.1
Q ss_pred eccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHH-----HHHHHHHHHHHHhCCCCCeee
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVM-----EQQFQQEVMMLATLKHLNIVR 200 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~ 200 (306)
..++|++++.||+|+||.||+|.+. ++.||||++............. ...+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4468999999999999999999882 4689999987643211111111 123456777788899999999
Q ss_pred EEEEEEeC----CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc--CC
Q 021897 201 FIGACRKR----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--AD 274 (306)
Q Consensus 201 l~~~~~~~----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~--~~ 274 (306)
+++++... ...||||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++ .+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 99999764 4589999999 99999999864 35699999999999999999999999999999999999999 88
Q ss_pred CcEEEEcccCeeeeecCCC--------ccCCCCCCcccCC
Q 021897 275 KSIKIADFGVARIEVQTEG--------MTPETGTYRWMAP 306 (306)
Q Consensus 275 ~~vkl~DFGla~~~~~~~~--------~~~~~gt~~y~AP 306 (306)
+.+||+|||+|+....... ....+||+.|+||
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 230 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI 230 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCH
Confidence 9999999999986543221 1334599999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=244.37 Aligned_cols=163 Identities=26% Similarity=0.411 Sum_probs=136.6
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM-- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 209 (306)
.++|++.+.||+|+||.||+|.+ +++.||||++....... ...+++.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH----HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH----HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 36799999999999999999998 68899999996654332 22467889999999999999999999997653
Q ss_pred ----eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 210 ----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 210 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7899999976 35899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+.... .....+||+.|+||
T Consensus 176 ~~~~~--~~~~~~~t~~y~aP 194 (367)
T 1cm8_A 176 RQADS--EMTGYVVTRWYRAP 194 (367)
T ss_dssp EECCS--SCCSSCSCGGGCCT
T ss_pred ccccc--ccCcCcCCCCcCCH
Confidence 87543 34556899999999
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=240.41 Aligned_cols=175 Identities=29% Similarity=0.554 Sum_probs=146.9
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCe
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNI 198 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 198 (306)
..+|.+..++|++++.||+|+||.||+|++ +++.||||+++...... ..+.+.+|+.+++++ +||||
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH-----HHHHHHHHHHHHHhcccCCCe
Confidence 357888999999999999999999999985 34789999997543321 235788999999999 69999
Q ss_pred eeEEEEEEeCC-eEEEEEeecCCCCHHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021897 199 VRFIGACRKRM-VWCIVTEYAKGGSVRQFLTRRQN--------------RAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (306)
Q Consensus 199 v~l~~~~~~~~-~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrD 263 (306)
+++++++.... .+++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.||+|||
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d 173 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 99999997754 58999999999999999986432 1278999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 264 lkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|||+|||++.++.+||+|||+++....... .....||+.|+||
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP 219 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 219 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence 999999999999999999999986433221 1234578899998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=231.39 Aligned_cols=174 Identities=26% Similarity=0.422 Sum_probs=146.3
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
..++.+...++.....||+|+||.||+|++ +++.||||++....... .+.+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~ 87 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY------SQPLHEEIALHKHLKHKNIVQYLGS 87 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH------HHHHHHHHHHHHhCCCCCEeeEeeE
Confidence 345566667777778999999999999998 67899999997653321 2578899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEcc
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADF 282 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~-~~~vkl~DF 282 (306)
+......++||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+||+++. ++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Df 167 (295)
T 2clq_A 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF 167 (295)
T ss_dssp EEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred EEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeec
Confidence 999999999999999999999998653 234678889999999999999999999999999999999987 899999999
Q ss_pred cCeeeeecCC-CccCCCCCCcccCC
Q 021897 283 GVARIEVQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~-~~~~~~gt~~y~AP 306 (306)
|+++...... ......||+.|+||
T Consensus 168 g~~~~~~~~~~~~~~~~~~~~y~aP 192 (295)
T 2clq_A 168 GTSKRLAGINPCTETFTGTLQYMAP 192 (295)
T ss_dssp TTCEESCC-----CCCCCCGGGCCH
T ss_pred ccccccCCCCCcccccCCCccccCh
Confidence 9998654322 23445799999998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=232.45 Aligned_cols=165 Identities=27% Similarity=0.492 Sum_probs=144.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|++ +++.||||++....... ..+.+.+|+.+++.++||||+++++++.+....|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh-----hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 5788999999999999999998 58899999997543322 1357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999999864 3458999999999999999999999999999999999999999999999999998654221
Q ss_pred ---CccCCCCCCcccCC
Q 021897 293 ---GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ---~~~~~~gt~~y~AP 306 (306)
......||+.|+||
T Consensus 160 ~~~~~~~~~~~~~y~aP 176 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAP 176 (276)
T ss_dssp EECCBCCCCSCGGGCCG
T ss_pred chhcccCCccccCccCh
Confidence 23455799999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-31 Score=238.19 Aligned_cols=161 Identities=35% Similarity=0.578 Sum_probs=141.5
Q ss_pred ccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh--CCCCCeeeEEEEEEeCC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT--LKHLNIVRFIGACRKRM-- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~-- 209 (306)
.++|++.+.||+|+||.||+|+++++.||||++.... .+.+.+|+.+++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3678999999999999999999999999999985321 2467788888887 78999999999998875
Q ss_pred --eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCcEEEcCCCcEEE
Q 021897 210 --VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--------GLGFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 210 --~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH--------~~~iiHrDlkp~NILv~~~~~vkl 279 (306)
.+++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.+|+||||||+||||+.++.+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 78999999999999999975 35899999999999999999999 899999999999999999999999
Q ss_pred EcccCeeeeecCC-----CccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTE-----GMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~-----~~~~~~gt~~y~AP 306 (306)
+|||+++...... ......||+.|+||
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aP 220 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCH
T ss_pred EECCCceeccccccccccccccCCcCcccCCH
Confidence 9999998765443 23445799999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=233.45 Aligned_cols=172 Identities=24% Similarity=0.495 Sum_probs=142.7
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
..|.+..++|++.+.||+|+||.||+|++. +..||||+++...... ..+.+.+|+.++++++||||++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-----NKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH-----HHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch-----HHHHHHHHHHHHHhCCCCCcceEE
Confidence 356778899999999999999999999862 2359999987643221 236789999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
+++.+.. .|+||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 80 GIIEEEP-TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp EEECSSS-CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred EEEcCCC-CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCcc
Confidence 9987654 589999999999999998653 45899999999999999999999999999999999999999999999999
Q ss_pred cCeeeeecCCC--ccCCCCCCcccCC
Q 021897 283 GVARIEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~--~~~~~gt~~y~AP 306 (306)
|+++....... .....+|+.|+||
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aP 183 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSP 183 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCH
T ss_pred CCCcccccccccccccCCCCcceeCc
Confidence 99986543321 2334578899998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=245.17 Aligned_cols=171 Identities=27% Similarity=0.429 Sum_probs=138.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|+||.||+|.+ +++.||+|++....... ......+.+.+|+.++++++||||+++++++.+....+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ-INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC----CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc-cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 6788999999999999999988 67799999986431100 00112367899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 021897 213 IVTEYAKGGSVRQFLTRRQ--------------------------------------NRAVPLKLAVKQALDVARGMAYV 254 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~--------------------------------------~~~~~~~~~~~i~~qi~~gl~yL 254 (306)
+||||+++|+|.+++.... ...+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985210 11235777889999999999999
Q ss_pred HhCCccccCCCCCcEEEcCCC--cEEEEcccCeeeeecCC-----CccCCCCCCcccCC
Q 021897 255 HGLGFIHRDLKSDNLLISADK--SIKIADFGVARIEVQTE-----GMTPETGTYRWMAP 306 (306)
Q Consensus 255 H~~~iiHrDlkp~NILv~~~~--~vkl~DFGla~~~~~~~-----~~~~~~gt~~y~AP 306 (306)
|+.+|+||||||+|||++.++ .+||+|||+|+...... ......||+.|+||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence 999999999999999998776 89999999998653322 13455799999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=240.93 Aligned_cols=168 Identities=26% Similarity=0.412 Sum_probs=141.6
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--- 207 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 207 (306)
...+|++++.||+|+||.||+|++ +++.||||++......... ...+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc----hHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 347899999999999999999998 6889999998655433221 1467799999999999999999999977
Q ss_pred -----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 208 -----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 208 -----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
...+|+||||+++ +|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999975 8888886543 45999999999999999999999999999999999999999999999999
Q ss_pred cCeeeeec-----CCCccCCCCCCcccCC
Q 021897 283 GVARIEVQ-----TEGMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~-----~~~~~~~~gt~~y~AP 306 (306)
|+|+.... ........||+.|+||
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aP 197 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPP 197 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCH
T ss_pred hhcccccccccccccccCCcccccCccCc
Confidence 99986542 1223455789999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=240.93 Aligned_cols=169 Identities=27% Similarity=0.378 Sum_probs=138.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
++|++.+.||+|+||.||+|.+ +++.||||++........ ........+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5788999999999999999988 678999999975432211 11112345889999999999999999999997765
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc---EEEEcccCeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADFGVARI 287 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~---vkl~DFGla~~ 287 (306)
.|+||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 7999999999999999865 356899999999999999999999999999999999999987664 99999999987
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
...........||+.|+||
T Consensus 167 ~~~~~~~~~~~gt~~y~aP 185 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAP 185 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCH
T ss_pred cccccccccccCCcCccCc
Confidence 6543333445689999998
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=233.06 Aligned_cols=170 Identities=28% Similarity=0.514 Sum_probs=144.0
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHH-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKA-QVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
+..++|++.+.||+|+||.||+|++ +++.||||++.......... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4557899999999999999999998 68899999987654432211 11125788999999999999999999999776
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcCCCc-----EEEEc
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISADKS-----IKIAD 281 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlkp~NILv~~~~~-----vkl~D 281 (306)
. ++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6 7999999999999998754 356999999999999999999999999 999999999999988776 99999
Q ss_pred ccCeeeeecCCCccCCCCCCcccCC
Q 021897 282 FGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
||+|+.... ......||+.|+||
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aP 195 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAP 195 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCG
T ss_pred CCccccccc--cccccCCCccccCc
Confidence 999985432 34556899999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.43 Aligned_cols=174 Identities=23% Similarity=0.375 Sum_probs=133.6
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHH-HHHhCCCCCeeeEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM-MLATLKHLNIVRFIG 203 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~ 203 (306)
...|.+..++|++.+.||+|+||.||+|.+ +++.||||+++....... ...+.+|+. +++.++||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-----QKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-----HHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-----HHHHHHHHHHHHHcCCCCcEeeeee
Confidence 467888999999999999999999999998 588999999976543221 234555555 778889999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEE
Q 021897 204 ACRKRMVWCIVTEYAKGGSVRQFLTR---RQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~~vkl 279 (306)
++......++||||+++ +|.+++.. .....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 99999999999999975 88888763 2346789999999999999999999998 9999999999999999999999
Q ss_pred EcccCeeeeecCCCccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|||+++............||+.|+||
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aP 194 (327)
T 3aln_A 168 CDFGISGQLVDSIAKTRDAGCRPYMAP 194 (327)
T ss_dssp CCCSSSCC-------------------
T ss_pred ccCCCceecccccccccCCCCccccCc
Confidence 999999876554444555799999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=241.89 Aligned_cols=168 Identities=27% Similarity=0.524 Sum_probs=137.2
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCee----EEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
+..++|++.+.||+|+||.||+|++ +++. ||+|++........ .+.+.+|+.++++++||||+++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-----FQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-----BCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-----HHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 4557899999999999999999987 4443 88888754432221 13567899999999999999999998
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.. ...++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 85 ~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 85 PG-SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp CB-SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred cC-CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence 64 4578999999999999999754 245888999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC---ccCCCCCCcccCC
Q 021897 286 RIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+....... .....||+.|+||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aP 186 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMAL 186 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCH
T ss_pred cccCcccccccccCCCCcccccCh
Confidence 86543321 2344678899998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=242.78 Aligned_cols=170 Identities=22% Similarity=0.354 Sum_probs=137.4
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++++.||+|+||.||+|++ +++.||||+++....... .....+.+.+|+.+++.++||||+++++++.....+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh-hhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 46788999999999999999988 578999999975433211 111224678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~- 290 (306)
++||||+++ +|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 999999976 898888653 34588889999999999999999999999999999999999999999999999986532
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
.......+||+.|+||
T Consensus 166 ~~~~~~~~~t~~y~aP 181 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAP 181 (346)
T ss_dssp CCCCCCSCCCCTTCCH
T ss_pred cccCCcccccccccCc
Confidence 2234556899999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=236.09 Aligned_cols=171 Identities=28% Similarity=0.537 Sum_probs=143.6
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
...+..++|++++.||+|+||.||+|++ +++.||||++...... ..+.+.+|+.++++++||||++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~ 108 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------HLRDFEREIEILKSLQHDNIVKYK 108 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH------HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH------HHHHHHHHHHHHHhCCCCCeeeEE
Confidence 3445678899999999999999999985 5789999999753221 235788999999999999999999
Q ss_pred EEEEeCC--eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 203 GACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 203 ~~~~~~~--~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
+++.... .+++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+
T Consensus 109 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~ 187 (326)
T 2w1i_A 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG 187 (326)
T ss_dssp EEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEEC
T ss_pred EEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEe
Confidence 9986643 6899999999999999998643 458999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCCC----ccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~----~~~~~gt~~y~AP 306 (306)
|||+++....... .....+|+.|+||
T Consensus 188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 217 (326)
T 2w1i_A 188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217 (326)
T ss_dssp CCTTCEECCSSCSEEECSSCCSCCGGGCCH
T ss_pred cCcchhhccccccccccccCCCCceeEECc
Confidence 9999987644322 2334577889998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=237.99 Aligned_cols=173 Identities=21% Similarity=0.293 Sum_probs=143.5
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
+.+.++.++|++.+.||+|+||.||++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ------QDREEAQREADMHRLFNHPNILRLVAYC 95 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH------HHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH------HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34567778999999999999999999997 788999999865321 1235788999999999999999999998
Q ss_pred Ee----CCeEEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 021897 206 RK----RMVWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 206 ~~----~~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl 279 (306)
.. ....++||||+++++|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEE
Confidence 63 34789999999999999999863 3456899999999999999999999999999999999999999999999
Q ss_pred EcccCeeeeecCCC----------ccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTEG----------MTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~----------~~~~~gt~~y~AP 306 (306)
+|||+++....... .....||+.|+||
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 212 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCH
Confidence 99999875421110 1223578999998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-32 Score=248.67 Aligned_cols=171 Identities=16% Similarity=0.204 Sum_probs=137.0
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHH---HHHHhCCCCCeeeEE-
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV---MMLATLKHLNIVRFI- 202 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~- 202 (306)
+|....++|++.+.||+|+||.||+|++ +++.||||++......... ..+.+.+|+ .++++++||||++++
T Consensus 67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN---AIKQMKEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT---HHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH---HHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence 3444567899999999999999999986 6899999999854332221 135788999 555666899999998
Q ss_pred ------EEEEeCC-----------------eEEEEEeecCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHH
Q 021897 203 ------GACRKRM-----------------VWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYV 254 (306)
Q Consensus 203 ------~~~~~~~-----------------~~~iv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gl~yL 254 (306)
+++..++ ..||||||+ +|+|.+++..... ..+++..++.++.||+.||+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 7766553 279999999 6799999986421 1123478888999999999999
Q ss_pred HhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 255 H~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|++||+||||||+||||+.++.+||+|||+|+.... .....+| +.|+||
T Consensus 223 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aP 271 (377)
T 3byv_A 223 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPP 271 (377)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCH
T ss_pred HhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccCh
Confidence 999999999999999999999999999999986332 3455678 999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=233.98 Aligned_cols=163 Identities=26% Similarity=0.430 Sum_probs=141.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|+. +++.||||+++...... .+.+.+|+.++++++||||+++++++......|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR------DSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc------hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 5788999999999999999998 68899999998643221 246889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEcccCeeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIEV 289 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv---~~~~~vkl~DFGla~~~~ 289 (306)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++||||||+|||+ +.++.+||+|||+++...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999999999765 358999999999999999999999999999999999999 778899999999997644
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.. .....+||+.|+||
T Consensus 161 ~~-~~~~~~~~~~y~aP 176 (304)
T 2jam_A 161 NG-IMSTACGTPGYVAP 176 (304)
T ss_dssp CB-TTHHHHSCCCBCCT
T ss_pred CC-ccccccCCCCccCh
Confidence 32 23344699999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=232.16 Aligned_cols=166 Identities=28% Similarity=0.451 Sum_probs=140.3
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
...++|++.+.||+|+||.||+|.+ +++.||||++...... +.+.+|+.++++++||||+++++++....
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--------QEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH--------HHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 3457889999999999999999998 4889999999764432 46889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++...
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999999999754 3568999999999999999999999999999999999999999999999999998654
Q ss_pred cCC-CccCCCCCCcccCC
Q 021897 290 QTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~-~~~~~~gt~~y~AP 306 (306)
... ......||+.|+||
T Consensus 177 ~~~~~~~~~~~~~~y~aP 194 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAP 194 (314)
T ss_dssp TTBSCBCCCCSCGGGCCH
T ss_pred hhccccCccCCCCCccCh
Confidence 332 23445799999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=238.21 Aligned_cols=163 Identities=37% Similarity=0.624 Sum_probs=134.5
Q ss_pred eeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
++.++|++.+.||+|+||.||+|++.++.||||++.... ..+.+.+|+.++++++||||+++++++.+. .
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 74 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--------ERKAFIVELRQLSRVNHPNIVKLYGACLNP--V 74 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT--------HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--T
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh--------HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--c
Confidence 567889999999999999999999999999999986421 125788999999999999999999988744 6
Q ss_pred EEEEeecCCCCHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCcEEEcCCCc-EEEEcccCee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQN-RAVPLKLAVKQALDVARGMAYVHG---LGFIHRDLKSDNLLISADKS-IKIADFGVAR 286 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlkp~NILv~~~~~-vkl~DFGla~ 286 (306)
++||||+++++|.+++..... ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++. +||+|||+++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 899999999999999985432 247889999999999999999999 89999999999999998886 7999999997
Q ss_pred eeecCCCccCCCCCCcccCC
Q 021897 287 IEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~AP 306 (306)
..... .....||+.|+||
T Consensus 155 ~~~~~--~~~~~gt~~y~aP 172 (307)
T 2eva_A 155 DIQTH--MTNNKGSAAWMAP 172 (307)
T ss_dssp ------------CCTTSSCH
T ss_pred ccccc--cccCCCCCceECh
Confidence 55432 3345799999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=232.27 Aligned_cols=164 Identities=27% Similarity=0.454 Sum_probs=135.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (306)
++|++++.||+|+||.||+|+. +++.||||+++.. ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 5688999999999999999997 6889999999642 1223678899999999999999999999865
Q ss_pred --------CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 021897 208 --------RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 208 --------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl 279 (306)
....|+||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 35789999999999999999863 345788999999999999999999999999999999999999999999
Q ss_pred EcccCeeeeecC---------------CCccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQT---------------EGMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~---------------~~~~~~~gt~~y~AP 306 (306)
+|||+++..... .......||+.|+||
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 199 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT 199 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCc
Confidence 999999754321 122345689999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=244.60 Aligned_cols=161 Identities=27% Similarity=0.433 Sum_probs=136.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (306)
.+|++.+.||+|+||.||+|++ +++.||||++..... .+.+|+.+++.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 4688899999999999999998 688999999875432 233799999999999999999998542
Q ss_pred --CeEEEEEeecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-CcEEEEccc
Q 021897 209 --MVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFG 283 (306)
Q Consensus 209 --~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~-~~vkl~DFG 283 (306)
..+++||||+++ +|.+++.. .....+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 246799999975 77777653 334679999999999999999999999999999999999999965 578999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|+...........+||+.|+||
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aP 225 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAP 225 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCH
T ss_pred hhhhcccCCCceeeeeCCCcCCH
Confidence 99976555555667899999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=235.29 Aligned_cols=168 Identities=27% Similarity=0.457 Sum_probs=141.3
Q ss_pred ccCceecceeeeeccEEEEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEE-
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACR- 206 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~- 206 (306)
.++|++.+.||+|+||.||+|++ +++.||||+++......... ..+.+|+.+++.+ .||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----CTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC----chhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 47899999999999999999987 46899999987543321110 2355677666655 8999999999997
Q ss_pred ----eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 207 ----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 207 ----~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
....+++||||++ |+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999997 69999998766666999999999999999999999999999999999999999999999999
Q ss_pred cCeeeeecCCCccCCCCCCcccCC
Q 021897 283 GVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|+++............||+.|+||
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aP 188 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAP 188 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCH
T ss_pred cccccccCCCCccccccccceeCH
Confidence 999876544445566899999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-31 Score=236.85 Aligned_cols=172 Identities=27% Similarity=0.418 Sum_probs=135.0
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGA 204 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 204 (306)
..+++...+|++.+.||+|+||.||+|++ +++.||||++..... ...+.+.+|+.+++++. ||||++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE------EKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH------HHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch------HHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 45667778999999999999999999998 788999999865321 12357889999999996 9999999999
Q ss_pred EE--------eCCeEEEEEeecCCCCHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEcC
Q 021897 205 CR--------KRMVWCIVTEYAKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLISA 273 (306)
Q Consensus 205 ~~--------~~~~~~iv~E~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlkp~NILv~~ 273 (306)
+. ....+++||||+. |+|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC
Confidence 94 3446899999995 699999875 23456999999999999999999999999 999999999999999
Q ss_pred CCcEEEEcccCeeeeecCCCc-------------cCCCCCCcccCC
Q 021897 274 DKSIKIADFGVARIEVQTEGM-------------TPETGTYRWMAP 306 (306)
Q Consensus 274 ~~~vkl~DFGla~~~~~~~~~-------------~~~~gt~~y~AP 306 (306)
++.+||+|||+++........ ....||+.|+||
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP 219 (337)
T 3ll6_A 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219 (337)
T ss_dssp TSCEEBCCCTTCBCCSSCC---------------------------
T ss_pred CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCCh
Confidence 999999999999865432211 134689999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=239.36 Aligned_cols=172 Identities=20% Similarity=0.312 Sum_probs=135.4
Q ss_pred eccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChh-----HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE-----KAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
...+|++++.||+|+||.||+|.. +++.||||++........ ......+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 347889999999999999999987 788999999865433211 12233468999999999999999999999985
Q ss_pred e-----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEc
Q 021897 207 K-----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIAD 281 (306)
Q Consensus 207 ~-----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~D 281 (306)
. ...+|+||||++ |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 4 346899999997 6898888753 34689999999999999999999999999999999999999999999999
Q ss_pred ccCeeeeecCCCccCCCCCCcccCC
Q 021897 282 FGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
||+++............||+.|+||
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aP 202 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAP 202 (362)
T ss_dssp TTC---------------CGGGCCH
T ss_pred cCcccccccccccceecccceecCc
Confidence 9999865555555666899999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=239.31 Aligned_cols=171 Identities=16% Similarity=0.256 Sum_probs=136.2
Q ss_pred eccCceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQV-----MEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
..++|++++.||+|+||.||+|.+ .+..+|||++............ ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 347899999999999999999998 4568999999865432211111 113477889999999999999999
Q ss_pred EEEEe----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC--c
Q 021897 203 GACRK----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK--S 276 (306)
Q Consensus 203 ~~~~~----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~--~ 276 (306)
+++.. ....|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 99988 77899999999 999999997643 699999999999999999999999999999999999999887 9
Q ss_pred EEEEcccCeeeeecCCC--------ccCCCCCCcccCC
Q 021897 277 IKIADFGVARIEVQTEG--------MTPETGTYRWMAP 306 (306)
Q Consensus 277 vkl~DFGla~~~~~~~~--------~~~~~gt~~y~AP 306 (306)
+||+|||+|+....... .....||+.|+||
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 229 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSL 229 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCH
Confidence 99999999986533211 1445799999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=238.02 Aligned_cols=163 Identities=26% Similarity=0.377 Sum_probs=140.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (306)
.+|++.+.||+|+||.||+|.. +++.||||++...... ...+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc-----HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 5799999999999999999987 6789999999753321 2236788999999999999999999999765
Q ss_pred -CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 36899999997 599999875 3589999999999999999999999999999999999999999999999999987
Q ss_pred eecCCC----ccCCCCCCcccCC
Q 021897 288 EVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~----~~~~~gt~~y~AP 306 (306)
...... ....+||+.|+||
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aP 200 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAP 200 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCH
T ss_pred cCCCCCccccccccccccCCCCC
Confidence 543322 2445899999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=242.43 Aligned_cols=175 Identities=21% Similarity=0.370 Sum_probs=149.2
Q ss_pred eeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHH-----------HHHHHHHHHHHHHHHhCCCCCee
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKA-----------QVMEQQFQQEVMMLATLKHLNIV 199 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv 199 (306)
.+...+|++++.||+|+||.||+|+++++.||||++.......... ....+.+.+|+.++++++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3456899999999999999999999999999999987432111000 00115788999999999999999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHH------HHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEc
Q 021897 200 RFIGACRKRMVWCIVTEYAKGGSVRQF------LTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLIS 272 (306)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~ 272 (306)
++++++.....+++||||+++++|.++ +.......+++..++.++.||+.||+|||+ +|++||||||+|||++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999998 655445679999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 273 ~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
.++.+||+|||+++..... ......||+.|+||
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aP 219 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPP 219 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCG
T ss_pred CCCcEEEeccccccccccc-cccCCCCCcCccCc
Confidence 9999999999999875443 34556799999998
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=232.46 Aligned_cols=166 Identities=29% Similarity=0.474 Sum_probs=137.2
Q ss_pred cCceecceeeeeccEEEEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eC
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR-KR 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~ 208 (306)
.+|++.+.||+|+||.||+|++. ...+|+|.++..... ...+.+.+|+.++++++||||+++++++. .+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-----HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-----HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 46788999999999999999862 235899988653322 12367889999999999999999999964 45
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 6789999999999999999753 356899999999999999999999999999999999999999999999999999854
Q ss_pred ecCC-----CccCCCCCCcccCC
Q 021897 289 VQTE-----GMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~-----~~~~~~gt~~y~AP 306 (306)
.... ......||+.|+||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aP 201 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMAL 201 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCH
T ss_pred cccchhccccccCCCCCccccCh
Confidence 3322 12334577889998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=233.65 Aligned_cols=167 Identities=28% Similarity=0.468 Sum_probs=139.1
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
..+.|++.+.||+|+||.||+|++ +++.||+|++....... .+.+.+|+.+++.++||||+++++++.....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE------LEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC------HHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH------HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 346889999999999999999998 47899999986543221 2578899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999999999987643 4589999999999999999999999999999999999999999999999999764321
Q ss_pred -CCCccCCCCCCcccCC
Q 021897 291 -TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 -~~~~~~~~gt~~y~AP 306 (306)
........||+.|+||
T Consensus 170 ~~~~~~~~~~~~~y~aP 186 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAP 186 (302)
T ss_dssp HHHC-----CCGGGCCH
T ss_pred cccccccccCChhhcCC
Confidence 1123345799999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=233.81 Aligned_cols=169 Identities=24% Similarity=0.414 Sum_probs=140.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCCe
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR--KRMV 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 210 (306)
.+|++++.||+|+||.||+|.. +++.||||+++...... .....+.+.+|+.++++++||||+++++++. +...
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc--cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 6788999999999999999988 67899999986422110 0112367899999999999999999999984 4567
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
.++||||++++ |.+++.......+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999875 88888876667799999999999999999999999999999999999999999999999999986542
Q ss_pred C---CCccCCCCCCcccCC
Q 021897 291 T---EGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~---~~~~~~~gt~~y~AP 306 (306)
. .......||+.|+||
T Consensus 162 ~~~~~~~~~~~~~~~y~aP 180 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPP 180 (305)
T ss_dssp TCSSCEECCCCSCGGGCCH
T ss_pred cccccccccCCCCCCCcCh
Confidence 2 122345799999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=240.15 Aligned_cols=162 Identities=24% Similarity=0.400 Sum_probs=135.9
Q ss_pred ccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC---
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 209 (306)
..+|++.+.||+|+||.||+|++ .+..+|+|.+...... ..+|+.+++.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 35789999999999999999998 5566999988654322 237999999999999999999996543
Q ss_pred ---eEEEEEeecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEccc
Q 021897 210 ---VWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADFG 283 (306)
Q Consensus 210 ---~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~-~~~~vkl~DFG 283 (306)
.+++||||+++ ++.+.+.. .....+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||
T Consensus 109 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 38899999976 55444432 2345799999999999999999999999999999999999999 79999999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|+............||+.|+||
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aP 210 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAP 210 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCH
T ss_pred CcccccCCCCCcccccCcCccCH
Confidence 99977665556667899999998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=242.30 Aligned_cols=167 Identities=26% Similarity=0.416 Sum_probs=126.0
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.|++. ++|++.+.||+|+||.||+|.. +++.||||++........ ..+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 35554 7899999999999999999987 788999999976543322 2357889999999999999999999996
Q ss_pred eC------CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 207 KR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 207 ~~------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
.. ..+|+|+|++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~ 174 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEe
Confidence 54 5679999999 6799999865 459999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCCCccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|||+|+.... .....+||+.|+||
T Consensus 175 DFG~a~~~~~--~~~~~~~t~~y~aP 198 (367)
T 2fst_X 175 DFGLARHTAD--EMTGYVATRWYRAP 198 (367)
T ss_dssp C-----------------CCCTTCCH
T ss_pred eccccccccc--cCCCcCcCcCccCh
Confidence 9999986543 24456899999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=235.10 Aligned_cols=168 Identities=24% Similarity=0.494 Sum_probs=134.7
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCee----EEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGED----VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
+...+|++.+.||+|+||.||+|.+ +++. ||+|.+........ .+.+.+|+.++++++||||+++++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCC-----HHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHH-----HHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 3457899999999999999999987 4443 57777754433222 25788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.... .++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 8766 689999999999999998653 46899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC---ccCCCCCCcccCC
Q 021897 286 RIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+....... .....+|+.|+||
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aP 188 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMAL 188 (327)
T ss_dssp ---------------CCCGGGSCH
T ss_pred eEccCccccccccCCCccccccCH
Confidence 86543222 2233567889998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=230.35 Aligned_cols=166 Identities=26% Similarity=0.464 Sum_probs=143.8
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||.||+|+. +++.||||++......... .+.+.+|+.++++++||||+++++++.....++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH----HHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 6788999999999999999998 6889999999754332221 257889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC---CcEEEEcccCeeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD---KSIKIADFGVARIEV 289 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~---~~vkl~DFGla~~~~ 289 (306)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.+ +.+||+|||+++...
T Consensus 98 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999999998765 358999999999999999999999999999999999999754 479999999998665
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
.........||+.|+||
T Consensus 176 ~~~~~~~~~~~~~y~aP 192 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAP 192 (287)
T ss_dssp CCSSCSCHHHHHTTCCH
T ss_pred CCCccccccCcccccCh
Confidence 44444445688999998
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=242.84 Aligned_cols=165 Identities=30% Similarity=0.521 Sum_probs=129.8
Q ss_pred CceecceeeeeccEEEEEEEE---CC--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CC
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY---NG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RM 209 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~---~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 209 (306)
.|++.+.||+|+||.||+|++ ++ ..||||.++....... .+++.+|+.++++++||||+++++++.. ..
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHH-----HHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHH-----HHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 467889999999999999987 22 3689999875433322 3678999999999999999999999754 45
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 789999999999999999754 3458899999999999999999999999999999999999999999999999998543
Q ss_pred cCC-----CccCCCCCCcccCC
Q 021897 290 QTE-----GMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~-----~~~~~~gt~~y~AP 306 (306)
... ......+|+.|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aP 265 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMAL 265 (373)
T ss_dssp --------------CCGGGSCH
T ss_pred ccccccccccCCCCCcccccCh
Confidence 222 12334577899998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-31 Score=231.30 Aligned_cols=169 Identities=24% Similarity=0.411 Sum_probs=142.7
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CC
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RM 209 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 209 (306)
.++|++.+.||+|+||.||+|.+ +++.||+|++......... .+.+.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 46888999999999999999998 6889999999876554322 3678899999999999999999998854 56
Q ss_pred eEEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCcEEEcCCCcEEEEcc
Q 021897 210 VWCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG-----FIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~-----iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
.+++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 899999999999999999753 2345899999999999999999999999 999999999999999999999999
Q ss_pred cCeeeeecCCC-ccCCCCCCcccCC
Q 021897 283 GVARIEVQTEG-MTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~-~~~~~gt~~y~AP 306 (306)
|+++....... .....||+.|+||
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aP 185 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSP 185 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCH
T ss_pred chheeeccccccccccCCCccccCh
Confidence 99976543221 2234689999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-30 Score=240.45 Aligned_cols=163 Identities=21% Similarity=0.354 Sum_probs=141.1
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC------CCCCeeeEEEEE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL------KHLNIVRFIGAC 205 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~ 205 (306)
..+|++++.||+|+||.||+|.+ +++.||||+++... ...+.+.+|+.+++.+ .|+||+++++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-------chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 46799999999999999999988 57899999996421 1234677788888776 577999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc--EEEEccc
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFG 283 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~--vkl~DFG 283 (306)
.....+++||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+||||+.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999996 69999998876667999999999999999999999999999999999999999887 9999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|+.... .....+||+.|+||
T Consensus 248 ~a~~~~~--~~~~~~gt~~y~aP 268 (429)
T 3kvw_A 248 SSCYEHQ--RVYTYIQSRFYRAP 268 (429)
T ss_dssp TCEETTC--CCCSSCSCGGGCCH
T ss_pred cceecCC--cccccCCCCCccCh
Confidence 9976432 34456899999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-30 Score=236.72 Aligned_cols=165 Identities=21% Similarity=0.360 Sum_probs=140.9
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--------CCCeeeE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--------HLNIVRF 201 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l 201 (306)
+-..+|++.+.||+|+||.||+|+. +++.||||+++.. ....+.+.+|+.+++.++ |+||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 3457899999999999999999987 6789999999642 122357889999999986 7889999
Q ss_pred EEEEE----eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCC-
Q 021897 202 IGACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADK- 275 (306)
Q Consensus 202 ~~~~~----~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~- 275 (306)
++++. ....+|+||||+ +++|.+.+.......+++..++.++.||+.||+|||++ ||+||||||+||||+.++
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99997 456899999999 66888887766556799999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------------cEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 276 ------------------------------------------------SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 276 ------------------------------------------------~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
.+||+|||+|+..... ....+||+.|+||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aP 262 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCC
Confidence 7999999999865432 4556899999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-30 Score=228.74 Aligned_cols=173 Identities=27% Similarity=0.432 Sum_probs=141.0
Q ss_pred Ccceeecc--CceecceeeeeccEEEEEEEE--CC---eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021897 128 DEWTIDLR--KLNMGTAFAQGAFGKLYRGTY--NG---EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (306)
Q Consensus 128 ~~~~i~~~--~~~~~~~lG~G~fG~V~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (306)
.++.++.. .|+.++.||+|+||.||+|++ ++ ..+|+|++...... ...+.+.+|+.++++++||||++
T Consensus 12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~ 86 (298)
T 3pls_A 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-----QQVEAFLREGLLMRGLNHPNVLA 86 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-----HHHHHHHHHHHHHHhCCCCCeee
Confidence 34444444 445679999999999999987 32 27999998653322 12367889999999999999999
Q ss_pred EEEEEEeCCeE-EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 021897 201 FIGACRKRMVW-CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 201 l~~~~~~~~~~-~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl 279 (306)
+++++...... ++||||+.+++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEe
Confidence 99999776554 9999999999999999763 356899999999999999999999999999999999999999999999
Q ss_pred EcccCeeeeecC-----CCccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQT-----EGMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~-----~~~~~~~gt~~y~AP 306 (306)
+|||+++..... .......+|+.|+||
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aP 197 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTAL 197 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCH
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccCh
Confidence 999999754321 122344678899997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=240.07 Aligned_cols=171 Identities=14% Similarity=0.130 Sum_probs=126.6
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC--CCCCeeeEE--
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL--KHLNIVRFI-- 202 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~-- 202 (306)
.|.....+|++.+.||+|+||.||+|++ +++.||||+++........ ..+.+.+|+.+++.+ +||||++++
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~~~~l~~~hp~iv~~~~~ 132 (371)
T 3q60_A 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---ELERLHEATFAAARLLGESPEEARDRRR 132 (371)
T ss_dssp TTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHH---HHHHHHHHHHHHHHHHC----------C
T ss_pred cCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccccc---HHHHHHHHHHHHHHhcccChhhhhhcee
Confidence 3444556799999999999999999997 6889999999876554322 235677885544444 699988766
Q ss_pred -----EEEEeC-----------------CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHH
Q 021897 203 -----GACRKR-----------------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA------VKQALDVARGMAYV 254 (306)
Q Consensus 203 -----~~~~~~-----------------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~qi~~gl~yL 254 (306)
+++..+ ..+||||||++ |+|.+++.... ..+++..+ +.++.||+.||+||
T Consensus 133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 555433 34899999998 89999998642 23445555 67789999999999
Q ss_pred HhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 255 H~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|++||+||||||+||||+.++.+||+|||+|+..... .....+|+.|+||
T Consensus 211 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aP 260 (371)
T 3q60_A 211 QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPR 260 (371)
T ss_dssp HHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCH
T ss_pred HHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcCh
Confidence 9999999999999999999999999999999865322 2244677999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=234.26 Aligned_cols=163 Identities=28% Similarity=0.426 Sum_probs=138.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR---- 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 208 (306)
++|++.+.||+|+||.||+|++ +++.||||+++..... .....+.+|+.++++++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-----LFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH-----HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc-----hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 6889999999999999999998 5889999999643221 2235788999999999999999999998764
Q ss_pred -CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 209 -MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67899999996 599999876 3589999999999999999999999999999999999999999999999999986
Q ss_pred eecCC-----------CccCCCCCCcccCC
Q 021897 288 EVQTE-----------GMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~-----------~~~~~~gt~~y~AP 306 (306)
..... .....+||+.|+||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAP 191 (353)
T ss_dssp CC----------------CCCCCCGGGCCH
T ss_pred cccccccccCccccccchhhccccccccCC
Confidence 54221 12234789999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=235.73 Aligned_cols=172 Identities=28% Similarity=0.471 Sum_probs=140.6
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
.++..++|++.+.||+|+||.||+|++ +++.||||++...... ....++.+|+.++++++||||++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-----QDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH-----HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch-----hhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 356778999999999999999999984 4568999999643322 1235788999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---C
Q 021897 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQN-----RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---D 274 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~ 274 (306)
+++......|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 999999889999999999999999987532 34889999999999999999999999999999999999984 4
Q ss_pred CcEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 275 KSIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 275 ~~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
..+||+|||+++...... ......||+.|+||
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 214 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCH
Confidence 469999999997543221 12234578999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=255.58 Aligned_cols=160 Identities=18% Similarity=0.190 Sum_probs=125.6
Q ss_pred eeeeeccEEEEEEE--ECCeeEEEEEeeCCCC----ChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEEEE
Q 021897 142 AFAQGAFGKLYRGT--YNGEDVAIKILERPEN----NPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 142 ~lG~G~fG~V~~~~--~~~~~vavK~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv 214 (306)
....|++|.+..++ +.|+.+|||++..... ...+.+...++|.+|+++|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34556666665543 3788999999986532 2334445557899999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-CC
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT-EG 293 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~-~~ 293 (306)
|||++|++|.+++.+. .+++.. +|+.||+.||+|||++|||||||||+||||+++|++||+|||+|+..... ..
T Consensus 321 MEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 9999999999999764 456654 57899999999999999999999999999999999999999999865432 23
Q ss_pred ccCCCCCCcccCC
Q 021897 294 MTPETGTYRWMAP 306 (306)
Q Consensus 294 ~~~~~gt~~y~AP 306 (306)
..+.+||+.||||
T Consensus 396 ~~t~vGTp~YmAP 408 (569)
T 4azs_A 396 PTNLVQSFFVFVN 408 (569)
T ss_dssp SHHHHHHHHHHHH
T ss_pred ccCceechhhccH
Confidence 4456799999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=237.20 Aligned_cols=167 Identities=26% Similarity=0.458 Sum_probs=139.6
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
..|++. ++|.+.+.||+|+||.||+|.+ +++.||||++....... ...+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~ 110 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE----IFAKRAYRELLLLKHMQHENVIGLLDVF 110 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch----hHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence 445554 6899999999999999999987 68899999997654432 2246788999999999999999999999
Q ss_pred EeCCeE------EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 021897 206 RKRMVW------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKI 279 (306)
Q Consensus 206 ~~~~~~------~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl 279 (306)
...... |+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEE
Confidence 877654 99999997 58887763 34999999999999999999999999999999999999999999999
Q ss_pred EcccCeeeeecCCCccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|||+|+.... .....+||+.|+||
T Consensus 186 ~Dfg~a~~~~~--~~~~~~~t~~y~aP 210 (371)
T 4exu_A 186 LDFGLARHADA--EMTGYVVTRWYRAP 210 (371)
T ss_dssp CSTTCC----------CTTCCCTTSCH
T ss_pred EecCccccccc--CcCCcccCccccCH
Confidence 99999986543 24556899999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=231.19 Aligned_cols=173 Identities=22% Similarity=0.406 Sum_probs=130.8
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
..|.+..++|++.+.||+|+||.||+|.+ +++.||||++........ ..+.+.++..+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 56777889999999999999999999998 688999999986543221 123455566678889999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
.....+++||||+ ++.+..+.... ...+++..++.++.|++.||+|||+. |++||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999 55565555433 45699999999999999999999995 999999999999999999999999999
Q ss_pred eeeeecCCCccCCCCCCcccCC
Q 021897 285 ARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~AP 306 (306)
++............||+.|+||
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aP 193 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAP 193 (318)
T ss_dssp C--------------CCTTCCH
T ss_pred chhccCCccccccCCCccccCh
Confidence 9866554444556799999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=237.43 Aligned_cols=176 Identities=24% Similarity=0.352 Sum_probs=145.3
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIG 203 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~ 203 (306)
.+.+.-..+|++++.||+|+||.||+|++ +++.||||+++.............+.+.+|+.++++++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 44455568899999999999999999987 78899999997654322100000134668999999996 599999999
Q ss_pred EEEeCCeEEEEEeecCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEc
Q 021897 204 ACRKRMVWCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIAD 281 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~-~~~~vkl~D 281 (306)
++......++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999999976 8999999864 4589999999999999999999999999999999999999 789999999
Q ss_pred ccCeeeeecCCCccCCCCCCcccCC
Q 021897 282 FGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
||+++..... ......||+.|+||
T Consensus 194 fg~~~~~~~~-~~~~~~gt~~y~aP 217 (320)
T 3a99_A 194 FGSGALLKDT-VYTDFDGTRVYSPP 217 (320)
T ss_dssp CTTCEECCSS-CBCCCCSCGGGSCH
T ss_pred Cccccccccc-cccCCCCCccCCCh
Confidence 9999876543 34456799999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=229.17 Aligned_cols=165 Identities=24% Similarity=0.376 Sum_probs=142.1
Q ss_pred eeccCceecceeeeeccEEEEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC------CeeeEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL------NIVRFI 202 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~ 202 (306)
+-..+|++.+.||+|+||.||+|.+ +++.||||+++... ...+.+.+|+.+++.++|+ ++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-------RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-------chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3457899999999999999999987 57899999996421 1235678899999888765 499999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---------
Q 021897 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--------- 273 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~--------- 273 (306)
+++.....+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 889999998766567899999999999999999999999999999999999987
Q ss_pred ----------CCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 274 ----------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 274 ----------~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
++.+||+|||+++.... ......||+.|+||
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aP 203 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAP 203 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCH
T ss_pred ccccccccccCCCceEeeCcccccCcc--ccccccCCccccCh
Confidence 66899999999986433 23456899999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=242.75 Aligned_cols=161 Identities=24% Similarity=0.432 Sum_probs=123.3
Q ss_pred cee-cceeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CC
Q 021897 137 LNM-GTAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RM 209 (306)
Q Consensus 137 ~~~-~~~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 209 (306)
|++ +++||+|+||.||+|++ +++.||||++...... ..+.+|+.++++++||||+++++++.. ..
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--------HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--------HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 444 56899999999999996 3678999999754433 357799999999999999999999954 67
Q ss_pred eEEEEEeecCCCCHHHHHHhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE----cCCCcEE
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQ-------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI----SADKSIK 278 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv----~~~~~vk 278 (306)
.+|+||||++ ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 8999999996 58888886321 1248999999999999999999999999999999999999 6778999
Q ss_pred EEcccCeeeeecC----CCccCCCCCCcccCC
Q 021897 279 IADFGVARIEVQT----EGMTPETGTYRWMAP 306 (306)
Q Consensus 279 l~DFGla~~~~~~----~~~~~~~gt~~y~AP 306 (306)
|+|||+|+..... ......+||+.|+||
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 204 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCc
Confidence 9999999865432 223456799999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=238.39 Aligned_cols=161 Identities=13% Similarity=0.250 Sum_probs=138.0
Q ss_pred ccCceecceeeeeccEEEEEEEEC----------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee---
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTYN----------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR--- 200 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--- 200 (306)
.++|++.+.||+|+||.||+|++. ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 109 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----------GRLFNEQNFFQRAAKPLQVNKWK 109 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----------chHHHHHHHHHHhcccchhhhhh
Confidence 478999999999999999999873 679999999753 25779999999999999887
Q ss_pred ------------EEEEEEe-CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021897 201 ------------FIGACRK-RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSD 267 (306)
Q Consensus 201 ------------l~~~~~~-~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~ 267 (306)
+++++.. ...+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 188 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE 188 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 6777776 67899999999 999999998754567999999999999999999999999999999999
Q ss_pred cEEEcCCC--cEEEEcccCeeeeecCC--------CccCCCCCCcccCC
Q 021897 268 NLLISADK--SIKIADFGVARIEVQTE--------GMTPETGTYRWMAP 306 (306)
Q Consensus 268 NILv~~~~--~vkl~DFGla~~~~~~~--------~~~~~~gt~~y~AP 306 (306)
|||++.++ .+||+|||+|+...... ......||+.|+||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 237 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM 237 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCH
Confidence 99999998 99999999997654322 12334799999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=239.58 Aligned_cols=174 Identities=29% Similarity=0.593 Sum_probs=145.3
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
....|+++.++|++++.||+|+||.||+|++.+ .+|+|+++........ .+.+.+|+.++++++||||+++++++
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ----LKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC----CCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH----HHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 467899999999999999999999999999865 5999998755432221 13577899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.....+++||||+++++|.+++... ...+++..++.++.||+.||+|||++|++||||||+|||++ ++.+||+|||++
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence 9999999999999999999999753 34689999999999999999999999999999999999998 789999999998
Q ss_pred eeeec------CCCccCCCCCCcccCC
Q 021897 286 RIEVQ------TEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~------~~~~~~~~gt~~y~AP 306 (306)
+.... ........||+.|+||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aP 203 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAP 203 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCH
T ss_pred cccccccccccccccccCCCcccccCh
Confidence 75321 1123344689999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=233.64 Aligned_cols=173 Identities=21% Similarity=0.291 Sum_probs=137.3
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC----CCCCeeeEEEE
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL----KHLNIVRFIGA 204 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~niv~l~~~ 204 (306)
+.-.++|++++.||+|+||.||+|.+ +++.||||++................+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 33457899999999999999999987 6789999999765443322212234566899999988 89999999999
Q ss_pred EEeCCeEEEEEee-cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEEcc
Q 021897 205 CRKRMVWCIVTEY-AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKSIKIADF 282 (306)
Q Consensus 205 ~~~~~~~~iv~E~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~-~~~~vkl~DF 282 (306)
+......++|||+ +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 9998899999999 7899999999875 3589999999999999999999999999999999999999 8899999999
Q ss_pred cCeeeeecCCCccCCCCCCcccCC
Q 021897 283 GVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|+++..... ......||+.|+||
T Consensus 185 g~~~~~~~~-~~~~~~~~~~y~aP 207 (312)
T 2iwi_A 185 GSGALLHDE-PYTDFDGTRVYSPP 207 (312)
T ss_dssp SSCEECCSS-CBCCCCSCTTTSCH
T ss_pred chhhhcccC-cccccCCcccccCc
Confidence 999876543 34556799999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-29 Score=223.73 Aligned_cols=162 Identities=28% Similarity=0.409 Sum_probs=138.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-EeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~ 211 (306)
++|++.+.||+|+||.||+|++ +++.||||++...... +.+.+|+.+++.++|++++..+..+ ......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--------hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 6789999999999999999996 7899999998765443 2578999999999988876666555 667788
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEcccCeeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv---~~~~~vkl~DFGla~~~ 288 (306)
++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999999 89999999754 3569999999999999999999999999999999999999 48889999999999875
Q ss_pred ecCCC--------ccCCCCCCcccCC
Q 021897 289 VQTEG--------MTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~--------~~~~~gt~~y~AP 306 (306)
..... .....||+.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCH
T ss_pred cccccccccccccccccccccccCCh
Confidence 54322 2445799999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-30 Score=252.59 Aligned_cols=174 Identities=26% Similarity=0.516 Sum_probs=144.2
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (306)
....|++..++|++++.||+|+||.||+|.+. +..||||+++..... ...+.+.+|+.++++++||||++
T Consensus 381 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~ 455 (656)
T 2j0j_A 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVK 455 (656)
T ss_dssp CGGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-----HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-----HHHHHHHHHHHHHHhCCCCCCCe
Confidence 34578888899999999999999999999872 357999988653321 22467899999999999999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
+++++.+ ...|+||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 456 l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 456 LIGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp EEEEECS-SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEec-CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEE
Confidence 9999854 4579999999999999999864 3468999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCCCc--cCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEGM--TPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~~--~~~~gt~~y~AP 306 (306)
|||+|+........ ....+|+.|+||
T Consensus 534 DFG~a~~~~~~~~~~~~~~~~t~~y~aP 561 (656)
T 2j0j_A 534 DFGLSRYMEDSTYYKASKGKLPIKWMAP 561 (656)
T ss_dssp CCCCCCSCCC----------CCGGGCCH
T ss_pred ecCCCeecCCCcceeccCCCCCcceeCH
Confidence 99999865433222 233577899998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-30 Score=233.34 Aligned_cols=168 Identities=25% Similarity=0.341 Sum_probs=130.8
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
....++|++.+.||+|+||.||+|++ +++.||||++....... ..+.+|+..++.++||||+++++++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-------CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-------HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 34567899999999999999999998 58899999987644332 2456788888999999999999999664
Q ss_pred C-------eEEEEEeecCCCCHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCcEEEcC-CCc
Q 021897 209 M-------VWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVH--GLGFIHRDLKSDNLLISA-DKS 276 (306)
Q Consensus 209 ~-------~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlkp~NILv~~-~~~ 276 (306)
. .+++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 3 28999999976 66655543 23456899999999999999999999 999999999999999996 899
Q ss_pred EEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 277 IKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 277 vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+||+|||+|+............||+.|+||
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP 200 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAP 200 (360)
T ss_dssp EEECCCTTCBCCCTTSCCCSTTSCGGGCCH
T ss_pred EEEeeCCCceecCCCCCcccccCCcceeCH
Confidence 999999999877665555667899999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-30 Score=253.61 Aligned_cols=162 Identities=24% Similarity=0.370 Sum_probs=137.7
Q ss_pred eeccCceecceeeeeccEEEEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR 208 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 208 (306)
+-..+|++.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.++++++||||+++++++...
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-----EAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH-----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH-----HHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 4457899999999999999999987 5789999998653321 1235788999999999999999999999876
Q ss_pred Ce-----EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 209 MV-----WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 209 ~~-----~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
.. .||||||+++++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecc
Confidence 54 7999999999999988753 59999999999999999999999999999999999999975 89999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+++..... ...+||+.|+||
T Consensus 227 ~a~~~~~~---~~~~gt~~y~aP 246 (681)
T 2pzi_A 227 AVSRINSF---GYLYGTPGFQAP 246 (681)
T ss_dssp TCEETTCC---SCCCCCTTTSCT
T ss_pred cchhcccC---CccCCCccccCH
Confidence 99865432 456799999999
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-30 Score=227.51 Aligned_cols=171 Identities=32% Similarity=0.490 Sum_probs=133.5
Q ss_pred eeeccCceecceeeeeccEEEEEEEE---CCe--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY---NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
.+..++|++.+.||+|+||.||+|++ +++ .||||+++....... ...+.+.+|+.++++++||||+++++++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 45668899999999999999999986 222 689999875433221 2246789999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.... .++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 8766 789999999999999998653 45899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC----ccCCCCCCcccCC
Q 021897 286 RIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~----~~~~~gt~~y~AP 306 (306)
+....... .....+|+.|+||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aP 193 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAP 193 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCH
T ss_pred ccccccccchhhhccCCCCceeeCc
Confidence 86543321 2234578889998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=224.19 Aligned_cols=162 Identities=28% Similarity=0.409 Sum_probs=135.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-EeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~ 211 (306)
++|++.+.||+|+||.||+|++ +++.||||++...... +.+.+|+.+++.++|++++..+..+ ......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 5789999999999999999996 7889999987654433 2477899999999988877766655 667888
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEcccCeeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARIE 288 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv---~~~~~vkl~DFGla~~~ 288 (306)
++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999999 89999999854 3469999999999999999999999999999999999999 78899999999999875
Q ss_pred ecCCC--------ccCCCCCCcccCC
Q 021897 289 VQTEG--------MTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~--------~~~~~gt~~y~AP 306 (306)
..... .....||+.|+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aP 184 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASI 184 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCH
T ss_pred cCcccCccCCCCcccccCCCccccch
Confidence 44322 2345799999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=228.67 Aligned_cols=161 Identities=22% Similarity=0.354 Sum_probs=121.2
Q ss_pred cCceec-ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----
Q 021897 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK---- 207 (306)
Q Consensus 135 ~~~~~~-~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 207 (306)
.+|++. +.||+|+||.||+|.+ +++.||||++.... ....+....++.+.||||+++++++..
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----------KARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----------HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 567775 4699999999999998 58899999996421 112223344667899999999999976
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEcccC
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGV 284 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~~~vkl~DFGl 284 (306)
...+++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 456899999999999999998766667999999999999999999999999999999999999976 45699999999
Q ss_pred eeeeecCCCccCCCCCCcccCC
Q 021897 285 ARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~~~~~~~gt~~y~AP 306 (306)
++..... .....+||+.|+||
T Consensus 178 ~~~~~~~-~~~~~~~t~~y~aP 198 (336)
T 3fhr_A 178 AKETTQN-ALQTPCYTPYYVAP 198 (336)
T ss_dssp CEEC------------------
T ss_pred ceecccc-ccccCCCCcCccCh
Confidence 9865433 34456789999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=227.25 Aligned_cols=163 Identities=26% Similarity=0.347 Sum_probs=131.3
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR----- 206 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----- 206 (306)
..+|++.+.||+|+||.||+|.+ +++.||||++.... . ...+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--P----QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--H----HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--h----HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 36789999999999999999998 48899999987532 1 12357889999999999999999999873
Q ss_pred ---------eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCc
Q 021897 207 ---------KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS-ADKS 276 (306)
Q Consensus 207 ---------~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~-~~~~ 276 (306)
+....|+||||++ |+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++ +++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence 3468899999997 599999864 4689999999999999999999999999999999999997 5679
Q ss_pred EEEEcccCeeeeecC----CCccCCCCCCcccCC
Q 021897 277 IKIADFGVARIEVQT----EGMTPETGTYRWMAP 306 (306)
Q Consensus 277 vkl~DFGla~~~~~~----~~~~~~~gt~~y~AP 306 (306)
+||+|||+++..... .......+|+.|+||
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP 193 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCH
T ss_pred EEEccCccccccCCCcccccccccccccccccCc
Confidence 999999999865322 122334578999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=225.84 Aligned_cols=172 Identities=20% Similarity=0.311 Sum_probs=142.4
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIG 203 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~ 203 (306)
+....+..++|++.+.||+|+||.||++.+ +++.||||++........ ..+.+.+|+.++++++ ||||+++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHH----HHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccccc----chHHHHHHHHHHHhccccCCceEEEEE
Confidence 455667778899999999999999999988 678999999976554432 2367889999999997 599999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
++.....+++||| +.+++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++ ++.+||+|||
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg 171 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFG 171 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecc
Confidence 9999999999999 5578999999864 4689999999999999999999999999999999999996 5899999999
Q ss_pred CeeeeecCCC---ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~---~~~~~gt~~y~AP 306 (306)
+++....... .....||+.|+||
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aP 197 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPP 197 (313)
T ss_dssp SSCC--------------CCGGGCCH
T ss_pred ccccccCccccccccCCCCCCCcCCH
Confidence 9986543221 2345799999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=237.75 Aligned_cols=163 Identities=27% Similarity=0.385 Sum_probs=139.0
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCe
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKRMV 210 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 210 (306)
.++|++++.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++| ++|+.+..++.+...
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--------PQLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 36789999999999999999997 6889999998765443 247799999999987 556666677778889
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---cCCCcEEEEcccCeee
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI---SADKSIKIADFGVARI 287 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv---~~~~~vkl~DFGla~~ 287 (306)
.+|||||+ +++|.+++... ...+++..++.++.||+.||+|||+++||||||||+|||| +.++.+||+|||+|+.
T Consensus 78 ~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99999999 89999999854 3569999999999999999999999999999999999999 5889999999999987
Q ss_pred eecCCC--------ccCCCCCCcccCC
Q 021897 288 EVQTEG--------MTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~--------~~~~~gt~~y~AP 306 (306)
...... ....+||+.|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aP 182 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASV 182 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred ccCCccccccccccccccCCCccccCH
Confidence 654322 1255799999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-29 Score=226.58 Aligned_cols=163 Identities=24% Similarity=0.379 Sum_probs=140.1
Q ss_pred ccCceecceeeeeccEEEEEEEE--CC-eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC------eeeEEEE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NG-EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN------IVRFIGA 204 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~-~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~ 204 (306)
.++|++.+.||+|+||.||+|.. ++ +.||||+++... ...+.+.+|+.+++.++|++ ++.++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-------KYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-------cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 47899999999999999999987 34 789999996421 12356788999999987766 9999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-------------
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI------------- 271 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv------------- 271 (306)
+.....+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 6788888877655679999999999999999999999999999999999999
Q ss_pred ------cCCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 272 ------SADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 272 ------~~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
+.++.+||+|||+++.... .....+||+.|+||
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aP 208 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPP 208 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCH
T ss_pred cccccccCCCcEEEeecCccccccc--cccCCcCCCcccCC
Confidence 5678999999999986432 34556899999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=232.40 Aligned_cols=166 Identities=26% Similarity=0.466 Sum_probs=137.7
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.|++ .++|.+.+.||+|+||.||+|.+ +++.||||++....... ...+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE----IFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch----HHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 3444 36799999999999999999987 68899999997654332 22467889999999999999999999998
Q ss_pred eCCe------EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 207 KRMV------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 207 ~~~~------~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
.... +|+||||++ ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 168 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred cccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEe
Confidence 7653 499999997 58887763 348999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCCCccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|||+++..... .....||+.|+||
T Consensus 169 Dfg~~~~~~~~--~~~~~~t~~y~aP 192 (353)
T 3coi_A 169 DFGLARHADAE--MTGYVVTRWYRAP 192 (353)
T ss_dssp STTCTTC----------CCSBCCSCH
T ss_pred ecccccCCCCC--ccccccCcCcCCH
Confidence 99999864432 3455789999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=229.56 Aligned_cols=166 Identities=22% Similarity=0.356 Sum_probs=141.4
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-----------CCC
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----------HLN 197 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~n 197 (306)
.+...+|++.+.||+|+||.||+|++ +++.||||++.... ...+.+.+|+.+++++. |||
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-------cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 34567899999999999999999997 78899999996421 12356788999988876 899
Q ss_pred eeeEEEEEEeCC----eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEc
Q 021897 198 IVRFIGACRKRM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL-GFIHRDLKSDNLLIS 272 (306)
Q Consensus 198 iv~l~~~~~~~~----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlkp~NILv~ 272 (306)
|+++++++.... .+++|||++ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+||||+
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 999999997654 789999999 88999999886666799999999999999999999998 999999999999994
Q ss_pred ------CCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 273 ------ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 273 ------~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
..+.+||+|||+|+.... ......||+.|+||
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aP 204 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSP 204 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCH
T ss_pred ccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCc
Confidence 344899999999986543 23456899999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=238.56 Aligned_cols=169 Identities=25% Similarity=0.389 Sum_probs=134.5
Q ss_pred CCcceeeccCceecceeeeeccEE-EEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGK-LYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGA 204 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~-V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 204 (306)
...+.+...+|+..+.||+|+||. ||++..+++.||||++...... .+.+|+.+++.+ +|||||+++++
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---------~~~~E~~~l~~l~~HpnIv~l~~~ 86 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---------FADREVQLLRESDEHPNVIRYFCT 86 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---------ECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---------HHHHHHHHHHhccCCCCcCeEEEE
Confidence 445667777899999999999998 5566669999999999653321 345899999999 79999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---C--CcEEE
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---D--KSIKI 279 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~--~~vkl 279 (306)
+.+....||||||+. |+|.+++.... ....+..++.++.||+.||+|||++||+||||||+|||++. + ..+||
T Consensus 87 ~~~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 87 EKDRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EEETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred EecCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 999999999999996 59999998643 23444556789999999999999999999999999999953 2 36889
Q ss_pred EcccCeeeeecCC----CccCCCCCCcccCC
Q 021897 280 ADFGVARIEVQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 280 ~DFGla~~~~~~~----~~~~~~gt~~y~AP 306 (306)
+|||+|+...... .....+||+.|+||
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~AP 195 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCG
T ss_pred ecccceeeccCCCcceeeccccCCCcCccCh
Confidence 9999998654321 23445799999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=227.56 Aligned_cols=163 Identities=27% Similarity=0.378 Sum_probs=139.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CC-----CeeeEEEEE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HL-----NIVRFIGAC 205 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~ 205 (306)
..+|++.+.||+|+||.||+|.. +++.||||+++... ...+.+.+|+.+++.+. |+ +|+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-------HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 57899999999999999999988 67899999996421 12356778888888875 44 499999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCcEEEc--CCCcEEEEc
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH--GLGFIHRDLKSDNLLIS--ADKSIKIAD 281 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlkp~NILv~--~~~~vkl~D 281 (306)
.....+|+||||++ ++|.+++.......+++..++.++.|++.||.||| +.||+||||||+||||+ .++.+||+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999996 59999998766567999999999999999999999 57999999999999995 477899999
Q ss_pred ccCeeeeecCCCccCCCCCCcccCC
Q 021897 282 FGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 282 FGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
||+|+.... .....+||+.|+||
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aP 227 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSP 227 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCH
T ss_pred ccCceeccc--ccccccCCccccCh
Confidence 999987543 24556899999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=217.81 Aligned_cols=144 Identities=13% Similarity=0.145 Sum_probs=127.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++.+.||+|+||.||+|++ +++.||||+++....... ...+.+.+|+.++++++||||+++++++......|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD---DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCH---HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 6789999999999999999998 489999999986554332 22467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
+||||+++++|.+++.. . .....+..++.||+.||+|||++||+||||||+|||++.++.+||++++..
T Consensus 108 lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence 99999999999999853 2 355568889999999999999999999999999999999999999987754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-28 Score=216.97 Aligned_cols=144 Identities=24% Similarity=0.394 Sum_probs=127.2
Q ss_pred cCceec-ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHH-HhCCCCCeeeEEEEEEe---
Q 021897 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML-ATLKHLNIVRFIGACRK--- 207 (306)
Q Consensus 135 ~~~~~~-~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~--- 207 (306)
.+|.+. +.||+|+||.||+|.. +++.||||+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 456665 7899999999999988 6789999999641 2466888887 66789999999999987
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEccc
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~~~vkl~DFG 283 (306)
...+++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 678999999999999999999866667999999999999999999999999999999999999998 7899999999
Q ss_pred Ceeeee
Q 021897 284 VARIEV 289 (306)
Q Consensus 284 la~~~~ 289 (306)
+|+...
T Consensus 166 ~a~~~~ 171 (299)
T 3m2w_A 166 FAKETT 171 (299)
T ss_dssp TCEECT
T ss_pred cccccc
Confidence 997543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=231.89 Aligned_cols=160 Identities=23% Similarity=0.346 Sum_probs=123.4
Q ss_pred ceecceeeeeccEEEEEE-EECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCeEEEE
Q 021897 137 LNMGTAFAQGAFGKLYRG-TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv 214 (306)
|...+.||+|+||.||.+ ..+++.||||++.... .+.+.+|+.+++++ +||||+++++++.....+|||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 445688999999999755 4589999999986421 13567899999876 899999999999999999999
Q ss_pred EeecCCCCHHHHHHhhCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC-------------Cc
Q 021897 215 TEYAKGGSVRQFLTRRQNRAV-----PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-------------KS 276 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~-----~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~-------------~~ 276 (306)
|||+. |+|.+++........ ++..++.++.||+.||+|||++||+||||||+|||++.+ +.
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 699999976432111 223457899999999999999999999999999999754 48
Q ss_pred EEEEcccCeeeeecCCC-----ccCCCCCCcccCC
Q 021897 277 IKIADFGVARIEVQTEG-----MTPETGTYRWMAP 306 (306)
Q Consensus 277 vkl~DFGla~~~~~~~~-----~~~~~gt~~y~AP 306 (306)
+||+|||+|+....... ....+||+.|+||
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aP 201 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP 201 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCH
Confidence 99999999987543321 2345799999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-29 Score=246.37 Aligned_cols=167 Identities=26% Similarity=0.373 Sum_probs=141.9
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (306)
.+|++.+.||+|+||.||+|.+ +++.||||+++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-----KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH-----HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH-----HHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 6788899999999999999987 6889999998754321 123578899999999999999999999755
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc---EEEEcc
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRRQ-NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKS---IKIADF 282 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~---vkl~DF 282 (306)
....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.||+||||||+|||++.++. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 667899999999999999998643 235888999999999999999999999999999999999997664 999999
Q ss_pred cCeeeeecCCCccCCCCCCcccCC
Q 021897 283 GVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|+++............||+.|+||
T Consensus 169 G~a~~~~~~~~~~~~~gt~~Y~AP 192 (676)
T 3qa8_A 169 GYAKELDQGELCTEFVGTLQYLAP 192 (676)
T ss_dssp CCCCBTTSCCCCCCCCSCCTTCSS
T ss_pred ccccccccccccccccCCcccCCh
Confidence 999876655555667899999998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-29 Score=244.01 Aligned_cols=156 Identities=20% Similarity=0.205 Sum_probs=121.5
Q ss_pred ecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChh--HHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEe
Q 021897 139 MGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPE--KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 139 ~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E 216 (306)
..+.||+|+||.||+|++.++.+++|.......... ......+++.+|+.++++++||||+++..++......|||||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 356899999999999998999999998765433222 222335678999999999999999954444445666699999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC---
Q 021897 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~--- 293 (306)
|+++++|.+++.. ++.++.|++.||+|||+++|+||||||+|||++. .+||+|||+|+.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999864 5688999999999999999999999999999998 999999999997654321
Q ss_pred -----ccCCCCCCcccCC
Q 021897 294 -----MTPETGTYRWMAP 306 (306)
Q Consensus 294 -----~~~~~gt~~y~AP 306 (306)
....+||+.||||
T Consensus 488 ~~~~~~~~~~GT~~y~AP 505 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFD 505 (540)
T ss_dssp HHHHHHHHHHHHCGGGHH
T ss_pred chhhhhhhhcCCCCcCCH
Confidence 1345799999998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-28 Score=224.66 Aligned_cols=170 Identities=17% Similarity=0.231 Sum_probs=127.4
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CC---------
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LN--------- 197 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~n--------- 197 (306)
+....++|..++.||+|+||.||+|++ +++.||||+++....... ...+.+.+|+.+++.++| ++
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---NAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-------CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH---HHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 344556788999999999999999998 589999999874433321 123578899999999987 21
Q ss_pred ee------------eEEEEEEe-----CCeEEEEEeecCCCCHHHHHHh-----hCCCCCCHHHHHHHHHHHHHHHHHHH
Q 021897 198 IV------------RFIGACRK-----RMVWCIVTEYAKGGSVRQFLTR-----RQNRAVPLKLAVKQALDVARGMAYVH 255 (306)
Q Consensus 198 iv------------~l~~~~~~-----~~~~~iv~E~~~~gsL~~~l~~-----~~~~~~~~~~~~~i~~qi~~gl~yLH 255 (306)
++ .++..+.. ...++++|+++ +++|.+++.. .....+++..++.++.||+.||+|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 11 11111111 22457778776 6799999852 22345778889999999999999999
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 256 ~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
++||+||||||+||||+.++.+||+|||+|+..... ....+| +.|+||
T Consensus 229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aP 276 (413)
T 3dzo_A 229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPP 276 (413)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCH
T ss_pred hCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCc
Confidence 999999999999999999999999999999865433 455678 999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-26 Score=202.31 Aligned_cols=151 Identities=14% Similarity=0.118 Sum_probs=115.2
Q ss_pred CCCCCcceeeccC---------------ceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChh------------H
Q 021897 124 LENYDEWTIDLRK---------------LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPE------------K 175 (306)
Q Consensus 124 ~~~~~~~~i~~~~---------------~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~------------~ 175 (306)
...++.|++.... |.+++.||+|+||.||+|++ +++.||||+++....... .
T Consensus 64 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w 143 (282)
T 1zar_A 64 QKDYEGSTFTFIGLSLYSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHF 143 (282)
T ss_dssp CSSSCEEEECHHHHHHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CH
T ss_pred CCCccceeeecCCccHHHHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhh
Confidence 4456777776333 34669999999999999999 688999999965332110 0
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 021897 176 AQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH 255 (306)
Q Consensus 176 ~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH 255 (306)
.......+.+|+.++++++| +++++++.. ...|+||||+++++|.+ +.. .....++.|++.||+|||
T Consensus 144 ~~~~~~~~~~E~~~l~~l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH 210 (282)
T 1zar_A 144 SVLAIRSARNEFRALQKLQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY 210 (282)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH
Confidence 00234678999999999995 444444433 34599999999999988 421 124578999999999999
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 256 ~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
++||+||||||+|||++ ++.+||+|||+|+..
T Consensus 211 ~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~ 242 (282)
T 1zar_A 211 HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 242 (282)
T ss_dssp HTTEECSCCSTTSEEEE-TTEEEECCCTTCEET
T ss_pred HCCCEeCCCCHHHEEEE-CCcEEEEECCCCeEC
Confidence 99999999999999999 999999999999753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=183.88 Aligned_cols=141 Identities=16% Similarity=0.153 Sum_probs=107.4
Q ss_pred ceecceeeeeccEEEEEEEE--CCee--EEEEEeeCCCCChhH------------------HHHHHHHHHHHHHHHHhCC
Q 021897 137 LNMGTAFAQGAFGKLYRGTY--NGED--VAIKILERPENNPEK------------------AQVMEQQFQQEVMMLATLK 194 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~--~~~~--vavK~~~~~~~~~~~------------------~~~~~~~~~~E~~~l~~l~ 194 (306)
|.+.+.||+|+||.||+|.+ +|+. ||||+++........ .......+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 46778999999999999988 8888 999998654221100 1122346889999999998
Q ss_pred CCC--eeeEEEEEEeCCeEEEEEeecCC-C----CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCC
Q 021897 195 HLN--IVRFIGACRKRMVWCIVTEYAKG-G----SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKS 266 (306)
Q Consensus 195 h~n--iv~l~~~~~~~~~~~iv~E~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH-~~~iiHrDlkp 266 (306)
|++ ++..++. ...+|||||+.+ | +|.++... .++..+..++.|++.+|.||| ++||+||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 875 3445543 234899999942 3 67666432 224457789999999999999 99999999999
Q ss_pred CcEEEcCCCcEEEEcccCeeee
Q 021897 267 DNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 267 ~NILv~~~~~vkl~DFGla~~~ 288 (306)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=9.4e-20 Score=167.86 Aligned_cols=139 Identities=18% Similarity=0.170 Sum_probs=100.4
Q ss_pred ceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCC--------------hhHHH--HHHHHHHHHHHHHHhCCCCCe-
Q 021897 137 LNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENN--------------PEKAQ--VMEQQFQQEVMMLATLKHLNI- 198 (306)
Q Consensus 137 ~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~--------------~~~~~--~~~~~~~~E~~~l~~l~h~ni- 198 (306)
|.++..||+|+||.||+|.. +|+.||||+++..... ..... ...-...+|...|.++.+..+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 67889999999999999987 7899999998643111 00011 111123467778888765443
Q ss_pred -eeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC--
Q 021897 199 -VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-- 275 (306)
Q Consensus 199 -v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-- 275 (306)
...+++ .. .+|||||++|++|.++.. . .....++.||+.+|.|||++|||||||||.|||+++++
T Consensus 177 vp~p~~~--~~--~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SR--HTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ET--TEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cC--ceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 333332 22 279999999988865431 1 12456789999999999999999999999999998877
Q ss_pred --------cEEEEcccCeee
Q 021897 276 --------SIKIADFGVARI 287 (306)
Q Consensus 276 --------~vkl~DFGla~~ 287 (306)
.+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 389999998753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.9e-14 Score=125.67 Aligned_cols=140 Identities=17% Similarity=0.138 Sum_probs=110.0
Q ss_pred CceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeEEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv 214 (306)
.|++...++.|+.+.||++...++.+++|+......... ..+.+|+.+++.+. +..++++++++......|+|
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH------HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 455667788888899999988888999999864221111 24778999999885 67788999999988899999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-------------------------------------- 256 (306)
|||++|.+|.+.+.. ......++.+++.+|+.||+
T Consensus 89 ~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999998776311 11234678889999999998
Q ss_pred ---------------------CCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 257 ---------------------LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 257 ---------------------~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..++|+|++|.|||++.++.+.|+||+.+...
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 34899999999999987666789999988653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.40 E-value=8.5e-13 Score=114.36 Aligned_cols=126 Identities=13% Similarity=0.089 Sum_probs=94.2
Q ss_pred eeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC--eeeEEEEEEeCCeEEEEEeecCC
Q 021897 144 AQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN--IVRFIGACRKRMVWCIVTEYAKG 220 (306)
Q Consensus 144 G~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~iv~E~~~~ 220 (306)
+.|..+.||++.. +|+.+++|+...... ..+.+|+.+++.+.+.+ +++++++.......++||||++|
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~---------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGAL---------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCTT---------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcccc---------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 3555689999976 467899999765411 24668888888886444 56789988887788999999999
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 021897 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG------------------------------------------ 258 (306)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~------------------------------------------ 258 (306)
.+|. +.. ... ..++.+++..|..||+..
T Consensus 100 ~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 100 QDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp EETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 8884 211 121 245667777777777643
Q ss_pred ----------------ccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 259 ----------------FIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 259 ----------------iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
++|+|++|.|||++.++.++|+||+.|...
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987766789999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=119.38 Aligned_cols=139 Identities=13% Similarity=0.250 Sum_probs=105.7
Q ss_pred cceeeeeccEEEEEEEECCeeEEEEEee--CCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEeC---CeEE
Q 021897 140 GTAFAQGAFGKLYRGTYNGEDVAIKILE--RPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKR---MVWC 212 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~ 212 (306)
.+.|+.|.++.||+.+..+..+++|+.. ....... ...+.+|+.+++.+. +..+++++.++.+. ...|
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~-----~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPS-----AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCc-----HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3678999999999999878889999775 3221111 136778999999887 45688999998776 3478
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG------------------------------------ 256 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~------------------------------------ 256 (306)
+||||++|..+.+.. -..++......++.+++..|+.||+
T Consensus 118 ~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999987774321 1236777788899999999999997
Q ss_pred ----------------------CCccccCCCCCcEEEcCCCc--EEEEcccCeee
Q 021897 257 ----------------------LGFIHRDLKSDNLLISADKS--IKIADFGVARI 287 (306)
Q Consensus 257 ----------------------~~iiHrDlkp~NILv~~~~~--vkl~DFGla~~ 287 (306)
..++|+|++|.|||++.++. +.|+||+.|..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 69999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=3.3e-09 Score=94.46 Aligned_cols=133 Identities=23% Similarity=0.243 Sum_probs=97.4
Q ss_pred ceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCC--eeeEEEEEEeCC---eEEEE
Q 021897 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLN--IVRFIGACRKRM---VWCIV 214 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~iv 214 (306)
+.++.|....||+.. ..+++|+.... .....+.+|+.+++.+. +.. +.+.+....... ..|+|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 468999999999874 67899986421 11256889999998873 322 455665544333 34889
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-------------------------------------- 256 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-------------------------------------- 256 (306)
||+++|.+|.+.... .++......++.+++..|+.||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999888754332 26667777788888888888885
Q ss_pred --------------------CCccccCCCCCcEEEcC--CCcEEEEcccCeeee
Q 021897 257 --------------------LGFIHRDLKSDNLLISA--DKSIKIADFGVARIE 288 (306)
Q Consensus 257 --------------------~~iiHrDlkp~NILv~~--~~~vkl~DFGla~~~ 288 (306)
..++|+|++|.||++++ ...+.|+||+.+...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13699999999999998 456899999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=7.3e-08 Score=85.99 Aligned_cols=133 Identities=19% Similarity=0.197 Sum_probs=90.8
Q ss_pred ceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCC---CeeeEEEEEE-eCCeEEEEEe
Q 021897 141 TAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHL---NIVRFIGACR-KRMVWCIVTE 216 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~iv~E 216 (306)
+.++.|....||+. +..+++|+-.. . .....+.+|+.+|+.+.+. .+.+.+.++. .....++|||
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS----Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS----H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC----c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 46788988999988 67889998421 1 1135788999999998752 3567777764 3455689999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 021897 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL--------------------------------------- 257 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~--------------------------------------- 257 (306)
+++|.+|.+.... .++......++.++...|+.||+.
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999887663211 123333344444444444444421
Q ss_pred ---------------------CccccCCCCCcEEEcC---CCc-EEEEcccCeeee
Q 021897 258 ---------------------GFIHRDLKSDNLLISA---DKS-IKIADFGVARIE 288 (306)
Q Consensus 258 ---------------------~iiHrDlkp~NILv~~---~~~-vkl~DFGla~~~ 288 (306)
.++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999997 355 589999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=1.1e-07 Score=82.85 Aligned_cols=132 Identities=20% Similarity=0.165 Sum_probs=93.9
Q ss_pred eeeeeccE-EEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeEEEEEee
Q 021897 142 AFAQGAFG-KLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 142 ~lG~G~fG-~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
.+..|..| .||+... .+..+++|+-... . ...+.+|...|+.+. +--+.+.++++.+.+..|+|||+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----V----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----H----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----C----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 34556555 6898765 4568999986532 1 135778999888775 33477889999998999999999
Q ss_pred cCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 021897 218 AKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL---------------------------------------- 257 (306)
Q Consensus 218 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---------------------------------------- 257 (306)
++|.++.+...... .....++.+++..|.-||+.
T Consensus 102 l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 102 IPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp CCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred eCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 99988877654311 11233445555566666631
Q ss_pred ------------------CccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 258 ------------------GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 258 ------------------~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.++|+|+.+.|||++.++.+-|+||+.+...
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 1589999999999998777789999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=5.7e-08 Score=88.19 Aligned_cols=78 Identities=9% Similarity=0.074 Sum_probs=53.0
Q ss_pred ccee-eeeccEEEEEEEEC--------CeeEEEEEeeCCC---CChhHHHHHHHHHHHHHHHHHhCC-C--CCeeeEEEE
Q 021897 140 GTAF-AQGAFGKLYRGTYN--------GEDVAIKILERPE---NNPEKAQVMEQQFQQEVMMLATLK-H--LNIVRFIGA 204 (306)
Q Consensus 140 ~~~l-G~G~fG~V~~~~~~--------~~~vavK~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~ 204 (306)
.+.| +.|....+|+.+.. ++.+++|+..... .... ..+.+|+.+++.+. + ..+.+++.+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~------~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT------YRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC------CCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch------hHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3567 78888999998765 6789999865422 1000 13557777777764 2 357778888
Q ss_pred EEeC---CeEEEEEeecCCCCH
Q 021897 205 CRKR---MVWCIVTEYAKGGSV 223 (306)
Q Consensus 205 ~~~~---~~~~iv~E~~~~gsL 223 (306)
+.+. ...|+||||++|..+
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCC
T ss_pred ccCCCccCCceEEEEecCCCCh
Confidence 7655 346899999988654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=2.7e-07 Score=85.05 Aligned_cols=79 Identities=11% Similarity=-0.032 Sum_probs=47.7
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCC-ChhHHHHHHHHHHHHHHHHHhCCC--C-CeeeEEEEEEeCCeEEEE
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPEN-NPEKAQVMEQQFQQEVMMLATLKH--L-NIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~iv 214 (306)
+.||.|..+.||+++. .++.++||...+... ..........++..|..+++.+.. | .+++++.+. ....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence 5789999999999964 567899998753221 000000011345678888877642 3 345666543 3334799
Q ss_pred EeecCCC
Q 021897 215 TEYAKGG 221 (306)
Q Consensus 215 ~E~~~~g 221 (306)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.49 E-value=1.1e-06 Score=78.64 Aligned_cols=31 Identities=19% Similarity=0.383 Sum_probs=28.2
Q ss_pred CCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 257 ~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.16 E-value=9.4e-06 Score=72.55 Aligned_cols=75 Identities=19% Similarity=0.173 Sum_probs=59.8
Q ss_pred cceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCeEEEEEe
Q 021897 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~iv~E 216 (306)
.+.|+.|....+|+.+.++..+++|+..... ...+.+|+..|+.|. ...+++.+.++......++|||
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~---------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY---------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGG---------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCccc---------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 3678999999999998888899999876421 246778888888774 3568889998888888999999
Q ss_pred ecCCCCH
Q 021897 217 YAKGGSV 223 (306)
Q Consensus 217 ~~~~gsL 223 (306)
|+++..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.6e-05 Score=73.75 Aligned_cols=32 Identities=19% Similarity=0.374 Sum_probs=28.0
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 256 GLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 256 ~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
...++|+|++|.|||++.++ ++|+||+.+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 45799999999999999776 999999998753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=98.09 E-value=7.6e-08 Score=90.91 Aligned_cols=135 Identities=12% Similarity=0.039 Sum_probs=58.9
Q ss_pred cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCceeEeeeeeeec--CCccccccCchHHHHHH
Q 021897 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVGQSVFR--PGKVTHALNDDALAQAL 114 (306)
Q Consensus 37 ~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~v~~~~~~~~l~~~l 114 (306)
..|+|++++|++ .+|.|++|++.. ..++|+.|.. ++.|++. ...|. ++.+. |+++..+
T Consensus 70 ~~G~FLvR~S~~---~~g~~~Lsv~~~---------~~v~H~~I~~-~g~~~~~--~~~F~sl~~Lv~-----dGl~~~~ 129 (463)
T 3cxl_A 70 AEGSYLIRESQR---QPGTYTLALRFG---------SQTRNFRLYY-DGKHFVG--EKRFESIHDLVT-----DGLITLY 129 (463)
T ss_dssp STTEEEEEECSS---STTCEEEEEECS---------SSEEEEECEE-SSSEESS--SCCBSCHHHHHH-----HHHHHHH
T ss_pred CCCeEEEeccCC---CCCCEEEEEEEC---------CEEEEEEEec-CCeEEEC--CCccCCHHHHHH-----HHHHhhh
Confidence 379999999876 678899999962 2569999987 6667653 22332 22222 5555555
Q ss_pred hcCCCCCCCCCCCCcceeeccCceecceeeeeccEEEEEEEECC--eeEEE------EEeeCCCCChhHHHHHHHHHHHH
Q 021897 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG--EDVAI------KILERPENNPEKAQVMEQQFQQE 186 (306)
Q Consensus 115 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~~~~~E 186 (306)
..+...... ....+ -.+.+.|| ||.||+|.+.+ .+||| |..+......+ ..+.+.+|
T Consensus 130 ~~~~~~~~~----l~~~i----~~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e----~~~~~~re 194 (463)
T 3cxl_A 130 IETKAAEYI----AKMTI----NPIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEK----RLTSLVRR 194 (463)
T ss_dssp HHHHTHHHH----HHTTS----SCSTTTSS---BCCC---------CCBGGGC---------------------------
T ss_pred ccCCCcchh----hcccc----ccccccCC---chhhhcccccccCCchhhhhccCcccccccccccc----cccccccc
Confidence 433210000 00001 13456776 99999999854 58888 66654333222 12468899
Q ss_pred HHHHHhCCCCCeeeEEEEEE
Q 021897 187 VMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 187 ~~~l~~l~h~niv~l~~~~~ 206 (306)
..+++.++|||+++.+++..
T Consensus 195 a~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 195 ATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp ------------CBCCCEEE
T ss_pred ccccccccccccCCCcceEE
Confidence 99999999999999888763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.05 E-value=5.1e-05 Score=66.60 Aligned_cols=77 Identities=16% Similarity=0.160 Sum_probs=54.0
Q ss_pred CceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC---CCeeeEEEEEEeCCeE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH---LNIVRFIGACRKRMVW 211 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~ 211 (306)
++.-.+.+|.|..+.||+.+. +|+.+.+|+......... ..|.+|+..|+.|.. -.+++.+++. ..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~------~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~-- 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD------GLFRAEALGLDWLGRSFGSPVPQVAGWD--DR-- 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT------THHHHHHHHHHHHTCSTTCCSCCEEEEE--TT--
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh------hHHHHHHHHHHHHHhhCCCCcceEEecc--Cc--
Confidence 344557899999999999998 789999998654332211 256789888887742 2355666543 22
Q ss_pred EEEEeecCCCC
Q 021897 212 CIVTEYAKGGS 222 (306)
Q Consensus 212 ~iv~E~~~~gs 222 (306)
++||||++++.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 78999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.99 E-value=2.6e-05 Score=68.90 Aligned_cols=71 Identities=11% Similarity=0.123 Sum_probs=42.7
Q ss_pred cceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCeEEEEEeec
Q 021897 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEYA 218 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~iv~E~~ 218 (306)
.+.|+.|....+|+. ..+++|+......... ...+|+.+++.+....+ .++++.+.+. -++++||+
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~-------~r~~E~~~l~~l~~~g~~P~~~~~~~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYI-------NRANEAVAAREAAKAGVSPEVLHVDPAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----CC-------CHHHHHHHHHHHHHTTSSCCEEEECTTT--CCEEEECC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcccee-------CHHHHHHHHHHHHHcCCCCceEEEECCC--CEEEEeec
Confidence 478888999999999 6789998864321110 12356666665532122 4566554332 36899999
Q ss_pred -CCCCH
Q 021897 219 -KGGSV 223 (306)
Q Consensus 219 -~~gsL 223 (306)
++.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 66444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.88 E-value=8.8e-05 Score=65.89 Aligned_cols=140 Identities=14% Similarity=0.138 Sum_probs=77.7
Q ss_pred cceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-----CCCeeeEE-E--EEEeCCeE
Q 021897 140 GTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----HLNIVRFI-G--ACRKRMVW 211 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~ 211 (306)
.+.|+.|....+|+.+..+..+++|+....... ..+..|+.+++.+. -|.++... | +....+..
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~--------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK--------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC---C--------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCCH--------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 457778888999999886668999998753111 13445666655543 23333210 0 01223567
Q ss_pred EEEEeecCCCCHH-----------HH---HHhh-CC--CC----CC---HHHHHH------------HHHHHHHHHHHHH
Q 021897 212 CIVTEYAKGGSVR-----------QF---LTRR-QN--RA----VP---LKLAVK------------QALDVARGMAYVH 255 (306)
Q Consensus 212 ~iv~E~~~~gsL~-----------~~---l~~~-~~--~~----~~---~~~~~~------------i~~qi~~gl~yLH 255 (306)
++++||++|..+. +. ++.. .. .. .. +...+. +...+...++.++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999885431 11 1111 11 00 11 111000 0012344556665
Q ss_pred h-------CCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 256 G-------LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 256 ~-------~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
. .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3 3689999999999999776668999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.85 E-value=6.4e-05 Score=67.28 Aligned_cols=137 Identities=16% Similarity=0.194 Sum_probs=72.2
Q ss_pred ceeeeeccEE-EEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEeCCeEEEEEe
Q 021897 141 TAFAQGAFGK-LYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 141 ~~lG~G~fG~-V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~iv~E 216 (306)
+.|+.|+... +|+.+.. +..+++|........ .+..|+.+++.+. .-.+.+++.+..... +++||
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~---------~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e 92 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGG---------DTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIE 92 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTTC---------CSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEEC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCc---------cccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEe
Confidence 4565565554 6777764 777888865432211 2234555555543 223566776654444 68999
Q ss_pred ecCCCCHHHHHHhhC------------------C------CCCCHHHHH-------H-------------HHHHHHHHHH
Q 021897 217 YAKGGSVRQFLTRRQ------------------N------RAVPLKLAV-------K-------------QALDVARGMA 252 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~------------------~------~~~~~~~~~-------~-------------i~~qi~~gl~ 252 (306)
++.+..+.+.+.... . ......... . ....+...++
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 997766654443110 0 011111110 0 0011112233
Q ss_pred HHH------hCCccccCCCCCcEEEcCC----CcEEEEcccCeeee
Q 021897 253 YVH------GLGFIHRDLKSDNLLISAD----KSIKIADFGVARIE 288 (306)
Q Consensus 253 yLH------~~~iiHrDlkp~NILv~~~----~~vkl~DFGla~~~ 288 (306)
.|- ...++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 331 2469999999999999874 68999999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00041 Score=61.67 Aligned_cols=136 Identities=15% Similarity=0.143 Sum_probs=75.9
Q ss_pred eeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC--CCeeeEEEE-----EEeCCeEEE
Q 021897 142 AFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH--LNIVRFIGA-----CRKRMVWCI 213 (306)
Q Consensus 142 ~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~-----~~~~~~~~i 213 (306)
.++ |....||+... +|+.+++|+.+...... ..+..|..+++.+.. -.+++.+.. ....+..++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~-------~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH-------HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 455 77789998876 56689999987543322 245566666665531 123333332 122456688
Q ss_pred EEeecCCCCHH-----------HHH---Hh-hCC------CCCCHHHH----HHH---------------HHHHHHHHHH
Q 021897 214 VTEYAKGGSVR-----------QFL---TR-RQN------RAVPLKLA----VKQ---------------ALDVARGMAY 253 (306)
Q Consensus 214 v~E~~~~gsL~-----------~~l---~~-~~~------~~~~~~~~----~~i---------------~~qi~~gl~y 253 (306)
+||+++|..+. ..+ +. ... ........ ..+ ...+-..++.
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999874321 111 11 000 01111111 000 0011112333
Q ss_pred HH-------hCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 254 VH-------GLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 254 LH-------~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
+. ...++|+|+++.|||++ + .+.|+||+.+..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 32 23589999999999999 4 899999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.0018 Score=60.75 Aligned_cols=71 Identities=13% Similarity=0.076 Sum_probs=46.8
Q ss_pred ceeeeeccEEEEEEEECC--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEEeCCeEEEEEee
Q 021897 141 TAFAQGAFGKLYRGTYNG--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI-VRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~iv~E~ 217 (306)
+.|+.|....+|+....+ ..+++|+......... ...+|..+++.|...++ +++++.+. . .+|+||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-------dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-------NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-------CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-------CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence 578888889999999866 8899998754321110 11378888888864444 56777762 2 359999
Q ss_pred cCCCC
Q 021897 218 AKGGS 222 (306)
Q Consensus 218 ~~~gs 222 (306)
++|.+
T Consensus 183 I~G~~ 187 (458)
T 2qg7_A 183 MDGYA 187 (458)
T ss_dssp CCSEE
T ss_pred eCCcc
Confidence 98743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00041 Score=64.57 Aligned_cols=70 Identities=13% Similarity=0.195 Sum_probs=47.2
Q ss_pred cceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEEeCC
Q 021897 140 GTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRM 209 (306)
Q Consensus 140 ~~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~ 209 (306)
.+.|+.|....+|++... +..+++|+.... ... ..+.+|..+++.+...+ .+++++.+..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~-------~~li~E~~~l~~L~~~g~~P~l~~~~~~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE-------SHLVAESVIFTLLSERHLGPKLYGIFSG-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH-------HHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcH-------HHHHHHHHHHHHHHhCCCCCcEEEEeCC--
Confidence 357888888999999874 468999988432 110 23447888887775333 3567776532
Q ss_pred eEEEEEeecCCC
Q 021897 210 VWCIVTEYAKGG 221 (306)
Q Consensus 210 ~~~iv~E~~~~g 221 (306)
.+|+||++|.
T Consensus 148 --g~v~e~l~G~ 157 (429)
T 1nw1_A 148 --GRLEEYIPSR 157 (429)
T ss_dssp --EEEECCCCEE
T ss_pred --CEEEEEeCCc
Confidence 3899999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00027 Score=64.77 Aligned_cols=136 Identities=14% Similarity=0.229 Sum_probs=78.5
Q ss_pred ceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCe
Q 021897 141 TAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 210 (306)
+.|..|....+|+.+.. ++.+++|+.-..... ...+.+|..+++.+. +.-..++++.+..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~-------~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG-------VDSLVLESVMFAILAERSLGPQLYGVFPE--- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC-------HHHHHHHHHHHHHHHHTTSSCCEEEEETT---
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch-------HHHHHHHHHHHHHHHhcCCCCeEEEEcCC---
Confidence 46777888899999873 368999985321111 124558888887774 2223567776643
Q ss_pred EEEEEeecCCCCHH--------------HHHHhhC------CCCCC--HHHHHHHHHHHH-------------------H
Q 021897 211 WCIVTEYAKGGSVR--------------QFLTRRQ------NRAVP--LKLAVKQALDVA-------------------R 249 (306)
Q Consensus 211 ~~iv~E~~~~gsL~--------------~~l~~~~------~~~~~--~~~~~~i~~qi~-------------------~ 249 (306)
.+||||++|..|. +.|.+.. .+... +..+.++..++. .
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 2899999875432 1122111 11111 233444443321 1
Q ss_pred HHHHHH----hC----CccccCCCCCcEEEcCC----CcEEEEcccCeee
Q 021897 250 GMAYVH----GL----GFIHRDLKSDNLLISAD----KSIKIADFGVARI 287 (306)
Q Consensus 250 gl~yLH----~~----~iiHrDlkp~NILv~~~----~~vkl~DFGla~~ 287 (306)
.++.|. .. .++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233333 22 48999999999999876 7899999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00018 Score=65.37 Aligned_cols=71 Identities=11% Similarity=0.166 Sum_probs=41.8
Q ss_pred ceeeeeccEEEEEEEECC----------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEEeCC
Q 021897 141 TAFAQGAFGKLYRGTYNG----------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRFIGACRKRM 209 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~ 209 (306)
+.|+.|....+|+....+ ..+++|+........ .....|..+++.+.... ++++++.. ..
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~~~~E~~~l~~L~~~g~~P~~~~~~--~~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-------YNTISEFEVYKTMSKYKIAPQLLNTF--NG 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-------SCHHHHHHHHHHHHHTTSSCCEEEEE--TT
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-------ecHHHHHHHHHHHHhcCCCCceEEec--CC
Confidence 567778888999998754 688999875421110 01246777776664222 44666554 23
Q ss_pred eEEEEEeecCCCC
Q 021897 210 VWCIVTEYAKGGS 222 (306)
Q Consensus 210 ~~~iv~E~~~~gs 222 (306)
++||||++|.+
T Consensus 110 --~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 --GRIEEWLYGDP 120 (369)
T ss_dssp --EEEEECCCSEE
T ss_pred --cEEEEEecCCc
Confidence 68999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0059 Score=54.73 Aligned_cols=32 Identities=25% Similarity=0.466 Sum_probs=28.2
Q ss_pred CCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 257 ~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 35899999999999998888999999988753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0024 Score=59.24 Aligned_cols=71 Identities=11% Similarity=0.084 Sum_probs=45.4
Q ss_pred ceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCe
Q 021897 141 TAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMV 210 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 210 (306)
+.+..|....+|+.+.. +..+++|+......... ...+|..+++.+. +.-..++++.+ .+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-------dR~~E~~~l~~L~~~gi~P~l~~~~--~~- 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-------DSKVELDVFRYLSNINIAPNIIADF--PE- 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-------CHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-------CHHHHHHHHHHHHhcCCCCCEEEEc--CC-
Confidence 56777888899999875 67899998644321110 1236777776664 22245566533 23
Q ss_pred EEEEEeecCCCC
Q 021897 211 WCIVTEYAKGGS 222 (306)
Q Consensus 211 ~~iv~E~~~~gs 222 (306)
++|+||++|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 68999999855
|
| >1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F* | Back alignment and structure |
|---|
Probab=96.13 E-value=0.00095 Score=49.43 Aligned_cols=72 Identities=17% Similarity=0.242 Sum_probs=47.9
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR- 84 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~- 84 (306)
-+||++.+. -.-+....+..| .|+|+++.|++ .+|.|++|++...... ...++|+.|....
T Consensus 5 ~~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~~~LSv~~~~~~~----~~~v~H~~I~~~~~ 68 (106)
T 1aot_F 5 EEWYFGKLG---------RKDAERQLLSFGNPRGTFLIRESET---TKGAYSLSIRDWDDMK----GDHVKHYKIRKLDN 68 (106)
T ss_dssp SSSCCBSCC---------HHHHHHHHHTTTCCTTEECCBCBSS---SSSBBCCEEECCBTTT----BCCEEECCBEEETT
T ss_pred CccCCCCCC---------HHHHHHHHhhCCCCCcEEEEEeCCC---CCCCEEEEEEecccCC----CCcEEEEEEEEeCC
Confidence 378887774 234444555444 79999998875 5689999998643211 1367999998764
Q ss_pred CceeEeeeeeee
Q 021897 85 HNYSVSVGQSVF 96 (306)
Q Consensus 85 ~~~~i~~~~~~~ 96 (306)
+.|++. +...|
T Consensus 69 g~~~l~-~~~~F 79 (106)
T 1aot_F 69 GGYYIT-TRAQF 79 (106)
T ss_dssp TEEEEE-TTEEE
T ss_pred CCEEEC-CCCcc
Confidence 678876 33444
|
| >3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.07 E-value=0.00031 Score=53.49 Aligned_cols=73 Identities=8% Similarity=0.093 Sum_probs=51.6
Q ss_pred cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCceeEeee-eeeec--CCcccc-ccCchHHHH
Q 021897 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVSVG-QSVFR--PGKVTH-ALNDDALAQ 112 (306)
Q Consensus 37 ~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~--~~~v~~-~~~~~~l~~ 112 (306)
..|+|+++.|+. . ++||+||++... ...++||.|+...++|+|... ...|. ++.|.| ..+.++++.
T Consensus 36 ~~GaFLVR~Se~---~-~~ySLSVR~~~~------~~~VKHYkI~~~~G~y~I~~~~~~~F~SL~eLV~yY~~~adGl~~ 105 (125)
T 3maz_A 36 SLGNMILRPGSD---S-RNYSITIRQEID------IPRIKHYKVMSVGQNYTIELEKPVTLPNLFSVIDYFVKETRGNLR 105 (125)
T ss_dssp GGCSEEEEECTT---S-SSEEEEEEECSS------SCEEEEEEEEEETTEEEECSSSCEEESSHHHHHHHHHHHTTTCCC
T ss_pred CCCcEEEEeCCC---C-CCEEEEEEecCC------CCCEeeeEEEEeCCEEEEecCCCcCcCCHHHHHHHHHhCCCcCcc
Confidence 479999998854 2 389999998532 237899999988888998853 34553 566665 667788887
Q ss_pred HHhcCCC
Q 021897 113 ALMDHRY 119 (306)
Q Consensus 113 ~l~~~~~ 119 (306)
.|..+|.
T Consensus 106 ~L~~~c~ 112 (125)
T 3maz_A 106 PFIASTD 112 (125)
T ss_dssp BCCC---
T ss_pred ccccccc
Confidence 7777763
|
| >3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B | Back alignment and structure |
|---|
Probab=95.73 E-value=0.003 Score=47.62 Aligned_cols=98 Identities=22% Similarity=0.232 Sum_probs=59.4
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCcc--c-c
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLK--P-V 83 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~--~-~ 83 (306)
-+||++.+. -.-+....+..+ .|+|+++.| + ..|.|++|++....... ...++|+.|+ . .
T Consensus 9 ~~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S-~---~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~~ 72 (118)
T 3s9k_A 9 YEWYNKSIS---------RDKAEKLLLDTGKEGAFMVRDS-R---TPGTYTVSVFTKAIISE---NPCIKHYHIKETNDS 72 (118)
T ss_dssp STTBCTTCC---------HHHHHHHHHHHCCTTCEEEEEC-S---STTCEEEEEEECCSCSS---SCEEEEEEEEECSCS
T ss_pred CceecCCCC---------HHHHHHHHHhcCCCCeEEEEee-C---CCCCEEEEEEecccccC---CCceEEEEEeEEECC
Confidence 378887774 334455665555 899999988 4 46899999997543221 1368999993 3 3
Q ss_pred CCceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCCCCC
Q 021897 84 RHNYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYPTE 122 (306)
Q Consensus 84 ~~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~~~ 122 (306)
++.|++. ....|. ++.|.| ..+.+++...|..|+.+..
T Consensus 73 ~g~~~~~-~~~~F~sl~~LV~~y~~~~~~l~~~L~~Pv~~~~ 113 (118)
T 3s9k_A 73 PKRYYVA-EKYVFDSIPLLIQYHQYNGGGLVTRLRYPVCGSP 113 (118)
T ss_dssp SCCEEEE-CSCCCSCHHHHHHHHHHCCTTSSSCCCCCCCCST
T ss_pred CCCEEEC-CCcccCCHHHHHHHheeCCCCCccCCCCcCCCCC
Confidence 4668775 333442 344443 3444555555555554433
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=95.27 E-value=0.0015 Score=52.94 Aligned_cols=82 Identities=20% Similarity=0.258 Sum_probs=51.2
Q ss_pred chHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-CceeEeeeeeeec--CCcccc
Q 021897 29 TQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH 103 (306)
Q Consensus 29 ~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~--~~~v~~ 103 (306)
+....+..| .|+|+++.|.+ ..|.|++|++......+ ..++|+.|.... +.|++. ....|. +..|.|
T Consensus 86 ae~lL~~~~~~~G~FLVR~S~~---~~g~y~LSv~~~~~~~~----~~v~H~~I~~~~~g~~~~~-~~~~F~sl~~LV~~ 157 (175)
T 4d8k_A 86 AERQLLAPGNTHGSFLIRESES---TAGSFSLSVRDFDQNQG----EVVKHYKIRNLDNGGFYIS-PRITFPGLHELVRH 157 (175)
T ss_dssp HHHHHHSTTCCTTCEEEEECSS---STTCEEEEEEEECTTSC----EEEEEEEEEECSSSCEESS-TTSEESSHHHHHHH
T ss_pred HHHHHhcCCCCCCEEEEEECCC---CCCeEEEEEEeCcccCC----CceEEEEEEECCCCCEEEC-CCCccCCHHHHHHH
Confidence 344555444 89999998865 57899999986443222 367999998755 667765 333442 344443
Q ss_pred -ccCchHHHHHHhcCC
Q 021897 104 -ALNDDALAQALMDHR 118 (306)
Q Consensus 104 -~~~~~~l~~~l~~~~ 118 (306)
..+.++++..|..||
T Consensus 158 y~~~~~gl~~~L~~Pc 173 (175)
T 4d8k_A 158 YTNASDGLCTRLSRPC 173 (175)
T ss_dssp HHHCCTTSSSCCCSBC
T ss_pred HhhCCCCCcccCCCcC
Confidence 445555555555554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.15 E-value=0.08 Score=48.44 Aligned_cols=29 Identities=28% Similarity=0.556 Sum_probs=25.4
Q ss_pred ccccCCCCCcEEE------cCCCcEEEEcccCeee
Q 021897 259 FIHRDLKSDNLLI------SADKSIKIADFGVARI 287 (306)
Q Consensus 259 iiHrDlkp~NILv------~~~~~vkl~DFGla~~ 287 (306)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999999875
|
| >1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A | Back alignment and structure |
|---|
Probab=95.13 E-value=0.0032 Score=47.19 Aligned_cols=92 Identities=20% Similarity=0.217 Sum_probs=55.2
Q ss_pred CCCccccccCccCCCCCccccchHHHHHh--cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL--GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR- 84 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~- 84 (306)
-+||++.+. -.-+....+.. -.|+|+++.|.+ .+|.|++|++..... ...++|+.|....
T Consensus 12 ~~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~y~LSv~~~~~~-----~~~v~H~~I~~~~~ 74 (114)
T 1blj_A 12 EKWFFRTIS---------RKDAERQLLAPMNKAGSFLIRESES---NKGAFSLSVKDITTQ-----GEVVKHYKIRSLDN 74 (114)
T ss_dssp SSSBCCSCC---------HHHHHHHHSSTTCCTTCEEBCBCTT---CSSCEEEEECBCCTT-----TCBCCCEEEEEETT
T ss_pred CCccCCCCC---------HHHHHHHHhhCCCCCceEEEEeCCC---CCCCEEEEEEEecCC-----CCcEEEEEEEEcCC
Confidence 378887774 23344444432 369999998875 568999999965422 1367999998764
Q ss_pred CceeEeeeeeeec--CCcccc-ccCchHHHHHHhcC
Q 021897 85 HNYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDH 117 (306)
Q Consensus 85 ~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~ 117 (306)
+.|++. ....|. ++.|.| ..+.+++...|..|
T Consensus 75 g~~~l~-~~~~F~sl~~LV~~y~~~~~~l~~~L~~p 109 (114)
T 1blj_A 75 GGYYIS-PRITFPTLQALVQHYSKKGDGLCQKLTLP 109 (114)
T ss_dssp TEEEEE-TTEEESSHHHHHHHHHHCCSSSSSCCCCC
T ss_pred CCEEEC-CCcccCCHHHHHHHhhhCCCCCceecCcc
Confidence 678876 334442 344443 33334443333333
|
| >3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A | Back alignment and structure |
|---|
Probab=94.86 E-value=0.0012 Score=48.19 Aligned_cols=62 Identities=16% Similarity=0.109 Sum_probs=43.6
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||++.+. -..+....+..-.|+|+++.|.+ .+|.|++|++.. ..++|+.|...++.|
T Consensus 5 ~~Wyhg~is---------r~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~~ 63 (98)
T 3us4_A 5 MPWFHGKIS---------GQEAVQQLQPPEDGLFLVRESAR---HPGDYVLCVSFG---------RDVIHYRVLHRDGHL 63 (98)
T ss_dssp CTTBCCSCC---------HHHHHHHTCSCCTTCEEEEECSS---STTCEEEEEEET---------TEEEEEEEEEETTEE
T ss_pred CcccCCCCC---------HHHHHHHccCCCCcEEEEEeCCC---CCCcEEEEEEEC---------CceEEEEEEEeCCEE
Confidence 368887774 22333444433579999998765 568999999962 257899998877778
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
++.
T Consensus 64 ~~~ 66 (98)
T 3us4_A 64 TID 66 (98)
T ss_dssp ESS
T ss_pred EEC
Confidence 775
|
| >1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=94.61 E-value=0.0033 Score=45.94 Aligned_cols=61 Identities=18% Similarity=0.151 Sum_probs=42.9
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -.-+....+..| .|+|+++.|++ .+|.|++|++.. ..++|+.|.... +
T Consensus 3 ~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g 61 (100)
T 1rja_A 3 PWFFGCIS---------RSEAVRRLQAEGNATGAFLIRVSEK---PSADYVLSVRDT---------QAVRHYKIWRRAGG 61 (100)
T ss_dssp CCBCTTCC---------HHHHHHHHSSTTCSSCCEEEEECSS---SSSCEEEEECTT---------SSCEEEEEEECSSS
T ss_pred CcccCCCC---------HHHHHHHHhccCCCCCEEEEEeCCC---CCCCEEEEEEEC---------CEEEEEEEEEcCCC
Confidence 57776664 334445555544 79999998875 468899999852 257899998754 6
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 62 ~~~l~ 66 (100)
T 1rja_A 62 RLHLN 66 (100)
T ss_dssp CEEEE
T ss_pred cEEEC
Confidence 78776
|
| >3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A | Back alignment and structure |
|---|
Probab=94.26 E-value=0.0019 Score=47.79 Aligned_cols=92 Identities=17% Similarity=0.209 Sum_probs=55.0
Q ss_pred cccCCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC
Q 021897 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (306)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~ 84 (306)
+-.-+||++.+. -..+....+..-.|+|+++.|.+ .+|.|++|++.. ..++|+.|...+
T Consensus 5 L~~~~Wyhg~is---------r~~Ae~lL~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~ 63 (106)
T 3eaz_A 5 LSLMPWFHGKIT---------REQAERLLYPPETGLFLVRESTN---YPGDYTLCVSSD---------GKVEHYRIMYHA 63 (106)
T ss_dssp GGGCTTBCCSCC---------HHHHHHHTCSCCTTEEEEEECTT---STTCEEEEEEET---------TEEEEEECEEET
T ss_pred cccCCCcCCCCC---------HHHHHHHhCCCCCCEEEEEECCC---CCCcEEEEEEeC---------CceEEEEEEecC
Confidence 334478888774 22333344333579999998865 568999999862 267899998766
Q ss_pred CceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCC
Q 021897 85 HNYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHR 118 (306)
Q Consensus 85 ~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~ 118 (306)
+.|++.. ...|. ++.+.| ..+.+++...|..|+
T Consensus 64 g~~~l~~-~~~F~sl~~Lv~~y~~~~~gl~~~L~~P~ 99 (106)
T 3eaz_A 64 SKLSIDE-EVYFENLMQLVEHYTSDADGLCTRLIKPK 99 (106)
T ss_dssp TEEESSS-SSCBSSHHHHHHHHHHCCTTSSSCCCEEC
T ss_pred CEEEECC-CCccCCHHHHHHHHhhCCCCCCeecCCcC
Confidence 7777652 23332 333333 334444444444443
|
| >1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A* | Back alignment and structure |
|---|
Probab=94.15 E-value=0.0022 Score=47.28 Aligned_cols=66 Identities=17% Similarity=0.208 Sum_probs=43.8
Q ss_pred CCccccccCccCCCCCccccchHHHHHh--cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKL--GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -.-+....+.. -.|+|+++.|.+ .+|.|++|++...... ...++|+.|.... +
T Consensus 5 ~Wyhg~is---------R~~Ae~lL~~~~~~~G~FLVR~S~~---~~g~~~LSv~~~~~~~----~~~v~H~~I~~~~~g 68 (105)
T 1lkk_A 5 PWFFKNLS---------RKDAERQLLAPGNTHGSFLIRESES---TAGSFSLSVRDFDQNQ----GEVVKHYKIRNLDNG 68 (105)
T ss_dssp TTBCTTCC---------HHHHHHHHTSTTCCTTCEEEEECSS---STTCEEEEEEEEETTT----EEEEEEEEEEECTTS
T ss_pred ceecCCCC---------HHHHHHHHHhcCCCCceEEEEECCC---CCCcEEEEEEEcccCC----CCcEEEEEEEECCCC
Confidence 68877764 23344444432 369999998875 5689999998643211 1367999998764 6
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 69 ~~~l~ 73 (105)
T 1lkk_A 69 GFYIS 73 (105)
T ss_dssp CEESS
T ss_pred CEEEC
Confidence 67765
|
| >3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A | Back alignment and structure |
|---|
Probab=93.99 E-value=0.0041 Score=46.83 Aligned_cols=61 Identities=18% Similarity=0.175 Sum_probs=43.3
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCcccc--C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV--R 84 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~--~ 84 (306)
+||++.+. -..+....+..| .|+|+++.|.+ .+|.|++|++.. ..++|+.|... .
T Consensus 15 ~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~ 73 (117)
T 3pqz_A 15 LWFHGRIS---------REESQRLIGQQGLVDGLFLVRESQR---NPQGFVLSLCHL---------QKVKHYLILPSEEE 73 (117)
T ss_dssp TTBCCSCC---------HHHHHHHHHHTTCCTTEEEEEECCC----CCCEEEEEEET---------TEEEEEEEEEECCT
T ss_pred ccccCCCC---------HHHHHHHHhcCCCCCCEEEEEecCC---CCCcEEEEEEeC---------CeeEEEEEEEecCC
Confidence 68887774 345566676655 79999998875 568999999962 26799999874 3
Q ss_pred CceeEe
Q 021897 85 HNYSVS 90 (306)
Q Consensus 85 ~~~~i~ 90 (306)
+.|++.
T Consensus 74 g~~~~~ 79 (117)
T 3pqz_A 74 GRLYFS 79 (117)
T ss_dssp TCCEEE
T ss_pred CCEEEE
Confidence 545544
|
| >2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=93.81 E-value=0.0096 Score=45.11 Aligned_cols=90 Identities=19% Similarity=0.199 Sum_probs=55.3
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCcccc-C
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-R 84 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~-~ 84 (306)
-+||++.+. -.-+.......| .|+|+++.|.+ ..|.|++|++.. ..++|+.|... +
T Consensus 16 ~~WyhG~is---------R~eAe~lL~~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~ 74 (121)
T 2dly_A 16 EPWFFGAIK---------RADAEKQLLYSENQTGAFLIRESES---QKGDFSLSVLDE---------GVVKHYRIRRLDE 74 (121)
T ss_dssp CSSBCSSCC---------HHHHHHHHTSSSCCTTCEEEEECSS---SSSCEEEEEESS---------SCEEEEEEEECSS
T ss_pred CCccccCCC---------HHHHHHHHhcCCCCCCEEEEEcCCC---CCCceEEEEEEC---------CeEEEEEEEEcCC
Confidence 378877764 233344444333 59999998865 568899999852 26799999874 4
Q ss_pred CceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCC
Q 021897 85 HNYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRY 119 (306)
Q Consensus 85 ~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~ 119 (306)
+.|++. +...|. ++.|.| ..+.+++...|..++.
T Consensus 75 g~~~l~-~~~~F~sl~eLV~~y~~~~~~l~~~L~~P~~ 111 (121)
T 2dly_A 75 GGFFLT-RRKVFSTLNEFVNYYTTTSDGLCVKLEKPCL 111 (121)
T ss_dssp SCEEEE-TTEEESSHHHHHHHHTTCCSSSSSCCCSBCC
T ss_pred CCEEEC-CCCccCCHHHHHHHHhhCCCCCceeCCeecC
Confidence 778876 344453 344544 3344444444444443
|
| >2kno_A Tensin-like C1 domain-containing phosphatase; SH2 domain, TENC1, solution structure, cell junctio membrane, hydrolase, membrane, metal-binding; NMR {Homo sapiens} PDB: 2l6k_A | Back alignment and structure |
|---|
Probab=93.55 E-value=0.0053 Score=47.28 Aligned_cols=59 Identities=8% Similarity=0.108 Sum_probs=40.0
Q ss_pred cchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCC----CCC--cccccccCCccccCCceeE
Q 021897 28 FTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGS----NDS--LTHILSHPGLKPVRHNYSV 89 (306)
Q Consensus 28 ~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s----~~~--~~~~~~~~~~~~~~~~~~i 89 (306)
-+....+....|+|+++.|.+ .+|.|++|++....+. ..+ ....++|+.|.....+|++
T Consensus 31 eAe~lL~~~~~G~FLVR~S~s---~~g~y~LSv~~~~~~~~~~~~~g~~~~~~v~H~~I~~~~~g~~l 95 (131)
T 2kno_A 31 QAIALLKDKDPGAFLIRDSHS---FQGAYGLALKVATPPPSAQPWKGDPVEQLVRHFLIETGPKGVKI 95 (131)
T ss_dssp HHHHHHTTSCTTBEEEEECSS---STTEEEEEEECSCCSSSSSSCCSCHHHHHEEEEEEECCSSCCCE
T ss_pred HHHHHhcCCCCCeEEEecCCC---CCCCEEEEEEeCCCCcccccccccccCCceEEEEEEECCCCCEE
Confidence 444555545689999999875 6789999999753210 000 0136899999887766887
|
| >2ecd_A Tyrosine-protein kinase ABL2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.49 E-value=0.011 Score=44.76 Aligned_cols=90 Identities=18% Similarity=0.179 Sum_probs=55.2
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cc
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~ 86 (306)
-+||++.+. -.-+....+..-.|+|+++.|.+ ..|.|++|++.. ..++|+.|.... +.
T Consensus 16 ~~WyhG~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g~ 74 (119)
T 2ecd_A 16 HSWYHGPVS---------RSAAEYLLSSLINGSFLVRESES---SPGQLSISLRYE---------GRVYHYRINTTADGK 74 (119)
T ss_dssp SSSEEEECC---------HHHHHHHHHTSCTTBEEEEEESS---STTEEEEEEECS---------SCEEEECCCCCSSSC
T ss_pred CccccCCCC---------HHHHHHHhcCCCCCeEEEEeCCC---CCCCEEEEEEEC---------CeEEEEEEEEcCCCC
Confidence 368887774 23444555544589999998875 568999999952 257999998754 66
Q ss_pred eeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCC
Q 021897 87 YSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRY 119 (306)
Q Consensus 87 ~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~ 119 (306)
|++. ....|. ++.|.| ....+++...|..|+.
T Consensus 75 ~~l~-~~~~F~sl~~LV~~y~~~~~gl~~~L~~P~~ 109 (119)
T 2ecd_A 75 VYVT-AESRFSTLAELVHHHSTVADGLVTTLHYPAP 109 (119)
T ss_dssp CCCC-SSCCCSSHHHHHHHHHHCCTTSSSCCCBCCS
T ss_pred EEEc-CCCcCCCHHHHHHHHhhCCCCCceECCCccC
Confidence 7664 233342 344443 3344444444444443
|
| >1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A | Back alignment and structure |
|---|
Probab=93.35 E-value=0.0048 Score=45.49 Aligned_cols=54 Identities=15% Similarity=0.214 Sum_probs=39.8
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCcccc
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV 83 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~ 83 (306)
+||++.+. -.-+....+..| .|+|+++.|++ .+|.|++|++.. ..++|+.|...
T Consensus 6 ~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~ 61 (105)
T 1nrv_A 6 HWFHGRIS---------REESHRIIKQQGLVDGLFLLRDSQS---NPKAFVLTLCHH---------QKIKNFQILPC 61 (105)
T ss_dssp TTBCTTCC---------HHHHHHHHHHTTCCTTEEEEEECSS---CTTCEEEEEEET---------TEEEEEEEEEC
T ss_pred cccCCCCC---------HHHHHHHHHhcCCCCceEEEEeCCC---CCCCEEEEEEeC---------CEEEEEEEEEE
Confidence 67777764 344556666655 79999998875 568999999863 26799999864
|
| >2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.21 E-value=0.053 Score=40.73 Aligned_cols=66 Identities=18% Similarity=0.166 Sum_probs=45.5
Q ss_pred CCCccccccCccCCCCCccccchHHHHHh-cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCc
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN 86 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~ 86 (306)
-+||++.+. -..+.....+. -.|+|+++.|++ .+|.|++|++....+ ...++|+.|....+.
T Consensus 21 ~~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~~---~~g~y~LSv~~~~~~-----~~~v~H~~I~~~~g~ 83 (118)
T 2el8_A 21 TPSCFLKVS---------RLEAQLLLERYPECGNLLLRPSGD---GADGVSVTTRQMHNG-----THVVRHYKVKREGPK 83 (118)
T ss_dssp SCTTCCCCC---------HHHHHHHHHHSSTTCSBEEEECCS---SSSSEEEEECCCBTT-----BCCCEEECBCCBTTB
T ss_pred CCceecCCC---------HHHHHHHHhhCCCCcEEEEeeCCC---CCCceEEEEEEecCC-----CCcEEEEEEEEcCCE
Confidence 367776664 33455555443 369999998876 578999999864421 136799999885577
Q ss_pred eeEe
Q 021897 87 YSVS 90 (306)
Q Consensus 87 ~~i~ 90 (306)
|++.
T Consensus 84 ~~i~ 87 (118)
T 2el8_A 84 YVID 87 (118)
T ss_dssp CCBS
T ss_pred EEEe
Confidence 8775
|
| >3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A | Back alignment and structure |
|---|
Probab=93.08 E-value=0.0036 Score=46.74 Aligned_cols=90 Identities=18% Similarity=0.147 Sum_probs=55.1
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cc
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~ 86 (306)
-+||++.+. -..+....+....|+|+++.|.+ ..|.|++|++.. ..++|+.|.... +.
T Consensus 5 ~~Wyhg~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g~ 63 (112)
T 3k2m_A 5 HSWYHGPVS---------RNAAEYLLSSGINGSFLVRESES---SPGQRSISLRYE---------GRVYHYRINTASDGK 63 (112)
T ss_dssp STTEEESCC---------HHHHHHHTTTCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTSC
T ss_pred CcceeeCCC---------HHHHHHHhccCCCceEEEEeCCC---CCCCEEEEEEeC---------CcEEEEEEEECCCCc
Confidence 368877764 22343444433479999998865 578999999962 257999998754 56
Q ss_pred eeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCC
Q 021897 87 YSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRY 119 (306)
Q Consensus 87 ~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~ 119 (306)
|.+. +...|. ++.|.| ..+.+++...|..|+.
T Consensus 64 ~~~~-~~~~F~sl~~LV~~y~~~~~~l~~~L~~P~~ 98 (112)
T 3k2m_A 64 LYVS-SESRFNTLAELVHHHSTVADGLITTLHYPAP 98 (112)
T ss_dssp EESS-TTCCBSSHHHHHHHHHHCCTTSSSCCCEECC
T ss_pred EEEC-CCCeECCHHHHHHHHhhCCCCCccCCCCCCC
Confidence 6654 233442 344443 3445555555555544
|
| >1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A* | Back alignment and structure |
|---|
Probab=92.69 E-value=0.049 Score=39.26 Aligned_cols=61 Identities=21% Similarity=0.163 Sum_probs=44.5
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cc
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~ 86 (306)
+||++.+. -.-+....+..+ .|+|+++.|.+ .+|.|++|++.. ..++|+.|.... +.
T Consensus 4 ~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g~ 62 (96)
T 1jyr_A 4 AWFFGKIP---------RAKAEEMLSKQRHDGAFLIRESES---APGDFSLSVKFG---------NDVQHFKVLRDGAGK 62 (96)
T ss_dssp TTBCCSCC---------HHHHHHHHHTCCSTTBEEEEECSS---STTCEEEEEEET---------TEEEEEECEECTTSC
T ss_pred ceeccCCC---------HHHHHHHHhcCCCCcEEEEEecCC---CCCCEEEEEEeC---------CeEEEEEEEEcCCCC
Confidence 57777664 334556666666 89999998875 568899999962 267999998754 66
Q ss_pred eeEe
Q 021897 87 YSVS 90 (306)
Q Consensus 87 ~~i~ 90 (306)
|.+.
T Consensus 63 ~~l~ 66 (96)
T 1jyr_A 63 YFLW 66 (96)
T ss_dssp EESS
T ss_pred EEEC
Confidence 7764
|
| >2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.53 E-value=0.0085 Score=45.79 Aligned_cols=61 Identities=21% Similarity=0.258 Sum_probs=43.1
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCcccc--C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV--R 84 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~--~ 84 (306)
+||++.+. -.-+....+..| .|+|+++.|++ .+|.|++|++.. ..++|+.|... +
T Consensus 27 ~WyhG~is---------R~eAe~lL~~~g~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~ 85 (126)
T 2aug_A 27 PWFHHKIS---------RDEAQRLIIQQGLVDGVFLVRDSQS---NPKTFVLSMSHG---------QKIKHFQIIPVEDD 85 (126)
T ss_dssp TTEETTCC---------HHHHHHHHHTTTCCTTEEEEEECSS---SSCCEEEEEEET---------TEEEEEEEEEEEET
T ss_pred CcccCCCC---------HHHHHHHHhccCCCCCEEEEeecCC---CCCCEEEEEEcC---------CeEEEEEEEEECCC
Confidence 67777664 344556666555 69999998875 568999999962 26799999875 3
Q ss_pred CceeEe
Q 021897 85 HNYSVS 90 (306)
Q Consensus 85 ~~~~i~ 90 (306)
+.|++.
T Consensus 86 G~~~~~ 91 (126)
T 2aug_A 86 GEMFHT 91 (126)
T ss_dssp TEEEEE
T ss_pred CeEEEE
Confidence 556553
|
| >2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.37 E-value=0.0091 Score=44.36 Aligned_cols=67 Identities=16% Similarity=0.166 Sum_probs=45.3
Q ss_pred CCCccccccCccCCCCCccccchHHHHHh-cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
-+||++.+. -.-+....+.. -.|+|+++.|+ .+|.|++|++....+.. ...++|+.|.... +
T Consensus 11 ~~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S~----~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~g 74 (110)
T 2ekx_A 11 YDWFAGNIS---------RSQSEQLLRQKGKEGAFMVRNSS----QVGMYTVSLFSKAVNDK---KGTVKHYHVHTNAEN 74 (110)
T ss_dssp SSSBCCSCC---------HHHHHHHHHHTCCTTEEEEEECS----STTCEEEEECCCCSSCS---SCCCEEEECEECTTC
T ss_pred CCeecCCCC---------HHHHHHHHhccCCCceEEEEecC----CCCCEEEEEEeccccCC---CCcEEEEEEEECCCC
Confidence 378887774 33444555554 46999999883 47899999996542211 1367999998765 5
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 75 ~~~l~ 79 (110)
T 2ekx_A 75 KLYLA 79 (110)
T ss_dssp CEESS
T ss_pred CEEEC
Confidence 57765
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=92.30 E-value=0.021 Score=49.04 Aligned_cols=92 Identities=15% Similarity=0.172 Sum_probs=60.2
Q ss_pred CCccccccCccCCCCCccccchHHHHHh--cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCcccc-CC
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKL--GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RH 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~-~~ 85 (306)
+||++.+. -..+....... -.|+|+++.|.+ ..|.|++|++.. ..++|+.|... .+
T Consensus 7 ~Wyhg~is---------R~~Ae~lL~~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 65 (254)
T 2oq1_A 7 PFFYGSIS---------RAEAEEHLKLAGMADGLFLLRQCLR---SLGGYVLSLVHD---------VRFHHFPIERQLNG 65 (254)
T ss_dssp TTBCBSCC---------HHHHHHHHHHTTCCTTCEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CccCCCCC---------HHHHHHHHhccCCCCcEEEEEeCCC---CCCCEEEEEEEC---------CeEEEEEEEEeCCC
Confidence 68887774 34455555443 479999998875 578999999952 26799999984 47
Q ss_pred ceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCCCCC
Q 021897 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYPTE 122 (306)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~~~ 122 (306)
.|++. +...|. ++.|.| ..+.+++...|..|+.+..
T Consensus 66 ~~~l~-~~~~F~sl~~LV~~y~~~~~~l~~~L~~p~~~~~ 104 (254)
T 2oq1_A 66 TYAIA-GGKAHCGPAELCEFYSRDPDGLPCNLRKPCNRPS 104 (254)
T ss_dssp CEEET-TSCCBSSHHHHHHHHHHCCTTSSSCCCSBCCCCT
T ss_pred CEEeC-CCCccCCHHHHHHHHHhCCCCcccccccccCCCC
Confidence 78876 334442 445544 4455666666666665433
|
| >2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.17 E-value=0.013 Score=44.61 Aligned_cols=67 Identities=16% Similarity=0.177 Sum_probs=45.9
Q ss_pred CCCccccccCccCCCCCccccchHHHHHh-cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
-+||.+.+. -.-+....+.. -.|+|+++.|+ ..|.|++|++..+.+.. ...++|+.|.... +
T Consensus 11 ~~WyhG~is---------R~eAe~lL~~~g~~G~FLVR~Ss----~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~g 74 (125)
T 2ge9_A 11 YEWYSKHMT---------RSQAEQLLKQEGKEGGFIVRDSS----KAGKYTVSVFAKSTGDP---QGVIRHYVVCSTPQS 74 (125)
T ss_dssp SSSEETTCC---------HHHHHHHHHHHTCTTEEEEEECS----SSCCEEEEEEESSSSST---TCEEEEEECEEETTT
T ss_pred CCccccCCC---------HHHHHHHHhhcCCCceEEEEecC----CCCCEEEEEEeccccCC---CCeEEEEEEEEcCCC
Confidence 378877774 33455566555 47999999883 47899999997543221 1367999998765 5
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 75 ~~~l~ 79 (125)
T 2ge9_A 75 QYYLA 79 (125)
T ss_dssp EEESS
T ss_pred CEEEC
Confidence 57765
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=91.78 E-value=0.024 Score=48.76 Aligned_cols=90 Identities=18% Similarity=0.210 Sum_probs=58.5
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCcccc-CC
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RH 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~-~~ 85 (306)
+||++.+. -..+....+..| .|+|+++.|++ .+|.|++|++.. ..++|+.|... ++
T Consensus 6 ~Wy~g~is---------R~~Ae~lL~~~g~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 64 (254)
T 1a81_A 6 PFFFGNIT---------REEAEDYLVQGGMSDGLYLLRQSRN---YLGGFALSVAHG---------RKAHHYTIERELNG 64 (254)
T ss_dssp TTBCSSCC---------HHHHHHHHHHTTCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred ccccCCCC---------HHHHHHHHhcCCCCCcEEEEEecCC---CCCCEEEEEEEC---------CeeEEEEEEEcCCC
Confidence 67877764 344555565444 79999998875 578999999952 26799999874 47
Q ss_pred ceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCCC
Q 021897 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYP 120 (306)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~ 120 (306)
.|++. +...|. ++.|.| ..+.++++..|..|+..
T Consensus 65 ~~~l~-~~~~F~sl~eLv~~y~~~~~~l~~~L~~p~~~ 101 (254)
T 1a81_A 65 TYAIA-GGRTHASPADLCHYHSQESDGLVCLLKKPFNR 101 (254)
T ss_dssp CEEET-TSCCBSSHHHHHHHHTTCCTTSSSCCCEECCC
T ss_pred CEEeC-CCCCcCCHHHHHHHHHhCCCCceECCccccCC
Confidence 78876 234442 444544 44555565555555543
|
| >2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.72 E-value=0.027 Score=42.81 Aligned_cols=67 Identities=19% Similarity=0.129 Sum_probs=44.8
Q ss_pred CCCccccccCccCCCCCccccchHHHHHh-cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
-+||++.+. -.-+....+.. -.|+|+++.|+ ..|.|++|++....+.. ...++|+.|.... +
T Consensus 16 ~~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~----~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~g 79 (125)
T 2dm0_A 16 YEWYHRNIT---------RNQAEHLLRQESKEGAFIVRDSR----HLGSYTISVFMGARRST---EAAIKHYQIKKNDSG 79 (125)
T ss_dssp SSSBCCSCC---------HHHHHHHHHHHCSTTCBCEEEET----TEEEEEEEEECCCSSSS---SCCEEEEEEEECTTC
T ss_pred CCcccCCCC---------HHHHHHHHhhcCCCCEEEEEecC----CCCCEEEEEEeccccCC---CCcEEEEEEEEcCCC
Confidence 367777664 33444555544 47999999983 46899999996542211 1367999998765 5
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 80 ~~~l~ 84 (125)
T 2dm0_A 80 QWYVA 84 (125)
T ss_dssp CEESS
T ss_pred CEEEC
Confidence 67765
|
| >2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.55 E-value=0.038 Score=41.62 Aligned_cols=62 Identities=13% Similarity=0.132 Sum_probs=44.0
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
-+||++.+. -.-+....+..| .|+|+++.|.+ ..|.|++|++.. ..++|+.|.... +
T Consensus 16 ~~WyhG~is---------R~~Ae~lL~~~g~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 74 (119)
T 2gsb_A 16 KIWFHGKIS---------KQEAYNLLMTVGQVCSFLVRPSDN---TPGDYSLYFRTN---------ENIQRFKICPTPNN 74 (119)
T ss_dssp CSSBCCSSC---------HHHHHHHHHHTCCSSEEEEEECSS---STTCEEEEEECS---------SCBCCCCEEEETTT
T ss_pred CCcccCCCC---------HHHHHHHHhhcCCCCeEEEEeCCC---CCCceEEEEEEC---------CEEEEEEEEEcCCC
Confidence 367877664 334455666544 69999998875 568999999853 257999998754 6
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|.+.
T Consensus 75 ~~~l~ 79 (119)
T 2gsb_A 75 QFMMG 79 (119)
T ss_dssp EEEES
T ss_pred CEEEC
Confidence 67764
|
| >1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A* | Back alignment and structure |
|---|
Probab=90.83 E-value=0.027 Score=41.28 Aligned_cols=61 Identities=13% Similarity=0.129 Sum_probs=43.3
Q ss_pred CCccccccCccCCCCCccccchHHHHHh-cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cc
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~ 86 (306)
+||++.+. -.-+....+.. -.|+|+++.|++ .+|.|++|++.. ..++|+.|.... +.
T Consensus 5 ~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g~ 63 (104)
T 1d4t_A 5 AVYHGKIS---------RETGEKLLLATGLDGSYLLRDSES---VPGVYCLCVLYH---------GYIYTYRVSQTETGS 63 (104)
T ss_dssp TTBCCSCC---------HHHHHHHHHHHCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTSC
T ss_pred ceEccCCC---------HHHHHHHHHhcCCCCEEEEeeCCC---CCCCEEEEEEEC---------CeEEEEEEEECCCCe
Confidence 68887764 33445555544 479999998865 568999999862 267999998654 66
Q ss_pred eeEe
Q 021897 87 YSVS 90 (306)
Q Consensus 87 ~~i~ 90 (306)
|.+.
T Consensus 64 ~~l~ 67 (104)
T 1d4t_A 64 WSAE 67 (104)
T ss_dssp EEEC
T ss_pred EEEe
Confidence 7765
|
| >1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=90.67 E-value=0.022 Score=41.60 Aligned_cols=62 Identities=15% Similarity=0.174 Sum_probs=42.6
Q ss_pred CCCccccccCccCCCCCccccchHHHHHh-cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
=+||++.+. -.-+....+.. -.|+|+++.|++ .+|.|++|++.. ..++|+.|.... +
T Consensus 3 ~~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g 61 (103)
T 1i3z_A 3 LPYYHGCLT---------KRECEALLLKGGVDGNFLIRDSES---VPGALCLCVSFK---------KLVYSYRIFREKHG 61 (103)
T ss_dssp CTTEESSCC---------HHHHHHHHHTTCSTTEEEEEECSS---STTCEEEEEECS---------SSEEEEEEEECTTS
T ss_pred CccccCCCC---------HHHHHHHHhhcCCCceEEEEeCCC---CCCCEEEEEEEC---------CEEEEEEEEECCCC
Confidence 367777664 33444455432 369999998865 567999999852 257999998654 6
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 62 ~~~l~ 66 (103)
T 1i3z_A 62 YYRIE 66 (103)
T ss_dssp CEEEC
T ss_pred eEEEe
Confidence 67775
|
| >1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A | Back alignment and structure |
|---|
Probab=90.63 E-value=0.055 Score=41.26 Aligned_cols=61 Identities=13% Similarity=0.129 Sum_probs=43.7
Q ss_pred CCccccccCccCCCCCccccchHHHHHh-cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cc
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~ 86 (306)
+||++.+. -.-+....+.. -.|+|+++.|++ ..|.|++|++.. ..++|+.|.... +.
T Consensus 5 ~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g~ 63 (128)
T 1ka6_A 5 AVYHGKIS---------RETGEKLLLATGLDGSYLLRDSES---VPGVYCLCVLYH---------GYIYTYRVSQTETGS 63 (128)
T ss_dssp SSBCCSCC---------HHHHHHHHHHHCCTTCEEEEECSS---STTCEEEEEESS---------SCEEEEEEEECTTSC
T ss_pred cccCCCCC---------HHHHHHHHhcCCCCCEEEEeecCC---CCCCEEEEEEeC---------CEEEEEEEEECCCCe
Confidence 68887774 33455555543 469999998875 568999999852 257999998654 66
Q ss_pred eeEe
Q 021897 87 YSVS 90 (306)
Q Consensus 87 ~~i~ 90 (306)
|.+.
T Consensus 64 ~~l~ 67 (128)
T 1ka6_A 64 WSAE 67 (128)
T ss_dssp EEEE
T ss_pred EEEe
Confidence 8776
|
| >1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A* | Back alignment and structure |
|---|
Probab=89.80 E-value=0.14 Score=37.15 Aligned_cols=62 Identities=16% Similarity=0.073 Sum_probs=43.9
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cc
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~ 86 (306)
-+||++.+. -.-+....+....|+|+++.|.+ .+|.|++|++.. ..++|+.|.... +.
T Consensus 9 ~~Wyhg~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g~ 67 (100)
T 1r1p_A 9 PEWFHEGLS---------RHQAENLLMGKDIGFFIIRASQS---SPGDFSISVRHE---------DDVQHFKVMRDTKGN 67 (100)
T ss_dssp TTTSCTTCC---------HHHHHHHHHTSCTTBEEEEECSS---STTCEEEEEECS---------SSEEEEECEECTTCC
T ss_pred CCccccCCC---------HHHHHHHhcCCCCCEEEEEecCC---CCCCEEEEEEEC---------CEEEEEEEEEcCCCC
Confidence 378887764 33444555555689999998875 568899999962 257899998754 66
Q ss_pred eeEe
Q 021897 87 YSVS 90 (306)
Q Consensus 87 ~~i~ 90 (306)
|.+.
T Consensus 68 ~~l~ 71 (100)
T 1r1p_A 68 YFLW 71 (100)
T ss_dssp EESS
T ss_pred EEEe
Confidence 7764
|
| >2lnw_A VAV-2, guanine nucleotide exchange factor VAV2; signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2lnx_A | Back alignment and structure |
|---|
Probab=89.49 E-value=0.11 Score=39.26 Aligned_cols=62 Identities=13% Similarity=0.161 Sum_probs=44.7
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||.+.+. -.-+....+....|+|+++.|.+ .+|.|++|++.. ..++|+.|...++.|
T Consensus 22 ~~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~~ 80 (122)
T 2lnw_A 22 YPWFAGNME---------RQQTDNLLKSHASGTYLIRERPA---EAERFAISIKFN---------DEVKHIKVVEKDNWI 80 (122)
T ss_dssp STTBCCSCC---------HHHHHHHHHHSCTTBEEEEECCC---SSEEEEEEEECS---------SCEEEEEEEEETTEE
T ss_pred CcCCCcCCC---------HHHHHHHhcCCCCCeEEEEeCCC---CCCcEEEEEEeC---------CcEEEEEEEEcCCEE
Confidence 367777664 33445555555689999998864 568999999962 257899998766777
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
++.
T Consensus 81 ~l~ 83 (122)
T 2lnw_A 81 HIT 83 (122)
T ss_dssp ESS
T ss_pred EEC
Confidence 765
|
| >4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A* | Back alignment and structure |
|---|
Probab=89.32 E-value=0.043 Score=46.90 Aligned_cols=54 Identities=17% Similarity=0.238 Sum_probs=36.7
Q ss_pred cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCC----ceeEeeeeeeec--CCcccc
Q 021897 37 GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRH----NYSVSVGQSVFR--PGKVTH 103 (306)
Q Consensus 37 ~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~----~~~i~~~~~~~~--~~~v~~ 103 (306)
..|+|+++.|.+ ..|.|++|++... .++|+.|..... .|++. ....|. ++.|.|
T Consensus 35 ~dG~FLVR~S~s---~~G~y~LSv~~~~---------~v~H~~I~~~~~~g~~~~~~~-~~~~F~sl~~LV~~ 94 (246)
T 4fbn_A 35 PDGSFLVRESET---FVGDYTLSFWRNG---------KVQHCRIHSRQDAGTPKFFLT-DNLVFDSLYDLITH 94 (246)
T ss_dssp CTTCEEEEECSS---STTCEEEEEEETT---------EEEEEEEEEECGGGCCEEEEE-TTEEESSHHHHHHH
T ss_pred CCCEEEEEcCCC---CCCCEEEEEEECC---------EEEEEEEEEECCCCceeEEec-CCcccCCHHHHHHh
Confidence 369999999876 6799999998532 578999976552 36665 334442 444544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=89.17 E-value=0.055 Score=52.71 Aligned_cols=90 Identities=18% Similarity=0.198 Sum_probs=63.7
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||.+.+. -.-+....+..| .|+|++++|++ .+|.|++|++... .++|+.|.... +
T Consensus 14 ~Wy~g~is---------r~~Ae~~L~~~~~~~G~FLvR~S~~---~~g~y~lsv~~~~---------~v~h~~i~~~~~g 72 (635)
T 4fl3_A 14 PFFFGNIT---------REEAEDYLVQGGMSDGLYLLRQSRN---YLGGFALSVAHGR---------KAHHYTIERELNG 72 (635)
T ss_dssp TTBCBSCC---------HHHHHHHHHHTTCCTTEEEEEECTT---SSSCEEEEEEETT---------EEEEEEEEECTTS
T ss_pred CccCCCCC---------HHHHHHHHhcCCCCCceEEEeeccc---CCCCEEEEEEeCC---------EEEeEEEEEcCCC
Confidence 68887775 334556666655 79999999875 6789999999622 67999998774 7
Q ss_pred ceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCCC
Q 021897 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYP 120 (306)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~ 120 (306)
.|++. +...|. ++.|.| ..+.++++..|..|+..
T Consensus 73 ~~~~~-~~~~f~sl~~Lv~~y~~~~~~l~~~L~~p~~~ 109 (635)
T 4fl3_A 73 TYAIA-GGRTHASPADLCHYHSQESDGLVCLLKKPFNR 109 (635)
T ss_dssp CEEST-TCCCBSSHHHHHHHHTTCCTTSSSCCCEECCC
T ss_pred CEEeC-CCCccCCHHHHHHHHhhCCCCCeeccCCcCCC
Confidence 78775 334453 455554 56777887777777653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.74 E-value=0.055 Score=52.45 Aligned_cols=90 Identities=17% Similarity=0.187 Sum_probs=61.5
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -.-+.......| .|+|++++|++ ..|.|++|++.. ..++|+.|.... +
T Consensus 9 ~W~~g~i~---------r~~ae~~L~~~~~~~G~fLvR~s~~---~~g~~~ls~~~~---------~~~~h~~i~~~~~g 67 (613)
T 2ozo_A 9 PFFYGSIS---------RAEAEEHLKLAGMADGLFLLRQCLR---SLGGYVLSLVHD---------VRFHHFPIERQLNG 67 (613)
T ss_dssp TTBCBSCC---------HHHHHHHHHTTTCCTTEEEEEECTT---BTTCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CCcCccCC---------HHHHHHHHhccCCCCCeEEEEecCC---CCCCEEEEEEEC---------CeEEEEEEEECCCC
Confidence 68888775 223444553334 59999998876 679999999962 257899998764 6
Q ss_pred ceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCCC
Q 021897 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYP 120 (306)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~ 120 (306)
.|++. +...|. ++.|.| ..+.++++..|..|+..
T Consensus 68 ~~~~~-~~~~f~sl~~Lv~~y~~~~~~l~~~L~~p~~~ 104 (613)
T 2ozo_A 68 TYAIA-GGKAHCGPAELCEFYSRDPDGLPCNLRKPCNR 104 (613)
T ss_dssp CEEET-TSCCBSSHHHHHHHHTSCCTTSSSCCCSBCCC
T ss_pred cEEEC-CCCCcCCHHHHHHHHhhCCCCCCccCCccCCC
Confidence 77775 444453 455655 55667787778777754
|
| >3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A | Back alignment and structure |
|---|
Probab=88.46 E-value=0.2 Score=36.79 Aligned_cols=64 Identities=14% Similarity=0.130 Sum_probs=43.5
Q ss_pred ccCCCccccccCccCCCCCccccchHHHHHh-cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC
Q 021897 6 VEGPKFTGLIGGNNNNDNNYYDFTQGFYQKL-GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (306)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~ 84 (306)
.+-+||++.+. -.-+....+.. -.|+|+++.|++ .+|.|++|++.. ..++|+.|....
T Consensus 5 ~~~~Wyhg~is---------r~~Ae~lL~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~ 63 (109)
T 3tkz_A 5 TSRRWFHPNIT---------GVEAENLLLTRGVDGSFLARPSKS---NPGDFTLSVRRN---------GAVTHIKIQNTG 63 (109)
T ss_dssp --CCSBCTTCC---------HHHHHHHHHHHCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECS
T ss_pred ccCCceecCCC---------HHHHHHHHhcCCCCCEEEEEecCC---CCCCEEEEEEEC---------CEEEEEEEEeCC
Confidence 34588888774 33444555554 379999998875 578999999962 257899998755
Q ss_pred CceeEe
Q 021897 85 HNYSVS 90 (306)
Q Consensus 85 ~~~~i~ 90 (306)
+.|.+.
T Consensus 64 ~~~~~~ 69 (109)
T 3tkz_A 64 DYYDLY 69 (109)
T ss_dssp SCEESS
T ss_pred CEEEec
Confidence 555543
|
| >2bbu_A Suppressor of cytokine signaling 3; SH2 domain, extended SH2 subdomain, PEST motif, protein complex, cytokine regulator; HET: PTR; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=88.45 E-value=0.19 Score=40.05 Aligned_cols=62 Identities=11% Similarity=0.003 Sum_probs=45.5
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||++.+. -..+....+..-.|+|++++|++ ..|.|++|++.. ..++|+.|....+.|
T Consensus 23 ~~WyhG~Is---------R~eAe~lL~~~~~GtFLVR~S~s---~~g~y~LSvr~~---------~~v~H~rI~~~~g~f 81 (164)
T 2bbu_A 23 SGFYWSAVT---------GGEANLLLSAEPAGTFLIRDSSD---QRHFFTLSVKTQ---------SGTKNLRIQCEGGSF 81 (164)
T ss_dssp TSCCCTTSC---------HHHHHHHHHHSSTTCCEEEECST---TSCCEEEEECCT---------TCCEEEECEEETTEE
T ss_pred CCccCCCCC---------HHHHHHHhcCCCCCCEEEEECCC---CCCCEEEEEEEC---------CceEEEEEEeCCCeE
Confidence 378887774 34455566555689999999875 568999999852 257899998766778
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
++.
T Consensus 82 ~l~ 84 (164)
T 2bbu_A 82 SLQ 84 (164)
T ss_dssp ESS
T ss_pred EEe
Confidence 776
|
| >2c9w_A Suppressor of cytokine signaling 2; growth regulation, SH2 domain, signal transduction inhibitor nuclear protein; 1.9A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=88.26 E-value=0.18 Score=40.28 Aligned_cols=62 Identities=15% Similarity=0.108 Sum_probs=45.6
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||++.+. -.-+....+....|+|++++|++ ..|.|++|++... .++|+.|...++.|
T Consensus 17 ~~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~---~~~~~~LSv~~~~---------~v~H~rI~~~~g~~ 75 (169)
T 2c9w_A 17 TGWYWGSMT---------VNEAKEKLKEAPEGTFLIRDSSH---SDYLLTISVKTSA---------GPTNLRIEYQDGKF 75 (169)
T ss_dssp TSCBCTTCC---------HHHHHHHHTTSCTTCEEEEECCS---TTCSEEEEEEETT---------EEEEEEEEEETTEE
T ss_pred CCccccCCC---------HHHHHHHcCCCCCcEEEEecCCC---CCCeEEEEEEECC---------eeEEEEEEEeCCEE
Confidence 478887774 33455555544579999999875 5789999998632 56899998866778
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
++.
T Consensus 76 ~l~ 78 (169)
T 2c9w_A 76 RLD 78 (169)
T ss_dssp EEC
T ss_pred EEc
Confidence 876
|
| >3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ... | Back alignment and structure |
|---|
Probab=88.21 E-value=0.24 Score=36.98 Aligned_cols=63 Identities=22% Similarity=0.186 Sum_probs=44.7
Q ss_pred cCCCccccccCccCCCCCccccchHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-
Q 021897 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR- 84 (306)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~- 84 (306)
.-+||++.+. -..+....+..+ .|+|+++.|.+ .+|.|++|++.. ..++|+.|....
T Consensus 5 ~~~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~ 63 (117)
T 3ov1_A 5 PHPWFFGKIP---------RAKAEEMLSKQRHDGAFLIRESES---APGDFSLSVKFG---------NDVQHFKVLRDGA 63 (117)
T ss_dssp CCTTBCCSCC---------HHHHHHHHHTCCSTTBEEEEECSS---STTCEEEEEEET---------TEEEEEECEECTT
T ss_pred cCCcccCCCC---------HHHHHHHHhCCCCCCcEEEEeCCC---CCCCEEEEEecC---------CceEEEEEEECCC
Confidence 4478888774 344555665533 59999998865 568999999862 257999997654
Q ss_pred CceeEe
Q 021897 85 HNYSVS 90 (306)
Q Consensus 85 ~~~~i~ 90 (306)
+.|.+.
T Consensus 64 g~~~l~ 69 (117)
T 3ov1_A 64 GKYFLW 69 (117)
T ss_dssp SCEESS
T ss_pred CeEEEC
Confidence 667765
|
| >2vif_A Suppressor of cytokine signalling 6; growth regulation, signal transduction inhibitor, KIT regula phosphotyrosine, signaling protein; HET: PTR; 1.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.76 E-value=0.17 Score=39.15 Aligned_cols=61 Identities=16% Similarity=0.106 Sum_probs=44.0
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCcee
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYS 88 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~ 88 (306)
+||++.+. -..+....+..-.|+|+++.|++ ..|.|++|++.. ..++|+.|...++.|.
T Consensus 25 ~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~---~~~~~~LSv~~~---------~~v~H~~I~~~~g~~~ 83 (141)
T 2vif_A 25 GWYWGPIT---------RWEAEGKLANVPDGSFLVRDSSD---DRYLLSLSFRSH---------GKTLHTRIEHSNGRFS 83 (141)
T ss_dssp TCBCCSCC---------HHHHHHHTTTSCTTCEEEEECSS---TTCSEEEEEEET---------TEEEEEEEEEETTEEE
T ss_pred CCcccCCC---------HHHHHHHhcCCCCceEEEEecCC---CCCCEEEEEEEC---------CEEEEEEEEEECCEEE
Confidence 67777664 23344444444579999999875 578999999862 2578999988777788
Q ss_pred Ee
Q 021897 89 VS 90 (306)
Q Consensus 89 i~ 90 (306)
+.
T Consensus 84 l~ 85 (141)
T 2vif_A 84 FY 85 (141)
T ss_dssp ET
T ss_pred Ee
Confidence 76
|
| >2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A* | Back alignment and structure |
|---|
Probab=87.37 E-value=0.11 Score=45.77 Aligned_cols=88 Identities=16% Similarity=0.158 Sum_probs=56.5
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cce
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNY 87 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~ 87 (306)
+||++.+. -.-+....+..-.|+|+++.|.+ ..|.|++|++.. ..++|+.|.... +.|
T Consensus 13 ~Wyhg~is---------R~~Ae~lL~~~~~G~FLvR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g~~ 71 (303)
T 2lqn_A 13 AWYMGPVS---------RQEAQTRLQGQRHGMFLVRDSST---CPGDYVLSVSEN---------SRVSHYIINSLPNRRF 71 (303)
Confidence 78887775 23344444444679999998865 578899999852 257999999855 557
Q ss_pred eEeeeeeee--cCCccccccCchHHHHHHhcCCC
Q 021897 88 SVSVGQSVF--RPGKVTHALNDDALAQALMDHRY 119 (306)
Q Consensus 88 ~i~~~~~~~--~~~~v~~~~~~~~l~~~l~~~~~ 119 (306)
.+. ...| .+.+|.|......++..|..++.
T Consensus 72 ~~~--~~~F~sl~~Lv~~y~~~~~~~~~L~~P~~ 103 (303)
T 2lqn_A 72 KIG--DQEFDHLPALLEFYKIHYLDTTTLIEPAP 103 (303)
Confidence 665 2445 36777664433334555555543
|
| >2dlz_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.37 E-value=0.19 Score=37.59 Aligned_cols=62 Identities=13% Similarity=0.161 Sum_probs=44.8
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||++.+. -.-+....+..-.|+|+++.|.+ ..|.|++|++.. ..++|+.|...++.|
T Consensus 16 ~~WyhG~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~g~~ 74 (118)
T 2dlz_A 16 YPWFAGNME---------RQQTDNLLKSHASGTYLIRERPA---EAERFAISIKFN---------DEVKHIKVVEKDNWI 74 (118)
T ss_dssp STTEEESCC---------HHHHHHHHHHSCTTBEEEECCSC---SSCCEEEEEECS---------SSEEEEEEEEETTEE
T ss_pred CCceecCCC---------HHHHHHHhcCCCCCEEEEEeCCC---CCCCEEEEEEEC---------CcEEEEEEEEcCCEE
Confidence 368877764 33445555555689999998875 568999999952 257899998766777
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
++.
T Consensus 75 ~l~ 77 (118)
T 2dlz_A 75 HIT 77 (118)
T ss_dssp EST
T ss_pred EEe
Confidence 765
|
| >2y3a_B Phosphatidylinositol 3-kinase regulatory subunit; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} | Back alignment and structure |
|---|
Probab=87.29 E-value=0.062 Score=47.29 Aligned_cols=48 Identities=15% Similarity=0.111 Sum_probs=34.7
Q ss_pred hHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCceeEe
Q 021897 30 QGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (306)
Q Consensus 30 ~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~i~ 90 (306)
....+..-.|+|+++.| + .+|.|++|++.. ..++|+.|.....+|++.
T Consensus 207 E~lL~~~~~GtFLVR~S-s---~~g~y~LSv~~~---------~~V~H~rI~~~~~g~~~~ 254 (302)
T 2y3a_B 207 EEMLSGKRDGTFLIRES-S---QRGCYACSVVVD---------GDTKHCVIYRTATGFGFA 254 (302)
T ss_dssp HHHHTTSCTTBEEBCCC-S---STTCEEEEEECS---------SSEEEEEEEEETTEEESB
T ss_pred HHHhcCCCCCcEEEEec-c---CCCceEEEEEeC---------CeeEEEEEEECCCceEEe
Confidence 33443345799999988 3 568999999852 257999998877776654
|
| >2hmh_A Suppressor of cytokine signaling 3; SOCS3, GP130, PTyr, peptide complex, cytokine regulator; HET: PTR; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=87.19 E-value=0.21 Score=39.23 Aligned_cols=62 Identities=11% Similarity=0.025 Sum_probs=45.1
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||++.+. -.-+....+..-.|+|++++|++ ..|.|++|++.. ..++|+.|...++.|
T Consensus 34 ~~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~rI~~~~g~f 92 (152)
T 2hmh_A 34 SGFYWSAVT---------GGEANLLLSAEPAGTFLIRDSSD---QRHFFTLSVKTQ---------SGTKNLRIQXEGGSF 92 (152)
T ss_dssp TSSEETTCC---------HHHHHHHHHTSCTTEEEEEECCS---TTCSEEEEEEET---------TEEEEEEEECGGGCB
T ss_pred CCCcCCCCC---------HHHHHHHhcCCCCCcEEEEeCCC---CCCcEEEEEEcC---------CceEEEEEEecCCEE
Confidence 367777664 33444555545689999999875 578999999862 267999998855778
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
.+.
T Consensus 93 ~l~ 95 (152)
T 2hmh_A 93 SLQ 95 (152)
T ss_dssp EEC
T ss_pred EEe
Confidence 876
|
| >2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A* | Back alignment and structure |
|---|
Probab=86.59 E-value=0.25 Score=35.81 Aligned_cols=61 Identities=18% Similarity=0.127 Sum_probs=42.3
Q ss_pred CCccccccCccCCCCCccccchHHHHH-hcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQK-LGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
+||++.+. -.-+....+. .-.|+|+++.|++ ..|.|++|++.. ..++|+.|...++.|
T Consensus 6 ~Wyhg~is---------R~~Ae~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~---------~~v~H~~I~~~~g~~ 64 (102)
T 2cia_A 6 EWYYGNVT---------RHQAECALNERGVEGDFLIRDSES---SPSDFSVSLKAS---------GKNKHFKVQLVDNVY 64 (102)
T ss_dssp TTBCCSCC---------HHHHHHHHHHHCCTTEEEEEECSS---STTCEEEEECCS---------SSCEEEEEEEETTEE
T ss_pred ccccCCCC---------HHHHHHHHhhCCCCcEEEEEECCC---CCCCEEEEEEeC---------CeeEEEEEEecCCEE
Confidence 57776664 2334445532 3479999998875 568999999852 256899998655778
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
.+.
T Consensus 65 ~l~ 67 (102)
T 2cia_A 65 CIG 67 (102)
T ss_dssp EET
T ss_pred EEC
Confidence 775
|
| >2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C* | Back alignment and structure |
|---|
Probab=86.43 E-value=0.29 Score=36.13 Aligned_cols=63 Identities=14% Similarity=0.088 Sum_probs=44.1
Q ss_pred cCCCccccccCccCCCCCccccchHHHHHh---cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCcccc
Q 021897 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKL---GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV 83 (306)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~ 83 (306)
.-+||++.+. -.-+....+.. -.|+|+++.|.+ .+|.|++|++.. ..++|+.|...
T Consensus 8 ~~~WyhG~is---------R~~Ae~lL~~~g~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~ 66 (111)
T 2hdv_A 8 GYPWFHGMLS---------RLKAAQLVLEGGTGSHGVFLVRQSET---RRGECVLTFNFQ---------GKAKHLRLSLN 66 (111)
T ss_dssp GSTTEEEECC---------HHHHHHHHHTTGGGGTTEEEEEECSS---CTTEEEEEEEET---------TEEEEEEEEEC
T ss_pred cCCCcCCCCC---------HHHHHHHHHHcCCCCCCeEEEEecCC---CCCCEEEEEEeC---------CeEEEEEEEEc
Confidence 3478887774 33445555544 479999998875 568899999962 26799999865
Q ss_pred C-CceeEe
Q 021897 84 R-HNYSVS 90 (306)
Q Consensus 84 ~-~~~~i~ 90 (306)
. +.|.+.
T Consensus 67 ~~g~~~l~ 74 (111)
T 2hdv_A 67 AAGQCRVQ 74 (111)
T ss_dssp TTCCEEET
T ss_pred CCCCEEeC
Confidence 4 566654
|
| >2iug_A Phosphatidylinositol 3-kinase regulatory alpha subunit; transferase, polymorphism, UBL conjugation, phosphorylation, SH2, PI3K, SH2 domain; 1.89A {Homo sapiens} PDB: 2iuh_A* 2iui_A* 1fu5_A* 1fu6_A 1oo3_A 1oo4_A* 2pna_A 2pnb_A | Back alignment and structure |
|---|
Probab=85.83 E-value=0.17 Score=37.96 Aligned_cols=63 Identities=13% Similarity=0.095 Sum_probs=44.1
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||++.+. -.-+....+..-.|+|+++.|++. .+|.|++|++.. ..++|+.|...++.|
T Consensus 11 ~~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~~--~~g~y~LSv~~~---------~~v~H~~I~~~~g~~ 70 (120)
T 2iug_A 11 AEWYWGDIS---------REEVNEKLRDTADGTFLVRDASTK--MHGDYTLTLRKG---------GNNKLIKIFHRDGKY 70 (120)
T ss_dssp CTTBCCSCC---------HHHHHHHHTTCCTTEEEEEECSSG--GGCSEEEEEEET---------TEEEEEEEEEETTEE
T ss_pred CCccccCCC---------HHHHHHHhcCCCCcEEEEECCCCC--CCCcEEEEEEEC---------CEEEEEEEEEcCCEE
Confidence 378887774 233444554445799999988752 168999999852 156899998877778
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
++.
T Consensus 71 ~l~ 73 (120)
T 2iug_A 71 GFS 73 (120)
T ss_dssp ESS
T ss_pred EEC
Confidence 775
|
| >2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.81 E-value=0.33 Score=36.26 Aligned_cols=61 Identities=11% Similarity=0.074 Sum_probs=43.8
Q ss_pred CCccccccCccCCCCCccccchHHHHH-hcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cc
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQK-LGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~ 86 (306)
+||++.+. -.-+....+. .-.|+|+++.|.+ ..|.|++|++.. ..++|+.|.... +.
T Consensus 11 ~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g~ 69 (119)
T 2ysx_A 11 CWNHGNIT---------RSKAEELLSRTGKDGSFLVRASES---ISRAYALCVLYR---------NCVYTYRILPNEDDK 69 (119)
T ss_dssp SSEEESCC---------HHHHHHHHHHHCCTTEEEEEECSS---CTTSEEEEEECS---------SCEEEEEEEECTTSC
T ss_pred ccccCCCC---------HHHHHHHHhhcCCCCEEEEEeCCC---CCCCEEEEEEEC---------CEEEEEEEEEcCCCC
Confidence 78887774 3344555554 3469999998875 568999999952 257999998654 67
Q ss_pred eeEe
Q 021897 87 YSVS 90 (306)
Q Consensus 87 ~~i~ 90 (306)
|++.
T Consensus 70 ~~l~ 73 (119)
T 2ysx_A 70 FTVQ 73 (119)
T ss_dssp EEEC
T ss_pred EEEe
Confidence 8776
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.64 E-value=2.8 Score=34.87 Aligned_cols=84 Identities=10% Similarity=-0.045 Sum_probs=57.7
Q ss_pred CCCCeeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCcEEEc
Q 021897 194 KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMA-YVHGLGFIHRDLKSDNLLIS 272 (306)
Q Consensus 194 ~h~niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~-yLH~~~iiHrDlkp~NILv~ 272 (306)
.||.+ -...-.+.+.+.|.++.-+++.-...++ .++....++++.+|+.... ++ ..-+|--|.|+||+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 57777 3333466677777776654443333443 2677888888888776554 33 4456777899999999
Q ss_pred CCCcEEEEcccCee
Q 021897 273 ADKSIKIADFGVAR 286 (306)
Q Consensus 273 ~~~~vkl~DFGla~ 286 (306)
.++.++|.-.|+-.
T Consensus 119 ~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 119 RALEPFFLHVGVKE 132 (219)
T ss_dssp TTCCEEESCCEETT
T ss_pred CCCcEEEEEcCCcc
Confidence 99999999988743
|
| >1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=85.13 E-value=0.087 Score=45.15 Aligned_cols=60 Identities=15% Similarity=0.168 Sum_probs=42.1
Q ss_pred CCccccccCccCCCCCccccchHHHHHh--cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKL--GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -.-+....+.. -.|+|+++.| + .+|.|++|++.. ..++|+.|.... +
T Consensus 159 ~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S-~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g 216 (254)
T 1a81_A 159 PWFHGKIS---------REESEQIVLIGSKTNGKFLIRAR-D---NNGSYALCLLHE---------GKVLHYRIDKDKTG 216 (254)
T ss_dssp TTEEEECC---------HHHHHHHHHSSCCCTTCEEEEEC-S---SSSCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CccccCCC---------HHHHHHHHHhcCCCCceEEEEec-C---CCCCEEEEEEEC---------CEEEEEEEEEcCCC
Confidence 67877664 33444555544 3799999988 3 568999999952 267999998754 6
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 217 ~~~l~ 221 (254)
T 1a81_A 217 KLSIP 221 (254)
T ss_dssp CEECT
T ss_pred CEEec
Confidence 67764
|
| >1h9o_A Phosphatidylinositol 3-kinase; transferase/receptor, complex (phosphotransferase/receptor), phosphotransferase, SH2 domain; HET: PTR; 1.79A {Homo sapiens} SCOP: d.93.1.1 PDB: 1pic_A* 1bfi_A 1bfj_A 1qad_A | Back alignment and structure |
|---|
Probab=84.85 E-value=0.21 Score=36.88 Aligned_cols=62 Identities=16% Similarity=0.142 Sum_probs=42.1
Q ss_pred cCCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCc
Q 021897 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN 86 (306)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~ 86 (306)
+-+||++.+. -.-+....+..-.|+|+++.| + .+|.|++|++.. ..++|+.|.....+
T Consensus 9 ~~~Wyhg~is---------R~~Ae~lL~~~~~G~FLVR~S-~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 66 (112)
T 1h9o_A 9 EKTWNVGSSN---------RNKAENLLRGKRDGTFLVRES-S---KQGCYACSVVVD---------GEVKHCVINKTATG 66 (112)
T ss_dssp GGGTBCCSCC---------HHHHHHHHTTCCTTEEEEEEC-S---STTCEEEEEEET---------TEEEEEEEEEETTE
T ss_pred CCCcccCCCC---------HHHHHHHhcCCCCceEEEeec-C---CCCCEEEEEEEC---------CEEEEEEEEEcCCc
Confidence 3467777664 233444444345799999988 4 468899999962 26799999877766
Q ss_pred eeEe
Q 021897 87 YSVS 90 (306)
Q Consensus 87 ~~i~ 90 (306)
|++.
T Consensus 67 ~~~~ 70 (112)
T 1h9o_A 67 YGFA 70 (112)
T ss_dssp EESS
T ss_pred eEEe
Confidence 6543
|
| >2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A | Back alignment and structure |
|---|
Probab=84.64 E-value=0.071 Score=45.72 Aligned_cols=60 Identities=10% Similarity=0.138 Sum_probs=42.0
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -.-+....+..| .|+|+++.| + .+|.|++|++.. ..++|+.|.... +
T Consensus 160 ~Wyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S-~---~~g~~~LSv~~~---------~~v~H~~I~~~~~g 217 (254)
T 2oq1_A 160 PWYHSSLT---------REEAERKLYSGAQTDGKFLLRPR-K---EQGTYALSLIYG---------KTVYHYLISQDKAG 217 (254)
T ss_dssp TTBCSSCC---------HHHHHHHHHSSCCCTTEEEEEEC-S---STTEEEEEEEET---------TEEEEEEEEECTTS
T ss_pred cccccCCC---------HHHHHHHHHhcCCCCceEEEEec-C---CCCCEEEEEEEC---------CeEEEEEEEEcCCC
Confidence 67776664 334445555443 799999988 3 568999999962 267999998654 6
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 218 ~~~~~ 222 (254)
T 2oq1_A 218 KYCIP 222 (254)
T ss_dssp CEEST
T ss_pred CEEEC
Confidence 67765
|
| >2cs0_A Hematopoietic SH2 domain containing; ALX, FLJ14886, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=84.26 E-value=0.36 Score=36.09 Aligned_cols=60 Identities=15% Similarity=0.133 Sum_probs=42.1
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cce
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNY 87 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~ 87 (306)
+||++.+. -.-+....+..-.|+|+++.|.+ .+| |++|++.. ..++|+.|.... +.|
T Consensus 17 ~WyhG~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~~-y~LSv~~~---------~~v~H~~I~~~~~g~~ 74 (119)
T 2cs0_A 17 EWFHGAIS---------REDAENLLESQPLGSFLIRVSHS---HVG-YTLSYKAQ---------SSCCHFMVKLLDDGTF 74 (119)
T ss_dssp SSBCSSCC---------HHHHHHHHHTSCTTCEEEEECSS---SSS-EEEEECCS---------SSCEEEEEEECTTSCE
T ss_pred CccccCCC---------HHHHHHHhcCCCCCEEEEEecCC---CCC-EEEEEEEC---------CEEEEEEEEEcCCCcE
Confidence 67877664 33455566544579999998875 345 99999852 257899998765 567
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
.+.
T Consensus 75 ~l~ 77 (119)
T 2cs0_A 75 MIP 77 (119)
T ss_dssp ECT
T ss_pred EEe
Confidence 764
|
| >1ju5_A CRK; CRK, SH2, SH3, adaptor protein, phosphopeptide, protein binding/transferase complex; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 | Back alignment and structure |
|---|
Probab=83.45 E-value=0.44 Score=34.97 Aligned_cols=45 Identities=20% Similarity=0.163 Sum_probs=31.9
Q ss_pred cchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC
Q 021897 28 FTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (306)
Q Consensus 28 ~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~ 84 (306)
-+....+..-.|+|+++.|++ .+|.|++|++.. ..++|+.|....
T Consensus 11 ~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~ 55 (109)
T 1ju5_A 11 EAVALLQGQRHGVFLVRDSST---SPGDYVLSVSEN---------SRVSHYIINSSG 55 (109)
T ss_dssp HHHHHHTTCCTTEEEEEECSS---STTEEEEEEECS---------SCEEEEEEECCS
T ss_pred HHHHHhcCCCCCEEEEEecCC---CCCCEEEEEEEC---------CeEEEEEEEECC
Confidence 344455444479999998875 468999999852 246888887655
|
| >2cr4_A 3BP-2, SH3 domain-binding protein 2; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.38 E-value=0.44 Score=36.12 Aligned_cols=41 Identities=7% Similarity=0.041 Sum_probs=32.2
Q ss_pred CCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCceeEe
Q 021897 39 GTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (306)
Q Consensus 39 g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~i~ 90 (306)
|+|++++|+ .+|.|++|++... ...++|+.|...++.|++.
T Consensus 45 G~FLVR~S~----~~g~y~LSv~~~~-------~~~vkH~rI~~~~~~~~i~ 85 (126)
T 2cr4_A 45 GLYCIRNSS----TKSGKVLVVWDET-------SNKVRNYRIFEKDSKFYLE 85 (126)
T ss_dssp TCEEEEECS----STTCEEEEEEETT-------TTEECCEECEEETTEEESS
T ss_pred CeEEEEecC----CCCCEEEEEEeCC-------CCCEEEEEEEECCCeEEEc
Confidence 999999886 4689999999742 1367999998777777765
|
| >2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.31 E-value=0.26 Score=36.36 Aligned_cols=50 Identities=20% Similarity=0.239 Sum_probs=35.4
Q ss_pred chHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCcccc-CCceeEe
Q 021897 29 TQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPV-RHNYSVS 90 (306)
Q Consensus 29 ~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~-~~~~~i~ 90 (306)
+....+..-.|+|+++.|.+ .+|.|++|++.. ..++|+.|... ++.|.+.
T Consensus 31 Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~ 81 (111)
T 2eo3_A 31 AQTRLQGQRHGMFLVRDSST---CPGDYVLSVSEN---------SRVSHYIINSLPNRRFKIG 81 (111)
T ss_dssp HHHHHSSCCTTCEEEEECSS---SSSCEEEEEEET---------TEEEEEEEEEETTTEEEET
T ss_pred HHHHhcCCCCceEEEEeecC---CCCCEEEEEEeC---------CeEEEEEEEEcCCCCEEEC
Confidence 33444433579999998875 468999999852 26789999874 4667764
|
| >2izv_A Suppressor of cytokine signaling 4; signal transduction inhibitor, growth regulation, signal transduction, SH2 domain, nuclear protein; 2.55A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1 | Back alignment and structure |
|---|
Probab=83.14 E-value=0.32 Score=39.59 Aligned_cols=62 Identities=23% Similarity=0.242 Sum_probs=43.8
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||++.+. -.-+....+....|+|++++|++ ..+.+++|++.. ..++|+.|...++.|
T Consensus 34 ~~WYhG~is---------R~eAE~lL~~~~dGtFLVR~S~~---~~~~lsLSvr~~---------~~v~H~rI~~~~g~f 92 (187)
T 2izv_A 34 NPCYWGVMD---------KYAAEALLEGKPEGTFLLRDSAQ---EDYLFSVSFRRY---------SRSLHARIEQWNHNF 92 (187)
T ss_dssp CTTEEEECC---------HHHHHHHHTTCCTTEEEEEECSS---TTCSEEEEEEET---------TEEEEEECEEETTEE
T ss_pred CCccccCCC---------HHHHHHHhcCCCCCcEEEEECCC---CCceEEEEEeeC---------CeEEEEEEEECCCEE
Confidence 367777764 22334445444579999999984 567899999852 257899998877778
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
++.
T Consensus 93 ~l~ 95 (187)
T 2izv_A 93 SFD 95 (187)
T ss_dssp ESC
T ss_pred EEe
Confidence 765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=82.61 E-value=3.8 Score=34.21 Aligned_cols=60 Identities=13% Similarity=0.083 Sum_probs=46.5
Q ss_pred CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEcCCCcEEEEc
Q 021897 221 GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIHRDLKSDNLLISADKSIKIAD 281 (306)
Q Consensus 221 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH-~~~iiHrDlkp~NILv~~~~~vkl~D 281 (306)
-+|.++|... +.+++++.+|.++.|.+.+|.-+- .+.-..+=+.|..|++..+|.|.+.+
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 3799999876 578999999999999999987762 12222344467899999999998764
|
| >2crh_A VAV proto-oncogene; oncoprotein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2ror_A* 2lct_A* | Back alignment and structure |
|---|
Probab=82.24 E-value=0.31 Score=37.53 Aligned_cols=48 Identities=10% Similarity=0.221 Sum_probs=34.6
Q ss_pred HHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCceeEe
Q 021897 31 GFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYSVS 90 (306)
Q Consensus 31 ~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~i~ 90 (306)
...+..-.|+|+++.|++ .+|.|++|++.. ..++|+.|+...+.|++.
T Consensus 40 ~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~g~~~l~ 87 (138)
T 2crh_A 40 SILANRSDGTFLVRQRVK---DAAEFAISIKYN---------VEVKHIKIMTAEGLYRIT 87 (138)
T ss_dssp HHTTTSCTTEEEEECCSS---TTCCCEEEEEET---------TEEEEEECEEETTEEESS
T ss_pred HHhcCCCCCEEEEEECCC---CCCCEEEEEEEC---------CeEEEEEEEeCCCEEEEC
Confidence 344334479999998875 568999999962 267999997545667765
|
| >2eob_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 2; SH2, phosphoinositide phospholipase C, PLC-gamma-2, phospholipase C-gamma-2; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=82.20 E-value=0.51 Score=35.53 Aligned_cols=60 Identities=7% Similarity=0.140 Sum_probs=42.0
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
+||++.+. -.-+....+..+ .|+|+++.|. ..|.|++|++.. ..++|+.|....+.|
T Consensus 20 ~WyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~----~~g~y~LSv~~~---------~~v~H~~I~~~~~~~ 77 (124)
T 2eob_A 20 PWYYDRLS---------RGEAEDMLMRIPRDGAFLIRKRE----GTDSYAITFRAR---------GKVKHCRINRDGRHF 77 (124)
T ss_dssp TTEESSCC---------HHHHHHHHHHCCSSSEEEEECCT----TSSCEEEEEEET---------TEEEEEEEEESSSCE
T ss_pred CCeecCCC---------HHHHHHHHhcCCCCCEEEEEecC----CCCCEEEEEEeC---------CeEEEEEEEECCCEE
Confidence 67776664 334455565555 6999999887 368999999862 267899998755556
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
.+.
T Consensus 78 ~~~ 80 (124)
T 2eob_A 78 VLG 80 (124)
T ss_dssp ESS
T ss_pred EEC
Confidence 554
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.97 E-value=1.9 Score=35.82 Aligned_cols=85 Identities=9% Similarity=0.011 Sum_probs=59.0
Q ss_pred CCCCCeeeEEEEEEeCCeEEEEEeecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 021897 193 LKHLNIVRFIGACRKRMVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLI 271 (306)
Q Consensus 193 l~h~niv~l~~~~~~~~~~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv 271 (306)
..||+++.. .+-...+.+.|.++.-+.+ ++.. ++ .++....++++.+|+....++ ..-+|=-|.|+||++
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f 112 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFF 112 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEE
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEE
Confidence 357877765 4555666666666655422 3332 32 367788889999888776444 334566789999999
Q ss_pred cCCCcEEEEcccCee
Q 021897 272 SADKSIKIADFGVAR 286 (306)
Q Consensus 272 ~~~~~vkl~DFGla~ 286 (306)
+.++.++|.-.|+-.
T Consensus 113 ~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 113 TRDGLPIAKTRGLQN 127 (215)
T ss_dssp CTTSCEEESCCEETT
T ss_pred cCCCCEEEEEccCcc
Confidence 999999999888743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 306 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-40 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-37 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-37 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-16 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 7e-49
Identities = 59/182 (32%), Positives = 99/182 (54%), Gaps = 10/182 (5%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEV 187
D+W I ++ +G G+FG +Y+G ++G DVA+K+L P+ Q F+ EV
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ----QLQAFKNEV 55
Query: 188 MMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDV 247
+L +H+NI+ F+G + IVT++ +G S+ L + + + + A
Sbjct: 56 GVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQT 113
Query: 248 ARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWM 304
A+GM Y+H IHRDLKS+N+ + D ++KI DFG+A ++ + G +G+ WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 305 AP 306
AP
Sbjct: 174 AP 175
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 9e-45
Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMM 189
W +++++L + +G FG + G Y G VA+K ++ Q F E +
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--------TAQAFLAEASV 53
Query: 190 LATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
+ L+H N+V+ +G ++ IVTEY GS+ +L R + +K +LDV
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 249 RGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
M Y+ G F+HRDL + N+L+S D K++DFG+ + + +W AP
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAP 169
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-43
Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQE 186
DEW + L + G FG+++ G YN VA+K L+ + + F E
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-------QGSMSPDAFLAE 58
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ L+H +VR + ++ I+TEY + GS+ FL + + + A
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWM 304
+A GMA++ +IHRDL++ N+L+S S KIADFG+AR+ + + +W
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 305 AP 306
AP
Sbjct: 178 AP 179
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-42
Identities = 58/190 (30%), Positives = 93/190 (48%), Gaps = 12/190 (6%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQV 178
T+GL D W I L + QG FG+++ GT+ VAIK L+ +
Sbjct: 3 QTQGL-AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-------PGTM 54
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLK 238
+ F QE ++ L+H +V+ + ++ IVTEY GS+ FL + + L
Sbjct: 55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLP 113
Query: 239 LAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTP 296
V A +A GMAYV + ++HRDL++ N+L+ + K+ADFG+AR+ + +
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173
Query: 297 ETGTYRWMAP 306
+W AP
Sbjct: 174 AKFPIKWTAP 183
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (364), Expect = 5e-42
Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 16/196 (8%)
Query: 115 MDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENN 172
MD P NYD+W ++ + M G +G++Y G + VA+K L+
Sbjct: 2 MDPSSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----- 51
Query: 173 PEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN 232
+ + ++F +E ++ +KH N+V+ +G C + + I+TE+ G++ +L
Sbjct: 52 --EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 109
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQ 290
+ V + + A ++ M Y+ FIHRDL + N L+ + +K+ADFG++R+
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169
Query: 291 TEGMTPETGTYRWMAP 306
+W AP
Sbjct: 170 YTAHAGAKFPIKWTAP 185
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-41
Identities = 46/180 (25%), Positives = 85/180 (47%), Gaps = 10/180 (5%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQE 186
+W ++ +G +G FG +Y + +A+K+L + + +E Q ++E
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG---VEHQLRRE 56
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
V + + L+H NI+R G ++ EYA G+V + L ++ + +
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 114
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+A ++Y H IHRD+K +NLL+ + +KIADFG + + T GT ++ P
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPP 173
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-41
Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 11/165 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G G +++ ++ +G +A K++ + E + Q +E+ +L IV F
Sbjct: 16 AGNGGVVFKVSHKPSGLVMARKLI-----HLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH-GLGFIH 261
GA I E+ GGS+ Q L + +P ++ K ++ V +G+ Y+ +H
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMH 128
Query: 262 RDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
RD+K N+L+++ IK+ DFGV+ + + + GT +M+P
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSP 172
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 9e-41
Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 10/164 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y N E VAIK + + Q +EV L L+H N +++
Sbjct: 25 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G + +V EY G + L + + +G+AY+H IHR
Sbjct: 82 GCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
D+K+ N+L+S +K+ DFG A I GT WMAP
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAP 180
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-40
Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G++ E VA+KI+ + ++A + ++E+ + L H N+V+F
Sbjct: 15 EGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
G R+ + + EY GG + + + +P A + + G+ Y+HG+G HR
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127
Query: 263 DLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAP 306
D+K +NLL+ ++KI+DFG+A + + + GT ++AP
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-40
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFGK+Y+ A K+++ K++ + + E+ +LA+ H NIV+ +
Sbjct: 22 DGAFGKVYKAQNKETSVLAAAKVIDT------KSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A I+ E+ GG+V + + R + + Y+H IHR
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHR 134
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 306
DLK+ N+L + D IK+ADFGV+ +T + GT WMAP
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-38
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 11/178 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID + L G FG + G + DVAIK+++ + + E +F +E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C K+ I+TEY G + +L ++R + ++ DV
Sbjct: 54 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEA 112
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWMAP 306
M Y+ F+HRDL + N L++ +K++DFG++R + + RW P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-38
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 15/170 (8%)
Query: 145 QGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200
G FG + +G Y DVAIK+L + ++ +E ++ L + IVR
Sbjct: 19 CGNFGSVRQGVYRMRKKQIDVAIKVL-----KQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
IG C+ +V E A GG + +FL + +P+ + V+ GM Y+ F+
Sbjct: 74 LIGVCQA-EALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 261 HRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAP 306
HRDL + N+L+ KI+DFG+++ + + +W AP
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (341), Expect = 5e-38
Identities = 38/184 (20%), Positives = 74/184 (40%), Gaps = 18/184 (9%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQ 184
YD + I L +L GAFG ++R G K + P + + +
Sbjct: 28 YDYYDI-LEEL------GSGAFGVVHRCVEKATGRVFVAKFINTPY------PLDKYTVK 74
Query: 185 QEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
E+ ++ L H ++ A + ++ E+ GG + + ++ + +
Sbjct: 75 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYM 133
Query: 245 LDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYR 302
G+ ++H +H D+K +N++ K+ +KI DFG+A E + T T
Sbjct: 134 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 193
Query: 303 WMAP 306
+ AP
Sbjct: 194 FAAP 197
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-37
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 116 DHRY--PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKIL 166
++ Y PT+ L +W +L+ G GAFGK+ T VA+K+L
Sbjct: 3 NYVYIDPTQ-LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 167 ERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
P + E+ +L+ L H+NIV +GAC ++TEY G +
Sbjct: 62 -----KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 226 FLTRRQNR----------------AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269
FL R+++ A+ L+ + + VA+GMA++ IHRDL + N+
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176
Query: 270 LISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
L++ + KI DFG+AR + +WMAP
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-37
Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 21/184 (11%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLYRGTYN----GEDVAIKILERPENNPEKAQVMEQQFQQE 186
T++ ++L G FG + +G Y + VA+KIL+ N+P ++ + E
Sbjct: 9 TLEDKEL------GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAE 58
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
++ L + IVR IG C W +V E A+ G + ++L + NR V K ++
Sbjct: 59 ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQ 115
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYR 302
V+ GM Y+ F+HRDL + N+L+ KI+DFG+++ E + T +
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 303 WMAP 306
W AP
Sbjct: 176 WYAP 179
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 134 bits (337), Expect = 2e-37
Identities = 39/166 (23%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAFG ++R T G + A K + P + ++ ++E+ ++ L+H +V
Sbjct: 36 TGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLH 89
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A ++ E+ GG + + + N+ + AV+ V +G+ ++H ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHL 148
Query: 263 DLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +N++ + +S +K+ DFG+ + + TGT + AP
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-37
Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 27/179 (15%)
Query: 145 QGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204
+G FG+++RG + GE+VA+KI + + E+ L+H NI+ FI A
Sbjct: 13 KGRFGEVWRGKWRGEEVAVKIFS-------SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 205 CRKR----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVH----- 255
K +V++Y + GS+ +L R V ++ +K AL A G+A++H
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 256 ---GLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRWMAP 306
HRDLKS N+L+ + + IAD G+A + GT R+MAP
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-37
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 11/178 (6%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMML 190
ID +L G FG ++ G + N + VAIK + + + E+ F +E ++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-------EGAMSEEDFIEEAEVM 54
Query: 191 ATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARG 250
L H +V+ G C ++ C+V E+ + G + + R Q + + LDV G
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEG 113
Query: 251 MAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTYRWMAP 306
MAY+ IHRDL + N L+ ++ IK++DFG+ R + Q T +W +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-37
Identities = 52/214 (24%), Positives = 82/214 (38%), Gaps = 38/214 (17%)
Query: 126 NYDE-WTIDLRKLNMGTAFAQGAFGKLYRG-------TYNGEDVAIKILERPENNPEKAQ 177
YD W L G GAFGK+ T VA+K+L +
Sbjct: 27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-----KEKADS 81
Query: 178 VMEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR--- 233
+ E+ M+ L H NIV +GAC ++ EY G + +L ++ +
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141
Query: 234 ------------------AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK 275
+ + + A VA+GM ++ +HRDL + N+L++ K
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 201
Query: 276 SIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
+KI DFG+AR + +WMAP
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 5e-37
Identities = 50/185 (27%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVM 188
+ D R L +G+F +Y+G +VA L+ + + Q+F++E
Sbjct: 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAE 60
Query: 189 MLATLKHLNIVRFIGAC----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQA 244
ML L+H NIVRF + + + +VTE G+++ +L ++ + + +K+
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWC 118
Query: 245 LDVARGMAYVH--GLGFIHRDLKSDNLLISA-DKSIKIADFGVARIEVQTEGMTPETGTY 301
+ +G+ ++H IHRDLK DN+ I+ S+KI D G+A + + GT
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTP 177
Query: 302 RWMAP 306
+MAP
Sbjct: 178 EFMAP 182
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 130 bits (328), Expect = 8e-37
Identities = 39/168 (23%), Positives = 76/168 (45%), Gaps = 8/168 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILER---PENNPEKAQVMEQQFQQEVMMLATLK-HLNI 198
+G + R + ++ A+KI++ + E+ Q + + +EV +L + H NI
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
++ + +V + K G + +L + + K K + + +H L
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLN 130
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK +N+L+ D +IK+ DFG + E + GT ++AP
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 8e-37
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QGA G +Y G++VAI+ + + P+K + E++++ K+ NIV ++
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQM-NLQQQPKK-----ELIINEILVMRENKNPNIVNYL 83
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ +V EY GGS+ +T + + + ++H IHR
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
D+KSDN+L+ D S+K+ DFG I + + GT WMAP
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-35
Identities = 43/174 (24%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G++G+ + +G+ + K L+ + +Q EV +L LKH NIVR+
Sbjct: 14 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYY 69
Query: 203 GAC--RKRMVWCIVTEYAKGGSVRQFLTR--RQNRAVPLKLAVKQALDVARGMAYVH--- 255
R IV EY +GG + +T+ ++ + + + ++ + + H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 256 --GLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
G +HRDLK N+ + +++K+ DFG+AR + T GT +M+P
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-35
Identities = 47/184 (25%), Positives = 89/184 (48%), Gaps = 14/184 (7%)
Query: 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQF 183
++ I ++ +G +G FG +++G Y VAIK + + + ++F
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-----CTSDSVREKF 55
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
QE + + H +IV+ IG + VW I+ E G +R FL R+ + L +
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLASLILY 113
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI--EVQTEGMTPETGTY 301
A ++ +AY+ F+HRD+ + N+L+S++ +K+ DFG++R + +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 302 RWMA 305
+WMA
Sbjct: 174 KWMA 177
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (318), Expect = 4e-35
Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 18/198 (9%)
Query: 120 PTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPE 174
P E + + + ID+ + + G FG++ G VAIK L
Sbjct: 12 PNEAVREFAK-EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-----KSG 65
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRA 234
+ + F E ++ H N++ G K I+TE+ + GS+ F R+ +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQ 124
Query: 235 VPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI------E 288
+ V +A GM Y+ + ++HRDL + N+L++++ K++DFG++R +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 289 VQTEGMTPETGTYRWMAP 306
RW AP
Sbjct: 185 PTYTSALGGKIPIRWTAP 202
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 8e-34
Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 24/194 (12%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGE----DVAIKILERPENNPEKAQVMEQQFQQEV 187
+D + +G FG++ + + D AIK + ++ + F E+
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGEL 61
Query: 188 MMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------N 232
+L L H NI+ +GAC R + EYA G++ FL + +
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 233 RAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292
+ + + A DVARGM Y+ FIHRDL + N+L+ + KIADFG++R +
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 293 GMTPETGTYRWMAP 306
T RWMA
Sbjct: 182 KKTMGRLPVRWMAI 195
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 9e-34
Identities = 33/186 (17%), Positives = 72/186 (38%), Gaps = 19/186 (10%)
Query: 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQ 182
E Y+++ I L +G FG ++R T + + K ++ + +
Sbjct: 2 ELYEKYMI-AEDL------GRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVL 47
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
++E+ +L +H NI+ + ++ E+ G + + + + + V
Sbjct: 48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVS 106
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKS--IKIADFGVARIEVQTEGMTPETGT 300
V + ++H H D++ +N++ +S IKI +FG AR +
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
Query: 301 YRWMAP 306
+ AP
Sbjct: 167 PEYYAP 172
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-33
Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 14/184 (7%)
Query: 132 IDLRKLNMGTAFAQGAFGKLYRGTYNGED-----VAIKILERPENNPEKAQVMEQQFQQE 186
I + L + G+FG + RG ++ VA+K L+ + +A F +E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM---DDFIRE 61
Query: 187 VMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALD 246
V + +L H N++R G + +VTE A GS+ L + Q L + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQ 119
Query: 247 VARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG----MTPETGTYR 302
VA GM Y+ FIHRDL + NLL++ +KI DFG+ R Q + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 303 WMAP 306
W AP
Sbjct: 180 WCAP 183
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 1e-33
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 37/212 (17%)
Query: 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVM 179
+ +GAFG++++ VA+K+L E + M
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADM 59
Query: 180 EQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAV---- 235
+ FQ+E ++A + NIV+ +G C C++ EY G + +FL V
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 236 ------------------PLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSI 277
+ A VA GMAY+ F+HRDL + N L+ + +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 179
Query: 278 KIADFGVARIEVQTEGMTPET---GTYRWMAP 306
KIADFG++R + + RWM P
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-33
Identities = 48/197 (24%), Positives = 82/197 (41%), Gaps = 23/197 (11%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVME 180
DEW + K+ M QG+FG +Y G VAIK + N +
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 67
Query: 181 QQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNR------- 233
+F E ++ ++VR +G + ++ E G ++ +L +
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 234 -AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI---EV 289
L ++ A ++A GMAY++ F+HRDL + N +++ D ++KI DFG+ R
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 290 QTEGMTPETGTYRWMAP 306
RWM+P
Sbjct: 188 YYRKGGKGLLPVRWMSP 204
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 2e-33
Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 12/167 (7%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GAF ++ + VAIK + + + E + E+ +L +KH NIV
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKCI-----AKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
++ + GG + + + + A + V + Y+H LG +HR
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 263 DLKSDNLLIS---ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +NLL D I I+DFG++++E ++ GT ++AP
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 122 bits (307), Expect = 7e-33
Identities = 33/163 (20%), Positives = 70/163 (42%), Gaps = 5/163 (3%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FG++Y G+ A+K L++ ++ + + + + +++T IV
Sbjct: 14 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + + GG + L Q+ A ++ G+ ++H ++R
Sbjct: 74 YAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 131
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMA 305
DLK N+L+ ++I+D G+A + + GT+ +MA
Sbjct: 132 DLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMA 173
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 7e-33
Identities = 40/165 (24%), Positives = 75/165 (45%), Gaps = 7/165 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+FGK++ + + AIK L++ + +E ++ ++ +H +
Sbjct: 12 KGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ + V EY GG + + + L A A ++ G+ ++H G ++R
Sbjct: 70 CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 127
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK DN+L+ D IKIADFG+ + + GT ++AP
Sbjct: 128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 7e-33
Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 10/167 (5%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G+F + + AIKILE+ E +E +++ L H V+
Sbjct: 18 EGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFVKLY 74
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ YAK G + +++ + + ++ + Y+HG G IHR
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHR 132
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 306
DLK +N+L++ D I+I DFG A++ GT ++++P
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-32
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 16/172 (9%)
Query: 145 QGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
G FG++Y+G VAIK L + F E ++ H NI
Sbjct: 17 AGEFGEVYKGMLKTSSGKKEVPVAIKTL-----KAGYTEKQRVDFLGEAGIMGQFSHHNI 71
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+R G K I+TEY + G++ +F R ++ + V +A GM Y+ +
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAP 306
++HRDL + N+L++++ K++DFG++R+ T + RW AP
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-32
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQV 178
+ +W +L +G +GAFG++ VA+K+L+ + E
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 60
Query: 179 MEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
+ +++ HLN+V +GAC + ++ E+ K G++ +L ++N VP
Sbjct: 61 -RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 238 KL--------------AVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
K+ + + VA+GM ++ IHRDL + N+L+S +KI DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 284 VARIEVQTEGMTPET---GTYRWMAP 306
+AR + + +WMAP
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAP 205
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-32
Identities = 39/172 (22%), Positives = 72/172 (41%), Gaps = 21/172 (12%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEV-MMLATLKHLNIVRF 201
G GK+ + E A+K+L+ + ++EV + + +IVR
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 70
Query: 202 IGACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ R IV E GG + + R ++A + A + + + Y+H +
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 258 GFIHRDLKSDNLLISA---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +NLL ++ + +K+ DFG A+ +T T ++AP
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 7e-32
Identities = 37/168 (22%), Positives = 71/168 (42%), Gaps = 8/168 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F + + G A K +++ + V + ++EV +L ++H N++
Sbjct: 20 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+ ++ E GG + FL +++ + + A + + G+ Y+H L H
Sbjct: 80 EVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 263 DLKSDNLLISAD----KSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK +N+++ IKI DFG+A GT ++AP
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-31
Identities = 35/167 (20%), Positives = 69/167 (41%), Gaps = 7/167 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVR 200
G FG +Y G + VAIK +E+ + + EV++L + ++R
Sbjct: 14 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73
Query: 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFI 260
+ + + ++ E + + + +LA V + + H G +
Sbjct: 74 LLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVL 132
Query: 261 HRDLKSDNLLISADK-SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
HRD+K +N+LI ++ +K+ DFG + ++ T GT + P
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDFDGTRVYSPP 178
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 5e-31
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 19/183 (10%)
Query: 130 WTID----LRKLNMGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQF 183
+++ LR L G+FG+++ +NG A+K+L++ K +
Sbjct: 1 YSLQDFQILRTL------GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK---QVEHT 51
Query: 184 QQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 243
E +ML+ + H I+R G + ++ +Y +GG + L + Q P +A
Sbjct: 52 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFY 109
Query: 244 ALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 303
A +V + Y+H I+RDLK +N+L+ + IKI DFG A+ + GT +
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDY 167
Query: 304 MAP 306
+AP
Sbjct: 168 IAP 170
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 6e-31
Identities = 38/165 (23%), Positives = 75/165 (45%), Gaps = 6/165 (3%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G F +Y+ + VAIK + + + E + + +E+ +L L H NI+ +
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 66
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + +V ++ + + + + + + L +G+ Y+H +HR
Sbjct: 67 DAFGHKSNISLVFDFMET--DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 263 DLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 306
DLK +NLL+ + +K+ADFG+A+ T + T + AP
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 9e-31
Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 19/198 (9%)
Query: 122 EGLENYDEWTI--DLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPE 174
E ++ I ++ +G FG +Y GT A+K L N
Sbjct: 12 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-----NRI 66
Query: 175 KAQVMEQQFQQEVMMLATLKHLNIVRFIGAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNR 233
QF E +++ H N++ +G C R +V Y K G +R F+ +
Sbjct: 67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 126
Query: 234 AVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG 293
+K + L VA+GM ++ F+HRDL + N ++ ++K+ADFG+AR E
Sbjct: 127 -PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 294 MTPET-----GTYRWMAP 306
+ +WMA
Sbjct: 186 DSVHNKTGAKLPVKWMAL 203
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-30
Identities = 42/171 (24%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 145 QGAFGKLYRGTYNGED------VAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI 198
GAFG +Y+G + E VAIK L R +P+ ++ E ++A++ + ++
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK----ANKEILDEAYVMASVDNPHV 73
Query: 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R +G C V I + G + ++ ++ + + + + +A+GM Y+
Sbjct: 74 CRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI---EVQTEGMTPETGTYRWMAP 306
+HRDL + N+L+ + +KI DFG+A++ E + +WMA
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-30
Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 18/172 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+GA+G + N VAIK + +P + Q Q+ +E+ +L +H NI+
Sbjct: 18 EGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 203 GACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
R ++M + + G + + L + + + + RG+ Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKYIHSAN 129
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARI----EVQTEGMTPETGTYRWMAP 306
+HRDLK NLL++ +KI DFG+AR+ T +T T + AP
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-30
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 32/206 (15%)
Query: 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGED---------VAIKILERPENNPEKAQV 178
W + +L +G +GAFG++ G D VA+K+L + +
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-----KSDATEK 60
Query: 179 MEQQFQQEVMMLATL-KHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ------ 231
E+ M+ + KH NI+ +GAC + ++ EYA G++R++L R+
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 232 --------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283
+ K V A VARGM Y+ IHRDL + N+L++ D +KIADFG
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 284 VARIEVQTEGMT---PETGTYRWMAP 306
+AR + +WMAP
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAP 206
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 111 bits (279), Expect = 1e-29
Identities = 46/184 (25%), Positives = 73/184 (39%), Gaps = 17/184 (9%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQ 182
+E Y L K+ +G +G +Y+ N GE A+K + + + +
Sbjct: 1 MEKYHG----LEKI------GEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPST 46
Query: 183 FQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVK 242
+E+ +L LKH NIV+ + +V E+ + + A
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKS 104
Query: 243 QALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYR 302
L + G+AY H +HRDLK NLLI+ + +KIADFG+AR
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 303 WMAP 306
W
Sbjct: 165 WYRA 168
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-29
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 18/186 (9%)
Query: 124 LENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQ 181
+EN+ + + K+ +G +G +Y+ GE VA+K + +
Sbjct: 1 MENFQK----VEKI------GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPS 46
Query: 182 QFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 241
+E+ +L L H NIV+ + +V E+ +++F+ +PL L
Sbjct: 47 TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK 105
Query: 242 KQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR-IEVQTEGMTPETGT 300
+ +G+A+ H +HRDLK NLLI+ + +IK+ADFG+AR V T E T
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 301 YRWMAP 306
+ AP
Sbjct: 166 LWYRAP 171
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 110 bits (276), Expect = 3e-29
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 15/172 (8%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G +++ DVA+K+L + + +F++E A L H IV
Sbjct: 17 FGGMSEVHLARDLRLHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 203 GACR----KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG 258
+ IV EY G ++R + + K A++ D + + + H G
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQNG 131
Query: 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 306
IHRD+K N++ISA ++K+ DFG+AR + +T GT ++++P
Sbjct: 132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-28
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 145 QGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRF 201
+GA+GK+++ G VA+K + R + E + + + L T +H N+VR
Sbjct: 17 EGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 75
Query: 202 IGAC-----RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
C + +V E+ + +L + VP + + RG+ ++H
Sbjct: 76 FDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
+HRDLK N+L+++ IK+ADFG+ARI +T T + AP
Sbjct: 135 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-28
Identities = 37/164 (22%), Positives = 68/164 (41%), Gaps = 8/164 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G +G +++ E VA+K + +++ + +E+ +L LKH NIVR
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLH 67
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
+V E+ + N + ++ + +G+ + H +HR
Sbjct: 68 DVLHSDKKLTLVFEFCD--QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
DLK NLLI+ + +K+A+FG+AR W P
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 7e-28
Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 8/165 (4%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
+G FGK+ G A+KIL R E K +V E +L +H +
Sbjct: 15 KGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEV--AHTVTESRVLQNTRHPFLTALK 71
Query: 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262
A + C V EYA GG + L+R + + A ++ + Y+H ++R
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 263 DLKSDNLLISADKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 306
D+K +NL++ D IKI DFG+ + + GT ++AP
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 5e-27
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y+ +GE VAIK + + + + +E+ ++ L H NIVR
Sbjct: 30 NGSFGVVYQAKLCDSGELVAIKKVLQDK----------RFKNRELQIMRKLDHCNIVRLR 79
Query: 203 GAC------RKRMVWCIVTEYAKGGSVRQFLTR-RQNRAVPLKLAVKQALDVARGMAYVH 255
+ + +V +Y R R + +P+ + R +AY+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 256 GLGFIHRDLKSDNLLISADKS-IKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G HRD+K NLL+ D + +K+ DFG A+ V+ E + + AP
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (260), Expect = 2e-26
Identities = 47/201 (23%), Positives = 79/201 (39%), Gaps = 16/201 (7%)
Query: 108 DALAQALMDHRYPTEGLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKI 165
A L P++ D++ ++ L G+FG++ + +G A+KI
Sbjct: 21 KAKEDFLKKWETPSQNTAQLDQFDR-IKTL------GTGSFGRVMLVKHKESGNHYAMKI 73
Query: 166 LERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTEYAKGGSVRQ 225
L++ + K + E +L + +V+ + + +V EY GG +
Sbjct: 74 LDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 226 FLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285
L R A A + Y+H L I+RDLK +NLLI I++ DFG A
Sbjct: 131 HLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 286 RIEVQTEGMTPETGTYRWMAP 306
+ GT +AP
Sbjct: 189 K--RVKGRTWTLCGTPEALAP 207
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 103 bits (258), Expect = 3e-26
Identities = 30/190 (15%), Positives = 78/190 (41%), Gaps = 23/190 (12%)
Query: 126 NYDEWTIDLRKLN---MGTAFAQGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVME 180
+Y+ ++ + + +G + +++ N E V +KIL+ V +
Sbjct: 23 DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---------VKK 73
Query: 181 QQFQQEVMMLATLK-HLNIVRFIGACRKRM--VWCIVTEYAKGGSVRQFLTRRQNRAVPL 237
++ ++E+ +L L+ NI+ + + +V E+ +Q + +
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTD 128
Query: 238 KLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTP 296
++ + + Y H +G +HRD+K N++I + + +++ D+G+A +
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 297 ETGTYRWMAP 306
+ + P
Sbjct: 189 RVASRYFKGP 198
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-26
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 17/170 (10%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA G + +VAIK L RP N ++ +E++++ + H NI+ +
Sbjct: 27 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLL 82
Query: 203 GACRKRMVW------CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V E + + + G+ ++H
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHS 137
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G IHRDLK N+++ +D ++KI DFG+AR + MTP T + AP
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 4e-26
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 21/177 (11%)
Query: 145 QGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
QG FG++++ + G+ VA+K + EN E +E+ +L LKH N+V I
Sbjct: 20 QGTFGEVFKARHRKTGQKVALKKV-LMENEKEG---FPITALREIKILQLLKHENVVNLI 75
Query: 203 GACRKRMV--------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYV 254
CR + +V ++ + L + + G+ Y+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF--TLSEIKRVMQMLLNGLYYI 133
Query: 255 HGLGFIHRDLKSDNLLISADKSIKIADFGVARI-----EVQTEGMTPETGTYRWMAP 306
H +HRD+K+ N+LI+ D +K+ADFG+AR Q T T + P
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (254), Expect = 6e-26
Identities = 44/176 (25%), Positives = 68/176 (38%), Gaps = 24/176 (13%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G+FG +Y GT GE+VAIK+ + Q E + ++ + I
Sbjct: 17 SGSFGDIYLGTDIAAGEEVAIKLE--------CVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 203 GAC-RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
C + +V E + L +R LK + A + + Y+H FIH
Sbjct: 69 RWCGAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 262 RDLKSDNLLISADKS---IKIADFGVARIEVQTEG--------MTPETGTYRWMAP 306
RD+K DN L+ K + I DFG+A+ TGT R+ +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 1e-24
Identities = 43/191 (22%), Positives = 89/191 (46%), Gaps = 22/191 (11%)
Query: 123 GLENYDEWTIDLRKLNMGTAFAQGAFGKLYRGT-----YNGEDVAIKILERPENNPEKAQ 177
G+EN++ L+ L GA+GK++ G+ A+K+L + +KA+
Sbjct: 22 GIENFEL----LKVL------GTGAYGKVFLVRKISGHDTGKLYAMKVL-KKATIVQKAK 70
Query: 178 VMEQQFQQEVMMLATLKHL-NIVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVP 236
E + E +L ++ +V A + ++ +Y GG + L++R+
Sbjct: 71 TTEH-TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FT 127
Query: 237 LKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR--IEVQTEGM 294
++ + ++H LG I+RD+K +N+L+ ++ + + DFG+++ + +TE
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187
Query: 295 TPETGTYRWMA 305
GT +MA
Sbjct: 188 YDFCGTIEYMA 198
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 2e-24
Identities = 41/170 (24%), Positives = 69/170 (40%), Gaps = 18/170 (10%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G + G VAIK L RP + ++ +E+ +L ++H N++ +
Sbjct: 28 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLL 83
Query: 203 GACRKR------MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG 256
+ +V + ++ + + +G+ Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTD----LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 257 LGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
G IHRDLK NL ++ D +KI DFG+AR MT T + AP
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAP 187
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 97.2 bits (241), Expect = 4e-24
Identities = 38/178 (21%), Positives = 65/178 (36%), Gaps = 26/178 (14%)
Query: 145 QGAFGKLYRGT--YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN-IVRF 201
+G+FG ++ GT N + VAIK R + P Q + E L I
Sbjct: 15 EGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--------QLRDEYRTYKLLAGCTGIPNV 66
Query: 202 IGACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIH 261
++ + +V + G + L R +K A + + +H ++
Sbjct: 67 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 262 RDLKSDNLLISA-----DKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 306
RD+K DN LI I + DFG+ + + +GT R+M+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 4e-22
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 16/169 (9%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
GA+G + T G VA+K L RP + A+ + +E+ +L +KH N++ +
Sbjct: 28 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYRELRLLKHMKHENVIGLL 83
Query: 203 GACRKRMVWC-----IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL 257
+ + G + + ++ ++ + Q + RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ---ILRGLKYIHSA 140
Query: 258 GFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306
IHRDLK NL ++ D +KI DFG+AR MT T + AP
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAP 187
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 1e-17
Identities = 21/143 (14%), Positives = 52/143 (36%), Gaps = 3/143 (2%)
Query: 145 QGAFGKLYRGT-YNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203
+G ++ + +K + + +K + +LA N R +
Sbjct: 10 EGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69
Query: 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263
+ V + + + + + ++ V ++ + + +A + G +H D
Sbjct: 70 KLQGLAVPKVY-AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGD 128
Query: 264 LKSDNLLISADKSIKIADFGVAR 286
L N+L+S ++ I I DF +
Sbjct: 129 LSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.0 bits (188), Expect = 1e-16
Identities = 33/185 (17%), Positives = 69/185 (37%), Gaps = 32/185 (17%)
Query: 145 QGAFGKLYRG--TYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202
G F ++ N VA+KI+ +V + + E+ +L + + +
Sbjct: 23 WGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 203 GACRKRMV--------------WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 248
++ ++ G ++ + + ++R +PL + + +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 249 RGMAYVH-GLGFIHRDLKSDNLLISADK------SIKIADFGVARIEVQTEGMTPETGTY 301
G+ Y+H G IH D+K +N+L+ IKIAD G A + + T
Sbjct: 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTR 193
Query: 302 RWMAP 306
+ +P
Sbjct: 194 EYRSP 198
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 306 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.31 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.97 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.08 | |
| d2oq1a1 | 130 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 96.93 | |
| d1blja_ | 114 | P55 Blk protein tyrosine kinase {Mouse (Mus muscul | 95.35 | |
| d1a81a1 | 129 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 95.2 | |
| d1rjaa_ | 100 | Tyrosine-protein kinase 6 (Breast tumor kinase, Br | 94.88 | |
| d1jwoa_ | 97 | Csk homologous kinase Chk {Human (Homo sapiens) [T | 94.77 | |
| d1k9aa2 | 101 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 94.54 | |
| d1o48a_ | 106 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 94.5 | |
| d1g83a2 | 104 | Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: | 94.23 | |
| d1nrva_ | 105 | Growth factor receptor-bound protein 10, GRB10 {Hu | 94.02 | |
| d1lkka_ | 105 | p56-lck tyrosine kinase {Human (Homo sapiens) [Tax | 93.87 | |
| d2oq1a2 | 124 | Tyrosine-protein kinase zap-70 {Human (Homo sapien | 92.99 | |
| d1opka2 | 101 | Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: | 92.9 | |
| d2fcia1 | 105 | Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: | 92.83 | |
| d1qcfa2 | 103 | Hemopoetic cell kinase Hck {Human (Homo sapiens) [ | 92.22 | |
| d1luia_ | 108 | Itk/tsk protein tyrosine kinase {Mouse (Mus muscul | 91.75 | |
| d2qmsa1 | 113 | Growth factor receptor-bound protein 7 {Human (Hom | 91.35 | |
| d2shpa2 | 109 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 91.06 | |
| d1d4ta_ | 104 | The Xlp protein Sap {Human (Homo sapiens) [TaxId: | 90.96 | |
| d1mila_ | 104 | Shc adaptor protein {Human (Homo sapiens) [TaxId: | 89.57 | |
| d1a81a2 | 125 | Syk tyrosine kinase {Human (Homo sapiens) [TaxId: | 89.13 | |
| d2c9wa2 | 103 | Suppressor of cytokine signaling 2, SOCS-2 {Human | 88.78 | |
| d2cs0a1 | 106 | Hematopoietic SH2 domain containing protein HSH2D | 88.06 | |
| d1i3za_ | 103 | Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus | 87.19 | |
| d1jyra_ | 96 | Growth factor receptor-bound protein 2 (GRB2) {Hum | 87.06 | |
| d1r1qa_ | 97 | GRB2-related adaptor protein 2 (MONA, GRID) {Mouse | 86.23 | |
| d2izva2 | 112 | Suppressor of cytokine signaling 4, SOCS-4 {Human | 85.44 | |
| d1rpya_ | 86 | Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI | 83.92 | |
| d1fu6a_ | 111 | Phosphatidylinositol 3-kinase, p85-alpha subunit { | 81.76 | |
| d2shpa3 | 108 | Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T | 80.87 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-43 Score=310.72 Aligned_cols=175 Identities=27% Similarity=0.566 Sum_probs=156.5
Q ss_pred CCCCcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 021897 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFI 202 (306)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 202 (306)
+.+++|+|+.++|++.+.||+|+||+||+|++ +++.||||+++..... .++|.+|+.+|++++|||||+++
T Consensus 7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~E~~il~~l~HpnIv~~~ 79 (287)
T d1opja_ 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLL 79 (287)
T ss_dssp TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC-------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch-------HHHHHHHHHHHHhCCCCCEecCC
Confidence 36789999999999999999999999999998 5889999999765443 24688999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 203 GACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
++|.+.+.+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||||++++.+||+||
T Consensus 80 ~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred ccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccc
Confidence 99999999999999999999999998776778999999999999999999999999999999999999999999999999
Q ss_pred cCeeeeecCCC--ccCCCCCCcccCC
Q 021897 283 GVARIEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~~--~~~~~gt~~y~AP 306 (306)
|+|+....... .....||+.|+||
T Consensus 160 G~a~~~~~~~~~~~~~~~g~~~y~aP 185 (287)
T d1opja_ 160 GLSRLMTGDTYTAHAGAKFPIKWTAP 185 (287)
T ss_dssp CCTTTCCSSSSEEETTEEECGGGCCH
T ss_pred cceeecCCCCceeeccccccccccCh
Confidence 99986544322 2223578999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=302.61 Aligned_cols=172 Identities=34% Similarity=0.648 Sum_probs=147.0
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
|+|+|+.++|++++.||+|+||+||+|++.+ .||||+++........ .+.|.+|+.+|++++|||||++++++.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH----HHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 6899999999999999999999999998765 5999999766544332 3678999999999999999999998865
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
+ .++|||||+++|+|.+++... ...+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.
T Consensus 76 ~-~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 76 P-QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp S-SCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred c-EEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence 4 579999999999999999754 34699999999999999999999999999999999999999999999999999986
Q ss_pred eecCC---CccCCCCCCcccCC
Q 021897 288 EVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~---~~~~~~gt~~y~AP 306 (306)
..... .....+||+.||||
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~AP 175 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAP 175 (276)
T ss_dssp ------------CCCCGGGCCH
T ss_pred ccccCCcccccccccCcccCCH
Confidence 54322 23456799999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=299.50 Aligned_cols=173 Identities=31% Similarity=0.558 Sum_probs=151.9
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
..++|+|+.++|++++.||+|+||.||+|++ +++.||||+++...... +.|.+|+.++++++|||||+++|+
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-------DAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH-------HHHHHHHHHHHhCCCCCEeEEEee
Confidence 3588999999999999999999999999999 56789999997644332 468999999999999999999998
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
+.++ .+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||||++++.+||+|||+
T Consensus 77 ~~~~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 77 VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp ECSS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eccC-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence 8654 568999999999999988765555699999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC--CccCCCCCCcccCC
Q 021897 285 ARIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~AP 306 (306)
|+...... ......||+.|+||
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~AP 179 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAP 179 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCH
T ss_pred eEEccCCccccccccCCcccccCh
Confidence 99765433 23445789999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=297.48 Aligned_cols=165 Identities=27% Similarity=0.492 Sum_probs=144.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|+||+||+|++ +++.||||+++...... ..+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 5788999999999999999998 68899999997643322 1256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
|||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+......
T Consensus 80 ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999999999864 3569999999999999999999999999999999999999999999999999998754322
Q ss_pred ---CccCCCCCCcccCC
Q 021897 293 ---GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ---~~~~~~gt~~y~AP 306 (306)
.....+||+.||||
T Consensus 158 ~~~~~~~~~GT~~Y~AP 174 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAP 174 (271)
T ss_dssp EECCBCCCCSCGGGSCT
T ss_pred ccccccceeeCcCccCH
Confidence 24556899999999
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=292.07 Aligned_cols=170 Identities=28% Similarity=0.474 Sum_probs=148.4
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
+|. +++|++++.||+|+||+||+|++ +++.||||++.+..... ....+.+.+|+.++++++|||||++++++.
T Consensus 2 ~~~--l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 2 QWA--LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK---AGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp CCC--GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred Ccc--hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC---hHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 455 46899999999999999999998 67899999986422111 112357889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
++..+||||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceee
Confidence 999999999999999999999865 459999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCccCCCCCCcccCC
Q 021897 287 IEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~AP 306 (306)
..... .....+||+.||||
T Consensus 155 ~~~~~-~~~~~~Gt~~Y~AP 173 (263)
T d2j4za1 155 HAPSS-RRTTLCGTLDYLPP 173 (263)
T ss_dssp CCCCC-CCEETTEEGGGCCH
T ss_pred ecCCC-cccccCCCCcccCH
Confidence 65443 34556899999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-40 Score=292.65 Aligned_cols=163 Identities=27% Similarity=0.451 Sum_probs=145.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++.+.||+|+||+||+|++ +|+.||||+++...... .+.+.+|+.++++++|||||++++++.+++.+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH------HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 5688899999999999999987 68999999997644332 246889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
|||||+++|+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 94 ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 99999999999998865 359999999999999999999999999999999999999999999999999998764433
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
.....+||+.|+||
T Consensus 171 ~~~~~~~gt~~Y~aP 185 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAP 185 (293)
T ss_dssp CCBCCCCSCGGGCCH
T ss_pred ccccccccCCCccCh
Confidence 34556899999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=293.22 Aligned_cols=173 Identities=33% Similarity=0.582 Sum_probs=147.2
Q ss_pred CCCcceeeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 126 NYDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 126 ~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
..++|+|+.++|++++.||+|+||+||+|++ +++.||||+++...... +.|.+|+.++++++|||||+++|+
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~-------~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH-------HHHHHHHHHHHhcccCCEeEEEEE
Confidence 5789999999999999999999999999998 55689999997654432 468999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
|.++ ..++||||+++|+|..++.......+++..++.++.||+.||+|||+.+|+||||||+||||++++++||+|||+
T Consensus 81 ~~~~-~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 81 VSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp ECSS-SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EecC-CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence 9655 468999999999999998876556799999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC--CccCCCCCCcccCC
Q 021897 285 ARIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~--~~~~~~gt~~y~AP 306 (306)
|+...... ......||+.|+||
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aP 183 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAP 183 (285)
T ss_dssp TC--------------CCGGGSCH
T ss_pred hhhccCCCceeeccccccccccCh
Confidence 98654333 23345799999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=289.83 Aligned_cols=167 Identities=28% Similarity=0.526 Sum_probs=139.0
Q ss_pred eeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
|+.++|++++.||+|+||.||+|++ +++.||||+++...... ++|.+|+.++++++|||||+++|+|..+..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH-------HHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence 5678899999999999999999998 67789999997644432 468999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||++++.+||+|||+|+....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred eEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 99999999999999998754 35689999999999999999999999999999999999999999999999999986544
Q ss_pred CCC--ccCCCCCCcccCC
Q 021897 291 TEG--MTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~--~~~~~gt~~y~AP 306 (306)
... .....||+.|+||
T Consensus 154 ~~~~~~~~~~gt~~y~aP 171 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASP 171 (263)
T ss_dssp -----------CTTSCCH
T ss_pred CCceeecceecCcccCCh
Confidence 332 2335789999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=298.47 Aligned_cols=167 Identities=25% Similarity=0.381 Sum_probs=146.8
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
+..++|++++.||+|+||.||+|++ +++.||+|+++....... .+.+.+|+.+|++++|||||+++++|.++.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----RNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTH-----HHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4567899999999999999999998 688999999986543321 357889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.+||||||+++|+|.+++.+. ..+++..++.++.|++.||.|||+ +||+||||||+||||+.++++||+|||+|+..
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999999999865 359999999999999999999997 59999999999999999999999999999865
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
.+. ...+.+||+.|+||
T Consensus 156 ~~~-~~~~~~GT~~Y~AP 172 (322)
T d1s9ja_ 156 IDS-MANSFVGTRSYMSP 172 (322)
T ss_dssp HHH-TC---CCSSCCCCH
T ss_pred CCC-ccccccCCccccCc
Confidence 543 34567999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-40 Score=290.76 Aligned_cols=165 Identities=28% Similarity=0.446 Sum_probs=145.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|++++.||+|+||.||+|++ +++.||||+++...... .+.+.+|+++|++++|||||++++++.++..+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG------GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence 3578999999999999999998 67899999997653322 246889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
|||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999999999998764 3569999999999999999999999999999999999999999999999999998654322
Q ss_pred -CccCCCCCCcccCC
Q 021897 293 -GMTPETGTYRWMAP 306 (306)
Q Consensus 293 -~~~~~~gt~~y~AP 306 (306)
.....+||+.|+||
T Consensus 165 ~~~~~~~Gt~~y~AP 179 (288)
T d2jfla1 165 QRRDSFIGTPYWMAP 179 (288)
T ss_dssp HHHTCCCSCCTTCCH
T ss_pred ccccccccccccCCH
Confidence 23456899999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-40 Score=295.78 Aligned_cols=174 Identities=30% Similarity=0.535 Sum_probs=146.9
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEECC-------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCee
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYNG-------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIV 199 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 199 (306)
.+|+|+.++|++++.||+|+||+||+|++.+ ..||+|.+........ .+.+.+|+.+++++ +|||||
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-----REALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHH-----HHHHHHHHHHHHHhcCCCcEe
Confidence 4699999999999999999999999998722 2699999865433222 25788999999998 899999
Q ss_pred eEEEEEEeCCeEEEEEeecCCCCHHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021897 200 RFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQN---------------------RAVPLKLAVKQALDVARGMAYVHGLG 258 (306)
Q Consensus 200 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~gl~yLH~~~ 258 (306)
++++++.+...+||||||+++|+|.++++.... ..+++..++.++.||+.||+|||+++
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~ 184 (325)
T d1rjba_ 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184 (325)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976432 35889999999999999999999999
Q ss_pred ccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCCc---cCCCCCCcccCC
Q 021897 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGM---TPETGTYRWMAP 306 (306)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~~---~~~~gt~~y~AP 306 (306)
||||||||+|||++.++.+||+|||+|+........ ....||+.||||
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 235 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence 999999999999999999999999999865543322 234679999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=294.84 Aligned_cols=170 Identities=25% Similarity=0.387 Sum_probs=149.4
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM 209 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 209 (306)
|..++|++++.||+|+||.||+|+. +++.||||++++..... ....+.+.+|+.+|++++||||+++++++.++.
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC---HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 5678899999999999999999997 78899999997432111 112357889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeee
Q 021897 210 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEV 289 (306)
Q Consensus 210 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~ 289 (306)
.+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+|||++++|.+||+|||+|+...
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999999999875 458999999999999999999999999999999999999999999999999998653
Q ss_pred c-CCCccCCCCCCcccCC
Q 021897 290 Q-TEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~-~~~~~~~~gt~~y~AP 306 (306)
. .......+||+.|+||
T Consensus 157 ~~~~~~~~~~GT~~Y~aP 174 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAP 174 (337)
T ss_dssp CTTCCBCCCEECGGGCCG
T ss_pred cCCcccccceeCHHHhhh
Confidence 3 3344567899999999
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-40 Score=290.12 Aligned_cols=168 Identities=23% Similarity=0.395 Sum_probs=144.1
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++++.||+|+||+||+|++ +++.||||++++..... ....+.+.+|+.++++++|||||++++++.++..+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC---HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 46799999999999999999998 68899999997432111 11135788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
||||||+++|+|.+++... ..+++..++.++.|++.||+|||++|||||||||+|||+++++.+||+|||+|+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999999998865 45999999999999999999999999999999999999999999999999999875432
Q ss_pred C---CccCCCCCCcccCC
Q 021897 292 E---GMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~---~~~~~~gt~~y~AP 306 (306)
. .....+||+.|+||
T Consensus 162 ~~~~~~~~~~GT~~Y~AP 179 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSP 179 (288)
T ss_dssp --------CCCCGGGCCH
T ss_pred CcccccccccCCccccCc
Confidence 2 23456899999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=287.86 Aligned_cols=170 Identities=22% Similarity=0.392 Sum_probs=150.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|++++.||+|+||+||+|++ +|+.||||++++............+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4689999999999999999998 68899999998654433222222367899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEEcccCeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK----SIKIADFGVARIE 288 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~----~vkl~DFGla~~~ 288 (306)
||||||++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+..
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999875 3599999999999999999999999999999999999998776 5999999999987
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
..........||+.|+||
T Consensus 168 ~~~~~~~~~~~t~~y~AP 185 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAP 185 (293)
T ss_dssp TTSCBCSCCCCCGGGCCH
T ss_pred CCCccccccCCCCcccCH
Confidence 666666677899999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-38 Score=281.64 Aligned_cols=170 Identities=24% Similarity=0.368 Sum_probs=153.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCCh---hHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNP---EKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 208 (306)
++|++.+.||+|+||+||+|+. +++.||||++++..... ...+...+++.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6789999999999999999998 78999999998765432 333445577999999999997 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+||||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999865 46999999999999999999999999999999999999999999999999999987
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
.........+||+.|+||
T Consensus 161 ~~~~~~~~~~gt~~y~~P 178 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAP 178 (277)
T ss_dssp CTTCCBCCCCSCGGGCCH
T ss_pred cCCCceeeeeccCCCCCH
Confidence 766556667899999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-39 Score=282.84 Aligned_cols=165 Identities=30% Similarity=0.515 Sum_probs=142.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----C
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----R 208 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~ 208 (306)
+.|++.++||+|+||+||+|++ +++.||+|++......... .+.+.+|+++|++++|||||++++++.. .
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH----HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 3457778999999999999998 5779999999765544322 3578999999999999999999999865 3
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEc-CCCcEEEEcccCe
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLG--FIHRDLKSDNLLIS-ADKSIKIADFGVA 285 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlkp~NILv~-~~~~vkl~DFGla 285 (306)
..+||||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 5689999999999999999865 45999999999999999999999998 99999999999996 5789999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+..... .....+||+.||||
T Consensus 163 ~~~~~~-~~~~~~GT~~Y~aP 182 (270)
T d1t4ha_ 163 TLKRAS-FAKAVIGTPEFMAP 182 (270)
T ss_dssp GGCCTT-SBEESCSSCCCCCG
T ss_pred eeccCC-ccCCcccCccccCH
Confidence 865433 34556899999999
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-39 Score=288.47 Aligned_cols=164 Identities=28% Similarity=0.444 Sum_probs=145.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|+..+.||+|+||.||+|++ +++.||||+++........ ..+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHH---HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence 3588899999999999999987 6889999999876554322 2467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
||||||++|+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 92 iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 999999999887666543 5699999999999999999999999999999999999999999999999999986543
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
....+||+.||||
T Consensus 168 -~~~~~GT~~Y~AP 180 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAP 180 (309)
T ss_dssp -BCCCCSCGGGCCH
T ss_pred -CCccccCccccCH
Confidence 3456899999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=286.35 Aligned_cols=168 Identities=24% Similarity=0.405 Sum_probs=135.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCe
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK--RMV 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 210 (306)
++|++.+.||+|+||+||+|++ +|+.||||+++........ .+.+.+|++++++++|||||++++++.+ ...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH----HHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH----HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence 5788999999999999999988 6889999999876554322 3578899999999999999999999965 456
Q ss_pred EEEEEeecCCCCHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCcEEEcCCCcEEEEccc
Q 021897 211 WCIVTEYAKGGSVRQFLTRR--QNRAVPLKLAVKQALDVARGMAYVHGLG-----FIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~-----iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
+||||||+++|+|.+++.+. ....+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 89999999999999998752 3467999999999999999999999876 9999999999999999999999999
Q ss_pred CeeeeecCC-CccCCCCCCcccCC
Q 021897 284 VARIEVQTE-GMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~-~~~~~~gt~~y~AP 306 (306)
+|+...... .....+||+.||||
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~AP 183 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSP 183 (269)
T ss_dssp HHHHC-----------CCCSCCCH
T ss_pred ceeecccCCCccccCCCCcccCCH
Confidence 998754433 33456899999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-39 Score=280.19 Aligned_cols=167 Identities=28% Similarity=0.509 Sum_probs=147.9
Q ss_pred eeccCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
++.++|+++++||+|+||+||+|++ +++.||||+++...... ++|.+|+.++++++||||++++|+|.++..
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~ 73 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 73 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH-------HHHHHHHHHHHTCCCTTBCCEEEEECCSSS
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH-------HHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Confidence 3568899999999999999999999 56799999998765542 468999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+++||||+++|+|.+++.... ..+++..+++++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred eEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 999999999999999987543 4688999999999999999999999999999999999999999999999999986544
Q ss_pred CCC--ccCCCCCCcccCC
Q 021897 291 TEG--MTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~--~~~~~gt~~y~AP 306 (306)
... .....||+.|+||
T Consensus 153 ~~~~~~~~~~~t~~y~aP 170 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPP 170 (258)
T ss_dssp SSCCCCCCSCCCGGGCCH
T ss_pred CCceeecccCCCCCcCCc
Confidence 332 2345789999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-39 Score=290.88 Aligned_cols=165 Identities=25% Similarity=0.413 Sum_probs=129.0
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
+.|++++.||+|+||+||+|++ +++.||||++........ .+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-----EGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4589999999999999999998 688999999976544322 246889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc---CCCcEEEEcccCeeeee
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS---ADKSIKIADFGVARIEV 289 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~---~~~~vkl~DFGla~~~~ 289 (306)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+. +++.+||+|||+|+...
T Consensus 84 lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999999999753 5699999999999999999999999999999999999995 57899999999999776
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
........+||+.||||
T Consensus 162 ~~~~~~~~~GT~~y~AP 178 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAP 178 (307)
T ss_dssp -----------CTTSCH
T ss_pred CCCeeeeeeeCccccCc
Confidence 66556667899999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-39 Score=292.96 Aligned_cols=166 Identities=23% Similarity=0.430 Sum_probs=147.5
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++++.||+|+||.||+|++ +|+.||||++...... ..+.+.+|+.+|++++|||||++++++.++..+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH------HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh------hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999998 6899999999654321 135788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC--CCcEEEEcccCeeeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA--DKSIKIADFGVARIEV 289 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~--~~~vkl~DFGla~~~~ 289 (306)
|||||||++|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999999999654 346999999999999999999999999999999999999964 6789999999999876
Q ss_pred cCCCccCCCCCCcccCC
Q 021897 290 QTEGMTPETGTYRWMAP 306 (306)
Q Consensus 290 ~~~~~~~~~gt~~y~AP 306 (306)
........+||+.||||
T Consensus 178 ~~~~~~~~~gT~~Y~aP 194 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAP 194 (350)
T ss_dssp TTSCEEEECSCTTTCCH
T ss_pred cccccceecCcccccCH
Confidence 66656667899999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-39 Score=288.11 Aligned_cols=170 Identities=26% Similarity=0.490 Sum_probs=135.1
Q ss_pred eeeccCceecceeeeeccEEEEEEEE--CCe---eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTY--NGE---DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~---~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
+++.++|++.+.||+|+||+||+|++ +++ .||||.+....... ..+.|.+|+.+|++++|||||+++|+|
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-----QRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH-----HHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 46778899999999999999999987 232 58888876543321 235799999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
..+..+|+|||||++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++++||+|||+|
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence 9999999999999999999998754 346899999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCc------cCCCCCCcccCC
Q 021897 286 RIEVQTEGM------TPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~------~~~~gt~~y~AP 306 (306)
+........ ....||+.||||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aP 202 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAP 202 (299)
T ss_dssp --------------------CGGGSCH
T ss_pred eEccCCCCcceeeecccccCCccccCH
Confidence 865433221 223578999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-39 Score=283.41 Aligned_cols=171 Identities=27% Similarity=0.529 Sum_probs=144.5
Q ss_pred cceeeccCceecc-eeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021897 129 EWTIDLRKLNMGT-AFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (306)
Q Consensus 129 ~~~i~~~~~~~~~-~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (306)
+|.+..+++.+.+ +||+|+||.||+|.+ ++..||||+++...... ..++|.+|+.+|++++|||||+++|
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----DTEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH-----HHHHHHHHHHHHHhCCCCCEeeEee
Confidence 4567778888888 499999999999976 34579999997643221 2367999999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
++..+ .+||||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||
T Consensus 77 ~~~~~-~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 77 VCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp EEESS-SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred eeccC-eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccch
Confidence 99765 579999999999999998643 3569999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCC----ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~----~~~~~gt~~y~AP 306 (306)
+|+....... ....+||+.|+||
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aP 181 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAP 181 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCH
T ss_pred hhhcccccccccccccccccCccccCh
Confidence 9986543221 2344689999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-39 Score=289.01 Aligned_cols=166 Identities=27% Similarity=0.433 Sum_probs=146.3
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
+++|++++.||+|+||+||+|++ +|+.||||++++..... ....+.+.+|+.++++++|||||++++++.++..+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence 47899999999999999999997 68899999997432111 11135788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
|+||||+++|+|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 80 ~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999999998764 45889999999999999999999999999999999999999999999999999876433
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
....+||+.||||
T Consensus 158 --~~~~~Gt~~Y~AP 170 (316)
T d1fota_ 158 --TYTLCGTPDYIAP 170 (316)
T ss_dssp --BCCCCSCTTTCCH
T ss_pred --cccccCcccccCH
Confidence 4557899999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.9e-39 Score=291.43 Aligned_cols=165 Identities=20% Similarity=0.338 Sum_probs=147.1
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
.+|++++.||+|+||.||+|++ +++.||||+++..... ..+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL------DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5689999999999999999998 6889999999764321 1256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc--CCCcEEEEcccCeeeeec
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS--ADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~--~~~~vkl~DFGla~~~~~ 290 (306)
|||||+++|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+....
T Consensus 103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999999999987643 34699999999999999999999999999999999999998 678999999999998776
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
.......+||+.|+||
T Consensus 182 ~~~~~~~~gt~~y~aP 197 (352)
T d1koba_ 182 DEIVKVTTATAEFAAP 197 (352)
T ss_dssp TSCEEEECSSGGGCCH
T ss_pred CCceeeccCcccccCH
Confidence 6556667899999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=281.47 Aligned_cols=170 Identities=27% Similarity=0.487 Sum_probs=140.1
Q ss_pred eeeccCceecceeeeeccEEEEEEEECC------eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 131 TIDLRKLNMGTAFAQGAFGKLYRGTYNG------EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 131 ~i~~~~~~~~~~lG~G~fG~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
+|+.+.|+..+.||+|+||.||+|.+.+ ..||||+++...... ...+|.+|+.++++++|||||+++|+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-----QRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-----HHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 4677889999999999999999998732 379999996543321 13578999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
+.+...+++||||+.++++.+++... ...+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EecCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999999988754 35699999999999999999999999999999999999999999999999999
Q ss_pred eeeeecCC----CccCCCCCCcccCC
Q 021897 285 ARIEVQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 285 a~~~~~~~----~~~~~~gt~~y~AP 306 (306)
|+...... ......||+.||||
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~AP 182 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAP 182 (283)
T ss_dssp -----------------CCCGGGSCH
T ss_pred hhcccCCCccceEeccCCCCccccCH
Confidence 98654322 12334689999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-38 Score=291.46 Aligned_cols=171 Identities=19% Similarity=0.277 Sum_probs=144.7
Q ss_pred eccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCe
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMV 210 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 210 (306)
..++|++++.||+|+||.||+|++ +|+.||||++.+................+|+.+++.++|||||++++++.+...
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 457899999999999999999998 688999999864322211111112233345777888899999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ 290 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~ 290 (306)
+||||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999999865 4589999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
. .....+||+.|+||
T Consensus 160 ~-~~~~~~GT~~y~AP 174 (364)
T d1omwa3 160 K-KPHASVGTHGYMAP 174 (364)
T ss_dssp S-CCCSCCSCGGGCCH
T ss_pred C-cccccccccccchh
Confidence 4 34556899999998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-39 Score=281.19 Aligned_cols=167 Identities=31% Similarity=0.600 Sum_probs=141.5
Q ss_pred ceeeccCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-C
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-R 208 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 208 (306)
|+|+.++|++++.||+|+||.||+|+++++.||||+++.... .+.|.+|+.++++++||||++++|+|.+ +
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH--------HHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 999999999999999999999999999999999999965332 2468899999999999999999999865 4
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
..+|+||||+++|+|.+++.......+++..+++++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 56899999999999999998655456899999999999999999999999999999999999999999999999999865
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
... .....+|+.|+||
T Consensus 154 ~~~--~~~~~~~~~y~aP 169 (262)
T d1byga_ 154 SST--QDTGKLPVKWTAP 169 (262)
T ss_dssp ----------CCTTTSCH
T ss_pred CCC--CccccccccCCCh
Confidence 432 3445789999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=279.10 Aligned_cols=171 Identities=27% Similarity=0.528 Sum_probs=136.2
Q ss_pred cceeeccCceecceeeeeccEEEEEEEEC-----CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTYN-----GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIG 203 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 203 (306)
+|+|+.++|++++.||+|+||.||+|++. +..||||.++..... ...+.|.+|+.++++++|||||++++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~ 75 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVKLIG 75 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 59999999999999999999999999873 246888887543322 22367999999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 204 ACRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 204 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
++.+ +.+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||
T Consensus 76 ~~~~-~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 76 VITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EECS-SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEec-CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence 9964 5679999999999999988754 3568999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCC--ccCCCCCCcccCC
Q 021897 284 VARIEVQTEG--MTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~--~~~~~gt~~y~AP 306 (306)
+|+....... .....||+.|+||
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~ap 178 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAP 178 (273)
T ss_dssp -----------------CCGGGCCH
T ss_pred hheeccCCcceeccceecCcccchh
Confidence 9987543322 2344689999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-38 Score=277.57 Aligned_cols=159 Identities=31% Similarity=0.582 Sum_probs=132.3
Q ss_pred ceeeeeccEEEEEEEE----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEe
Q 021897 141 TAFAQGAFGKLYRGTY----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E 216 (306)
++||+|+||+||+|.+ .++.||||+++....... ..++|.+|+.+|++++|||||+++++|..+ .++||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----HHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH----HHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence 5799999999999987 235799999975443322 236799999999999999999999999655 5689999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCCC---
Q 021897 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEG--- 293 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~~--- 293 (306)
|+++|+|.+++... ..+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+.......
T Consensus 88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999999999764 4699999999999999999999999999999999999999999999999999986543322
Q ss_pred -ccCCCCCCcccCC
Q 021897 294 -MTPETGTYRWMAP 306 (306)
Q Consensus 294 -~~~~~gt~~y~AP 306 (306)
.....||+.||||
T Consensus 166 ~~~~~~gt~~y~AP 179 (277)
T d1xbba_ 166 AQTHGKWPVKWYAP 179 (277)
T ss_dssp C----CCCGGGCCH
T ss_pred cccccCCCceecCc
Confidence 2234689999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=280.73 Aligned_cols=175 Identities=28% Similarity=0.547 Sum_probs=138.7
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCe
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNI 198 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 198 (306)
.++|+|+.++|++++.||+|+||.||+|++ +++.||||+++...... ..+.+.+|..++.++ +|+||
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i 79 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLNV 79 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-----HHHHHHHHHHHHHhhcCCCeE
Confidence 468999999999999999999999999987 23579999987543322 235677888877776 68999
Q ss_pred eeEEEEEEeC-CeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021897 199 VRFIGACRKR-MVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (306)
Q Consensus 199 v~l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrD 263 (306)
+.+++++.+. ..+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++|||||
T Consensus 80 v~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrD 159 (299)
T d1ywna1 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 159 (299)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCc
Confidence 9999998764 46899999999999999997542 23478999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 264 LKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 264 lkp~NILv~~~~~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
|||+||||+.++.+||+|||+|+...... .....+||+.|+||
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 205 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 205 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence 99999999999999999999998654332 23345799999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=280.78 Aligned_cols=164 Identities=17% Similarity=0.281 Sum_probs=144.6
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|+||+||+|.+ +++.||||+++..... ...+.+|+.+|++++|||||++++++.++..+|
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-------HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 5688999999999999999998 6889999999753211 246789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC--CcEEEEcccCeeeeec
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISAD--KSIKIADFGVARIEVQ 290 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~--~~vkl~DFGla~~~~~ 290 (306)
||||||++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+ ..+||+|||+++....
T Consensus 78 lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999999999754 3468999999999999999999999999999999999999854 4899999999987665
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
.......+||+.|+||
T Consensus 157 ~~~~~~~~~t~~y~ap 172 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAP 172 (321)
T ss_dssp TCEEEEEESCGGGSCH
T ss_pred CCcccccccccccccc
Confidence 5545556899999997
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-38 Score=285.02 Aligned_cols=166 Identities=25% Similarity=0.337 Sum_probs=146.3
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeE
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 211 (306)
.++|++++.||+|+||.||+|++ +|+.||||++.+..... ....+.+.+|+.+|+.++|||||++++++.....+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC---HHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 46789999999999999999998 68999999986422111 11235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++||||||||+||||+.++.+||+|||+|+.....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999999999875 35999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
....+||+.||||
T Consensus 195 --~~~~~Gt~~Y~AP 207 (350)
T d1rdqe_ 195 --TWTLCGTPEALAP 207 (350)
T ss_dssp --BCCCEECGGGCCH
T ss_pred --cccccCccccCCH
Confidence 4456899999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-38 Score=280.03 Aligned_cols=177 Identities=27% Similarity=0.476 Sum_probs=151.4
Q ss_pred CCCCcceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCC
Q 021897 125 ENYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLN 197 (306)
Q Consensus 125 ~~~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 197 (306)
...++|+|+.++|++++.||+|+||.||+|++. ++.||||+++...... ....|.+|+.++++++|||
T Consensus 10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~-----~~~~~~~E~~il~~l~h~n 84 (308)
T d1p4oa_ 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHH 84 (308)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCCTT
T ss_pred cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH-----HHHHHHHHHHHHHHcCCCC
Confidence 344789999999999999999999999999873 4689999997543221 2357899999999999999
Q ss_pred eeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 021897 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNL 269 (306)
Q Consensus 198 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NI 269 (306)
||+++++|..+...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 85 Iv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~Ni 164 (308)
T d1p4oa_ 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 164 (308)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred EeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCce
Confidence 9999999999999999999999999999987432 23468899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 270 LISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 270 Lv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
||+.++++||+|||+|+....... .....||+.|+||
T Consensus 165 Lld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP 204 (308)
T d1p4oa_ 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204 (308)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred eecCCceEEEeecccceeccCCcceeeccceecccccCCH
Confidence 999999999999999986543322 2334689999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-37 Score=278.59 Aligned_cols=174 Identities=28% Similarity=0.487 Sum_probs=148.2
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEEC-------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeee
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN-------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVR 200 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 200 (306)
..|+++.++|++++.||+|+||.||+|++. ++.||||+++..... ...++|.+|+.++++++||||++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-----HHHHHHHHHHHHHHhcCCCCccc
Confidence 457888899999999999999999999874 368999998754322 12467999999999999999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCCHHHHHHhhC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021897 201 FIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------------------NRAVPLKLAVKQALDVARGMAYVHGLG 258 (306)
Q Consensus 201 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~ 258 (306)
++++|......+++|||+++|+|.+++.... ...+++..++.++.|++.||+|||+++
T Consensus 81 ~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 9999999999999999999999999997532 224788999999999999999999999
Q ss_pred ccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC---CccCCCCCCcccCC
Q 021897 259 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP 306 (306)
Q Consensus 259 iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~---~~~~~~gt~~y~AP 306 (306)
||||||||+||||+.++.+||+|||+|+...... .....+||+.|+||
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP 211 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence 9999999999999999999999999998653322 22345788999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-37 Score=279.23 Aligned_cols=161 Identities=24% Similarity=0.376 Sum_probs=140.6
Q ss_pred cCceec-ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEEe---
Q 021897 135 RKLNMG-TAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLAT-LKHLNIVRFIGACRK--- 207 (306)
Q Consensus 135 ~~~~~~-~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~--- 207 (306)
.+|++. +.||+|+||.||+|++ +++.||||+++.. ..+.+|+.++.+ ++|||||++++++.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 567766 4699999999999997 6889999999641 356789988655 589999999999875
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEccc
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFG 283 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~~~vkl~DFG 283 (306)
...+|||||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 467899999999999999998765567999999999999999999999999999999999999985 5679999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+|+...........+||+.|+||
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aP 182 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAP 182 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCC
T ss_pred eeeeccCCCccccccCCcccCCc
Confidence 99987666666777999999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-37 Score=275.43 Aligned_cols=175 Identities=32% Similarity=0.543 Sum_probs=151.0
Q ss_pred CCcceeeccCceecceeeeeccEEEEEEEE-------CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCe
Q 021897 127 YDEWTIDLRKLNMGTAFAQGAFGKLYRGTY-------NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNI 198 (306)
Q Consensus 127 ~~~~~i~~~~~~~~~~lG~G~fG~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 198 (306)
-.+|+|+.++|++++.||+|+||.||+|++ +++.||||+++....... ...|.+|+.+++++ +||||
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~E~~~~~~l~~HpnI 89 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHMNI 89 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----HHHHHHHHHHHHHHCCCTTB
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH-----HHHHHHHHHHHHhccCCCCE
Confidence 357999999999999999999999999986 335899999976543222 35788999999999 69999
Q ss_pred eeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021897 199 VRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ----------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHR 262 (306)
Q Consensus 199 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHr 262 (306)
|+++++|.++..++|||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++++||
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr 169 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 999999999999999999999999999998643 2258899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 263 DLKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 263 Dlkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
||||+|||++.++.+||+|||+++....... ....+||+.|+||
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP 216 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence 9999999999999999999999986543322 2345789999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-37 Score=273.34 Aligned_cols=167 Identities=28% Similarity=0.462 Sum_probs=142.5
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|+||+||+|++ +++.||||+++...... ...+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE----GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh----HHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 5788999999999999999998 68899999996543221 12357889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC-
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT- 291 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~- 291 (306)
+||||+.+ .+.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 78 iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 78 LVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999964 6667776665677999999999999999999999999999999999999999999999999999865432
Q ss_pred CCccCCCCCCcccCC
Q 021897 292 EGMTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~~~~~~gt~~y~AP 306 (306)
.......||+.|+||
T Consensus 157 ~~~~~~~gt~~y~ap 171 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAP 171 (298)
T ss_dssp BCTTCCBCCCTTCCH
T ss_pred ccceeecccceeeeh
Confidence 334456899999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-37 Score=275.03 Aligned_cols=170 Identities=32% Similarity=0.541 Sum_probs=143.5
Q ss_pred eeccCceecceeeeeccEEEEEEEE--CCe--eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY--NGE--DVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLNIVRFIGACR 206 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 206 (306)
|+.++|++.+.||+|+||.||+|++ ++. .||||.++....... .+.|.+|+.+|+++ +|||||+++++|.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH-----HHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 6778999999999999999999988 454 577887764333221 35789999999998 6999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRR--------------QNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLIS 272 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~ 272 (306)
++..+||||||+++|+|.+++... ....+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 999999999999999999999753 235689999999999999999999999999999999999999
Q ss_pred CCCcEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 273 ADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 273 ~~~~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
.++.+||+|||+|+............||+.|+||
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aP 195 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 195 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCH
T ss_pred CCCceEEccccccccccccccccceecCCcccch
Confidence 9999999999999876655445556799999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-37 Score=274.77 Aligned_cols=167 Identities=25% Similarity=0.384 Sum_probs=142.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEEeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLA-TLKHLNIVRFIGACRKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~ 211 (306)
++|++++.||+|+||+||+|++ +++.||||++++...... ...+.+.+|..++. .++|||||++++++.++..+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~---~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT---TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh---HHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 5789999999999999999998 789999999974221110 11235566666654 78999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeec-
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQ- 290 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~- 290 (306)
||||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+....
T Consensus 79 yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999999865 4589999999999999999999999999999999999999999999999999986543
Q ss_pred CCCccCCCCCCcccCC
Q 021897 291 TEGMTPETGTYRWMAP 306 (306)
Q Consensus 291 ~~~~~~~~gt~~y~AP 306 (306)
....+..+||+.|+||
T Consensus 157 ~~~~~~~~gt~~y~aP 172 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAP 172 (320)
T ss_dssp TCCBCCCCSCGGGCCH
T ss_pred cccccccCCCCCcCCH
Confidence 2334556899999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-37 Score=272.79 Aligned_cols=174 Identities=33% Similarity=0.568 Sum_probs=144.8
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC-CCCC
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL-KHLN 197 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 197 (306)
.+|+|+.++|++++.||+|+||.||+|++. +..||||+++....... ..++.+|...+.++ +|||
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH-----HHHHHHHHHHHHHHCCCTT
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH-----HHHHHHHHHHHHHhcCCCe
Confidence 459999999999999999999999999862 24799999976443221 35788899988888 7999
Q ss_pred eeeEEEEEEeCCeEEEEEeecCCCCHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021897 198 IVRFIGACRKRMVWCIVTEYAKGGSVRQFLTRRQ--------------NRAVPLKLAVKQALDVARGMAYVHGLGFIHRD 263 (306)
Q Consensus 198 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrD 263 (306)
||+++++|.++..+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++|||||
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence 9999999999999999999999999999997543 24589999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEcccCeeeeecCCC---ccCCCCCCcccCC
Q 021897 264 LKSDNLLISADKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 264 lkp~NILv~~~~~vkl~DFGla~~~~~~~~---~~~~~gt~~y~AP 306 (306)
|||+|||++.++.+||+|||+++....... .....||+.|+||
T Consensus 161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 206 (299)
T d1fgka_ 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP 206 (299)
T ss_dssp CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence 999999999999999999999986544332 2335789999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-36 Score=267.07 Aligned_cols=167 Identities=26% Similarity=0.424 Sum_probs=137.7
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC---
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM--- 209 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 209 (306)
++|++.+.||+|+||.||+|++ +++.||||+++....... ...+.+.+|+.++++++|||||++++++....
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH---HHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 4688999999999999999997 689999999986544322 23467999999999999999999999997643
Q ss_pred -eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 210 -VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 210 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.+||||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred ceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 489999999999999998765 45999999999999999999999999999999999999999999999999998754
Q ss_pred ecCC----CccCCCCCCcccCC
Q 021897 289 VQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~----~~~~~~gt~~y~AP 306 (306)
.... .....+||+.|+||
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aP 183 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSP 183 (277)
T ss_dssp C----------------TTCCH
T ss_pred ccccccccccccccCcccccCH
Confidence 3222 23445799999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-37 Score=270.58 Aligned_cols=169 Identities=24% Similarity=0.382 Sum_probs=142.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEeCCe
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKRMV 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 210 (306)
++|++++.||+|+||.||+|++ +++.||||++++............+++.+|+.++++++ |||||++++++.++..
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5789999999999999999998 68899999997543322110000124668999999987 8999999999999999
Q ss_pred EEEEEeecCC-CCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEEcccCeeee
Q 021897 211 WCIVTEYAKG-GSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-DKSIKIADFGVARIE 288 (306)
Q Consensus 211 ~~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~-~~~vkl~DFGla~~~ 288 (306)
+|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 5888888764 45999999999999999999999999999999999999985 479999999999875
Q ss_pred ecCCCccCCCCCCcccCC
Q 021897 289 VQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~~~~~~gt~~y~AP 306 (306)
... ..+..+||+.|+||
T Consensus 162 ~~~-~~~~~~GT~~y~aP 178 (273)
T d1xwsa_ 162 KDT-VYTDFDGTRVYSPP 178 (273)
T ss_dssp CSS-CBCCCCSCGGGSCH
T ss_pred ccc-cccccccCCCcCCH
Confidence 443 35667899999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-36 Score=270.96 Aligned_cols=166 Identities=24% Similarity=0.488 Sum_probs=136.2
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCe----eEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGE----DVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
..+|++++.||+|+||+||+|++ +++ +||+|.++...... ..++|.+|+.++++++|||||+++|+|.+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C-----THHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35799999999999999999987 343 68999886533221 13579999999999999999999999987
Q ss_pred CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 208 RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 208 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
+. .++++|++.+|+|.+++... ...+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~~-~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 83 ST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred CC-eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 65 57889999999999998764 45699999999999999999999999999999999999999999999999999986
Q ss_pred eecCCC---ccCCCCCCcccCC
Q 021897 288 EVQTEG---MTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~---~~~~~gt~~y~AP 306 (306)
...... .....||+.|+||
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~AP 182 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMAL 182 (317)
T ss_dssp TTTTCC--------CCTTTSCH
T ss_pred cccccccccccccccCccccCh
Confidence 543322 2234689999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-37 Score=272.49 Aligned_cols=165 Identities=22% Similarity=0.328 Sum_probs=134.7
Q ss_pred ecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEEEEe
Q 021897 139 MGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCIVTE 216 (306)
Q Consensus 139 ~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~E 216 (306)
.++.||+|+||+||+|++ +++.||||+++....... .....+.+.+|+.++++++|||||++++++..+..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA-KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh-hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 347899999999999987 688999999976543321 12223578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-Ccc
Q 021897 217 YAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE-GMT 295 (306)
Q Consensus 217 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~-~~~ 295 (306)
|++++++..+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 81 ~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 998876655543 24568899999999999999999999999999999999999999999999999998654332 334
Q ss_pred CCCCCCcccCC
Q 021897 296 PETGTYRWMAP 306 (306)
Q Consensus 296 ~~~gt~~y~AP 306 (306)
..+||+.|+||
T Consensus 159 ~~~gt~~y~aP 169 (299)
T d1ua2a_ 159 HQVVTRWYRAP 169 (299)
T ss_dssp CSCCCCTTCCH
T ss_pred ceecChhhccH
Confidence 56899999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-36 Score=270.84 Aligned_cols=162 Identities=34% Similarity=0.540 Sum_probs=135.4
Q ss_pred cCceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----e
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRM----V 210 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 210 (306)
++|.+.+.||+|+||.||+|+++|+.||||+++... .. ......|+..+++++|||||+++++|.+.. .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-----~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-----HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 567888999999999999999999999999985421 11 112334666667889999999999997653 6
Q ss_pred EEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCcEEEcCCCcEEEEcc
Q 021897 211 WCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG--------LGFIHRDLKSDNLLISADKSIKIADF 282 (306)
Q Consensus 211 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~--------~~iiHrDlkp~NILv~~~~~vkl~DF 282 (306)
+|+|||||++|+|.+++++. .+++..++.++.|++.||.|||+ .||+||||||+||||+.++.+||+||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 89999999999999999863 58999999999999999999996 59999999999999999999999999
Q ss_pred cCeeeeecCC-----CccCCCCCCcccCC
Q 021897 283 GVARIEVQTE-----GMTPETGTYRWMAP 306 (306)
Q Consensus 283 Gla~~~~~~~-----~~~~~~gt~~y~AP 306 (306)
|+++...... .....+||+.|+||
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aP 181 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAP 181 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCH
T ss_pred CccccccCCCcceeccccceecccCcCCh
Confidence 9998765433 23346799999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=267.96 Aligned_cols=170 Identities=32% Similarity=0.493 Sum_probs=133.6
Q ss_pred eeccCceecceeeeeccEEEEEEEEC---C--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
|+.++|++.+.||+|+||+||+|++. + .+||||++++...... ...++|.+|+.+|++++|||||+++|+|.
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 56789999999999999999999872 2 3799999876544322 22367999999999999999999999997
Q ss_pred eCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 207 KRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 207 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
++ .+++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+
T Consensus 82 ~~-~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 82 TP-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ec-chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhh
Confidence 64 5689999999999999887653 459999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCC----ccCCCCCCcccCC
Q 021897 287 IEVQTEG----MTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~----~~~~~gt~~y~AP 306 (306)
....... .....||+.|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aP 183 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAP 183 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCH
T ss_pred hcccCCCcceecCccccCcccCCH
Confidence 7543322 2334578899998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-35 Score=262.47 Aligned_cols=166 Identities=28% Similarity=0.376 Sum_probs=138.5
Q ss_pred cCceecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWCI 213 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i 213 (306)
++|++.++||+|+||.||+|++ +++.||||+++....... ..+.+.+|+.+|++++|||||++++++......++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC----CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH----HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 5789999999999999999998 678999999976543221 13578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC-
Q 021897 214 VTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE- 292 (306)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~- 292 (306)
++|++.++.+..+... ...+++..++.++.||+.||+|||+.+||||||||+|||++.++.+||+|||+|.......
T Consensus 78 ~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999977655555433 3569999999999999999999999999999999999999999999999999998654322
Q ss_pred CccCCCCCCcccCC
Q 021897 293 GMTPETGTYRWMAP 306 (306)
Q Consensus 293 ~~~~~~gt~~y~AP 306 (306)
......||+.|+||
T Consensus 156 ~~~~~~~~~~y~~p 169 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAP 169 (286)
T ss_dssp ------CCCTTCCH
T ss_pred ccceecccchhhhH
Confidence 23445689999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.3e-35 Score=265.19 Aligned_cols=159 Identities=18% Similarity=0.381 Sum_probs=139.7
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeC--
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKR-- 208 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-- 208 (306)
.++|+++++||+|+||+||+|++ +++.||||+++... .+++.+|+.+|++++ ||||+++++++...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 36799999999999999999998 68899999996432 146789999999996 99999999999754
Q ss_pred CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEcccCeee
Q 021897 209 MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVARI 287 (306)
Q Consensus 209 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-~vkl~DFGla~~ 287 (306)
..+++||||+++++|.++. +.+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.
T Consensus 105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 5689999999999987653 3599999999999999999999999999999999999998655 699999999998
Q ss_pred eecCCCccCCCCCCcccCC
Q 021897 288 EVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 288 ~~~~~~~~~~~gt~~y~AP 306 (306)
..........+||+.|+||
T Consensus 180 ~~~~~~~~~~~~t~~y~aP 198 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGP 198 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCH
T ss_pred ccCCCcccccccCccccCc
Confidence 7666666777899999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-35 Score=265.66 Aligned_cols=161 Identities=27% Similarity=0.419 Sum_probs=136.6
Q ss_pred CceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----
Q 021897 136 KLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKR----- 208 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 208 (306)
+|+.+++||+|+||+||+|++ +++.||||+++..... +.+|+.+|++++||||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 688889999999999999998 6889999999764332 34799999999999999999998543
Q ss_pred -CeEEEEEeecCCCCHHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC-cEEEEcccCe
Q 021897 209 -MVWCIVTEYAKGGSVRQFLT-RRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADK-SIKIADFGVA 285 (306)
Q Consensus 209 -~~~~iv~E~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~-~vkl~DFGla 285 (306)
..+||||||++++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 35899999997654333332 23456799999999999999999999999999999999999999775 8999999999
Q ss_pred eeeecCCCccCCCCCCcccCC
Q 021897 286 RIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~~~~~~~gt~~y~AP 306 (306)
+...........+||+.|+||
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aP 191 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAP 191 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCH
T ss_pred hhccCCcccccccccccccCh
Confidence 987666666777899999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=259.53 Aligned_cols=163 Identities=29% Similarity=0.491 Sum_probs=136.0
Q ss_pred eecceeeeeccEEEEEEEEC---C--eeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCeE
Q 021897 138 NMGTAFAQGAFGKLYRGTYN---G--EDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK-RMVW 211 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 211 (306)
++.++||+|+||+||+|++. + ..||||.++..... ...++|.+|+++|++++||||++++|++.+ +...
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH-----HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH-----HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence 34678999999999999872 2 36899998643321 123679999999999999999999999876 4688
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecC
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQT 291 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~ 291 (306)
++|||||++|+|.+++... ....++..++.++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++.....
T Consensus 105 ~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999999999998754 345788889999999999999999999999999999999999999999999999864332
Q ss_pred CC-----ccCCCCCCcccCC
Q 021897 292 EG-----MTPETGTYRWMAP 306 (306)
Q Consensus 292 ~~-----~~~~~gt~~y~AP 306 (306)
.. .....||+.|+||
T Consensus 184 ~~~~~~~~~~~~gt~~y~aP 203 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMAL 203 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCH
T ss_pred ccccceecccccccccccCh
Confidence 21 2234689999998
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-35 Score=264.68 Aligned_cols=167 Identities=26% Similarity=0.426 Sum_probs=138.9
Q ss_pred cceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Q 021897 129 EWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACR 206 (306)
Q Consensus 129 ~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 206 (306)
.|++ .++|+++++||+|+||.||+|++ +++.||||+++....... ..+.+.+|+.+|+.++|||||+++++|.
T Consensus 13 ~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 13 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred eeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH----HHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 4666 47899999999999999999998 689999999976544332 2467889999999999999999999997
Q ss_pred eCC------eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 207 KRM------VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 207 ~~~------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
... .+|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~ 163 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 163 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccc
Confidence 654 579999999 5678777754 359999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCCCccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|||+|+.... ..+..+||+.|+||
T Consensus 164 Dfg~a~~~~~--~~~~~~~t~~y~aP 187 (346)
T d1cm8a_ 164 DFGLARQADS--EMTGYVVTRWYRAP 187 (346)
T ss_dssp CCTTCEECCS--SCCSSCSCGGGCCT
T ss_pred cccceeccCC--ccccccccccccCH
Confidence 9999987543 34567899999999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-35 Score=264.65 Aligned_cols=168 Identities=24% Similarity=0.356 Sum_probs=136.4
Q ss_pred ceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Q 021897 130 WTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK 207 (306)
Q Consensus 130 ~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 207 (306)
|+|. .+|++++.||+|+||+||+|+. +++.||||+++..... ...+++++|+.+|++++||||+++++++..
T Consensus 4 ~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 4 FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh-----HHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 3443 3499999999999999999987 6899999999754321 223578899999999999999999999976
Q ss_pred CC----eEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 208 RM----VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 208 ~~----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
.. ..++++|++.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG 154 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 154 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccccccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccC
Confidence 53 22344556668999999975 359999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCC----CccCCCCCCcccCC
Q 021897 284 VARIEVQTE----GMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~----~~~~~~gt~~y~AP 306 (306)
+|+...... .....+||+.|+||
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aP 181 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAP 181 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCG
T ss_pred ceeeccCCCccceeeccccccceechH
Confidence 998654322 23445799999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=259.15 Aligned_cols=167 Identities=27% Similarity=0.451 Sum_probs=137.5
Q ss_pred cCceecceeeeeccEEEEEEEE---CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEEe-
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY---NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATL---KHLNIVRFIGACRK- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~- 207 (306)
++|++++.||+|+||+||+|++ .++.||||+++......... ..+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH----HHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 6899999999999999999987 25679999997543322111 2355677766655 79999999999853
Q ss_pred ----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 208 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
...++++|||++++.+. +........+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHH-HHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccccCceEEEEEEeccCCchh-hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 34789999999875554 4444455679999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCCCccCCCCCCcccCC
Q 021897 284 VARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~~~~~~~gt~~y~AP 306 (306)
+++...........+||+.|+||
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~AP 184 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAP 184 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCH
T ss_pred hhhhhcccccCCCcccChhhcCc
Confidence 99876666666777999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-33 Score=250.02 Aligned_cols=166 Identities=24% Similarity=0.392 Sum_probs=143.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCeEE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRKRMVWC 212 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 212 (306)
++|++++.||+|+||+||+|++ +++.||||+++....... ..+++.+|+.+|+.++||||+++++++......+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT----HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH----HHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence 5789999999999999999998 678999999976554322 2367889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCeeeeecCC
Q 021897 213 IVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTE 292 (306)
Q Consensus 213 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~~~~~~~ 292 (306)
+|+|++.+++|..++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+......
T Consensus 78 iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred EEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999999888877754 3568999999999999999999999999999999999999999999999999998765443
Q ss_pred Cc-cCCCCCCcccCC
Q 021897 293 GM-TPETGTYRWMAP 306 (306)
Q Consensus 293 ~~-~~~~gt~~y~AP 306 (306)
.. ....+++.|+||
T Consensus 156 ~~~~~~~~~~~~~~p 170 (292)
T d1unla_ 156 RCYSAEVVTLWYRPP 170 (292)
T ss_dssp SCCCSCCSCGGGCCH
T ss_pred ccceeeccccchhhh
Confidence 33 333566777765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-33 Score=251.08 Aligned_cols=162 Identities=24% Similarity=0.360 Sum_probs=139.4
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGACRKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~ 211 (306)
++|++++.||+|+||+||+|++ +++.||||++...... ..+.+|+++++.++| +|++.+++++......
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 5789999999999999999997 6889999998764432 246688999999975 8999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-----CCcEEEEcccCee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA-----DKSIKIADFGVAR 286 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~-----~~~vkl~DFGla~ 286 (306)
++||||+ +++|.+++... ...+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+
T Consensus 77 ~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 9999999 68999998754 456999999999999999999999999999999999999974 5789999999998
Q ss_pred eeecCC--------CccCCCCCCcccCC
Q 021897 287 IEVQTE--------GMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~--------~~~~~~gt~~y~AP 306 (306)
...... .....+||+.||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aP 182 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSI 182 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred EcccCccccceeecccCceEEchhhcCH
Confidence 754321 12345799999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-34 Score=255.59 Aligned_cols=167 Identities=25% Similarity=0.393 Sum_probs=135.6
Q ss_pred ccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----
Q 021897 134 LRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK---- 207 (306)
Q Consensus 134 ~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 207 (306)
.++|+++++||+|+||+||+|++ +|+.||||++........ ..+++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS----SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH----HHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 57899999999999999999998 688999999865543321 12568899999999999999999999855
Q ss_pred ----CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEccc
Q 021897 208 ----RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFG 283 (306)
Q Consensus 208 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFG 283 (306)
+..+|+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence 346899999998765554332 34568999999999999999999999999999999999999999999999999
Q ss_pred CeeeeecCC-----CccCCCCCCcccCC
Q 021897 284 VARIEVQTE-----GMTPETGTYRWMAP 306 (306)
Q Consensus 284 la~~~~~~~-----~~~~~~gt~~y~AP 306 (306)
+|+...... .....+||+.|+||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aP 190 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPP 190 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCH
T ss_pred eeeecccccccccccccceecCHHHhhH
Confidence 997644221 23345799999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-33 Score=246.24 Aligned_cols=162 Identities=27% Similarity=0.377 Sum_probs=133.8
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCee-eEEEEEEeCCeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIV-RFIGACRKRMVW 211 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~ 211 (306)
.+|++++.||+|+||.||+|++ +++.||||++...... +++.+|+++++.++|++++ .+.++..+....
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--------HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 3689999999999999999998 6889999998765433 2467899999999877654 555666778889
Q ss_pred EEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC---CCcEEEEcccCeeee
Q 021897 212 CIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISA---DKSIKIADFGVARIE 288 (306)
Q Consensus 212 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~---~~~vkl~DFGla~~~ 288 (306)
++||||+ +++|.+.+... ...+++..++.++.|++.||+|||++|||||||||+|||++. +..+||+|||+|+..
T Consensus 79 ~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9999999 56777776643 456999999999999999999999999999999999999864 457999999999976
Q ss_pred ecCCC--------ccCCCCCCcccCC
Q 021897 289 VQTEG--------MTPETGTYRWMAP 306 (306)
Q Consensus 289 ~~~~~--------~~~~~gt~~y~AP 306 (306)
..... ....+||+.||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aP 182 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASI 182 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCH
T ss_pred cccccccceeccccCCcCCCccccCH
Confidence 54321 2345799999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-34 Score=257.28 Aligned_cols=171 Identities=21% Similarity=0.372 Sum_probs=144.4
Q ss_pred eeccCceecceeeeeccEEEEEEEE-----CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCC-CCeeeEEEEE
Q 021897 132 IDLRKLNMGTAFAQGAFGKLYRGTY-----NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKH-LNIVRFIGAC 205 (306)
Q Consensus 132 i~~~~~~~~~~lG~G~fG~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~ 205 (306)
+.+++|++++.||+|+||+||+|.. +|+.||||++++....... ...+.+.+|+.++++++| |||+++++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~--~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch--HHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 4568899999999999999999976 4689999998643221100 011467899999999976 8999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCe
Q 021897 206 RKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVA 285 (306)
Q Consensus 206 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla 285 (306)
.+...++++|||+.+|+|.+++.... .+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999999998753 5788999999999999999999999999999999999999999999999999
Q ss_pred eeeecCC--CccCCCCCCcccCC
Q 021897 286 RIEVQTE--GMTPETGTYRWMAP 306 (306)
Q Consensus 286 ~~~~~~~--~~~~~~gt~~y~AP 306 (306)
+...... ......||+.|+||
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~p 199 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAP 199 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCH
T ss_pred hhhcccccccccccccccccchh
Confidence 8654322 23445799999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-33 Score=255.64 Aligned_cols=163 Identities=26% Similarity=0.359 Sum_probs=129.2
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGACRK----- 207 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 207 (306)
++|+++++||+|+||+||+|.+ +|+.||||+++........ .+++.+|+.++++++|||||++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHH----HHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 6799999999999999999998 6899999999876554322 3578899999999999999999999964
Q ss_pred -CCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccCee
Q 021897 208 -RMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVAR 286 (306)
Q Consensus 208 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGla~ 286 (306)
...+|+||||+.+ ++.+.+. ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 93 EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence 3688999999966 5555553 358999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCccCCCCCCcccCC
Q 021897 287 IEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 287 ~~~~~~~~~~~~gt~~y~AP 306 (306)
...........+||+.|+||
T Consensus 168 ~~~~~~~~~~~~~t~~y~aP 187 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAP 187 (355)
T ss_dssp -------------CCTTCCH
T ss_pred ccccccccccccccccccCh
Confidence 77666666677899999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-33 Score=257.22 Aligned_cols=169 Identities=25% Similarity=0.389 Sum_probs=139.9
Q ss_pred CcceeeccCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 021897 128 DEWTIDLRKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNIVRFIGAC 205 (306)
Q Consensus 128 ~~~~i~~~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 205 (306)
..|+++ ++|+++++||+|+||+||+|++ +++.||||+++........ .+++.+|+.+|++++|||||++++++
T Consensus 12 ~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~h~~iv~~~~~~ 86 (348)
T d2gfsa1 12 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH----AKRTYRELRLLKHMKHENVIGLLDVF 86 (348)
T ss_dssp SEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH----HHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 457774 6799999999999999999987 6899999999865544322 35788999999999999999999999
Q ss_pred EeC-----CeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEE
Q 021897 206 RKR-----MVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIA 280 (306)
Q Consensus 206 ~~~-----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~ 280 (306)
... ...++++|++.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++
T Consensus 87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 87 TPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccc
Confidence 643 234566777889999999854 459999999999999999999999999999999999999999999999
Q ss_pred cccCeeeeecCCCccCCCCCCcccCC
Q 021897 281 DFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 281 DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
|||+|..... ......||+.|+||
T Consensus 164 dfg~a~~~~~--~~~~~~g~~~y~ap 187 (348)
T d2gfsa1 164 DFGLARHTDD--EMTGYVATRWYRAP 187 (348)
T ss_dssp CC----CCTG--GGSSSCHHHHTSCH
T ss_pred ccchhcccCc--ccccccccccccCc
Confidence 9999976433 24556789999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=2.1e-27 Score=216.03 Aligned_cols=163 Identities=21% Similarity=0.355 Sum_probs=130.3
Q ss_pred cCceecceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-----------CCCeeeE
Q 021897 135 RKLNMGTAFAQGAFGKLYRGTY--NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-----------HLNIVRF 201 (306)
Q Consensus 135 ~~~~~~~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l 201 (306)
.+|+++++||+|+||+||+|+. +|+.||||+++.... ..+.+.+|+.+++.+. |+||+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-------~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-------YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-------HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-------chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 4599999999999999999987 789999999975321 1246778888887775 5789999
Q ss_pred EEEEEe--CCeEEEEEeecCCC-CHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCC--
Q 021897 202 IGACRK--RMVWCIVTEYAKGG-SVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHG-LGFIHRDLKSDNLLISADK-- 275 (306)
Q Consensus 202 ~~~~~~--~~~~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlkp~NILv~~~~-- 275 (306)
++++.. ....+++++++..+ .............+++..+..++.||+.||+|||+ .||+||||||+||||+.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 998854 34566777766544 44444455556778999999999999999999998 8999999999999998665
Q ss_pred ----cEEEEcccCeeeeecCCCccCCCCCCcccCC
Q 021897 276 ----SIKIADFGVARIEVQTEGMTPETGTYRWMAP 306 (306)
Q Consensus 276 ----~vkl~DFGla~~~~~~~~~~~~~gt~~y~AP 306 (306)
.+||+|||.|..... .....+||+.|+||
T Consensus 166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aP 198 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSP 198 (362)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCH
T ss_pred cccceeeEeeccccccccc--ccccccccccccCh
Confidence 399999999986543 33556899999998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=3.3e-26 Score=190.19 Aligned_cols=137 Identities=15% Similarity=0.154 Sum_probs=106.7
Q ss_pred eecceeeeeccEEEEEEEE-CCeeEEEEEeeCCCCCh------------hHHHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 021897 138 NMGTAFAQGAFGKLYRGTY-NGEDVAIKILERPENNP------------EKAQVMEQQFQQEVMMLATLKHLNIVRFIGA 204 (306)
Q Consensus 138 ~~~~~lG~G~fG~V~~~~~-~~~~vavK~~~~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 204 (306)
.++++||+|+||.||+|+. +|+.||||+++...... ...........+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999999987 78999999986432210 0112223456678999999999999998876
Q ss_pred EEeCCeEEEEEeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEEcccC
Q 021897 205 CRKRMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGV 284 (306)
Q Consensus 205 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlkp~NILv~~~~~vkl~DFGl 284 (306)
.. . +++|||+++..+.+ ++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||+
T Consensus 83 ~~--~--~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 83 EG--N--AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp ET--T--EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred cC--C--EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 32 2 79999998765432 3344567889999999999999999999999999999965 589999999
Q ss_pred eeee
Q 021897 285 ARIE 288 (306)
Q Consensus 285 a~~~ 288 (306)
|+..
T Consensus 149 a~~~ 152 (191)
T d1zara2 149 SVEV 152 (191)
T ss_dssp CEET
T ss_pred cccC
Confidence 9754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=1.6e-08 Score=85.65 Aligned_cols=140 Identities=16% Similarity=0.142 Sum_probs=91.8
Q ss_pred CceecceeeeeccEEEEEEEECCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCeEEEE
Q 021897 136 KLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 136 ~~~~~~~lG~G~fG~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv 214 (306)
.++..+..+-++...||+.+.+++.+.||.......... ..+.+|...+..+. +--+.+++.++..++..++|
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch------hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 344444433344568999988888889998764432211 13567887777664 43467788888888889999
Q ss_pred EeecCCCCHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 021897 215 TEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGL------------------------------------- 257 (306)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~------------------------------------- 257 (306)
|++++|.++.+..... .. ...++.++...++.||+.
T Consensus 89 ~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999997775543211 11 112233334444444421
Q ss_pred ----------------------CccccCCCCCcEEEcCCCcEEEEcccCeeee
Q 021897 258 ----------------------GFIHRDLKSDNLLISADKSIKIADFGVARIE 288 (306)
Q Consensus 258 ----------------------~iiHrDlkp~NILv~~~~~vkl~DFGla~~~ 288 (306)
.++|+|+.|.|||+++++.+-|+||+.+...
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 2589999999999997776789999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.31 E-value=9.3e-07 Score=73.96 Aligned_cols=137 Identities=14% Similarity=0.081 Sum_probs=82.2
Q ss_pred eeeeecc-EEEEEEEEC-CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEEeCCeEEEEEee
Q 021897 142 AFAQGAF-GKLYRGTYN-GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK--HLNIVRFIGACRKRMVWCIVTEY 217 (306)
Q Consensus 142 ~lG~G~f-G~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~iv~E~ 217 (306)
.+..|.. ..||+.+.+ +..+++|........ .+.+|+..++.+. .-.+.+++.++.++...++|||+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence 3444543 579999874 456888976544322 3556777766653 23367788888888888999999
Q ss_pred cCCCCHHH--------------HHHhhCC-----CC--CCHHHHHHHHH--------------------HHHHHHHHHHh
Q 021897 218 AKGGSVRQ--------------FLTRRQN-----RA--VPLKLAVKQAL--------------------DVARGMAYVHG 256 (306)
Q Consensus 218 ~~~gsL~~--------------~l~~~~~-----~~--~~~~~~~~i~~--------------------qi~~gl~yLH~ 256 (306)
++|.++.+ .+.+... .. ........... .....+..+..
T Consensus 88 i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (255)
T d1nd4a_ 88 VPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 167 (255)
T ss_dssp CSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred eeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence 98755421 1111110 00 01111100000 11222333333
Q ss_pred C-------CccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 257 L-------GFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 257 ~-------~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
. .++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2 279999999999999877778999999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.97 E-value=4e-06 Score=75.13 Aligned_cols=80 Identities=11% Similarity=-0.036 Sum_probs=45.9
Q ss_pred ceeeeeccEEEEEEEE--CCeeEEEEEeeCCCCC-hhHHHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEEeCCeEEEE
Q 021897 141 TAFAQGAFGKLYRGTY--NGEDVAIKILERPENN-PEKAQVMEQQFQQEVMMLATLK---HLNIVRFIGACRKRMVWCIV 214 (306)
Q Consensus 141 ~~lG~G~fG~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~iv 214 (306)
+.||.|....||+.+. .++.++||.-.+.... .+.......+...|...|+.+. ...+++++.+..+. .++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~--~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEM--AVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTT--TEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCC--CEEE
Confidence 5689999999999975 4678999975421000 0000000123345666666552 24566777664433 3789
Q ss_pred EeecCCCC
Q 021897 215 TEYAKGGS 222 (306)
Q Consensus 215 ~E~~~~gs 222 (306)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.52 E-value=0.00019 Score=62.05 Aligned_cols=65 Identities=11% Similarity=0.115 Sum_probs=41.6
Q ss_pred EEEEEEEE-CCeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCCCCCe--eeEEE-----EEEeCCeEEEEEeecCC
Q 021897 149 GKLYRGTY-NGEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLKHLNI--VRFIG-----ACRKRMVWCIVTEYAKG 220 (306)
Q Consensus 149 G~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~iv~E~~~~ 220 (306)
-.||+++. +|+.+++|+.++...+. +++..|...+..|....+ +..+. .+......+.++++++|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~-------~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH-------HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 47999987 78899999997765543 346667776666542211 11111 12345667889999976
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.09 E-value=0.00062 Score=60.33 Aligned_cols=77 Identities=13% Similarity=0.195 Sum_probs=49.0
Q ss_pred eccCceecceeeeeccEEEEEEEEC---------CeeEEEEEeeCCCCChhHHHHHHHHHHHHHHHHHhCC-CCCeeeEE
Q 021897 133 DLRKLNMGTAFAQGAFGKLYRGTYN---------GEDVAIKILERPENNPEKAQVMEQQFQQEVMMLATLK-HLNIVRFI 202 (306)
Q Consensus 133 ~~~~~~~~~~lG~G~fG~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~ 202 (306)
+.+++++ +.|+-|-.-.+|+++.. .+.|.+++.-. .... ....+|..+++.+. +.-.++++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~-------idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE-------SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH-------HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh-------hHHHHHHHHHHHHHhCCCCCeEE
Confidence 3344444 56777888899999863 24577777642 2111 12347788877775 33345788
Q ss_pred EEEEeCCeEEEEEeecCCCC
Q 021897 203 GACRKRMVWCIVTEYAKGGS 222 (306)
Q Consensus 203 ~~~~~~~~~~iv~E~~~~gs 222 (306)
+++.. .+|+||++|..
T Consensus 112 ~~~~~----g~I~efi~g~~ 127 (395)
T d1nw1a_ 112 GIFSG----GRLEEYIPSRP 127 (395)
T ss_dssp EEETT----EEEECCCCEEE
T ss_pred EEcCC----ceEEEEecccc
Confidence 87743 68999998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.08 E-value=0.00058 Score=58.33 Aligned_cols=31 Identities=35% Similarity=0.434 Sum_probs=27.8
Q ss_pred CCccccCCCCCcEEEcCCCcEEEEcccCeee
Q 021897 257 LGFIHRDLKSDNLLISADKSIKIADFGVARI 287 (306)
Q Consensus 257 ~~iiHrDlkp~NILv~~~~~vkl~DFGla~~ 287 (306)
.|+||+|+.++||+++.+...-|+||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999888789999999864
|
| >d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.93 E-value=4e-06 Score=63.18 Aligned_cols=117 Identities=15% Similarity=0.179 Sum_probs=72.0
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -.-+....+..| .|+|+++.|.+ ..|.|++|++.. ..+.|+.|.... +
T Consensus 7 pWy~g~i~---------R~~Ae~~L~~~g~~~G~FLVR~S~~---~~g~yvLSv~~~---------~~v~H~~I~~~~~g 65 (130)
T d2oq1a1 7 PFFYGSIS---------RAEAEEHLKLAGMADGLFLLRQCLR---SLGGYVLSLVHD---------VRFHHFPIERQLNG 65 (130)
T ss_dssp TTBCBSCC---------HHHHHHHHHHTTCCTTCEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CCccCCCC---------HHHHHHHHHhcCCCCceEEEEecCC---CCccEEEEEeeC---------CceEEEEEEEcCCC
Confidence 67776664 334455566555 49999998765 678899999852 257899997665 6
Q ss_pred ceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCCCCCCCCC-CCcceeeccCceecceeeeeccEEEEE
Q 021897 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRYPTEGLEN-YDEWTIDLRKLNMGTAFAQGAFGKLYR 153 (306)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~~~~~~~~-~~~~~i~~~~~~~~~~lG~G~fG~V~~ 153 (306)
.|++.. ...|. ...+.+ ..+.++|...|..|+........ -..|+ .+.+.+|+|.||+||+
T Consensus 66 ~~~l~~-~~~F~sl~~Lv~~Y~~~~~gL~~~L~~P~~r~~~~~~~~~~~~------~~~~~~~~~~~~~~w~ 130 (130)
T d2oq1a1 66 TYAIAG-GKAHCGPAELCEFYSRDPDGLPCNLRKPCNRPSGLEPQPGVFD------CLRDAMVRDYVRQTWK 130 (130)
T ss_dssp CEEETT-SCCBSSHHHHHHHHHHCCTTSSSCCCSBCCCCTTCCCBCCHHH------HHHHHHHHHHHHHHHC
T ss_pred ceeccC-CCCcCCHHHHHHHHhhCCCCCCccCCccCCCCCCCCCCcchHH------HHHHHHHHhhccCccC
Confidence 688753 33452 344444 55666776667766653322211 11111 1336778888888774
|
| >d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: P55 Blk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.35 E-value=0.00098 Score=48.32 Aligned_cols=93 Identities=19% Similarity=0.198 Sum_probs=58.0
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||.+-+. -..+.....+.+ .|+|+++.|.. .+|.|++|++..... .+.+.|+.+.... +
T Consensus 13 ~Wy~g~is---------R~eAe~~L~~~~~~~G~FLVR~S~~---~~g~~~Lsv~~~~~~-----~~~v~H~~i~~~~~g 75 (114)
T d1blja_ 13 KWFFRTIS---------RKDAERQLLAPMNKAGSFLIRESES---NKGAFSLSVKDITTQ-----GEVVKHYKIRSLDNG 75 (114)
T ss_dssp SSBCCSCC---------HHHHHHHHSSTTCCTTCEEBCBCTT---CSSCEEEEECBCCTT-----TCBCCCEEEEEETTT
T ss_pred CCcCCCCC---------HHHHHHHHHhcCCCCceEEEeccCC---CCCCeEEEEEeeccC-----CCEEEEEEEEEcCCC
Confidence 78887664 334444443323 59999998864 678999999854321 1367899998775 6
Q ss_pred ceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCC
Q 021897 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRY 119 (306)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~ 119 (306)
.|++. ....|. ...|.+ ..+.++|...|..||.
T Consensus 76 ~~~l~-~~~~F~sl~eLV~~y~~~~~gL~~~L~~PC~ 111 (114)
T d1blja_ 76 GYYIS-PRITFPTLQALVQHYSKKGDGLCQKLTLPCV 111 (114)
T ss_dssp EEEEE-TTEEESSHHHHHHHHHHCCSSSSSCCCCCSC
T ss_pred CEEec-CCceECCHHHHHHHHhhCCCCCCccCCccCc
Confidence 78876 444453 344443 4455556555555553
|
| >d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.20 E-value=0.0011 Score=49.21 Aligned_cols=89 Identities=18% Similarity=0.207 Sum_probs=58.1
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -.-+.......| .|+|+++.|.+ ..|.|++|++.. ..+.|+.|.... +
T Consensus 6 PWyhg~is---------R~~Ae~lL~~~g~~dG~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 64 (129)
T d1a81a1 6 PFFFGNIT---------REEAEDYLVQGGMSDGLYLLRQSRN---YLGGFALSVAHG---------RKAHHYTIERELNG 64 (129)
T ss_dssp TTBCSSCC---------HHHHHHHHHHTTCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CcccCCCC---------HHHHHHHHHhcCCCCccEEEEccCC---CCcceEEEeeec---------ccceEEEEEEcCCC
Confidence 67776664 344556665555 49999998765 568999999842 257999997665 5
Q ss_pred ceeEeeeeeeec--CCcccc-ccCchHHHHHHhcCCC
Q 021897 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDHRY 119 (306)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~~~ 119 (306)
.|++. ....|. ...|.| ..+.+++...|..|+.
T Consensus 65 ~~~i~-~~~~F~sl~eLV~~Y~~~~~gl~~~L~~P~~ 100 (129)
T d1a81a1 65 TYAIA-GGRTHASPADLCHYHSQESDGLVCLLKKPFN 100 (129)
T ss_dssp CEEET-TSCCBSSHHHHHHHHTTCCTTSSSCCCEECC
T ss_pred Ceeec-CCcccCCHHHHHHHHhhCCCCCcccCCCCCC
Confidence 67775 333442 344544 4556667666666653
|
| >d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.88 E-value=0.0012 Score=46.64 Aligned_cols=61 Identities=18% Similarity=0.151 Sum_probs=41.3
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||.+-+. -.-+....++.| .|+|+++.|.+ ..|.|++|++.. ..+.|+.|.... +
T Consensus 3 pWy~g~is---------R~~Ae~~L~~~~~~~G~FLvR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~g 61 (100)
T d1rjaa_ 3 PWFFGCIS---------RSEAVRRLQAEGNATGAFLIRVSEK---PSADYVLSVRDT---------QAVRHYKIWRRAGG 61 (100)
T ss_dssp CCBCTTCC---------HHHHHHHHSSTTCSSCCEEEEECSS---SSSCEEEEECTT---------SSCEEEEEEECSSS
T ss_pred CCcCCCCC---------HHHHHHHHhccCCCCCeEEeecCCC---CCCCEEEEEEcC---------CCceEEEEEECCCC
Confidence 57776654 233444454434 49999998765 568999999842 146899998765 6
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 62 ~~~l~ 66 (100)
T d1rjaa_ 62 RLHLN 66 (100)
T ss_dssp CEEEE
T ss_pred CEEec
Confidence 68875
|
| >d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Csk homologous kinase Chk species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.77 E-value=0.00042 Score=48.83 Aligned_cols=61 Identities=16% Similarity=0.129 Sum_probs=42.3
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCcee
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYS 88 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~ 88 (306)
+||++.+. -.-+....+....|+|+++.|++ ..|.|++|+... ..+.|+.|...++.|+
T Consensus 5 PWy~g~is---------R~eAe~~L~~~~~G~FLVR~S~~---~~g~~vLSv~~~---------~~v~H~~I~~~~~~~~ 63 (97)
T d1jwoa_ 5 PWFHGKIS---------GQEAVQQLQPPEDGLFLVRESAR---HPGDYVLCVSFG---------RDVIHYRVLHRDGHLT 63 (97)
T ss_dssp TTEEESCC---------HHHHHHHTCSCCTTCEEEEECSS---STTCEEEEEEET---------TEEEEEEEEESSSEES
T ss_pred CccCCCCC---------HHHHHHHhcCCCCCeEEEEecCC---CCccEEEEEEec---------CceEEEEEEEcCCcEE
Confidence 67776664 22333444445679999998764 678999999852 2468999987777777
Q ss_pred Ee
Q 021897 89 VS 90 (306)
Q Consensus 89 i~ 90 (306)
+.
T Consensus 64 ~~ 65 (97)
T d1jwoa_ 64 ID 65 (97)
T ss_dssp ST
T ss_pred ec
Confidence 65
|
| >d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.54 E-value=0.0005 Score=48.85 Aligned_cols=61 Identities=16% Similarity=0.175 Sum_probs=41.9
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCcee
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYS 88 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~ 88 (306)
+||.+.+. -.-+....+....|+|+++.|.+ ..|.|++|++.. ..++|+.|....+.|+
T Consensus 5 PWy~g~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~~~ 63 (101)
T d1k9aa2 5 PWFHGKIT---------REQAERLLYPPETGLFLVRESTN---YPGDYTLCVSCE---------GKVEHYRIMYHASKLS 63 (101)
T ss_dssp TTBCTTCC---------HHHHHHHTCSCCTTEEEEEECSS---STTSEEEEEECS---------SSEEEEEEEEETTEEE
T ss_pred CccCCCCC---------HHHHHHHHcCCCCCCEEEeccCC---CCCCEEEEEEeC---------CccEEEEEEEcCCCce
Confidence 57766654 22233344445579999998754 668899999842 2578999988778887
Q ss_pred Ee
Q 021897 89 VS 90 (306)
Q Consensus 89 i~ 90 (306)
+.
T Consensus 64 ~~ 65 (101)
T d1k9aa2 64 ID 65 (101)
T ss_dssp SS
T ss_pred ec
Confidence 75
|
| >d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.50 E-value=0.00081 Score=48.09 Aligned_cols=92 Identities=15% Similarity=0.201 Sum_probs=53.9
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -.-+.....+.| .|+|+++.|.+ ..|.|++|++....... ..+.|+.+.... +
T Consensus 6 ~Wy~g~i~---------R~eAe~lL~~~~~~~G~FLVR~S~~---~~g~y~LSv~~~~~~~~----~~i~h~~i~~~~~g 69 (106)
T d1o48a_ 6 EWYFGKIT---------RRESERLLLNAENPRGTFLVRESET---TKGAYCLSVSDFDNAKG----LNVKHYKIRKLDSG 69 (106)
T ss_dssp TTEEESCC---------HHHHHHHHCCTTCCTTCEEEEECSS---STTCEEEEEEEEETTTE----EEEEEEEEEECTTS
T ss_pred CccCCCCC---------HHHHHHHHHhcCCCCCcEEEEcccC---CCCCEEEEEEecccCcc----cceEEEEEEEecCC
Confidence 78887774 344555565444 59999998865 67899999985443222 246788777665 6
Q ss_pred ceeEeeeeeeec--CCcccc-ccCchHHHHHHhcC
Q 021897 86 NYSVSVGQSVFR--PGKVTH-ALNDDALAQALMDH 117 (306)
Q Consensus 86 ~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~l~~~ 117 (306)
.|.+. +...|. .+.|.+ ..+.++|...|..|
T Consensus 70 ~~~~~-~~~~F~sl~eLV~~y~~~~~gL~~~L~~p 103 (106)
T d1o48a_ 70 GFYIT-SRTQFNSLQQLVAYYSKHADGLCHRLTTV 103 (106)
T ss_dssp CEESS-TTSEESSHHHHHHHHTTCCTTSSSCCCSB
T ss_pred CEEEc-CCeeECCHHHHHHHHhhCCCCCCccCCCc
Confidence 67665 333342 333433 33444444444333
|
| >d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine kinase Fyn species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.23 E-value=0.0022 Score=45.51 Aligned_cols=66 Identities=17% Similarity=0.241 Sum_probs=44.6
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||.+.+. -.-+.....+.| .|+|+++.|.+ ..|.|++|++......+ ..+.|+.|.... +
T Consensus 7 ~Wy~g~i~---------R~eAe~~L~~~g~~~G~FLVR~S~~---~~g~~~Lsv~~~~~~~~----~~v~h~~i~~~~~g 70 (104)
T d1g83a2 7 EWYFGKLG---------RKDAERQLLSFGNPRGTFLIRESET---TKGAYSLSIRDWDDMKG----DHVKHYKIRKLDNG 70 (104)
T ss_dssp SSBCTTCC---------HHHHHHHHHSTTCCTTCEEEEECSS---STTCEEEEEEEECSSSC----EEEEEEEEEECTTS
T ss_pred CCcCCCCC---------HHHHHHHHHhcCCCCCcEEEeccCC---CCCCeEEEEEEeecCcC----CeEEEEEEEEcCCC
Confidence 68877664 233444454444 59999998865 67899999987665433 257888887665 5
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 71 ~~~~~ 75 (104)
T d1g83a2 71 GYYIT 75 (104)
T ss_dssp CEEET
T ss_pred CEEec
Confidence 56654
|
| >d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 10, GRB10 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.02 E-value=0.0014 Score=46.62 Aligned_cols=55 Identities=15% Similarity=0.180 Sum_probs=38.4
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcC--CCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGE--GTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~ 84 (306)
+||.+.+. -..+.......|. |+|+++.|.+ .+|.|.+|+... ..+.|+.|....
T Consensus 6 ~Wyhg~is---------R~~Ae~lL~~~g~~dG~FLVR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~ 62 (105)
T d1nrva_ 6 HWFHGRIS---------REESHRIIKQQGLVDGLFLLRDSQS---NPKAFVLTLCHH---------QKIKNFQILPCE 62 (105)
T ss_dssp TTBCTTCC---------HHHHHHHHHHTTCCTTEEEEEECSS---CTTCEEEEEEET---------TEEEEEEEEEC-
T ss_pred cccCCCCC---------HHHHHHHHhhcCCCCceEEEEeCCC---CCCCEEEEEEEC---------CceeEEEEEEec
Confidence 67777664 4455566665554 9999998765 668899999852 256888887654
|
| >d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: p56-lck tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.87 E-value=0.0012 Score=47.04 Aligned_cols=66 Identities=17% Similarity=0.215 Sum_probs=43.4
Q ss_pred CCccccccCccCCCCCccccchHHHHHh--cCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKL--GEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||.+.+. -.-+.....+. -.|+|+++.|.+ ..|.+++|+.......+ ..+.|+.+.... +
T Consensus 5 pWy~g~is---------R~eAe~~L~~~~~~~GtFLVR~S~~---~~g~~~lsv~~~~~~~~----~~v~h~~i~~~~~~ 68 (105)
T d1lkka_ 5 PWFFKNLS---------RKDAERQLLAPGNTHGSFLIRESES---TAGSFSLSVRDFDQNQG----EVVKHYKIRNLDNG 68 (105)
T ss_dssp TTBCTTCC---------HHHHHHHHTSTTCCTTCEEEEECSS---STTCEEEEEEEEETTTE----EEEEEEEEEECTTS
T ss_pred CccCCCCC---------HHHHHHHHHhcCCCCCcEEEEccCC---CCCCEEEEEEEcccCCC----ccEEEEEEEEcCCC
Confidence 67877664 23333444333 359999998765 67899999986543322 357888887765 6
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 69 ~~~~~ 73 (105)
T d1lkka_ 69 GFYIS 73 (105)
T ss_dssp CEESS
T ss_pred CEEec
Confidence 67765
|
| >d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine-protein kinase zap-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.99 E-value=0.0027 Score=46.69 Aligned_cols=60 Identities=10% Similarity=0.112 Sum_probs=41.7
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcC--CCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGE--GTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -.-+....++.|. |+|+++.|+ ..|.|.+|+... ..+.|+.|...+ +
T Consensus 30 pWyhg~is---------R~eAe~lL~~~~~~dGtFLVR~S~----~~g~yvLSv~~~---------~~v~H~~I~~~~~g 87 (124)
T d2oq1a2 30 PWYHSSLT---------REEAERKLYSGAQTDGKFLLRPRK----EQGTYALSLIYG---------KTVYHYLISQDKAG 87 (124)
T ss_dssp TTBCSSCC---------HHHHHHHHHSSCCCTTEEEEEECS----STTEEEEEEEET---------TEEEEEEEEECTTS
T ss_pred CCccCCCC---------HHHHHHHHhhcCCCCceEEeEecC----CCCCEEEEeecC---------CceEEEEEEECCCC
Confidence 68887774 3344455555454 999999884 358899999852 157899998766 5
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|++.
T Consensus 88 ~~~l~ 92 (124)
T d2oq1a2 88 KYCIP 92 (124)
T ss_dssp CEEST
T ss_pred CEEeC
Confidence 67764
|
| >d1opka2 d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Abl tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.90 E-value=0.0033 Score=44.32 Aligned_cols=61 Identities=15% Similarity=0.138 Sum_probs=42.3
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cce
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNY 87 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~ 87 (306)
+||++.+. -.-+....+....|+|+++.|.. ..|.|++|++... .+.|+.|.... +.|
T Consensus 6 ~Wy~g~is---------R~eAe~lL~~~~~G~FLVR~S~~---~~~~~~LSv~~~~---------~v~H~~I~~~~~g~~ 64 (101)
T d1opka2 6 SWYHGPVS---------RNAAEYLLSSGINGSFLVRESES---SPGQRSISLRYEG---------RVYHYRINTASDGKL 64 (101)
T ss_dssp TTEEEECC---------HHHHHHHGGGCCTTEEEEEECSS---STTCEEEEEEETT---------EEEEEECEECTTSCE
T ss_pred cccCCCCC---------HHHHHHHhcCCCCCeEEEEecCC---CCCCEEEEEEcCc---------ceEEEEeEECCCCCE
Confidence 68887774 22344455556689999997755 5688999998522 56899998776 455
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
.+.
T Consensus 65 ~~~ 67 (101)
T d1opka2 65 YVS 67 (101)
T ss_dssp ESS
T ss_pred EeC
Confidence 543
|
| >d2fcia1 d.93.1.1 (A:1-105) Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phospholipase C-gamma-1 species: Cow (Bos taurus) [TaxId: 9913]
Probab=92.83 E-value=0.01 Score=42.02 Aligned_cols=60 Identities=7% Similarity=0.081 Sum_probs=41.6
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
+||.+.+. -.-+.......+ .|+|+++.|+ ..|.|++|+.... .+.|+.|......|
T Consensus 10 ~Wy~g~i~---------R~eAe~lL~~~~~~G~FLVR~S~----~~~~yvLSv~~~~---------~v~H~~I~~~~~~~ 67 (105)
T d2fcia1 10 EWYHASLT---------RAQAEHMLMRVPRDGAFLVRKRN----EPNSYAISFRAEG---------KIKHCRVQQEGQTV 67 (105)
T ss_dssp CCCCSSSC---------SHHHHHHHHHSSSSCCEEEEECS----STTCEEEEEEETT---------EECCCEEBCCSSCE
T ss_pred CCccCCCC---------HHHHHHHHHhCCCCCeEEEEecC----CCCCEEEEEEecc---------ccEEEEEEecCCeE
Confidence 68888775 344555666666 5999999874 3578999998521 46899987655555
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
.+.
T Consensus 68 ~~~ 70 (105)
T d2fcia1 68 MLG 70 (105)
T ss_dssp ECS
T ss_pred ecC
Confidence 543
|
| >d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hemopoetic cell kinase Hck species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.22 E-value=0.0039 Score=44.04 Aligned_cols=73 Identities=26% Similarity=0.295 Sum_probs=43.6
Q ss_pred CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-CceeEeeeeeeec--CCcccc-ccCchHHHHH
Q 021897 38 EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HNYSVSVGQSVFR--PGKVTH-ALNDDALAQA 113 (306)
Q Consensus 38 ~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~--~~~v~~-~~~~~~l~~~ 113 (306)
.|+|+++.|.+ ..|.|++|++......+ ..+.|+.+.... +.|++. +...|. +..|.+ ..+.++|...
T Consensus 24 ~G~FLVR~S~~---~~g~~~Lsv~~~~~~~~----~~v~H~~i~~~~~g~~~~~-~~~~F~sl~~LV~~y~~~~~gL~~~ 95 (103)
T d1qcfa2 24 LGSFMIRDSET---TKGSYSLSVRDYDPRQG----DTVKHYKIRTLDNGGFYIS-PRSTFSTLQELVDHYKKGNDGLCQK 95 (103)
T ss_dssp TTCEEEEECSS---STTSEEEEEEEEETTTE----EEEEEEEEEECTTSCEESS-SSSCBSSHHHHHHHHTSSCTTSSSC
T ss_pred CCcEEEEccCC---CCCCeEEEEEecCCCcC----ceEEEEEEEEcCCCceeec-CCcccCCHHHHHHHHhhCCCCCCcc
Confidence 59999998875 67899999985432222 367899988776 666654 222332 333433 3344444444
Q ss_pred HhcCC
Q 021897 114 LMDHR 118 (306)
Q Consensus 114 l~~~~ 118 (306)
|..||
T Consensus 96 L~~PC 100 (103)
T d1qcfa2 96 LSVPC 100 (103)
T ss_dssp CCSBC
T ss_pred CCccC
Confidence 44444
|
| >d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Itk/tsk protein tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=91.75 E-value=0.0079 Score=42.80 Aligned_cols=60 Identities=22% Similarity=0.249 Sum_probs=38.9
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcC-CCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGE-GTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~ 84 (306)
.||.+.+. -.-+.......|. |+|++++|+ ..|.|++|++.......+ ..++|+.|....
T Consensus 7 ~Wy~g~is---------R~eAe~lL~~~~~~G~FLVR~S~----~~g~y~LSv~~~~~~~~~---~~i~h~~I~~~~ 67 (108)
T d1luia_ 7 EWYNKSIS---------RDKAEKLLLDTGKEGAFMVRDSR----TPGTYTVSVFTKAIISEN---PCIKHYHIKETN 67 (108)
T ss_dssp TTBCTTCC---------HHHHHHHHHHHCCTTEEEEEECC----TTTCEEEEEECSCCTTTC---SCEEEEECEECC
T ss_pred CCcCCCCC---------HHHHHHHHHhcCCCCeEEEEecC----CCCCEEEEEEecCCcccC---CceeEEEEEEec
Confidence 57776664 2334455544444 999999874 357899999865543332 367888887654
|
| >d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.35 E-value=0.0047 Score=44.44 Aligned_cols=55 Identities=18% Similarity=0.192 Sum_probs=39.4
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR 84 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~ 84 (306)
+||++.+. -.-+.......| .|+|+++.|.+ .+|.|++|+.... .+.|+.|...+
T Consensus 11 ~Wy~g~is---------R~~Ae~lL~~~g~~dG~FLvR~S~~---~~g~y~LSv~~~~---------~v~H~~I~~~~ 67 (113)
T d2qmsa1 11 LWFHGRIS---------REESQRLIGQQGLVDGLFLVRESQR---NPQGFVLSLCHLQ---------KVKHYLILPSE 67 (113)
T ss_dssp TTEEEEBC---------HHHHHHHHHHTTCCTTEEEEEECSS---CTTCEEEEEEETT---------EEEEEEEEEEE
T ss_pred CccCCCCC---------HHHHHHHHhccCCCCccEEEEeccC---CCCCEEEEEEeCC---------eEEEEEEEEeC
Confidence 78888775 344556665555 49999998875 6688999998532 57888887644
|
| >d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.06 E-value=0.057 Score=38.12 Aligned_cols=61 Identities=16% Similarity=0.204 Sum_probs=44.2
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
.||++.+. -.-+.......+ .|+|+++.|.+ ..|.|++|++.. ..+.|+.|....+.|
T Consensus 4 ~Wy~g~is---------R~~Ae~lL~~~~~~G~FLvR~S~~---~~g~y~LSv~~~---------~~v~H~~I~~~~~~~ 62 (109)
T d2shpa2 4 RWFHPNIT---------GVEAENLLLTRGVDGSFLARPSKS---NPGDLTLSVRRN---------GAVTHIKIQNTGDYY 62 (109)
T ss_dssp TTBCSSCC---------HHHHHHHHHHHCCTTEEEEEECSS---STTCEEEEEEET---------TEEEEEEEECSSSCE
T ss_pred ccccCCCC---------HHHHHHHHhhCCCCCeEEEEecCC---CCCCEEEEEEeC---------CcEEEEEEEEcCCeE
Confidence 57776664 334455666666 59999998864 568899999842 257899998877888
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
++.
T Consensus 63 ~~~ 65 (109)
T d2shpa2 63 DLY 65 (109)
T ss_dssp EET
T ss_pred EEc
Confidence 875
|
| >d1d4ta_ d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: The Xlp protein Sap species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.96 E-value=0.059 Score=37.51 Aligned_cols=60 Identities=15% Similarity=0.201 Sum_probs=42.7
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-Cc
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-HN 86 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~~ 86 (306)
+||++.+. -.-+....++.| .|+|+++.|.+ ..|.+++|+.... .+.|+.|.... +.
T Consensus 5 pwyhG~is---------R~eAe~lL~~~~~~G~FLVR~S~~---~~g~~~Lsv~~~~---------~v~H~~I~~~~~~~ 63 (104)
T d1d4ta_ 5 AVYHGKIS---------RETGEKLLLATGLDGSYLLRDSES---VPGVYCLCVLYHG---------YIYTYRVSQTETGS 63 (104)
T ss_dssp TTBCCSCC---------HHHHHHHHHHHCCTTEEEEEECSS---STTCEEEEEEETT---------EEEEEEEEECTTSC
T ss_pred CccccCCC---------HHHHHHHHhhCCCCCeEEEEecCC---CCCCEEEEEecCC---------CceEEEEEEcCCCc
Confidence 78888775 445556666666 59999998765 5689999998532 56899988766 44
Q ss_pred eeE
Q 021897 87 YSV 89 (306)
Q Consensus 87 ~~i 89 (306)
|.+
T Consensus 64 ~~~ 66 (104)
T d1d4ta_ 64 WSA 66 (104)
T ss_dssp EEE
T ss_pred EEE
Confidence 443
|
| >d1mila_ d.93.1.1 (A:) Shc adaptor protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Shc adaptor protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.57 E-value=0.04 Score=38.67 Aligned_cols=64 Identities=17% Similarity=0.151 Sum_probs=41.8
Q ss_pred ccccC-CCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccc
Q 021897 4 KMVEG-PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKP 82 (306)
Q Consensus 4 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~ 82 (306)
+=+++ +||++.+.- .-+....++ .|+|+++.|++ ..|.|++|++... .+.|+.|..
T Consensus 2 ~~l~~~pWyhG~i~R---------~~Ae~lL~~--~G~FLVR~S~~---~~g~~vLSv~~~~---------~v~H~~I~~ 58 (104)
T d1mila_ 2 SQLRGEPWFHGKLSR---------REAEALLQL--NGDFLVRESTT---TPGQYVLTGLQSG---------QPKHLLLVD 58 (104)
T ss_dssp CSTTTCTTBCSSCCH---------HHHHTTCCS--TTEEEEEECCS---SCSSEEEEEEETT---------EEEEEEEBC
T ss_pred cccccCCCcCCCCCH---------HHHHHHHhc--CCcEEEEecCC---CCCCEEEEEEEcc---------ccceEEEEe
Confidence 33444 899888753 112222222 59999998764 6789999998532 568999877
Q ss_pred cCCceeEe
Q 021897 83 VRHNYSVS 90 (306)
Q Consensus 83 ~~~~~~i~ 90 (306)
..+.|.+.
T Consensus 59 ~~~~~~~~ 66 (104)
T d1mila_ 59 PEGVVRTK 66 (104)
T ss_dssp TTSSEECS
T ss_pred CCCEEEeC
Confidence 66666643
|
| >d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Syk tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.13 E-value=0.015 Score=42.47 Aligned_cols=60 Identities=15% Similarity=0.159 Sum_probs=39.3
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc--CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-C
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG--EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR-H 85 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~-~ 85 (306)
+||++.+. -.-+.......| .|+|+++.|+ ..|+|++|++... .+.|+.|.... +
T Consensus 30 pWyhg~is---------R~~Ae~lL~~~g~~~G~FLVR~S~----~~~~yvLSv~~~~---------~v~H~~I~~~~~g 87 (125)
T d1a81a2 30 PWFHGKIS---------REESEQIVLIGSKTNGKFLIRARD----NNGSYALCLLHEG---------KVLHYRIDKDKTG 87 (125)
T ss_dssp TTEEEECC---------HHHHHHHHHSSCCCTTCEEEEECS----SSSCEEEEEEETT---------EEEEEEEEECTTS
T ss_pred CccCCCCC---------HHHHHHHHHhcCCCCceEEEEecC----CCCCEEEEeeccc---------cceeEeeeEcCCC
Confidence 58887774 223334443334 5999999764 3578999998522 46899998765 4
Q ss_pred ceeEe
Q 021897 86 NYSVS 90 (306)
Q Consensus 86 ~~~i~ 90 (306)
.|.+.
T Consensus 88 ~~~~~ 92 (125)
T d1a81a2 88 KLSIP 92 (125)
T ss_dssp CEECT
T ss_pred cEecc
Confidence 56654
|
| >d2c9wa2 d.93.1.1 (A:32-134) Suppressor of cytokine signaling 2, SOCS-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 2, SOCS-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.78 E-value=0.081 Score=36.78 Aligned_cols=62 Identities=15% Similarity=0.108 Sum_probs=44.0
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||.+.+. -+-+....+..+.|+|+++.|.+ ..|.+++|++... .+.|+.|....+.|
T Consensus 15 ~~Wy~g~i~---------R~~Ae~~L~~~~~GtFLVR~S~~---~~~~~~LSv~~~~---------~v~H~~I~~~~~~~ 73 (103)
T d2c9wa2 15 TGWYWGSMT---------VNEAKEKLKEAPEGTFLIRDSSH---SDYLLTISVKTSA---------GPTNLRIEYQDGKF 73 (103)
T ss_dssp TSCBCTTCC---------HHHHHHHHTTSCTTCEEEEECCS---TTCSEEEEEEETT---------EEEEEEEEEETTEE
T ss_pred CCCcCCCCC---------HHHHHHHhcCCCCCceEEeccCC---CCCCEEEEEEECC---------EEEEEEEEEcCCeE
Confidence 478876664 33455566666789999998864 6788999998532 46788887766777
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
.+.
T Consensus 74 ~~~ 76 (103)
T d2c9wa2 74 RLD 76 (103)
T ss_dssp EEC
T ss_pred eeC
Confidence 654
|
| >d2cs0a1 d.93.1.1 (A:8-113) Hematopoietic SH2 domain containing protein HSH2D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Hematopoietic SH2 domain containing protein HSH2D species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.06 E-value=0.11 Score=36.39 Aligned_cols=66 Identities=15% Similarity=0.167 Sum_probs=43.9
Q ss_pred cccccC---CCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCC
Q 021897 3 GKMVEG---PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPG 79 (306)
Q Consensus 3 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~ 79 (306)
|||+.+ +||.+.+. -.-+....+....|+|+++.|.+ .. .|+++++... .+.|+.
T Consensus 1 ~~~~~~~~~pWy~g~is---------R~eAe~lL~~~~~G~FLvR~S~~---~~-~y~Lsv~~~~---------~~~h~~ 58 (106)
T d2cs0a1 1 GQLAQDGVPEWFHGAIS---------REDAENLLESQPLGSFLIRVSHS---HV-GYTLSYKAQS---------SCCHFM 58 (106)
T ss_dssp SCCCSSSCCSSBCSSCC---------HHHHHHHHHTSCTTCEEEEECSS---SS-SEEEEECCSS---------SCEEEE
T ss_pred CCccCCCCCCCccCCCC---------HHHHHHHHcCCCCCcEEEEecCC---CC-CEEEEEEecC---------CceeEE
Confidence 677776 68887774 33345566655589999998753 22 3999998532 357888
Q ss_pred ccccC-CceeEe
Q 021897 80 LKPVR-HNYSVS 90 (306)
Q Consensus 80 ~~~~~-~~~~i~ 90 (306)
|.... +.|.+.
T Consensus 59 I~~~~~g~~~~~ 70 (106)
T d2cs0a1 59 VKLLDDGTFMIP 70 (106)
T ss_dssp EEECTTSCEECT
T ss_pred EEEcCCCCEEEe
Confidence 87766 445543
|
| >d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Ews/fli1 activated transcript 2, Eat2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=87.19 E-value=0.13 Score=35.65 Aligned_cols=63 Identities=16% Similarity=0.235 Sum_probs=40.6
Q ss_pred cCCCccccccCccCCCCCccccchHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccC-
Q 021897 7 EGPKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVR- 84 (306)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~- 84 (306)
+=+||++.+. -.-+.......+ .|+|+++.|.+ ..|.|++|++... .+.|+.|....
T Consensus 2 d~PWy~g~is---------R~~AE~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~~---------~v~H~~I~~~~~ 60 (103)
T d1i3za_ 2 DLPYYHGCLT---------KRECEALLLKGGVDGNFLIRDSES---VPGALCLCVSFKK---------LVYSYRIFREKH 60 (103)
T ss_dssp CCTTEESSCC---------HHHHHHHHHTTCSTTEEEEEECSS---STTCEEEEEECSS---------SEEEEEEEECTT
T ss_pred CCCcccCCCC---------HHHHHHHHHhCCCCCeEEEEecCC---CCCCEEEEEEeCC---------eEEEEEeEEcCC
Confidence 3467776664 223334443333 49999998765 5689999999422 56899887555
Q ss_pred CceeEe
Q 021897 85 HNYSVS 90 (306)
Q Consensus 85 ~~~~i~ 90 (306)
+.|.+.
T Consensus 61 g~~~~~ 66 (103)
T d1i3za_ 61 GYYRIE 66 (103)
T ss_dssp SCEEEC
T ss_pred CcEEEe
Confidence 566654
|
| >d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Growth factor receptor-bound protein 2 (GRB2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.06 E-value=0.16 Score=34.85 Aligned_cols=60 Identities=22% Similarity=0.183 Sum_probs=40.3
Q ss_pred CCccccccCccCCCCCccccchHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCc-
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHN- 86 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~- 86 (306)
|||.+.+. -.-+....++.+ .|+|+++.|.+ .+|.|++|++... .+.|+.|.....+
T Consensus 4 pWy~g~is---------R~~Ae~lL~~~~~~G~FLvR~S~~---~~g~~~LSv~~~~---------~v~H~~I~~~~~g~ 62 (96)
T d1jyra_ 4 AWFFGKIP---------RAKAEEMLSKQRHDGAFLIRESES---APGDFSLSVKFGN---------DVQHFKVLRDGAGK 62 (96)
T ss_dssp TTBCCSCC---------HHHHHHHHHTCCSTTBEEEEECSS---STTCEEEEEEETT---------EEEEEECEECTTSC
T ss_pred CccCCCCC---------HHHHHHHHhhCCCCCeEEEEecCC---CCCCEEEEEEeCC---------ceEEEEEEECCCCe
Confidence 67776664 333444554433 59999998864 5688999999522 5689999877644
Q ss_pred eeE
Q 021897 87 YSV 89 (306)
Q Consensus 87 ~~i 89 (306)
|.+
T Consensus 63 ~~~ 65 (96)
T d1jyra_ 63 YFL 65 (96)
T ss_dssp EES
T ss_pred EEe
Confidence 443
|
| >d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: GRB2-related adaptor protein 2 (MONA, GRID) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=86.23 E-value=0.18 Score=34.53 Aligned_cols=59 Identities=14% Similarity=0.040 Sum_probs=41.1
Q ss_pred CCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCcee
Q 021897 9 PKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNYS 88 (306)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~~ 88 (306)
+||.+.+. -.-+....+....|+|+++.|.+ .+|.|++|++... .+.|+.|.....+++
T Consensus 7 ~Wy~g~is---------R~~Ae~lL~~~~~G~FLVR~S~~---~~g~~~LSv~~~~---------~v~H~~I~~~~~g~~ 65 (97)
T d1r1qa_ 7 EWFHEGLS---------RHQAENLLMGKDIGFFIIRASQS---SPGDFSISVRHED---------DVQHFKVMRDTKGNY 65 (97)
T ss_dssp TTBCTTCC---------HHHHHHHHHTSCTTCEEEEECSS---STTCEEEEEECSS---------SEEEEECEECTTCCE
T ss_pred CccCCCCC---------HHHHHHHHhcCCCCCEEEeecCC---CCCCEEEEEEecC---------CeEEEEEEEcCCCeE
Confidence 57776664 33445556556689999998754 6689999998422 468999988774443
|
| >d2izva2 d.93.1.1 (A:274-385) Suppressor of cytokine signaling 4, SOCS-4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Suppressor of cytokine signaling 4, SOCS-4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.44 E-value=0.11 Score=36.76 Aligned_cols=62 Identities=24% Similarity=0.254 Sum_probs=43.2
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||.+.+. -.-+....+....|+|++++|.+ ..|.+++|++... .+.|+.|...++.|
T Consensus 11 ~~Wy~g~is---------R~~Ae~lL~~~~~GtFLVR~S~~---~~~~~~LSv~~~~---------~v~H~~I~~~~~~~ 69 (112)
T d2izva2 11 NPCYWGVMD---------KYAAEALLEGKPEGTFLLRDSAQ---EDYLFSVSFRRYS---------RSLHARIEQWNHNF 69 (112)
T ss_dssp CTTEEEECC---------HHHHHHHHTTCCTTEEEEEECSS---TTCSEEEEEEETT---------EEEEEECEEETTEE
T ss_pred CCCcCCCCC---------HHHHHHHHccCCCCcEEEeecCC---CCCCeEEEEEecC---------CceEEEEEEeCCeE
Confidence 367776664 22344455444579999998765 5688999998522 56899998877888
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
++.
T Consensus 70 ~l~ 72 (112)
T d2izva2 70 SFD 72 (112)
T ss_dssp ESC
T ss_pred EEe
Confidence 765
|
| >d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Adaptor protein Aps species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=83.92 E-value=0.27 Score=32.72 Aligned_cols=63 Identities=16% Similarity=0.125 Sum_probs=39.7
Q ss_pred cccCCCccccccCccCCCCCccccchHHHHHhc---CCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCcc
Q 021897 5 MVEGPKFTGLIGGNNNNDNNYYDFTQGFYQKLG---EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLK 81 (306)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~ 81 (306)
|-+=+||++.+. -.-+....+..| +|+|+++.|.+ ..|.|++|++... .+.|+.|.
T Consensus 2 l~~~pWyhg~is---------R~~Ae~lL~~~~~~~dG~FLvR~S~~---~~g~~~Lsv~~~~---------~v~h~~I~ 60 (86)
T d1rpya_ 2 LSDYPWFHGTLS---------RVKAAQLVLAGGPRSHGLFVIRQSET---RPGECVLTFNFQG---------KAKHLRLS 60 (86)
T ss_dssp GGGSTTBCTTCC---------HHHHHHHHHTTGGGGTTCEEEEECSS---STTCEEEEEEETT---------EEEEEEC-
T ss_pred CccCcccCCCCC---------HHHHHHHHHhCCCCCCceEEEEecCC---CCCcEEEEEEECC---------ceEEEEEE
Confidence 334578887774 334445555434 59999998764 6788999999522 57899887
Q ss_pred ccCCcee
Q 021897 82 PVRHNYS 88 (306)
Q Consensus 82 ~~~~~~~ 88 (306)
....+++
T Consensus 61 ~~~~~~~ 67 (86)
T d1rpya_ 61 LNGHGQC 67 (86)
T ss_dssp ---CCCH
T ss_pred EcCCceE
Confidence 7665544
|
| >d1fu6a_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Phosphatidylinositol 3-kinase, p85-alpha subunit species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=81.76 E-value=0.26 Score=34.51 Aligned_cols=63 Identities=13% Similarity=0.117 Sum_probs=42.2
Q ss_pred CCCccccccCccCCCCCccccchHHHHHhcCCCCCCcccccccCCCCcEEEEEeeCCCCCCCCcccccccCCccccCCce
Q 021897 8 GPKFTGLIGGNNNNDNNYYDFTQGFYQKLGEGTNMSIDSLQTSNAGGSVSMSVDNSSVGSNDSLTHILSHPGLKPVRHNY 87 (306)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~~~~~~~~~~~~~~~~~~~ 87 (306)
-+||++.+. -.-+....+..+.|+|+++.|++ ..++.+++++.... .+.|+.|...++.|
T Consensus 11 ~~WyhG~is---------R~eAe~lL~~~~~G~FLVR~S~~--~~~~~~~ls~~~~~---------~~~H~~I~~~~~~~ 70 (111)
T d1fu6a_ 11 AEWYWGDIS---------REEVNEKLRDTADGTFLVRDAST--KMHGDYTLTLRKGG---------NNKSIKIFHRDGKY 70 (111)
T ss_dssp CSSCCSSCC---------SHHHHHHSSSCSSCCCCCBSSCC--SSSCCSBCEEEETT---------EEEECCCCCTTTCC
T ss_pred CcCCCCCCC---------HHHHHHHhCcCCCCEEEEEeccC--CCCccEEEEEecCC---------ceEEEEEEEcCCeE
Confidence 377777664 22334444445689999998764 24577888887432 56899998777777
Q ss_pred eEe
Q 021897 88 SVS 90 (306)
Q Consensus 88 ~i~ 90 (306)
++.
T Consensus 71 ~~~ 73 (111)
T d1fu6a_ 71 GFS 73 (111)
T ss_dssp CTT
T ss_pred EEC
Confidence 764
|
| >d2shpa3 d.93.1.1 (A:111-218) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: SH2-like superfamily: SH2 domain family: SH2 domain domain: Tyrosine phoshatase shp-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.87 E-value=0.29 Score=33.92 Aligned_cols=59 Identities=15% Similarity=0.219 Sum_probs=35.1
Q ss_pred chHHHHHhc-CCCCCCcccccccCCCCcEEEEEeeCCCCCCC-CcccccccCCccccCCceeEe
Q 021897 29 TQGFYQKLG-EGTNMSIDSLQTSNAGGSVSMSVDNSSVGSND-SLTHILSHPGLKPVRHNYSVS 90 (306)
Q Consensus 29 ~~~~~~~~~-~g~~~~~~s~~~s~~~g~~s~s~~~~s~~s~~-~~~~~~~~~~~~~~~~~~~i~ 90 (306)
+....+..+ .|+|+++.|++ .+|.|++|+......... .....+.|+.+....+.|++.
T Consensus 12 Ae~lL~~~~~~G~FLVR~S~~---~~g~~~LSv~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 72 (108)
T d2shpa3 12 AEKLLTEKGKHGSFLVRESQS---HPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVG 72 (108)
T ss_dssp HHHHHHHTCCTTEEEEEECSS---STTCEEEEEEECC-----CCCCCEEEEEEEEEETTEEESS
T ss_pred HHHHHhhcCCCCeEEEEecCC---CCCCeEEEEEecCccccccccccceeeEEEEeCCCceEeC
Confidence 344554444 49999998864 678999999865433211 111235677776666666654
|